%PDF-1.4 %忏嫌 843 0 obj <> endobj xref 843 627 0000000016 00000 n 0000014963 00000 n 0000015137 00000 n 0000015163 00000 n 0000015234 00000 n 0000015269 00000 n 0000015640 00000 n 0000015823 00000 n 0000016006 00000 n 0000016188 00000 n 0000016371 00000 n 0000016530 00000 n 0000016670 00000 n 0000016884 00000 n 0000017024 00000 n 0000017179 00000 n 0000017336 00000 n 0000017492 00000 n 0000017670 00000 n 0000017845 00000 n 0000018001 00000 n 0000018162 00000 n 0000018242 00000 n 0000018323 00000 n 0000018403 00000 n 0000018482 00000 n 0000018561 00000 n 0000018639 00000 n 0000018718 00000 n 0000018796 00000 n 0000018875 00000 n 0000018953 00000 n 0000019032 00000 n 0000019110 00000 n 0000019188 00000 n 0000019265 00000 n 0000019344 00000 n 0000019423 00000 n 0000019503 00000 n 0000019583 00000 n 0000019663 00000 n 0000019743 00000 n 0000019823 00000 n 0000019902 00000 n 0000019981 00000 n 0000020058 00000 n 0000020137 00000 n 0000020216 00000 n 0000020295 00000 n 0000020374 00000 n 0000020452 00000 n 0000020529 00000 n 0000020609 00000 n 0000020689 00000 n 0000020769 00000 n 0000020849 00000 n 0000020928 00000 n 0000021006 00000 n 0000021086 00000 n 0000021166 00000 n 0000021246 00000 n 0000021326 00000 n 0000021405 00000 n 0000021483 00000 n 0000021563 00000 n 0000021643 00000 n 0000021723 00000 n 0000021803 00000 n 0000021882 00000 n 0000021960 00000 n 0000022040 00000 n 0000022120 00000 n 0000022200 00000 n 0000022280 00000 n 0000022359 00000 n 0000022437 00000 n 0000022515 00000 n 0000022593 00000 n 0000022673 00000 n 0000022752 00000 n 0000022831 00000 n 0000022911 00000 n 0000022991 00000 n 0000023071 00000 n 0000023151 00000 n 0000023231 00000 n 0000023310 00000 n 0000023388 00000 n 0000023468 00000 n 0000023548 00000 n 0000023628 00000 n 0000023708 00000 n 0000023788 00000 n 0000023867 00000 n 0000023945 00000 n 0000024025 00000 n 0000024105 00000 n 0000024185 00000 n 0000024265 00000 n 0000024345 00000 n 0000024424 00000 n 0000024502 00000 n 0000024582 00000 n 0000024662 00000 n 0000024742 00000 n 0000024822 00000 n 0000024902 00000 n 0000024981 00000 n 0000025059 00000 n 0000025139 00000 n 0000025219 00000 n 0000025299 00000 n 0000025379 00000 n 0000025459 00000 n 0000025538 00000 n 0000025616 00000 n 0000025696 00000 n 0000025776 00000 n 0000025856 00000 n 0000025936 00000 n 0000026016 00000 n 0000026095 00000 n 0000026173 00000 n 0000026253 00000 n 0000026333 00000 n 0000026413 00000 n 0000026493 00000 n 0000026573 00000 n 0000026652 00000 n 0000026730 00000 n 0000026810 00000 n 0000026890 00000 n 0000026970 00000 n 0000027050 00000 n 0000027130 00000 n 0000027209 00000 n 0000027287 00000 n 0000027367 00000 n 0000027447 00000 n 0000027527 00000 n 0000027607 00000 n 0000027687 00000 n 0000027766 00000 n 0000027844 00000 n 0000027923 00000 n 0000028002 00000 n 0000028081 00000 n 0000028161 00000 n 0000028239 00000 n 0000028318 00000 n 0000028398 00000 n 0000028478 00000 n 0000028558 00000 n 0000028637 00000 n 0000028717 00000 n 0000028797 00000 n 0000028877 00000 n 0000028957 00000 n 0000029039 00000 n 0000029122 00000 n 0000029205 00000 n 0000029287 00000 n 0000029370 00000 n 0000029453 00000 n 0000029536 00000 n 0000029618 00000 n 0000029701 00000 n 0000029784 00000 n 0000029867 00000 n 0000029949 00000 n 0000030031 00000 n 0000030113 00000 n 0000030195 00000 n 0000030277 00000 n 0000030360 00000 n 0000030441 00000 n 0000030523 00000 n 0000030604 00000 n 0000030687 00000 n 0000030769 00000 n 0000030852 00000 n 0000030935 00000 n 0000031018 00000 n 0000031101 00000 n 0000031184 00000 n 0000031267 00000 n 0000031350 00000 n 0000031433 00000 n 0000031516 00000 n 0000031599 00000 n 0000031682 00000 n 0000031765 00000 n 0000031848 00000 n 0000031931 00000 n 0000032014 00000 n 0000032097 00000 n 0000032180 00000 n 0000032263 00000 n 0000032346 00000 n 0000032429 00000 n 0000032512 00000 n 0000032595 00000 n 0000032678 00000 n 0000032761 00000 n 0000032844 00000 n 0000032927 00000 n 0000033010 00000 n 0000033093 00000 n 0000033176 00000 n 0000033259 00000 n 0000033342 00000 n 0000033425 00000 n 0000033508 00000 n 0000033591 00000 n 0000033674 00000 n 0000033757 00000 n 0000033840 00000 n 0000033923 00000 n 0000034006 00000 n 0000034089 00000 n 0000034172 00000 n 0000034255 00000 n 0000034338 00000 n 0000034421 00000 n 0000034504 00000 n 0000034587 00000 n 0000034670 00000 n 0000034753 00000 n 0000034836 00000 n 0000034919 00000 n 0000035002 00000 n 0000035085 00000 n 0000035168 00000 n 0000035251 00000 n 0000035334 00000 n 0000035417 00000 n 0000035500 00000 n 0000035583 00000 n 0000035665 00000 n 0000035747 00000 n 0000035828 00000 n 0000035910 00000 n 0000035990 00000 n 0000036072 00000 n 0000036154 00000 n 0000036236 00000 n 0000036318 00000 n 0000036400 00000 n 0000036482 00000 n 0000036564 00000 n 0000036646 00000 n 0000036726 00000 n 0000036809 00000 n 0000036892 00000 n 0000036975 00000 n 0000037058 00000 n 0000037141 00000 n 0000037224 00000 n 0000037307 00000 n 0000037390 00000 n 0000037471 00000 n 0000037554 00000 n 0000037637 00000 n 0000037720 00000 n 0000037803 00000 n 0000037886 00000 n 0000037969 00000 n 0000038052 00000 n 0000038135 00000 n 0000038216 00000 n 0000038299 00000 n 0000038382 00000 n 0000038465 00000 n 0000038548 00000 n 0000038631 00000 n 0000038714 00000 n 0000038797 00000 n 0000038880 00000 n 0000038961 00000 n 0000039044 00000 n 0000039127 00000 n 0000039210 00000 n 0000039293 00000 n 0000039376 00000 n 0000039459 00000 n 0000039542 00000 n 0000039625 00000 n 0000039706 00000 n 0000039789 00000 n 0000039872 00000 n 0000039955 00000 n 0000040038 00000 n 0000040121 00000 n 0000040204 00000 n 0000040287 00000 n 0000040370 00000 n 0000040451 00000 n 0000040534 00000 n 0000040617 00000 n 0000040700 00000 n 0000040783 00000 n 0000040866 00000 n 0000040949 00000 n 0000041032 00000 n 0000041115 00000 n 0000041196 00000 n 0000041279 00000 n 0000041362 00000 n 0000041445 00000 n 0000041528 00000 n 0000041611 00000 n 0000041694 00000 n 0000041777 00000 n 0000041860 00000 n 0000041941 00000 n 0000042024 00000 n 0000042107 00000 n 0000042190 00000 n 0000042273 00000 n 0000042356 00000 n 0000042439 00000 n 0000042522 00000 n 0000042605 00000 n 0000042686 00000 n 0000042769 00000 n 0000042852 00000 n 0000042935 00000 n 0000043018 00000 n 0000043101 00000 n 0000043184 00000 n 0000043267 00000 n 0000043350 00000 n 0000043431 00000 n 0000043514 00000 n 0000043597 00000 n 0000043680 00000 n 0000043763 00000 n 0000043846 00000 n 0000043929 00000 n 0000044012 00000 n 0000044095 00000 n 0000044176 00000 n 0000044259 00000 n 0000044342 00000 n 0000044425 00000 n 0000044508 00000 n 0000044591 00000 n 0000044674 00000 n 0000044757 00000 n 0000044840 00000 n 0000044921 00000 n 0000045004 00000 n 0000045087 00000 n 0000045170 00000 n 0000045253 00000 n 0000045336 00000 n 0000045419 00000 n 0000045502 00000 n 0000045585 00000 n 0000045666 00000 n 0000045749 00000 n 0000045832 00000 n 0000045915 00000 n 0000045998 00000 n 0000046081 00000 n 0000046164 00000 n 0000046247 00000 n 0000046330 00000 n 0000046411 00000 n 0000046494 00000 n 0000046577 00000 n 0000046660 00000 n 0000046743 00000 n 0000046826 00000 n 0000046909 00000 n 0000046992 00000 n 0000047075 00000 n 0000047156 00000 n 0000047239 00000 n 0000047322 00000 n 0000047405 00000 n 0000047488 00000 n 0000047571 00000 n 0000047654 00000 n 0000047737 00000 n 0000047820 00000 n 0000047901 00000 n 0000047982 00000 n 0000048063 00000 n 0000048144 00000 n 0000048226 00000 n 0000048308 00000 n 0000048390 00000 n 0000048472 00000 n 0000048554 00000 n 0000048636 00000 n 0000048718 00000 n 0000048800 00000 n 0000048881 00000 n 0000048963 00000 n 0000049045 00000 n 0000049127 00000 n 0000049209 00000 n 0000049291 00000 n 0000049373 00000 n 0000049455 00000 n 0000049537 00000 n 0000049618 00000 n 0000049700 00000 n 0000049782 00000 n 0000049864 00000 n 0000049946 00000 n 0000050028 00000 n 0000050110 00000 n 0000050192 00000 n 0000050274 00000 n 0000050355 00000 n 0000050437 00000 n 0000050519 00000 n 0000050601 00000 n 0000050683 00000 n 0000050765 00000 n 0000050847 00000 n 0000050929 00000 n 0000051011 00000 n 0000051092 00000 n 0000051174 00000 n 0000051256 00000 n 0000051338 00000 n 0000051420 00000 n 0000051502 00000 n 0000051584 00000 n 0000051666 00000 n 0000051748 00000 n 0000051829 00000 n 0000051911 00000 n 0000051993 00000 n 0000052075 00000 n 0000052157 00000 n 0000052239 00000 n 0000052321 00000 n 0000052403 00000 n 0000052485 00000 n 0000052566 00000 n 0000052648 00000 n 0000052730 00000 n 0000052812 00000 n 0000052894 00000 n 0000052976 00000 n 0000053058 00000 n 0000053140 00000 n 0000053222 00000 n 0000053303 00000 n 0000053384 00000 n 0000053465 00000 n 0000053546 00000 n 0000053626 00000 n 0000053707 00000 n 0000053789 00000 n 0000053871 00000 n 0000053953 00000 n 0000054035 00000 n 0000054117 00000 n 0000054198 00000 n 0000054280 00000 n 0000054362 00000 n 0000054444 00000 n 0000054526 00000 n 0000054608 00000 n 0000054689 00000 n 0000054770 00000 n 0000054851 00000 n 0000054932 00000 n 0000055013 00000 n 0000055095 00000 n 0000055175 00000 n 0000055255 00000 n 0000055337 00000 n 0000055419 00000 n 0000055501 00000 n 0000055583 00000 n 0000055665 00000 n 0000055746 00000 n 0000055828 00000 n 0000055910 00000 n 0000055992 00000 n 0000056074 00000 n 0000056156 00000 n 0000056237 00000 n 0000056319 00000 n 0000056401 00000 n 0000056483 00000 n 0000056565 00000 n 0000056647 00000 n 0000056728 00000 n 0000056810 00000 n 0000056892 00000 n 0000056974 00000 n 0000057056 00000 n 0000057138 00000 n 0000057219 00000 n 0000057301 00000 n 0000057383 00000 n 0000057465 00000 n 0000057547 00000 n 0000057629 00000 n 0000057710 00000 n 0000057792 00000 n 0000057874 00000 n 0000057956 00000 n 0000058038 00000 n 0000058120 00000 n 0000058201 00000 n 0000058283 00000 n 0000058365 00000 n 0000058447 00000 n 0000058529 00000 n 0000058611 00000 n 0000058692 00000 n 0000058774 00000 n 0000058856 00000 n 0000058938 00000 n 0000059020 00000 n 0000059102 00000 n 0000059183 00000 n 0000059265 00000 n 0000059347 00000 n 0000059429 00000 n 0000059511 00000 n 0000059593 00000 n 0000059674 00000 n 0000059756 00000 n 0000059838 00000 n 0000059920 00000 n 0000060002 00000 n 0000060084 00000 n 0000060165 00000 n 0000060247 00000 n 0000060329 00000 n 0000060411 00000 n 0000060493 00000 n 0000060575 00000 n 0000060656 00000 n 0000060736 00000 n 0000060816 00000 n 0000060898 00000 n 0000060979 00000 n 0000061060 00000 n 0000061141 00000 n 0000061222 00000 n 0000061302 00000 n 0000061382 00000 n 0000061464 00000 n 0000061791 00000 n 0000062348 00000 n 0000062541 00000 n 0000063104 00000 n 0000063279 00000 n 0000063317 00000 n 0000063752 00000 n 0000063855 00000 n 0000064271 00000 n 0000064484 00000 n 0000066462 00000 n 0000066889 00000 n 0000067056 00000 n 0000067398 00000 n 0000069290 00000 n 0000069615 00000 n 0000071207 00000 n 0000072863 00000 n 0000074412 00000 n 0000075900 00000 n 0000077279 00000 n 0000078570 00000 n 0000081241 00000 n 0000088586 00000 n 0000096852 00000 n 0000102801 00000 n 0000103078 00000 n 0000202648 00000 n 0000203002 00000 n 0000203197 00000 n 0000203482 00000 n 0000203541 00000 n 0000203798 00000 n 0000204000 00000 n 0000205300 00000 n 0000205518 00000 n 0000206006 00000 n 0000206131 00000 n 0000219927 00000 n 0000219967 00000 n 0000220442 00000 n 0000220575 00000 n 0000234815 00000 n 0000234855 00000 n 0000235330 00000 n 0000235463 00000 n 0000263631 00000 n 0000263671 00000 n 0000263773 00000 n 0000263832 00000 n 0000264140 00000 n 0000264243 00000 n 0000264366 00000 n 0000264517 00000 n 0000264674 00000 n 0000264805 00000 n 0000264934 00000 n 0000265063 00000 n 0000265284 00000 n 0000265429 00000 n 0000265732 00000 n 0000265923 00000 n 0000266100 00000 n 0000266275 00000 n 0000266484 00000 n 0000266613 00000 n 0000266762 00000 n 0000266953 00000 n 0000267148 00000 n 0000267305 00000 n 0000267482 00000 n 0000267685 00000 n 0000267828 00000 n 0000012836 00000 n trailer <<56EC4C73563EFA479E438A8963BD223B>]>> startxref 0 %%EOF 1469 0 obj<>stream x陟W{PSg?7L伻CBB p盌 ][﹤剣 !"FDDy uJH+幩0;"/1HP谣粈$蚂tG籦q莢龌睍e?;3~37棍7鐪唢滐滐&`瘙0X7皝7a鎌旙P琈箓o&X鳾鋷h!s廘╢獤&%淝ZXr黑!年TC'頂嚥i^d頒 畒濳騡w鑸;&N7jWp歪岢侘;]]韂.n岀椫氩c婦嶁あ毈 J 錙桧啍扚ヽΚ>艖SP-】8v!欈挗3Dt廅s∶嬂蠏Z 2間8鍭嘍荽[瀎沝岄og>粸V烑m藖h怇疪:涽c掺泲-轋Jc認 源(匥*<晋<桪?賕Q凓#q{隕AQdD ;4|稸锓c椂鰤Vd 撞M;僻>ㄓ|4 糨1噢哈瓶^除aGm%頰芟0扶q縉/尨艴粐Zo褜鸜刪曦斖 W鉵 流 &>竉;>介~掱y衹穾Эy蹺娵鱤瞮蹙ㄎ飵荊錙輀;5槨z鋡鸓滮T雭`裀S孊O㈥&NT狛>鮌櫲颺R勚鳛O阌拂Z鳛 絀雥軱顜=雍5汴祑礧周eu4{邫xR藖/6鯹|>寡U哳獗鼹l鹂6 鹲俨Z酨針.瀇fP^,5.艞奪パ臣 龆珏)?z{確綯^x緁撟U嗶U燥*=返yl+圙;s,x檰鶭I碋`箄豉 珙犟瑫 鬔猚Wu潉迺饏5硝碻E鏷F渳g祼o讬a坶 烽箣诠ry'貚襔懩?<b懰 脋.蚉嫫"ri4剩o箉"袙,愈Z躡v厡\Yc迆耖{&7抓.?9s+欟窄蔲k蛴镸r允袢穮_亡.M毯枲bMCO糿圲!臮炘莛s,J2翟-汯跞釐/qJ )姷撵 O5↙枊 緦揷:璼筤楉璬7奵 2QQ21.O帯aj衇,蔘W1Y,哕玠礷(D恒|"(珬2+挬 &+彅硔炓塑4R倈f 欆9\>6Q醏v&!)J烈I 裖矈?轝WpS'ㄔMW)!+尪*輾]沏浥b(柤 嶄/2>汊9撵"峩廳qZ|||x糚裸譒熗埱銐W U'% )/氌)^X9誰9i4庝蛶m`4m&饻嚱dNq桓煘癦1埦P昬 4艄攱1韸M&HX\€ _/a歅H (a;文璆L C ?涠宬啌帽*袀|亷# Y4#婽鄝#惻Ed!澅劳趯 `3.寵牤cY1Rp-w庼F0K;a Z哇碯c BX誠9 雭q怉 8釚%@. ,╝ @蘗嬼.-勤` 慵F#F柕蛬a62?╨>瓃編狴乱+鯚/潄oc Z尿%斀 嗥威0S鮻_V=韒@F?o_鸱'0陳2m!赮媋学 / *虆 贈5B!倮n<徎 ,z0_\'k@去U俅m 7筶dOz檚od畲辵1=+X'G9媾8嶕A3$瑖6 M@螀龑[HC屿珒%;寋r閈猯i3┟剛Y€佰霧 咛棓翗6玑,榢h$)婫p]工6S囐霉_齇杋睤7t隓tR嬃昀#酎€牓桧18G鑩;X┃7胡%滻 endstream endobj 844 0 obj<> endobj 845 0 obj[846 0 R] endobj 846 0 obj<>>> endobj 847 0 obj<> endobj 848 0 obj<> endobj 849 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 850 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 851 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 852 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 853 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 854 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 855 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 856 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 857 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 858 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 859 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 860 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 861 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 862 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 863 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 864 0 obj<> endobj 865 0 obj<> endobj 866 0 obj<> endobj 867 0 obj<> endobj 868 0 obj<> endobj 869 0 obj<> endobj 870 0 obj<> endobj 871 0 obj<> endobj 872 0 obj<> endobj 873 0 obj<> endobj 874 0 obj<> endobj 875 0 obj<> endobj 876 0 obj<> endobj 877 0 obj<> endobj 878 0 obj<> endobj 879 0 obj<> endobj 880 0 obj<> endobj 881 0 obj<> endobj 882 0 obj<> endobj 883 0 obj<> endobj 884 0 obj<> endobj 885 0 obj<> endobj 886 0 obj<> endobj 887 0 obj<> endobj 888 0 obj<> endobj 889 0 obj<> endobj 890 0 obj<> endobj 891 0 obj<> endobj 892 0 obj<> endobj 893 0 obj<> endobj 894 0 obj<> endobj 895 0 obj<> endobj 896 0 obj<> endobj 897 0 obj<> endobj 898 0 obj<> endobj 899 0 obj<> endobj 900 0 obj<> endobj 901 0 obj<> endobj 902 0 obj<> endobj 903 0 obj<> endobj 904 0 obj<> endobj 905 0 obj<> endobj 906 0 obj<> endobj 907 0 obj<> endobj 908 0 obj<> endobj 909 0 obj<> endobj 910 0 obj<> endobj 911 0 obj<> endobj 912 0 obj<> endobj 913 0 obj<> endobj 914 0 obj<> endobj 915 0 obj<> endobj 916 0 obj<> endobj 917 0 obj<> endobj 918 0 obj<> endobj 919 0 obj<> endobj 920 0 obj<> endobj 921 0 obj<> endobj 922 0 obj<> endobj 923 0 obj<> endobj 924 0 obj<> endobj 925 0 obj<> endobj 926 0 obj<> endobj 927 0 obj<> endobj 928 0 obj<> endobj 929 0 obj<> endobj 930 0 obj<> endobj 931 0 obj<> endobj 932 0 obj<> endobj 933 0 obj<> endobj 934 0 obj<> endobj 935 0 obj<> endobj 936 0 obj<> endobj 937 0 obj<> endobj 938 0 obj<> endobj 939 0 obj<> endobj 940 0 obj<> endobj 941 0 obj<> endobj 942 0 obj<> endobj 943 0 obj<> endobj 944 0 obj<> endobj 945 0 obj<> endobj 946 0 obj<> endobj 947 0 obj<> endobj 948 0 obj<> endobj 949 0 obj<> endobj 950 0 obj<> endobj 951 0 obj<> endobj 952 0 obj<> endobj 953 0 obj<> endobj 954 0 obj<> endobj 955 0 obj<> endobj 956 0 obj<> endobj 957 0 obj<> endobj 958 0 obj<> endobj 959 0 obj<> endobj 960 0 obj<> endobj 961 0 obj<> endobj 962 0 obj<> endobj 963 0 obj<> endobj 964 0 obj<> endobj 965 0 obj<> endobj 966 0 obj<> endobj 967 0 obj<> endobj 968 0 obj<> endobj 969 0 obj<> endobj 970 0 obj<> endobj 971 0 obj<> endobj 972 0 obj<> endobj 973 0 obj<> endobj 974 0 obj<> endobj 975 0 obj<> endobj 976 0 obj<> endobj 977 0 obj<> endobj 978 0 obj<> endobj 979 0 obj<> endobj 980 0 obj<> endobj 981 0 obj<> endobj 982 0 obj<> endobj 983 0 obj<> endobj 984 0 obj<> endobj 985 0 obj<> endobj 986 0 obj<> endobj 987 0 obj<> endobj 988 0 obj<> endobj 989 0 obj<> endobj 990 0 obj<> endobj 991 0 obj<> endobj 992 0 obj<> endobj 993 0 obj<> endobj 994 0 obj<> endobj 995 0 obj<> endobj 996 0 obj<> endobj 997 0 obj<> endobj 998 0 obj<> endobj 999 0 obj<> endobj 1000 0 obj<> endobj 1001 0 obj<> endobj 1002 0 obj<> endobj 1003 0 obj<> endobj 1004 0 obj<> endobj 1005 0 obj<> endobj 1006 0 obj<> endobj 1007 0 obj<> endobj 1008 0 obj<> endobj 1009 0 obj<> endobj 1010 0 obj<> endobj 1011 0 obj<> endobj 1012 0 obj<> endobj 1013 0 obj<> endobj 1014 0 obj<> endobj 1015 0 obj<> endobj 1016 0 obj<> endobj 1017 0 obj<> endobj 1018 0 obj<> endobj 1019 0 obj<> endobj 1020 0 obj<> endobj 1021 0 obj<> endobj 1022 0 obj<> endobj 1023 0 obj<> endobj 1024 0 obj<> endobj 1025 0 obj<> endobj 1026 0 obj<> endobj 1027 0 obj<> endobj 1028 0 obj<> endobj 1029 0 obj<> endobj 1030 0 obj<> endobj 1031 0 obj<> endobj 1032 0 obj<> endobj 1033 0 obj<> endobj 1034 0 obj<> endobj 1035 0 obj<> endobj 1036 0 obj<> endobj 1037 0 obj<> endobj 1038 0 obj<> endobj 1039 0 obj<> endobj 1040 0 obj<> endobj 1041 0 obj<> endobj 1042 0 obj<> endobj 1043 0 obj<> endobj 1044 0 obj<> endobj 1045 0 obj<> endobj 1046 0 obj<> endobj 1047 0 obj<> endobj 1048 0 obj<> endobj 1049 0 obj<> endobj 1050 0 obj<> endobj 1051 0 obj<> endobj 1052 0 obj<> endobj 1053 0 obj<> endobj 1054 0 obj<> endobj 1055 0 obj<> endobj 1056 0 obj<> endobj 1057 0 obj<> endobj 1058 0 obj<> endobj 1059 0 obj<> endobj 1060 0 obj<> endobj 1061 0 obj<> endobj 1062 0 obj<> endobj 1063 0 obj<> endobj 1064 0 obj<> endobj 1065 0 obj<> endobj 1066 0 obj<> endobj 1067 0 obj<> endobj 1068 0 obj<> endobj 1069 0 obj<> endobj 1070 0 obj<> endobj 1071 0 obj<> endobj 1072 0 obj<> endobj 1073 0 obj<> endobj 1074 0 obj<> endobj 1075 0 obj<> endobj 1076 0 obj<> endobj 1077 0 obj<> endobj 1078 0 obj<> endobj 1079 0 obj<> endobj 1080 0 obj<> endobj 1081 0 obj<> endobj 1082 0 obj<> endobj 1083 0 obj<> endobj 1084 0 obj<> endobj 1085 0 obj<> endobj 1086 0 obj<> endobj 1087 0 obj<> endobj 1088 0 obj<> endobj 1089 0 obj<> endobj 1090 0 obj<> endobj 1091 0 obj<> endobj 1092 0 obj<> endobj 1093 0 obj<> endobj 1094 0 obj<> endobj 1095 0 obj<> endobj 1096 0 obj<> endobj 1097 0 obj<> endobj 1098 0 obj<> endobj 1099 0 obj<> endobj 1100 0 obj<> endobj 1101 0 obj<> endobj 1102 0 obj<> endobj 1103 0 obj<> endobj 1104 0 obj<> endobj 1105 0 obj<> endobj 1106 0 obj<> endobj 1107 0 obj<> endobj 1108 0 obj<> endobj 1109 0 obj<> endobj 1110 0 obj<> endobj 1111 0 obj<> endobj 1112 0 obj<> endobj 1113 0 obj<> endobj 1114 0 obj<> endobj 1115 0 obj<> endobj 1116 0 obj<> endobj 1117 0 obj<> endobj 1118 0 obj<> endobj 1119 0 obj<> endobj 1120 0 obj<> endobj 1121 0 obj<> endobj 1122 0 obj<> endobj 1123 0 obj<> endobj 1124 0 obj<> endobj 1125 0 obj<> endobj 1126 0 obj<> endobj 1127 0 obj<> endobj 1128 0 obj<> endobj 1129 0 obj<> endobj 1130 0 obj<> endobj 1131 0 obj<> endobj 1132 0 obj<> endobj 1133 0 obj<> endobj 1134 0 obj<> endobj 1135 0 obj<> endobj 1136 0 obj<> endobj 1137 0 obj<> endobj 1138 0 obj<> endobj 1139 0 obj<> endobj 1140 0 obj<> endobj 1141 0 obj<> endobj 1142 0 obj<> endobj 1143 0 obj<> endobj 1144 0 obj<> endobj 1145 0 obj<> endobj 1146 0 obj<> endobj 1147 0 obj<> endobj 1148 0 obj<> endobj 1149 0 obj<> endobj 1150 0 obj<> endobj 1151 0 obj<> endobj 1152 0 obj<> endobj 1153 0 obj<> endobj 1154 0 obj<> endobj 1155 0 obj<> endobj 1156 0 obj<> endobj 1157 0 obj<> endobj 1158 0 obj<> endobj 1159 0 obj<> endobj 1160 0 obj<> endobj 1161 0 obj<> endobj 1162 0 obj<> endobj 1163 0 obj<> endobj 1164 0 obj<> endobj 1165 0 obj<> endobj 1166 0 obj<> endobj 1167 0 obj<> endobj 1168 0 obj<> endobj 1169 0 obj<> endobj 1170 0 obj<> endobj 1171 0 obj<> endobj 1172 0 obj<> endobj 1173 0 obj<> endobj 1174 0 obj<> endobj 1175 0 obj<> endobj 1176 0 obj<> endobj 1177 0 obj<> endobj 1178 0 obj<> endobj 1179 0 obj<> endobj 1180 0 obj<> endobj 1181 0 obj<> endobj 1182 0 obj<> endobj 1183 0 obj<> endobj 1184 0 obj<> endobj 1185 0 obj<> endobj 1186 0 obj<> endobj 1187 0 obj<> endobj 1188 0 obj<> endobj 1189 0 obj<> endobj 1190 0 obj<> endobj 1191 0 obj<> endobj 1192 0 obj<> endobj 1193 0 obj<> endobj 1194 0 obj<> endobj 1195 0 obj<> endobj 1196 0 obj<> endobj 1197 0 obj<> endobj 1198 0 obj<> endobj 1199 0 obj<> endobj 1200 0 obj<> endobj 1201 0 obj<> endobj 1202 0 obj<> endobj 1203 0 obj<> endobj 1204 0 obj<> endobj 1205 0 obj<> endobj 1206 0 obj<> endobj 1207 0 obj<> endobj 1208 0 obj<> endobj 1209 0 obj<> endobj 1210 0 obj<> endobj 1211 0 obj<> endobj 1212 0 obj<> endobj 1213 0 obj<> endobj 1214 0 obj<> endobj 1215 0 obj<> endobj 1216 0 obj<> endobj 1217 0 obj<> endobj 1218 0 obj<> endobj 1219 0 obj<> endobj 1220 0 obj<> endobj 1221 0 obj<> endobj 1222 0 obj<> endobj 1223 0 obj<> endobj 1224 0 obj<> endobj 1225 0 obj<> endobj 1226 0 obj<> endobj 1227 0 obj<> endobj 1228 0 obj<> endobj 1229 0 obj<> endobj 1230 0 obj<> endobj 1231 0 obj<> endobj 1232 0 obj<> endobj 1233 0 obj<> endobj 1234 0 obj<> endobj 1235 0 obj<> endobj 1236 0 obj<> endobj 1237 0 obj<> endobj 1238 0 obj<> endobj 1239 0 obj<> endobj 1240 0 obj<> endobj 1241 0 obj<> endobj 1242 0 obj<> endobj 1243 0 obj<> endobj 1244 0 obj<> endobj 1245 0 obj<> endobj 1246 0 obj<> endobj 1247 0 obj<> endobj 1248 0 obj<> endobj 1249 0 obj<> endobj 1250 0 obj<> endobj 1251 0 obj<> endobj 1252 0 obj<> endobj 1253 0 obj<> endobj 1254 0 obj<> endobj 1255 0 obj<> endobj 1256 0 obj<> endobj 1257 0 obj<> endobj 1258 0 obj<> endobj 1259 0 obj<> endobj 1260 0 obj<> endobj 1261 0 obj<> endobj 1262 0 obj<> endobj 1263 0 obj<> endobj 1264 0 obj<> endobj 1265 0 obj<> endobj 1266 0 obj<> endobj 1267 0 obj<> endobj 1268 0 obj<> endobj 1269 0 obj<> endobj 1270 0 obj<> endobj 1271 0 obj<> endobj 1272 0 obj<> endobj 1273 0 obj<> endobj 1274 0 obj<> endobj 1275 0 obj<> endobj 1276 0 obj<> endobj 1277 0 obj<> endobj 1278 0 obj<> endobj 1279 0 obj<> endobj 1280 0 obj<> endobj 1281 0 obj<> endobj 1282 0 obj<> endobj 1283 0 obj<> endobj 1284 0 obj<> endobj 1285 0 obj<> endobj 1286 0 obj<> endobj 1287 0 obj<> endobj 1288 0 obj<> endobj 1289 0 obj<> endobj 1290 0 obj<> endobj 1291 0 obj<> endobj 1292 0 obj<> endobj 1293 0 obj<> endobj 1294 0 obj<> endobj 1295 0 obj<> endobj 1296 0 obj<> endobj 1297 0 obj<> endobj 1298 0 obj<> endobj 1299 0 obj<> endobj 1300 0 obj<> endobj 1301 0 obj<> endobj 1302 0 obj<> endobj 1303 0 obj<> endobj 1304 0 obj<> endobj 1305 0 obj<> endobj 1306 0 obj<> endobj 1307 0 obj<> endobj 1308 0 obj<> endobj 1309 0 obj<> endobj 1310 0 obj<> endobj 1311 0 obj<> endobj 1312 0 obj<> endobj 1313 0 obj<> endobj 1314 0 obj<> endobj 1315 0 obj<> endobj 1316 0 obj<> endobj 1317 0 obj<> endobj 1318 0 obj<> endobj 1319 0 obj<> endobj 1320 0 obj<> endobj 1321 0 obj<> endobj 1322 0 obj<> endobj 1323 0 obj<> endobj 1324 0 obj<> endobj 1325 0 obj<> endobj 1326 0 obj<> endobj 1327 0 obj<> endobj 1328 0 obj<> endobj 1329 0 obj<> endobj 1330 0 obj<> endobj 1331 0 obj<> endobj 1332 0 obj<> endobj 1333 0 obj<> endobj 1334 0 obj<> endobj 1335 0 obj<> endobj 1336 0 obj<> endobj 1337 0 obj<> endobj 1338 0 obj<> endobj 1339 0 obj<> endobj 1340 0 obj<> endobj 1341 0 obj<> endobj 1342 0 obj<> endobj 1343 0 obj<> endobj 1344 0 obj<> endobj 1345 0 obj<> endobj 1346 0 obj<> endobj 1347 0 obj<> endobj 1348 0 obj<> endobj 1349 0 obj<> endobj 1350 0 obj<> endobj 1351 0 obj<> endobj 1352 0 obj<> endobj 1353 0 obj<> endobj 1354 0 obj<> endobj 1355 0 obj<> endobj 1356 0 obj<> endobj 1357 0 obj<> endobj 1358 0 obj<> endobj 1359 0 obj<> endobj 1360 0 obj<> endobj 1361 0 obj<> endobj 1362 0 obj<> endobj 1363 0 obj<> endobj 1364 0 obj<> endobj 1365 0 obj<> endobj 1366 0 obj<> endobj 1367 0 obj<> endobj 1368 0 obj<> endobj 1369 0 obj<> endobj 1370 0 obj<> endobj 1371 0 obj<> endobj 1372 0 obj<> endobj 1373 0 obj<> endobj 1374 0 obj<> endobj 1375 0 obj<> endobj 1376 0 obj<> endobj 1377 0 obj<> endobj 1378 0 obj<> endobj 1379 0 obj<> endobj 1380 0 obj<> endobj 1381 0 obj<> endobj 1382 0 obj<> endobj 1383 0 obj<> endobj 1384 0 obj<> endobj 1385 0 obj<> endobj 1386 0 obj<> endobj 1387 0 obj<> endobj 1388 0 obj<> endobj 1389 0 obj<> endobj 1390 0 obj<> endobj 1391 0 obj<> endobj 1392 0 obj<> endobj 1393 0 obj<> endobj 1394 0 obj<> endobj 1395 0 obj<>/ColorSpace<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/ExtGState<>>> endobj 1396 0 obj<> endobj 1397 0 obj<> endobj 1398 0 obj<> endobj 1399 0 obj<> endobj 1400 0 obj[/ICCBased 1417 0 R] endobj 1401 0 obj<> endobj 1402 0 obj<> endobj 1403 0 obj<> endobj 1404 0 obj<> endobj 1405 0 obj<>stream H墧W踤鉌E^z 殎臿_I>&轒宍;(Nh%q"^靧>`;ШH&/0c`x>u闠u胼錴7\|饭x鹘\烧f{8强U偪錨);棲曀撠i暞6噵wW僛暶*墺U箉u述"YmJ釬\M}镗1Z隓荍 c1N抿T莳貕4N綇攸系宔灨真圥战/呛k儧壍豽=&銥}6邜タ驧w<屉8輺-曍O嚔}=呛i篊qW (凒]Q杣雵`'e$ ,'Nl柶N衫IX*.疨Q:皜殔7aㄌ骤rr燐 Y,糇>4垍騸:鵑綷鯮崖yl-]u毰ZJeJZ.掓"a咹噹3'mmga瀿r弮-s^YB6v&U溤w峻\32N?&夛鏦`A_翦炃WT緂7* ?糨鐸*'蟣脎畓瓪敏c輛氀sXワ*晔L9E詍q(~M俇&i疅摖螕`F18@BMfH狥摾T杅,矮 3萮譃! 櫻簚敱邧E<玌 .媐●cY场抛-翿m鰏卪渌W]峪澘|軑T娋 I渆42=O禡媊襓蚚嫩坼嵷)I#燂`x!MCt//2戔wq语=&彌濺@K樐紽脠a号 a=賬u$'|旎]飮浽E1)暙鱃|U 5tG竔g-8"駅袚哛迃o婷x i+姱烏*6y僨N虧朻M亾AI飏$鴺03BXj%R錌fP6S D[潏|臌ū寲罅︱铅{鄽&Fa渭劇㎞(毀堭珽=逫岱懃閘褺糡皂$=2:RQ1|D5笅HЬ 0Y[KG窟7羝BS)?冮劤T臺2QG筽 $DC藯(D7Py$壁靄諹" 9+#p銲孻塑P5欥)F\=I{.P)姦薜E嫸P-^w麒0)熄 璗gUFt[鋩幏k㈤录Q ;zI勴婊 鴙E_駖襷叀@K且sM筘AP6€&]p+猪鰐(\蔆瀄嫖Q6裕/h2卐葧鉙n氢订嚱嚪鍵p 蓨;?囒絞@挙1糵齠^4鼰<嵅,樶貦7妼挘F緩,隒廫€p/zE肤 s騬\a敎a-蒗钱/X鯓5饨恼褨p鋶摎9> endobj 1407 0 obj<> endobj 1408 0 obj<> endobj 1409 0 obj<>stream H墧W[s6灳闣曦4@\踛玽摳抖i'"[^$迥€贺I闿蟲溗w畝?Nxr.R榇K讚鳜哒碉士嬮4*惮:?氩鑹①}叟#羻M嘁X畩嚔j穟 D廏掿p驥 侂/梕S鬵D癙6次R枚]惠尿cQU鄍yV糴江圣'汥3 A蜏凃1FtB1.顑鎷颰8躉凬3)t律鹒壶g2烋T+a阊{遏饲hS/V妼Q缞B^,*赟H鱪r濆kbN聅质靑姁{ _釈蠻z,(钚.$毵湧觭漲$嗾魷凃罳IL晹AVG,2=证+嘖逐OP!Z鸟cA x躏8擜"j丹戩籶\(_儍殤} v ъ#X帄!悊m瀀闕Fa1>6纳P搥b*纳1?#鯵p?+]瀝-瞕堡乸姴惭2.紹剚Wk蠕蕆ㄅj緢?L炶A: 8箅〧 ("娷*>m儤o炧≈煒鸻*`庢 1辍 i釭p喷C匞宥,bC+A 齫S=6T8u罐 $c凼?襔S庩m 嗷盯轖B) 黬}_6毹搽盛 停voy_'豁*hxr z#垝嚢魆鐕欈} 4 Hj哐>15产_V﨏Y暶c:N'婲5搮'2.3y唴I3甽波Q7*w\%鴹羲f聗汖鲱眄, A吒<闏<2.L郧應槫鍋挦佼e姌`o霜j 政aJ-г5輲:ER#9T>S J籛袽橹狀A诙廖&炐}BxZ踧."畑i 趑^姶-r$`塊'>嬨uo庲o;)V\醍蝰盛敨}>91g鉸Im艒L$挴盙勥筹C)J~B4r(-邩G士U泯3]覸-l#嚌6獠I踤M 啸q$峡5*F3.H`稑\剃舑U坼庌膳+慭^_M.NIY 齡滾,Geb褈崉炽俐7え啈灼g1(>7aN#閡眾0+E访霓'Y傅e_=6g#k津40/争~籡磐_哜鰿保iN/搚灏=A譾x!鐤;逥歝砍淁閳E懦1諝摁\钘r途絲{{;换yz鲦j鲣睇4k叡ぴ薡闆踹2 侬e紖6勪鏑HE襏彥袰経9蜆g0Fq颽绦曕r懺M专Z尖q鏤叒~BEf.2KJ饟烈>OsC"窻GA:VSlR揺ak储獍]N4M#[i幝龋<*苴洌ugt3?闢醼み0cHdd 熭) Y哣2&(j%N0€燭 <噶j 湸mZ黀i頻$6d(iv苇Vб雯nL讯偀鰣 [}D兢怚yp瓃頺p摺琹 9缛}劀C[u鋒2lM皠m&a"+蕅 endstream endobj 1410 0 obj<> endobj 1411 0 obj<>stream H墧W踨6}譝靀4$惂&奡;6濼m鈮P磁V"]^溕鬫鷹= €贺甧徢#-.荤,v ィ4搧扞d(楯x3&峑S臘駡骴3阿佖靗€檓搅R~籋荟x羟暆脚鴮#c5抵9讬泈蔚R諮脝濞h铈暤2#w璍寢昫憭倄lli岓9S 02E鎦7悩 k29&V,鷣牑t旕t μv 跘s胫$*n渍L就L綏G '穣啓侴9る缮3f>I(`婑缈渠D纆緸虾4(簚鞀z挛?豒uS敨U_栓h轴神4嗔鼁"!q(JFi汄@(峉@)驔q 毗q烽!>淰*&%扝)C{景焓p*Lii籶毮I敳e~绉2V4u遃_嚲\4帟鵭踺6琽?骘'8g<鍛袡鎜V肢8贂秋匀O1稰N恚 j屖B蕚麩6Of'g繜=悂 eW{n`0a环eQ-迕D 盚炏"F笴3褁=洕\0h桾唧螇G妻?QN 涑h鑲p5$儖咿湡齴z悅&夣=荗" ﹚$乃H)DXeI涛姣鏶~!' 鑿f湩@*纮c!:摌-!'Xo惃 よ 隣y}鉐P矎G栭"T碤憥欈G鬶#厇>愑"F砷#H8彛X 庛Q噾竚眣斔al寿c8剦;僄 艫鄞yIJ潍Q??咰蔋o访3€貆镵€%a-硫z訶2%q~m蔞j湑< 鑣eT瞎L卯l痎叜 m[纸kd珊>{G6x|臮庐噡hKKe|/,b僧鲗椃-驶r哲畗 螝腭Z爰込纪o猋鐆U #./姫.蝗薑鏆:[咮刍鱞d辈初z崭莲*ZS:睘q鯅'┤8"q欪山籸裈煂9扗涖 #J`澉?W蟸:P顛c崋:=P x腂爦 p 0膬冊?>呍褃8Ei:戽-Vオ貛]屠y缺口責FW7畳襗邒M:/U(q睜v$栖%!Gb *_+|晔V蚼I5鈇7g蛹@P S劀筈瑂論摃岸嚜(Lc5辦le;)藕厽楮;狟灢锑Ⅳ>杪U惁q殾~<`朵|9No嚷驹Bj@跢X满0咥8曈:湓瓲3lB叅]摍云亶僿uLO讏丟!赸[5 6穢澺鸪短=;柘|cDT驇kjJ卼2爘峚劧/T7E 徂>=uo#拪gE6挳l2怉惰8浲\aq鰡%$磘>W/'Z"%钬芻 曨2拓袝G銋定:魇&鬡Ak趹圂钵my6嫛仾%皝vJ*9;'呫c馨鄄]W=鮃守6w闸\焐+m凑MU+荁鶡W#厀vD6>ɑ/鳴q~桚x{5哧r隓愡秚構禱T得烑紈8稇,寃 endstream endobj 1412 0 obj<>stream H墝W蒼蹻较W鹑 l錴KAld1捝!0r8TDCf墤肯n拻+鯽諹寨嫮蛍珡睨05>\忒_[盒>瀘钋4Hd:讕X<輱G掹N窡鲧麘*礥戂~< 踂4锑纨jC{]鼾敖~&h?彠;姁 疵#\I活胣熨_5痷gb幫i靽N6u硐{ :蹫徝+<粉駒:7鏩嶋 E5囜癜邽{治洡榙*I妠获Tr箜缁笨=t惠GI俜麚,]埏w忳詅q漇Nw胵恷r{B靋鞘Ju羫摏缈渠a 龀綢>+1蓡蝛40琻'洏]g摓lr棈断l鰢p禝羺6禟y堆 鮢澈7嘿墚|鐣聉鴂栁:xj僼憡2霽礞W胪'8Zq ]?v,K鏤zB 畒﨣}i囅鲥|51!锞兕雒飋~|髹W/%B "w[銋劗}~刦58&*#x隵,泸梬/鄍髶迪b~拼漖崨d:傼i贾箣柗k鉮2`#諡灼 8)Y*89,51Xr疖1燼睂鋿郪n膛疹f豱図寰?飭嘢s裼[呒箌缓X妭堔CQ3蜒rV廴Tj5篺 赪|?c9HP"64€V@覻钄类s訐顾"雀硛榴-76Jp"圱:t狶乣\h刭v1h偭喩Y1.尚 s '楾 蘡梒汋樢 Z[7d0|娎9覈,炔s 臵h.= 倵蕽J溧|hx7'念疏Y嵻+迅刨j-+籷##俫 筄P泸*(p浲浙)1班偵1w谕d诃">Aa櫰$ N瞷*p> b坡O鍰"C儉 =閾e-Z毠5)-. 耨D-啤T銉%u磖'敶$猸kD|=铻莨_"Ptk脱lmI蛣 ∕亖毽跿! I hX僎2l畃I嗬t>-顃詔噥傽厈}匒xj1:M>€!倍.e襕縺 RrU0袶H髤`&晚*靓(Ze"V嘹d8=C6]b鑨( ko倄+丷@缻謆嚹昀榴6奔]偽X蔽幈Y Cb(燬y偘巖`>窳o瓷踖pt,6翘 fN -~9FXHse8#法泿-麄!,+},}惝V(]"澳碴峂\6O<収詐1惟儌>壒&湞 儑2仪TnDW H$璵孺r,E_维8#潅#/>斕*]μ+滼e昹ヮJ譬/暚叶欄苡颳w 棱k槩 郹箆捡y*鎥珁檻:'9绍潮锸堳\,1嘸 g9 瞦E4{c耎 炑Y?oN2桐 'U胎4@T8`坹挓旐苷攦`殺s,茢豟拪b-{懀f;谇c3'璩旴2Z+~蓃[hB&_唫鍁8靔浺T>贆鶊:W=熦,.>m.t [ 洣*驻靿嫷-W摜樲c'盼/堓*延p鶒i`=L endstream endobj 1413 0 obj<>stream H塴W1$9酐齺!x夏m1胲U滋瑱YH束祏>m屪掶鼃Xf_ s*b?M^靓枅ぷ膣偋A<*0W/啽m+Bd?m狡嗼殙笑碸/盷凬物g7Oh s峂妪];郕_鰇溑酈橈8粨作怍NB舏痑Y杯饺饾6'湋呿N樝"DB鐐<纠∏y憝y p/D1擁y儮|噅9曙c渏冉G2F瞴w8啱匀B/"蹲U1!z雥続锠滈铩搲,b (pO9脬9|薈S捸\F媗6消埁牴! R伌煸u:蒦+E駟B种E\bcI斈W螒TH'荥髉zy>,嘞兎锔`B搨+鐙藈脑 "渴<『_皩敷2鲻怟烈q>6 6帳u\~<.$#Wk+d晣甎京騿or窒g呎 幊樖等舾}彋37z~聂鱭E1蔒*E <<鶸灤餜e F-?裀.瑀A桡n}mA4佡z;狯Y僧穇Y7琗b呁=|QLy]蘥1(+眓55毳D騴徤\淌涪釺\耱 +^朂 梐0V讈稹骎*RAa(敃Cs]蜘#0r噉\m9锃嬀*格>7坔賭澓v3n昪Qv TP;B佖慣娐pN攃宥瓪L`館艖岏僈$o"農.Z桕4氍)-釫豛9縋t8s拍冃e* 抺使誮迱騆铏呸锺 k%O絒P祦p]313s a頌4',\0sIm 4昖陉0|暳T 嬕畊6碫硁%衬+蔹"垡x氧??裣猲銿Di鑬戥墅fF尲覍燵1<1蠟紋汁=kky焀冂鞂7€M : c伝,b4n\愒oy2s趵^#J橍傄#蹶;僎*,)繕l y+a3*/mvji薺*5盥/芘尀'uJe魏洡S洳л*Jq嘫憑厯浣`亡憳雷<眼鴀納敶詛`A脴_徼9瞺2鱝3猣$}$吷;盢詇嵦钗案 f.00頕%-眿鞲S鯵撗(闛b 赍鎛ec韃q圃=(w/歼 衊~UqU榪w项'$暦蕋馀 r]庥曤2櫧zWXl%矍 顀>stream H塴WI巆7 蓰継>Dqu尙r€BYH枸鐟詿蔝@義镶Z釸Ar<彼><`疶婽 M睌O*=u"J* 覓0+谲噟.9剬讏蚎舐}/χTz厔\B 獪燱%泆伦TW谎蜩酬/額`]k伕$猈F$圣Qk廿癠兾V噮┑閦焝蚎 68.筍b挷`邇巛%蒥绯0Ub壔W枝裟詃O秦H$:8%狃j鳬絧覷$,吽m*淂殘井簖詝i╩帐偔R菕安i敌<) *6|nTQZm鬎%\媫胭孒牠賙僰h.埭J1乞I硙妝=~<皶)當0A8褔>鶒 *伾$t想魵b嚿"標K 鈰0Nz3M 舴堂?>k8鄴砨I碌嶝"嶷;熯x7持洙-" [m|鏹$aI#jQ澊K2庽刃J-7卭*骡锇)K6/2爏E鉗鳔D剺 @%熓 薎渻躑薀珕 穴鯺u(D喀粱l烫q-实M矡迀撠3鈰擩膲擩櫦[x弎骟萚尫|缌洀a蠾l焮廴<_躘P仳&B sk拴藉绁崖"泴湣啣垅J*7橄o糟幈s2厲梪w矈橞此93r7>Ww哜y硍覲$&1袢腺玨阶HF, bL駩儁]魸Q2xQ迕+搘櫸d甬1麞塯s縄3鼗C)邫用椋绿(鈨y]13娵1瘿蹥qI誯璦?p01v!彽 ck儔蘧炶RCz湆琮*櫨,ie:G0<鮮[K楋:鎥)獽霖 W页R壥馱糶U悥Wz煨9 楶矁 >stream H塴WK巇9茏)m>O〨橙毰孴R輣鹈嘉\UE$1榃:趦VOD泷(蜳毥NG31跑Yq烧'V屧n貪廷彤x>vL澥t.f慖q濙唖 e庣 晃诽J樋拉T諸_堦 鉝'瀲廓b腏Ь2渟馀聦淛7LX5J42~腐zef歮迾侙袰0x 烩顜?9洽蚥樬沌0堔槜o晬ir;鳾 弇O獸<觝栫{5#&趟臭趼d鞏'?~跄琰L鐠:竦(0X2んKPV蒩豛*$q榥b翅荵朒笗釾倝扮h1榚;@e帔y/>?衹玗r=橪螖俩g踳B嬊M=L+K-4C⊕53Oe杍yさ憎I鸛z邸^6咣斨h氃3詪諰n璳嵘M獕iBT瞜ш軜5X€)6 e葆娭=灍氻9Jk鎡U瞯'+bz#"ΠYk!l卐wA娥l獫*+橏飩q0糧皜v笪|!=鋌於O[弥啯u踰隫鸱Z 侲苙4n唳m偕勝mUb#覵n#鄩出#记z坃櫺uqE#塰7AV厂殝c鹽& $0玨L稬I護圶T肆&#娠'髴擑3O1萚E}Y屇糯勑k亦k7i舂o榎,嵓嗧:伛菲伹  9=BI早鋩礙~秷OX.f噼U難W薨5Y桬舠n;润扤K衤ニ顚秖簎q眬bC儜5 轾S劅E龇聉]*;0赾飾.~n仑9砩舞磪诹8" D彛Jh鞏|H-/鹆劶椊 占g|*sf7峁%3p^吮#-*v7 澥€荲 eBT觮(滬脟瞼鱌嫣q+s贑桏%颤E藚D鰇胱vP!@Y婬M\妟鄦hE=8銁岅A餹鮗羈L#;Izma剏劍愧磷磒Y爁鳊[5\{稺>k軈櫷櫑2c縨橕 鉗\=l'欄鞵╩忀揢厧]呂x7z薂"^k珎M"瀅?[;喵餯榡硶\eV苒饐f醜糩^硛檸!C暨冄'_+纨.覚-s顁1饎椿Q儳h囧~${@3 翩2W 萭搴 1俰929>w箻泫%鯳&几 齶麪$VADo%釋桪`$譞羆WR+bm. Ne.S郃鬰釼鶬r珖%蛷d&秳喡h([怤s莻1萤荿蝬%Gu緀\C戊z<甈罆n/癊W[鬧zX2酉S漽pr骝C|%S endstream endobj 1416 0 obj<>stream H塴W藠d7 葑W埱,踆7!楡鐴!婸H&暨G圩阀湾湺<朷 攧暄い著x躟1-U 秪wn!燌;0戶m$蒭゛q,; 罩)檥E瓉∽ $迪螠戠訨}蔋&庶疁$pO羮篴)K踁滾M 揔; #)淠P娙聎轄)粵su7▲喩淨P*?ef喚S哠x荰e W駒滑0&鯬`穢礳,瞌V饎;滧顄mCI茰uV 淬8迂眞潞僘ww箃G 蒯R吷$呣1嶉p\1Kdx0&龃唍7g=跇~獦 韺$皍Ho+t'Ern獄9挥@}疏y+xaz"桸S)砰楗;骤6?Uu悲嘣P嬨趪)绛C嚚豟F炿鰈宰讨N@5R+祉已P働P 宻癁閆鮡@s召ql;@{嵺 *醘a庥莇F永岏毰鐤Y!2瑙<€]娑抣鴗;鰍xZ噇鶚囂" 1MO /嫏QL 3蔾w肓:簽y6朲M]軲姹<龉尃陂c$VrL,l扫鲫eS !nd噕11gH( '6\&鈇, 吓爫眽t妛-豏u蚥.o欵行嵩PXrYp}1Cq死P鋜qjV 稭锄蚼屿魔x&34; 痀竑4珌uP襊荘寺gj奫"棌S斥C銽祹勤6誒|6櫓賗aFy兔4(萓[C'禁聒F鏕蛀孢遪?k6崧赅1菡哫踽#[砊",磗K蹔J嬦d 戙^1CL噽1[常.痮u3_f冄M意驄€`A潂ph苸p践h'[恑 L匘6询襑p炯缐3訄]0c(鑼喘WΩz棣陣y[褔Z蒧o_u耼/熾耱zd V+玙$涂倄季黳饲鱃>2N珈溷泷/貊峄W<鴟$?>%贇< z銒齲;`3D女 endstream endobj 1417 0 obj<>stream H墱杫TSwo蔀悤懊c [€5laQIBHADED劒2謒tFOE.甤謢暌0觇8讕8G漀gτ秣9鱳镲葸谨濗'オ嫡0 嵵犗J屌b  2y.-;!鄴芀癦 鼖瀆恑"L世0-组 @8(數r;q7鐻測&哘腭q4眏灲鐋9谀 峍伋)g滲0駃淲8#8w诈曱8_刨ナ≦泓玅蔶@&籄)/琴g>'K傮萾;\ 鹰$蘸F絑Un儡(4T%)氆0C&瘮槫Zi樋鬁8bx憙E×罛;咜瘺縋斡撎篂A om?鏦= €x兑-尟莉鎇浰0窬绝蝳y)7ta揪貂>jボ荰7鸁緻锛锨t軟騚q2櫛蕗欔&6瓯Z滾?鈅yxg)藬z徣莽L璘犴*uSkSe豋4?赘竎.蚍 逡R 邅摁-晵25哚撄芟 S>樱V瓪嫇d錪r>n~萧Y&+`渷;翧4 鋩華9=-tl胉;涣~p寖徚 餑p| 畞[`L儑`< "A YA+鵆b(妵R,*乀2B- 陣啞衝梓蠶t}MA狅牀0觓l涣景巵Sx 瑐k&^粒>0|>_'釃,翯!"F$H:R垟!z镕慟d?r 9媆A&慓 攬rQ ⑨h殝恃鞥囇]鑑4z滲g凶翓郋#H *B=0H豂鴪p唒0MxJ$鵇1剺D, V泬侥你腒幕腨塪E"E愐I2拋訣贐贕鷮t4MzN叁r!YK 掲?%_&#竣(當0J:EAiQ(()訑WT6U@崰鍼+!陗阭嶆D 以村!陲h熡/']B/殡覐涌?a0n宧F!美X秦8砒汃軐k鎐&5S樀檷6籰鰳Ia2c楰橫藺!鍱#呭茠癲琕(k柾e嬝閘 粭絿}巬烠飧q9 N')蝅.聈鍶竢  w欸 xR^瘒鱗o茰ch瀏轥>b$峄癀*~ :滶寘襜嵟~嬎,m,-晼輺,痀敬卢猸*6X峓荼F=3Y煴~d贸 窇踭垂i 踷趂6踾`{羦治.袾g放顢#{緘磢咠€j囅檆1X6劃苀m崕;'_9 渞:8輖:嫕藴淥:细8袱勾胳u归Jq粬籲v=膪蘉鄸锒蕀茼纠R 4 n3埽躪蹽莜z=[=爵=<=GTB(/賁騼,]6*-晼網:#椚7*e框^YDY賫U刯jAyT鵣#礑="゜{懦属+:!kJ4Gmヶt祡uC%潡甂7YV畅fF煝遈 .=b噌?S岊茣譬喝簯虹鮵鯂 趩 崬峩5%4m7焞qlio橺砽G+訸趜餐弓砿zy怛]碓鍪?u鴘魒|"疟N晃鍧wW&踖芝锖*|睁砧j蹶5k冬y莪棹⑶痝扮嘵ykEk囍府l軩_p叨跄踮踝7Dm卣项o昕1m汜l爗帑M艣 n週輑<9旡O[笝$檺欬歨氄汢洴湁滣漝澮濦灝煁燏爄犡《&fで8ォо≧7┅獜玼琝璂-瘚皍瓣盽敝睰猜8钞%礈祳秠娥穐粪竃秆笿孤;旱.户!紱綇 緞縵旷纏漓羐零耞论肵迷腝奈臟湃艶泼茿强=燃:晒8史6硕5痰5偷6味7细9泻<丫?伊覦悠訧运誑昭諹重譢奏豥罔賚亳趘邴踿軍輺蔻)忒6嘟酓崽釹廑鉩汶鋝潼鍎 鏂绌2杓镕樾闧赍雙臌靻頊(畲顯锾餢疱駌驅螫4袈鮌蹀鰉鳆鲓8鶺鹷鼧)﨣m 鲃篼 endstream endobj 1418 0 obj<>stream H塗T}l旒|吢jwpN&单cQY獸t繰!6ぎ$涿豊|鲚亳鵿>?B鹼;燀粙m'M0:Q-[Q但訫B歵Y .h忑閩鮆稃鑩炦<&hi3栽詃踸発[vw銍wo{啮飛,> H勇茣隵nt箐7,痞掌徶焫jnj軆~Oo煼鉕?垩保齯麐n瑌彲飍蹙兜}魃擁怇`頌凎toOP船Z 狅B绪殹m托%袨招T儬]f樞Rh7DA棤w?A_5]k鹤\XrlI}i"X辦{A~Y绮瘲,./X]慪’\彬汐v瓃孵街OW#?x炖c蕷糈蟹v<你鱨囍醑鹺跚拽6穉?軉 仄緧s涼o捫N魝接瀗魁喹諪8魧樊;棵|鼞xK烠豕禀吝'竉"俜迺郗鞟=搟g痈m鯲1P?飢遞n憇(1琬狑{噤 鑍饩噻;壿(聚龘逕傊-YXch钉Z献lx%jl秥ie 啮痞杁绥嶆奎急軖搭l,反6摭膺秢猪嵶-蟍[;n|f3畍6甖蜅?薹圻1o蹖 阪瓖烀 KУ骑钰&玒E砶JA桹KUa2s莆]€gg鉭胸 ;>MW:吥.膮E)襈RA"屟炳d_軡晖 犻~%c挧@h牬jt閄z碵Tv6T#g{癢鈕逪)\A+}F洰咋5燤_#/2浯}<=;8刢#繄a彙飓T79@ x$;3G懼]繖 G瓩S>3欼肑%O$採X4聞B]/糹4vX>[;泀w釄虐<佧享[嚍65抭選&Q鵓1済姮f挕尚遣歖蜄DEVd ˊP3Z廼瑠*]狉T> Y%鸫'敐妵釲滄h庒~6辷指o1:k狇攨壟釕鳫<窨3e衣榟钴様)IU愺g8z>Ee|/b萵掊€趨哱~鼯4癏##E熶消2 2>筴3+*砼"Jy)+*嗾1m:7TG隒}诗A&竴菹 !H(0, X:o+xQ損暖惀爊河芻d疵钟'虸,核$6?↘艿餟:*_/譮k3珷z駔d\K&J鯾J\嶪溿m4硤别mfO嘑)d0粐慢熯G 1nu臸 e-桢猡 潸Tv櫃忤航NW:忎?閫8G貐耶爣 v 靨rHk狂p醡洦鐘99蚲鴗駪2闾feOE惼镧N罘6>z钢b 阈B軫d厞攂帉謾rd&暿餣羷槙2熺 S3'f毊y5T脺 涓! ;N2轆厝6鎚W擵唀R&%\翫L鬔樚臲.2l剦 蛦 '$Lafa.DTp%5!獨釳N鶄`朩驜卼Im櫔XF挪ゅ&dY斉烮cER X幹g郕簰+9并Z*+u堳i~vQgXSgM(H^~cq嫞/B2&(3趐,歀N*勱*&:{a77鰻磄貒8 : 祆冤艰;拧侽骾 ]t崨殕[崼萍侔)S俆緪蛬鶞( 2仁e菏b8伟G珆P繪攟I["﹢hQ瓉句蓤#肴擡R枷宓\.棁蘫I.椬掆%R&I1l辊蒸袳%蛬)炻h搿;4袩R殧?赋鋌鏌6+棭v纪氛|涊6倞x堍媣3瘿_沌僜8!&狨PZyQ[簕羅襣馭曀浳5緇0胒傎P嘜1)^J+'嗓\蕺忻乆閖:昺Ei =/ 冹.$椷 嚴l6i絀敪嬱瑈=虭楇撫~戽鐔駺]院P霙漐埍鈭堶畮筩V6*掑骔.RW浴伎伴l:僸虯:.筹訝淈[昤g'f&窪毓 3^LH y)QJ敀皧Y愯烷ing8岒/舷歐珑逇甚'獌A┱襩稪=j/?]C覯Sg疆%脍猊s怨菶烿碛:7MF雍S'K4 蔬_濿M窘媘H\"鰻蟅?"鬐O朧@7V 鼪e}翕A G矫芖 蟀€蘵Y@.3睪b 顐粑n惎A兤 ;d@諵婋胶琖LmG坜Cdp8鲩輣G-)rSV:?AW1醸鯢&汭e睺19秣3雃潨 鑑輰m袟礒濯妾厕5岰 f藎O^C彑:繉O_脧aジw媑`佝2}楕⒂S齸<梘桪6哰6YP-ydR趻ejK!I訢 c潪槵Fエ$菿QY( %^d "纽4Kβ0甩5]]瀇@%t鼼祐凨p樨;08%篏飴@疾予t踋e2&+泓- ﹥#f囔8:V.衕菴苁8嗝槂2F@G}銔舺嶃}玲軗飍 悑9~茷%V%fU韂礭3寊滿 VX{櫥@_竱L鰇@v萌6#击ndF璇c观裻:羼陃h滂;億暺o珺%b8廄*XΗ,Y蓲E4樌韰-'却皉 渔槕骑 熳g/摀獌洢vK觠擅[#镛毸叀啌闋;m1Uc齅6 栈 {&mI嗯 葿2熑'鱾}gKO遏サ+v桐W;76: S*橬d扽!菋at,庾 6厢3x s=E逹U凊P#\| 肛陘9夜-鏚臨蕳I睖﹏d踂W儵硕睻6&賈弊m5w幼!}~w徻甚鋷涸5汮Sk町8儀饘n驤曅犄Cr@儁_I;s歗_"'劉aXRO莜稢=端畎混€ 鰘]叨活 膂猞促9詼#圉2^皃$g6h潂f惩郌<玻飑E (M8鰀蜱{u@鶕亊2峠8堭(*埭 涘噜d湋右Q[w+〕擑饪\ &_煍a V覾:拵,#)>M)>廊 暝)閎FBoL獘 寑 0Y=my))'イ4S凯溊d(梔3 銋殛猬舷@鑛_fMeM}5齍拄qV5d''€}>澞鐁\."rK&窍粝才4粖RB斝Itn鷃9'鎓:匧iI愨厁!V榸<燎 "嘜a">I6$#&g嫘z +7汢8莈,8> `MA:欱 B丒鑳糜3sT#=ZB逺贵逇樬釃t硲暲F聸嶾搆藕 臚堆爅鰕平靛8挳竅p 饉"(恽迬箆┅.55ガ敍R史s盱YI2 聉證胤^*馻(AE0!QQ"x羷絜Η韩活棶陒U捉汉汉簑vv3 b柤P!勮凓癘"鬊忇W5K寠嗿j;;鐋I?镸篐7巂汭燔肼滼垏粓UkM礜訳F刺杉t磔藖;JS汼帏t_繈1q}桕7焬t 5:zW酋%Z9戔,藂u I融儦C4靦荶&皴仉搩 > -诗{!A]4QgX銷k悤澅 V逜篡J+8鍯.d己峏5狮`湮QS乪YFや=D抻秼瑙筐hE,靮j鐋 =焆扁}.q洇祒o\枩"樊W7"委觍H0懊馥 e+ 獼T砗脃籃в靔钢4担蚲褂鍫pp/X帼b<熈3弾>庮洤恕!飐?|2镳k&c寨`;{狣鉯xxJ&壴;鑾^禝"齤H圁楰$D虜q:闆116C+皝P况耬柀sU&V腯P休-u籿郁!< 蜦凸xa沅鮭8y┛k捀I:擮{魫廳D娖6灳 @孕鼙5E1_營3i$xc"嶚?b坖2(脄斕鸵bz檒BH絩樵8駧pw毋i ;鞒蒡;S鍢H汇锊6浭ZX最wt]镨轰鎹帯隣b 4奱X柉 繦┎n抖az%顴袁:e驸晟)z滨薩趬麪J距 g腵>嵼( 6盡謰+'維8滧Gf4Oι :劽洂8唰1懥甋B-c(u€m豩+.浜%c砖:! 嫭(q覝bI芟之 ,@务苡.觢:X5*椺津抖櫋V$謨s詊)j堍qP[睃眈硡o耻儯6蘁阖嚐濊垶寋ucmZ墋!遤v-①鐹(禯<偔 K⑻"2郅鯬r梀O=鹴4瘐?F^ L7^ 祭塦P虳嘐鯤;€Aq涅溝乩a隬1 `淈碉//聃'仃拐 ^#P Oj# i哘+N{a儘Q*XbEH三,P;怭w( 憂 箌駻 颉z|=1帨C9刪7崚9蛖剌}頊a/记[0#譵鱶絅瘒均棾Z鵘v g定r*锥費瀺 嘣痞nm沄){扰骼JLp 庒Y8撅卬鐵瞿B蘹co竈骲恓雘.殢Za+腫C誛<AG胝Tu⒅`$V`憱i郸-- m#痂J細扛z缃驱拢楚誠;M諻> 濆W釓g1躤澼刨:U濯\T袶狤玴V 6洕&鰢|頰a蝢{=忦z.\碌 kㄇ3魆恛/p礻g椶-皴.,?抂}qU拘/拷 w!氟訰吼麶 Gy笞偎st楋KxOC5垐Hk`v琟:唔0泱9i7 nj0F唆z跟靲uXG1葢犊碟{z肟~ 函jZ治?窤邶3#hi1銮樊%" n 韆Jbx 釁 {a傹鼚z鷠x~x`蟨 炑)琕啝N忉8櫀h呏陥Zm韒+:坨語Z韊說VMA5\Ka努毻Z 侌$h 異~#]襭-奺亮  謉ο? 女{;鳘涒褗BZ嘲:$n曻M腗$D歀6Kt{BL毂裸嶍泠函韦~ !錟l漠怓+儳U埵麨&憟榶跁K淘/僂< ~y':枘|€=抚pGw/.E孛,Xu坟"ry芳U[n齍v阒箍m丷钗猻67邃"ND傮 焹纫*铺0HsH機6熶姩Z疵粚躯Or垨U-j牜j* /f荠\v踹$" ~0扌!F[F0峿扉|迟M=①m翲jX$Tw垵 %躊&觔輆tu 浊~奎h|q({騊H#姏 娓菥C8=[10 循卷燙喷渟h嚥(玝擌瀅q)忩钀.jL玷T彎w"pR.蘨2澫 叙屁(犮+^瞙o g⒂up 扲E埣⑻(='诱鄞苼┊O│-SK鯼Zo4謁*i獠j*璪(EZZ欱雂貛隳蠅m:)q0A[ Am匵9l趗C趘鑕踑;41^ぷ>'}灴O秣摞}/韴#.f]蓵柍Jv9悝菰b軌袾虃g;煁J1畕CA赃筜)7枃籔/$k磸|T蕹{蟨>榍続#sTg'nfおHnò禮 抱軨氹*G6.冉覝-8傮崨l疑=蟥潀O鹏8Jp(^NY3]: -/苁/杯誶皑4j礔 畗浂VK窙A,BIМL 朸楋JJJ塒UR閤&瀻e劐 :h4?}/螦甙y巇CB鉼塇裡]裊Z祥Z.S眻2tY若9 麽鏭8t`x蜅Wou憬 笖4(盲腵醎笮{Q,| 麰幔%t2RH珷滅(骂Z铛_秘6俎=驮,蚫4eF3M92E;舨G&駅Pw醇}w~ 1 熎绤礝N"錛瀥5斉鴝諀 纉2@ 4qz 蕅<▉ FW(u紸麊'黣誘瓅Y36*噩郯怽宣j笄欒鋥餛 縀憫 L騀%d12<焷鲢csS#L嚺q6橞h>#ct瞕揖P?恶疈U踗鮶炫鄠*奣擷"9%El驔"鐮莃r _.<бZ/萻教椸TL籬掣蝰罽镟;u庿躜B暞V团3U畳I1v埣I澚燍覃枣a卂櫙^&)5茅iET$Y抏)')R^hz 4N譼 i€繆訽>琵=煋3/Xc祋6nE3w7t|恪鼒}衾Z枷忒遌n輎稏株泃m觧o筏vr揔l 鱢顳ZS媡}獠}懡xIJ\岑魔鎔#醞r淣幩c偀汲{髩幻5vZ淼醯璵梫Wv佥莃t囘>尙M甅镀U螎吓B\4 O'/EF,t^aG蜽|▄^疓诒:簱}4桦v绌板} endstream endobj 1419 0 obj<>stream H塗U}l)q^:0漣竷火1暕埗碍隯─)剢喠蔇穲E亜|;鲑>熛g鹟悄鲑珞座|>;v$$█盢*(碿毚亢〆6橐碷鴒螼希Wz轌稃<縒璟絁玼鶱G轻埴'N紇鷷}g鷡鹗J^喺薣譶>勹蝽涗m脲[_@6¬┱j7殰枴伭敝輌具猴鍡躾谫趇炊緀谗z鞫秿幎>輈m掉[-鳋窘扟璲V┲║氪T麤UomQ通T薯T苞}uJ]V汐梀錠輞&跟萰X褆 ~叉貧辡澫撖涡赸k媖匠N\wm 贏-秪脄鐔#7钯磜觼M囅5緖Pwbs'輗c薾=顐1諿蹘#;袓h5{韹;^1汲y梛W喵緔|Y+k彗錩臧槂u"3砦yrU縓 W酛9Q1)|. `+耖笮?粵粇E橎ㄞ靵槟h1!" 襹毾纟,窻D洕IG?A嫩SK 75]苭盢€u:Bo婍埿>}p(喷麒颪}V剓荦/犗ɑ豰籱9挨.玼墲@|;絅綁!X涶疣Qヶ芖u焝M5掞赇 ] %髼/u^CY項胍菰4O&泿h?鵋7WK* -[K&霍鬉鴅p|3灇ф*賦惙欂ax蠕w跴畲{L搊48鑱窬^7z&1€0)k鞉郣-p頫}獜F裃罵u9<齏€J楮o阕+{%籜+蜰Vg姞8s懟_[3h1i.噑齦`{廨縺u鹻宴v [蘻'p庼S?^疑麞媚'鈗(3< 嚽C羳"Zz}M窞桎椇o詇匸浨貶拝"蓅J继.uD↘S礘2-蛫3鈚¬獤げPB%55 CB€G<'3瀸;錖偆嬠`-Ha(F醊茈<9邟J仐r,萔g搵餦潶jh*係p0 8+c6Ag|CN4靥fj半盦虁1齿fsZ佊7岯讼ti挫_錷^I+P捯睷%4椖+⑴d佀鐁 *倲罃蔖%(QE<<瀠e=v[| 钪.薿帅赔號8W,漬6噦幮tFaiS毱貴P/嚜-U+.伢f3#龕6恌4醕榖蹾痲G蝿贡#3柮x纯Y,虔洘r螻$'拡,4 厌`xWf滇i躧o~咨彇4}}驉|柴o厜o洵:蟴x2-P鈯旵5"臲 -迸 瘓PFH %2迨 >駢琊#cS$6芚`噆<劊x Pt卟(璉1Я# 戉朒0 C懶J宩X哻2馮,伺@4泲蝠,M盅:9閽皰絗A茦0孈=iD〒O$岯Pκ+灏抡碫[m嗟趬揻鍜,*檍|S4ld赽蘌盟厒,盛怣部F5@}y败F!4岡z—T敗 墾╲2}蓟馠摡R U >T6pa罡圇y_$绤`#瞧c射f▂歇Gt0g宍.&N9壆逝%|痩6释Fm 湒zR/譑餍$B顎=屢 Qnwdd落捈 悞nr(嚟3垓,穔p4穗`簷磬唤5uB朕苧谩,茸P鵝<儥c棛#3C魏-n嬢>颋蒹3蘯1=S>均V$恁7Sd2B皺"WJ敃畗M坌菒@0!炴鑨帋Rh4碕挊疄}$U嵤『醉u穡誄罢儃n岆:l;\ U羪/汍fL鴵)1红蕡揋翗*譈筬辑b*.燴砅S啜劾⒅zv孜"7J塕-r叞I肘s9K劜檒斆G8 懚⒋% Qa6w璬5璾魂T]]_烞盆鬍眏6]┪砼.盙轊儑 c瑶+皇&賃顙G蠌kq浠Z>慱W舠))甁脕jo 緀宣洒u锶yD揯M<囁)柽O =馆6礪昺B5秹怕D逥j/ !!m韅}v"郷,羹=丩hO Z賖'┥讟 ] $t撪v摃_#E49阽6 ;Z稫肢=鎑=F諧麅确B€2 鲿a)[惠nЩ>TP遴绝唢#]S桽 譱%d8NP 酘/釽-<}荽@;黱翸椔64l嬑蟖Ws讑"Tm鐤6》秋泯nZ匂汻Mn%E箂q$(O厣亓-13>}IT&s摘.蹯蹫a┤C16k{j8厮垓VUm礫誑睆亟鑯竜 [顤诲.P6煕捧oL2蝤埀M詭8Z謯瓨厠科"Bfc褥-9V,|):嶋萻z5e8~kR\蹿計?'逤飘熼凯}踉匂|鸲丢療<乕葮缍3<#W蕸sAVf妡9幤J錮/昻e师R梕YJy+殒v麷鼼O地 5j-濪=贕RA氏x(锺&<盖撐儓潼2Y!藅僎QF峯飩湲韷v褈=鵯&1占儜戺鯾D? ?榵S痝?槧P彽o缻"僿 dD臆9H43diq8Rp f韮鉾?A>俷烜鎻<e棣$b窊 &谅闪唐囎堽z黦堽:! }鉢B幐湊4iC笡,17泓€9a衟F4}愂F瞈=梕r\6抍rl枀u輴`(|拪抰S便T岌 :~湂 Q1&潒J11&騌L娏称辀峩遣k\&F谴庼u凷,Yjv榨恨错.0jo'W緈陼;uu]]嘾祴杤騱皚~忣閪燙▌篢縙BK 贮<~ i ,6敹 貔莋 鱋dй<记懶栦.训w愍F8s涙.慦屃+募}丫h!f(i咎]/虉,葎菥}w#C檟牻衈铒諥n謰籊豎x签UДp走?B&幙dHg3~D兹*Y騃*Y陿#尙嬾葽&N襛| 紫霙C忟獘u,Us,!暙宻l鋒垺顐+n&崼It*ic*Ll韣蜪S缦vb莙b''q垴_$'='mO;"F%P51 毷廆BbwqwH庰櫮泃銌|蝼賿泖碂鱹掮娾g犹tf唼)饨7#籍眏MA擹I夼挴@儀1:練:9齑僉 y捰篩,鈍M嚓遂[6Nng媁昀-w隍z("芲ON6繖J?8沑H@t鲲駰襈 \Z蒎僃辒<頴<}h 貺踦戅P鬎cB8鍡技搘9+gN尥慌€ T$潬Sm2X删a鷣=QtG鶰扈PjN2Q3\羚]吾犊簧AOf荧@_當莉室J6 N昰5mW(a|鳕qu莆9w鉌u铺鑁'忟兣藡{|缟Z檢掖鄵鐂鰊V雰烹L郍 褛騲驩┠g癉杘.欘pmuVR蝋鬞貄.暭8杷e^n嚷栜8洇,,@劗l..华聩妪蛷S聩欲ヒ2撑萷#& .听鮝芆媒L%> 謧遮俰衁焩,鴾黍L:1颁_S摣5羝, 感V3宰L榃鞈n俧己鵌*y+鵞\<=s鳄T虻Xj鮁`弓V_$"珸>RClH$垈豩"\%_M耐鏢珂?L'`铠倌XG\嘷箴j]咃6釤崓涂3g搰6蝝莋猝訙蘨u\4龁誸狖8n'&#蛡"窩欠}3鞃鴺1:揪Q&鼢w3粷糄6鲃R澁"#魝唄b咗 p\鴽殤1頔Z蔢 0逆vj"-o 諱吱獔0 厱*m懳PbU鋃U=pM} 4)s欤,h矧%4K7舢ZW=Pq8T磽馑Uej5+乛*錥Y琓R魊ΔS}苀,醹q<叇}>V襶呾懜N欵籦W糺 N腃l獇饊}鷰o嶛S臉j7钁4Ω0錑5挎裿垹\ X, 錖Y牴*美{+%pm棷'鞹+姯}頚]IB鍞巅炿貣?肅茋籾詃A“偮0硤櫿藿奮i絊镶\禞 I癚"宗羠y蛣4k3珩*澓 $偠7.n渒机壋罎?烲&衍_貓礁莼婨櫛n茂9泒沗佁Z燀U{€@璛屫y|墺嗲y狩妮氂vMZ蛄艑j ㄉL渃親1郈<1]髖&@腣8/$3IHY祉頌曂d-''dD蚹 ざh媚_埖50鰌#?(9碈筶G叓唃罐爁HcK又oN13,[葼L昊X$6椭*艜jO"茶収~X |皃鏰F?k~枱夵(飌脷鹏稠C猪+]US粴幤澢焴/7串Β:/譲矒j阑BZ4W刴 €m鸝蟼姴 ~%狣9怅u嶅枫欲3i,0謋I44kU2&蚖Y唀綬4嬕蚵{&n糛4鶪褒~ 刼摏ef軜.W瓷>侓 -w 駾>KIQBO烰e蹼兘'82>pG裈歛袶_w{庒枛u ^夆,[H硱棃蟩莌#?撽織椧>$uO縤Oqkk舞嘆';!UU賅皚Y*厮漹鳡搃岀:6枚'p+0園KE%泗鲯糸mY搦m: 敒;Bcカ儘廤;崧诎嫘僓o.椪"鳅埕€蓖4塅9( !褆6l@K濳^L[-5lY襊r%ろ+迣}閬閆甿过閲赿廅祗LP 滴(骍勆g沇!tz稶鹚Q9 ,蘧嬣課櫱竬鉦鶉€沆8娐(3jx 8 "儅Y柣妭>斲敢墚x崰 E狧遒隤a譻Rj徣=(T鑚烜踾淟煏T税C觪()+D}洗兀2_~縨[W/VXfQ@-偐惻A闗€齲跜杣匕Yl];[沞N仲N,'!["%E駰$EM什,箥旌^Y=t縙M穈Ca:(絘嚧.-6臁#丆A各蝌渟削s鲵.[缇涴p謠g#孩甝i1褘槖A梥|%&i*怐憘4a06擞b㈱B猅@> 箫籹X;aGwO} 殾;嵯Cw鬮e哱L挋啌819醩y戉兘 u瓔価悫$U%詭$)K4砳6侎V}U :({搓8鲱3戣D嚐窬鋶弨B訜 q禒|臰下F~螫p璀H綨*tzF鉚V""j峑襎掙u U刏UL馶旳K$)B4J赽l劚&遻∵骰囤2踡 +N}*翩N) ~馅锄E$壷>g4罚tud玚鍗湒A磳<7隬K€`1嬂牔鏿炆L盌I<漡p篇"R5扡` 穤p;8}紗燵"鄠5pgp榹餜捌h?}静\m賄榲王侜戋恦9爵翊{盄绰b奦1 P羻j鬜=Sv鄇u 呢&6軰=b &8筕;敞危剳剳聵徭亹瀦奖姰;8葜辫罴V!乭圵疝R/阄芬H+莞<晿琇$懫2p]乓$B/Uρ㎏ +,.坉;墒晤C4歩}D3隲SO孆'<€6缹绿f:+烫罫:剻虡3"!甜!藹潽眑炉@瘶2A&X 犩~q?8雚€╆G榋茝q饫<楟/8嗫灅/蚰樆畹A董2P坾,渀=*劼蓅 溣砫f1蹈埾枽貍 垬 x蜷?{焿璓m3P*韪&粜AOkA蔢Fg恜*m襆筬芴43zv%g嫣|泃耡〈u晭$!臵A]r歬牣澁紟鲎 謋[6c=8 J/iT厘,JR镢b+ K#,-RD訆-*i踲蕽騔骨羰]篊u(回 o,'其揂犰鉻>$荒/⒊髪緮40絟-$闛P滟_喏N搛Oz'^餙鴕鋳菠鉏7H砽 ""X+U盏Z]NAI幩|E$C(9穚R賑穙$ⅦQ筮変陿'%\-鐳僗≯ 骗よf_5譙雈wl嘴6HQ麤 1|鯺雗8!J臨 傟啎朼En}顐=\H- 煞n%⑦编诊E姬G$V瓾1㏑g%Vb齈;uM窑茦詯狯R#窕6驆H垣蛷>異 %椔鵸f终`^] 缑/I鬄>stream H塗攜p荳6Z-D然Tr鸚RS嘔聰&觓BZ S6x  秛Y扺騤u璙襃浦嵴juK聡l!&觕歂埕/J'?陂L鏶Xg?殭螞呔龠丙掮鱹O乴hA 呮{G仅頦'N<n吖黯75B倍k髱廮{堋_ 龇'w`尧P|珫Q6|ah檚蟰=縢暇T譨嫿94_栾閦舎靭睬辝='D伌!葨d:嗢V 系 /(憲淅V涓镋恛罤 人鋗磤8U]鯉闛cg7钶樰魨6}坜堕犊l鰋薿+[-_9谵揞貣钬薇#賟o{埚縥鷚及S粨滓?w鰑.'?Uwnmф*蚨%€€-癝 Th@ 盾挂%o7(*囅靬 hQF褍r婻-邁4袔v薧e7玶姫>!CC諁珷Uz謙h騜"櫆L$餦T"8爍幡匓荖j?羱%Pz渲鮾╖zG4=憺皑p1-+|C梠攇k礿鮎e4[糡琁U‐眧1U 狢稊塸Pa栔/鉭>'@wJ洯K3旿Q鐂Xv 僗f醭L誟κT瓨h6嵿冹0m蜒杚珴磽6睵6暑不芣4呇T繧忄/pX#zr>壣2呢R9R%.オ綵k 改噩幫灁'鍤︹X渞茰D/j5zi>欖L&蒁"椨N└蠨垬&X6p!!泻v%T> 煯r誤曢滖=扠⒉未K蹞n 欬澫B挻簩^蘥 兠 连7 龃S磄9梽至 U.&y?鶎 F傑摿贬`8(飺澸↗辝褉煭漃俹9鶊幦煚j(!嶈网騆喩$!5I S杉>熖A 熋馚眽%樣9&鉑{w奐bI妭XhO4庋{"鸣漫0]謺k≮r╛蕤Op7罞 n"脓袖鉩覵黡j 汮 搃b鵵蟹燺鹫]G賾穳,mI 鳳朽3榧&:F帒.'G侲o仱艵2;灖!〆疣?毰zzΘ梖劰%\By](蟜_籀鑙l;錪鄿7膭麬 a8#y噹wZ1+颚 鐕垀8g鎙澄+探冀娍浖澖.輼絭橼衣*V浸烒S奆$蒃2\6 嬦A筓319b>樋;!,阈搤蔆S4錽2c蘕p尦c詼掗剺鉨<蟙2S鈘#鑳E釢q暼櫝-榒n2 齠澾L蹨垂,悪"=詐瀳7忮|h湻yyo惹脆- p"镠#bT宒爀1皍齓<+錘*酵wG皨,諶%榢1U浨U+RV罖:磬棜2/艴9/遵[vty7 粈糢~ 5M慜9幗く3]鉯茠V3>虤躒漿葬鮜QU1T潼Y熦歂竊┢\~!h騔u+E.襡鯔X59垁狝蟯餢s7鯙tS'莠//.6缩[EL簓G窯芗f3氙 ,7坏,%:E*邃莤尫[(緺驻7ym敁t挻1c~S8'F&]跇-彆5j迌yCW墔俑P幼RA藱b甈鳰徶岚弿红n硍^佯剐i怃)A:?S 嫸e闿尯竤W僕羮堸擵n鑇V*縳€/.u緔侯,;J都Y€ 0$噲!械4 尞閛易S跫試鶵闱}:>h4寖c}4F9艦$0鞏{垣Y;騕€厼晱aU?Y '騣鄡'#k 薹W磊挤w馣?i ,62?碾.褿旱磋衤k=w 糣譙鸡扖' Y&k9坢n!碊\鴬韭K|^愐y1椗>愲涗%U黚,泴篷TT弼P^bJ胘鍲酯 蛮殹ahX疉赉w邍韵6sy襙毾{锸麇煌|迥YTW>E了`E 﨣t祬8n濁νzH穮r[毿@7葿n挿R栰6沴wfg3c/#贃錭贃瘨e蓶%Y栧蹖澅g&K 圅眪)叴悧錉y/Oi鮾$l潱w淆旋谫掘輕_Vp^躼踼=縹佤靼6嵇3竮K5%##9+g嗍Tu/0 ]M谦ZMk銒窚[0w案]P ZA[薻糣捺 X!#"L@癆~u埘t谖蠞+cy圹虞額''薒廀91;杣ml鯂鼳鱄;拼c邃 R!Rcj@ ⑤皢i醈e`2姦(濼韆h忂俾莸诪.{藶;=髗铙K.,,q欙虃綇0#觜鴀頭欨0簿躛 16m覭沦倨辐犳l(殜1,喡{ 峋頥技廑I硕vO潨廨J%叫鎀Ne嫲F姫G7莰7醎齆易隫 聙舻+韸ZiU氬V筜>e&褈硟鞧颗?萎S涗羏(8 'V膔,栢\傕%辻玫V8 骰-跡浆蒠uX:$t]愻€&R敄芷d诞w饉蝏 2ePZL媕鸝b邎u尠(|奜#韾云鎌`醐qg 2澤'膿鉘铚曤# 殳甘队*2蛿m悹b/抔舙t)%M稄瀑1:蔔t膸S恾 3- <田sQ拫潏Y 侁m5T€5Z誀淘掙9€7吊w鲫%献Mu遷選<墣懮$.硝胕`r9荒骷縒;$L劊駂l/ ls金慀x]讯淂E唹 ;秦)~/U镙燇握#徎%碫G@DN,`bA(譆拊juQ!EEl壀ㄖ伋掙躖懦y腶+睮芙披胿弆 右-蚔蛠2刪 榒[侫t邷& RO臅0慙枊L UL3<揼髾荦/VM蚏鹙焚W芇罚夢 駠蠐[g伋娃镝顭躓灝4j 梛 憭P_璡,嫒"椼P!(枺c?*@蒊1#c鎙尦K僀€8 ?-襯抣$)昒2a渋D赚+ 迒ΨL牌d[俼楄">%П轿慴J|:鲤eP咾h珸梒a荦吴乬槁>酒y雄x礨-鶽害u4璭6{ ^zCiB2K輼碅马 逋u黽點碈 ︹T,汈tcx钒M烨"恏2Mう跦蟳琑獣2Y$謯E<渚簉33w汘S鵇煈71礝 8筯>%N@趤邮鱯f蜝?]酮H4懧蕦 伴箠U堂ty眕纖&皘 F顮N7稴kd绫=(崍綸W@{*f觝--k熭Ye鄖斕R軖鐆嬠拿u咆ll%&9枡馩 =?儠遦瘡Bdhx虨Cm至 udC誸菻2⒇襵傐錨盙騐舅u8#1-$慸J0硡ez朗蛩D_qν肾虦鬐鰌lMtL揳夛z匩A穗湚m"pD> r&Iw忐猈剴W剈(满ur J0詹t锤Gl*疯=JO9枬O* 蛮 ?r%,蘆腫a"赶%羢$2>埞 鵗煋谔 G醚51}鯠9'N缱Nc旉尐略狡顅¬ 莎蛘徎鰤 簳j4m奚[<芠V=Q 砂萊Ko鑫*&狸xJ, 4扊p憧步 %短)~虞黵窈鸀*笪橃尙蘩鑳諬陇Q_磀怪h4Q$8贿XkB%P鈪戙獣lU梨侀隋 Y?Ml滗V!M閚S%朵) j怼z玚U╆(PB撋&撋黿7肚闵坫駒&摪蒼 X碯U=韗C '8滉恕'-[Z︰驣怊稞y炵書vT襬<`t6打Nl刊梲卷鶠玺硁搣b_櫲CJ奱蝠9彽p1M雞%獲v肼鈰捏蘼x昛_f"袿邢g3ミ(x;娬坪0牊醰d 悄AN邌炻终)-S*FoV雃枧5(釁%3嚗笟U .\n綟糵簵) |u3軝臈B<竧h絨"(盤饃嚸u雟簹董i牡翎鉘q乛¤暿艶e胶·奒 {奅.婗猈 瘘潓息巫伷鬽㈠^ 潄=<庺1媵叔铝rt滻咄跽P (5P<賾潶%€`釿&W凧㏄7毸姞镳Ipawy; L喩幈骺营P=-厽撌樲O錀2P奭駂&鈉爦8i徣$裮鑀;駼";4bG %& B诃*F呠(b璓i!-.V晻璏蛜鐨鮶 $楒&;1pbp鮱y 壗Z甘熳6wK蒢繄嘖6愸o臰@6*kヵ襧m赈傯2傚B訧%◢+R嗰"1集J屟-1Ro6緸+'蛎軄;rp;匐7 Oa.KK:&垵吜笢 :Fh舨4艀<9仩笐 鹉[ 睉鑰扪萅$鶹N9+ *L丵& 埓\U62甘l3 =焆喀?滜x?" q踐◣雀瘍 l*y淐q6碓鞖]狈2W-t呐8;棃Io淦檤 w嶯vA氻锒錻a$荝(E蚉饏鐍4'丶臲\忢5z@7u絁娔Q鎖3y_1cX 虑\蘁確谬y(*宅4驮-e^酣瑦臮脝&盿BsAWo銀籼'来?繚>>O袂.`[z萱(媢Wr%O馯\鮝 ms猾Ω鹊踎5櫖5.06韗XN颙W&蚍庌盆.1斊鰔砳6m蒻-7P#r'1\鐰鴳90濴Kv嘓) 鬿垂4Y,7剢Pk惁*0驐/€7幀S葜D]詺骦6陵瘦泎2蔵]撽龊O酥/役s`崀vl蜖'`X蚵11++厦6=IneG湠 .胗裘箃}x烢秲鱗t庭sz2货Q靄z]礣玞潍f旖帣M仩:*胦禟猼]烠呙驄ox锭槉疹ゝ蹅0郹` ?p敲w鍼瘿3搤菪$橌涅,04軪p 芌K筹E>Ko违 UR抑+$蚳:[` ^o08殺夌>鲅飃!藁囪 endstream endobj 1421 0 obj<>stream H塨d`ad`dd攑貅tww譾L) I1N4M37162蒊恌!#鰶矸寨]?堪~W!佚=J垇墤岩9繝(3=A#YS寥览B!㏑+縓俩4,5/=QO1'GX(8胆,5E2 郹(``fdd葬麨黩g掕K6岈蝜|?L緵p{;秣縞 佚鳶`,@o endstream endobj 1422 0 obj<>stream Adobed€      ""A g  s!1AQa"q2憽盉#罵厌3b$r傫%C4S挗瞔s5D'摚6Tdt靡& 剶EFごV覷(蜚竽凿鬳u厱サ耪艴fv問Χ浦骣7GWgw嚄Х亲琪8HXhx垬ǜ蓉桫)9IYiy墮┕少轾*:JZjz姎授犏m!1AQa"q亼2”裂#BRbr3$4C扴%猜s5釪T &6E'dtU7颍趁()鱼髣敜茨凿鬳u厱サ耪艴FVfv問Χ浦骣GWgw嚄Х亲琪8HXhx垬ǜ蓉桫9IYiy墮┕少轾*:JZjz姎授犏 ?鮋LU亂Bk]0 Fc鯝8O?倔灟|纳;J YR粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Lv*镉:圀枯娀粑↑秣b3;Mj鲞钆Q鷚烏&?C)>R吨檓n@嗢策隃(?鎳N}硄父懻S情!甾P驅綽湤轹啉| 灴;L$0ー(]匵8X趀>啐鰺#;魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎G居bo鸒娀魙葵?郌*镅锎麊*搆濫5h蚀B9;: So乻妍揩吮r 02zn佹5O/苘K籜d鋧瓍<鳝w] 颚嚝J廚襛XE掬酇d∝Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼咡j镮u?{жRy潲鰠趋r偬O)〖嫃){嚄裤無柞a`榖]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b瑆8簏囯!戕Z琬`垳 楖箕; U^巬奎c_諈俛娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姳咛O噺yk燍儧"p2_骘\1W竬{9駦V *霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*0?銔?葉糝=瀵镱o鴫郎浛惚q筐臹徨秫幺5齒X&Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬4!Hx鳀靠9库'%幣曲{嚄裤無柞a`榖]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b瑆8狱囯!戕Z琬`垳 楖箕; U^巬奎c_諈俛娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姳咛向噺yk燍儧"p2_骘\1W疯5齒癎b]娀oj斧x玐Wb]娀okv*霼孬盬b璚okv*霼孬盬b璚okv*霼糢孬X玿玐Wb]娀oj斧x玐Wb]娀oj斧x玐Wb]娀okv*霼孬盬b璚okv*霼孬盬b璚okv*霼孬盬b璪]娀v*霼糢璪]娀v*霼糢璪]娀v*霼糢琔孬盬b]姺姷\U糢琔孬盬b]姺姷姺姷娀v*霼孬盫馰盫馰盬b]姺姷姺姷娀v*霼孬盫馰盫馰盬b]娀v*****霼孬盫馰盫馰盬b]娀v**誵V馰盬b]娀v**誵V馰盬b]娀v***霼孬盬b[臵***霼孬盬b[臵***霼孬盬b[臵臸娀v*霼孬x玌臶臵臸娀v*霼孬x玌臶臵臸娀v*霼孬x玐Wb]娀oj斧x玐Wb]娀oj斧x玐Wb]娀okv*霼孬盬b璚okv*霼孬盬b璚okv*霼孬盬b璪]娀v*霼糢琔糢琔孬盬b]姺姷姺姷娀v*霼孬盫馰盫馰盬b]姺姷姺姷娀v*霼孬盫馰盫馰盬b]娀v*****霼孬盫馰盫馰盬b]姳? ?葉糝?瀵镱o鴫艗7莃泯釆匠A?>唼1铝S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qV臤LU碍姟;KA[檼1姢?橚^4桗!5齒O惋+侵士@軂y鵥/9挏U籵,M霎 g軳*帍髎曙鰋zk1Te挎7楊M#緢拨*溭闢穻授d捓猕挧h評臵┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qWT猱┡]S姾uN*隃U8qT兿肙魚糝C瀵镱o鴫郎浛惚q*鐾 9駦V(霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫聯mo:F+ㄝG札脇U傠髴%牔梠8鴏U俴髳赫驍睅;U=樯军U哵~ay婑婯∣縛(I畀頽蚽eyIN*姺纗b疇臸腷<1V孞z孶ise蚴馭鵌猶g鶅2+鶏;3Tb杋蜟k6@&] 秭[锱Y謮9∞ j)%{巆gZ4峵鸽攽繓?qN 憡v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼 箫黴?^*C瀵镱o鴫郎浛惚q*鼋耕副FuqWWuqWWuqV電礬U张]\U张]\U张]\U张]\U张]\U张]\U衡璚n斧U臶猕=[Y惭7:屔 c皤庶9clLz$ rw荞@阸C碳鸣规-p%练彶灭~#s姲鵧y厣3s諛遭啽Wb]娀v*霼孬盬b]娀u1U蠱%粔`v嶢褦袑U橓w蘘④橕躾鈼g/O"-r礳4鴹F*=+V凑:|4M些锱(亨WWj斧珚焊姾斧珚焊玼臵*赈*赈*赈*赈*赈*赈*輖V珚穃U*赈*赈*赈*輖V珚焊姾斧珚焊姾斧珚焊姾斧珚穃Uj斧珚焊姾斧珚焊姺\U*赈*赈*赈*赈*赈*赈j斧u臵*赈*赈*赈*赈j斧珚焊姾斧珚焊姾斧珚焊姾斧u臵*輖V珚焊姾斧珚焊姾斧u臵*赈*赈*赈*赈*赈*赈*輖V珚穃U*赈*赈*赈*輖V珚焊姾斧珚焊姾斧珚焊姾斧珚焊姺\U*赈*赈*赈*輖V珚焊姾斧珚焊姾斧珚焊姾斧珚焊姺\U*赈*赈*赈*輖V珚焊姾斧珚焊姾斧珚焊姾斧珚焊姺\U*赈*赈*赈*輖V珚焊姾斧珚焊姾斧珚焊姾斧珚焊姺\U*赈*赈*赈*輖V珚焊姾斧珚焊姾斧珚焊姾斧珚焊姺\U*赈*赈*赈*輖V珚焊姾斧珚焊姾斧珚焊姾斧珚焊姺\U*赈*赈*赈*輖V珚焊姾斧珚焊姾斧珚焊姾斧珚焊姺\U*赈*赈*赈*輖V珚焊姾釜C缑岌?^*/-s0s腘,楖箕;脞痠邢麖宬厞6浮张]\U张]\U张]\U8姾斧猶WWuqWWuqWWuqWWuN*赈*隃U衡=_Z惭`7z斔J:彪馱峺服r-薨yn.#Л(哞O電紘W诛旦嵠3!谤亍娀v*霼孬盬b]娀v*霼孬盬b]娀v*+姡t}rE擮ξ8歆c馱G)¥d彁殡D?Z鈼磇:溅眓穤|4,* 灍? ET酑珚礬U张]\U张]\U张]S姾斧珚骇uqWWuqWWuqWWuqWT猱*赈臸\U张]S姾斧珚焊姾斧珚焊qWWuqWT猱*赈*赈*赈*隃U张]\U8姾斧猶WWuqWWuqWWuqWWuN*赈*隃U张]\U张]\U张]\U张]S姾斧珚骇uqWWuN*赈*赈*赈*赈臸\U张]S姾斧珚焊姾斧珚焊qWWuqWT猱*赈臸\U张]\U张]\U张]\U8姾斧猶WWuqWWuqWWuqWWuN*赈*隃U张]\U8姾斧珚焊姾斧珚骇uqWWuN*赈*赈*赈*赈臸\U张]S姾斧珚骇uqWWuqWWuqWWuqWT猱*赈臸\U张]\U张]\U张]\U8姾斧猶WWuqWT猱*赈*赈*赈*隃U张]\U8玼臵*赈j斧珚穃U獪U张[*誑*赈*赈*赈*赈*赈*隃U衡璚uN*輖V珚焊玼臵*赈juqV電礢姾斧珚焊姾斧珚焊姾斧珚骇n斧U臸S姺\U*輖V珚焊玼臵┡]\U衡璗猱*赈*赈*赈*赈*赈臶*誵WT猸j斧珚穃U*輖V猶WWn斧U8姾斧珚焊姾斧珚焊姾斧猶V電礬U8玼臵*赈j斧珚穃U獪U张[*誑*赈*赈*赈*赈*赈*隃U衡璚uN*憏稔8育紡薩哕唏亽7莃泯|U黶砜醏嵁*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*釦槄P*I*[",锨鴹/u8.y喿蘓陃F比7栈┡)*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀H俭yRS瀵镱o鴫郎惚q*=宬厒6斧珚焊姾斧珚焊姾斧珚焊姾斧珚瓂52HBX瀫 U'婵熯蛕亰軕й眾菸*榴C盬b]娀i ┡^郭Y4鷣M_R豲fow~y", 5║=盬栤]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼阓戣 去P窈褦髋X哝熶雐咍 KZ毚皫R鸼%(ov*霼孬盬b颍 ~-領:uA鼚偾衽/σE慍X*輖WWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWmAcA姞5MN襾71BGfp輮敖K筮6劋RI3帯P语8湊禣鳉沥O鄎T/ 浞姭9# 遡臤吹峲T矣Dvb^鋦T臲f擓曞鞹oyW爺?鹪臲2ら闌"2怓*uqWWuqWWuqWWuqU捾EgT"*J育臸鶭育臷u+A篂/1姭+€華S袔n斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊娀P:叒挱4`帬芭Z%i孇 b%i孇 b椒暩E*;u'V*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*豏zb3^劾i4逼蔪1T9状衖趸z艵臮V瞹掆8臦b2G!格*陡姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊獿罣& 詼UG魨/1娀魨/1娀魨/1姱婈腓荷N糎4臮+姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾釜E鐭O鬮愹-s0s腘K嫃躐W県匡奎c\,槴盬b]娀v*霼孬盬b]娀y_缈澠漛47I健1鴟*E(ov*霼孬盫檪姕U擾攦婋汈 v澢弨/i娂鹰燏旺盬朾]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼懟浚z瓄另娂c髃騾x竟%玀21W\P*霼孬盬bQLU銰踁孢x夑c瘊1K1Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姸猉衎珻歾/暳奿={∫( gx讬;递k擵,瓘歆冸鱞釭筼R嶷W=茉鈫€*霼孬盬b獿jw#|U4腰溪h t霗"#礿ф*麸.蜠芘-v躂;渠絿@熸謾0)庚Y{b〇*霼孬盬b^G9+莂i槌%d?dxg昼~奎镒8獚遢洽h鈼譄條[硕 膾`Z搳U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* U櫘-yIY朵|qT冯s縚鈬}n麟U潂E躂Uy椥m$b椧М*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姽T睜臹u鶃e迤k 8 "r:焞U鉠哝棙鯍~眝询a罯U嶬u14騂|Y壟 \郫#麾珫釻.娩qT锼~i誰镯+菇65e.J怷)奯\L( Uf*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀J<弈h讋lDM概_#-涨鸁8[~奎躯鄮*/櫎懙oQ勹延懎6/m臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬簶娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀H夻徸奀始谍8/髈黺.?着^立駥a`屌]娀v*霼孬盬b]娀v*霼痥phVjw'鱬)jx灷|*'\謌/φ.峞潽}嘸>C 盬b]娀h 獐]鼫7帪`栮ko碐響後奮霴輮祳集笙ェW栤]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼阓戄n綜z*4臹鵟l欬沥';?矗们y5躡嘼]娀v*徯u粛 J旭;彜b4=n運矉Q5奺鋥凃(霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲藳榤"k洍X釋U檷x?<畊_& _瞗辄yI1v$避摴8∝Wb]娀v*霼孬盩f彫辢颩暊榳S冰庿-?8 -4齕嵕聑,/雠/H;b璪]娀ygf?饷W卋嘼7b案$獐.垮鈻C娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bW/*唐涵嫙踱劮v*"圏鞪鈫/ハ\U琔孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姲蜲=慑9ml[嶕錌炾煷? U骾%樥墿'8∝WbQZGk U鯸lJ*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀J<5琰blU"鼯淧*霼鞜髮鈲玏?諍^蹔v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬獲O€'钆^蜙曛稲郗%cr爾;C信j蚯臸C?餑d邧煖:嚊5堡]矍F搾扢F*鯇U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*抷唼9<_哕唏亽6莃泯|U7o,QxWb]娀v*霼孬盬b]娂?蜑佳鵽鹇D揝d}豍顸P霼孬盬bY垮G怺蚖铰耕b 匎鸯凐鈼 *―Q@ @v*蜻曷嚃b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼?j脘1W猔K盫E1# 0=8蚠 7昽讨帼徆%?蕒聠娀v*霼孬|豠朹/\7紗客鸆娇]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bT/镯綦w技q糂|座曺梣骐廎裪榍_叠SC 臸娀_io-鋫 Tie=A5臲^淁I鎇秫鮤(銑S匋凅K蹔x摽釆?$<D奜鮋跖X委cF┰m%匞(J僼黴V馱b]!袝u5VGq娋€:.猧~凎o赨癜飱^.臸娀y_g曷噮鈬b猈b案蕅W譄驇駚qK!罈b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲咫鬮瘡妓[盔b梑Y玟g)緯=p%琔孬盬b]娀v*霼孬盬b]娀v*霼孬盬bWF紭U蚩鏂黑蠘n-T匉*;m W;v*璱eqz-by罷淯3J馄奫豺謦c╖薸bSq歆鶈*沩煘┾]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盩N衿孧"8P*霼炜髰kUK陴%孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\O逻隉諍<恪q踽b偱]姵?鵎G蓨_H郖盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼$蠓黵'1W杫k燍儧"qd客狂馗_z鰦疔1厞3;v*霼孬盬b]娀v*霼 琷遍6r逰笉O貴*;苔鰇5"Y亟O佽>孶,臸娀v*嵮ti趸豻跶Yf`叼佧 U鯂<絤遨羲@>&钋Wb-廜泘琔甯Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀z忎徻葫 U陎Wbゞ<筸鍷 4涣洼Xta蚺_(牒4糈m肖惐1倬淧伵]娀v*霼リR閃q_蹝睟醽>淯踔嫭C璝C鋥彛1Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼眠a娋z=tt{@4b?輲?€臹k娀] RO" 棔TT搳綃?悕 [21PhE﨨哂锱/]4-?F圼樾$1窟L 瑉搳qV鶡U誊鰖0鬟a緅悬檬OK攴M韹j焨閵尉@约7 甄n青>肾>cx∝UK[┈鍷玣)4LXub/泃募Z 匄&O礼睱U孬盬蜤6霟諍/;Q48O丝鵊4弗愨]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫庄褗継/黸.3硦霼孬<鼘敟?鈼襣*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bP跐汛掣筤盌?丞8. 说岭#?N([娀f>F_6jen龙嵏%?h鯨R鶲O-4貐綄)K(+櫯Zj7qWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b〨?銒y|;CxW5W~琑霈U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\~V*]巺屈do讑XV)h榊1K U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*抷埝9}[瀵镱o鴫艗6莃泯|U牒7o蘒孬盬b]娀v*霼孬盬b 'T2K樆獈铸淯呡贓w妘嚽碍s2[謐^1笴詀V.ARUu;v*48"|攖鸙譶謸\ DUN琮)z祋Wb]娂敷捻i硚琔遑Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀z囦徻葫 U陎Wb*驈蠌& 跶 EY@剽浮孬盬b\EqW=鶏鉊橅#鷡信/`臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬焴sy澌{M窌PGTN眙襞_8 猱臰)yd`'}!鵪鵤o錢铕,跍偓在0e?壟,鞉z猱臸娀v*霼琔 猧栚党豞 ?琤瘶0紤/5iR霾|P诡躡琧;v*慰&家t-q`懇kyH啐o攸qK閃R琓雠Z臸娂據r+寚xf(v*猶W棢驇駚qK!臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b_|冩O]苂齡%孬盫y)J/\U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姤^m椧询[z淯莜*b^8銰辕鼄e啐)z*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盩N衽孧娋G〖U孬?>肢<縑){V*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b?e空?|}荁泾27肱,U孬>鼉敶+鈼Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼$蟑黵&1Hyw柨抗9库'%幣曲拄鲉唼1,xWb]娀v*霼孬盬bU踖]膳^?-┺蛒鈪貖{ *喞R漡薞跔,脛轀*栗}隟jJ9G偾LP梑┫搢峻`窄U肐鸛ヵ刾k #宧€臰b]娀y鐕KO鯊昱^_娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬▇I5兹b疨臸娀v*詯ゑ娗"昦靟W绳s螂鵶W赣_欤rC﨣n浮%臸娀v*霼憕^k怼kv譛溘b椪n(v躡玵Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀qu峑Y f>胹娋S筮腾贱軼凜A U孬墻*鰺萶$y栺j宛蹆貇LR"k古]娀v*霼孬盬bX祖?铁<读A簣z悷緶U蚶ㄙ禶H?1臸娀謝-哠:b挤 [K悼敱*涒斍v*騩忳喯齭娂7;R4呄'}c鵾(顭玚芭V,v獬呵O ~糢$后鎯jJ蛓#7齒?炭-葂纵H臩k/0i椷-蘊猘陌浠[娀v*霼孬盬b]娀p閵築z鵉槳M鏼OzS靬~琔+?薩蜈筐-1U瘙eynf棲S齲獃k℡輲V忧 > 1TK#.銼[娀v*霼孬盬b]娀v*筎兵EqU:E珸臨粡7瓒吐k葍{qTyu熞[枣=>黆o嫱郪+笌酐@bsG(狝臰2}Un*霼孬盬bW'_犫瘣K盔劵v*?#(O魞u臵臸娀v*霼wo觨姷7伵]榉伵\Q梤1U斧盬b]娀v*霼鬲 釆粌xb7漜a∞ =齒垀曼盉黆孬?6w/麲絪夝臸镍b 幐玐Wb]娀]纴褥Uk;Y祷慖fc誃U4喇*霼耘]娂惑籷i髈諈^_娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬I瘣臹]姾槴盬b$蛉氈-v%dG%;凍O褏^娀v*霼Θ輛a概_Tk+[抷H#氻奩%0+盬Su1Wb*阞]LU耘]姾槴盬b*霼耘]LU孬簶 裻 F揮I麷鹇瘹Pb嗰Wb┓旤件b 矣e應缌8K8K[u J@獿U耘]姾槴u1WSv*娋`D 褷 秋c黔>*鸣瘞(w5衽\]{淯鬫銯ヵ-$騢)z0+盬蜠糣霚*痨P霼J霽錅U鯊彗黗\R岓櫞.埤oT擣囲幀橇F*窨3咿嘍圼Bv纣棍*骫SW秸洖<摲鵯M>X豹襞[1U% 蘬媒qVG`牒來.潗轰<擃8レ^K吁朳MYE澭 O钬g榕^暠R= 阞*霼耘]娀v*€5剞jr1曣}攗8U憔i渶垢&]=I7coyΛKW$2LfcO燽劦bU辁馰鴮U臕臶-j鈁vhIf瀄娏^_輋鴯=廞奮夸咄#虅[蕕輗徤篵耘]姾槴u1WSpZ1V%嫦 5巠D鰿頺顉 */0k殭)e莆訋LU僯:<摕蜇淧 1V UiㄅQv:嵵瀔e4悷b1Vc蝟0i$,覌竰壏o『鈼K螳I譢Z‐6脵[*B狋#±*阞[^緼炉慄K盔劵v*#垮(O廿魤喇*霼耘]LU弝畚謣Q7WG溚碤|齯;橿oa!1U/鵜~b栙鄮*稆Y~c栙鄮*虖4J 杰#*侷$獐{嚞XZ齝蘔Oqy(鞜囅eX耘]姾槴u1WSmF沌娋y髼鎻槾齰授-3AJ?錹鶡 UFK7=ネ(dXS8U (:b嗰Wb瑑漱}占愰L姄0g+概)攸痼7v凗\U唑<速?z/淝灥O4蓌毘#z*瑴:淯闃耘]LU鬲咍蹙 \轍盌ⅴ樣 紬蜔髳 <蒓鱰碘~Ky颈鶏 \煬莺)陸+ U4a鼗T标I 珚孶kBWL魺1jZ9N箹;+}孬<锌?u2┅#呄佑鹋/_虔44G事`&j'賴斛1VBE0+v*阞^c S藷T'リ兿迾U#听頕*稆[枱Di繘^e汄じ7慤;娋晀巨-J譑穔碎T*馩7]\砙y}0=Wc睿*=KY空 :吥硴讻 疉玡塜 鴱讑究蜃黶-圏T揩喇*霼耘]LU孬簶W會y鶡S玄.v€H7J衋W仕qV錱y恾涢~搳瑳?酞劖舻[}5燶=螡m<(蘋rFGu1Wb*阞^鏼gH朲}嗣l"F懢ag3蘥筐Gp閧/臦?榝詍騀嶄=A臺M炦!乑*阞瑊T敢t 涬&醧8穮p芋兺nG輮+兲 U?8<忆}孬遼仼躩鉹濫%弾/蘜i蛹值IDj~术f>藠納蘝髳:吜h鬤V幜澍槒豣;拯桐 [P箳Pd睜 P h茿姱(1V O*o笈S}/蚙稊G詎G靻8?.?9.t3\c5憿砬篑\R鳕慹厓凄a 郩张]\U张]\U张ZwTRဠU釤滙_3闉_s%d渳P鳸,wbjI闚(v*霼孬盬b]姶c姵熕蚚,J癪3\i愵a俭汴:價懞/e矢P梑U-粫m瓟4唺*I臺D~X缅堊PMM翘Da)g渥uqWWuqWWuqWWuqU稍|馱驌j燇V$XWb]娀v*霼靇髱?揸?軎){Mp+珚c辵笈彅璏刨;锽>=皤孢4P驟珊詃%I鴅郃1BO娀v*霼孬盬bWE$81然哠B1W叠X齞Ri霖g弗膻鼳鑠+U臸\U张]\U鉥髴{瓘涂x(v*嬔哭鹢煰}m6%嶓p%鴵M攞淩鶉|襟}篆rJ[!帄=黐c槨孬盪|请臺]鵮9栠駢V臸\U张]\U张]\U张]\U张^39仪齠齒U鉞∝獫趋m蚺_^y_96麯`Jg\U张]\U张]娀|琦)T燅?諈X(v*忩稂t"眾窘'~ j斧珚盻蚾鵈佝糢蜮}憛 盪瞹搳緝<雖%Y軴褴:0.)xf巩揠譓〩d暫?旼(@猱臸娀v*霼鬲7F诛tK吔觘0抬稦鯽躡.3瓅榨f)1K5喇臸\U张]\U张X鳚g O琞|s亏P幀|O傗瘺<渔4]}sQz屿 (=囻聞v*霼孬盬bQ絳燶!嶦;佈噧{鯂燀|邋毁"濅Q,^c奯8^斧c|垸),%齒U傗嘼]娀v*霼鬲+G{砩殛臺a1轵Z臸\U孬兪蔿l€汼a猖鸐0璌R赫'k基Zi溤!馱b]娀v*霼磛崉1I誝v 獐i7.歄榅+,w`O`?-菆喇*霼张]\U 罂-烨а銑綺謚浗n眭 A虛9镅G虔€廿鐇∝WWZ虀糢踝麑宬Jc\U张]\U张]\U张]\U张]\U鉥髴Gk鯖鮞臫?籵*裆腇庐*赈*赅W卂:蔝'黗忰b;G鵶:秲-\U踣!KU臸\U婠j燍诊佝糢螋db呚獶WlU雨 S礳種痐1T*調u>"/递e}K[GT煲| 鼔)陗Ey棩瘜qT-玟鐧+屋Z熑峥V*孽 :隡撗緟|U孬盪k麔:t匠s箝娋狉渂骬樂倠r;0矧8焊U张]\ 冎u沵蜯F=攞*鵪蜑h阁>&~盅痚A P攂]姫ZZ蟵 傄'歋裀T猬核套€ _鏯刊2~Cy昑HY粡Qv臨=c蛩:D~蹬:幘椙OsLUT擿U嘝z鈬bń/U挂鋓:S剽↙U孬盬6}璠){MqWWuqT徫緇嬍赾2襺様訛槴瀛CQ冈頳窘ns膛櫩(C猱臷M:猢瀰鍗O^~m皇?灁A髄U榊﨏鶔b=e%聃)F8鳜%.#f瓠1T駽潭嬐b嶦%?v*胾=&驤撗 硖_(B猱臸娊[蛷mx 稃﹪8侅猫ル妫c乑*赆U;浉!掙sH眚斧?74j2j3摾"^蕽(I盬b\U恏~A5潦握 煈8蛆 "犎"V=紷qU 熑3CVH鈛-~霼庪>E拄m铐$彷恟Q#HC穛7娀i€aC娊框3蟁^+yv斧U臸\U张]\U张^O9 杤簜嶃L鼪|U∝WbSO*迃OV蹈=d'錦R|c姷\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U红橇[鮞瘞f溰J虬c吀V]溫/邐窘覡[k+xe%Q R壆*赈*赈*赈*赈*赈*赈*赈*赈*赈(渾xl譴U狲∝WM*魺?蔆(僻幤炕A矷镬弗詈^梘囤|+K訄→O|UZ絨V珚篅病奺F聟XTxo鍖:BwH^6煸! 鲻臹U娀g?捄庇li2釵倥/bF*陡姺Pf4 *O芭_2~fO4阬P拹痗膺3姳,P霼V挝k橐艺 撌x獛{麇潺杽墈*躩=hwD棍/F绲美t臯lb∕WI持!6簩K4L)F彂韸/颚_-╥湧覱陬腰麲*笮k姶垄槴锜煽;N6m[0撜摫:R想姾斧珚皁:.iW礿^]倠N催|=膳 猱臩(y>魍w烺U轎D}?溯'(穳e鈾臱無迮,樄8猸#*梜轢狱对醂T妑騨|戼iqD6!⑸M+\U呪嘼0é*;炭c南dx婖(z}1K+姷\Ur灴#娋G1v怄齲.臸姵鵌誉0)}N珚o髛煏l嶍岖潱寎 U/<藋鍷圃/诋vU鞁 P朾QZV晆%啚哰  U魪屣遢瘬睐m. 洄€,哺姾斧珚焊姾斧珚焊姾斧珚囱嫩樞撛臵鬭}臨O<携魶pC| )雠 馱b痩渪Tk;頷整B砍奮甸C鷱b}'臰*刄痎"槴珚稶碁*I=/炭9I鎹Y枑+:酚姳LP霼挠z暹菣0i千笊蝠_|R鱩撕n嘚稨倞r?6阸T墓=N*赈8YW劒$C,*>霼鐬w鼧吁祂$-ワZ??g枧^鱶5素槯N狑概覛彏*砸次胰j頹O壟VM*杉s狊祻佣,/R糨+驩墆j7O3*>淯=迭栻.霉v釜曪鋡曨w壓;謖Vmej杙%b5 >CV*赈*赈*赈*赈*窨畺?敕昱^9姪v,U踝枤篣#垖R樧uqWWuqWWlU蟑缈RV*纐C盩椏悃k鯇U跤!奦uqV-鏦cW碎鯢(]娀v*堄t蹗R;$2O)*敽o柭茌w}J朼皓餟8箪6猸#*務4-Z# N噊坣>G*疬蘝少t$}OG&k弧葶舚W檭QQ臸姴熕9I錧Q&56硲遂z7褗_O騐斦X镃姷\U张[歜 驩/⒀-诒[R徐\酐*蜍P霼挠g?晽>k"蜩44/鸒鞜E蟒煛掳i$J€鴱秃淯0,O\U珒憡盻8i^jJ蕚揿哾?靽韇瘽<湾丝._>潀2焻┏痜+臸娀v*玉j8馣+姾斧c}盬儈~y冸氦z\G鱲玏鍩炫^a姶M1W猖W,)怂 ;3LR"娰V璞F:* 竍姾斧`B旰U灟 Z,0′7#剽瘺2紙|#剹矞r墢o?,U塨嘼ㄍ耢u k◤嶵j鼛*%鮍e=\Ku臵d嵎dV>$qV窟i1U矯 咥'鱩#|乽^(S臸姵锶€V揵*1K鑣?铷郌*颋/髭缹U(遡1U跖Z*〃j橹疫\E ?GlU虔汓蛁鎚FMN錈屟波1BS娀L脊逅1.煣')[rOE購*7煽桗W昪V讋|s0┋?1K*.OS姯*豣:b?櫦&yCS1σ 潁 U蠓灱亄蛑B})GB<伵X(v*躵.矰J葎2瓣臺Q~]y庱鳃粯弗扺uqV 5棗$#G竨J麀*E(oh 獐g鼧蹈礯0陥%2蹻芦A鸏;鸼棻r犫(A姷\U衡-Q欧a>{狱Kj塵(%E乔|鍄g5岒Z\ =(R臸姡t-fm J埯萪#酷娋贩篕⊕=褽 >慭R靖姾斧珚焊姾斧珚焊姾釜M3鈌1Hy煐靠9库'%幣曲蒸忳*赈*赈*赈*赈*傋nE絽魔磎O1W捽(諒R+乁1Wb]姶MqWⅨ莪舻妍l_8U?*赈*赈*赈2?/W樷]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼榭掃j脘1WuqWWuqWWuqV1鶝-鳁o 槗0qW搜毃>亍v*霼孬盪)剒*|_v*D溝蘻(O1J2斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊Z氀cn漽b瘣缨襮B霼鬲/F^z叒业1O坆棱魻焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊娂 ̄r]+0∝VC*75h D 髷(眙襞/ㄡ;x肄 `**焊姾斧珚YE╗蒭p♀橨恾*'X疫I綗N梬侭匌8 娀M<ㄥ5SC鯓库C}k1*赈'髢狋Gネ哳椖趏|堍倶〖Uⅶ*鳠?#.沬鷝駅up?t歆忹,R絷猱*赈*赈璉L)VS袃娋a騫虍疾R蘒裏8臩!y嵓画[遰`掵pm)}O5~薾>GuqU勺~濕W蘝>cm{]歅k 簭淇踈U奲嘼枓轔,G8O%yJ呤簉X+3|S?vo;b旜斧珚焊姾釜T亦-$觨hfR廸1W生鎽&峿>0<⒔莄XVq1熸D"[嶿:z1膓Jc\U张]\U张]\U张_;蔛'黗忰b;G鵺:枺芔齲ヵ!姷\U张X锋熿^*鶇z P*霼 淯鬐澉仹.斁岶铦楅電Y齫WWuqWWuqWlAVV 獐澘7鼕瀂綶%鉩uR鑽*辣C盫埊N斧閛蔕1!}k麠4柽H,聘姟umHi7鞳蹻峡z U駿侦椨蓋1逑襨盬b瑳蝻赏娼Qm②!蝔肃>xヴ宓6惀堘EqWWuqWWuqV5鶇湄假Φ] B?f|$RB 蔙D%YOPF([娀v*锏闩/g*赈?!\U澋贩,罈旑=杜R^k銑蘹猬擈鉉廮醉l$ M轸鈼袁{ € U*赈*赈9穀t(鋋馝 *~{b療馛盪;塋HdWq娋姥2i霎z擊孯姰*赈*禵钿Q縑*渲i??)猱臲镤?c緣*赈*赈*虔舷4 k8(捪G攛 ?y臹姼+1儞1軠U麸蹇掆驗毐[衫y熃O禳矚猱*赈*赈 B敷寶e喱rC輀*鵖X襢询%赢E$亰镘v?N(A猱臲玟窓Ckb諷K{验汈 俦K瓒赜j斧?曃搉T褊lU嚆;iU翮錏鈃鵥停"ēX)∨,姾斧珚b.&¥Y蓀'@$衾丿徬`_虔忌V藦\P唿2詹泐Y'鬻檟歩鼑跖/Ⅻ€.揂硣P墶簬>.徳猢齫WWuqWWuqWWuqWWuqWWuqT浳_袷涜!鏋Z琬`垳 楖服;脞疺?(?铝娀v*霼孬盬b]娀H嘝笉vF齲U娀v*验娋旤」鮸嵚)fU喇*赈*赈*赈*赈*赈*赈*赈*赈*赈瘊鲆?i ?N3B霼鬲#L撘挤擓eCU踉/4鍼p%}qWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWyG!A馻炉臯範'}3鵐m.[绔W焊姾斧珚U笙鐬辀Q硡X(v*檡c}b颂_!娋祼麲VmN躔哳臺%y桿:订u~輊晱銋 v*霼瀪I)節8茮淩黧玒鰴!乚鶽育鼰餋w閗?黩}w閗?黩 U撺呱1W~柍'1W~柍'臥`喊接.碲x0!l*鵈嵲u 盬b痭測訪杗簲2b?絕:櫝絉埾疡aW螥PS;q臺A~E開T衺堵抃菼.张]\U张]\U张]\U颁t8珇淯甮w3鈗V珚焊玧qW蓗f課3~(KqWb瑮蜱虗ykW:バ, Q諛姣4辻烏诳锎鞁1BS娀v*鯚萠6[貹&卲獟NyE'v?萇昱/l;lp+珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾釜G鐝^'齒U驍暴雠 槴盬<燈+諍^礬 赈*1蓘8 Q=z鰓陹碿錈鹇(v*瓤.戳單驺賥齲ヵ#濔+U臸\U张]\U张]\U张^q ;>8&燆H閰^ qC盫埁*+騁Tk.鰻憮桧奩錺+珚約熨|埒aW庘嘼^8鳎u0鴾圵蹘鏄ル绽*赈*赈*赈*赈*赈*赈*赈渾躖 紈;S羹肀W\跮)%1*赈*赈*赈癁?=)據0G臦帩伏d_讑痉'aZ*赈琜驪纬y酋獐榗# b8?t祳码Pa袼"獰駺軁甑喇*赈*赈*赈躡瘲?1魰襹羪h倯箧撮F 碧P霼扊[j煝irM6廿`V珚糲"舸僥UgorMy(v*玤m醌埈邟*}ym[C $h萡JWWuqWWuqWWuqV .5*mH 辄p55鈫馱b痎渙鸝亇.檙(u烀鐓 U孬盫鉬墐腏04齒,5济 繋)f:o幐盋盪矚)鵥/醁45M翂O+奩qWWuqWWuqWWuqWWuqWWuqWWuqV轧琔騡悌w^境~糚梑]娀v*霼鬲瑗xf剷e#1W椌rO5i媟M.x&^鼑韡瞛猱*赈*赈*赈*赈*赈*赈*赈*抷窴哮|(雠 馱b痡測x锟2膓K謐姾斧珚篃姵臺#2z拂R 肕!(Bb^孂 睡饰+沦榺){,U张]\U张]\U张]\U张X-昂蜣悗玘U蛞}憡b^8齫事 顜璒)z漲WWx鼽6馑孢x(v*qW旜 c逅^隉沚朳\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U憧髳,恐o諍納;S羹砭Xo-擔.医}81*赈*赈*赈癁=)據0曲盫姡KS"糢酴=>C礬U张X锋漟簖忞臺2'A臵n囧娋擖灧6睼^.y鬟猱*赈*赈*赈 *?蠜u媅咵2肧顲LU∝+H櫊径慼H1炕 U蹯9斧?e-獲嚔D)翕2臩$D砶1焚2婟)j斧珚焊姾斧珚焊狾8杕7S*鵏b嗰Wb痌渜鸝XH鷅呚W<螋镪G菪w飱^筡U张^A9 宜尕qC盫泀LU鮋"舸 >? t)蛁WWuqWWuqWWuqWWuqWWuqWWuqWWuqW蜝tY縑*耢P霼N钲鍔敬蛏qV燅?鴪)峲WWuqWWuqWW|鼯)L燅/諍,P霼屣芔齲F=>C*赈琠驥浵?|式(oiU翮鍥逅":p8WuqWWuqWWuqWWp電'篥餙琜D:5臹i姫Z纂盈獰!娋紞塃-謧弗衡劗$'g塰>X盋盫A鵼 浱V傿f}D莬R誵WWuqWWuqWWuqT 蚪=&臺)黀匶旧]娀v*霼孬盪[;轨e[9梡萮F*鲲藦网鮎篺窪w}#棦勘餷R趄)迸Z*赈*赈*赈*赈*赈*擓傀9S}q瀵镱o鴫艗6莃泯|U:O鷥 V*霼孬盬b]娀uqWb锨7黣LU乣Wb]娀k根孶隫褪叟FT臸娀v*霼孬?粌齝V娀v*霼鬲嵳+艫=馮嗺K捼>$v*霼孬盬b]娀v*霼孬盬b^濝5淄qWb*霼孬盬b珣聻G犈_&y侽SQ踱 P霼孬盫廘U魢贰彖HX8猱臸姾斧盬Wv*霼孬珚v*赈]姾斧盬b*霼鋉髳zW羐S$x獐臸娊騅_]/Z6挒0荸S钽焘椥$P锈璪]\U孬珚v*霼张[AR*髼Y% '衽XF(v*禫啷1W涌枤w/ZCJs_P弙瞈U孬 O跷*~x蔇(_謖V姦^W幣?澧?讑景慄G*瞲屟V鸭玹宗_:熄N1VM娂楟r!栀瓦檁x(v*禥U#}G 劅A砲攠 P鈹uqWb]\U孬盬Wv*霼孬盬b珢綧跐嫑踱効v*霼憏^m鹫-搚e欤面qK镸K堆mR屡@倲5臹浏痤u玜tK%:+wLU僢嘼"斧$<餉>\絡僔穎?zLR肚uqWb]\U孬盬Wv*霼张]娀uqWb/澘銐y燉b瘯m鲘~Xv*鰺摸厈汶諍^瘖uqV誽?沴U騘ォ轊觿/芮 盬b疉鼖糑o02縔燿_滱ワ鏻U张]娀v*霼孬盫7鶗z-|穦kFt 2qW(((]娀{忎 t蹤(酵1K玉Wb 渼? 椡繂*耢P霼粳驈黴l~琑氣]娀v*霼张]娀v*霼孬盬b^?9 宜齠齒馛盪9脇盬謂Z?*誉0G2臸\U孬盬Wv*筇淄V*辣C盩w椏悃k彡-~黆鯖!奪*霼孇i3y酋獐櫁犈 猸7C蚺_F﨤滩yV獸X7碑)f槴盬Wv*霼张]姸紽*螈霱9b*獈x臦:T-5醮i U踯玢8斧? H:糩y~(v*焬鋃鶄聅&垿*鷯庻襁祳焊Wb]\U孬篬o._H唢U 襞 猱臹8弼礯渪レ槴盫櫿DPI'纀瘹1|/汋汜硠晠;P~痒8臷M:猢鐥<懌鶎给 徏嶐O_ J渵z辕7?皨育楒b瑲球G硕詉=i\u渎囸臩隷 e 畞縙*歔i6VΧ鲴F蒔1TkN驮獐 渶幁瘪剘硦伎;Cp逨*E?6晓a堚擼qWbV升軣7昱_"\}'踱厴Vw)P榞/姾斧盬b煛7憮@c8羹扰 盬U阓暱栚/4.#7颀)鱞朷*+薧7?08颌汲鉺?鏈UQ^Z窆憙臷"嫉剀攘4猱瀵燍?鏈U唑⒓点s#娀W柤n鋊歲W蕣蜃嵪鼘驨*稆Q^Z窆憙臸*+薧7?08錏yk歧﨔d騿熷;V耙国.鍲戜qTv*赈\槳濆7╅]茡'蚋b琜U蝾$'忲b珿S渵呹ty~8$济gVu`躨姳-G塌枤舗恁@:盨渠 (Kov*霼:hA#迸_Cy冱莁mn蚾m@ 檣6)gX娀v*霼张]娀uqWbR7*o嚋yk燍儧"p2_孢\瘖紺JxPa`壆*赈*赈*赈*赈*赈灄枑酏梀V+xWbZm厊1W﹊2z朧j5?EWuqWWuqWWuqV!鶍 X琔呪]娀v*霼輛=1TEY>8>痨qT朒6忖刡玵Wb]娀v*霼孬盬b]娀zw渥鱳_5臹媆U张]\U张]\U张P号钦.'=#崗釆綥扴+磵筬'衽 b]娀Z鐖$獐/緛f嚭rJ\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张R/=_裯l€瑴9○+具>槴逍鳱膌~孭*霼tSI2FC)#}=鋙4舁瘲i晎桩)O盬WuqWWuqWWuqWWuqT刻Z鋃6?H斝x灷b瘯n.せ曨f5扚,O题汻絾4芖澛$1WU珬鴅瘮<K盔踢%孬盩凼~[椞簲z\ 纺eGS娋毿M4u=伧f(赈ゞ欬橍鵷藣儕+刡瘲5-6}.闗点4,U(C猱臰<栻$1Ic`拭1W>A髣~i毳肃?毂K"臸\U张]\U张]\U张]\U张]\U张]\U张]\U&螬p棢駢V*鵝啕爹b匧U孬?;秫士絑斧珚焊蹕釆緃E鶈($oW|U媌嘼┫挼aるvw巌IG國鈼燥纸埁鷔U蹬]\U张]\U张]\U张^i-緱偀尥/"? 臵cA\U鬫滏榯.湃Q撹'o矹猱*M炙孢x(v*低qW站Utk!~琑欁uqWWuqWWuqWWuqWWuqWWuqWWuqWWyK/鯖鮞臫琨 蚺_YypSK馜奡 猱*赈*赈鋌瘻7菣.~湿a浮鬲?算^*鹼)[\U张X擎忺熿^*鶜?1B霼孬 址歿峕]W鼩o棯uqWWuqWWuqWW\敪N纖臺)y)^%o烙%槴盫A鶀捵祉|_c)}A#U壟VyW熽ZZjr [x(v*)揶X鎸褢站鉢U醯嶁^跜w狫娎斧珚焊姾斧珚y晴懂逗DV*yp麖騀*饘P霼孬?>肢髲綂斧珚隘=l閪_t寫%踷;u娋uQ@(ov*蔕 G)逷0祜狎馣遖 峚匓FTP U衡*赈*赈逿?馠齡y~(v*嚳岜W讂/黶?鴰)EuqWWjO钿Q縑*沱??,臸姵先嚣JGI奯AWuqWWuqT>﹉范s8l>歮娋Jx輾鸋J煚鈫盬b痙渵d遦:)z誵WWuqWWuqWWuqWb]娀v*霼孬盬b]姾斧珚猱r$R挩t=C 孶妝囼籄肿鈥[少▲w*癔<~Y啭X;J'孬臸姴蕀i艨0缷最熷垴/c姷\U张]\U张]\U张]\U张]\U张R77褗C吸谍8.髈黺.?着^煠燈8?X"盬b]娀v*霼孬盬bv琗O}01W梉#Pz亖U1Wb]姶EE1W爕.滠i狔 *瀊]娀v*霼圑b鯊昱Xf*霼孬盬b]娀Q捍庡x>烒狢{ドm汜臱(v*嵮5W/犜#40簱瓇!鱞m钜钺頴#奤1Wb]娀v*€柞槾; ;乀刅'苞qW枏筙21髳猸忶葯+閻猸伏鋄觚寙斧褆熸9<搔E獻V v槳u姤>q葚ǐIo娋UCQ鴅呚WHy4軻M>f鈯衹8ワDi娀v*霼孬盬z29,O€qW兽l瘴豹苓哲Tt V*霼梸Si縙菊鮋1K5$璪鹋_(y孲S駍~糚椻Y夸ど[緡=qWbyw鏾捦_砕だ~7蘠烩嘼Y恷'晆5卉跧餖*k1K闃g庘5H*v*霼孬盬b]娀v*霼孬盩椢罗'齒{钭鍔1Wb痟渳?鑇 ??V)z*霼孬盬蜙ie.m5%G>~*驅P霼徦4/槾x'"G(>駣Y>*霼孬盬b[Q_*骃太r<'阋岠佔衽X(v*(M谋愧髹}gベ +{%J焢(淯孬? 幹_61C盪*)娋熏忺P揩Wb]娀v*霼孬盬b]娀v*.朹7昱^A姯憏)8 #Q协.傈8?臸娀v*霼芔匷g1偳1Wa钥I闣7犝e暀'lP€臸姡軑踱譄!奪臸姳鵉?佝糢:}憡bY?濮槅伄Cq#q係镠O@緱4;疌根b]娀v*霼孬hZ%膜襥嚗&雉 U*齴淧*霼Y怪&溅盅Tv截飱b煔欳j綸笁Z*M娋kF衽 猸]盬緙Iy島#魌嶜3/~pqK旭Wb]娀v* U鬅孢橶\仲`nPZ/いt$线姲蘌霼孬肢髲綇v*R俘緸槴邱C盪摽賴P+娋烖酚仪酥iIPJ~m灨U梎V馱b]娀a邩焍鯊曷3v*霼孬盬b]娀w]廘U/椝弣'&S#I/,娌斄r9╝LUKv*霼孬盬b]娀v*粝上眜骪U孬盬b]娂丑鱎衄-霢 區'娀v*霼0蝽ɑ原G銑井X #S罾栺Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀H<皴H枷=媭&Z/0+媔me{{呫,lU侅F(Y娀v*/3顋癊澬3i虀享'蝴{b椊h谡灣河錣c=hw膙8娀v*霼孬F€$抺b#U よV5Yg?誄x锟s娀]2\H癇 I! 爓'}A鋸-/4╰9H铉ЦWb*x!炉臯NilU赭迩謃駥b朓乚娀v*霼孬邕鵋楟a柞*辣C盩鲜唏俦槃臺V縎-b^}邈﹉怫m图Jx5;q剽痏鼧篁圂…m賻揲1K)乚娀v*霼h1W圑ty5)F嘼軤勚V囲甭0臶広K蔣X*N*AJ皞:D€>/Q+縉囧娋g蜥5QH%^[沸p臰E+"M$lH霨C娋橋溹骍偺-訞,绍纟R蓀+盬b]娂泱徫毳Y芽.艫 7aW*〖U挠|U愞_,缰d鐒g鼇遵/T喇臷1Wc帴唿fo讌 ~*霼淊K蔎燅咇K鑼 霼鬲讔dS€20!侇\U骔7撨竖汥凖bZ鞳妁*篷C盬\U拁x埸;z埘穋襞/`0+盬b]娀v*霼孬盬b]姢~w-琰a諍綴務 猱臹8騘芔堚棳`Wb]姳刻?.4i煸VU<梲烲*鶎_吪lG伵 猱臲G遄漑蕷彮%Z蝚,;腷椧V稱^B梀G$a袃乁qWb]娀y珂谉覦祄&瞳}p磈鉙哝{aWLP*霼滯Oyk羝卜2娵冱m郲R氾乚娀xK/ * P霼﹂娋?CYS煫S\U孬盬b]娀v*霼孬盬b]娀y茻鯈& ?笟)區娀{?橶記B櫒历悆軂嘏/^喇臸娀v*9.嫥6輫.譀R~}矮珲〖U鬲;@帟伏d_讑颈瘗諄.臸姳o/鵉佝*z P*霼B{垮烻U礭蹰{鹔<=)zNv*霼孬盪捜#K+fbh馱欈wi针+z瑄顊酚匵~(v*4臺C~Mh?Ⅳ4濫しg辕?硦Yv*禜抎he嵙V 獐朁注>叒\i襪楣+┹ (J盬b┣<7杣~% 夵蕑孶艮摣[j雯d後怲伧躟J3v*霼孬盫 珏蝽“5.?輏haW螶)箅臸娀z悃壅>q鈼侧Wb渷啨蕁罽* P霼d闥娋燑涸庠|縢$F緮b'鰁雭,v*霼孬盩縙譵 '辕[宷崌vn剩|宫瓴犄砵睱啪^ xU 醁X{bt?Z8嵟]娀[/鱮ㄟ|弙)<€1齲Pg懸獃亰_B`Wb]娀y珑楆発-J阠?c 納;h专4#|U?錩炪 娰馨!n碻z簬<}馣9喇臸娀v*瞃$ie`睜,蘉8炭95"8噺媫8U夆嘼╃憈CV秂yG3}F|m眷 v*?+&hln擳uc岚x(v*揶E#I#!旣孶?晐4鑟硗j8uSlU孬盬b[^⒒ U燉(=v觋泄P折 *霼9騏砞k杤轹濧鴅椩妥v*霼孬盬b]娀v*搚傀9搣<笏_哕唏%辪幣曲觮凗鷥糢张]娀uqWb]\U孬盫炸j1W楇禕荝5?賝匬孬盬bS/,]媇F7愐6O挑臹抳kv*霼孬珚蘋鮝V娀v*霼孬盬bZ&槳s^鏣!若帼c咤姵/I芬佑禯靭 ’yr薦嬕絁胞.6a翕$驡/t"e值唠豒^槴xWb]娀v*霼闊摽b腈斧勋乚娀uqWb衔}c膪隱)瑅>gs匵.(v*霼孬盫a鵎5R甭 费編cRNj斧盬b*霼孬珚v*赈]娀v*赈]姾斧盬b]Zb0:攇[1忂"鮱堬區 qCxWbń'X窖:t 兒潖蘷臹洝~~I埖珇`u/磣k砿;髃朔q鑇齍扩>x衒婠31T=擎7梎剡哪l@臱址刼s 頔8U鎊m占蘆J2@鶲S姳P閵臸姶Hz湎悎#蘘:鵁襞/_&孬盬Wy_珩B鍦*駆P霼N郪6#};鵳鏮寈`Wb*霼孬伵_?~w蔇矿刊 槨娀L<俊O纽踼㎝ 钸F*鷱J 襪"暗b匓彛p%姾斧k娋Qt庵齲P椻Y蜂伏ぉ[緡'uqWb蟸S復c贊-嗝酚娋d -鋒&R财J矠爩([娀_騕H摾舉崈+腷<囨椟薛ペ衆'20絧%慴]姾斧盬b*霼孬珚uqT撐驱螺'齒6岹*b^8騘芔堚棲v*赈瓎〃臹 浏绪骏鞧%养€鑿唼 俭;v*藎忶晑錠鬙镬 #>閵^邋=hJ哳X}?*曊6q櫘Yy棟:邬|夌;徺_鮸Nx佩茏=沼'愓滜')bW羙%虊o棖B@頝*鷎葹TO+閴d(go嶸伥 d臸姾斧? _6U8∝玀娋忺q瑖黀煫SZ猱臸娀v*赈]姾斧盬b*霼孬珚ぞt衅唬荛鉭u洄輜,か, 腶C盬b◢;P烳箮鲅窶S蜢}盬I蛹膵 k铊+)f岳*w歾稲,H?iy餂:4乐=.甴@鱖醀囮吰;蒉9杫 Y(P臸娀Gh^*>CZ臸姳鵉?佝*z P*霼鬲鹻-媣),fb*鱿#~s[l跻-俹豲焷/L唄鏏,.te 儊W锈臨輐虤n垎MJt姏€N玟1W唝驨胩挡 <煷酤ool*羳(v*霼;騡%.剓%yH :1W聬F癉8 @ ]\U孬珚伎蟪蒮痁g€R`?i?淉x5〖U孬%騑燂姬/?yh撇Bzq鄎K菁幅仯腭┒漅b7夦`qVFE0+╭U;媹瓙;琿幀苺b7蠓=嗃Baqt>鼢8U鈼左捷蹤'愓橑 Wb^8膂礝渪レu喇臹{5願稱姷礈淉S甭⒏〖U孬)燁|9狌l?紜6_|R鳢/y螶皾L嚞lh沔N閵粔鹋\v;姳4~h柁_O琝v-=矮脇葭[5\z鳝%%*?夨 *霼鬲蓷衽_RyQMKC锤堯>舦罃鰢kuqW}|‘耟.!m奌缽 8Tv叕MCㄛ剋S笈_F槡6 >(溠斷Jx/釫b玙S碆鍬X袳EI臦T堡矛Y帅軍2曺氰臺-雤4%旌m肖1賴甭*霼Z弃}>t汲s駳 U頌O苍8踜t禑Ж+闊s躡棧Z^坜Йk" 瑿姾槳S矺袗尽:P€諒萣阁 6V犛h歄踅桨A7姶苽斧%|╰=礙暐瓦侬Qo焊锌N钘j+ 讂}8&攁F鄍〖U孬!騙/|﹕贳瀡{杳R?.~gh氿)淉.瓶勃w1WP鴅*吙-4艴/fHW艌|>涘騃q喷"倿 篑炉!с娀zW鋇€o5uW憾^(咤熿/s璸+珚v*赈]姾斧盬bR72o槛薩哕唏%辪幣曲觮忳,X娀v*赈]\U张]姾斧珚皬>簡韣)V>悝c孬盬bZ,P嘳at酸}m狸焲U姾斧珚uqV!鶈~??a窾孬盬b]娀_oo%藞燫顉姵] 蒕垡k鶬'P潎锨e (6袄]姽€`U€*v *兰座a 賙&慘云~藎y呡溨R.懀晍 b猉Wb]娀v*艨蛇眘骪U枵喇臸姾斧盩.瓇簘滣巋!崯;肭靖掝SW晪8Pv*霼孬? 4%黼彽罷\R跆 赈]姾斧盬b*霼张]\U孬珚v*赈]姾斧盬WuqWb瓎#|U錈旻r啛4 唿# 紈A1C盬b]姶T斧倎觢U*刿*霼孬盬z鍩鍎氥)K5D;^){"@TP乕*霼孬珚汲篼?鍦*駆P霼d違獐. d暸]姾斧盬b瓋娋~攨^`x∝猘瀵Y藾!娋畇 [\U孬珚毕=y25貨w鴑#摾鴟*R觧t粭步C駳X雎6*霼鬲鹹ザnp;七浔N!笃錉|R篛>k)G綌╆+姢撏%胹澽CB躑孬盩缡^T后=曩趥#采賅*鷆H襪磠X,棇1 釵估擽*霼张[槴7/灺v4仉k!l1x*k概 猱臵*\U4绑>(幰闠U9OM?録鶠HKOzb敡SИ/ne#鮞劥:b[Dyc塊蠕Q$雠_A~V3no.骺渱C叁8郬WuqV遭瘮寂;蔬 黆孬6鼥敃? 鈼续琔张]姸 1W巭v,F锰6k砆n耢 紬;v*赛佹黩兢$搈'2庩{)}/ :,邪hR:p*霼孬珚v*赈]\U张]姾釜K鏾&齒钭鍏 槴盬?紬狂8リ绽]姾斧盩6━踛窒cz佮擯凓歉臺7洒~T1 诠&)GB<U巄嘼Z兩IS *溭y薢[轏爐J.泱#蘷#屪虬v臨K鞪隤`譻I!|Li鱞0t臶臸姼*俋:淯??枃GX誛1穷?畎{燆忈奮梊 赈]\U?髳=,緈0qC盫榃}Q&畭dO?VΦ臸姾斧盬b*霼孬珚v*赈]\U张[V‘*體蔒嗿!xK?/衤;v*>#*欃y烾盦翟ǎ^*墰:涿寳拺笈)M珍鱩吴Y$?1#钆 @S*砦*莁s姦緀蜢轤窴;擕讐%#脴>孶*臸姡[艵齲>CZ臸姳復鵉佝*>扰 盬b﹨緟sq9[廴鄙N牥?,U/斧埉*徱谍CH%贷!'炼T童2(o1J塍3蘷;I}'豐c蓃鎅荬s輭?-臸娀pVbfc@RN*#虺'6[〓泂F^升qK4喇*霼张ZtIGXU髼鍻慸虻釚!事sX貇?斑 P霼孬\w U8丑幊d踋蕘z|U齲7鎔檉^_蔊褗ず啽{綋 }亍 盫馮n墹O脓ZSLh=嘡qU-J衁軰l }&+_*嚺]娊g垌隉8馣仉乚姟=>=N襨 簼 7訆綸僸燺K :霼7徬汈j/e =馢澴5臾紩撀待X狶鍦驊欅艍'衽臸姼歜颢蝓踣仼F z?鉢R鬏喞P €孬珚 7臹 錈凶レ湔a蟌7l*蠹P霼孬T藿堧姦V~c造2>"qJj煓E嗪劇zSo閵.<癞\2轏苗姢覯$鐢晤蔮^([v*霼WZ踱i+蔠;炇;迸_L鵦硕皬N弟 鴽鶝估斢uqWb]\U孬珚焊WWuqTM唏虠枧!缇Z琬`垳Y.髈黺.?着^棨紁1`嬇]娀uqWb]\U孬盬bR模糉*蘜X<9吩c**B篙Xx儏 X5閵v*霼孬盬b*蕓濝u﹜濫d_B慰6#古/爘藉//Z瓥灉}>,p*e姾斧盬bZtY"咶e;*裣>~L糴.嶪窄敫S鷄W斎槬M 啊5娀v*霼孬盬b}嵠:谫Fe櫷*丝蕯jZ逽酫呵齕氾乚姾斧盫遭瘮济+ (v*涂%%O廿)雭]娀v*霼J曛+萟粥奤*励U渱/杣)4化(浥L(IqWb"籦痐鼣蠓0|絲蹗砩黃鴮R跫 赈]\U张]娀uqWb*霼%蠓黴n~琔蛘亏k蚵匧U孬倏 ?;徴奮珌]\U孬盬bP跒沵猍綕 `怭凓莵臹 鏾蕧CA懏,茇uwd閰X-{w鹋 猱臸娀v*霼鬲/J扬u塃緷M!旖挑臹妁w鵞梹吭B通莡忎<}馣>&絧+盬b*霼鋉髳,抠aW愨嘼玙ω*燋eO髀~ L馱Wv*霼张]姾斧珚uqWWv*霼张]娀J加迦<千骚\硭tn昝∨_7y椝轠6殏S} 酈U娀v*霼孬盫漩*+7Mo[彞 伏M€)绫瘷浏?諍 P霼芔臺W愉0%*4w熿^|*霼爝悥裖iZソ !扵VS袔8y虍锼铟歾欞騥俄餫釆0吏 猱臸娀v*霼tQ嘉澳ヤc@N*隹/氏袻憾矤辵>?s昱/N&絧+盬b*霼鬲S-礙v辰孠 8<簌[{迤k汙n4騤n<V槨糢孬盬b]姫ZZ蛖*踆!杇4U]8/四蚣 ywF詄C #飚)x6縖 盬b疿渨鸝墉波8ワ﨧=嚂!1趲w?y3uooa乊*霼孬珚焊Wb*霼张]娀J<躣縁)>蜃鼢?7麯馍w惚q*舡+圐A厒&斧珚焊姾斧珚焊姺\U*猥 1娟聞b,钩{ 塵%5x荦千釆]娀v*璫z7!zrJ"0}8UuqV珚焊姳?#餉饼X嘺Wb]姱傓KBボ4<'荆稍'a篑臲0豵]€*赈j斧珚焊姾斧珚感偓*Ж8驩鍖W|"棭嬾O嗣y曞溨R.惽*鮒臫盬b]娊+騵靅|*:猸j斧珚工X陨! >|社17榰i飶劐+芭 *霼孬盬b┫4V謚{{E^a燒U茆 醈攍.*誵WWuqV電礬U衡璚uqWWn斧U臸\U衡璚uqV電礬U张[*誵WWn斧U臸\U衡猈v修闹鱄材aPqW漼囼;O棘篖S-簘*笸c虺_疑-!鹮殐魎臱粗驚&奃#鶖徸鶐暸]蘹猱眘蘵I臹洡桷z<"跲塨寈 咸猕殊璚uqWWuqWW`汘H矿W湛G!箋猬喗邐箕T喗邐扂cW疯vocйZI鲠峇┾1TeqWWuqWWuqWWn斧U臸\U张]\U张]\U张]\U衡璚A-灥nm5劚曣=*5~H]趽>勥X孆糅8鷝U鐨啅}7 粂##臡>M:眢臵幐ル濸<籌Z躲e?孬2,I┡^e鶓鵢mR襠&峍*j1V5*#V枠苦O跖]*'V枠苦O跖U粝 Z烛柛尋n7犈^諳O惻]\U琯<畏w酋獐氂鞂Pv*鰺鉓6黿諍^稱鄎V 鎻身+X5楘蛇>臊1W檏_敋鰱IH境笄:猬R嫫暾奜℅閵w鶎U搂'V侗汉`怌+摱菻Ve爚Nkzt⑽鸒?%ル~R尹谰y_r?震臲1$飱礬U衡璚uqV電礬U张[灞pv 猬#擹F碙雒陾'糲'艞鷅4&蹴<狈Aw踥懪X曓晎hJ蟧*懛豭}襞RuF8玨"懢HN*檌轜誹& ii+3t獣塖g'銷D殰薾澭wo喀)z棖|棩鵰8谿P售国qT殿*馦K駽V患為n" +峼猹颌uo鵬孇\Uy珵1罒電硂石 ^鵃镽O瑫忝1Vy\U张[*誵T縗螨喗 吩bY砈鈅鮊*蚩0~D\EYtY末96o喀*恋/$kz`&暌E鵊/鴯qT澀鏮 F4怢b)鋵*嵈蟒B羕1'齲'&{C4bw 砞*守5i卺囲хz6潷踚 {噀臦堖y祖:胍滽Je婑考C鰀>>蛫W虍设挹虱﨡z%寧帶扩WW惲+|憦鹋Y窅|嚟晨捹捼 C6,R鼢5bG*陡玼臷 ?惔2U颿=)昵硙>?N*髰G k+磘飕c?>d劄逘諊跖P'蜚 匈=~忞姽-苽呻O鵒5 {花}腿俬>X獀臵*誵WWuqT.━Zj複_P塮徚嘜戫娂鉢鼑禍椧n $锲Aa姲]c颢_伊s#铍姳婶涜 $稑W+c1B扙伲p}遭}&?( U7<彮陘KI釺臲巺╘玱t]埴 R暨-y H蜱莈)窟瞡哔姴拟璚uqV電礬U张[*嘣臱w?*磢}屯 瞪暄1W沰?抸諌-dV?渗H#姳+-j歽鉺k*戉琍u4dp| 憡悼伵]披#82螮考<`稌忷剘糢旈摵1k?€,丝抁e阹笹祠O臹僶V爆璞幕Q@1U跖[*誵V電礬U张]\U衡璚uqV電礬U张R62_C蜃鼢?7麯馍w惚q*魨(∶铝\U张]\U张]\U张]\U张]\U张]\U棱+蟅>嵦w鉪攑鯂LU 喇臸娀v*e濱争)觘;=莙鬭VS姾斧珚焊?諍包U孬U*涜轟冈:zp鱟1Vw6鷅p禯靭淯\U张]\U张]\U张]\U张]\U张]\U张R韘硕Z鋨濌U囐qy7欬峺/髦蒂追c槴xWOwu珚焊姾斧9:蘦汁K泭Oxp豣嘼]娀v*踹葈 怽弲g弼盞肢姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姸孶F庖掼R$擙`*昞y#AvT鮜烩╫鵚>^(霼^"h舭亪Z淯0堆4隨 X>!F*2姯璹WWuqWWuqWWuqWWuqWWuN*#姷肉*赈*赈*赈*赈*赈臸\U张]\U张]\U张]\U张[F*禭銢V鶎U/楐箞il醨(@b]娀v*玦g%祚诼*虬QOs娋Pth碖磋~蘆>'估攙*霼孬盬b*霼孬盬b]娀v*霼孬盬b]娀v*霼张]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬Wv*赈]娀v*霼孬珚uqWb*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b*霼孬盬b]娀v*霼孬盬b]娀v*霼张]娀uqWWv*霼张]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼张]\U张]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姾斧珚焊Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姾斧盬Wv*霼孬攏稞忞炉洆犈 猱臹所?/蠈滕.)zv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼张]\U孬盬b]娀v*霼孬盬b]娀v*霼张]娀v*霼孬盬Wv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀uqWb]娀v*霼孬盬b]娀v*霼孬盬b*霼孬盬b]姾斧盬b㎡銠/褗C蜃鼢?7麯馍w惚q*鬽(∶艂&窾张]\U张]\U张]\U张]\U张]\U张[槴髥濙;檄忣:0韸孬盬b]姦Z糙\誱鄛渪{猬0`MT妰姺\*赈琌◥V*撹轟冈3{憋蚺Y茮椹螺hOV=N*嬇]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张[*栯瀆持泗.>喧qW旟浫骱魼醐:嵡d煋+據P+姷\U盝苺nI0+?4践 国厵"咄0臸娀v*霼榭扊[虤遭绷餑_=~霷鰝qV珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姳:暹讑緊N7娀{/ 燺瘎鑯跖/P*誵WWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWJ贾躭縁瀵镱o鴫+价嫃躐K裻楚鷥 MqWWuqWWuqWWuqWWuqWWuqWWuqT肠j鐾鸭t8@t&)G褔v*霼孬盬b\U恲g蘝T"疏鍙犁鯫侖卢软姷\U yz$銞_E 纕臸\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张\hAV╆LU.音].Ye砠cVQ揖8猚\U臹I鶔>叅据&腇*騚)娀v*霼鬲#M觛.1礮R试xw?F*鷒塌$:孼u阿F7>-茆斅斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姳啭G.佝糢髠t〖U孬 哭燅R 猱*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈¦殢麔楄缾<谍8惚q)z&楟駽铝\U张]\U张]\U张]\U张]\U张]\U张]\U张X棟4殼Cn臱5穵v*霼孬DWc姴O-鶕阴堢鰙彾eU*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*臱棛<穗膊?Gq哓b:謡沷x柬w7弿`鷨檘?厊c8 娀v*霼+娊楎_&.謷宛d:斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧?螽]饼x1B霼孬 哭燅R酊猱*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈¦毧銢/褋!債k燍儧"qJ6莃泯|R=/圐A厒'v*霼孬盬b]娀v*霼孬盬b玣&F奞P冡娂隨疫I6gx叟}*]娀v*霼孬DWc姧)单メ?昌棕鸻V`C┆澚Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*鎌奭萓I1V2浭赮欰褬uo炫R糢F暌+1N≡8 旨$柭疂xe匵IV0(v*霼據^5|9奩BA暭緢$(@佖 Uv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*擓螴梄'禹薐觢U忝騑_仭?I臸*__駠猸徤m箛獐E驆鐤-nm飱矼(u+*恬Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盩?裎楄!儁k燍儧"p%w惚q)z!Pa`夊娀*頧b娀*頧b娀*頧b娀*頧 Y矣S0段7F*箢/432 。 *霼孬盬bZ"釜c抽噴黳灗{|矮5吁85鏽=怎"斧筨娀*頧b娀*頧b娀*頧b娀*頧b姸 qT6—[樯闬5eO褗碍_^刚媬v骼﹑豣]娀Ju-陉偖8K僮`z緛uシ颳擼渢臫tm&鉠粡O医€頝(}%瀵/垸z,-€二f顀Jgw,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臸w,U鼙Wr臨4燋/褗C蜃鼢?7麯郕6莃泯|R /圐A厒+v*霼孬盬b]娀v*霼孬盬b]姢h蜷\禒粚R潩|繂*#~c缻=]娀v*霼孬盬b#骡XX刡瑳K髝o蓐:8}8U懪"L♀`蔈j1U孬盬b]娀v*霼孬盬b]娀v*霼l窑 蝔 淯巎瀙 X赳它}c;替Y樇嚛8孬盬b]娀v*2γ-┿\U擓蓈嶎s90)臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bR4:_瀵镱o鴫罆辪幣曲YD圐A厒&斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姺\U妝矦j锭b祊+,c鰢蚩^*茽'A$f猵**霼孬盬b]姷J猹稐sY;w+軒晴姴;9o棄轺aT  蠾W"槴盫盬WuqWWuqWWv**霼繵*oj呮慇^⒌?v*恄y蘿v轺b瑅铌k晴p逑`zR**霼孬盬b]姯扐溘 U擓_@)K駪X玄嚣G 瞓qWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWJ>孯G柨抗9库'Wy服;脞杴紣0癉uqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWpjb琄T1籣閶罐X嘋糢徝2始楅>Sv*霼孬盬b]娀h1T售虠鏊羂8,T酺疫嗡益搓雷鹋S+o2豛鞄A(SF齬唬6.тF*è[u躡1败 UM~莹鶓姮7v泯臥3鶜墓f臨麖:*誤勛1T虠*Q(=訮猢g濴Io乕臶臸娀v*霼孬盬b$怓*孬#蝼朓+{-8蟧v髀氣*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈銦/褗隘-s0s腘K价嫃躐K=?轍X"1V馰盫馱b璪璪[臵臸娀v*霼糢孬X玚觪姳3yY畼}:,熜琟)媩)嶲鰬簝乁qWb]娀v*霼孬盬bZ*\UL谀zㄅ\彂臦 s:l哺U蟩;煲Um辗bO套l[7 +姱 U糢孬盬b]娀v*霼孬盪厜!#R7EN*蚀,媟//€i轲熢酼BMz猸b[臵臶臵臶臵臶臵臸姺姷娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bゞ銦'褗翱-s0s腘K价嫃躐K黆蒙柦鋼锱[M~I麾珦肾jjY圬淯杢< [淖L"8(鵥娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bR2}1-s0s腘o黺.?着,譔?璞0癉WuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWK|渠餓鬮惸嫉宵镣8煌狂馗_矼<罿斧|盫珚焊珅盫珚穃U*輖V珚穃U*隃U张]S姺\U鼙V猶WT猱*赈*赈j斧珚焊姾斧珚焊姾斧珚匪j斧珚焊姾斧珚焊姾斧珚焊姾斧珚穃U*輖V猶V電礬U张]\U8qWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWK$1Hb~Z琬`垳 ]孢\瘖Y枮癣Ta`痋U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚焊姾斧珚axd1V)瀵镱o鴫郎w惚q)f:yF孆Q厒絨WWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqT刻Ob綵琬`垳 梱服;脞朼`癣Ta`璡U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U张]\U/A撹!孂k燍儧"p%w惚q)e4_陮, *霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*楇烣*劈谍8.髈黸鵻X[莀X+uqWWuqWWuqWTb*赈*赈臸Q姾uqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuqWWuF*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*赈*楇琮 OcZ琬`垳 x祂mb錥nM葇*8炓6^薈XⅠWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盩+2ы9b悡yN靴掝Q鯿礃燌,唧c薽>stream H塨d`ab`dd攑貅tw髟vL) 盠24JN11訬K蒊a!#州誒_诛汓遳豢/b`fd鋚(退ts20t/,蔐(Q蠬諸020癙H猅鹗/Vp*,K蚄O許p躺Q)V(J-N-*KM衙皰亖睗亯憫﹫锴*?僂/櫣磅齗'三G愊慡s俣L\3c壾襞崇蜐1w泣)篼9祥9】豢刊玂韩矾籓趶匠 ;荆掸Y罕境砃井>稻咕┅殻躬4_?蓊靯艋eu endstream endobj 1424 0 obj<> endobj 1425 0 obj<>stream H塗P=0 荏+<"篇 |埪跜怫Ezu"7IJ埩秥鲩螙籮_ /靦K啽wk稏 _儽:梯攗<菻>`WQ銧(劶芶x勁a呈 蟣-蛋稿鳠詢!葼,羆#漕Iu2>豰氅蟝ag镑J#+j,/_ 蓔晓廎*6wg4币)oz`庌' I綺鉂OZ)腟€hn endstream endobj 1426 0 obj<> endobj 1427 0 obj<>stream H塨d`ad`dd攑貅趄u觱L) 盠24JN1162蒊恌!#鰶矸寨稛_X+W忐!睦娜h殚淿PY敊濹懍ーd``T┼昣T歒枤棡ě鄻摚VS琍擹淶T枤a€宒掑!霨犺o危9壳滬鬂77餆f6>€k9K endstream endobj 1428 0 obj<> endobj 1429 0 obj<>stream H塡S踥跿v谫eb(汹脦 鈋尡uR6 塹k6憾Isu'遵%v'q4I漑洊]幢 1 匂0墬]4腲@< g竵涅I琥}鷠縮俱秾.楇風:疴揲乇c/:1=丙洚赏m5佝負龀鲷璯禯<炤颈 q筤;/癅唂蝲>j项轔H铩@佧ft&骟9顾粀n;膭!_婛?纒LG喔 x匝8/oW]|浞?oaw'蠌5Ek蟒Q傝)芯絞7@2\T)66涠:C葉C 铙_<湃U1 oC鲨脹犇炏 (\幥r|>a1_4T YMU唱(*殗R嘇I淌.壊$奩eUepZe髄懻87`&鈤€Y預謘 J顣h毅 狟鍐裍陯Z觝f筓剫f;逨瘽g&nF+s)X咊哘wp藣獌斖"瑱璏:谂籕沆I剳澙$F%}gt铭,魊襕j製琋G蔳褏蠷*倗S8I惐D蚜t(:a屺誵臥 轵&成寲g裛h檵"AER罷0?癥囬:&斱缭蓤轳LT!托k祕昭縍]┒+2\町祴L磭鳍召?猝旎C!琢B71>注jX"夾4袄覣屛/軣 牛N#C蓎89舷 %+退X鉘畿z}韡鸕甠篭簜^鴮g4L/a.毮r聲犳烢>J"}閶铁蕾鑙 8:3<爣 03k檷s堐_髳{6 *g茲帘忎Le榴F℡q\d8瞑W隖C_q7蛗 5tY*岍儬 *倫Q2嗡s旙#胐(盄嫌箝@f釋驽Y骶0O)[R蕵RVt凋暐孧B-╫韕z拷礊€#牻 z遃AaQN0鑒禾梮]%X宜矌昱瑨钦湌C槊81/s(Wsq溙S扭炘閆zN7呣黳蛕模g濘楻Q漘uw6t宁FLJ刺屗t杄懓FF潵媓U=S0[柚Vk59虧赤A潰)UW 蜳(,廔蠷奙$S嬌N肻x!@蒤>幥 塨JO閘昸繺]lu鬟 G[ endstream endobj 1430 0 obj<> endobj 1431 0 obj<>stream H墱捔n0 嗭{ ;hj+q6bY姟艕瓾 4稡憰D,2 {y鯤{呇v抲E胣?E蜚o殦qQH k筓&タ^~RⅡ>^蜧s7;u橱r箍{鸅9绞&m覗當繧[jS%mJyn2A=3J(R簹癡 H艫|N6灄脖 沭3>L|綢譥4孯p cM觿虴h龞嶃8fEQ€A趺oS}>:禉* 吢朙8便爇Y (kH蟮!妠5/ &恠仠 {鸣7r溯鹍L  猟%pg)漹E銿牒=Z湋跡.N&\韚口\0〆) Thd軁b.1蓏闞>B灮z槑 4{輨h9tM5;夋f浺6儒喿h6[|_.缬欧/廜;胝掴铡t諞Q=婟量v8∟瀗冇盞铖 0麺 endstream endobj 1432 0 obj<> endobj 1433 0 obj<>stream 2022-03-25T15:04:36+08:00 2022-03-25T15:04:36+08:00 2022-03-25T15:04:36+08:00 Adobe Illustrator CC 2017 (Windows) 256 52 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f Hx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8f/8AAEQgANAEAAwER AAIRAQMRAf/EAaIAAAAHAQEBAQEAAAAAAAAAAAQFAwIGAQAHCAkKCwEAAgIDAQEBAQEAAAAAAAAA AQACAwQFBgcICQoLEAACAQMDAgQCBgcDBAIGAnMBAgMRBAAFIRIxQVEGE2EicYEUMpGhBxWxQiPB UtHhMxZi8CRygvElQzRTkqKyY3PCNUQnk6OzNhdUZHTD0uIIJoMJChgZhJRFRqS0VtNVKBry4/PE 1OT0ZXWFlaW1xdXl9WZ2hpamtsbW5vY3R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo+Ck5SVlpeYmZ qbnJ2en5KjpKWmp6ipqqusra6voRAAICAQIDBQUEBQYECAMDbQEAAhEDBCESMUEFURNhIgZxgZEy obHwFMHR4SNCFVJicvEzJDRDghaSUyWiY7LCB3PSNeJEgxdUkwgJChgZJjZFGidkdFU38qOzwygp 0+PzhJSktMTU5PRldYWVpbXF1eX1RlZmdoaWprbG1ub2R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo +DlJWWl5iZmpucnZ6fkqOkpaanqKmqq6ytrq+v/aAAwDAQACEQMRAD8A9GaPo2i3WkWNzdWFtPcz 28Uk80kMbu7ugLMzEEkkmpJxSi/8O+XP+rXZ/wDIiL/mnFDv8O+XP+rXZ/8AIiL/AJpxVYmieVnc omn2LOv2lEMRI+YAxVf/AId8uf8AVrs/+REX/NOKu/w75c/6tdn/AMiIv+acVd/h3y5/1a7P/kRF /wA04q7/AA75c/6tdn/yIi/5pxV3+HfLn/Vrs/8AkRF/zTirv8O+XP8Aq12f/IiL/mnFXf4d8uf9 Wuz/AOREX/NOKu/w75c/6tdn/wAiIv8AmnFXf4d8uf8AVrs/+REX/NOKu/w75c/6tdn/AMiIv+ac Vd/h3y5/1a7P/kRF/wA04q7/AA75c/6tdn/yIi/5pxV3+HfLn/Vrs/8AkRF/zTirv8O+XP8Aq12f /IiL/mnFXf4d8uf9Wuz/AOREX/NOKu/w75c/6tdn/wAiIv8AmnFXf4d8uf8AVrs/+REX/NOKu/w7 5c/6tdn/AMiIv+acVd/h3y5/1a7P/kRF/wA04q7/AA75c/6tdn/yIi/5pxV3+HfLn/Vrs/8AkRF/ zTirv8O+XP8Aq12f/IiL/mnFXf4d8uf9Wuz/AOREX/NOKu/w75c/6tdn/wAiIv8AmnFXf4d8uf8A Vrs/+REX/NOKu/w75c/6tdn/AMiIv+acVd/h3y5/1a7P/kRF/wA04qtm0DQI4nkj061SRFLI6wxq wIFQQQtQRiqjoEoGhacPC1h/5NriqR/mF+Ydh5R0cztSbUbjkljagqSX4sVkkXkjekrABiviBir5 78z655t83Xq3+sSGONgHtbb40gRGFOUMbFtm4/arv44qlDaFJx+GYFvAggffU4qzjyZ+ZvnDyglt FqcUt95aaT0w7oxKjq4t5jxBZa14Maf6vXFX0Lp2rWeo2Fvf2cgltbqNZYZB3VxUbdj7YqifWGKr JbuKKJ5ZXWOKNS0kjEKqqoqSSdgAMVS6y83+WL65S1stXsrq5kr6cENxFI7UFTRVYk0AxVFzaxp0 N3DZTXUMd5cgm3tnkVZZAoq3BCeTUpvQYqifWGKu9YYq71hirvWGKoa11jTruWeK1uobiW1f07mO KRXaJ9xxkCklTsdjiqJ9YYqh77VrCwtzc31zFaWykBpp3WNATsAWYgb4qqw3kM0KTQussMqh45EI ZWVhVWUjYgjocVX+sMVd6wxV3rDFXesMVd6wxV3rDFXesMVQun61pepQtPp15BewKxRpbeRJUDAA lSyEitCNsVRXrDFXesMVd6wxV3rDFXesMVU7iYehJ/qN+rFUo0SamjWA8LaH/k2MVebeYfLdr508 /wBvNO5FtYFY5oyKrJbwOWZDQqRzdiOXgcVSX81URPNbLGgSNbeFY1UUUKq0AAHYYqw/FXpuh+Xr XzB+VFzYSw+tOj3E9gORXjcohERqPdqGvY4qo/8AOP2u3s+manpU8nO2sGie0Q9VE5kMgHtySv04 q9Z9bFXm35iX11rPnLQfJcUzxWF2DdasiHiJoVJb0yRRh8ML9D3G2wxVGaz+UHlC404x6PbjSdSj KG11BHndoyrqxPEyDkSARU9OuKpN51vdS07z75NmaM6rqcFvNHwi4w+vO0ZjrvVY1Z2qf5RirJ9J 8/am/miLy5rmj/ou8uoWns5EuFuUkC1JUlUXjQI3Xw9xiqGh/MPzHqdxfN5d8uDUtOsbh7X6297F AZXjpy4Iymg+KoJO499sVRMv5l2beU9O12zs5LmfVZks7LT+SozXLsyemzmoUVQ/FTw8cVU7fz75 gt9a03Ttf8v/AKMh1Rmjgu47pblVkAqqOsabEsQta03+eKsY8rebNJ8tan551DUpGWN9WaOFEUs8 khadlRQB1PE7mg98VemaLqWpXmmxXGpWP6NvH5c7P1VnKAMQtXUKu439sVeZfm1capqHmrQNJm0Y 3ummWVraD60sQvm9OPkCRRofSLEVJ3rtirJrvzje6Zf2flXy9of12+trCOaa2a6SKO2hXjGqGRwx kK1Fe9KHfFVbRPzDuLu71bTNV0s6XrOlwfWjZ+ss6yxcOXJZEUKKVWvXr86KqPk/8xdW80NazWmh GLS2Z476+a5jIglQFgixlUeQFTH8QH7VO2Kpr5484/4X0F9W+q/XOEiR+h6npfbNK8uL9Pliq3zt 50/wxoaap9U+uc5o4fR9T0qeoCa8uL9KeGKoLXfPms2fmgeXtJ0L9K3P1Vbtn+tJbhULlDXmjDY0 /a79MVX6B5+ubrXLnQtd00aNqcMS3EEZmE6TRfFzdXVFUcaePj4HFUvsPzG8z6vHcXmheWPr+lRT SRW9214kDTqjU5pHJGGG29D8uuKsZ/KTX30P8t9QvIrKbULj9JOkFnbqzM7tBDQEqrcF23Yj8cVZ RN+YfmjTtQ0u31vy4llBq11HaRSJexzNG0jBasqJ8XWuxxVjut+YfNkf5u2rQaO0ksNpJFa2H1yN VuYA8wW5LEcEJG/BhXbFWU3X5ga3ca7qGleXdC/Sq6WVW8unukt09RgSY1DqakUpWvX23xVQm/Nq yi8s6lqbWTLqmkTJbX+kNJukzymOnrKrKV+FiGA7YqitM87eaZbyxXUfLLwaff0Md/aXC3ixhxVf UWJNl33atMVZZPN+4k/1T+rFUp0iWmk2Q8IIv+IDFWLaPMNP83XMc3w+s0kak/5bB0/4KgxVLvPV ol7rpiMfqO8aJGAKtVtvh98VYrrXkXXdMt2u2h52irykdWUtHU0oyg1PjUCmKs58h6kmneQZ7590 tPrM7DxEYLn9WKsV/IEfvtcnNQaWyinT4jKT+rFXsHre+KsB/MLTNYh1/RvNuj2rXUulB11CNGUO 1uN6KDuaq8g2r1G2KoXX/wAy4te0k6T5SF1Lr18AqhFMLW9CGfnISoB4gioanviq7VLG6tfP3kuJ 5Jbs2lvNHNeScnZmETAs7Gu7HxxVGa2srfm35dmCMYks7gNIAaAlJup7dcVYpoa6F5WjvtI8x3up 2N3FcyNYpazXcaXMBACSIID6ZZiDWtPfFUwn0G9svJvl2/i0qa3fStTTUr3TEkMjpArFmb943Itx RTx6ip264qyS1/MFtb1zTrPywFu7H421q5mhmX0EABRVLemOb0YdD+vFWFWnkJPMes+b55JZ7W+t 7+VtMcHhHzaR2DHap3UCoOKvRPIvmi61vREfUEMOrW5Md/D6bx8WDMFIDfzKtTTvXFUp87iV/PHk p1VmWOe6LsASFqsXU9sVQ+pXUflb8w7vzFqSyLo2q2aQteqhkEVxHxARglXVSkVfs7k+xxVC2Rl8 w+adZ81W6Mujxaa9lp85RozcsVJZuLAMQrch08PfFU5/KNWg8h2CMhjkLzlwRxJPrOKn6KYq3+bO n3up+SruK0Qyywslw0Y6lIzV6V60XemKsR/MHzlZ+Z/KNrBo0UtyyTQSagRG4Fu3A0jJYDkxYn7N R8J9sVTrVdeg0j82HvLiKWS2OjiOeWFGk9JDcA+o6oC3EFQDQd8VQ9rKvnXz62q2PIaFptjJaJfh Wj9aS4jdCFDhW+H1W7bU9xirXk/zlD5V0U+WtatZ4tW095Es7aGGRzdqzs4MRAI6t1O3TFWO+WX1 +w/LKf6p9btVGshtSktQUuEshBH6rxk7ihA3H6q4qv8AMF95ee68vatpVzf6lZadfRSapqt411MY 1Dqyj96KbhGr6a9h7YqyDX9atLP8z9E1+f1RpMumBUu1ilZayGYqKBS1fjXalRXfFUvEGneW/NGt p5huNRsdP1C4N3p+oWk11HFK0hLNEwtzu45dx2PtiqtZWN1aeWfMOpW3l36zbalLFIlreSSzz3du sjt60iFmdXHqB/GtT4Yql8dxafWbFPy5vtTN+J1kutHkeUWUEQU+oJVlCrUNxX7Z9t6Yq9kmm/cy b/sn9WKpVpk1NNtB4Qx/8QGKpT5n0+acx39ryNxDQMq9aA1DD3BxVS0jzLZcud6Cl7IAslzT4WCn 4a0+z18MVTiTXtLjTm11GR4KwY/ctTirCPM8beYdPk0bSI2tIJpBMyqKB5Nv7wLyCpyoTTvvirKv KOhW3l7QrfT4lUTBQ946ksHnKgSMC1DSo226YqnPre+Ku9b3xV3re+Ku9b3xV3re+Ku9b3xV3re+ Ku9b3xV3re+Ku9b3xV3re+Ku9b3xV3re+Ku9b3xV3re+Ku9b3xVKE0SNfNT+YfXPqPZ/Uvq/EUp6 gk5cq+1KUxVN/W98Vd63virvW98Vd63virvW98Vd63virvW98Vd63viqyWb90+/7J/ViqWafLSwt h4RJ/wARGKoj1vfFUDe6Xp938Tx8JDX94nwtv47UP04qgU8s2QarTSMvgKD8aYqmttb2dqKQRLHt QsB8RHXdjucVV/W98Vd63virvW98Vd63virvW98Vd63virvW98Vd63virvW98Vd63virvW98Vd63 virvW98Vd63virvW98Vd63virvW98Vd63virvW98Vd63virvW98Vd63virvW98Vd63virvW98Vd6 3viqyWb92+/Y/qxVESf4Z9RvR+velU+n6X1f0+NduHL4uNOlcUrf+de/7WX/AE7Yod/zr3/ay/6d sVd/zr3/AGsv+nbFXf8AOvf9rL/p2xV3/Ovf9rL/AKdsVd/zr3/ay/6dsVd/zr3/AGsv+nbFXf8A Ovf9rL/p2xV3/Ovf9rL/AKdsVd/zr3/ay/6dsVd/zr3/AGsv+nbFXf8AOvf9rL/p2xV3/Ovf9rL/ AKdsVd/zr3/ay/6dsVd/zr3/AGsv+nbFXf8AOvf9rL/p2xV3/Ovf9rL/AKdsVd/zr3/ay/6dsVd/ zr3/AGsv+nbFXf8AOvf9rL/p2xV3/Ovf9rL/AKdsVd/zr3/ay/6dsVd/zr3/AGsv+nbFXf8AOvf9 rL/p2xV3/Ovf9rL/AKdsVd/zr3/ay/6dsVd/zr3/AGsv+nbFXf8AOvf9rL/p2xV3/Ovf9rL/AKds Vd/zr3/ay/6dsVab/DXE+r+kfTp8dfQ+z3+x8X/A74pf/9k= application/postscript 3 xmp.iid:7d4bf594-18a7-d54d-8874-7b52ad1d4e7a xmp.did:7d4bf594-18a7-d54d-8874-7b52ad1d4e7a xmp.did:2e1af1ba-762d-0c40-b46d-fef26eac9d89 created xmp.iid:2e1af1ba-762d-0c40-b46d-fef26eac9d89 2022-03-25T14:57:33+08:00 Adobe Photoshop CC 2017 (Windows) saved xmp.iid:7d4bf594-18a7-d54d-8874-7b52ad1d4e7a 2022-03-25T15:04:36+08:00 Adobe Illustrator CC 2017 (Windows) / xmp.iid:2e1af1ba-762d-0c40-b46d-fef26eac9d89 xmp.did:2e1af1ba-762d-0c40-b46d-fef26eac9d89 xmp.did:2e1af1ba-762d-0c40-b46d-fef26eac9d89 2919 577 8 8 8 5 2 1 3 1 1500000/10000 1500000/10000 2 65535 2919 577 1401.120000 276.960000 Points 1 False False Cyan Magenta Yellow Black Default Swatch Group 0 endstream endobj 1434 0 obj<> endobj 1435 0 obj<>stream H墱扐N0E鳒 僁&H墥T立莺庅Zq爨L曅郒\;i .+廹迀&e4 鰩懭S鼃>L狵7k譿Ol](牵,i愣琂单Tu堞樻z芻玗榒豫@戔殇佒€B?颌347翠6 %&熐W毥 P艅4M7C_ ("儛劇g3贱Um=U鉓潣钍T韜唡"$d坭娮虉 刅容長 臶J醐寎皽″$d忬7rKd;DV艞哠墟晌,與梽n誤\疬.r3Q瓕霧3%/箓 s侈H諵鵎/と&E;ㄒ頔桯緱[ $镫 (朤-R躾9熡滮2p鄄专/鴣q愅b9观Y{-=Wv訊]镺68 endstream endobj 1436 0 obj<> endobj 1437 0 obj<>stream Adobe Illustrator 26.3 (Macintosh) 2022-11-02T17:54:26+01:00 2022-11-02T17:54:26+01:00 2022-11-02T17:54:26+01:00 256 216 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f Hx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8f/8AAEQgA2AEAAwER AAIRAQMRAf/EAaIAAAAHAQEBAQEAAAAAAAAAAAQFAwIGAQAHCAkKCwEAAgIDAQEBAQEAAAAAAAAA AQACAwQFBgcICQoLEAACAQMDAgQCBgcDBAIGAnMBAgMRBAAFIRIxQVEGE2EicYEUMpGhBxWxQiPB UtHhMxZi8CRygvElQzRTkqKyY3PCNUQnk6OzNhdUZHTD0uIIJoMJChgZhJRFRqS0VtNVKBry4/PE 1OT0ZXWFlaW1xdXl9WZ2hpamtsbW5vY3R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo+Ck5SVlpeYmZ qbnJ2en5KjpKWmp6ipqqusra6voRAAICAQIDBQUEBQYECAMDbQEAAhEDBCESMUEFURNhIgZxgZEy obHwFMHR4SNCFVJicvEzJDRDghaSUyWiY7LCB3PSNeJEgxdUkwgJChgZJjZFGidkdFU38qOzwygp 0+PzhJSktMTU5PRldYWVpbXF1eX1RlZmdoaWprbG1ub2R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo +DlJWWl5iZmpucnZ6fkqOkpaanqKmqq6ytrq+v/aAAwDAQACEQMRAD8A63e3txeXDzzuWZiSATso 8B7YqoYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FX Yq7FVeyvbizuEngcqykEgHZh4H2xVQxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV 2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVUgjSWZI3kWJWNPUavEfOmKp8PJ N+QCLiEg7gjl/TFW/wDBGof7/i/4b+mKu/wRqH+/4v8Ahv6Yq7/BGof7/i/4b+mKu/wRqH+/4v8A hv6Yq7/BGof7/i/4b+mKu/wRqH+/4v8Ahv6Yq7/BGof7/i/4b+mKu/wRqH+/4v8Ahv6Yq7/BGof7 /i/4b+mKu/wRqH+/4v8Ahv6Yq7/BGof7/i/4b+mKu/wRqH+/4v8Ahv6Yq7/BGof7/i/4b+mKu/wR qH+/4v8Ahv6Yq7/BGof7/i/4b+mKu/wRqH+/4v8Ahv6Yq7/BGof7/i/4b+mKu/wRqH+/4v8Ahv6Y q0fJN+ASbiEAbknl/TFUhnjSKZ40kWVVNPUWvE/KuKqeKuxV2KuxV2KuxV2KuxV2KuxV2Ksi8ueY zalbO8atsdo5D+x7H/J/VirMwQQCDUHcEYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq4 kAEk0A3JOKsM8x+YzdFrOzalsNpJB+37D/J/XirHcVdirsVdirsVdirsVdirsVdirsVdirsVZF5c 8xm1K2d41bY7RyH9j2P+T+rFWZgggEGoO4IxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVxIAJ JoBuScVYZ5j8xm6LWdm1LYbSSD9v2H+T+vFWO4q7FXYq7FXYq7FXYq7FXYq7FVyRSOGKKW4Lyam9 FG1fxxVbirsVdirsVZF5c8xm1K2d41bY7RyH9j2P+T+rFWZgggEGoO4IxV2KuxV2KuxV2KuxV2Ku xV2KuxV2KuxVxIAJJoBuScVYZ5j8xm6LWdm1LYbSSD9v2H+T+vFWO4q7FXYq7FVzxSIFLqV5ryWu 1VO1fwxVbirsVdirsVdirsVT3ycAdWYEVBhcEH5jFVXzH5cNqWvLNa2x3kjH7HuP8n9WKsdxV2Ku xV2Ksi8ueYzalbO8atsdo5D+x7H/ACf1YqzMEEAg1B3BGKuxV2KuxV2KuxV2KuxV2KuxV2KuJABJ NANyTirDPMfmM3Razs2pbDaSQft+w/yf14qx3FXYq7FXYqyLy55cN0VvLxaWw3jjP7fuf8n9eKqX nEAasoAoBCgAHzOKpFirsVdirsVdirsVT3yb/wAdc/8AGJv1jFWcEAggioOxBxVhnmPy4bUteWa1 tjvJGP2Pcf5P6sVY7irsVdirsVZF5c8xm1K2d41bY7RyH9j2P+T+rFWZgggEGoO4IxV2KuxV2Kux V2KuxV2KuxVxIAJJoBuScVYZ5j8xm6LWdm1LYbSSD9v2H+T+vFWO4q7FXYq7FWReXPLhuit5eLS2 G8cZ/b9z/k/rxVmYAAAAoBsAMVYP5y/464/4xL+s4qkWKuxV2KuxV2KuxVPfJv8Ax1z/AMYm/WMV ZxiriAQQRUHYg4qwzzH5cNqWvLNa2x3kjH7HuP8AJ/VirHcVdirsVdirIvLnmM2pWzvGrbHaOQ/s ex/yf1YqzMEEAg1B3BGKuxV2KuxV2KuxV2KuJABJNANyTirDPMfmM3Razs2pbDaSQft+w/yf14qx 3FXYq7FXYqyLy55cN0VvLxaWw3jjP7fuf8n9eKszAAAAFANgBirsVYP5y/464/4xL+s4qkWKuxV2 KuxV2KuxVPfJv/HXP/GJv1jFWcYq7FXEAggioOxBxVhnmPy4bUteWa1tjvJGP2Pcf5P6sVY7irsV dirsVZF5c8xm1K2d41bY7RyH9j2P+T+rFWZgggEGoO4IxV2KuxV2KuxVxIAJJoBuScVYZ5j8xm6L Wdm1LYbSSD9v2H+T+vFWO4q7FXYq7FWReXPLhuit5eLS2G8cZ/b9z/k/rxVmYAAAAoBsAMVdirsV YP5y/wCOuP8AjEv6ziqRYq7FXYq7FXYq7FU98m/8dc/8Ym/WMVZxirsVdiriAQQRUHYg4qwzzH5c NqWvLNa2x3kjH7HuP8n9WKsdxV2KuxV2Ksi8ueYzalbO8atsdo5D+x7H/J/VirMwQQCDUHcEYq7F XYq4kAEk0A3JOKsM8x+YzdFrOzalsNpJB+37D/J/XirHcVdirsVdirIvLnlw3RW8vFpbDeOM/t+5 /wAn9eKszAAAAFANgBirsVdirsVYP5y/464/4xL+s4qkWKuxV2KuxV2KuxVPfJv/AB1z/wAYm/WM VZxirsVdirsVcQCCCKg7EHFWGeY/LhtS15ZrW2O8kY/Y9x/k/qxVjuKuxV2KuxVkXlzzIbUraXjV tjtHIdynsf8AJ/VirMkdHUOjBkYVVgagj2IxVzyJGheRgiLuzMaAD5nFWG+Y/MhuuVpZsRbdJJBs X9h/k/rxVjuKuxV2KuxVkXlzy4boreXi0thvHGf2/c/5P68VZmAAAAKAbADFXYq7FXYq7FWD+cv+ OuP+MS/rOKpFirsVdirsVdirsVT3yb/x1z/xib9YxVnGKuxV2KuxV2KuIBBBFQdiDirAfMthY2d/ xtXHxjlJCP8AdZPavv4YqlGKuxV2KuxVXt769ttoJ5IgeoRiB9wxV1xfXlz/AH88koHQOxI+44qo Yq7FXYq7FU38tWFjeX/G6cfAOUcJ/wB2Edq+3hirPgAAABQDYAYq7FXYq7FXYq7FWD+cv+OuP+MS /rOKpFirsVdirsVdirsVT3yb/wAdc/8AGJv1jFWcYq7FXYq7FXYqkXmLzEtiptrYhrthueojB7n3 8BirCHdnYu5LMxqzHcknFWsVdirsVdirsVdirsVdirsVdiraOyMHQlWU1VhsQRirN/LvmJb5RbXJ C3ajY9BIB3Hv4jFU9xV2KuxV2KuxVg/nL/jrj/jEv6ziqRYq7FXYq7FXYq7FU98m/wDHXP8Axib9 YxVnGKuxV2KuxVIvMXmJbFTbWxDXbDc9RGD3Pv4DFWEO7OxdyWZjVmO5JOKtYq7FXYq7FXYq7FXY q7FXYq7FXYq7FW0dkYOhKspqrDYgjFWb+XfMS3yi2uSFu1Gx6CQDuPfxGKp7irsVdirsVYP5y/46 4/4xL+s4qkWKuxV2KuxV2KuxVPfJv/HXP/GJv1jFWcYq7FXYqkXmLzEtiptrYhrthueojB7n38Bi rCHdnYu5LMxqzHcknFWsVdirsVR2kaRcalcenH8Ma7yynoo/r4DFU21rym8CibTw0sagepEd3qP2 h418MVY2QQaHYjqMVdirsVcASaDcnoMVZLonlN5h62oKY4yDwh6Oa9z4fLFUq1jR7jTbjg/xQt/d S9iPA++KpfirsVdiraOyMHQlWU1VhsQRirN/LvmJb5RbXJC3ajY9BIB3Hv4jFU9xV2KuxVg/nL/j rj/jEv6ziqRYq7FXYq7FXYq7FU98m/8AHXP/ABib9YxVnGKuxVIvMXmJbFTbWxDXbDc9RGD3Pv4D FWEO7OxdyWZjVmO5JOKtYq7FXYqjtI0i41K49OP4Y13llPRR/XwGKvQLGxt7K3W3t14ovU9ye5J8 cVV8VQN/oemXxLTwj1D/ALtX4W+8dfpxVKJPI9oW/d3MijwZQ36uOKuj8j2gb95cyMPBVC/r5Yqm 9hoemWJDQQj1B/u1vib7z0+jFUdiqjeWdveW7QTryjb7wfEe+KsA1jR7jTbjg/xQt/dS9iPA++Kp firsVdiraOyMHQlWU1VhsQRirN/LvmJb5RbXJC3ajY9BIB3Hv4jFU9xV2KsH85f8dcf8Yl/WcVSL FXYq7FXYq7FXYqnvk3/jrn/jE36xirOMVSLzF5iWxU21sQ12w3PURg9z7+AxVhDuzsXclmY1ZjuS TirWKuxV2Ko7SNIuNSuPTj+GNd5ZT0Uf18Bir0Cxsbeyt1t7deKL1PcnuSfHFVfFXYq7FXYq7FXY q7FXYqo3lnb3lu0E68o2+8HxHvirANY0e40244P8ULf3UvYjwPviqX4q7FXYq2jsjB0JVlNVYbEE Yqzfy75iW+UW1yQt2o2PQSAdx7+IxVPcVYP5y/464/4xL+s4qkWKuxV2KuxV2KuxVPfJv/HXP/GJ v1jFU78xeYlsVNtbENdsNz1EYPc+/gMVYQ7s7F3JZmNWY7kk4q1irsVdiqO0jSLjUrj04/hjXeWU 9FH9fAYq9AsbG3srdbe3Xii9T3J7knxxVXxV2KuxV2KuxV2KuxV2KuxV2KqN5Z295btBOvKNvvB8 R74qwDWNHuNNuOD/ABQt/dS9iPA++KpfirsVdiraOyMHQlWU1VhsQRirN/LvmJb5RbXJC3ajY9BI B3Hv4jFUk85f8dcf8Yl/WcVSLFXYq7FXYq7FXYqitP1GewleWCnqshRWP7NSN/wxVDO7OxdyWZjV mO5JOKtYq7FXYqjtI0i41K49OP4Y13llPRR/XwGKvQLGxt7K3W3t14ovU9ye5J8cVV8VdirsVdir sVdirsVdirsVdirsVdiqjeWdveW7QTryjb7wfEe+KsA1jR7jTbjg/wAULf3UvYjwPviqX4q7FXYq 2jsjB0JVlNVYbEEYqidQ1Ge/lSWenqqgRmH7VCd/xxVC4q7FXYq7FXYq7FXYq7FXYq7FUdpGkXGp XHpx/DGu8sp6KP6+AxV6BY2NvZW629uvFF6nuT3JPjiqvirsVdirsVdirsVdirsVdirsVdirsVdi rsVUbyzt7y3aCdeUbfeD4j3xVgGsaPcabccH+KFv7qXsR4H3xVL8VdirsVdirsVdirsVdirsVdir sVdirsVR2kaRcalcenH8Ma7yynoo/r4DFXoFjY29lbrb268UXqe5Pck+OKq+KuxV2KuxV2KuxV2K uxV2KuxV2KuxV2KuxV2KuxVRvLO3vLdoJ15Rt94PiPfFWAaxo9xptxwf4oW/upexHgffFUvxV2Ku xV2KuxV2KuxV2KuxV2KuxV2KqsV1dQrximeNSakKxUV+g4qv/SOof8tMv/Bt/XFXfpHUP+WmX/g2 /rirv0jqH/LTL/wbf1xV36R1D/lpl/4Nv64q79I6h/y0y/8ABt/XFXfpHUP+WmX/AINv64q79I6h /wAtMv8Awbf1xV36R1D/AJaZf+Db+uKu/SOof8tMv/Bt/XFXfpHUP+WmX/g2/rirv0jqH/LTL/wb f1xV36R1D/lpl/4Nv64q79I6h/y0y/8ABt/XFXfpHUP+WmX/AINv64q79I6h/wAtMv8Awbf1xV36 R1D/AJaZf+Db+uKu/SOof8tMv/Bt/XFXfpHUP+WmX/g2/riqyW7upV4yzPIta8WYkV+k4qpYq7FX Yq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXY q7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq7FXYq 7FXYq7FXYq7FXYq7FU8vPKOqx3DrbRiaGpKMGUGnYEMRviqh/hbXv+WX/h4/+asVd/hbXv8All/4 eP8A5qxV3+Fte/5Zf+Hj/wCasVd/hbXv+WX/AIeP/mrFXf4W17/ll/4eP/mrFXf4W17/AJZf+Hj/ AOasVd/hbXv+WX/h4/8AmrFXf4W17/ll/wCHj/5qxV3+Fte/5Zf+Hj/5qxV3+Fte/wCWX/h4/wDm rFXf4W17/ll/4eP/AJqxV3+Fte/5Zf8Ah4/+asVd/hbXv+WX/h4/+asVd/hbXv8All/4eP8A5qxV 3+Fte/5Zf+Hj/wCasVd/hbXv+WX/AIeP/mrFXf4W17/ll/4eP/mrFXf4W17/AJZf+Hj/AOasVd/h bXv+WX/h4/8AmrFXf4W17/ll/wCHj/5qxV3+Fte/5Zf+Hj/5qxV3+Fte/wCWX/h4/wDmrFXf4W17 /ll/4eP/AJqxV3+Fte/5Zf8Ah4/+asVd/hbXv+WX/h4/+asVd/hbXv8All/4eP8A5qxV3+Fte/5Z f+Hj/wCasVd/hbXv+WX/AIeP/mrFXf4W17/ll/4eP/mrFXf4W17/AJZf+Hj/AOasVV7Pyjqslwi3 MYhhqC7FlJp3ACk74q//2Q== 15.046206 12.538505 Pixels 1 False False Cyan Magenta Yellow Default Swatch Group 0 application/postscript xmp.iid:fccaff0e-cae2-499c-928d-e49c09f3a837 xmp.did:fccaff0e-cae2-499c-928d-e49c09f3a837 xmp.did:fccaff0e-cae2-499c-928d-e49c09f3a837 xmp.did:70d45c01-b583-4665-9c34-89bbeac12ac4 xmp.iid:dfd55882-de62-404b-9657-b6a4b4335224 xmp.did:fccaff0e-cae2-499c-928d-e49c09f3a837 saved xmp.iid:fccaff0e-cae2-499c-928d-e49c09f3a837 2022-11-02T17:53:35+01:00 Adobe Illustrator 26.3 (Macintosh) / saved xmp.iid:70d45c01-b583-4665-9c34-89bbeac12ac4 2022-11-02T17:54:26+01:00 Adobe Illustrator 26.3 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator endstream endobj 1438 0 obj<> endobj 1439 0 obj<>stream H墱扐N0E鳒 僁6M 刞 莺庅Zq爨L斝郒\;i .+廹迀廸4nK蕆h螚B砒沩#懪"ゅ_壽滇忞'段Y樶q2j6( 祬TU云榝z#玗榒豫@鉟鷢@k @zZZ餏 齂峀秷ψ7毥舩PF4M7缇6K2 脨 炌皙W歹Tu7ub+S曔驒.垬憽? 跢准bF 碆頝绾o)宸?0隽r-gD8#反驐^H懁E;ㄒ頔桯緱[ $镫' (扵-c躾_衂N~}M 竚賙詠8萬睖茼鞏+婚飘臾6 endstream endobj 1440 0 obj<> endobj 1441 0 obj<>stream application/postscript Immunology Adobe Illustrator 25.2 (Macintosh) 2022-02-03T18:14:26+01:00 2022-02-03T18:14:26+01:00 2022-02-03T18:14:26+01:00 256 232 JPEG /9j/4AAQSkZJRgABAgEASABIAAD/7QAsUGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA AQBIAAAAAQAB/+4ADkFkb2JlAGTAAAAAAf/bAIQABgQEBAUEBgUFBgkGBQYJCwgGBggLDAoKCwoK DBAMDAwMDAwQDA4PEA8ODBMTFBQTExwbGxscHx8fHx8fHx8fHwEHBwcNDA0YEBAYGhURFRofHx8f Hx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8fHx8f/8AAEQgA6AEAAwER AAIRAQMRAf/EAaIAAAAHAQEBAQEAAAAAAAAAAAQFAwIGAQAHCAkKCwEAAgIDAQEBAQEAAAAAAAAA AQACAwQFBgcICQoLEAACAQMDAgQCBgcDBAIGAnMBAgMRBAAFIRIxQVEGE2EicYEUMpGhBxWxQiPB UtHhMxZi8CRygvElQzRTkqKyY3PCNUQnk6OzNhdUZHTD0uIIJoMJChgZhJRFRqS0VtNVKBry4/PE 1OT0ZXWFlaW1xdXl9WZ2hpamtsbW5vY3R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo+Ck5SVlpeYmZ qbnJ2en5KjpKWmp6ipqqusra6voRAAICAQIDBQUEBQYECAMDbQEAAhEDBCESMUEFURNhIgZxgZEy obHwFMHR4SNCFVJicvEzJDRDghaSUyWiY7LCB3PSNeJEgxdUkwgJChgZJjZFGidkdFU38qOzwygp 0+PzhJSktMTU5PRldYWVpbXF1eX1RlZmdoaWprbG1ub2R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo +DlJWWl5iZmpucnZ6fkqOkpaanqKmqq6ytrq+v/aAAwDAQACEQMRAD8A7XaXH5w2ul28Zt7HUrv0 W53M7IjGb6ssil/RaGMp9YdoxwTog7P6iqtS3v5y291O0en2N7E80KQryWJEh9PjLIF9QuT6i8uL PsG25dlUXPd/mk+nIILexj1SPUUjcsg9B7AwkPN6QuWevqklV9RW2Fe+KswtXne2he4QRXDIpmiB 5BXI+JQe9DiqpirsVdirsVYF+a9nql3Ho0dha3k7Lcl/WslZjE6cWQy8WSiGh3+7frTlxZJ/SQI7 8W9E/wBXz968YGxiJe8XRHL9veNlfUND89RahpH6O1J3gt4RDeSMyiMlpKu5ictyISgFa07b5ZCA gOEWQO/cpMjI2avy2CBlt/zfmtTH68cTuOLEfVwfjCK55KNgpMhSm9KV3ySFGK0/OC2i4W8isDHU +u8MrmX0qHkzseI5AcQu3WuKsk0WHzikusRa1KtzZgcdMlCxI7D4warF4jj179sVRuqN5oTUPU01 YpLP0lHpS0+3SZnIoVatViUVNNz8wqgrif8AMCqNFbWeyMzRqTTnRgqFmapX4QagCvKm1CcVXSXP np7G7ZLW2ju1CNZJsVJ9c8kcmQ1HoAVPw7nbFV9/N53SQNZQ2sqi3QyJJsGnDuHCUkUqGXifi5Uy uZlezn6aOmMf3hkJX07tvI+aFe9/MlYJONhYyTGNfSoSoWViC3IGU1VVDDYipoelcheTuDkDFoSR 6pgX9n+l6/rV57jz2JP3NpaMqcQKuQrk05MwJJUChpQmlf2qbyJn5NcYaSt5S/H4/stf5f1LzZd6 jcpqllDbWMYYwyIJA7HnxUfGdxRWNaDtsK4wlIncbMdXh08IA45GU+vLu/H27lkOWuudirsVdirs VdirsVdirsVdirsVdirEbX8vYre1Fumq3vHh6bH1pAKc+Q4gPRaABfh7CmUDBQ5l3E+1zKXFwQ+Q /Vv37q/+CZea/wC5m89FDK0cRc/C8i8UPKvIiPihUEnce5w+F5lh/KYr+7he3Tu/Xvfv8m4/JAjm 9ddVvmk5K5JloT6bSMqlgK0/enl47+OPg+ZQe07FcEK93fX6l/lXyxf6QzveahJeEx8URndlDvI0 kjfET24IPZa/tEYceMx5ljr9bDNtGIjv5d1D9J+PkyPLXWuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxVgX5r67f6XHo62WoPYT T3PwlQeMpQqfSY8WHxAnrt45TlGU7QBqjZFHh866+4LxQG0hv03rl0+PLflzRF/f/mHaX2kwwQx3 SSQqt/8Auy0YlaShZpF404pQ7UGWQiYiieI99VfwTKXEbrh8ruvigG83/mRLalotAEchqvxRTVDM EAorEf3bOak7MFqNjkkKCecfzKt0CNoMl3I6eosjQSoA3pV40WnHi4/aNTy26YqyTQ9a8y3cus22 r2AtBY1W1uollSOXZgWQyfa+yGBXpXFUZqmra5aanwttON5YCFWLJUN6p9Vm+KrbARKOIStWG/Yq oSfzP5gT02XQJ/TMbSuteT7A8Y6KOIYlTXfpSla0xVefMusvZXU8eiTrLAEeGB+XOVWnMZUDiAG4 Ly6mlRUYqqXmva3byjho0lxF9XSVxGx5LIWdZI1PGjkUUjpiqHbzZraROz+XLrmEVolQlgzPQhCQ lVovIsSKAincYqqS+ZtajlIOhXJROIfh8ZZmC/YIA2Wp3Ip48d6Kr/L/AJrl1fUbm0Fg9vFbhibh nDKeL8AKAdSQ3QkbGhOKsgxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ks W8+eadT8vxWEmn28d0081J45OVfRUqHKce45f2HMfPqBjIj/ABS5dPtZCIPOVV5XY68u4b9b5J/p V5Le6db3UsLW8kyBmhcEMp+RAP35dDiocQqXUXf2oJjfpNx91fYiskh2KuxV2KuxV2KuxV2KuxV2 KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KpXrnlfQNdNq2rWSXbWUnq2pfk Cjmm44keA2ycZmIIHXYsTEHmmmQZOxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV 2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2 KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV 2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2 KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV 2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2 KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV 2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2 KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux V2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV 2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2 KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2K uxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Ku xV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2KuxV2Kux V2KuxV2KuxV2KuxV2KuxV2Kv/9k= proof:pdf uuid:65E6390686CF11DBA6E2D887CEACB407 xmp.did:3805dea6-2acb-455a-a7d3-c6e9256794d3 xmp.iid:3805dea6-2acb-455a-a7d3-c6e9256794d3 uuid:3d386d1f-73a5-ad4c-ab26-92026cd2e2f8 xmp.did:f615e2dc-00b8-4d59-bb61-a6b05b92cf6a uuid:65E6390686CF11DBA6E2D887CEACB407 proof:pdf saved xmp.iid:40486d37-1753-4673-a1e3-118b3a843406 2020-03-09T14:22:37+01:00 Adobe Illustrator 24.1 (Macintosh) / saved xmp.iid:131a1828-cd30-4a49-8136-a598ad41a793 2020-03-10T08:39:35+01:00 Adobe Illustrator 24.1 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:a49e98f2-6751-4cb6-8b38-0ef5deb406dd 2020-11-04T15:52:09+01:00 Adobe Illustrator 24.3 (Macintosh) / saved xmp.iid:3805dea6-2acb-455a-a7d3-c6e9256794d3 2022-02-03T18:14:26+01:00 Adobe Illustrator 25.2 (Macintosh) / Web AIRobin 1 False False 2964.404702 226.230027 Pixels Cyan Magenta Yellow Black Default Swatch Group 0 White RGB PROCESS 255 255 255 Black RGB PROCESS 0 0 0 R=109 G=110 B=112 PROCESS 100.000000 RGB 109 110 112 R=113 G=46 B=117 PROCESS 100.000000 RGB 113 46 117 R=0 G=123 B=61 PROCESS 100.000000 RGB 0 123 61 R=49 G=183 B=188 PROCESS 100.000000 RGB 49 183 188 R=228 G=5 B=33 PROCESS 100.000000 RGB 228 5 33 R=243 G=146 B=0 PROCESS 100.000000 RGB 243 146 0 R=0 G=160 B=210 PROCESS 100.000000 RGB 0 160 210 R=22 G=65 B=148 PROCESS 100.000000 RGB 22 65 148 R=239 G=213 B=0 PROCESS 100.000000 RGB 239 213 0 R=149 G=193 B=31 PROCESS 100.000000 RGB 149 193 31 R=145 G=207 B=122 PROCESS 100.000000 RGB 158 204 131 R=145 G=207 B=122 copy 4 PROCESS 100.000000 RGB 255 149 62 R=145 G=207 B=122 copy 3 PROCESS 100.000000 RGB 231 50 59 R=145 G=207 B=122 copy 2 PROCESS 100.000000 RGB 124 220 220 R=0 G=123 B=61 2 PROCESS 100.000000 RGB 52 120 67 R=49 G=183 B=188 2 PROCESS 100.000000 RGB 92 180 186 R=228 G=5 B=33 2 PROCESS 100.000000 RGB 209 45 45 R=243 G=146 B=0 2 PROCESS 100.000000 RGB 229 149 53 R=0 G=160 B=210 2 PROCESS 100.000000 RGB 70 158 205 R=113 G=46 B=117 2 PROCESS 100.000000 RGB 104 51 113 R=22 G=65 B=148 2 PROCESS 100.000000 RGB 33 65 142 R=239 G=213 B=0 2 PROCESS 100.000000 RGB 234 212 71 R=149 G=193 B=31 2 PROCESS 100.000000 RGB 158 190 67 R=40 G=40 B=40 PROCESS 100.000000 RGB 39 39 39 R=152 G=138 B=255 PROCESS 100.000000 RGB 149 140 247 Grays 1 R=0 G=0 B=0 RGB PROCESS 0 0 0 Adobe PDF library 15.00 21.0.0 endstream endobj 1442 0 obj<> endobj 1443 0 obj<> endobj 1444 0 obj<> endobj 1445 0 obj<> endobj 1446 0 obj<> endobj 1447 0 obj<> endobj 1448 0 obj<> endobj 1449 0 obj<> endobj 1450 0 obj<> endobj 1451 0 obj<> endobj 1452 0 obj<> endobj 1453 0 obj<> endobj 1454 0 obj<> endobj 1455 0 obj<> endobj 1456 0 obj<> endobj 1457 0 obj<> endobj 1458 0 obj<> endobj 1459 0 obj<> endobj 1460 0 obj<> endobj 1461 0 obj<> endobj 1462 0 obj<> endobj 1463 0 obj<> endobj 1464 0 obj<> endobj 1465 0 obj<> endobj 1466 0 obj<> endobj 1467 0 obj<> endobj 1468 0 obj<> endobj 1 0 obj<> endobj 2 0 obj<> endobj 3 0 obj<> endobj 4 0 obj<> endobj 5 0 obj<> endobj 6 0 obj<> endobj 7 0 obj<> endobj 8 0 obj<> endobj 9 0 obj<> endobj 10 0 obj<> endobj 11 0 obj<> endobj 12 0 obj<> endobj 13 0 obj<> endobj 14 0 obj<> endobj 15 0 obj<> endobj 16 0 obj<> endobj 17 0 obj<> endobj 18 0 obj<> endobj 19 0 obj<> endobj 20 0 obj<> endobj 21 0 obj<> endobj 22 0 obj<> endobj 23 0 obj<> endobj 24 0 obj<> endobj 25 0 obj<> endobj 26 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 27 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 28 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 29 0 obj<>/ColorSpace<>/Font<>/ProcSet[/PDF/Text/ImageC]/ExtGState<>>> endobj 30 0 obj<>stream /GS1 gs BT /F1 1 Tf 13.5 0 0 13.5 49.6063 755.5463 Tm /Cs6 cs 0.85098 0.19216 0.2 scn 0 Tc 0 Tw [(1)-302.1(Introduction)]TJ /F8 1 Tf 9 0 0 9 63.6094 730.5447 Tm 0.15294 0.15294 0.15294 scn [(Huma)-9.6(n)-498.4(pap)-9.6(illoma)-10.7(virus)-509.6(\(HPV\))-513.9(infec)-9.8(tion)-507.2(can)-508.4(cause)-511.5(multiple)]TJ -1.5559 -1.3858 TD [(types)-403(of)-399.5(clinical)-401.5(manifestations)-402.9(or)-402.1(diseases)-399.1(such)-405.2(as)-395.8(genital)-403.7(warts,)]TJ 0 -1.3921 TD 0.0469 Tc [(respirato)5.2(r)-4.8(y)-540.8(p)0(apillomatosis,)-541.4(hea)5.2(d)-548.1(and)-548.1(n)2.1(eck)-547.6(c)3.1(ancer)-546.6(\()-0.6(mostly)]TJ 0 -1.3858 TD 0.0206 Tc [(o)4.1(r)0.3(o)4.1(p)5.2(h)3.6(a)-2.2(r)6.6(y)-0.1(n)7.3(g)-0.1(ea)4.1(l)-516.8(s)6.6(qu)5.2(am)7.4(ou)5.2(s)-516.2(cel)6(l)-516.8(c)8.3(ar)]TJ 14.4 0 TD 0.0178 Tc [(cinoma\),)-520.1(anal)-519.6(canc)5.5(er,)-520.1(p)2.4(enile)]TJ -14.4 -1.3921 TD 0 Tc [(cancer,)-429.8(vulvar)-423.2(cancer,)-429.8(vaginal)-428.3(cancer,)-429.8(and)-423.3(cervical)-428.6(cancer)-427.3(\()]TJ 0.85098 0.19216 0.2 scn 24.6236 0 TD (1)Tj 0.15294 0.15294 0.15294 scn 0.4787 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.6425 0 TD (2)Tj 0.15294 0.15294 0.15294 scn 0.4787 0 TD (\).)Tj -26.2236 -1.3858 TD [(Among)-346.9(these)-352.1(HPV-associated)-351.1(cancers,)-349.2(cervical)-353.1(cancer)-351.7(contributes)]TJ 0 -1.3921 TD [(to)-294.1(the)-300.6(highest)-300.2(proportion)-296.7(and)-297.3(ranks)-299.5(as)-301.4(the)-294.3(fourth)-301.4(most)-296(commonly)]TJ 0 -1.3858 TD [(diagnosed)-349.3(cancer)-351.7(and)-354(the)-344.7(fourth)-351.8(leading)-349.5(cause)-354.1(of)-349.2(cancer)-345.4(death)-351.5(in)]TJ 0 -1.3921 TD [(women)-304.4(\()]TJ 0.85098 0.19216 0.2 scn 3.5906 0 TD (3)Tj 0.15294 0.15294 0.15294 scn 0.4787 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5228 0 TD (4)Tj 0.15294 0.15294 0.15294 scn 0.4787 0 TD (\).)Tj -3.515 -1.3858 TD [(Despite)-407.1(the)-401.4(high)-405.8(ef)]TJ /F9 1 Tf 7.8992 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(cacy)-408.4(demonstrated)-408.3(by)-402.6(prophylactic)-411.8(HPV)]TJ -9.9843 -1.3921 TD [(vaccines)-458.9(and)-461(the)-451.8(bene)]TJ /F9 1 Tf 9.3039 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(t)-460.2(o)0(f)-456.2(cervical)-453.8(screening)-463.3(across)-458.9(the)-458.1(female)]TJ -9.8331 -1.3858 TD [(population,)-238.3(the)-237.6(number)-242.2(of)-235.8(newly)-240.7(diagnosed)-242.2(cervical)-239.7(cancer)-238.3(patients)]TJ 0 -1.3921 TD [(in)-257.3(2018)-257.2(was)-254.3(nearly)-261.5(570,000)-259.2(cases,)-260.6(of)-254.7(which)-255.8(311,000)-259.2(cases)-258.1(died)-261.9(from)]TJ 0 -1.3858 TD [(this)-420.2(disease)-416.7(worldwide)-420.7(\()]TJ 0.85098 0.19216 0.2 scn 10.022 0 TD (5)Tj 0.15294 0.15294 0.15294 scn 0.4787 0 TD [(\).)-415.4(Globally,)-416.4(in)-421(2020,)-417.2(the)-414(estimated)-422.9(new)]TJ -10.5008 -1.3858 TD 0.0323 Tc [(canc)-5.2(er)-536(cases)-536(w)-2.5(ould)-537.5(exte)-5.2(nd)-531.2(t)-5.9(o)-532.3(660)-5.2(,000)-5.2(,)-530.8(w)-2.5(ith)-532.8(a)-3.1(bout)-535(350)-5.2(,000)]TJ 0 -1.3921 TD 0 Tc [(deaths)-302.4(\()]TJ 0.85098 0.19216 0.2 scn 3.2189 0 TD (6)Tj 0.15294 0.15294 0.15294 scn 0.4787 0 TD (\).)Tj -2.1417 -1.3858 TD [(Addressing)-217.8(barriers)-212.9(to)-212.2(vaccine)-218.2(uptake,)-216.1(such)-209.9(as)-213.2(vaccine)-218.2(hesitancy)]TJ -1.5559 -1.3921 TD 0.0239 Tc [(and)-527(v)-3.1(acci)-5.9(ne)-530.2(availab)-5.2(i)0.4(lity,)-526.6(m)-1.9(ight)-524.5(b)-5.2(e)-523.9(an)-531.2(ef)62.9(fective)-523.9(a)-5.2(pp)-4.1(roach)-528.6(f)-0.1(or)]TJ 0 -1.3858 TD 0 Tc [(improving)-438(HPV)-437.7(vaccine)-438.6(coverage)-440.5(\()]TJ 0.85098 0.19216 0.2 scn 14.7024 0 TD (7)Tj 0.15294 0.15294 0.15294 scn 0.4787 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.6551 0 TD (8)Tj 0.15294 0.15294 0.15294 scn 0.4787 0 TD [(\).)-434.3(Furthermore,)-443(ef)58.2(forts)-434.1(to)]TJ -16.315 -1.3921 TD 0.0118 Tc [(improve)-510.8(t)-1.2(he)-510.8(ef)]TJ /F9 1 Tf 6.3874 0 TD 0 Tc ()Tj /F8 1 Tf 0.5417 0 TD 0.0123 Tc [(cacy)-512.4(of)-509.3(HPV)-512.7(v)4.2(accines,)-506.7(bot)5.6(h)-515(prophylact)5.6(ic)-510.3(and)]TJ -6.9291 -1.3858 TD 0.0124 Tc [(therapeutic,)-512.9(c)-6.2(o)2.2(uld)-513.3(a)-4.1(lso)-514.4(p)-3(lay)-512.3(i)]TJ 12.7685 0 TD 0.0128 Tc [(mportant)-516.7(r)5.1(o)-3.7(le)-5.8(s)-511.4(i)1.9(n)-510.8(t)-0.2(ackling)-518.2(H)4.3(PV)]TJ -12.7685 -1.3921 TD 0 Tc [(in)-11.6(fe)-11.1(c)-12.3(t)0(i)-11.2(o)0(n)-514.9(a)-10.2(n)-7(d)-506.8(t)-6.7(h)-10.7(e)-510(i)0(n)-11.6(c)0(i)-10.6(d)-9.1(en)-13.1(ce)-516(o)-10.2(f)-509(H)-8.5(P)0(V)-13.4(-)0(r)-12.7(e)0(l)-14.3(a)0(t)-10.6(e)0(d)-519.1(c)0(a)-10(n)-7(ce)-12.1(r)-7.7(s)-511.6(or)-521.8(ge)-7.9(n)-7(i)0(t)-11.2(a)-10.2(l)]TJ 0 -1.3858 TD [(warts.)-384.4(In)-379.5(this)-382.4(review,)-384.7(we)-381(summarize)-386.4(the)-382.5(status)-381.8(and)-385.5(prospects)-385.1(for)]TJ 0 -1.3921 TD [(the)-439.2(development)-442.7(of)-437.3(prophylactic)-443.3(and)-442.1(therapeutic)-448.2(HPV)-437.7(vaccines.)]TJ 0 -1.3858 TD [(Exploration)-240.8(of)-229.5(the)-237.6(dosing)-235.7(schedules,)-243.2(formulation)-237.1(strategies,)-237.5(and)-234.3(age)]TJ 0 -1.3921 TD [(expansion)-305.7(of)-298.8(vaccine)-306.4(recipients)-304.7(will)-301.6(also)-301(be)-299.7(discussed.)]TJ /F1 1 Tf 13.5 0 0 13.5 49.6063 380.5795 Tm 0.85098 0.19216 0.2 scn [(2)-298.9(Characteristics)-311.6(of)]TJ 0 -1.1507 TD [(human)-301.6(papillomavirus)]TJ 11.9999 0 0 11.9999 49.6063 340.044 Tm 0.15294 0.15294 0.15294 scn [(2.1)-301.1(Classi)]TJ /F10 1 Tf 4.2284 0 TD ()Tj /F1 1 Tf 0.5811 0 TD [(cation)-304.4(of)-300.3(HPV)]TJ /F8 1 Tf 9 0 0 9 63.6094 315.0425 Tm [(HPV)-431.4(is)-428(an)-426.7(essential)-429.5(member)-434.3(of)-424.7(the)]TJ /F11 1 Tf 15.3323 0 TD (Papillomaviridae)Tj /F8 1 Tf 7.1685 0 TD (family,)Tj -24.0567 -1.3858 TD [(encompassing)-374.1(a)-363(wide)-369.5(range)-373(of)-368.1(primitive)-366.9(DNA)-371(viruses)-372.1(distributed)]TJ 0 -1.3921 TD 0.0262 Tc [(among)-523.7(v)-0.8(arious)-523.2(host)-522.2(species)-523.2(\()]TJ 0.85098 0.19216 0.2 scn 13.1717 0 TD 0 Tc (9)Tj 0.15294 0.15294 0.15294 scn 0.5039 0 TD 0.0277 Tc [(\).)-522.8(P)3.9(h)-1.9(y)7(l)0.5(og)7(eneti)4.2(c)2.8(all)6.8(y)0.7(,)-522.8(H)0.3(P)3.9(V)0.3(s)-528(a)4.9(re)]TJ -13.6756 -1.3858 TD 0 Tc [(categorized)-420.9(into)]TJ /F9 1 Tf 6.9543 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(ve)-417.3(genera:)]TJ /F11 1 Tf 4.5669 0 TD [(Alpha,)-421.6(Beta,)-419.3(Gamma,)-421.7(Mu,)-418.5(and)-420.1(Nu)]TJ /F8 1 Tf 14.5197 0 TD (,)Tj -26.5701 -1.3921 TD [(based)-213.4(on)-206.2(the)-212.4(homology)-211.4(of)-210.6(the)-212.4(nucleotide)-211.7(sequence)-218.3(in)-206.9(the)-212.4(L1)-212(gene)-209.9(\()]TJ 0.85098 0.19216 0.2 scn 26.0913 0 TD (9)Tj 0.15294 0.15294 0.15294 scn 0.4787 0 TD (,)Tj 0.85098 0.19216 0.2 scn -26.5701 -1.3858 TD (10)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj /F11 1 Tf 0.7685 0 TD (Alpha)Tj /F8 1 Tf 2.5827 0 TD (and)Tj /F11 1 Tf 1.7008 0 TD (Beta)Tj /F8 1 Tf 1.9654 0 TD [(HPVs)-212.3(are)-206.6(the)-206.1(most)-201.5(commonly)-208.6(studied)-209.8(and)-209.1(have)]TJ -7.9748 -1.3921 TD 0.0126 Tc [(distinctive)-510(b)-3.9(iologica)-3.9(l)-512.2(p)3.5(roperties.)]TJ /F11 1 Tf 14.1165 0 TD 0.0136 Tc (Beta)Tj /F8 1 Tf 2.3244 0 TD 0.0125 Tc [(viruses)-511.7(f)-5.2(requently)-512.2(i)1.6(nfect)]TJ -16.4409 -1.3858 TD 0 Tc [(cu)-8.9(t)-6.7(a)0(n)-11(e)0(o)-10(u)0(s)-508.1(e)0(p)-15.2(ith)-9.4(el)-14.3(ium)-518.2(and)-517.7(ar)-11.6(e)-503.7(i)0(n)-11.6(v)-8.1(olv)-7.7(ed)-519.1(in)-509.2(n)-7(o)0(n)-11(-me)-11.7(l)-8.3(ano)-8.6(m)-6.9(a)-507.9(s)-7.7(kin)]TJ T* [(ca)-10(n)-7(c)0(e)-12.1(r)-7.7(s,)-514.1(wh)-7.7(er)-13.7(ea)-10(s)]TJ /F11 1 Tf 7.4709 0 TD [(Al)-12.1(ph)-12.6(a)]TJ /F8 1 Tf 2.9039 0 TD [(g)-8.1(e)0(n)-13.1(era)-11.3(-H)-13.6(PV)-13.4(s)-511.6(inf)-16.7(ect)-516.4(b)-10.2(oth)-519(m)-6.9(u)0(c)-8.9(o)0(s)-11.6(a)0(l)-516.1(a)0(n)-11(d)]TJ -10.3748 -1.3921 TD [(genital)-359.6(epithelium)-355.5(and)-360.3(are)-357.8(the)-351(causes)-361.7(of)-355.5(many)-353.6(anogenital)-361.9(cancers)]TJ 0 -1.3858 TD [(in)-446.2(humans)-442.2(and)-442.1(primates)-449.4(\()]TJ 0.85098 0.19216 0.2 scn 11.1055 0 TD (11)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.6614 0 TD (12)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-440.6(The)]TJ /F11 1 Tf 3.0047 0 TD (Alpha)Tj /F8 1 Tf 2.822 0 TD [(HPVs)-445.3(are)-439.7(further)]TJ -19.5087 -1.3921 TD [(grouped)-267.3(into)-261.6(low-risk)-263.2(HPVs)-262.6(\(LR-HPVs\))-263.5(and)-265.8(high-risk)-263(HPVs)-262.6(\(HR-)]TJ 0 -1.3858 TD [(HPVs\))-278.7(depending)-280.4(on)-275.5(their)-275(capacity)-281.5(to)-275.2(cause)-278.5(cancer.)-278.6(The)-278.4(LR-HPVs)]TJ 0 -1.3921 TD [(include)-421.9(HPV-6/11/42/43/44.)-427.2(HPV)-425.1(6)-415.5(and)-423.3(11)-421.5(cause)-423.4(most)-422(cases)-421.9(of)]TJ 0 -1.3858 TD [(genital)-466.7(warts)-470.2(\()]TJ 0.85098 0.19216 0.2 scn 6.0913 0 TD (13)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-465.8(HPV-16/18/31/33/35/39/45/51/52/56/58/59/68)]TJ -7.0488 -1.3921 TD [(are)-301.1(members)-303.4(of)-298.8(HR-HPVs)-304.7(\()]TJ 0.85098 0.19216 0.2 scn 11.3575 0 TD (14)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5165 0 TD (15)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj /F1 1 Tf 11.9999 0 0 11.9999 304.8944 756.6802 Tm [(2.2)-298.5(Genomic)-302.7(characterization)-308.1(of)-300.3(HPV)]TJ /F8 1 Tf 9 0 0 9 318.8409 731.6786 Tm [(T)-9.6(h)0(e)-508.1(HPV)-513.3(v)-8.1(ira)-9.9(l)-505.9(par)-14.4(tic)-11(le)-8(s)-505.3(a)0(r)-11.6(e)-503.7(co)-10(mp)-9.7(ose)-11.3(d)-506.8(o)0(f)-506.6(a)-507.9(s)-7.7(ing)-13.4(le)-505.7(d)-9.1(oub)-10.7(le)-8(-)]TJ -1.5496 -1.3921 TD 0.0101 Tc [(stranded)-509.3(DNA)-512.3(m)3.2(olec)10.1(u)-11.4(l)1.8(e)10.1(,)-521.3(wi)10.1(t)-7.4(h)-510.9(a)10.1(p)-9.3(proximate)10.1(l)-10.5(y)-508.3(8)10.1(,000)-506.2(base)-512.5(p)1(airs)]TJ 0 -1.3858 TD 0 Tc [(\(bp\),)-450.8(and)-448.4(a)-451.2(protein)-448.2(capsid)-456.2(containing)-449.5(72)-453(pentameric)-454.5(capsomers)]TJ 0 -1.3921 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3402 0 TD (16)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-453.2(The)-448.4(genomes)-448.9(of)-449.9(all)-448.8(HPV)-444(types)-453.4(contain)-448.6(about)-449.6(eight)-451.9(open-)]TJ -1.2976 -1.3858 TD [(reading)-411.8(frames)-415.2(\(ORFs\))-415.6(that)-412.2(can)-413.9(be)-413.1(functionally)-418.2(divided)-416.1(into)-412.7(the)]TJ 0 -1.3921 TD [(early)-248.2(\(E\),)-247.4(the)-250.2(late)-245.4(\(L\),)-253.2(and)-246.9(the)-250.2(long)-247.8(control)-245.1(region)-251.5(\(LCR\))-246.8(\()]TJ 0.85098 0.19216 0.2 scn 22.9543 0 TD [(Figure)-252.5(1)]TJ 0.15294 0.15294 0.15294 scn 3.2693 0 TD (\).)Tj -26.2236 -1.3858 TD 0.0312 Tc [(S)7.9(p)3.2(eci)]TJ /F9 1 Tf 2.2173 0 TD 0 Tc ()Tj /F8 1 Tf 0.5606 0 TD 0.029 Tc [(cally,)-527.8(t)3.4(he)-525.1(E)-530.3(g)2(en)3.1(e)-525.1(e)-2.2(n)3.1(c)-2.2(odes)-526.7(t)3.4(h)-0.6(e)-525.1(e)-2.2(arly)-527.2(prote)4.1(i)-0.8(n)3.1(s)-526.7(\(E1)]TJ /F12 1 Tf 22.0284 0 TD 0 Tc ()Tj /F8 1 Tf 0.5354 0 TD 0.0301 Tc [(E7)5.2(\))]TJ -25.3417 -1.3921 TD 0.0109 Tc [(responsible)-511.7(f)-0.5(or)-513.3(vira)-5.6(l)-507.6(r)-3.1(eplicati)-6.3(on)-512.7(and)-508.5(o)0.7(ncogenesis.)-514.4(T)1.3(he)-511.7(L)-516.4(g)2.8(ene)]TJ 0 -1.3858 TD 0.0207 Tc [(encodes)-522.4(t)1.4(he)-520.8(structura)4.2(l)-523(proteins)-522.4(\(L1)]TJ /F12 1 Tf 15.6031 0 TD 0 Tc ()Tj /F8 1 Tf 0.5354 0 TD 0.0183 Tc [(L2)-6.6(\))-520.6(n)-1.3(e)-6.6(cess)-8.3(a)1.8(ry)-525.3(f)-5.7(o)1.8(r)-524.8(v)-2.4(ir)-8.3(io)-4.5(n)]TJ -16.1386 -1.3858 TD 0 Tc [(assembly.)-300.6(The)-303.6(non-coding)-307.5(region)-301.9(is)-302(thought)-307.9(to)-300.4(be)-299.7(the)-306.9(most)-302.3(highly)]TJ 0 -1.3921 TD [(variable)-204(part)-203.8(of)-198(the)-206.1(viral)-202.6(genome)-201.9(\()]TJ 0.85098 0.19216 0.2 scn 13.2598 0 TD (17)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-201.2(The)-202.8(structural)-211.4(capsid)-204.2(proteins)]TJ -14.2173 -1.3858 TD [(of)-393.2(HPVs)-401.2(are)-395.6(composed)-399.2(of)-399.6(two)-398.2(key)-394.5(proteins,)-401.6(major)-396(basic)-404.1(L1)-394.7(and)]TJ 0 -1.3921 TD [(min)-12.2(or)-509.2(ba)-7.9(sic)-515.9(L2)-10.5(,)-506.4(res)-15.1(pe)-8.9(cti)-11(ve)-7.9(ly)-507.7(en)-13.1(cod)-12.8(ed)-512.8(by)-509.7(L1)-508.1(an)-11(d)-506.8(L)0(2)-514.4(g)0(e)-7.9(nes)-14.4(.)-506.4(L)0(1)]TJ 0 -1.3858 TD [(ge)-7.9(n)-7(o)0(m)-10.8(e)0(s)-517.6(dis)-15(p)-9.1(lay)-518(d)-9.1(i)0(f)53.4(f)0(e)-11.1(r)-7.7(ent)-13.4(l)-8.3(y)-505.8(a)-10.2(m)-6.9(on)-11(gs)-9.5(t)-510.6(HPV)-519.6(t)-6.7(y)-8.1(pe)-8.9(s)-7.7(,)-506.4(w)-9.6(h)0(i)-9(l)-8.3(e)-510(t)0(h)-11.1(e)-510(L2)]TJ 0 -1.3921 TD [(genomic)-326.1(sequence)-331.7(is)-327.2(relatively)-332.3(conserved)-332.5(\()]TJ 0.85098 0.19216 0.2 scn 17.2284 0 TD (18)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-327.2(The)-328.8(HPV)-330.6(capsid)-330.2(is)]TJ -18.1858 -1.3858 TD [(made)-315.8(up)-314.3(of)-317.7(360)-314.2(copies)-314.5(of)-317.7(major)-314.1(\(L1\))-319.7(and)-316.2(72)-314.4(copies)-314.5(of)-317.7(minor)-313.5(\(L2\))]TJ 0 -1.3921 TD [(capsid)-210.5(proteins)-210.1(\()]TJ 0.85098 0.19216 0.2 scn 6.5512 0 TD (19)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-207.5(The)-215.4(L1)-205.7(protein)-215.1(is)-207.5(self-assembled)-217.6(into)-211.2(the)-206.1(virus-)]TJ -7.5087 -1.3858 TD [(like)-424.4(particles)-431.6(\(VLP\),)-430.4(while)-423.5(the)-426.6(L2)-426.2(protein,)-431.7(as)-427.3(a)-426(minor)-426.9(structural)]TJ 0 -1.3921 TD [(molecule,)-328(is)-333.5(unable)-334.4(to)-331.9(form)-332.2(VLPs.)-330.3(Although)-334.4(the)-325.8(L2)-331.7(protein)-334.8(is)-333.5(not)]TJ 0 -1.3858 TD [(responsible)-311.3(for)-312.7(binding)-308.9(to)-306.7(and)-316.2(entering)-311.4(cells)-307.1(during)-316.5(the)-306.9(process)-312.7(of)]TJ 0 -1.3921 TD [(infection,)-343.2(it)-345.1(plays)-352.1(a)-344.1(key)-344.1(role)-347.2(in)-345.5(enhancing)-344(L1)-350.6(assembly)-342.3(into)-349.7(VLPs)]TJ 0 -1.3858 TD [(and)-297.3(viral)-303.4(genome)-302.6(encapsidation)-306.4(\()]TJ 0.85098 0.19216 0.2 scn 13.4803 0 TD (20)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-302(Once)-300.6(entering)-305.1(host)-306.1(cells,)-303.3(the)]TJ -14.4378 -1.3921 TD [(viral)-309.7(E6)-307(and)-309.9(E7)-307(oncoproteins)-319.3(are)-307.4(responsible)-311.3(for)-312.7(viral)-309.7(oncogenesis)]TJ 0 -1.3858 TD [(by)-327(af)60.3(fecting)-339.6(the)-332.1(function)-339.2(of)-330.3(tumor)-336.6(suppressors)-341.5(p53)-329.9(and)-335.1(pRB)-336.5(\()]TJ 0.85098 0.19216 0.2 scn 25.2661 0 TD (21)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj -26.2236 -1.3921 TD [(HPV)-292.8(types)-295.9(that)-292.6(cause)-291.1(genital)-296.6(warts)-293.8(are)-294.8(called)-293.7(low-risk,)-297.2(while)-291.2(those)]TJ 0 -1.3858 TD [(types)-220.3(that)-223.3(cause)-228.1(cervical)-220.8(cancer)-225.7(are)-225.5(considered)-224.7(high-risk)-225.2(\()]TJ 0.85098 0.19216 0.2 scn 22.6772 0 TD (22)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-226.4(High-)]TJ ET 0.63529 0.63529 0.63529 scn 304.894 397.984 m 545.953 397.984 l 545.726 397.757 l 305.121 397.757 l f* 545.953 397.984 m 545.953 127.332 l 545.726 127.616 l 545.726 397.757 l f* 545.953 127.332 m 304.894 127.332 l 305.121 127.616 l 545.726 127.616 l f* 304.894 127.332 m 304.894 397.984 l 305.121 397.757 l 305.121 127.616 l f* q 319.124 385.228 m 531.666 385.228 l 531.666 197.575 l 319.124 197.575 l W n q 212.541672 0 0 187.653473 319.124329 197.574829 cm /Im2 Do Q Q BT /F5 1 Tf 5.5001 0 0 5.5001 316.1196 185.1024 Tm 0.49804 0.49804 0.49412 scn [(FIGURE)-305.5(1)]TJ /F3 1 Tf 6.9999 0 0 6.9999 316.1196 176.0882 Tm [(HPV)-302.7(genome)-303.1(organization.)-301.7(The)-298.7(genome)-303.1(of)-305.1(HPVs,)-299(about)-300.9(8000)-302(base)]TJ 0 -1.2878 TD [(pairs)-300.6(in)-297.6(length,)-308.8(is)-297.8(consists)-301(of)-305.1(approximately)-307.2(eight)-298.5(open)-300.3(reading)]TJ 0 -1.2797 TD [(frames)-298.3(\(ORFs\),)-303.9(which)-302.1(can)-301.7(be)-298.6(functionally)-309.2(categorized)-305.2(into)-298.2(three)]TJ 0 -1.2878 TD [(main)-299(regions:)-304.3(the)-305.7(E)-296.5(region,)-299.2(the)-305.7(L)-299.9(region,)-299.2(and)-300.2(the)-305.7(long)-300.3(control)]TJ T* [(region)-303.3(\(LCR\).)]TJ /F1 1 Tf -38.074 94.4116 TD [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.5051 0 TD (02)Tj ET endstream endobj 31 0 obj<>stream Adobed€      ""  s!1AQa"q2憽盉#罵厌3b$r傫%C4S挗瞔s5D'摚6Tdt靡& 剶EFごV覷(蜚竽凿鬳u厱サ耪艴fv問Χ浦骣7GWgw嚄Х亲琪8HXhx垬ǜ蓉桫)9IYiy墮┕少轾*:JZjz姎授犏m!1AQa"q亼2”裂#BRbr3$4C扴%猜s5釪T &6E'dtU7颍趁()鱼髣敜茨凿鬳u厱サ耪艴FVfv問Χ浦骣GWgw嚄Х亲琪8HXhx垬ǜ蓉桫9IYiy墮┕少轾*:JZjz姎授犏 ?鮊*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼张]Qh歜]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*8旚E- U2蜫hVW粼(舦娊/薩樅g槕e眫J蹔猬wl锥*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫妞蟒幰.~駣=鮗簴O碷貜もㄍ;挖稒D豆0絹臹╀=GBQ;妛c}m/_P.-涇穵2翘v7纝Re柦L梟М**霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bU孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬LU騑煘"'D嵕8灖稔蘒HQ.腷ㄛ&隨,小bM臥砕M蔊#Y槢愘嘗U淁[髲]蝻礀>x鼪9^譂櫱卶W簓O髢GK$敷1Vo 袷迹`秘T臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼v** 澅WpqV曺|盬 恔姷鳊]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姤k?E槌荻逇~x~hy伒韓k谠?8鹦 馱?髱織V棣%碓*耇姴9~@i`c )娂髬譠qi4畇幋臹=W血/t衽X4;b-f稣傐L隒獐铛 CGibC衦5踻U8WbZ *濮c\U糢孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*< 棏倎鈗W梸c~yi~Z厲蔾W途j湑.?㈠x悶跖X龡7沗q阇1@w\U韄柨髶癨葨殢&懚鋤bt璮逺乶m*釜a娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\qWA娂c7蝛od璅臺 4屒;淯拁]桉贲r計烒G:dzfqEω獂\U僱U忞﨏襲纞捀8莽蓿K{b渨誰/#蕞/A诟O孙+.i塲旾1VR:b/:民L罻苡I;ivG婳?雽U %?'姧愱杦J r嗝E燯z{br臶臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲[喯C穔荤8熚I. Yh飙ǒCLU髥~\jd竩bOrN*厃KlUi5U係惷1W?髰洸 啗|5茆鉷t ]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bV溶P膘 臺蜬y-gQ鱿菵J芭^#L碝I艄咊'鞅澅W秠7穀)kr柄"€揘焩*飨*蜟W謅蠸疢霸眭8齂v洄|UQLU糢A韇暔圈涺b<踘寤Sqx _s娋I湕怎^嗡彙磕 1W娺y嘅裉4洑姟啳v/^O3齫Ve鍙_D*栓'}I鵌9g疐枟=)AN斧脌谩U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬珘︾a^{膀 ,挮葿8Wq娋6矿D淮v鏍痗娂櫦X猬呷?旡棜甐 m鹍m娋Ⅱ屈鉓厤播冥1W渵q<9驩(迠1W妥044O) 猳F]?Q窉*L >x兪椘驩呄_M?V*渂Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]乚匽娀v(v)p臸娀v*霼妦ey4 &K4貜~u闣<剬U.櫮h*X€>淯旉_柡泞,玱#F爉*苙%秐!FA臸iy-`b;孶歽o髢]$隦庆獐w7擮浦[粨|僣V秛b輥閵矞Uq閻5茕篆qW?沇秔刽 靓*耩jy6<騁&f榙C迾m>捶<向価槴<馘+-Nmn攤z1T&儵庭]Gs *罋{U麋錀潎毚qp氢J/輮v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼ldnqW唦l蜝勹懮g?鶫*q约蟫筠結4&槳C2Lb琿W件P:辥顥~鉬\U跸<ヽ犤:孶9缒鸦襞PZ鯏wvrだ丘臺淊~穵Z醓殛7肱R/%(哒O讑縃鼡l`!'昱S霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]乚匽娀v*霼爍Kx∝V 翕瘶+<靋咊x垅隠U騅1cSz?鋑摽内袇柅钸鴅#衜炁,銭W犾1W橓服q盟诏)Y鬎*裢w蕎$灂kM伵R$-A臺X&鵱qo-哉爅娾锾6Rh5$昷)蟒躑駞钠f26靭猬咨2SK$Z凖qW邽E騗瘲l"me幡孬屣 赝石颱6犈_(0<:儕纠淐J1Wr}#娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*曺揕}F袜奀w,U鍈CD$2蒖萜*>*W狇臲錆龝窘Z頪娋嗟ke捤彜胉1TY#琂d愌F錇孬?;釆]娀u{b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬`祐6]娀q臯ㄅmv*霼鬲\vR鼙爫KW~}酤%膐>煄*箢'*O"屹5*%JW棹躑魤珮WZ瘳伺臫8旨嫟闔R[X贈鰣閵紀蜔髪v椃\稕嚴克{憒,叅4 憡:刭3皩~釆>?8艰bj#,旟 U€U磉揯t蛹漢5W圜*~岭姵3夔魵+_砼^т熛'_ .$H\霎*<慑]?婉 Y68<8檏4'鯜蘒渵K~W7懎瞳1挰O#娊_v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZ-LU鼙WP 馱+姸@;U溥炦暠蓬B啚%*鴎\裯磱栍顏 1T涞;斧屑9e, ?J蝗;腋<9-DF弙4粝1Y($咲5(b﹫`胏Q娀豣玗昅O\Ux5v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]倳匾WS+耙vv*霼孬盬b]娀v*霼孬盬`WaWb]娀52v*厣-l5.%bc盬b]娀v*霼孬盬b]娀v*霼耘繠Z劵 轞Hv4]L(u1Zu0;]娀y忕繙SB$&嗎 獐腺爻=膳UbOL&檐b%"4O嘐漒,{ 鲳臺C馅v涪KyA焯+姴4慸B{猸銑穵v*蜻7嚧n`诱鸼瘉.艴f抇鎟~髪█NO?$:6★挠U旨儵i 殊6Р淯$布毱A4G娋侟閽阧艋$|Ua蓒猥盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼猹S%%4A遭_蝾怢r\◥v臱-琰漕攭效庁獁蜦$螈表娊J驠煬(kIC釆Σ z*诫娋d湒k刴[N幉3T€; U騮苯紖$蚺S-[寡.RV+姵8~x陗a遏 1T獐4歡暯I馮螻蚓—({X釆籙虻鰱笲籦㎎!n槴Gs姫舠$旗жe綴誸"=9礼c娊蝗髺掃QTH4臺B;'H0R淚) bG6荟$姖**霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]\Qn*赈*霷霼孬盬b]娀v*霼孬盬`Wb]乚扺bZ6霼8b暶&翠.%]伇孬盬b]娀v*霼孬盬b]娀v*霼孬癛WaWb]姾斧珚v*霼婵斞V懶切);獐椉8莴i<毱's\U鍤菛o礂醲*晣(~G概S'秃帤帷欽軒*&蜶旰8[y 1*骺(蜠hZ淐霌狶{b疦业=U枓S*$譨姸*鵪魈{T癝篒跟F*鵊g斁E6jK S}徨O"豩玨(*+姠<卿?V硸贖PsZT(ㄅ_~o5jw臺l?鵜4M(趣凓b疨^]馱芲髷轤6窂◥k#玉臺>G姆怯}8刊[[+n* 饀臱鳠<墺Oq3q!*1W绉楽瑲偡.}馮梩呎甊Q3驌Im'硕秐(cZbv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬汘s瘮殆L錴犫湨懅k判銑緯蚍滛2.4麈釜z[半姸+v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼姽(╄1W瓤髸?2Mq崵&赅w臺3€X衭8 %&)6昝c娋眯g"祶R沵姦刉cIuO'橼嫭揃执臩;馈Pv#v*銑紵笄颡4i<*hT睹rqW聑灄>;AvI[B[=极4F對犫跨8E姚憕彺}.C妼U;幐獼y * b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b(稺 -媖樍K难|4耐i 13X髞杂$"詒(=黭諃蓀5湭-琜/Y锩繶k鰦韄&1枆绀菤-縹[M'P昞佤潂Z巍)倔L{zw|嶼4隼闞牲旋癷Z惟-熖遇?~O驆gT倹7)父''( s浴%骵w瞅璃(9<蟰萃掽?2厸虠3d啙橲a=el楀左*m灢禟繥uz貄~aO糨琨醣u:収W?钪蓪 2;舡琨醢 ?0卣铤斔 t3璵Z稞爄戀O昱_欪捶胰jVH4柩 忲虋褾*螋z6 (d峏#e€w飱处⒏玿WbT阝5匕鐘 Y兒*鶉G騢譴Sp)*鵉窅拟對Gy^烢篬玽饫婞伵_v~K~l[# Y#M|F*鮘U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬壟窗肔8柎燼&jMr>a苺缸-$95!0梊y沂碞L@コ~gi滨'&1柍+键匾I-\8薉$w邫:d違禿宮"Gs YMT湸ck9 U{! 酸8箁敠鏠缧湼b?奝.烨┧ 厘+Ae飾Gj9K|酃藛 謘鶐鵫蝏頲' R磼pp!pZ徉 酔&1咇 09!1 洅zd0!r拙 /圵騖F0!\dY檘qLEkmc洝3mv產d嫳2鯊$=,!鶑針Y"玢憐/萭9.oQ彁W銜笰倍,浝 P奭乚匼qAk 姸0%廿孬盬b]姶膩)K葿0鍟珊窚鶕蛌v捜$'l菓vX岢 凅+MY( V笰.`茮邺j檠'$skJ湸I脼芜;M攢勗澍"汚鏚i尼鈑8;}r6棱Fペ7L6謄Qa挾翤q釫. 噳轟嘼]娀v*霼孬EA臶臵=(1V]O UF&夾P喋鷔W潫髱2梷KF@#芊田娋i贼;:V倀`蔵锈2$Q涝 U務T擈臹戼q?﹜瞕'顗pF*鹓螂葨B糏椣e€*v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼 G*[驲K_L眤H,U-X愃鸏j~x猚暹,揠挻6KVQS姯<祔⑸閉!疌姤鲎2[H%寪蔶1W二Y蜦_h<-od電警騁鎛涙x鄍浽孶^槴盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盩鸦XH恱灍,U鏎WY鬲Io糌縋 U鶺洵F+*啬k$钆S躑孬盬 古P簼鸨穥嗚⒏|9J$襔.孬捧/終Pi纠韸酒瘴[]籙猬働硦3m:咶*鴞篌驏o/_淀簱蘕娂z移[=+u.敲}38轾W螚HQZ納U鯋#祺玿Wb]娀v*霼孬盬b]€WaWb]娀vvv*霼孬盫*遼U张熬*k2Xe飭榪┑) <,|D<毥乎恊i9噝o2ZG諥KY;?輧- D躇プ榁懼2薛q危&键詩?盋枍+-G歏浤瞅璆?歄{鶢fbx .`,缃&惑翢鯢d #龚==贫e5銝 C箒蕒HenGl癰蚲)颴,莝Y蕒r~頰趺-9捿2灼]L癉#埛 腪8衃ZFEm))娥R]\4\+XU豒睊 銚4啿W ]逎补崣舕汓∝醶蠏(~c鴉#雌蹼_翱!溰菇4Z錏蛬x;v*霼孬盬b]娀v]匽娀v*觔個絗:錜r0O焲鮰 砺E雝-AYI9"钽剋"力Rd柔蜀^鷠扁c鄮鋧繕氒 R0墷XrM1鍒w杚窯M錆YH燁睋'ぞ壨 T@\28r袨潋?退o赼 ,'0袋直擁H&&闼E.滏唧 N|.6摚梤am骐)EVPrbm2涫遈侻6檂!稱睜l悡A 諲Gl癐瑐銙艊,┠*郚*;v*霼孬盪9郔郧 П繳坹楎稩謤鸭B銾€?髬趀鉹 怋i]'J`掀Zx対摚6zb堩aH俐Q塒歞Y;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*b璴億U妦d.閞#vBW~|3y婸掤V$7j猢% ;垼f閵臼渓婰碝b韞<葿:m娊'攝_欌1$LE9娋O渰框魨5偞裋)娂r贽Kw1始Xv臩.y荘'I礤p╦T*鷥蚍v+6z圀1飱緞氧薓Z15渹E"籦*衜獀臶臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲咟>*V*螯歠穚\PI!#a势} 稆棚?&¨5ニ廤 S釆緛臸娀i0≤b﹡户谍/F臺灴滫`<藆k鴾U儌;獐5'佳爠4臹;髋X邽<漦鎷-擇娂咳髰鰖-群紞X跇簇!/J猥* 痵姺娀v*霼孬盬b]娀v*霼孬盬b]娀v*誴狈W稺倲馾鈏€* 蒘5(幡 BO$}r褞d躲萄FhA藛,)熚株蹆 9耊w绔nM饻癮-g8b鬓u颠c欍N]Y=yv;r謚!+浱0I'- Q詣︹v悞枌%犼Q洰Z0枺*p禣-~0S1┺檖芚湣疕xd2悄 耡郼/ 掄bf 'S 8洣<槖赆甃q蒢礬m-d璖玹胘阛祑6敦\6垛12V€锐*0悜g蝉儠豠z菕(~c鴉+灯觖_翱!溰菇&4Z錏蛬x;v*霼孬盬b]娀v]匽娀v*訚$ 狽~;>k筝屻0f^跭徱m簉l翍z(枎橝抏埈鴓q5e縈ON格(乆之{鋢嬴EL谌;鋭聕嗖癲i=擦5)n∩寔錄Z塥^?5楁鸎X5$尭M覱JYE忔茻 h85羡&&嵯I&Sca,6泓鹐 p''<韒rO91懥瀽j袹紑脤p夲釺m掋j鹗)% *2bM$R-r胘v*霼%甔倍電m&菘lR逳弗j& `K珚奭娀uqC盬b梑]娀v*霼孬盬b]娀v*霼孬盬b]娀R歍峅狜'a娋$湂}v柆B[盫?鏫U帷9t臲囧h砿j唠鵲SLU錓炀d殚 1T镸F1T6俛T;娂C;[嶅雁X=?|ョ?藵O蕮榥榁昒4臱鯐浲4i捙€颻葻*^韬P7 p}*粢瑢(zb獉T|[猸丩U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姼覜襞_)蜺~_;8玭J弨T猸 6*v*霼孬盬b]娀v*霼孬(.K盬b]姯m鞍!g,揧.鐛#壾閸/絊倱(蟨*粶渀K)*焄:#lC坲'惑|YD说褾面/<躵枣[5/u$皧o撘+湏樻L.噟m茢U:%苲eV%竟9+f$袖rbM淜卤2bI鈃閹!$q-eQ$$臈%J慙糓炙n3J 悰T易\@&&庀L&戠泩C,pg 鍡鎱郂/\焾毵 譔笸粤 % Z@蒻<$Μ9tf嘞NN!訷荓碔茤  r嵌LO\儝b霵捣履霖p2篵杉 潑祴aVk ;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬目"4梩,``.埁鷅瘓+觷;\公萰鬲錌v臷幯濰J戃m娊/蝮蠓T蚧/狓^*蜻笞J4k颡莸QLU笖^澅U骔愳<庨RqW掕燇嵵zV蹲塛媕Tm迸^韐h惵唉罖{b療>?<蠗eK9兺巂Tg鍡ウ陈 VE嵨臹绉關j壄洅08!貜彻臰 U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b$$R槳A孢X嬏:d謓wJ)=盬邕'懏|Ke"~68臹7ufg亪P)y媲蘓<2(b胅馰GZ嵄U扟!^NqW攡rY鵽芀x漝曌n'q娋产针奚鰺D3艘k趯vQ倅淯鵴爚呇X|J磁YA槎*霼腤v*霼孬盬b]娀v*霼孬盬b]娀v*銘U埬濟a 娻丈1wL塛)h*,Ry.QM 枅覆鏣5'{灞芀,嫡"襟2獆2婞28<o6+珁瞖?邘d頷瀞\囟f鄱%91 = 轥紏寙檖;歟橑爁鸳歹虡4矠8竩5'2c8捠Wr=r !X,*|4都t艐嫙)イ繋)俚'霰A_ ,i継啻SD柊ZZ$郬WK筦掸V霼廿烙 0;惵簇lJ:誵WWuqWW"Uv梂o朮挢K(骕援a鍁^鲙/樛nWk夒鲞a~C9箂z\hナ溫穪摪+矮盬b]娀v*霼豒孬*釆i补%亂「E沠,烁妖/浖益MJC汁汏椃覠HQ`m汏S錦爺毯€雎y(=2mK"枙^ 'uびM"襳$'|, 娻|FEP6c抜睊b`^'甃I胋頔貼K壟軝Z鶌:!蓂48頳:O毊壂螼/屳~M0綥譋髙槈y臛綵&釱L;檝熸櫀н.屳vL褠Z耆@# :獒=嗓*h搲(幥%囊bWN袾 clHi:aA]馪7b]LP阞]姷娀 郎孬盬b]娀v*霼孬盬b]娀v*霼孬盬A\U娾'淈嘺%烫%j{獐€?5柬7毜6簐%+%P菳 盬铱髲戰j甬—7S鸢風Ug婵|痔:h 臺>j謺!婇 鴬b獄N祏ぬ.,芮"#}鵘916標m珫=}C瀵;辁鬮[yR>蛍臲5獶H柬=枦,秬橜蹚\U鶖鼢毚堦X鮝姳{G栜7?,>/N鞭纫肞雠_[髎L驦j巡祈$飱车p猹j**霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬慰64◎e0詴併笈_骃T髐薓t原E跇-鼇浭鬟T懴燇鹋_qiZ7 ∕Q盩O#盪R+娀v*霼y/鐝錞^n癮l暩Z睜疬|;鏐箋K曘F#钆R翠 S*庶y洩鵡@鰪^=84 艌-( mLU鏌}Bh,YH;b 欙5袍蘫譴U-t`€}q8睐'.U糟哶戇}&孬xWb]娀v*霼孬盬b]娀v*霼孬盬b獻=盵h=>諮R逿d┇ Or⒒涓ZeV0绿ㄋc垪Z槺 w7羧台樗=LX^虇#巉樺餃 走3!劯s种'裉ㄢ.4綕峏迕j朠τ;鍦 m€蒡b,L2氬€5阱釂LSEZR|众8m6?lm-孤兜腑"i8椑歮X鈪匾非+`匾A慍杜-d暯瞛釀卾F暚i]倳篳0+D`!V)摪R穃l2涫#u襟 +甭充鲙/瀔r籠a胫縜~C9蓅z,h凳嫏,輥\0Wb]娀v*霼孬珚划*釆S櫒23坹'鎹閹92铘戀:эo]弾k縈7%濘d2掄賚CYom2迲诺)ZV涒达^槺1w諪-f茈嵃0.甒l槔鉮\H9%kjs嗁R胟陇懻嫂蓧4K碙.衿@'锷壐夷i喉 臂-pra)謬缤J)B—{満3u4鋿gb叱腜e鈔秡b/鶖]+J~#枆萴$=r厣脼"?Yn=*つ寴, U仺5v*霼孬盬b]姼猸-郈盬b嘼枆聳!孬盬b]娀v*霼孬盬bZ譂盬镗|97nj訿1W/!5庿9駿菣uH}5n9|盬桇8tK4磩QWL8G*蘝葝'蛨驢jGM馱樋1銽幗;b5柀E;2獐R鼕缘檜X韙鈁負銑抉引U磮O_*姯E*鎁"*=馱淊`~Ji~hG晼拹H狅娋N鼛渣革1帒-~霼錜芶b嘼:猢繓甲y咫乽f菢霫*鶶驘pNV踎)-1W襷'榤u‥艣rF閵 玚Sv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀y乡/弪yj闒U餙櫦籷≥5铰昤O_*枊咶W忈u鐵*鷩€挌6Ⅴ >U鮀s珔h鱒ㄅU懶Wov*霼蘦+姪i硵9:尭 濎S艼8#/聹wL aN邓D偘8Z輩]娀v*霼孬盬WpWb嘼梑)o娀v*霼孬盬b]娀v*霼踻U儈mk鱖N+伲3觔斧篌蚙岤啠,鱑3n\U+`盾b跨茧*^餡挃-鬮敉Z逺圤l嵝3h韸窏l鮄學懍伝*;D洕=則邐幙*!*栤[嫈なiR7臹鄓*颖^偢玧j7臷罏啒 鸉丛枟,儱|8觨居XDE[倧炫_*鶙首~_筯.枪臨厱憙氓1W_j瀂凰@ \U雩鍙潵骍€濰孌Sf鉲U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼k0T=qW髴?V咍[芭_遈Ig3(!∨U磢Vm.醤mR? U/嬖~fY>玘槴伄*霼孬盪勻RB艳2窩吥▕FLE*咋0頤5b粬跎R L+MW"璕碩d m"糔銇B阶u 蔒T舢*蓗[婡皫弩*攘è臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姟钹[0省#z獐"'_I燈晜朑%逎*祋VQ;,j軧莻殤]盬>w囂鷇WQ2斧(韸侧;b瓬U孬A侀姤Z櫖(M朋堉唲圑rB阢Z幝 b痮语掹笀誜TbU孬盬b]娀v*霼孬盬b]娀v*霼孬X玿珟D瞰离噮仒 e蛄塪i/祅檋芀巗掙^g硦6% r鴄-;豋榺醡舽9鎌膡渋fUK7攽O藛#茚0甽f[塪f鷖2藝<85\歠L`\Id(F^ 衦,b掅ΙJ讪i !莲 洵V撩hl`V(v*0RL<*0襐64惁rL箩娵{酑盉眚B(uu4bx z鉲[猓V8-V朹h0響2 ┣ f"V恟w詆=宔Qt雰4叉" 2蹭Eq撇 ld扺b]娀qL鄈\竃爻v*銑 躂2⑻15_澗剒>~k师?鮯A0崢m+樢"'迂f!菼9湰咲)瑖*5=0▊ESanNd櫘%櫺杜X蓒 En烒<嶚 琸委s 鸛$3橼K誥筕臹莽鵪M喾(猤aLUv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*沩姾奖T浲>Z僟矑襲 蚳+娋 浭Z湵拼€t犤y*踹冗凸|癨96顴禄b=^ V.m2矁悲Q姦; U亊`~ji綰穡f 郪€飱;詜;薶wU8,窙址$HlU鱿w灟5籄avE>W糕]娀v*霼孬盬b]娀k 閬4霼廿孬盪皜俰M濡X"阆% 5刄9|1掅d]C0@;鎀t辶扫 OX筇*=36p鍦<颳髸嚼`鐸痋吻動<庳趔%8 S2"銣隶訙I危2#尭蚴#魵0q工(Z"謊jh9:`K妬噶 牘'!L罿啷礒\X曯琅猚ipo&喠颅鋹輗T嘺 +G#IZF4茡n4粠(w:m &濌bd歬杖p攅fi郱騍*9!尒z讳<@寺UH赸寥惵UV翛溉溋焵USGv飼溋惱U怛洳}*91(橖叨26 9E卿珕釤迨.呷5倨Vs喨槭6?"]6~\"左寍p萯*?!軓斞z6夌{{槗姂,尀w6槻óP飾:鵤!{N#霔 @0怲e",K*阞lU糝oeV剽渮斌 <諬1┅臺%y垓稲蛱鞉#:w i姲颕斣$o*鮋煽蘉f譗婲侳鬤顮U鱃.d覆嶆27*檨娀I鎘M荮簎j€qW浛髴g;"nx-菰梤7|U慁7蝥,0#]蕷b,?l4碖漐5扟=*鳊?M婳A 搞1T]1V笂Sl歰姼猱臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\EqWb6囃歴(_迠殎*鳪娃W熕鱫o2狫!梑 qW髰?淔腠#u&Н鲡 絧wJ综xo7%瘲a{=.E{←&槴銸5魈s欘槉毿LU(扯桋栟V'o}=8=霾寛 v)鴅<藉薓輒@QJ€8猭娀v*霼孬盬b]娀v*霼-]\$礬&偣+C筎WU滒鸬櫓9檂婦驉撨jUzfT1[槹絆纬!€甽1輋L尕圭[ 砤 !罇b擎宙竍鶖1(#5飾,匟K戾-\k珠芞W塊熨`k.($扑樸i Xm)[倰銘V綞4噤郣├嘩坙aV騢u@+\唉漇挼n乩 鋈昲儜从jやx檖甦$皓2灲渤槃瓞\佁Y/^*杛aUaㄊe湽6趓Nh買蝄仹 碸R秖R*袼h荗騇紓牅佋栝俼m;n熨湺~T&二B搭蜁灏ib欃勋Fl)>@促A詵靴杓搄看r刻cJ邮V诵湉嶻(U_,;9e鵣+袦9e鵣獨,@8b蘨篓砚9 8UM65閻9 f4訮o儗Ю 吅噔Q/ M] 厦 z 藯|x撫叝n瓏墎"lm`d v**霼亍廿孬盬bvv*霼啊*2$2 o蜌\WP! \狝賗'Ry/毤昳}(曍誆Tb睿槺I紞h剱)1r()u鐥HRs粮jJY%€彟T`坖JV(i愢n=I@zu瑞9[IG>1\瑞#*仾+0O6V4蹺A墜h叐゜+戓f1嗁噇i4冶=q.#3g#\ ﹛龋參q5愞-猱臷*:b臫%撯9*l9嬱鋗x苖埩kkD)!玠剺晢V伖&LI瑓9g掅乵〇 5趯:e袨.lBB橿曠k榙ES2D載舯g_笈虛2)枆梇桰 #]朤洢艇怑rX{鍬摥)Xh搹- 2l-~-嵿K盬b梑'[遭Xㄝ9U鄱c谭0_92瓟(嗁9;l兡甂w ㄌ)M01%*買浘艑Z寲伤97g)<灋囡 根 -R踁= e.C5蜻滎c嫍FN.$=SE蟓账ㄢ8S甦翹.!抂觑tH~贀氩i腟>a脇碔卒#U%m.胔(-u聠嘼梑7<瓳主1R糆qW?髮V埈#1鑛O銑?髱煉S貺5]V>匿跁蘒 匭羦姱b汓譳遨G汉nX玿Wb]娀v*霼孬盬b'ur*諨ベU* 蝄Q怵F吋2b-#謡脔5)3!嗆櫂N郭旈%秄懔] 櫠婷5>]JXa3疋騯賠掚8s6鲣郞&/;Jjs$A3-r&請 w\\禨&媇LP磳 v!-aW`V娮&謶#K彤x)4笶N 癄杀j槬6*禍--渪捊T隳锤秋戙l郣bW継" 祌桶c騑j)9|燮/$M稅驓sy非抲m鋲.}Zeg7沨龄焂~UI* z億昨蘒蒋粌Qm師8饵卜寍JVu%葞熒5夫挱 c*:掑C2#厍郡2敞.P;戱鵥蒃=1暅鸥a葮tX021m!軋]*輟 萨コ诗c齺戙,1塄堆疎瘸埋庂e<1答噏-xC笇6!蹻衝梎W乚娀 v*QM郖矮盬b]娀;v* *8R鄍玤陡X蚃昲猓 "9%宠v騯宒rc槑)<痟輇屺(Y鼡e2耵詄f 2PR~[ q丝 2vE葴nT5*狐e!銉聅各7煍8葴M阎擼I爴 `涿S}X掑-W╘藥4埫炼9愅鎳鍳,藛Q捃R褀8 艫藿e芐聨5M煚扔`捰D 綟梺,璫 抖 諻厞1WP Ui枠獳鵥46埉 k卜2驼8趼観zd韻,4dJ祎i夾闁 踋v{99h搲< 鬙t9p蚇賾:己q\灀屣替篐谩虡脱f易Gz竉l糏詄谅滶2綳$R举m眝Uchm惵枆聲エ+晵€7c何宠珡se賎舉狺f鬁挙怭袚汓噖⒂廑净3\聭w 矋矝vH觽哯湗,N瓯F爀牭潘@誠%壜Du煓钺恜b/寶'枋t锾櫖据Z箈洣夕<蝼!紙0R+擇m?Zz櫘Ar赝觗肐袩.q8U R2Hv*霼孬埁*︷,嬄AQ姪資莌#A5臮瘞*傉5磋驼藙岹~槴庀蟧 u帅钡c!*hv#xp瓁幐%&n<蓆梬hV;娋烛繒縩吨(ω猽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀q痩Uyi腗篓輖W髴?is侗h熀暠W蠀 貎LURT=1V}鵶;秂1'顝*蜊騝N颏 ?@M|qW *敢8玞v*霼孬盬b]娀v*霼孬盬bJ炊`dⅡe€8驓忤 4#a柶.L大1熞#l藥' YC条#/丁:`3O€W埐^4脫 e褧:=F槖鯘2Nイ"檤en6焻朮荬隤s$Q80诞1p*逝﹨庁yt颧*摀棐y刻駿4眱劓B\[紇蜿i]滛┩~C挥iK鏱'0d睢屢!:W*l"斎ωZdV鶾ar!竓筯d:跛Ad -FZ 槜4=FK壜L麸1\貞$m剱粝+鯥bWaL辿Y儏隯VQ乳檘暫<樃S$甧D覆 汝I諦,]娀p臸娀鮞用y晴>嚛牒[亻齆5yj鸈簒蜾we?撨7>p訳V5垅|籵/贕i €x€v1T瘥b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀q臨_6hkV/k:H*1W?攚綶誐耽4%^爐┉?U渵R:彤柱登唭=E曚Qx邂衦Z颸發李3A+鵚 8R諨-郈\贝觀1鉠\Ω8勇笐兡^>B格懊8[ 摱4偕*)h瞁H莬嘓Qp€-H".Td 琛朞賺,嶑聣M&頠UBsY軜榄柉,sZ桒-;狱痻躃@z2辗GG嫖暨*F蚍犿;>Vx},涠荓浢F>詝A菿=#⒊)臔蕦湼猡J妕蕢r)~@秶S&糢孬盬`u0+矮盬b]娀v*霼孬盬b*霼孬v*霼)]匽娀v*霼孬盬b]娀v*阞*霼8X觍`K)u1E;u1E:槶;"斄I单罥'矯継虐d(It槡牗5萷秾-熓霾 釹鬱8啝陛S啥莈丮}X轂=a>< wX犻2搲孛_淞o|唉Tq箰诌D篯&秳e&|5'Q寡潽)R+\亱赃aQ `4袖Ei儏*〞;di-jt聽霢4ī8is0頀3€鈁\6蠀`eM揬-~#斪 '債薙3_I联3&G⒂a⑵丈R99n#AJx順せ薳[v*紃2暩嶋叇B#z洎龠$4c96j鲳蓂#舧 u媚詒Z敱37ɑcn4稴饭粏e昫`溷>W窠>r鉹M腻E;溔嶹Q揊慑3佘脸?硪缑蒙斄x拪谈衫攊^)9-r薺*乇p5臸娀v*阞2賲qV嫦瘦+:I+耕TS打dB8g湬姵jb*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bRMO生~0腹彄丩U3脖喭=8Zb]娀v*霼孬盬bZ4媜磓5抈 aA4剼#4b訐砼朖Iu7谯5泔椙 .<0=k霄rDh\賑凄O) ynhb餂8c秠KX赾孺d`|鎖sB羴藙YI綧\し洒1mP竀挚耯06Zn竚U9竜"桖S]Z郕諦rQ簆屽攷%驭.錖mi![皻諂|Ng耼.槼 vè|u竺Ia+馐t5;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]芭\EqWb]娀v*霼孬盬b8牠X0諥.&楡A4Ⅶ 絩YIu]q!诖虉b.4驀燍撎黏跩zx孚弒_7渏z鶓+揰|藛7y|襋;厚;鎑13丝5Hm袀]诽攘脰G0 > i%bHH$鍊)TYV涻R=2*>K倱CapZv普87啎躴ザ娪[ZA罫沒*⒏LN隵e耫EO.橸榣*嶖NQ,∪2嫸觧G箥,=蕟苌<眗驉c蘨f頣p炴KB~s&q\軠x 騠v\鄫圹5蛭;輴纚撹t该粼m針!飊$T6h勓FTfK|q"*v噬r?%(:dIl\L腫8Y覚遽卛z蝻+!.臶绹b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b(v)v*霼"UaS懄V蠶\矚歞〃繠m褍J倷跲l巎@谅蘈$鷝砊 ?FD藕9MsI柢bRO禓撂帲蛣>P晸h囕樢児俩蛠霝J1&佫念磌籛`S(9庺湁7Pb!擶7F琋TC乗!r4$+L乮射 4鞗*i安\ 1f"'!蚰咋!$,Ta塰怐&輗层柲 d+唋 K埗侷ヶ噲&笶FFV斢馐6.+嚭^台]絞葀鲖+募譅Q/c蛞H!瑵k朳箱(虵"F,iA2N(抆=鶟[.Q宽f1/C竟.O%1C挃p4筁嫶缀qZ す do怚_暝cN9Rr@50)vLV\ 拢"毿ck乱栗 1敦e捡F諓韱襛kod巃Hw渋岜 倡$ⅸ靤&u欞婀=7蕕k Ud旚顂.ty翩=S司f逗&抰倘尚迓{檥滖Jy箰 瑴HF錃qCXP乩梑梑]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼犤噔@ 1慷q(蛂2枧派捧3莑k68翡杭簚?1&5 w蛿4辶灓0漁X]FNH)欌篩职b塬桭&I k崟螧6嗣Xn9R5 湸諗95╙珦#*)%S嶢姏0%z>坂U,l dW 矘 !w鉎SqF銗,肍H霅% m 乒L騍t19,濱`跆s9L糨甸樢橀/尹,$G=@:sl疘告甛PfM@s遍0瞅肂逅 Y羢#)溅歛&箯<栦2況 L繾eN9枅葠€o-C盬b]LU孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬\F(聤u1Zu1Zo'b╗!0!(踭2p彈 0#lsq闌`c笎常6c<踁沟崷懥√yA阝 cwVMdT6邻CRd;泳T`鏕P胷49Q嫅窕鰥鴃醡|\N4鉅{馓埊LR>⒏鲌g嫷唀=-Sh祕 じ舎穎5蕯8/Jo坮"zk|榞k /鰒甔* B諡N hk2㈦黇a爕~X痓甧c&l傣_*h扜#7-巉<(秢g 亁撓H贙鏅剉?虍T\9|彐鞬魠7飻τ艘默来_rs嚑4Ya: b靟蟯!za:錰.df4e篸)JK 赣I+耂 q8Y叺艙筦M7詃SMT磵雼*_$誢 8.峣 隈臇bk Qn穄冯W韊憮FHZ"諥鶙 礻3$+yet$秅Fo?桸wz邧 塐S橮辱b;对VE漵 I訩#2v褻t缕毰[.臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼Mぇ^ TR-IR歟坮=2橬橆M 鎑1郞1 7Y羲堥Zh桿桺i绾彑畁兆j沴X湵粵搕牽\8'1(讖L)3U鯉LE莲杸襕 揈4!O&兰嵃+珚慭 -iS6豐倳wL;!谤;E.鴽$陨,F資揱嵀K葻驂d-哑啾掞xi樼)rF澵~_jW@? 巏箨\草+蚨q"际F`S睅2'蛞&f枹箥=Irˇ 毭蕱譀FO訕姨K 8偵c閿Jd筈2"" 硋I]娀v*4]娀v(uq[v)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vu1Wb]\PJ諴輕怭:rL(r鴈1c呵挱o悿勗鴈' Q 3V秡p#1鍗巽謻瑍W芮;4*J'皢皷){咫Zq%顃殏BJ悶N:鍇.萫*揑91 b銯e血0)窱菠`M刁艍.(LP 塂晵@:錏爢宙!JMi薼k,`gK荋兴c.SE掕綯航;偪h屖宂踅却9 颓嵵缰肐Km芿堄∷溚7]止._i^%/V)旿 丕麦 s驏妺Z(0wxu)俴煏棏恈O別概/u≥Y1嶶赽I4抯渤>#評霑穢吰圜萐0m六鄊坬Z崵粣羓罱02j刞d赅M揋4晝韹虯8)[閂 搆遧%蒙+愀鬑l.瞲AdZo涙乀EBA酸愛i 48虡..=I骫襟樸j憴1澓|歾O猓/"椾樆v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b玠0 $'纄眿<+^髧 m櫢82锿孓c髈諮€3i ~N&_6%}蛵7蛿!滑濩\醒焺誾鎈E8r暥(E:e·# 2堵鋩E璵耙B饁艎蜘葨K憆6臅 (ZqV盞伮∧U2 歞$i!S亦*r&珁囊暿6q% m@p哻# i蝸鵩鳢C53_59信'¤曔UCY畺牴衤;欈棦}Z5Bzf,蜊檹 tN 320A釕%1T A緵罈aWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀; *#I 頃鳓Vb襉uX敇贡薒^i暼挏矙霖轷Dmo4'0y讄1w0詙半/I膅)!賑涂50(!劂潽+儠(2孻﹔鄇pD++ 丄A鋈宝|C &憫9*y !剭!VA椘.In欒z9M弾\"牦湄铟$yM桹3詢檘嬏d藽循瑌謨2)窒/c(3$曓豬嫎TdHdr v'*1o),狙齨 蓡zy鳂/驮8zT赼鳀j綟}=虧 %s)甽f{烥+Zw蘺c a覚孋逼ws肅禫\齬K壆 b)W(0跐pL剠穻L 頀ゑ9$瑬斄l8U @Wc尼屭rcr]W(膕2#'[顉彂嗋:m檺洠葬蝉]戵 螌.*dQ8qQ"椾樆v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬珚v*霼孬盬b$移滷豿Z鍞%蒡牓Er萩%耐0m虛@$P谩1樯t吃傫齩7sB诈蛶<ゑNgK60腯|鏹OST虘昐3覂%Mkc毝^妹2纶)i卲贐肖dm6海 P筃F怌LA珤ゥ旯164媂菐k*+儗2+%耐1nV(蠻オ许槆(r-24E!軲>Y<崾K恤?%ZHU橬賰桺:9隔鍧閊T抖R5跈疄[v8饠鲋藼(3泂b軕埊镭霼孬盬b]娀v*霼孬盬b]娀vvv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v(u1Zv*霷霼腷珟(h娽A 觢 倷凷 C0P于z?L3;>猪h隲犃伺熃鎊j53倛ze2腯 H睫[.M鹛ya.(7<2塩!巽)捎*"湵5(邏faP倣荜穿磊1捼|#掱蓜4袡!銞8Y稌b. 摍1嫤蜆[-集赎蕑鍸`桴9秢摛Gi 苾a機蜲-Wl"淵 \檓搬l庳眥 KE<2 C懄#d赽蒧|9Q薒7虨N稙6Y甉(籐:獃樇檊猕k槖兗弄接厡緲箣(y8%1;v 登-鍻\ゃ,{'S愢,ir潽0rO ~痩KM[%牧$u邵0!0芈dNZLrV脡ⅴ彾VY産V$6偘苼i憟gv园F7|;8!m訇砐744甦芵:l豂%>C髰菭D)\蛦P簌磼СhZ╤曑m櫛洠藙аTe噗侲6\ 瞭脠7\ 穊梑]姾斧盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀u0+矮盬b獲脏KO韯4<罞N纄€8&斵甓璧i算雛dy餂L籿9懊 輋l<覻斟欅'橥"闚DL啲k檖 2汦爁\CA揫鍗v2% -ur隻8诖pZZ8M僉UpNY德.;涿[錖暠h=軑N檹,嶥qg4E1鍛蓭$拭J2 DH9厳.頛13.鵩W,d嚡禷O59懧蟭?.Th卥針褥q廨撣谾燪@JN焉QA鍲粠 g赂`d盞盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀X镽U1hh\3串O妛4邈0m神H%x▄e3嫹哩隇X篋f0懢bN.)ㄩ火"箛(8鏣*Sf \竏釩蟨宧;dx\蘫"M皃寡査f怑禮磂刹睱砷婒虡E裫r/>[怽,]绘\"蠛屰綏C蟚@汲.|淟岪掚豠V陕璖簶U孬y5*l拸 CdeLZ#慐#炠L儫-<>S鯓缺(混蚪O俗懠渁4(1w8鮥談袪y┋L▏e廞azJlWHA\茞rT兙VC>j萹 f+殗-  胕宨豰$;'md:竚5\塪顃YmE8哦!U%绫涩肳6釫犐辔-Z逰h緹"狑刷]nL{=Sh 崶=绘n9:mFOf氧hSL蟿瀢>-痈檇躥@摥:T銙E7亾*霼孬奭娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼v6+M) )#j[90臄%妥€@9tb徜嚷低~T嶦邫傟砮/*欘8]鹒tq妘y2沜S^It釬;廀 `_)σ越K檻嫰3*J=6犔垎&ErFゆP d禼4Z聽d +k 玨嗁60『aWq肒m肒mSM 瓻%沂@葤燴39+3nF賈)?Fc!r#':?0~鱢矖6=蜃-鋶^H陷榮蘽苋填撬V眬U)氋$\靫 1碰E3Y r銊RDL*虏VK觷鍁[\2A]匽匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬D`!]L玿┺樢x愺B峆/\苅= 榔薢嫙廝F+P氮廘溑-T廤檏轢 嘓 針覂挂&\豞83rS酌*醱惾慏MT後ov_篯黙I,0p砯5烷濻 c h蟦贀<霪1畂g掖hb!m檻兺f蘋4轙"渰e噪寳芃2a砎O\) XNM孭岫]\P皫Y [i#"b菻4態2哛抇鵥G聥W禕洨燦&!}p諩5嗀S睼妐胔醃,刄8詃Y椅 鳦dB⑵燭aY4┋l6鉐*R厰麭& (R84;q9 89p偼<ユ攵綰2|4餀Q檜Y瘩'撣<杯=$ =/,娻H6贪]9*+W$膯馛盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼 p+xB磓惖jA+鞱QfL`K<0?1y和%h歂&櫞脠簂貳<籡终藌NM}骻u矄9}N櫃:上u哦阚.醧IiO b暮 +V刷闄单$埇葦亦や)V覙叶 x*b肑Spz`fJ儤覑碊栨崨犔yL7L4y|=zf&L佁菆硩藈懓9<⑤\$r麲3漬I邙條糆膽^貝,'MW,4誶朗殽rI簇敭R犨 Z饳 郢L*閒P`2H娐镉+3lSa綱r6/鎭砓.蠲擁#讼v湽w蘄尜藛 迲"D7!3嘺<耙Lk薾h&躼 2sY FWn@ C'aWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶qKq!8q抹 !M枺<(禙T愱^\y鉧袭U梨肦淁NE <.P N4.=璢蛄嗡,m _抳孮L-硧St罋v)v*霼孬盪*k喺q拉R竂觍S@j涒暜;e t嚉锌C曫非%1c藃Ne!,v眇jD^AH鉽gNc久赖=-翩鸧sPv鹪嗋!猢苠ts2 #lg鈀7E>愥f 瑦塃FF浡FU讽伌"L渿*壆痪鸫阘am €竍艇4胢R沬倞慭2萘墇柤甓V慏嵗蛯f骙4鏋亭j,J繮e翹6" 荚蕢u搳黑x[7亾盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*淳裘Mf[躾淅q鍜-S恬Z ~忍渪笢鶊5鏇鷐$V钩啘suS蝆}_捪Jf儺瀊#k60t/鄎爄倫顄-4p劥ra!瑩7V楻顄融W|谱讕6怜Z榤x]虦L竄eq維,吅0 I$瑺/s槻蔦竍 逕击R堤Y!蓭檀o什蘈€5Y5籐xE3 0贓膬Z彻袄u緵j?g1%悧:@F朗L湣箳m礪cJv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀u1E;Z$19芀~cM!j$孭a挳L-v(v*霼孬盬b]乚匽娀v*霼孬埉@ %.O劁9U.鉺晿;Z6y鐨+杢 5,n皸檍瀁赣d11%o A)D軘駖菙]劏娇=芓b嫫K懦ed9Q+8+-醔  J5略J赼 |躵lv k6E眮眃 *[:4參啩,d)儥1泤揘)瀥o驝&+gm篺n9:}F榯{夋╫骗R3>y熠zdir20ㄟ梊揑;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬+Li CK(F$羲Sj鍰1撋聻P3y乃,壜曂灈p甑YEsy撵ne46袃〝1鑃甮.溻冒√罭2襯EVǔ*篸谮# f闣珌*僱 怂踿Pd#,€\涺蕦沜D3硎檳9拱苳橵変煭膸$闒k騟蹧 F=KF騱認踟f綵6|檷晣o3澔,x憟5)禦K裚殮錯!68d偡臸娀v* 眚;ッC睯霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZj雎 T7亾*信]厞簄谊`f-W-,氝V飞瞝 P;v*霼孬盬b]乗k姼b  "[#a-挤読禨!nf9S吸卒憉;I蠄该焝x瞽迕bn@艤i唛29薋!跥 颹u}(!螌倐/鋫垥@Z寕<$摼-U瞐嫘啥-D8 €mpnq^ Ⅷz鄇u)f8肺"暊"蜤功刖fc.6;<瀰&i懿mL豤?ɡd^y溳窧(s,M彦罙欅LV筸簷茟*軈F!孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬Ll,Hq槴H8&驭昑{e憢91鎉`劾$F3眂碴蜾yo欬遱#67x眕騮'l铑[ 弓sc雛!阹疴齔l2性C€'|1i睯郛,脭)+扇0ZND劦#颅é )T0排烂kKb悆膃&NLb+49L楡-睲(GR~屆濧nv襶n斃縱e:<淤炜6/謏裉槆O樭謄忾E9x畕P&]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼绽HB阰L罾|蜩r鎚uJ瑎m銢=>0]VlG珁婃釿>胀,A詄蔢鼌錴Hkc毵斲M"ㄠd汰崛m剢8`bW$職z醀 2J訊癒 枇9PRU€hk-挾r)iz 艤湪Eej騸?Fb蝞T`蝲靛瑙.駷U鹜\i a辁?楉2#ˇkg樆 X$傎UE3 R%阢D,J: ㄉ €拨氨ヘv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b8∝ギmM?瞚)*s冥嬈A\-悪槮垮鸞嗕c3p跲槑/朥g惻{f圄3鳠\滦KJf$忸qd佰惷1Hvp搰偈d'%┢ 宮葓] x ]駻"牡刀L襽p^<#4 U婙e6]3R巜>現旑3*1ty逞嫦&刿态盨2>L叜梞m鯯甧D:蒐攟p*}丩4_5lX;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼媍]-8'q;d怞檃摝 =釪9摪善碠(厃滋#!榫f饽m譭 <攮舠vYd=u鴮糲u箄b嬚<逛cmr=2釐兴P蚻舫7閽p瞗崔8鴰筦媱MZSy5u1Zo'b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶p.瓻.'獻96睵耻k,宮茢<蚽捠劃佁靟p'愲樆WX下I投瞮$*頉林JeZI柢e8拻捴 %x杀h郕脕.罇[.. 嗚?k╕:29嫞秠0睰w72+:驺毈)踓6z49--誩QQ毤蟯x 1Τ+T 0u0LV潑]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬`WaWb]乗p*沄0.m皑繷. 馿h;麘r\秹04闚芭嵳鍥蓇蛁頽dp倜┥憢#$暨7h t跈W枽e饑茸 2L t(v瑦銳B羴搕 誯!甌"炊V%ED朄.邈悢秅钴V|踓07e 鞘>U2)s鹩5俨Qv榓持灞hX颞=砄!wX眴Uv)a凘6影%%v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬`祐6]娀;粅(kv;葙$; 杉6嘾曍U琍*v*霼孬盬b]娀v*霼张].庐臸娀;k㈧l%糝霼孬+盬aWb]姼錰倚瓼7j轡嘼]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b奪 喲K﹣V;晵眽+儿Ar"i剏徦YvriPw蕦m趇s赦~b驈仗掦 蔐^舵苐;槆\-/.蝼懳憸嶐埜3m完\[u岓2宴蜬-呆€ 鷈郤S$yQ禯bUM嫳WU琔孬xヘWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vvv*霼 祾E4豖,騫V-坔旈婋鷽羘0;;.&`=腧M2qj頉lxi凿瑮腑w9眴"毵 负1谈 )伯€筸鸽\B艕讄6葏Gz,m丞 d:b0畭9L媊親粹;f4銓瓑PM ,艦QN^,&偾楛6d;鹒驀i %隯'棤説sY-,X鰀怈#"檭)[磩i2,; v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲襴%.U睋[蓚嘺Wb]LU C羔[k秹*q玜)5︶GS噣祒羇緢u`>>_-mN軂邶Ge-c苋筐C$1狸9孛鰳}-G汰:I5Ь%NiK7?萂囩b谓)e肯枇`;舣錹篾1鼘御)风帢?e肯枨3_瘟g-7鵞#5瀂g蚍﨔k6?=礋篾1鼘檦`/_= 熝囼2_虆A+熝忎d熖刣_涄\€|#%F鸣暓M袩韧2冰峙0'E 繖 :瀣dZ騿Rq焖 拴纙:!繱Auta鬣,艪絛S .0海#L`き`W( 0R€喥L!豒,\1PN臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬U,]\ 祳9u怴磘;eD6劷 +惁靤Ⅲ1h0 馈5痩蹸P彆鼑i$煜獒儏敷!W蜉)綥E滤ňL黑"P),窒-⑻j軫X弅賓!*霷霵霼耘]奭娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* 礛N9Z&2J槑诞蚇6臂┫攪弝嬐7Qq^曬彤\尕こ5脙!闆Xcu撎]籼亓臇B誮7雽4融碗禙誻$唸)嬧4職t祥歛QF芊R犐 芃媫r2Hu旑3$┧ L|咖}nb52n靉圫尹冲$垪耩蛌L;XEK-釐x伔秌g樆h` 蘰(3商=i惙(,輩]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫娮 cj1郬S +钡upZ焊F瓒筪Jr,c搇0堐\睷Sy鎷;}.Y醄I螙\~d镻 z罍8 i枿剰P秷珪l@襲j?濿kjr沥猌4炵螈OL 8@j Mw鶃}s詴梿*贵 渎哤I敲 鉉嬠69dpp釻[mB^庣8穰誗D载9((& 鍈^_鱍虄6 zWI*|5唑饔d|`c蜚Y?顡戱馒m徦Mgp~`/嗊]gp~`/喆#p吨 +8Fe祰t棇鼎|ζ&渗嬆N >湕)斁N8/媕5=W鞄S,`顝慥辧椒?N@ 馢ok鶙}︾槿樚S{O屋J貁b 蒜r厂 9O,;z璜會\6 鍜浂R又慦+:p蘪 wo鶏6榃(:r象)澂檓.簆r>f5 奬囕r lmQ^l地乑b韶-]匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬XX礬P纫C|r,鞦Y4檟WO-X﹄Yi-8m琫fz謌勮d9L翎^儭YH神9-=9鄙a椱k64翡V'梨!Td幃A必Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬(hb1牘4艜!.QMXd€l孹繖|雖筯T!O32#i\è 寫ra曃$(3憆DU-. )L>▂蟨6期PcZ.6H=sN-杰q舶<膊t鉒塜橲嶹W娀v*霼孬+盬aWaWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬W#j赉j鞉膏*赅礩#&藪]╘寭s"稺瀟[姣35ぁ夋 l#O桻 ^Y9L葩(:╁$牐q跳c鉑!W逄m櫚8覚Z 筽 FK庂厤L牪QS韴 \F鹴肑箹1@-(挡#Hm漏埔鏀嶴扵輮6嵃唁桓U^0'惞鹉т+Mb纅6rk秼袑摫郿€{枟瓻s"埲辔 饪.橾4翼!孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v娀窊Wb&楡Eˉ樞頄次{0?2莉A菭9趁娸.|倶低蠊+]巊Gt鵪簚^)%Y羲⒅[a\6e€ア-!abj}_勬&^l旸^樒-d$+禴S%Ao?樣.\韧3H7蔍 M貱阳唆h偦宙E閆v垨仛逛穉 D&i樹贡茐 鵔.h.瘸vI]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZ葦琭儐衑I&薓) N翀9v鼡 l 3#?/祾dq扽v' p偗EI4穩S愡&隠m(N愭焿阚"(Ⅳ璬镾 挗yA赀椏?XI}BI0闼誸MX]* PL鄜U繸)W"霖∝K盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* 霼豒孬盬b* 祲0ldvC膛w刷L庣6Gk8丂3_扸0聭e逵xヘP轍+矮盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b璬U)-+X淅j%╦餣芧G烓lq駆,旙?7~m b董zTfn=8廏y墆>М虅杇秅B艛銼] 7殦 郑.9 TK諀冰Wo`A篞!硻禚荌反^0燪氶2vX塭b+榝R#€/2簷 WS%h梑]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b槩潑]L+EA臛|暊顛mx€,嶳 ^y鎻蕡.=s6砹*y>蜂浲1;仚Q 蛤(i>g詔V鹟頁瘜嚞yG骲+邪輡'12`*买 懳 唊 v潱k斒軔芈*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*+姶M1W汏覲簥崍^97"/評冠ic晧榬駝Sl摋劯OI笌鳿涪T|$悋珩d櫔澠I乭7l 郈珚 P 1b瞊沗,HM鬗~孳$)!@di臄_@yoZ"嶪Q"\L懄j6+!!YMr Ne疞 覓:猥盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* 霼豒孬盪KD醖嘭翹()<茂邰Mm劳(郏陨恸1憎推!常-+`se郕H嗆鍬i%w*奵mmㄋ& 柸Z@S&f) h鍋*敤銋乵T0- <顳<撡吻l兯>\7Q7壨fl佡崞^镥恁.佴蠍qN8萔\篳K耙$]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬(({墥屯" i #蚠樦鷓e壘,藛sx讟|鵶┍N_鹛谿勝qdm※B鸜q罥C椣Q搞%膻S偵D/菤旃澎涿, Hl缻@篺綴栲(M穪K玁(&,2t0轌&赸匽娀#J阘せ&嘼]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b*-釕!+x眈d乣B J嗸8H爟項C%8笄o8髈2 W9潖8)7橙迪-輎R8*P霎d尃带D'Q家輳畃p綏樦: _骺1g=銣i'9凟9饤翱7b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b玙Hb^b裠節Z寭€鶑蕳pO,袒''a1a$5[&娇聒d汚U婰-牎抣P d5Jo€爢寥皍qb赆Cx≌ 梥姟nw錆+\婽5驀榖坊堒}%娜箦1踛LR\乸&,r)蕼eQ禘媢v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀k6輕&輮\EqU22L乸]竦闯SW*€澆靚Qa釣k稻蹒猬A9煄T榈韮Ce:失橥<:<胤\"嫫m质M讝e嫩A $鹚D-6^ 聹0j肥lu谅瓾6谂飺鈃B$蘗螠 dZ溣q'!\渔铣姑娝奂繝#嶣丠λ気 860 潳1l)"軕硛Ky%vv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\M2$一$*霼-]匷鍌F揘)+ZX觪#I蒊圭KM22艛庚溕莯雀痴S劈垸玵{! QN3-坿NT2s枾%|('#驍O奇筢ъ懽(扫跊a喫蒸/[i際杒;r銌揁)禫-h旑r<,鴽 L@E笂鋬-趺l8仑轍vu1WSv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bJ*霼孬盬b]娀v*霼孬癛 碫竂悢j吃悏cR蔷[斦,V9~S5筰m庌3a澝炆顠臫22Fw鄃~M柾V卩#:?裕Y醶i靂/沵55y炠劻锨ㄢN肳1幬X6笟aEv)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫榃#洵. 栻fa朌箈<#娃Y炓/Ua4''np棠!oPqo嗃FE"讲a2p9 $/3举&踡曐T扔誵`W(5\V栻聻郥m.褣0擯钇$8忧l蓑X氁g斒h莽咢X^?3ぷkl易梶瑖X殍^$鮑j袢褽+垲0玚b霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姼鈧0眝*n臸LU耘T$S,岅室2c:u鵤o:贮弞c.措櫚洦藦vf[v㏒60摣0捪擂焼l!7P\慗E鎈f謄敌亲2剼HhM ;/)0S_傲L]CV<狰FU9S82阳W9q郎譫洷OV騉暏KE+\裦搜哙嗭J皠[巴\嘶hK奭娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀璚+釱u蓜; U<\詺A6檇 飽 R闰7~o-gC5 ^骍涽昳}0qxm晊W蚓隩"[€ {錽薒銕匏瀵$Y梃8'3 y塺銓2eE3*1~E必Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*4+*駋Q殼-噛擈QE苕Dr8驄屈争ky;K=>嘞& '_灰d*陒,.l徜&媯 綽[e訋嶐訧陽Z剋H6汞8\鴇歐甎m^SM醀b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*獎羊'LO魏k躘蛩r+xW<=澛a\恟bX葧#琞艸91*q僙涿嗥籨泜菟o塮WJ浧q`[E 馀(FA矩 =qd閐疞-ei勅諦挢2茞d濶誚魯鍪藝 /$暄7閻.$2稅葨穊]娀vvv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*1C啊紜'b]匳H閯57NB ZLR滳G 憴泧慔nXh`%煽窮飏蝻氻鮴乂┷5S翪祮P (1j湜得]匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*便,丆^趬Hq撐辶yt寁r繺埳鈠顔癩8堅兙L9Q扻#O\摃)凵巩J軃Z濧危 tJ鋼k X5萣妐1H]冏JWLR占e枾 挈E2% %9訠祶閬( \YE鑯A驦k"\Y澎轜語钚JGS倻YE+T晽呎绹b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盋盞+珌\qU }8璏rH*k墠ˇ癐7a 訌,V擼鵡赽艛屓\ 湛+璯壸埆fTsxK 湛-^罣糘A櫚I`,^M{ =659扒榌亾 い輦臤l豤vLEz?=2@牙W,u4=rヾo2黑&3荁i槻豣/I颛搼頲i@$屢牝媤l&灔}4釿(9f8潳0悶$t5蘠\姩蕥;"杉臸娀v)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫壢H曳揥b€婨覅攀B 99(纶g挒o鏾跳,暊€占Fl1`6崴+频=f骙柆K:fqA_[vFcK1sa=F^€ 谊2sδ)攑檯n脕}2簺去月+盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫樣 8o匼蚅!4旊ZTFY殯Te8鬂$蝛-$3_,陹%?綘Ip秠cS7W [`q2 盚;趵\2 r m猱臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]奣!*rH躉:W梱废WVq迢9E\塁蟭_苇b鍬擆J)昃Z蟓逘仢楋饰刺4蚛\盉脨刖Ui蓯G浵|颓垗9e嶷咟悄I'3糚s^囦?蕠灄7輗寵翭 =揗!` ff<$-2, 综m郈矮盬b]乚匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶F鳻愞D瞤笇Z m#l (譼5H孲 exn&|&|+鏮薻(炊kc釴俠么Mf鉈 冞$q憯統#踂孌睇7蘈歳渮垨pTf鍲@穪摫W`祐v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]€]匼}盪)P1擀Hq)F癄脄H*'nD2W7忶纤怗t鞮淜棌(窌轅精q靣'(d 恠銔 [w8# F1ZIcA啒>)/V"惒Uqm寳@鸥L.2W厛努畹8蘒kr&C觸▏Qg杶i7孖鴛\8計菁龚5苤8c簐)!!P鋁v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀k-琖 瞿Ι戃)√楨/摷醑Ff籘供鋨嫖!^K璸峌r2阣< 釘W"b疍騱烞\1栰')攎/k颛潿鍍7!否秠m湿Q佸1ㄝRb)'ㄊ鳵 DU7肑*喙 偕*笑德呚ヘWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬`p≥qUrT lr@*壨,稒dy黧%!m 豣怕雜O尲}嵨穟AW鋜騒F/_鍞v攴k梨 骀B;絁h(b掓E["拓Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼+1础, :B拃A蛉櫰7鶉鵭Ik婹范m标-誒天锂tIRэ衰.&ㄇ呿榠|赦搦儣洀%=.)剙2`慛tek 幤曍U耘霷霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vw\*祤 儏,wW裞<驵恦蓡>c靴奿e羰╟9q,f(剢2VIT脷 \驘S堥\榤辞 湶L u瞿飙嫳Hv,1d媾怮a$I剟錷*枳偲B受v雀k譪{G鮢,侁V"DV]憎嗍;+禔ヘWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼掌漳韰PwW壁娍|癋茵咛=[Z<4?d鎫8鞐:蛰秸援爢f$f1T酬矣ㄋ竃.傎€5纀▼DXY橑蕦R<圭4藃痎笰=檬邲簅暙幅羰g!雤O烄瘻$@0Z輭匜S()X6羧乙聿4嘽J赈\M0珌*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬壟 bIJ涳禦K y琫 3"阪hZ蹈17侐窋-磆嚶9佔9贴l=Qd镴m橊6騢v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬嶧E]+U缕8 d磹v8攱a^s$琺"ㄤl1e遷[7傠綶汫滙RPt劬l80Yw暹鎀朢 v痑榊!ndd鱩>.![4鍲H拎2歰恶せ v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀q臫Djk挾@牭K2@赌7驩薘>爜L9皳踢Kh錯f 迓KI嘬k\恟bW&踥 颖WV槬【*踡姩8$酛>E鄝 B+48絺牣D!V赒鐵Q{慄撇逩鹑窼喯_逗Y# C8R%^訣.绹b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀笩 誯$B鍳H賭 蓘<7骭巫IcO讬豤阥鶑['訰0鄊沨艗]"|59獋"箶U7翿8颟%LY*淎cJ塄6薭偄ga摝*秝,U旝侍X碙€€ !甤N S;揲w(飿覀w┩4€厾幺5ヴO<莝 産!Yr5W|爡\敠7匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀h妎冊u$眻)渁e mA痛 饙锻* 須熨誊蘕S逬欢aLXv1絎垿F1踶4;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼祐u1E8銳Z(\i6 "& T 骻擁鮧r=3/c雀90堫;鶕藄$ 袣|7汙,域唧*Ky暶|€e€-褲=乙u〃"箖!N\f鄊 潑v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶*丰"楻眰J ,gY僐淜%h2冷罈暇k嗅淳!4&. 獨錅〞`X鋬 O禡凳qU甶姸krqTLP+\ii伄誼q"/岲4禙u=b鉅IN共艞. 珥wK烜羔涝禉昺WOI箝F[+9=3.=沘=匏o*始姓OB36掌A5 杉娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]A姯*l)泭涿`y嚊<遆 錌ra推^qi,軔飺s"T5=rA蓧tΗl鄙&輖U9[j軖w臦,眎f#a姯*濼茆壹瀊"穪M寥-饽止`Uh%8=G驄Z(n=w鉤曻0S(涧G糦实蔰7u賐m2僀盬U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*禙 mSQ)s 姮IjhrT﹏瘇鑫+8$>U蠼翟\ 幙<阢)甦杛蝯虉軧:1\ 踭T奷夜6葦瑦2Kお%2%Nf$;濉姢>k钱P綟鴰c贪N鼡g磰O#針(}O鵆鋥;ㄍFS傲m#宐1塀叭Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬珚=6雮謻璱馻卣(]荪斞FHD柟d徭?虖#森瓫櫢瓴, 粟乒pT;2堓鬙摷蠶堖5'nl"蔠.-郿霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b7L勁剢晇 D穈辿M鰒8a:V檲9Y€竏Y;$]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼繾( I2t婹綵,<塍1j媢歧6r..7呠+瘈`|3/汬兕煑^{MF%俈|盟嫧r变6魖娼;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v(q+!怋咣勧 4虓潰" 榬-9FSL洶+鴶DOL搙+o:alP冯匤0饱&.臸\n暲LX礥榔+Q-膁K嫄n*kI/⒕ d 魣(賂 +A禔ɑ A廿孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\pXco圝;($敓+桭$モ?6H?g馇E撴5鶂2玪sc*卿┃3b炬"汼,*贛+d箙ErATO\)t Um卲%u零倳 覒禝廘疱響%X墭DK爕JmA旾0&//,o#鮢緎{蛵爞徖楻暠碆2(oW`Wd曍Wb]娀v*霼孬盬b]娀v*霼孬盬bV儔` d赢TKc侊搳 筮沘噎]yRB6厅8痺]#鐩嫏uT文TW6$S%on:倌.&_彣產f蒣';zR(QA汄]凟2v+盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姼鋎臸\-輖U巵8D槝凼4|.U產]a !族嗭 5)t{$曕9盀駊abO<楁ǖ沞<%7)蹻l慔]噟┌\獵饲"鼗]匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼亍廿孬盪燼K旷鉣蜭鳬銅s颢Er禡蠈瀜%獶鋢.D$吣$錎睹朙7偋橛$受Z楶,[琅霼枛(良1i攚g綬骻 窻 \I莋籬z亟r0输腧Cd*!!01ΙN臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀X+\U~*滴月w5垹觧-J√壤瞸夌1G℡U8瀅se顤 2侫特┍ D躂$N=騟P垳rお蜊 N 韰V^R鷯%) eR6苉 v蘗I嬣'紮-荽钕墟 渑魲敶骾 裢l舞OT咆W`*霼豒孬盬b]娀v*霼孬盬b]娀v*霼孬盬bV呣竂粷k晿踐4攜兲镻9/菎菫J|坨0M痎勸V"櫣€犼Чg楀躝N>C6P,8鱷m"4缁非 vv**霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b8祊 V婁樣堐l塪L5莳!嶢Pr貧h渕?>C6r垏霉4亭sXp讯=鋸7伞/2x cd蛎^I$谍摉[ <_%窎BN翈I蕜抂r势瓛dd垿L9 〩羯喤09a[oo ]娀'`d;瓾11]≥zWj鋞9馕/r讝k?g*摨R礈JQp'DdZ輮v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬簇R7W 採_ #d噲y锾訄/aㄨG晏綽夯抎赓皜輶_筇竻l2禱磚遨 U殴ejR読-叏聳迅湗KrxU℉崺樹皃@糖)慍.覗e( ゼ蔶9咒 ^聛W缺Ub{e2(o&豒孬矮盬b]娀v*霼孬盬b]娀v*霼孬盬b]姷uB闣⒁晬(+桞i J~W~_胦 )5%H{緱j)€=rBe敗孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*鞀 S濹諐嵷L衳祖W灲~V栱菃膸毅洢訪棝鵾D焄MMyfL 产K兽^婯礑E 蹺}驟杮惶p瀬L.9h $竌d娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫!X窚祃T€*k栭驉wqu舕Z矝H1啸 ∥ 蹳祯鲜:嫊 Nb{婊S廀9&E[争駜秈)k椙掁I臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bT錊隒2!. 艑憰,2x<,郬忈叨X貣 |7-dJ"27薰'"%宾&醒3v% 郖3 6埄錾a踒闵Z悟KcTb2$8?,|碾Э/堯膑pf砮t衣廚)!!璔晼娥∝Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬+矮U臥侥蔼樔<蟔洖h炦T1銢 q犐髺9栱輱y6l9q^箶\ V渎[9aKYWd€W榠[t/M獙*z )5=+染Z补坏斊w`zfI+ 损Z厁V啓$2h讏拏娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b乚'鶗羲7穲襯*333土濦v|}b荬m8K吥8烝~])4婾y鬓9嚊-桙x;]3硛图娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bT銻汜飫l耓嚉~hj05秃黗fv 豂/岛汧漜_呫#杔嚚:箝/狘呮仵65~櫕蟿乶PM3L!7+矮盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲忧=詉"#c 憏锋~栄€津*鋃鎳mgH奷脹芉惘)\恟bUYX甀緔&制]慘u廊)砨匦r1M獹%z醝搒-F 噽2(j于[4Q0渷pD鵡y%皦渹J錏翋NQ贰蕷薁5懒豒孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vur6*鞇V檪顁J量25闯?媿Nd鈰 '髧X3挈朆~谺;%仒媩u甽`则虋Kl0%L鋫]%4RV罓葧R曶蕢W#懜胜Uke5軀:餁鵐鬻杁娹蔞 伃>y墥J鞲)氶 玡d眝!]匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b厜)^猾n頝酦[6Zg7叹l譭织L$E3q(Pu潡Ty w几w蛜Y影 {Da0L溋 _'W稺"J]扺b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲襀閭EZ 儕儌&!o ?犳钬T暴板盢47b椌h:戡嘸{鍲XqE杈愐o鹏 0杪梗 w瞦#伯NC矮盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲摮豏5隠,侷/ R怠|6y餅3>F徎,s#'婈v璙+rc%`惝IS%n@v5奪M癞)ob受獿Z舒5棱.咠=藭葪q{鲯蹬栺螽允媷("" +!膾5鹊v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]*諩.7揟瓁栋串vd蠓6ˋ5靤;d4yj36幪#^1P酽g*9檜%cHr+觸R嫠Z]L楿び次H豦R*颎 籼yk晏藾g)+-讥u╔B擇xf禦j}_ -嗖%㈡$洮)璼婌+矮盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*abJ湌樞 D幽?5<庀#赱8濗;\I蓨yY醌!&爹婷)ǜ签魚廯6 qI[荒)M3!v\枟 偈渫 ]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬+蔼[甶q_[葞嚤"晻娦ee翑vL恉 A]臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬+璻挵熗-N my筆鍺8怰蟴谊j7-镍媲P培>.拱€d$艔3礠伾惿9QU蔵慘d&釗 賚挰$ "w2▄枓3eS"2陾腡乗艛曱箱v%稈Rx^<謉揫哉J)樚W:ee嫴)o&*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姯c0慳fM&摄SIYv态P杰<挧螪M璡).+權8劸傸或忚Ke &|耐桍 怸簩.!躆r簂]!繿b%摪Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼R釁8髲/(~挿i鈅帩砤輛xXxV泂.弤$zm駉)HI灼>橋O#,謄jNi骳Y&c9n臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姯e怭朆 榤壿欥 衲G輺.xg榤鋫唰搼哸饖跎;× `D菂拑}硡*羦聟動 仾W+,PV覆DZ 趼-訢a#M4+i";0仕 鱫$j玸x壢焺d)┝Jm暽聮瓻儽Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼章72餑4瑜 涂:).)]三y矆C邃訰鬚/ff (\L36d盖E鐧慤8萺e(貲拠} n=2A-绅渎瓾* *╠()Zf,湿匍2^馏 e^8聘綑Y.aNt4此E_絪R I鋔@5蔍bW湰‖奫蓜; v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬+蔼T綤8ZG49dcm347y咛铽^rx  q!d繒綨2軁nQ舝軗8芙% f樖菪婗氯穃 n.臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶副哿l淣嚫凩V0h礃<驡赏'坾2歠n<躲O(~Y閃Kk!3榴#n 拆}gr,嬔卻K!F濅M卨'b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bT r@嶚@OL+x'斞陯瀮&錏埲C)潀m頍曓t吤|K叉&\=C 魠挧0H&2嫡[臵甐d&修M]娀v*霼孬盬b]娀v*霼孬盬b]娀vF闸p倐赇樭@oN夭 {n廈莶`撋鉗歔 !潖銢8T澞(#3 叴羝Z#'3LUQ狒诪*&*瑡藎Up匶^XUY6 ┤貘kL 飹詎宭踮箛愳囋_拁O斗皵5 鍤斐:TV嶼5蜖0lb&槴盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀q閵竍X= y491]颤q层蝨U說謓9顈歋7舾6鰪氏&冋擴熲蘭N^仏8=54蜴韈蓈I摫Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬(*N紘69 訡煽6<爂F藿2倨擽[褰ZM$w逃竡佪艨5T詍抲5,3W4鎐抪羰\稗簷W +矮盬b]娀v*霼孬盬b]娀v*霼孬盬b獹瞝 %@月 lM1齙C庢VvrA蓙袤鳈toFY豻 r莔L>腤$偢`Y'L5惌N, %€"馈欦葦呹+伌4藡hX\*受K璭15F.,灡鵌謄"]~=汳机腂O狝!NV重绹`Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b+DJA-E頇B0ZF8'萠汘a竇z鋝仨c;%鍿5捊骵柆諄,d€愝肳*V轳WG]b*曇L _C56粁 鋳1愣U"嘮%蘗I^鼩衜n57_L龔霕9%N7D幝D┊`d挷媢 1dX擡2 ]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZ9%怓价犐D1/驢簲[苬7盨ι=+6卌貙1 qn_FZ@!峜鞝 咽[粁Gd@6v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]乚\Uk兊2AmF/!h躎rQ4翾吠蜾歮醏( $f9嫖(荚枔6續懲寪溷栵f墐5$;]]驔莸嫉臸娀v*霼孬盬b]娀v*霼孬盬b]娀v* 涯 礚翣啛|!楤\DX擁 /髇怢w/O榲;<抺s@涿x-BL6偆O#L5U^;郻V冀盽VAui媊Z蛬b栖`UH L泴哢漭K闬阨\塸縴*鳿i焉銜愥J,憰8雵\臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀"U豒d0o牽-几篣):婊U掱r舯輾慮砏"礅竏偦 v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姾)]匼F(鵠u 聫g鄸瞰$wxf泒6晍: *=珱) c烳鵢ZMN$CZ螜ν弰箻鏋 箮彘q览1Hv)v*霼孬盬b]娀v*霼孬盬b]娀v*霼耘 aE8璄0$8璸瞂馰 `>h愉6w-嵌賎vq浡u沋# 薓騛蓪扝G翧|K€鈑抦 灔E1U6N惃焔叜1l D`f1VLZ婯EQ 餙娄蠢\\憑峰为墹BynO羧砰J Q 卬B筟Yo;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀q葧h镉$抷氬韒鼲醱虒|灪舨^AB櫚存F5蛣蒔櫨1L虋\A阹誹1V馱Wh.*┦R@Y馚獈钂{$PS %I蘄澬 h鄙l迲軒佼湊竖j谳3*觢卒61修;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姼鈧嚫p奬鬩騚4掟O涂5}v柃膥f=淵蟯士*5饥 w虊溽'椥V艾C妸歽瘦(RG7)睎+盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姟ol宙6崋蜄耚&躽逻8鶀磵FY励衒鈖$)憕O鶗YL適9鉯劑頷姘噀/8qAp閵嘼梑]娀v*霼孬盬b]娀v*霼孬盬b]娀;v*攌P -uh.L 0疮玐O孃d脹<邍5W$鋮1lイ郱^b]Z鈻笇Y5 ⒇X嗉凿KT冄紮46P臹 乹毳$鱍晽_&q奺E+1v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vE]娀茨w蓜y 練]槏/6伫'*.f崲b择蜄0Q橋特rV┙s(2m\顿47L挻qWW_衎,V8 WtP 魇$X猋き抹q榊鑮3鵾⑻襐AJ5*C葁VV咆Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬(,W陂v嶪:338媮歍E.瓂蘮I9箘6p 烪y @e0.⒐υKwc,5鎂鏢u蓞%燥匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼i S蓙鵣j東蠻斣泜[红鈨链膣47C#9磤 逰?YMN7璠廀┫毂撽婧苤鵨愝[伞孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼F㏒'q/6颐X 隹嗠V遅`#,v2'\摏G閶;鄃K閽 2骒,]S奫u1B峙娦 .嫧Di縣妪馫_>L1晽皏)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀+饱Zz郕嵲逌l酐#.埐W骃揲k駀vO欶擁fPHZX笢%-Wb喠-a PDk! 磌氂+檅鱿薿$5諅JG 卒;]L[{HW酣蚅寤)C盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼 B掛1,s蝂赣4%&:f^軠逰姝F聃[牾尜瞪皍孛=i+蘎L說;Cfn堢馣盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*誯0(恲祖邨栴杨TU詅跭枀:滾7x爷啍a\蜑崆喤翮桋u原u53E1N&覨d60斍搙;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZ瑼臨鞻与q>9l[鄆鉄殲]-}鰎戌c/1箣袛轻tJ擃0笰ME-姖p1-aWb喥:楿6*7菼塲糪q恏撘鼦畞}爪D3{|.佦+.&#+hv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼:蠖议k袾l1哋扅迁#*w6p瞓rI若杹7杽礘d驶&嘸B錦丆楽+(Qd>h2G-1ff獿菧慂凃揇Ь`;,睚8訴瑧bQ9Z娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b8 ┒臑賎j/>UJ風厦pr [蜻@:嵰 鍺S矲0>€3S#n2 ;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b玌玕%凨攐\6&椦\T惹:萸|绥]!赐BcJ/-硍qu$Qzw淝柅d玮甡f堑箻Щ0Km郿霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*) 衐胉`{7*郪-f>OF;97:% ML[AZ1R(v)o X誾dd偑嬏d<=5(獄塸A鵥<韾.@蕫詄E+!孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲攨仩 d翪顼Zes閈賑>h蓟g#]骻 礜匒枂Nl%V郬e坬4 凶!$:CM矑叞爒擀Q3忶Sゥ艹=3 RC晗薦6(t錘45蛜in@兌b-郈盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬MZm倎援叺换澛熣柶6阄T鵲:籮Wn蚐Fa p.尴鵎屣 mv蘬觨 7\貖 婘67扺b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼h-`n沞2 “8rA蒌?溵\蹉Y#v投瀢敞辸鵼疂3QZ(2r泼N3婚2郳@矎&@眈瑎nvv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姼娾狽沝乫 WㄘG;U哴&|夔K*jwF蕆梨谋h滏h1r釽怉∨圈廿%v*釁+雲*o璄迖!&%U鋈磿澯PF`r%艕{镥葶藄'#QL乸 瀾 訵+!膼W瓵┴Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲U狾r|MCL善6H|幅伀Fg籃軮蜏'囃軓啬*‐稒叀i&霒旱%vD+侧喞.闀 NNPP娨榨" 表樄N葅蜂V<揙3[)!舣- 6<喺9C`WaWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬D醔^oㄙ堻E╯3 草恂Y游)$$W'68/咖 D剉B4櫈橧.@vE[色盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*阞妚-. T復:R哔失s挠2盢媴o樀7襫JF _6蜍:貖/?,踽ㄙ劖Ljj5嗘嘼梑]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫榓 Y捁lKtK脇绀.甧 Q均c騅i淗y np筿(箇∨N德屋扠盞哎,枩Y7a&軀g 訸夜V魅敢e粤箵~釲=sO浽帲 \,僼哣修;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姲/;搡WsJ|G踽s"[怃牡蛏漓'b韶R,譁扺C"X梢6Eǜ"&k鵬頫撣 \I嚰y^胫跺飸pD泴ǜ吋v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姪2>,悕5脑鴖c€7虓螾欁貰)~霗 舁929魅K W`栮靾 謀鞗櫢$k鱭_膾-淊Mh驣鍷rG鰧老/J-鰲杢鞒迦R功懘[!爬Svv*霼孬盬b]娀uqWb]娀v*霼孬盬b]娀v*霼#髜ざt覸.]E潘擥涘鼴媵濊澐6#w_) 烢hM獞NTl略;7`(,膄砲僜 洣 We坴*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bV5 贙EI虥i1\gN9↓wMr 葑e仹咘r弭鞪0*>鶠G圁荆絮镜I性詄 ┶釔酟 K掄k*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀i嗀BB抎杒Q3贜)L钀鶉X觀%憸S?'n|$憟镭忮腪T 俞磁蓳缃U3{媛 CGs4%舎N柅敂汗镐碌匽!r歶藰)J.磱攭jU€噕/?'集鮩r趈譲g>>.9(V喇喇庐臸娀v*霼孬盬b\qWb]娀v*霼孬盬b\r2Wa ]匷; 1/*着碽|踚围Tl汲鳃1辕0*儥S-ìa聢;(唄ネ弈l瘧d霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bYv鹛宺-y幯/4"巌泑E謉n譋逎粆+鴉n^OEs亀M3o 娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬Un5沽"转湏dK羭酡{9%痵v>o2X陑羯嘽峊奷脁ZNr奱C樶K珔榰0蔴2%楽-綞扫箩蒣N浶r9銞粇S^z篕m鸰 \y 逈 禦C1翰鋃Cx;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vvv* i妝颰p準>W铸mYXL兮$<︹Nr鈙aC\ nC塉叔%.磖a\0!篹孞鷦伧菻眔M皗嬭B2/胪~Cjy&苉{瓤╢,鯟詥kXvvv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬`*霣 ┸I椤c豥鎕>mPk閽3o僠阺nY_渚婩彺筤yRq妻詽3TxヘWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]乂H>榡'剘p鑒襏旼圮嬗 :軄7瑌^襝瘃儒嵍@衹r庛59*譨Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬GQ>JG埳6骭添#菺Z鍋推wx%拧儺M劂*j> 涿栽 犅55聳佭 `UωY厱葨K鹊蓃.$溡疬"Zz族V付鷖!霑A鞿u袣$q躤E滋#霅hv)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬`U1240贒G骹f沈w鎉贃1赽+ 5,3:!(e璫\J埭ヘ劯儞 00!pn;洵塒綋)^儺S2艞鵒I鮣禂t2/胪vI1}婴@B燋ZyIJn3嫳WdU豒豒孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀I佳~稏m# 嚷,笝e虫 贋鳅E_嫇溬Gg[緡"峀镣+4錬17`霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姯~楥 騚_殮1匠3磌櫂eN@餺.O籊S諃黶2轷F憄&穳AW1Nt$榚NK盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼q臯0氯鶃lLu>9`s1澾=y[疝暽嘽尋駇`r猓诼晊脜 P龘厯J7绿"LY ,慿揕l.1 @痋塲!梱V袅nU|r惭 7薘s矂炿晽['Y[岇U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]乀n噩d,4噳,朠芽k68馍蜱. 畔&56X喩I鈃2!*(2舁\寬欷サ稿墨c 嗼S,JW矇/s蝠炍襼?揣-喧至b窫齓,Qy;vA]扺aWb]娀v*霼孬盬b]娀v*霼孬盬b]娀;"R崖^m-緶bS馱6:xon43渌V颊"^疼鎀 D7}K媂!衒猺岔1莇^T揿U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬+矮盬b! _橅>砪4?檀"wh淿.k:y语)纼半fh線諪7潦芛捞'<;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姯v)Hn迟2,F.o瞂=O筮&2耈羃怖鏑揌讳/摝,囲)p雲*摱,履薷 &閼k-6聐0&趍蟹^'+.<瞄(O穙:虂戝N盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vER0蘞矐莂梒鎼鶉箫\懍¨骹'傑LO6X$,崹s2!+l*p颸甀^r 怟yhVur8汕|,[]I蘚厠靇蛇/您7膪砋旑嚤膴3\K 諩[庐+盬b]娀v*霼孬盬b]娀v*霼孬盬b\qAZNBE!﹡蛗2Q4?j追3u42收?'/璏鯍?籰u;2粱逷m歳礅6]慺*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼vI]娀pP0*z恔恷睐饱mRY詜'7x7嫤痛摽三W n莢m4vrq澽蕲RFk n臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b#AjH睝T羯嘃|;Ё)ra劂/箯覑犓C皣&訮d櫖s\(n5⑨J搌[騰绿-嬀DdX9zb鸳m7{9崹2层>曭F>賙#+.禷!ㄊ輞o;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬┚F晭oKJ櫕M#輴|忶隯@汱a/1d賿涙XU踏尩.凴筎捈錏+rA-尨+h錯娛佔+K鍕u 昛墟&B木悬ゴ酎絣础4賓撼樑a+啊 祽V皤睯霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫c&嶴6QCj3zV襀v夤v-萢摀<摭wRg牃W槲 徒擈揔6枀埀*轮I扔D5E蹹l v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vE]扺b8W :纯鬫筶踚rmN<涂-k獵h o撋欍惙訍Hr驫-潨 []娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姟顤睉 ;济骦咴(+O硭]'堧戰籩闁g彃&jI孤卹(1J侂抣 洣a▄銳Wr塹 8湁AC迀o禓阁s騈6弊}2nG矴衐 +!孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bP殕灑Yv臨黧m慃.>駣㈧祷{矵靟Tv*霼孬盬盫厏孶糢鬲 颴兜n2b)假e迮>cMmn14f猹斧盬b]娀v*霼q4a?3猦 3/荼穹/V舓C泋2 Ud6蛦.L攪\筓廘*0+%]L \( 。揵銗(R"箟摀▇Si鎘iM+緆脖/ 嘓匫唈r驜#甤卂扺aW`WaWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*导2櫎1:_2揃P6xc腕a.!{]T铹|"皥3澰.進癗溡橮sCc懲v莃]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬訊鰷c穿吮sk'螝l浚礒s9蠯閥库}9錥凯伽例鰌畲韶#晌vIZ扰Kc$€霷霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b璪叢弰鋬8骮緔嫄L洷酿6 A芞>IQ5&荄烩旾黏!桩I*稬Yq,儫&-m蜤p*j寜i撗|檝E藕做哣]l逨[扏鵨Ru睼5v*霼孬盫迸R軨蘓#澙-姩嫶鬣*骟}€v糱獹4v糱涺<偪1姸辬釉釉x臵p由Ж>駣甇6;YO概SxT:儕]姶T猥 匞&燶U-撎鯥!埜=*鹤號wR#pX猢b]娀v*霼?髼:抵暎A-屢Sc1W瓤鉣`趸楋臹8虫+僦阦 S戼b壹EqV馱b]娀jΥ*=*冋u8篡v箿匱|Uq}ㄈ歮"蜊夨臹N|氍穂箏黆54擓b蔵溁睺搳砽U孬盬b]娀v*鞀雌€湊W楟m觇4:仜Q輼|i玙媱 {f楰嵆?&M袼Ur 幺┅├vSS綣*\NM婦錮⌒[欅執L噁/z鼑衂[9夓侪蔢椩\氟綌q 誨鎰(Wd曍U豒孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶F跏7W榽rj縏8聋`屬閱罨)yg戶▓蜡|陉ヂ€蒴畱┼s費梜€l"8u轮劳孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*冋鲱O晁 h皸'兽f祂{C孺鼪嬑戧{珏V'觔喛甶vzS90摪€vv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b璦b詿g1_5[z乺?|跜hvX翁g&險 秙ALaf慷,泴R \貭6轮鍻PSV4"Zど{弃,ee譒>牨煒+恥硦3+iv*霼孬盬b玡^J~X燍1_橼1跮=*鹩=`擒縹*啉蟉聃/邐叠3:齤Oly覺惡捒黆$M`齤OL47j騘 7Ru衽_曮>乲$琞暑N*时Wb:=1W榽u[h:L珠([哋唶z獐.践)楇R倉馱9鶙P街!嗏g3w>鞞6猸揂姼b]娀v*5#|kLUYΑ?腰1W赨牣**霼孬盬U瓳歸臥of竨PUy鞮貮3 鰖ft92Uu犐[|姫蕍廓)⑾俾╱鸊$崖P銜H0螋k偒針y蘝M>X8矠客氒{諕2B5虫処 ]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼k5 1`M<螵跬秅t?涠瀃R0蹘]獥8铟鴧h潇駣 6,@oN臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼耘]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姯晊+/8C驤腨@*溵FV ;*鼜詫2[摬.bjF蜼橆鰜氉h奭娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b d8C 搆1s銝9構驴2预e岇筚秎搙*憸-丣s馻f0砞\R筽i眀V,W %揔P7#|硄荙圐q暩﹖K$丟€输腧 擖v*霼孬盬b??,U'mN >xF*鰋/>i弡吀雉猬?]C遇辇qWA8鹒?铭猸奎-餫N?*/廋猃qTN8焳k(挶眚斧/'璇㈤愗INQb┪*釦莒1W燓fYyN諜驊\U鎤辬减Y塃&暸XP |U頍髮OMv衽_s娀v*霼孬盬b瘽3裤卪?埮_獐裤 U鰭玿Wb]娂矬s=<捅扱饍茆瘧0>uO7矴-`C鼏槴速セ拕梫;T猥g呿厍 釜4臺抐綯?馸*蝢Wb]娀v*霼 猈啇$瑦姣斂3u@m.捒磗s3焍搼9硛fP籼葐K茼劒7适產\姯UV=2aT馈h媃D% 氯vb*呐e8+5筀佰奆秌逋 橰&]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b猻d僃B鶝繎+^-浖cgXN顳鼧褒萝莹52艄8嗭X\9峒 2j霼孬盬b]娀v*霼孬盬b]娀v*揽03Ⅱ渱錉逈獐:?髷v葾蚺Y??=m记?^奖W#P谩臶臸娀c}髷~VR=馱揑9Gdぱ揷N鬲;G湊吃钺礦Z柿v臹佋0+姰臹9缦想o+陹閚W攡8狜?)lb獌捗o? Uk蜵+а姶?)琷~$1TU奕冾臩?/梭惒\(*洗9楹陠睌=wN峃輲*喸叕シ雠^u99omrm溧(HU9Ch酰&,U杩櫠辬峀L 慫 U 盬b]姪\%$4Wx柟9%g=$╅姞湥盫⒉b汃L栜YAˇ*鬠5臶臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼噡w貣簬P6 =9uYBO9v-/輭!L上 XM行%4s氽6庳8 穪摪Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀q閵.止hr`^)珉nZ渼鴈眝X蜗'檌+I48[儱茚m ,毰W!繮鈗bKT聠誐qf惰褏2塚戌銄(ee翗}/ 遃`举\漹Q6[傡U孬盬bZ~囧娋%湳幀?#娂}8mO鹛噪臹\U孬8珘*霼张T/n叕FV1W欉髶|襒Y獟く*蜑s襟薥;|_砈LU%H惤6獛* ?NA否臺r猱臸娀v*霼孬鏾秫醄芆1W茦/鑌}}⒔**霼孬盬b瘶跨4-%笂繠'a|数W蘲'幙词i娋岒7L:-j枙S釆緍皧胈炥@Х訆奥k娍F$<馰s娀v*霼孬盬b*啝io)!縑HsW宁~越_璆_踑涮<鴾阢 -64["Ulo怴長![甖瑨禓顂Hf6唌@\寥vb驏辛m*萤蚮f/I圦@"呝+盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲RF\鏊`-奈i蛳輏擏浉廗搋鵆i鑘言o殱D穠槂:産%张Zr槤7!孬盬b]娀v*霼孬盬b]娀v*霼蜻輈碦擑孶驄W古^8 j洕 U鲗姱臸娀x |38!姧邨蚆z渠3.*,场UlU9*刁メ攮盬朢籦"槴壆***诒SU貙U榶G/V螋萡湀}濝Ao孥e崓&賥;獐G謑筭-矿黧肥鏎洲)Z淯鐣+=qW-y撮乍o蓠狘qW跶$@悖 孶v*霼孬2+転粡~|y傸哌MqN*儊=I;锱_k,y5磵"I.G捻萕{舺b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼4U孢涄w玧佑u\亻庮8巽綩6穳诂msGg_尵0~P●Q毸眞XN葥[J9"k廉D6 v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b╗暜X燸G鐩z逪耷.嫳苬x涌$鋮媴蓩g|-霖Y4qC斷,[艍laU斆桖偦IP稱膘資pA輫 ?+摦6znV脎臸娀v*郁?,U/黸※U嘭Oo8YhZ恩r"枓粴w8楏OG$?!娀Zz1V湘瀸?萆1W=燂據bń3蠔ぢi撪棱瑯bゞ樧晸孶=P褻2P*/薩^U附鴆?猜槴5<━/┟臺+P;|; U磉髮i荾凖o銑俱臸娀v*霼孬盬芜髾唏露専腷瘝1W衉髩_裥跟?*鸈z U糢孬盬bX鐩<峜鎔咃0*橀疁(c@ ?\UWXZ诟梭鎘爘壟X.*鼡'a_鬓*蝢Wb]娀v*霼貐Bj燂4渠+詒a/€z^铋^oqtd.曝iA!++綝()iNAW1)r- 珤CO(Y谔i!隉耛X凕孔02rb戎 .巎髺%旀"慦d曍Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼媬a]汳2IGl儴纟试齡Rv>oG译G扎g肾B瘟"f廝wwX聐橊m.1p霕矜剞^嘼]娀v*霼孬盬b]娀v*霼孬盬藷髼q弛;I麱*;{寍鮟#Q1U盬b湣4裞?U疠.燹O?/Eu.*-#鮞lU9*大攮盬梑疻鼱r氐籦疓O=QUl髩锺Uo*劈8镰+Ka e5臹9~顳樭薤槳]娊騥屙j銬`燥穃U鼢楑!℡Ev D偢燍#r绠呚 W|ЬL譀I詂 *?U5漭Q5-2辝5"5姧槴盬b瘷?+坚槔鶫;酽*"Φ8$'梕1 駏c虍*蚨枤n ()H挚v*沚]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼输琯蠴ネ蛲啍鷾<鉭0V邡0;8齳饺6u0/┘穝鯆4o9漈xd顃且禨 $諒殺羧嗱;v*霼孬盬b]娀v*霼孬盬b]娀v(v)v*霼鬲屆'燃畚v湲$oc椗豤漯=J.7鄙9qP榎üw萝p瞆乇-莯+埮婾聬6囟啍rBre璙u>鵜p骣o驶P)甆7' .臸娀v*郁?,U/黸※U嘭%.鋱p佪A$b嵢v奎臶鱇駔Uo 燋U恳5赮?鄮*/筫粥Idr 鱞qW荜:b獁6箩Lo鯪*旗.t籏柣T 靔j臲x盬裚髪>I{峀3 纳祕t8擯t槴xWb]姶y1<骚yV6p3儕\湻栤G@;Pn*戁蜶_狞輁 n*魪&蝂哩蕱梫&溫n*錾|鱡}"姲!t貦懜哠M*隣m6釺厁肇/_U W(?~*瑬d墆HxqW滪泱縄蜾N袶揌冹兘qW卥髼碴)檑鄞D砼X 蚩啐斧-蜃鶂7V琶 鼰tF龏飱侧SP1U((w臫/欪.*驧K箅M案kiJ偩'A燍冉.務>黆钖k岛癕K殑u鍔紦'Z螥 榳S5_浰 Q磘?蹔;2撥燀臹轾}〣萔;P淯0虛(x萫=*糱*!EIa瀖音%鍮臌5xw櫩0R7k[kZ侞`n*翛~@sS^1T螶湱贡"Icik诳蹔絢瓤髶e④"趻i84韋跿A-湯 'G症1U輖V3绡;垸J賜瓾57臱;蜤i@uJVA突?2H牙弥L<轾懅yf乍扗iW+*髼韕@啘侂瑀r婗%ef哽qW[-.&?蹔界L枕镯酿犬穿#`煒?澸g斻b寳( 飱]湺氶葌AJ'飉e踯4孅蹬^}9Ok傭!翡躯qW婚Z哦炓E概Q斧@顀U0E.娂胛邼歘枒坱欵隊颸U釟紬Z兝砼X蜲_瑏纑<+姴/蝅$ =筽H燀臹镤+瘫$H鋙佼;W 紨U蕐n:b _ov*霼孬盬b]娀v*霼孬盬b]娀v*霼 Y鎕}k 膃5>]症襜邲M百?遢咧4嗬魻蚇#壧襀鸩纒FN钤r_L蒃8b梑]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬`^n償騍驺;>~",啮c婺ケ8at槶聲禇&@皊ba65 塳%▍i/K鼱?O熹q3Gg举宋凳d^H$嫀鄎@-郿霼孬O鯫|I9]h~Gx>*?:;枰]橴=+鼷b疓髩p"€gV?/炫[萗)氙蔟槳8□最蘒RO籿Z 楒b蝼/*墉0苔犫痑臸娀v*痫娣鷺蘒髮?褫凖o銑惧臸娀v*霼孬盬芜髾唏露専腷瘝1W衉髩_裥跟?*鸈z U糢孬盬b]娀Bj唢,,U)=紫鴾U傗仙O鵈,?*1Wb]娀v*霼"UU*袔襲娺是f`z陊-讻黙挃\EO巐"晫;c%\ 桑,汚斏.守璽&〧4蓶(啓5`暫晿箐%O冼公蕍C>(sY憠Lr; v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀y?鏜w嚹f鉐=.揢<腧孀挚嵖晢9yX箛訅鯣4铄豖窅,潚Wb]娀v*霼孬盬b]娀v*霼孬盬b瘲0哭('殊痏渢呚衦難鉮詥|U瑑鰢邐恢O~*颵?榼(nh眾凂|77踥櫯S锼鉓z潘娍K aC﨟齒*湕斨麋黐yf*2-}=娀RC轺臹mi寤%#洤脢>盬W*鼈癶|絢+th馱旿6鄡娍?>|②$銹N鋵U&敮|U髰辯:N淢飱鹃G*粚U糢亊qtMe&,d Uㄞ=茼,啢搳磌箹鸑h1W髲^U 遨w慽)?p臹珚v*霼雷|U穾*/?蜆|玠新魳誒佣*鴭_驟蕹3藀鋯b~俼T"2 8+,5ma=Kdx5螣r譏8I娂逬驇G变k8獤讳MGF掊*,u峰[F庡oc姤P$f圚8)?;/|祌栿I麠 *鸖c扼%掁┳M盬髾G唭nWbe#|jdc詼U闊鵛\棘C瞸*鸞醀51^警駆U锩k惌1V馰毥盫Wb]娂;k9*鴖{黽`[qWb]娀v*霼蠓w黳'LUW黷.>忈娋裗ov*霼孬盬bP毞'~x~u蔕u簋'`斧魋騍K姵孶孬盬b]娀v+髱"7撘6鼼6喬冕e藐燌笨^nq咾P ftR U藫 92傻9L暚 踣&3蓶*誊^刅;乜痔i◆咪龔 P燆甹曪V+臤5揵Q9R匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\qAxg鐓烱鼫輎~桰呻?Zv29yx箛蠮()歚頪8P阣J]扺b]娀v*霼孬盬b]娀v*霼孬盬b瘲0哭('蘒:蛳欑衑鯛電?璙0CP{猥屈鋨;oCV?~*嵇 [例髧鳈 蠋瑖蝼}~渠3.*-逮?U臺熯髵驓撄媌-QSC*OW床朡,爘A骓0歾隲UkLN抄1T梉写柑峳徫驧逝h吖Z僀迸^*豫G輮U褯X繋虴Kb藵;鬾卥jF钄臲.*?_+貤$娱臺鬲}漭di:掸娍D?.嫡拄x/1姴\U蚍棞IXm"= 烴*鵚g煋綸m[^$UA\UGc 勰(姠qWb]娀@雤堄熹=W~~vy綸w\灛LU衡=` 娋渮鼭]^穡绅Rⅲ*鷽I颔啑佫槳]嫦藑+\秞GaNT|9鵺/旛Yan榕^zqT鲜裨屔W闉瞾夐腇*3嘉<暎磄*.6粃鱓該诅姟 %祂璎S莑U鱓漉嚄糌氼%抝o萶z9鞋漻5簈穰*駸蒣=^垒Y票4@扁)|Ww珍xz馼+82髄&硁G$儢7H裕原謝岮盩溝麐檣暸_澾橂肹U寘诟?"*畚楛%c€嗹8鳃f 1U?0M th6|#鍙衈`炥%鈰狍8glU为肬阜曄U姳o蘋4G犻揕郕冞~|腕鶘濞慗澇軭 坮v4}y o娛鉻a{4鹵 6豣瓦:^);亰)浭殦")(O.孬驼0*~淯魪鎙标 ④濒qW兹釫粌概_=蝔m燵燌辐孶駰LU齨x硇绚!qW跓摱zf槜7鲍蚙麮{鵽耇艮*6穗m#柅l8伆|豵U{H}Yvb>x嚣菬蓻h項T緻鳻u{囹螢⊿蠳$t*鶙{蝣诼王kx*l1W藆$S**o蟅崱'慹O<7,lXm扳,t錴鍋蓨惵書咢眝梔僣攄抂繸藥捤?,f岐朧\l紵C鵽^jr㈦2Ч[埓u履.劳孬盫熿煐*鴵箕:悬*饇U龇薙P作颗盬縝|UwA姼b]娀v*痫娣鷺蘒髮?褫凖o銑惧臸娀v*霼孬盬芜髾唏露専腷瘝1W/j鳅m砻24x?0舨€瓷_跗*邺b間燄csiK鞳1姸?14 ̄鞳1姺$% cAF%V 噟U糢鬲U稅 U)鎨爘壟X&*鼤擱摸1猬v*霼孬盬b]乗p厁O逹箓火?6楩踢$迺掱B杰价2_脄2耉澪珋蓡M6L瞨2W暙` 榒轝臠毜N@1蝽[R亄蘄==L缨枣鋰矪 砙"莫dP霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼﹂1/?;/秊?7Z_ヒj兢珧.O?.鸳針鷥M竬嚪妯;€ヘU孬盬b]娀v*霼孬盬b]娀v*霼孬/鲓?麱*/^娤矀O*忳罍U逹}奎 臸 忳罍U逷}奎 臵{I搘FQ臫氲1VA鵼斧舳欲T~琔W~蜬蔾{簋-娂M碠4_h劦嬸-迸SE lkl 歹qT汻罪5棋 U/鈏\Ut<$歭=/栺'O{釿膄斞F*4毦籷j噹*筠}]8′@[肱輮茎臸娀v*霼孬>ュSG岫*蓟{筁覛迸U4藇笣cNもO.;//ZvM馰k姼婖臺;蝂(紞x瞎W苿SlU4蚬h?怃 U鷊えk(殚'麯b療.蹒安秵:凐獐 9汲仓牴噜嶑W蚬鬬81W瓮rXb94{ 郪l>蓄1Wj鬪﨏m渤鳒U.宇ML:‘*颴mS0!珦阻臲棞摉)@臺檿9=|qV-娋淺遥党酰.涒臷1W倪髷^澴?x&*W+璌O鱍啭孙1綕荡歴?*氼qV{-ScYqW鑵潨v憟aE1UlU孬'<矖瀄為Ef褗3=F*燃伃6懇G:歎攡8k史b風窋~詊 U徇髾框廩芲飧.U搤\[猪GP%Z獐=2-磴HU齒+x <磼侎)臺猢窌!2陽:R縹*+蜉刅V"€苿1Tx鍤忦蝰W曼)O鼞 J=ZD*&衃晠柜1W蝁y伌.層$U馣&-鈑姴墅;]^掴餡訍娋邍螫DU Q剥a姽;鬞 1T.希蟚2!鸔胞C概_ y蔏y/QEgc鳒U(备6婴锚怓*薣}_藡4Ξ 1W]娀v*霼孬盬b]娀v*霼孬盬b]娀v(Z2阁Yrx矇擞~Y衖 ≡M芊*韁痀突K深糸歊7w!紥v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀I鮰鸊劁脳彄<缃NX劝(鷕飽: *+\)*斉ìL]€2荲$"ZK"r51蚴藣棑'H]炃*.#(2!hb羦n臸姮wO肉瘔*诤琟;獐 愕qW髪h囱)a簎Vi+荼W/6擬=T议囱翆U唑棒翆U唑棒翆U唑棒翆U;拥8o蠯 Ц5臦xV樞Tb 湞jiл1W秘跨 r邨衽_sb8Wb]娀|9埮_\UR檂'd?鋻?V*b诲僶電霍棚_6斧縇^垮?o敉稃3齫T呤蓁誱A欱 XM磩Vて惻Q槴盩6n,U繗.廽姲24]馱杩錄7鳹臜*务Wb]娀v*霼孬Li!驐<鼃胻+'2|苭o驇m++r9xKN(pl2Z2缮斏-湱 +d,b )畔S_0Ο?/8_'5!阧6蛁b[绹aWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盪摲'a.O7'醯n^偌觹.揝3o入LL4叐o锰=|f.崆&咆*霼孬盬b]娀v*霼孬盬b]娀v*霼黡#|橽U拁]僙眶q娋嫉鼘妖5,H1Uo鵔(瑁b蕪芽缹U唑to#y?'鍗唶$鰛'}綣憍猢羼e~梇r熽徴姫獐巷鵐o~疟W栤┒嬪嬐`煪* 猢堻分僚\-醑魃臮*爹鰩販U=? |藊郔lB燈臹簌o8蒻l}H2盒续孶摚坶p-<1Tu1Wb7 0稧剽瘏#/3*?I臹8 U韄髮辬 :试⒕芜5.撳壆RR爮娋誳M踉-箂\UWD$詎匢#踱蕧t菋2 猬詺b]娀v*霼髳蟛h犺S|姴o栓}f摺8S杀传t^乹Tq臹I9'襄7釆 篰2樷﹪惬k擋獐=质'麯b瘮1ffkU=銑綿臰d21 韸 F鄽疮qV縃縚猸~惞殛鵊Rzu璑*陡?k嚣謅堷 U昃s供敷 摥蟔U寧斧飋kQ庤1W_蜺莚o橗x馱*婋R1W1龖? 蒼f?|訆姐~胾qLU鲟8Wb;4蛱踹娍>礯鳓O醣U;&"x辄膪馱梓錿ヴ[z鰨V*啉郲芲1W芚&:5~.*二?T臹9(駰臺猬抿盒\k壮qW桄)k饙V*埮^+9g(1W赂?A^W鲢-O鴲臺\巑aO鴪臺2蝍荽怉璇娋X^斧曎%$釆珴F錃檁猱!s赪8猐(ИX猕w璲皮猥qW谶髩簫|景熸臹鷝b'A\U糢孬盬b]娀v*霼孬盬b]娀v*霼孬盪嵾*4K撆?:亡敽-JK鵆q荝= Sf洆鑥闅傤G&%孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲['._#N3沉假櫵渢Q: 沏&樀$掝XCA&茙I-襍! B举Yq豺} 99F<ê墁纃B,`f霼鬲'鍔%湲5铡>xF耘Q助傣坈窇F*阎锟唑翜U7/\U匡噗1{楟 慨*镉匡噗钿烜孵X贬詺獐Y臸娀xg'O !臺慚*鰺@Fv妩qW軺臸娀v*霼孬盫鵱<駁 pj飱紶%疧Q1U&淓遡Smi鞮U淒1U8*"o穿LU- :瀓逈嗃}m$忶/1ULU鬲曑糓NB槴羭8衸哩I|dQ锨I#淗0瀪b癄<潬 M娎汑kLU:臸娀v*霼孬盬b蒐淐 笠谭@tя9孤6K莥r,O巑"蒥G蓖N*竐+[&Y礄L捁鷈hSV&+?A1Z玍菼 徤懽T_0r+鞜%B昃侉蜕 黤赴v**霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*i 燆N聕0岁jDy]шz卿< -aj\樄珛-鍒vv;v*霼孬盬b]娀v*霼孬盬b]娋_溌x専腷瘬1W95}繕b猁 U孬盬蜳歨夡8y聚|*焴^莮渠3.*/叠?T臺熯髵驓撄媌,臺T,h秡?j'|U魲;K|.*羊f 姫垸_O冹D*帋(>掠W斧盬b\E~孶?髸M[氚y顊雠_H6(z僀姦~V赃N 滿慖鵚{W缈鎮k栄豙防a@@=聦U*跖^8邋F誹話E琓臺wY蹕h%璜LUX8玿Wb]娂象隼襄拴G歃*臩'啐GR妔'~寏_]}kD禈~襜瑖v*mIlC|9媊Y)眂黴W锁跨荡痴捹喝}輮v*骭+炊蚣绫臺煼 'w 臮磠V构5齲囼钊阼质z樧鮞溚蟑蹮鴮U駧*蓙妗寢娍D-亢O鮃昱U1W蝍-黣歲W膞7~:腳氙肱_②鷭U|U饪髺驁窥|+姡tO骱唼2鬯燅偷?#|9櫑堨mfQ>錃e_棜 z僻 "G *?]8伾*0饎臸' 瞓畵喠4LU8縛+瞓疐兪V② 65fXWb]娀v*霼孬盬b]娀v*霼孬盬b]姮=Sh'拁y臟H吲硑.廟?)濡>筬洆閤稱歜#蓈竍梑]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盩%谠7儒伜徂n姂象90 颟E&槸#$飲Y]悡榲I保扠ck->D磾由砥資q豺} 鵵|ê軐鋞8叕X.劳孬盫楾娂s7/黓r丑QOU孝k軎*>0L塋Us#侻%LUL#1U摸q芼臸B*嵇O1W竳_7/b5ㄅYV*霼孬 驦.@mM馱笑z*."邮5U笟詁痜臸LU孬盬b]姶 U簅\U孬盬b]娀v*霼孬盬b]娀v*霼孬盬bj*栮矘婑餀8叢?=.伫氫烻洔Q贀腾!烤leK(2E4堰#h.甖Er謓橳俒z)(*h7朖尨1CI+F踖s*<廽祣鍐krKa鵉 Fj矟愅a0v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼Ki搥荩)狔k陀洯O胪鰹>桹椩^琦W[0|Tf<鞇03讯b鐤雮F攏赆 (v)v*霼孬盬b]娀v*霼孬盬b]娀|9|岈S窃#|泭移熖1W轕弫~C_娀v*馹3M?鯉*鴅o哆3姧棧芿臺ブ枯'鮞獣臺熆髵凭u靳徶qW栤徟%:p臺N猱臸娀v*霼孬盬b滛H5>[i彎1W/渢4蚇x\Pz嵡錦U$&y \拀馯▍萉遭鼱恑闚礊磁_A孶孬盬b]娀c?樬i贼+獼W歋~uF↖eJp臨榙糗7*阆1:Tzz&臹篭蔷*杂,*]臺"蜸~`&狅ⅲU>黆驠*歽_:柨駲?釩~氳駢?#x稂溥昇郸▉I臺 <*+碉汹宕頷侁qW钘5鹊$線誣M1T嬐^o瞅砘Ov躹4臹?蜸h蓇檫薍#jbN渼蚪鼔3/LU鑦7鞭'務N*杫艎椴懸涒唐 甆GJ猬X 獐韪6抉W┾_蜹:荥58盬+-u?(腮 U髶O:顨唱仔R孬釅=A*烓^] X吩"z淯'?5面*-R鋻b瑎qW3匯菭|9G鶏n鰭h1=Y鳓*7zG鋀?Nk薾狻@lU}V(?慇臹9沖瘕奎e+娋2"槴>鼩?頵QqW鑵)_U* O晵燂啭|G姵o蕄嫍蟑肱_②qT﨓齒#x鍣滶着_ b 隐农纤帣m_魇腇*/*4 W盬腞V徃b>銑溯W鬪祂;* 臺⑥W揍朱R&*洷牤lU#7毉鬕cq#PqW抜唧攝/產粬攂;v8.铱 急〩!唕\歋lU鑆7馹F&務N*埮]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼⒐Ay楃u航剈熨骋輋9嘩崡?6 $鉆痨OY箈晱q.掳6v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀Q筥劅c 鈄5鏚e[y豼-x继H`vP墡X*栛 T榫,[菼]€2 d跜壜歱8 %ㄅ2蝠舢y/Zd 崝l鳢蕶尠蔥笔嫪属A+p薠诞镭銑v*)娀v*阞槴盬b]娀v*霼孬盬Sh(玿Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b晀I电釽302?<$瘷頞9概蓳璼<3ZF%.e罜仓m尞I\2拝$48CP`FX℃@[+変h坑?誣^ya8萧f'&,癴#b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bP:佶隉諙C泹煋錩1?+X歼噤'汪'鍦|lPoɑL<櫐P鍠P鞇Ky$`K盬b]娀v*霼孬盬b]娀v*霼孬暹骗奝?埮_&獐`渜搸珽?hb← U孬盬蜵8]:1臺 M鲔鎞T蝠果斧艉T~琔P獐巷]x~_W7蕵?増i忟b馱娀v*霼孬盬bT鎴HpF*鴭s蕧i4)0$憡3n沇dK覜T皂Q娍D|墵洽楸跠o*缺Wb]娀v*鄈姮E1辅n斧鉥徦9lo$窄P晳诟A貙U泘]~f甍:b馯暬娋楎燑漉ざ伄慥Os侩臱_欢{;赋妑S玉臺5輄\n.鐁N*棏J U3蚩黸-2膯*3疑0S燅姟う蚸隦鐯臺襄涽鳫娊{u臱角縦别臹往A9u.6譐g 潎o娊&4舴嗤J癔鲡浳_栊FaT=A滕淯銋篃堅烒'<VJ鏈U**柉豇柞獐裮0q祱惪D揕U饪髺驁窥醧伴姡4?骶唼2Hb?,=2貞O堙麯b獨鏈殔湺鎰| 鵸s鍧I貾&m馱滶饉馦t臹霹I9u.*g坸澘X臹C9У8 +瓶蹔/體_6G鮇X*Px%藎DgT咀58嵒0TpI塌q觢5 諍珕*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬P^q涤隅 '7S摄嗀炗峘O杊2s.$NT揿U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼J沆懮Aw璩濉劂骜嚸i, 宋 qb偃I.瞞‖,浝傓Eé:)@纲y=昨堽鎋濾]NW/L┞-b羦n8Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vD珡L!X讱ムW33?9ョ鍷凗}Nm駌K \ 僩伞慉v\;-f阕+抂=2倐_$*32琅h6U4=C葠搣i巴fN闼褧灖5y9!搶腵霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲_Y塔躭鼰(叔?7>桽>oた/帩馫<縌vxYa仓Bj o$€ v*霼孬盬b]娀v*霼孬盬b]娀|9r(#蟀k?汆埯U肟髲才獟蔃;b`5崀C_娀v*馩5澧(O膠b瘓.璬YjT8a2攵.壤z素獐襨C麛?鋸諍5娋湉奼髛郦81〧麕*,2礊xw眾竁v*霼孬盬b]娀x鋰旻%藅媁D踠U痿趖,峗懪V}^jS僑鋛W2y?膑=輴EF*鹒$U孬盬b]娀hx猢/汓璵;6岛^U3娋1鼈掘粝qj晪v肟lU阌闂02F鄰騈*眒'1*葇歰BZ斺痎8驈桼驲Pn狢鬮孩汝-N*嶒奎u-2~糢鷊lm膻鶲鴪臦斧搀叧C2r橈\U褡鋠关勫'圦]盬溚к聏|觸誮裫'|$漇J暜,TjJ弆U銡棗飈ghg夰/S拟↖狺诙耷rZ75$猬皇:繖c稡娋包Ⅻ偟蜾b鏠:獐iU媋姫|馱髾4 籂$墈|*歃屟憗U瀪P鄞z 嚷/c娍C-MaC﨟齒獱^绠*鸠ㄤ熕Ib考眙b瘔崿v86磻uh檻€娼弾*屹^!﨎琔A娂[3鵜'條U鹳唥麕*嬔-f坷咿秦0臺\4迎GE?#L盫鶍鵾c婊7婇91臺兀贽_朓釶m%@y|趀藼忲'R#姸3兵cs_騈*?孙蒑S蚅4鈩逾b?+(瑋沴岥獐C鉙^鬲銑v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬(/<癘瀕4| G'岡$裰^m雍Q|碁缩o嫆3綯;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀S熿<嬑泯|;|!0鴕许 礒2a筿铝n,[9 % 諱8ad01.5攙}.6^Ouo芩笫双Lǜ%糥7亾*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]慦d晣_L狇誊 勉豌颂S焥泑\捘詅xfN%-dP]薡甎甒$秡e%O拦鼎X瘜巡櫋雫C寎r3Y摢境裈z曵蚟NHO3儽Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b﹚?)吭o諙C泹煋潆鲧t泓z冮u3纡o菳歭?陮焰鷭陈晌P鍠P鞇Ky$`K盬b]娀v*霼孬盬b]娀v*霼孬蟑恖胾A淖*?錌嫹*歽w驈N'7窑爪*卫牋臸娀v*搚熕€[ 5躡&_萂M萠U凃7K倄n#爃[悹臹挭**傈霹E﹄棷pw隥姤囼G環筐8)驘,X趤V閵睵磁[臸娀v*霼孬盬bPz緯﹏殖€U1W濳 迦鸼=奞~霼旟C6^Y艴UolU撯]娀v*霼孬LHo姷$5孥姞阒$oMd噇UV馐邬|"麏猬?[5&,"D瘋猢}囦n廽+{臲啎-;M傓5#窺娂塔r~鵰几韘轺b瘏fnr3x搳部 隁#赀*-*;Fp'iU w輮\D+姳Mk驘F躁}B|b!鼉严e伵S#颍F永刼O)骋璴-蛆"槳&槴x獏闸蹹芯挲qW焜煈鶹)欯9lU 魚:.姵A僂禟X WL盬姲4~VXy嗗>觰I囦&廝h搳>R狱穜鱒qJSf繱q臯電瓪9T0狢瑈 I杂嬠(*舊鼔唁qQ_騫T~曺7冶#优qV[a妍(旔Q姦臵"玿罂-假n栕F妽萣琑_萞"B 哀LUMizl4`rS^槴B(Q b淈鎘Aes鯝*每錌h臾伵U粝.耡o淨r许 き 蕽鞍+N(vBJ恔&\,浝沫9矋襇&''箏P=a楃恥檭詁5Q敆M郹)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]*!X7$ y泚恷k艿9概蓳\ 掠梔P]薡甛甀q %d籗&喇岦c)娩5KXf'T>?贱3W搾旙1;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*梱圐鉀鼺齓d9纲>Lz啐s冮u纡葍摸ㄍ_ɑL,斿Yk!5窉@vv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盩穇Y蜲K娋 嚠M喘8 J湅5V閵電絒髷橄釉9>5臹穖] d!I駆U蜦柃RU乻N|垸争<瑕舟捙蚀8鱏飱谨s刹遤os*A孶鰯1埿 臰銑穵v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b骉V膤9把髐鷹唝L筫鶡讻g酤嶠蚯蛭{/註.H飑葀*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*瞣瞺XBC~O/6鯊胪ピO涢!祎Mg厯∷-d&≠ 栻H罈b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*EC娋z鼚沒 }蝔5a眙b瘮|娩}OAr棻穰*悗I覡猹Ⅱe2?臶汌Y@靑釴*5*溻疦鼏<:K$甑鴽~焩*;蝻6綬睭挃5/|U經枧[臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bX'娅R膤9耙su鷩嗼H譛S^m\愈79Qv#钵!孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲删声a (蟊D熼藘财瘗踠;H(V筦nl醏V孹9 %恔&律-寜j(;乭'二O芩笕:U冹尓\載躬dXv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZ&+d醀燓c32|s哳z箢sm嫇&6+欋恔n"Ak.!篸蒮誶窋拞隠,&與 H2櫋韄椦益宣屩潢囌赬須瑴悮f;b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bP瓠斂論6湤娩蚛疅齝⒁(篭緬鷂/銧鰽歕瘵? 2竟堨Z菼CtvI霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b"1WSq槳CF 7v!>8 t;->鬲F袈芨л姱渋尧摏0疛bH鼟蝓劄┑崗f趡昺Н4$=qV馱Sv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姾 W(/>搮姛媲I妥騔WSS^l虦 HN6秉矯楆.\n.窹 盞盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼d縟剣攜⑾翦豳鉿d麑;8)&減禆€(嫡瓸I Sf沙卜S["諮3N Zg身煋臌檦y_樈V2﹕u叉`霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀h雠 淩箫摊f醖驡;焥泑|捛应g咾G\慘m慤筯d9"涩o)(h涿赢X舠忁對h{g屮H殆屩潢戳駗蓧L嫳Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bo楜C搹6瑴*腙>疵ぱ.揝=缟7ela叉?2錫扭劲sX虃蛊L+睭罈b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬嶡獹傮熚F鉦<賗y喉G'忶r誕|I齳皳Oi=矴摍w8"2樁柶I廿孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*瞣瞺XC(紱午/氓 ;8-6磒禆(p输7€3h錂2J%+yi-99=抿s/ 雜=J饘狽綷卒Xv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\qWU邕n,吐椙?襁燑麥踓渖'L 枎"栛C 偕NL捿2拏辈a乶3綵痵斖^蠃~襪>c5:□^榽/5Y91)朿眝*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼 /+YG'鮠 騶;迄熥&嬮tz煩頮棬&矎賡U;#0蟤搨S5≤蒚,]+啊廿孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*鞀羔//梾宑賗y狠C-釉症缱3&i膵樗E弆姨铑q 笻m-寶盞盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼N瞺Y /$罅E熼藘称2徐噔2a惮-en,Z9\m5%\01-6A丗鐲暸2%''粇RGHefb糌救蔏€W`C盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬燓e璣<搪椙 绂?缭孥&LqN贋-"栘璭l鋴'Ln笽B七&袴k\1i埙*毥瞅嬗3Y憢戥-梏鐾^NHM嫳Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b▆@V錅!匇>]篝F+阺ぱ}.揝=s颚枭jv\贞9桙<靡燽Fw%P嫲卾;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶T猸猱*霼孬盬b]娀v*霼孬盬b]姷蘲氵ov*霼孬盬b]娀v*0^斧xWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b甿!撋=B孆l亻漗w瀪T璾细虒Β<澰97晢e睋Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盪)吻鍜 怛;L趐=蜞祚糦2徐噔ra礽l-e瓹.输;d焉3[扷藖乑 乥忩彦uOl塰松锟)Hee說z*咆ヘWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼侢c钛鎓I4G麨淈麥阢渖秅哅d奫8B禆咥硳,毷d曒矑偘跎V3A枂*G曂^争z閂1毺坿Wy鬴'$'1;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*迹a耚5@! 梏_Kピ齃騈q,r/騺3W╂[餿z茿禶;b钵綟L 8C0vv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀q電[$滏Kn|薳o€b℉q鮂*氎闝]/+v姠Tm笈\胢馰#臰b]娀v*-F*脈盪撥, Y*敓7楸m$6*璦鍷K玑n岱臩2 +*>8玿WbT.7^r(飱げy鏘F嘤€F*嫵Dp缑G莀磣秧姫R絨V馱bV爱莂姪]^Gj煎4A遭㏎鬄枻0*壎 盅脽 U1S蛗+姯h羄5臰FX張S]娀v*霼鬲骚HT紗1T坹鏚槳锺緰* 'Nm#竉R3Q姫猱臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼i篴 e摄?!郒6X^~Lg驃蹡,蜕鞂wN菶憃&]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b3?# 怦9歔軀蝄7薈磦鈘a礱轮Z-錼Hod焉3k$喿禢錹鳢枞枌紵A~U忀K笫拴属錏-孹嗱,潊]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬+矮儧G檟R敲_烻沑\1:m,9$秖 謀蜨瞜)扺v蔎 米&諣tX'+5z恌ポ5:□帊')>屨e鋭鬴#b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZqPF債梭殾8鏓→&d煇r~佛蚮[p澝趇綻;傗2%嫨$7 鞉v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姯pN烙b^|瞅将+郪€獐摷9┺N馄VD=*鬀熗_0\^榉臥所壄╀.釜uuy捔m纕臹稆e9=颔帰#}#P阷夃p蕓 qTb7,U糢孬盬b\HЕ*蚩嘻&﹢~騔V猶Wn渻椎9媃艽q1>孬擉\<阡U包左 價傞斺痋湕付#諽@I臺U鵖投綽6膖WOqWb<,I臹?e録 瞀斧逑2鶉W憣,鰙盫%'燉5i蒾Uky娎2淯?曔髶r貸桗4祠Z麥U>叝[霒骆諄喐猧姶i ,鎬b#彬4HC*>娋[骻缰楷LE邓G 姳6知I$淯l鶑O2佦{'鍩湫M!悂若^吨碇尜晝x猢犈]娀v*霼孬篝#苃B秉1W鳠礯碧B~8销够匷rAq娋顸ê栯IYfnLiVi娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b7LPy>减.Z/錶賎u9?'牠蔍鄏誊毐巾>蝚K箛&艬-嶄徐U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*嚭4V>&":]V侇r徐窦7, 滃伒脇-e耘儾$7€2h錂祾Ck亯['L乣檡=9迊響.>nO,c<ê湰駌测,yn庐臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫+L寯頇XR~p褆莗9灯vd秒秎%&94旱+侧Y蜭哅e2 n笽[L恅[a.伿姣P-覌薃蛌H□織%-唈r崘善a皏*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼凗vZ蚓?: :mH(~J遾^釪?鎭墚3D=屧;瀖kゼU豒孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b*霼孬盬b﹡供i%脷QIv*骭缣劚>3.y玆G閦蕤-W懪S-祱2確 姙斧栞<g盪笔0x ;孶鯂珂K2栌?&+汞o炫_P!Tw臶臸娀v*赈;驡沃肄驽竤 *毊<脇,J騤o诟#}盩L騀ИЛk$衽R齏C阂泤荫8 "刲F*Yt髓綦楜軑絅*鸕邛+堉h蚎U[y乡?灜汲/伶B#8}o\拐晪T灕釜X埼┡Y濅-Z駗X"釜Sㄩ撻锲鍃疙姞帐0w獐?6ザ粡F鼙闙N* 杁!_娂珞浵駓cM憏q欀珚 ?'/騠'焜韸%秉空oa0荰aQ姤qλ栎臥jx t*#楏Y贷乓镞h 5茆鄼g峞_猜i臰猱臸娀v*瓶0Et┛諍7u驱6踝踱呱馦>徴姵€岐lU睝電v*鄈娀v*鈏娀v*霼孬盬bcov*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姯fa剮蠚4nCj-z賎1綥抿^檀>6 捪p/e]唈$]紋6杄嫉臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b;鑢葐暇o镐厂z湴;,a鏥(z鍋貯箆9`oυ醏Cg东暽An 焉3Π贖mF, R 4訨s8薺{dd)鞘l>嘃縿溁湢含恜藖艌\ r,儼ヘWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*憏>DfF4嚺繚V鋣栢烻汱|0Bi秎⑸a薘迦昽-奀叉n输J1b踕&C?騆纯Xf 喧R蚋Фj3rAfY痐*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼悀tY-q3y>梂渘,nDW3 /"鉍涢X虵h 粖 =r箔鍔霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫婸忧s{猸猱臸姼獐7M袣H隦H~~闞.es諟熐L肌 R;v4 >髪攫鼱襱$2D捇**x娾_(iR/種'*w蚱荋眪^%圴擻U虍*胭,跸R"wm翕,穵凐bWb]LU7嚋嵱%[>淯0Z俼W珇Cy|質VE狣A5qW邡/恡2輆庉6a?斱n&蛁o,垊 馱職顤鷐覽#迸T魸I綦敽忢!臺抆b讞}邖N*U駁'J莪孶篪4樽{g峰瞴炰芪礖沺{獐膘<崵貵楗篠U鎋擹u鏁=頊J波趦|U鯯(T猕/k2h鱧wC/*諪ZJ X VQ#qB|*島{磄`8`+娊燓q黩<蟵萋稸m}棫yJ眻B'(6臹k?aIwg纎娋"->- 褕臮BK颧堮<拽~媬Zk氍i05(輮蔡U孬盬bX鐭\政G齒sY4繜2侩8}颽徸娍B(?w!sA逢臦4o咺沔{Wb蜛閝?薷!?6磎H1玽Z猬破泪旞b[oQ换幯 0U*`"静}鴘9泟s+7€8&Y%辅飱監0韬21磧|U塟蜠i3I翃.齥姵+H("2前8(IVE*贿┡[U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*喒搨=踩..C虫蘗}]^R;秏0l朕爹)k荎,淂﹏錬=35Rv藨€Kyr娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b8猈=猺绣>x驥真X涿鴰X7谒&%硜菗C+轊5叴6梂$&;aqと?.棡禬>N4>婒攟Q朗汕L儐V鈀.a糝霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀K鮄y曀駭嚽?瀡渱莗烯蜑.L濻96qd虚棩藨*轟柍vW$禂$6J鏻塁.騾Ba楽WF洕?赏F~L^€3^咆Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬^uk螶扐3el雞w婛*嗔―<\f'"崆涥)=H脅f侼 譧v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫矾*睰堄戆N*谑U8U纼娀h斧蟎U碌雠[臸娀v*?5|5%幞x?*嘴谝鷋X艶*庲f獨v 昌"罪臺〓J骬煯轳将U 懼槴 3D:岔飱緗湲髐瑲+*浪驶U衤*k锥*[齪'€P^*/J$OU臸娀v*03!1W缜琬犠~k贿岙遹臹p脦孬=;奣}#VS紖."hb9t6苒F(嬘8}8┋}fㄗh缨褗緝.~ 愽臺淿氉弎+缕T4臱攌蓚鴲1W芸髮轢婰觀D2('{c~槳 R觕挤{V>*>e级QEW犈Xi^&}8钱滳Mh €~琔 楏__mWY1▕FQ姲卦1W?髩zB[y~R免2W駆UA8獏愍O F猹A臺溸歾W評瞬EJi姲鴾屏 qW踎髩源墐擿1W烩]娀v*0卼┛諍85跚黣讑担竼9[8o?f掖c'跓v*疠s谭,淖j猢ai怲:猹朲劧 w獐t渹居[?u胞馱>] 竟l6蚙乢M*蝻齬}室軿8lU瘰韘酚姵听F鉜+w'z獐D渾鞍訜鈊※獐榰MZ颱澁,疼韁U}A裨孶3褆'祌锕臺L﨟蜠剿&煭IV臺NZN1,瘕VqWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲Y柃H.7''蘜e璲l|Xf蘅+m~q5=O枣a渫s]'88c窎!孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*銑约K忩NZ軀 N>,9Qip牰qq薈!&!紜0嘭楼-ri卶qd+″獜朆|渋騷迦#f1u鵍y"瞯)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姩*d鈏!/缃7.x忬┩'壿}稠沊瞙t虅 [薆C珦f轚%h尒\2A塙M騟倣$衭葦'轚窺ㄚ婎f$睁邋碌郎詆!楠吏蛈0ov*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀q葧b櫠苶&T3/Lwpuww.-?K逷鵱郞j sE怮vk7;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼 ﹋桗l&忾膓庣x/鬦C稻jTTb钥$uK 淛qT親湭袁嚇8紘91a]I|qW癶5 e:蒧 U9刖*嚲繆3,1W梱嬻堵 V :艵敼迸^潵5"V*嬇]娀v*4h蘋褋~*鵚筱.P韠d&瑇庣|穴7zczwQ樰O|U>蚯6恆櫴徺+渹债!1U攽J儕茧V瞵孱錳+釜g#jZ%,駬盬摕0yV9銹.〃z~*霼孬盬b〨'0i胰絾*7跄嵲淯夆lD42嶟D臹簚JUS|A9O`兲荥?xYU舣パ}R"v U翮煯Z跧朌1W鏦濈3犄.z椗Rhd_鯁* 鼡覧畭 ^q儕)*獾<盬繽髳)槷f_聪*颌k古_X<tZS}孥兜渝t闡囜娍6钾艴[=L馮 娭x}Ν枆jzk-i姽声b瘋"mT佰摐U鋅躲娋>筯靏A*鷳zo娀v*霼孬4姚QV*揠忴Br;{b蔀I襟]赱@暬孶鮛靘-Q顬pGLU鐝;籿{I(猡1W蕕s騧邥钔第T-釆緺?4p拹霦7淺H鱉r罱F*鶅V益翌^卩h(qWXg*苣x#a娋渨o6i  笈^1Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬笈纼K櫳db竃蠙釠倱褬S锿堎Ъm瑫H?哷g晽7=蘆s€vI]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b8羃?瞨戌c澌鉥攝 鮟l cC枃6 \&樄T酭釬-%,am&槫礠婽旴8敢f邥潢郤禕|淺湡Ch諄蘲氩=1j槺]仜矮盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* 銊+;&揬簈&o涱槈d_驇m嗌瞺!*斅獺Z桶i斏+嗼Z&檂`[叿缮娰X塳暋濮悌虑j蚴>誩!靨-蒓5 J'+C盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬R1邶f眨袼饸q3囁5F>o囈昵7羞朩㈢KF&qNf蘌涞匸羒vv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀iqWVⅲ|9;琨鶿NTb瘮d櫐s#麹聘剀I,lG肉猂F褮H臯鳘鞮U旟s7Z螨勡\U旰玨/鎔4跁臱鐪跨"u輆-ge伝\U婠^轎{鍷Ye5vz搳緾o〧∨Sl>a納劘ζU嵡9~XYM訤錅U@ U隉 BU弆U0l驾j捓~"+Bw臲z:猸猱臸姶拢I兼+*踄渰猬g~€?氳6唏z*霼馟Z供涇~糢郮稆]?鄎W Mo箪qW鏦惬q*曐z熾讑縀'蛅[斧;臸娋 湉N:扃篷W忊 :?G黭娋嶓伏seU縑*驩黸.+~糢魣圌kW鐿錂畬%齒盫熿煐*鳶TSS_鯉*駳鞮U/ ~釷衽_V猱臸娀v*0棖7鷱W纩叠鱋_麟硦#Nlw4臺g-y&;m1u' }姷M馱髷綢庲!w塳\U矜*?'広漤娍D4 羪e泠柛+1W柳擽瘩屈危8駽妊鵶IF L~*衄U脡閵0湬$Z膚瘿 p臍}8凉{o?E阞麓踯 U6*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶X娴鴭N鎈卫 蚺伖紛煵帼9檽`鈬誾r駚倧諝檚v"K盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盪畃剢尜阖鍋锨审婊5n齝\R豾9hs *U伾 7薺aJ 雼Y\FD-s韥!;廒ㄨqIlɡ%陵龋7驗荥 﨨BN&^O|穁 瞖X婡鈥N庐臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b j7/O?6Xy3|嫧7鶿[~价翏饣檃*2J誶a!艇L捁2-|, 瓖 甁LZ筧喂Z4a乞'+(K^笳娉(爐丢謉bQ笿娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姼銳ㄎ级9d|⑦.攘ㄌ*鹓Eピ?%o鵬;娉U毂逕毿鍡aHldK瞛霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬鋉?/遦后Z厍蛨?蝮N邛拐Y銙€觸U隫髲%>€躑圌淊q'G糣 _侦⒋齲8瘳桁Zx莝^槴说-"鏝撚篰 1TPt臦篺泂-璚摓}+80箣U悦F褠酥槴+kU1焻zbWb鞮U妦ey檤渐桔5~~3k趧捠抹cM馮捼想20麹`:嚺^=娋$?G黭娋婓F蚍昱_>i帩宵eo讑4窿^*鼝p(#鼰諍iU鸠瑏1N蘱W媌A%?U鮪*霼孬盬b琯熝R御鮞齱尟Wh懍棏+,1W'鋶氌鑺嬓玄盬b8訓o,^Jz猙,U6蚣+z孶3鵱鍹諒R槴湯:o鯁*;O紬d.侅U鶬宕 ("_諍臸娋w満訓晡氽+黴W飘$槴2鼭憮?钛娍Hó*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶棇唣慳薔 厜X齤粼}认癶嬭踖鈥x 陨劂+d輤珕!]匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盪)Z <畚w箰{榮彬x齝TP駣e∷偢509;錂*铅矅妱R嵃6$雷l"&b笴悲8qC娋渜5痝臷M:獐?( jz淯沅b跨4渥l勺枧_L垭:|憉*箪^柗vU#€褽>~€﨎輭魌讑 U轼珘T襞_炞4^%j獐:臺`閒 Ж堚5鸄sg*熶o諍5<媁籗赩齲猈j&F餫W髱嘛A, h纞糢弨8篌譖*旨d8i}w8mJ鈹~匕撶;蟔PE古u)卿.dr6銉Rh0€范庞5.賬譧*醾*鞉v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b╧ $慁蝤%鞁^&靋g奬I蕎X鍋蕣 9QY螞d脨{醖51b['T倫]電凘;`l l:湅"﹍Gx觕鐋兣8襺鵼d裗"B\鏶:屹琅h郩豏霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀 奟v4s:倪ㄥ餯+;甩媉蹑輶O畁qsJ斴r2樓翃TW%[S綫%m 鵿U]殐,(Pm虿呇靤L^欩#s荳&砍齭'$譃D熣壨{娉;W榟vDsWd肇Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼`什sP虔谓0r鰓齳秤濶Q顽柡€苍哪蠷櫟詝.<逰XI昴蝵n$NA蓈D+睯霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*)G G陵娋<^4弋*(u跹鮤輱9矎~呴墂o睔 Tv*7济墸I<鞞j? U痋 基霉#R樱J5* 鼨渝逞裦洫G蕵?臵+J飱笎78獷 *镾訠Ь*+蓑Yy庢閰踥尖*bX6,-溚-b,E[*梜卓Q睘闟E峩娍=8祭氾'紝→N*翪Pw臺o1y}4橈Ж槴坨凧|U【熸 PI!*罃擿{孶煕#氈[i[庳 U鬨€絨T熚酪4筼f41W鏶&Ψqy☉珚泵Bh斧锵豩烟E=X咙qWм/(]u#鹋_熯瀪WmWbE=f-娂賭^漲W走髨緃4怯澘x騦题厈猢_橎婫构_揌严}J娊sv*霼孬盫5鶄G韫#琔甋胱~侩臥;F"鮏\U鳈啠狆懌7*麾痬+Z韸禝"珚紀C_娤H栄趰"t臺 僀姴纤 1 z h臲~坹V同t qFU∨^e9V凋|尥1W霖'N撘箟鷔u?q臺曓c媆!hZ(誒輮1飱呆1W髼妜韒璟 瘯嬳膖臹8报k怾恔€孶黯*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* *霼孬盬b醰=旫瑴E柟椝q詬蓰5饽f<,菇燆婲1Z媯>阪彘F顴"櫒洺 籩j鋴7b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霵验!,榬q<*% 甝:瀝獠W$渑^SA吺濔穮 '6,  ㎝眀礈(l衾,莑塨U4(龟P2册L兢蝈 €札湲N7&W暩.臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\p+;牭h僛祟嶛瞦,冣;&簰煻邱投#篰w78'H*k"揹ó V庂D捸5市刷;W-(-(6M3A3晋睛[鼫廊6C?蕽C锥暭ks/D嵐(9凚d$]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b猨锋.殆Z*3翮w(|乍手w#变?^n3>饺炂&4y#E匍錫6=r5紛匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b7M盬汘z4B6顺-鱞瘉鮩%酐塦榪( 鳓*厒闋dx鰀 詛b湒汣E步屖6鴺鴠8湗又靥r獐7?;顋闶H夐]盬掞f朸N浲Z裋辈# U)犢; #P~亰樊]单湷(︰'|呯K:@>F燇掹墾`豉n*鷽;2y浰盻薧L{W爊qW?髸~C{=o鞸渽暝隞孶聒攓Rb瑥叁w熓发蜍T>*?髷址鰝k垨6$n*6%縅Z祬攟D奣?蹔緄杅梬菁qT轠沕寓祲 +1W鑟遛4= "(PP猬敋o娋V湦yj薦5>淯颢 Q姴丝>O錵2x}Q蜯Y5Ⅹ昙李yw骥s胫騣柋馡9蜦F,齫V[鵤)|奴El╖3叻\U錗1t6拚E=4猢臺/蜺 K諱Fi杂|爫閾萕鐘部讼>躽F.z吴誢tUp;燀臹W9 轪嵈鸈鄧鰯n*ig.鐂茆瑥>S贵桨,U晬<臺V訔O訝€ 岮鶃姦斧盬b]姳刻 ネ_諍7u罧雭侩臥[獐F鼰熒鷦nIh㈱碜}瑰徧'Y祹現枼kW6摚4韕剙h+娋&椡鳔觔逼H;娂/{唿恌赫a证S槟赃琮槴鞤N=:v臹=9T鏝淉o釆臶泴U髲淢鍥呌钲擱鹅N纀t;7&Kㄏ.臻姤~q<籲覚A電髷綿早湌b.J幟bq})Z韸炯淴捨 /顢嶥2}+娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b瑆乌徳瑱篢鴉F(賟采=&颬d;髎n9:惩粝,女t59晤v淪 9 鐔駻\霷霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶0剢?鍷廘&L9X苗锾+緕t\ 榾5z錅槷滍吶妵|-罳p瞝孭翼亯_\X3 颚,聦茘,$S+Y蚩穙蚱V\ 椩鶸窧+摦-揕v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*銑1Cx鮵B泓桚XBC探,%遇巑q偌輜9改R禿[ 敬\%d%[淪*挱C*薆'膔*丩塀鞘$勼蒘z7吔 賸陱熔-斊康氺{0s_>hV事 v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\qAh$悂 YJ漥/膆啲僩藶a代ZR國骒泃蓬煏:櫥*MxPf籖1g紽a;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀R箖諦嚕>黆蚍珑-牟WMQ楱%黭娋d居g硱*0+*呠飱痓E;u臯釜q爕n颹簬屋摎CLU龇銸浼^O卭甈}q枌~孶靻敮*梱弣6饪锒齒忬:cC}8(m各zR蛖DM^枕g 瘒9%<痻罄晠痌馱#"#ZZ焔a姷UqTU啑q|陳D =qW谉髲摬柩zC}NX珝鬲E,沛 -U姁+娋鼰津ッ窧c娾1(R×[S^8汖/J.u9肄b\佇髋_h??柇因馟烒鯻l猢'泑,$硱T笭臺 ~l_yf騃Q?q]€満|珁(孬[SF閦=围:[@孼C@hi娋測鼱o+D殨陱0?F*鲪)v*霼孬盬b琠O諍8u亏R暗{訍縹*燃箱嚠劇P髋R#1?Wb狏5臮59_痈z*刃nqVq鵴鵮{娅艓$!A槴羁薩#E錗~z摐9$妛9tΩ[⒈&k硒0.S\XS 斃晵璡|%瓻汏N埤.苡鰡V\ 椨k@>Y\漝'+iv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盪9T:缠儎%沕\H+苫^lq倬E厱I孥J愆碑e側6~蝄寨\蔼麚維%Q**笣瞐V硼殰盪K`b稌蕥{)谫\艠閏8o嫱~@木幯畾{Tzu蚮A昴敧霼孬盬b]娀v*霼孬盫ov*霼孬盬b]娀v*霼孬(+OQ,儱P蔄2Q-s澌求gK0陱2.npt砄%鮋珫亸;`耘{傯9v唁,潑v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀Y=約㊣T2灎娾/笄銿涙"螉娂{T淓X h%v雠RD淲/C/*蕋KrD犹震8<淁ImW+瑚#|U渽犡{b=^琙K#锱_)蝛敕糬\I'|氘/e抄LM}8竗滂 釆絯q猍瓂~覺埫u絳慭U>v淶罢樛o!C謯1W檁+\琅b婷L確0巸*鯫!兀i~W 虸0*8   USv*霼)<穏瑽b粛Z饺*饛;)Yj洓i 讂(臱髪螳q尮髋S/%墭5處斧<戼j岴晣r1W岯(U孬盩焈蚺灧嗗坠|8~驸轇奠*篼燍臝$F]*檋燇X瞍t5閵将扂g枖3*茹*籁qAA1U嘧ov*霼孬盩赪;)-荲Vx臺%0\苘'邱尖O蛵7 螆帻孬桦徦 SN1﹏ r#}*耧6'谳箹 Xw犈XD髪 8-虔E糔稺2%邏飱界蔨F彬麫C1VJ1V馱蜼7|姴溯鮄蛆KW忒溘/0i0Eu阅⒋雠^+踚錵汭[忪1V涛}2\U燍/Z螹q5脰=Ha娊姿葱跔P<1Tv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霵霷霼孬今V壜臈亊rk>奠朻)畂4阳:l缭咪迴n4 攅柾鳟蚞鋄乚圵aWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼Bi '$"7yw纩7/i嫇7嶽c宭 搙 擶 `[0a`3U1J湞pm-eq8X-)4紞2%狾`騨撓暌S9Yu/s厁衶e%譎X;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲注俼W濥mF铲v鞪澢跆躦v桥毝湒上廫垅)J!5S檧 珈鍸R曹绣o垖狫關e%+;^Wl盳0眏慈疢cf/\鼭6忠嶵┨ 隣&He"z郑5y;…k禦]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬PV)'禪{╀驈蝅#暀篞絪u6].aO5&uH#m+SK殍% e鑣煒㈩1 付v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b玿恦;bWLU鬲蟄w灏*笙蚈屉-椴:犬悴'鹋_ 糖蘻驣.e齲o蔁.@娚唣臲 *v*霼⒃臷A矶* 7n槴盬b\qW 髋Z4]馰馰放[臸娀v*霼o痌盪孬盬o娀v*霼孬盬b]姼衞姼妼UjLUv*阞5韸v*釆約楚P榭霼據^荝/鯒踱Ki鳆鹤鮞tqWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼豒畠 P:抛誱$淁V 墊挎紺魩び揯d7∫>反﨨Q瞓聟峴O瀃籰Qz(; 6宸\,\N@瞙b細v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲桌暲韰MJA嶩6脹趴9.會~90鏏渥2T頄嘽宭搾mY榃a`&K馾)p努葬M雭N9寜h涜$YR谳┴ee咒/IQ綪\b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀q臱熸-└裯#ㄌ淕v乔繖T6逊T骁^|緁艕V1d\ 杓肥浍_l牚1 帙`R裫錁#"BX僽闃箐牟&j塯(n鶃晪鞆售涓裛j┦7Vj檶嗮+盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼窼襟狾&5鏬0j6 m舫釗ㄏ审lnl5"泯昼6俜qq緲6ヵ:9墿9玩"裙臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀i棎*錚v貊臶"籦u+*踁泆臨3尿槌勝6>X呶众尯L頨櫒飱騅P{曉58xF4g腷"塧@(*v*霼耘]絵盬b]娀v*霼孬盬b0*妯卛**霼孬v*犸娀v*霼孬盬b]娀p臸娀k庻臶臵+]馰馱b斧?+?淉a娋臲?彗黸"Y^*蝼#й隹L孬x娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬vvZ莑恆&#鶉 k #v\绕i椢:m砡]讻?K}O<穊稏qQ熖w.4F┨hrl逋e貿f孴竐 鈼b]娀v*霼孬盬b]娀v*霼孬盬b]姼娾姢緅熝砪 伫驨0 烓0鏏偗蔷Z.K$谪U矩Y刟fl,謥\JY\ⅲtx丩X斔G孵#┤o萝摃梇惒ナ6!孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姤h3豀兏藂澷瀦舋 轳fK忙埬躈lG偬弗A賠U`m嶶$寸()X栻孬瞖]惔S`W"C璯x-枣&@谰狐sL#D祹ⅶl誨眥D,噋3ZUq9 \柶H!%v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬璦n)Tn!Y#e#8c#l%C= #gbsq侳CwY"<灆;痾褘*龝蕌訆e隒5庁; v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀Y蝀ロ扲呜Z疏貞厤秔M壟怙塕\z郻ü%F韞 -,sMh[┊@gw襘X劌*{.VKwNPPd Io娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲>q2烓d鞛ヲ眲鸜睬$綸﹤)鹜#睵擞3bRⅪ溄-│W$璵騻暎0栶挳缺\尗鳅bX捙(榖^鸣{k#(黶Y;^镾#C:擾諝箓奊錒v璬U眲+睯霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬`*霣 隔^5d窺矈溭閹委P7a桗氰垧鯛j 綽#抽{iD懌x?唅坵暘鋄娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b2aQ姯翥P}孬凲崅徎_娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZ蕭厮L*喚楨9q荩4秥苗}]痮eJ讒3べ益zw淦吢/Xn螟f嫕棲\纒€_憁v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]乗pp菍l} ?2u#:@|9x嗭 粩蜤{d澏 (2梨菗6略[N楶笢,倹am p沜 伻0+6葪e_3S霾脵蓓篫鷙瘰€仕瘲4x4v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* *霼鬲渹籨 蝻污@謵妦謋a'薀6;蜴禫.鎯32丣$桽)!-q茠阛WdIW`CD&臫辅输I秮7竹SoU?^`d)鳓卼:茻╢T鮉s乷怶a 鞉v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b7L!寴繜吹居鴤頇8gE镣|賜彠*6躕~假]竨O棳岼裓o氒癣鏰潠G槷s+盬aWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼牷蚺[臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b璭t麓M0牃b翔1彘8 ;厲[>w硤闦韡卺<. 酚濺覇檂栢}溦%+vZx鶶樓巆&!~莃]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盪JQ搶.9 "鶃|^翧顁?wy\-藎.U(/竂桒醟-L(v,掠抦 徼r%J纂亖[\僎Gi+蜆 塹轾Kh氟咦"醖Q晽 E恓v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼豒孬LH閫珗聳)珥.+f鍲$囀繙联厛Pq撑-<跺\瘑l R i(zfhJ麁P亽)iTBWR陡 U獾銯$+琠嶄r鱓R>儤}i鵰绔雥I灘 |鼙眇 X珒\瓔y;vI]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫% yn'墸=芛E6~bi-2IJ!;f班N,矧C\磾黮踼F=瓗 鸀臷;媝瘄 vvvv(v)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼腤pv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀WaU9€湊 2/宗r趐?Zf~8觾3i錨労嵢泹L-桯衖岱裵5R.牘憂v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v(q,o蘻爢辝p-d"[皱籊奡U,rn#A犅迥4甃6呫l輖`Z;醀 ,枚萝狆葧*r#禘乶H6葪I鲬麸 é@赋/~又文儢E寥wfQ筜p蒦2,]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vvv*]姤Z瞾飾翋|悦9潓焐髥盭钿O蛿 T-橌甽"桸K蛟矗 R膏J赽P歙+kZ尿攼7 痌_0[-v鷉a =R7l櫓觻歪敱l3溉_臸扺b]娀v*霼孬盬b]娀v*霼孬盬b]姼銳焊卾I kCOIPS琜嶋S櫢めd嬏<伃;S崼DRk麈0:'助kLP焘埂摶塅 僪o]娀 v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬dU%q聜杒7傊贗 灏竤撴5j崺_欕]轼嬷┡i蝻枸f檰騹s <涐 犔"鏕搙;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姷厓D馕/'螃绷"痓2许1噦/'a顁n1\ }7vI塸艃xUi虐-甀6寔IUJ慭婹i欍憅孰w2Tv e罹]€EoO|乸2印暩闻]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vvv*鞀底U忡.塮[鶍涏纞蝔;%毈-N醸6P)J<_|倭*巠迳Y"R醽.8J嗜Wd癷, ^Um~#N購$睴;鎳Y妀/儣虔W咋j2Г>9巶粃 绹b]娀v*霼孬盬b]娀v*霼孬盬b\qAk#$ -寷*檇1閶╖糽+E?2q寔蜴璪鶰盈C蓤撹tX?枤蜻谿 j然鏇$i跠硊;f3`f霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀w|v簇XI鏌>b;紽ec緂w嶚CIm_Q遵亭 q纡F盅6鉅f$穝迸1)%豒豒孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* rop蒹窞鮋!p曪枃s坙m-=騈!駞43+iL-e&.艃u聬0秵羔n r9 $ $荺僆S襾杶>Of娱q!塸疿砰荓乸r褎覚.臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼)\Ep櫀*)櫂3<瘠I鶭袷飚sa %缂*溫耭夜6e ZW扸m债 WdJ!XSk [R.C;荡鬯 k卻疤|傶; Z呭逛莂3U蓛遲衰笅殮H袮Ge僘ld偦$]娀v*霼孬盬b]娀v*霼孬盬b]娀u0曍Ui銵mKYx奷铺蝤祷> T嫦s愷梇8驔蘁锣芅螥+栮q喗>c#昏8[拞无咍艜穃壻 汗&KKoL5捇n臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀RyS%M{因*櫊銻嵟缊sm攄駷 沅瓦:雑W ? 6傩庖菃<驗&[5艴鴯瀑叐滶搪,渐.j怄靋^2T韶U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼l嵞WQH5璟;f馄勫9x |隅K縒S潝霳LeL~阜>鴌D?抛 .%WacN缕潑 [qnJ鎮€`,-!8寢D憕[祔/@販3撨?/4龇欩 d-卒栂C釖‥r,娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姟'U'慫灞,苗?>枞鰋O璑l燫屺I銢覂崻N蕴葦猈-KX ]娀Q乑j郬,}*[嘋C曚鋫鬫森]&滙鸜瓨b蝾箅:z筳餁uf# 寕 *霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\qAh酇h鈧?2<竞灍!悝賾儖椢忠I=6彤cnб蘒肿U瞃侌┧.脃驮纫礚)糝霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盪亀kum/+^]6耪M嵆7O婘u鷫n诊旛,鹿ㄓ/ぜ彙*蚦sC濾眈GvHV縁b潘+睯霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼p踖憁€y姒棬妟甖點g屵蘥竒=蜯虉h-鸢淵d艎釆碞,胏啦T-6鐿 塱慻>I {#甌]|诉4K5剴\乽9'6穪臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bqU帳 滢}裖懋猻c沈~乏Ikr;鎩%罕騉|蛠KYx)].8玐K`U`A`T,槟rn橽 ?'j怸m舠A嬯徥?0.惁Мad-'IQY|3]!LJ#+b*霼孬矮盬b]娀v*霼孬盬b]娀v*霼孬盬b]LV攏a鑢qi/薽ct蟥爏沑r鈛搹 w;鎻皵霳G.2S 虞b`t9"澊 呝拓U杖夯&]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀j词*7S垚硅71扑彋t鍭w镕~ P鏓FY*<醋W> 屆蛺Cf8坭<嬝f苣/l -孶孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼mh襉媓C∈j嫋:€0晒q 筗 m-#祬榲v,]姷%蕅d惱PK栟1-/Z騠暺N+.速m◆虿脘m嗰Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫傆q骹槻YNk筍檖揷錈蘉/胁2t>/1Tㄌ鐸[+L.,Ku+X+盫﹣W+暲∽ rA] q飿 ^鼯I#m$$W馓9莡}3√d秿檎A蚮A)4(`霼孬+矮盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v(q臜`?>^嵆=)笸啚n籕乮:剼]铽JiO65n雨*觊ㄙD鑚蹺sK4]9X 偈怹P'ze5賠娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*ゃ猱UVY^蘯觊朙谦3gヅ腯N&蠜 I猐2杅4Hu脀堰楟\M29?m梶5qY娄箖ns㎜盃;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bT&n$",?阭 2幁2墟銕 髰駫u-釚:HNy7$膓峦犥独亩E0 b韶“i姶qU腑 Pk-r)晹bP;叭R{煏葱 ee翙z,j鵜p T臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶N┵媹$忶2葨V髬蔀枛X龀a'蟴帩"餀厥ヮFe磨H遽-寴WaWb瓕姱 \Ukj9嶽寣怳/%峹1矡,琧H攽 脴輄_;虓=オ擌攆簈g猻+!孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盩)wB碌摄屟谤皿+薽'€构> 阹F)鼮骻犿m9鸉1层'轭 砙韶莓傦\2o$嘼]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姪O M呜伝 驥^\6vk洕,h<菩昢ZmF.躑旋鵹|<檃厙裿瓞(#Q@h'"K簚牘L 輶Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b硃`穡犓憣<[桃蒱憙芽; 辝鲯)'禭(忉禭鋩軆 愗郹W\Yb韶ヘ∝—b泞7葨櫀s錧n-鈠~惺藡"魍M(阚抸橻奫绹b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bV4`#)X选ǒ\)y嬷螙@?禉x撲锾,XK^68蔢9'3a+2俉e乚匷拉儕L 輞`W閨y偝-1 博1m&檈^+躥$脐鷖蝼蛼砓览P3_0囆主 'L资4倛守vv**霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\MpSH阔x鄪e蛞6: 蓻桦3Gw俰wRi殜譧従m vu鈁緱騨練ズ5$f4+wm哣Yw+s\, d拓Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b琒蠚鷌殀扴a檟#r4鰘M玘齚钜n&8C緫蜮h鯝H鴼嶗鏃S擺涤Gf[\舠\N迓€N臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬U堸叅廾,|顼3jFh傴9根编F 9癿邏‰ 茧1j-鄀b涩Yb, YlE"\|廻艺慈d>?+.$嬜頃U{ ず+嫲眑`K盞盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬Ddd獴V戼材]邡4虒gt債W箫Jh產嘺rM紓Hx}瓗g漓沍汕√卅)'甗Km謽氽播涏E*F腑/籂屶(*6 皮魇Z7:償J疎*阓`0畖旦灅`H蛜XPC)0胤\崼矮珎肇m]匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬T葊決勾[(猹{e睍4O虩+>檝'I澔f琒 6瀪Ry燴H稈毿u蘾僾%類%P镁j%帩2.b#臶3峤2L潑v*霼 v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀q4焊--r陋s\,@栘\悕禉S缦蚈4J霨P们6p铌&l咕2挨`TW,詆.<{晋0:L绮菆鄱虐d仆"&60$ v)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姮wd燃郢1庘>~9hx陪>kLv8n儙V^0鍲4鄙f甃3等$謉珝5澲湁H儇 t挪洢p LZ婓爱-&I茀e鯋踂!"忮涋級f眎1!]窿橾竑L受B瓙ku1E;v)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vTel4愸镂?-[\q3; 瓝錩;ZAm↖lNl鄓JJb饷巊墨澤4鹚铡N8鄁諩揷ui缢=1,K闀銷鵜Ba犼R[弈素4戮汓烍缀揊Mh孔5葅綄幨k汏€飿鑟$vvI]匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬*驴0|潱簥寒贆妢眧 撹梑3)`K丫B2j謤V瑺 祖;秂罙苕 嫳壻vI.喇庐臸姼$梔匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b,K€拉捼%H慲?櫨k]:佟崺.ec嘩$ o诮鑿砯N n鶦葹_]*4"扴|斟;9糕伤傡 輩]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼;v垅悜犏騙c抮"9鶍^扞阉儾€b冬ds\摑5*4洛H\鏩d殩-.#継8 VW磁w鄅掑_P敢/J褏蘳28Y嬟碖E偼#卜澯o 僑hk€;vv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀Wbd侭K玐莚A0鋞甧c,h刱&8囉8掤P5趩櫉1R债d$$惖 8 拸噇,攣#Wb女暳+慴鉇! ∴y崍蘨=C7] U蒈效跆僤>^豗02卐(;止夿 v适風VF;郩Q揥d曍Wb]娀v*霼孬盬b]娀v*霼孬盬b\1@v)S1"昦Pr@覾艊剘n鵇理}烨秎a+us$?椌f揑籋,w蒆Z i鬴潂梣,坖k .|'7*r渞\0卾I]娀WaWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬`Wb畁楶R韔SK g澣Er谾藦扥欬腈9u+臑櫞宧:樗v鵘滹R棑- 殜'[9嬞Q8糸汄\竻N橽媥 *霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b.臵# ☆む袈 -鎊v誏W.侞d湼裴殰堙慀摉嘺叞jHFI蝷輢钜吶 q瑰L奺$試#}挨搔 動5饚[郻W玼楞H<筼醌€Y簙U"u菼绿^A/哛\2U-郈盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀 ㎏n0Y馃虩$躚捃堀)艔l彼fO搉$蚱轁囓sa*磀q郛eD獡碍2蠷A\榝,.es,HR放U,娰⑩譵捎娶`Z荺榙啍P鈺5r塒籗陜跈阃搚cGu€ua.碎6颧"郒*词藥Kx霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀j橾%篴 $Br繷3舁飔I喈睚箷巉賉??鵵-& 銷跬倠aJ鮖帣$,揬*琷x,璌)得|莑(p,碵GlQm呭爪@珳m舧 喗:怤b(e_楟a汭笎"檹(晑a3y哽r荦擷=>婕爦B6ov*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]L+DTS%怷诐及毻橣d屔*-嬫璅謢鸫)4鵚6鋁u桹s髚zj矊镣埛c榸*舁蛅嫳-椬5萢E嗠€欻葚U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*5 /\ r)髼誔o墟"7p'騧I梊9歠h%舣旚D觤P曔59瞦? N5蛗釯s旒!孬盬b]€Wb]娀v*霼孬盬b]娀v*霼孬盬b1V砈H n鮝洒閽"谿%}&Tr=2`7穭k-z痋9B6* .t9496\%g叞贶z郔]J飦l1cK孻L 8S$岃N趯& K\%8玠 qg0鰪%yV狡龓@rb @2咨U+-k+盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼wA¬蟞鑆邓c蚠3蜛hf+X岻頉恷9{V魸9皦d(c$m秂D nX洱3$%]€丧g*t-M蜝敭IGl榃W'ZW"d畨K蘐t蔱%^∟Q)!B釯 <Lくたu 31蓰9獡:t翶t 譴*塀I∪*`C矮盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫榬鵂紘骳X嶎佦63[┧姙W‰Sh 獵駀T絅<}/涙8鯆%嬅4裿榬l萯榺4\秺W-按#!l喭; v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬`*袋8#c#LG蟐k廎穋_帣焽铍<旡葆cV唋n儑[綗蚯cYf踹5鵪碂;4|49羜4郎孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼圸聘[嫙A 亜j媔o 邔<椡瀉{7D|洕箅A#.p1倳萝€鋰姪芭塙N槹-6,T犬(_q葨辽T7%8H淴憫.$蕂5訢,+.$碎'Xt\儑"桑犡d 嶶琅孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬墽\*8R糩綣*筮= "B+C櫢 d+~e)m﹝h篡61&4~f\J珗i孺dJP=N賘UaJ跞牠X攅v興嵷`2U3尐蒘 &褭觋w)昬7抦歒>)昮>V/なL忐M坝=(A0塦酏:;X疤yTY璿适全睞]匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姟掝3偑z溽3訏噥~dy撮嵞K1甿鹣壵f S1V鏱梑]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬t,錝挦t掶掦甓扟0??k掙P)I蕡a ,Ed9 m熄'&!ㄣ(8[@^rm玨姷J饽-b旁 攎,傂臕鹊娶t 霨禗笓/X校鷭鷥~_ \I棸楠﹏埥咥聴4b嵉捒b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b%Uy電諕軈kL饶i!笙骁楇表3->j裕+6f翶j稡B儓'3#$瓎:y彼剴篠渺隳暕!c孽菾JU忠Y?矁6,闣扏坦Y毥 士椬4fkf鉣3SW癶棻O+P<3SVw暹(踆廊炙桂蘨IY涘跦>! 倉矙ISh-c圦Te$盷#@禘Ur% `V饏vvv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀i篳*晊嘐廡秇]A$PJq砪吠瀞蚣R笸G$I檦T-疅 {6|V ~r奷檡Fj3C(咏yc$-vI摫Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]乚圵aU 藬穳EQ股6Z睯冪锾8谍肹b;孓0绎#yV]r錕 ]蜺扵o}-6 >Bs_)[SxヘWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬Nv%*頀妓蟌舛沺坋嶾C玲櫑?揕.TCw'訠'2! eF59&Z>RV籥l"%[姰\X碅 孭(Q鮋┣ V檃A""葇櫑=呐j@躣K2飨"閭 2"\)蓷F丒蕥孞 ]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲桳 <酉栻羧凷巈;%騡毚9-o.dr>'3$鲍]^7鳫5獭0 #r^賕壏睊錞╇9BS?僳垸!e F賊矃/D驘洇璕]熛1蜳岭>]静熟暇Tr単楃/"(2償*om1+J&橻W]臸*誴%眲!豒豒孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼gS尮5巑蜚(沬墆笫i甗矐S汳>j雞6颫} 韺倕嵬褧嘝#R{7鍑濾鵈纪3S猪pe趱p#5; mv)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼;o+^@閽櫩聧gn0n,tm派;%裻yu粣*鋾蒴o捈春E╖Q5y瞇迸N3糝霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*雅.cA匓浗鳣dO╆慏⊿冷烖怒プ钋 柏摋獤甀mp筪; b嘼璻韸穵(CsH匟鐵X鏐馳頛摶眀p1娺O抮c郎7R8R串[XP霼篵璹臸Jb梤臯8,@Yq鎤e瀂袨[ǘ霅q$^殇 貺蜤*2%寥vf1暆躀趵戚\ 霷霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬dU 骋哨X围宥湴B,T$扼,塭Z^斨蔜湭S蹿f倐橧(.Z嵨Wh+珝 。$ダ`占楥矮*霼孬\qV馱b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZ瓸'u+A9kP%vS.m 89ddAk淎 駻嶧粊~{ 輅7O5蓡yW蘳h %HT;尪q$C+鶔V% 0躓|觗澠9l焑-闻]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]* di妝峭慼悥, 0趪嵛O<睡席Nd$'眾物@!敪章訅è脹(垿8釯{D0TP 訐n82 薰k材8b€靿K睯霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姪萮rA榒~}>ㄨ;a*噢j諺}E)-v%"澰R竅0=pj>I毃9$琿`v)n斧X礫{b罨Y.4物e驇慖鄌a%聶匐懊闅尙泆驎9v* ov*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬X∝P輕%张]奭乚倳丈+珚)姮戇$栔%SQ喇骈憭栻Ho$+盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姼娾倵犏\w饦霒耇8坨? 羯x攣固仁躢瀙桬漢軭橿蕥杩.鶄 Z%&│v鏸粄e7N[db!@q!O6m疞俄Kx∝Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]乚匽娀v*霼m v閼;╥峂l%l$l驧緩jH: 伺寬鈋)蠓泑6痯@5┷|贎p嘿e柨椣xV觏h筃Y觗 K墁l众5岪E6蚻V;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*銑 [ 劎]絢[s'q柲9卒欍s眬yN9掄奥鏡暴Q蚺 3R躂2Pm⑴盉 珦nI2I#./| 欣禗軒*) Z塭 $嶮IL淚澽R&^A艖贂丩籦嘸V馣 *霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬P )v K盬b璚|*ⅦAT歵m%:窓厞)Z鍍)甾`鷥"'y/ X€渽暓 =暇K肒?'鎇敕嗇()Z湆牤J咢猓1)q 9啺梔愞vvv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盪鹍栯Z :渆$詗#:j>蒖梓 ,JJ1跐硄%茲T臝w慄&"++绣qXr!:/爐]f-FEi歭搬v鏸挐哺螞涘-9篸d-N^樐R莘扺b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b剴褄a庫$i#'檃襛gb9P頇槹8y3S6y獇zfub$q蜖怕胛^$篁闳襧3 匰]Yg沦6髹:;X膒€爔f猄察a廳Z祐鹛q+.UR毂臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]乚匬7^;$!鍨~髢%袼C棇l裢c_{陇譴;凸d輤臄q缾T +絨R 衿槓袛xcL導枭 跒]p$JFA粡P瓻怳N@碔pL乭%膻G虼md5+\ǜ颲撤X袯嗍H瑡Yj竂[A糝霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vq拉V*U9$Q詠翡€d瞽晨]侊橯K蛈熖紹NE貫鵻>l諜檋:鳠檦&%釀$6瀌7*k痮鼱%琳H晣9\牤ゴ C譤堤L盩1祼V閸+$]匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*鞀$$ G(/菒怕蓪>y髲戠焰i堷Ezf#瞐鵾绌l&鬵o偞F玀R@閆攝"x岮Hp歷樼儺@H騧m篹琄棪*.臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\pU牃I递n="歋Jo椻舗6\旟阄緎焀竊璛壽7xt髾%/#色Lw 翅 逼髓-H娐b 义萪肀c2]3墒噇%vX嘼]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姳齨wXf9 !嗑s箉,^狚9p淅 90缌kx9k灴Y 搵Y*E9l(*瑫H€0盫鬉绿"8醠耣0册]琛"Z萛笇 珧荂K1a欲2层I額\遥喲R2搽蚴妢aF資.)+雭蓁纃毶U秀奪\)-郈盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b獽戂 &澥絭茣6砿c#伹甇€斢0t糕鋘s"/-髲 澈沎徒巈G^_轌f鉻情虂`W汋塘€檷O嶾 敠赈y溴瞓+c銶[|"颙L掶T0迻禨8_蓕yom&纥姎T婊47K諣昫AC墨 妒愞I喇庐臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b玁鵜謷O1h0甓€T魈9 瀨徨i鬹傃 O\哜槢6咚?緶雓3Us榸秅 $"偔涓X┸'!疳酻;栔Nji擭({夸嚋眙薎栦頪02/<报e蘛f(6勳w蘶-鈬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bT恃珤禫懚U嵈66c辢蚣Z祷+€^沠~ %族訔f虼%射>3y 翧硼萪轈{糖卛L譭门粨 虞4漟J4o餁硨盼嶡S 嵅-累x霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姼婖LlrMfI>垫4樬IH癀r鴆鈗岄z沀櫍亸唃&Iq渴>M沕竃m^%<€5緣蜱梒襪$0娉$鴭睬巶r+J;筺銜&`叀7甁谀w]伇孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*銑 *奭乗EFC況S嶩q1齝A{8$镐8瀛澉8#q摱釔<逽通ha嗃@曀e吉j拶+nSu4睼倌 0荃'塚!)卪#q22]=穸X叇 e栖bY檅岝4馕a>M5H鋽|4鹗Iur妠潔攙,瑮W0c^d5瓬€(敺t媦M邿v鳲S戔qNp歨_櫀I)洵3#骆2囫9!&Q3倏:黕%匿8M"詀c臜?#羅 '夏 /嗬馓鈽吤0霷霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姯擴OW會b荎笩橿>鶙伫W蜑k桍1聐Of9フ螧忐鋼0喨Wrh 摋% $劦|葘罦冴磲ェ#'聲P臱m%T拳1BE硴婹|4棵擫l虼 O2XP)|颿m②买胀7C 慹Uu`%P歞X qWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b 48雕n|皃秴&NF桨辽墍)/檤璂RQB{仚X硱鈊涅濰秆%AT镯泋藢:襥淇>\栌愹孭炠^\#斀宿b分 @芎W鐨湊. 競o9臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vv6>芁s蜑j僃厵鹚衤躨审餂|閣P}倂⊥酛H%鉛慮詷51 !陒梶H桥A5y29伛Rv蘠\M&枡2T謋筂Epq6頪(迿觵r娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀i匛2*蠵2L[,柌撣$'孲 *啶焌2`^q騶讗猍 吧[硷\>嶪3{咫隞z塋揾*攂(pυ鏄J鞌 !檳4葤韧掶g@7吐背 .I緰觮醮D敤(眄敀3e仝症W+.6G堽c隸闞p;S1fwtY驗'楴苠$灖#n)蔝濽雴豿ォn徝#9+f2攗Ν,f:试尼&9K<电獽y暜f 茚.9K写锾=.銻CS甗錍%綼陡-摱$)痒S嗃AWS嵎D)羗,輩]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬N*雠^[遄盒蝒李婉婀濠4蕍跳*Wn碯止瞆曺m梹%N&筽 Tw:鏊Zjd捈烒堰*櫎E ,*剨茨;m樄<榷遀啗_3qW羸&矒 P蛗币);;尅僰阐郩类b*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀qPqE;簶澱 BJ5/A狟"俰椕!媿oK媺5犔y:\ 巛Ym EsRu9f馃9Y絞樢;件墡︽#n慥枌(q""桗飶rD蔵#L銱璻q憂嶣枟琸"Mr|E磂,驤傖慥2+撯rc敵 ;+tOr釕9饭娴r釗db礍晒@洷Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀Z(48狹鎉:;)!=/佪撳镂*Cck侼lq敿=噶闄2 D紞s *ぴl%Fw甔‵)Zr%-償;, 掭![哵H纔&~焬s蘀F赎臄JW怛谖B8鮢&X殳o俖P;f磰`U舓恇衏Z ;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼%浩嶢朏t(v嘚墷穙辠橌. 槽玫]V鏫瀯扻鎖,c']~Z+=薯9rSE祧:|vh1Jf綬 F*k,釽`f霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]LUi\6沊葂 B晷Nq<梕t扭璻L臉蜂婽奪V,L<牦识躿鋪g7捈鲮Mz鉲%=凰鷇P"-~晵腧dW鸳Xb-^橳軫y€5!?喂奭>I噾jWOq1y:<购湨蕷寖孾&浮z 盵X囟 6$跺橢綣%癐jPW&蠈&衚瞃膊v蓚蘢 桞B癙焲.V√€昚t轱:釸2R橳怾€!賖U梳7"*V暩僂笶Z岻<仴2f?椶j烵闸烘Jυ4=(/,&膀L認 ^ 蒬銯c橆奧瘄瓔`∝U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬+盫埪鳀]U 嶭O叕罗;鶃鵲籓l6隌3g=很樲k穁>%ql鄟Oi騙鎙7"瀶胘烓儧J驷薕D豆K啝姊xɑHd爱2<笁Z$]匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬Dd U篴]扺Sv*礈i({珮醊r顀痦)鎊x幪5淡舁9煁 y-Ms┸骎i $6聇铛o丝薘H汗9嚐Q碂a洞庂q€蚅p賈斒lc綣阝廒霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀k従蹐绤n竚暊顃豦R專|暥 %/渌9淲 绸歡栱膦(78-甋F饥:\ w鶇鍳蛋wM╮M&-鵅I(%珍抁╗9.n 雾丩婭\.閬 ad]眅脑祅 蘄j匿鞮>娍|(鶰■蓚鋍染麜豀賎vXС攸灀阜gs2a躢/j亁]怖靊珤lv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬`WS 鏉怴檻奣腕挎菚P焽6豦瞋;k14wrD璍蛯挔勂*絪*%*覬d. S`)]稰r矀0€噀乗rj賠E0懛l▍E诜諊(vl撬恀六-'j囉轖誣S9壧倞幜p取豒孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬癛 i哤%R旿89d&CT眰蚩5 =沑:侹儞 汷佳';f'嫑/O'狔/驫鞾m1砢e=烱"#D纻a髤藁1Rlk磜?/Y)\锐DC彃Ot蚩搈魳詤綴ㄍ泩戾馇'們l譀s儏pB院/k!v茊栶!孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫庁涗Q"嚫`T 墣褃菧<課倇Q'臖)敀瓴I笳33苿湪含捹d1 比 R^h r.<庪i J86? d@ 1XN[鋀醋"p7,悕玓巧㎎鍋膛"hBJ筦v豠驰4J4`vL許&聴b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]*讶赩, B轊o"藻%恱g熂:Fw敉$椞讝5.T嶓e篟僲3"R∟賐P詎YYJ关`+k扖珤WV楿售*甖珣T4+IA葦{橸i烙)淧碳濇k!%F`□煋5讝捃<€朡5硦偗\娄4娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼c_T傌犆狁ef 稒v髅覒ifБ[咂R閥摋苩襭燮<貔[=婮階汱y乽髲 吃4 僝鏊矝 0涁|夰湕乤;罏;r'╗]2噲哹錐H59 v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫婸)朖4歲;e犤偪詁砠R2!屔茰╁^{9挡b :帣扒ΗSyC轢^甔酽[罫mLy 輂P瘉蘺e {櫑C"卙3U烸Gw3,&銬羗猦=r.N)v*鄈-廿孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盪叿葼9 FIPar洲襲Tzm斎红虞箫櫟 d繒佾儒D含揓]|瑮Y9,X霅%%xZ a m0襔臯懡qぎ幺B謏d侤Z湝頁\#,騀.foUj蓘祚Cw践#J+B觸!踑喬$;e幬!S c盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v WS 碬$敺P-訒ㄙlE忶︽迃>a Yl葏'y風kkC"Y硢Cj箸襞9蝔C!JI:&2*蚀?L漐[搧 譬P霩閵u 颅瘭l?liW8药舞hA菻1W岛彉 $醗^孥v傅墹? \紫C+^椺T婧Pkㄊ 汗 C睯霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬﹢媀笇,i)奿耘.*=T槕 R$鬅<~X羣唟QYQ櫢篑l\槟74 *o#2竚﹂榶#驠M.怽0魇e翑嚦hm嫡0礬鎏L樃\坒歹\湤渷2WW+&沍缃2潥I鍡S_鄈亹v K盬aWW[盞盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼豒孬盬b]姼歞diZ瓺I-湵 94蕼diiNI€d<"阆!墹僞鬂稐g`誊zgZ傫?7\j産剮 媸98彩JE※b颶怭堳j氬%1捋溥藍m5Gs锯箒揚y9P莑;u孮Ek728€TQ( 髇L渀的e柷吅`M:槬孬€(梑]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀vvv*霼孬盫廙餤 G 涠4+憄3住7悲3N9A.6B 实gNYMEr瞉L驔Y痋)I矶谣\Af衙j磳m.8赩衿夜F6;耖,+鋲意扞:lr瑀蓦?棜C 跈h鏞箋&媑鮴窼l發飌Gd蕯洛v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀H迪.FQ(n;S&%L丣礝,69揍恕;eo筠囮贅蠋g@顥寉婫['P{鎛2敄H€躥dJZ镐箰*韁姟坩8` 禔LUEN!<*A0*齓C(怋s錗p趈0礿篺U~Zy製 Aa霘毂皣璠込岪(L+虐qWaV盋xヘWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶P羝[擁礨蕝 缇_アX妹<蠃ese姮+]唋a ]t1 r鸌f寣1拟!贽NY婪ONG0蜞摀)Q吁X.4.5忧NM懄漵B湢m冷D奿p藗$錁 狻 毊B占毣v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫哣.屹誑4柗 Y閫5橰W猭恑鑎Wv#銣嫡寰lOaC3;hn闶\[计颮空?H 闄6譒簧邥 f菿%(冓4+坶0垜|syIo)>E孿竻L乶p+矮盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼J怙覴i"KD骟咸]|Eh谑d牦Kg圌W 鋞Qu庨,2㈥鎤[+i*疼a`翄'S:0獶`K(S8硧qo- 闂鵢K2\秋枃/7{4憂熹ut]鏆矵á7w孭T疟孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬* 蹻褳凷 JX>郭uo{ 薰 媐餩薿┫6銗K舥8荆9吇fdù聄#6%--乒2珜鄊慤&N[郬#9^Qe鈖*鍚7聁 玧',(t挩l瑒5 F 樵n3QC,1.4算4V檯+"~aΛl夜L罏$3k Z+蛿,L蔢穵簶%v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b0ㄈ萙,^]L)*7塸瑢.嶫q鍘辻嫦蕥k読鉥辠|5珒-<濫?P訛尨A釞C0揑翨織|駕牥Eo€m&h忉{暱3斓+~疰.M!瓫耜硔k璁c5蛅髒1 !i#T賤輕焊8掠绑V穑壖抅娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b∝ヘWb]姼湁 !⑿鱓I 梒@1;5O ?骔鏁8埙6粢捷~L=痽荘栅,Mc痮 兮腸土炿鋴璱膽!約)㈡b=徥煏秡`Yd_迧Yyom Je2暦 羠籰]7b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bVH葦]1]虌mo+2N&no螫 酹?禃氩d.$i峳㈦rKu暔銜E舏続叺矢o;vh郪哎疍捎'm稈蝠$e√ <╁&Iab; ;LX崌X媬檖29醩外(v)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姼銳胳0乹,筮"9~!Ffb葠_&~e5l5夅W圅嫦鯧窊吚︳4蛣dㄩ M2鸍_!<贝aO偣Rd z郩;dU禴bQ剄怶*2y 塻^B1[釙武纉:,鄧剥Uym.M1'{W宸溛$&:s $關岁 0 侃*輖Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*觮履锤擡硵捸堰c€Mi.4+mA Hⅶ綿闵M3莖$髲湟郾#纅}漬L;嘉昶鱃殌2佭6|[8&;)MЦ巂YzT湯.蘺炑9賘憘/34鵳饤i5咮(拢綼Jh.+KylC睄鵦QT榷v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姾WWWb潝(╅嚸鈐朖ca箦をVa308儔=EⅡn暀棙$f勸 租5\^9Z庐臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼4 嵀7L4 DB- 氫喫桐[fq猡萍娩[-N&>#82巧$&)螎鶏yπ@yS尼鹆G圕腰爹/+p[(,L骫柀Cn楪Tr趛葧恗淡>. d咚獲烒玚兏庐臷pR竎埔靘]娀u1<曍诤樬E5傊潔60谟哎孬盬b]娀v*霼孬盬b]娀v*霼孬墻5峨抂up-v)q葢j0p J箦丁尋R981g6梚qu#|!妛取孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀h酇h婝b茤楿q€葊撽轙本R$魉釔$w瘇O$牡  亮2髰S葪.詬圫謾& G KSP4笈$h閼 `惿|岿03籐c擪=咼zN嶚T醎榬繺ㄥ贆賧毱鞟巈╉\ㄣ!樔T9张U24萂P" xケ.臸姷\(q'5S7j瓍兜飥矈鞁7aWb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼:槴盞盬`礿W汚4吹{鍗D㊣p =鹫扁ぎ筇6闗L€乩枆M刱煖0贀)陃9 2萖基y_I:鎏翆w4,鱳o呻擆垒崚滆枟簺< 楡墇G椏'邑筦0绋8蒰趏,靲 ;$矑錑n'A樹筈 'Ll颌 mS2樆v*霼孬盬]盪爡鳬茆Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲湐鋁L鞎jz攙贝嶦]nY由1茧垄2d騨G"2:錯脭襓&錗.IZ燩齆@袱沪-乑.臷1UE8X璫S夿柰07;妋挦益<$ln8祯O*:b--巽冘lt e;HCt%鍬R卺-鈼b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\qV擲okz猱1V锡1U/M玕UT u臸娀v*霼孬*7瓵\缿禢%!婋2S2&O<沅郇.n頳覸'6樺/+簷n砳 nD@n鶒$旿"Y-錝-L抅&吶) \'|! 弼rJ玭7霊!+G樀;<Z 祿諂箛8顕Wy乌L湫翜 MyZ働逾箤 夜(2唗搖蘡b瓚C\.=+x Wd曍Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼粤J霼腤*磀毭{鄁8-4喓睅錔H,岄貛躇]>#0螮派動&'V?RQL蠁. 饢﹜;P迂0>-<$%癹wZk霅#乒Y€唆o蚼F曵蘨鴼f欸鏓慞稤筇ybr#6i鱊魵3%B銻 翦&%癲 鷃"檭m郖盞珎债C#N0x乮羴$ u伞张]奭娀v*霼孬盬b]娀v*]乚\ 誴Z穃6]匽姶pR 暍p媄(阹<犔(藍 @0{0捘庩繕m"F<3/扏翠a:乡E簰禿2,\N6瑍i7c?勧圗箍辉7nF奢-&歄抲 F瀫脬嚻x 8%fv èФ﹫d1-'蜚N予cM芺ORKl0怸E綔v鈶奻澒*#氖滱崶*abJ褾"陟U孬盬bX鳑硷a鍒>眤w臹5﹌q[9絷A臹酩+ˊ1殻1Tf*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZcA%u*=V徨惂桖缥VRZKD鷿2簂圾^.軪V噉\c59Z蒳#S 俉SSwU驭*赈Z 嶐%s倐&€萮2蘱gJ裡级oLwvX爄铪^烟v+塅Z登2:宕煦鼃0肠缆d霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀u1Wb]娀v*霼孬盬dJ祽猄C蜩蕶[<皴炡鞊N@媛K瀛o#J嬚SS\貱&镠db323Hm+S暃4雺 ЬB晍=p帄H*渕\怴挿豰 g蓇访(_py屒擯壯+"黒籪$爣緔6{]>谘b蹛}3 pW押uuY糵汄蘶 r葠啈玕姱Wd曍U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼瑇慚酜G 踴i+嗛H6%5淍'循мDRO埶哛詔釒k?栔Z4 匄 妀硝V剹佀{e5禍T胾 闢甎abv踩菼瑠Jf熬52;W.悫浃肑蠖¨ 硜鈘_忔~淁譿n4\噳蕆i儈=N太L巣 誗(:P5%斬~`樽CyT擮OM働欰甕w(?,8Kp螎嶶qU5饰*e廒戰 盯0p测嫡媚摧q鈀j格%横釼筪x绽祇&嘽J阠J霼豒孬+饱v4曉罦阠J阠庐4H东啈n4额XV豫&嚹,( 0赱{ \惱座劍L挬#2a傏帴婈剂d虂 2)﹡s躚UBq鵩Tt4滱a跅湳o釙厈棇!P喿P) 渰&歡妣迷厐=Y勰Y螕!營<哻;`;?.齑 #1e柮x粕m羲x?篍_愄s&夈L亾1艶頃7L<+nu1M\EqA穩胠x`f霼孬盬b7Sz1厨b瘍!<踸u;決+賙稴娂頚i=X氵}8琦寶輮i铱!M黴W *:b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b(uqK盫€茚KM銗,IR朸# Z* #虀lkY$枫袾TKㄍ曮龇5尿)嵑層%rNB輁洫v葤野婁Jm猄")v(n浮a8瞮qU-i x亰DW硥(7B;)ngd-衑;P蓓煐^]俦Z撑 灔go棰甛登憁奥*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZ臨mwO俴yU捈哶o溈4迹V<鈱兯33ixv璱2攷^贊巈)A笭3:%Z$L讥璐萊恦茣]dz酻臰跗债樬嶧8韰 冦 (膠b崝J,S/[康x9 俐98>嶞襟礞エ跜4闟у飿Y W糃pT`舼 s\E1*"CUZ晻Zゅj2A]揥b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZ萊[! *銆r6d丒- k|1!Jha艆A蓧(恄yL$N^3善8C(&阧LuU蜖郺愤捄:咅3柷P6ヽ1淦?她B戮-O" 襙B蜓?8xB,|拴Yt舿`徉婑'6刀芐OA?包铦)鯁f4阃愰6Uな顼儧M\湝;繙m翣V?龀.w姙Y淑#俌 z宅$O!8 ˊ$_!戰鼨x嬇蘂/0py'峸>黿呢 #壘X)唔a 敜卓漹埴A哶!伿X蕖r哕'鄦>!H.4u洠坃\逝=Z2R27z棞qae杝鈙_騈T@ 渋椬z仱*P麑ㄊ撀蔿?#瘶啓敮<萣秅 ̄P関隱槂>@阣撻綨蝇毎臠邒j眩饫W)憅r蟝岡莀濳恞#)%唁菿湘嵹nnkS懛]朘bi伮栯爪E媕0+N2%BMo;+mq64臮bANg貐;b錚59`rA穥2Fwe;涧@俞硛 臝甠毂Gd&靊=x廪=)+1v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬U聞aK骭柇礙_F`璿v9n蔬8y 谄B3c奍x啱%剿-v甽1IP!3/*7~8偄釋:8U 鋰犻啎U┷%h拉鋗i"59:E9 )!猙,诈 奓4]n鉏竅堓7蘺Ei鬐銰=畛q4r|AG巏瞔猜烜YS欓榬-#W(bl+x一$]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* *霼亍廿鬲 p笛\0mY8€瓬箟X蕆Md 胐Wi纀柀絧R簶)\W!E-p痋渓"偳磯)鶃杚p劜禬c鈲E|蓪厑€c殢5呯RW2翗啓b=▇E诙;葐~XK军櫤偪WFo2x鞔頲鳠栚`!|r鼀銂礝 俖/數X>詃}9 H)璷睨2'#饬|9(仟]勒9)釖:6^披m鳒墧SE0凅 .潺9 娑鷕蓽I渣柙棯.S酁"笄P肮+鈪泱螿}0~X 孂鐌5球舼`?<憅O?雀?*Q&卷帱眂銋'H鍔<`み灪楙翔蓗XEY?:57(诲 #I5 {翦8~a_縮麽郶$躲谭s1s#{r9@M噈V騗剮x吗晉lu X'xrFGZm2逳(黏幋謓 ZOx2d歸湓鞳+ 1xd懼嶑J踏v厳8'f黿%諔i邥6tO橚)oK#瞅醐阿膰龍劮G:;H撿_n E榳t臶ou1Wb]@杉楥﹨臸奭姯朥塊耿幐蟇都s棬臦槴盬WH|/ィ\總b8玞v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b8∶&漲J意榅9'b,€17kMef仪劐R.$妝游W\殂 &x褃蒴睳O維n扴R個讄鉕u哺狇繸窴Q臦01!hj郋,8Y8b嗰祃ch^E# 碦縉46J0V4 s1挠=颛朾氼~-.t m顉6  "!兮膍惻斔羦P仱B P;,胻绹b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲dXWHa緍蛲锭*<憇*33秄鵢+尸殞EU7闆Kd计7c? G* s(J誢$}2鄤妊/奞 儘O\*x胜栻さ 彀vM[7葧w瓼S 珌 )!S谭~^b鯮虥3Q`_P﨣y廉tq>粶聹P k鯐U搖o 聰B9MF買bu绬皤vvvv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀Y,k 睈=纯m蓂5p ︱帥/蹍N$p ./4塚嗰善t訿朚鵜`遝e3Y腞蹚靟108奯?浔怮搸 豿$$鼑='戼袕蕯;﨏]鰳aG鍔御x}a圀,T騄簖鶑媛?挆凖購媛?%o邩#蚺X~F^燋p鸣白鵥嚞,W徣[亏鹆萯2/醛R儜f4o$:湉?/呻u鸤N繓|@,+樣$m碿瓝8/魣 秷虍貐FG墭2-"=锐3QEE泋ヘWb]娀v*霼孬盬b]姼b璚zb8滌;淯圌敷CL蝌3I";-v|靳9)u[長.猓V鼈狗詺=Nc':(╊qW刂W q圈?~*瘖簼馰'q鑩r鯫馱玼酴赺U隷柨柅?)^6狇飱紦S眥 谮AFCC姧織瀔o,陸%j绒g廮觍笁>爱'⒏獼鼙V馱b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀V廞乑~&%NB錃dh$讠OCB犲R摤7巠厶R蚮,津抅^I铙In$焒j*%罃愹 \デ a籦S,韟+]筨'.晣"PW  )l2XG汭8n0}R萛詏桬籴幭s蜃椼A灊(Lg;橙t韖凴羯,7\)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀q臫侠jq 溼N 愺O9y*{犀蹹€騀贊 )撱齱蔤潗氭飘蹚櫷9貰Qk\ エ苰誾e馰剾r饤bU賂;)*ベ`*齑+`蚺W妒萒4嶴B1 皇zd"]擵茰U/3O捼谮'珪|辽zm曠{S0bQ帐樆p喇庐臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀u0!月醋喲骂^奵lx]TE_>qx牙腸萍!蹻q丑4&k&浍O僶LU膐\U糢孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬壟Z阷*请婽奭╦+d\<厂檡浲qY枣浥锆睭'j錎杭6個*%2+f悳RJ搵0QHqejr, Y姟6簶8P鋩K.kA⒋.K嶢{d纍z邞q("箃C妨迈Z8昘P仏噆乗!推{m吔NΩY撩;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬壟\q臯瞁$ mB蜍6浃} R 驴1(>yc惖I<~u蛦钌蠖垮+寻甿$$&[2"U 褣3 睧.錯-**阣;&獙+j<2J賔鹋Tu纫-鳧 :渷 VF祣G;!滪K蟽O簞戗輘$P??6窏UvTxHZˉ雟趷錸崂隠聰i榮+晼-猱臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* 霼孬盬`WSvI]娀v*霼孬盋盬b梎W`u1Wb]娀v*霼孬盬b]娀v*霼孬盬bR齋_惨2轏报衽^ 91o队€敐)躑'?2礯0JZY!龗qV,覚;|G*<冰s猭臵]> 1W?髮耳z-螤翭4Rtj*鷶\狝 V觪|菧P思巩Cm/飇0 绪锸 :乌U`'5髞W甸咨ˊ6裉I&qr+bW!挠ov*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b臸奭娀v* 霼豒孬盬b]娀v*霼孬盬b]娀v*霼鐭>睺Hj**漐讬汆歓履妎娂樨揝O|峰+韣P妒M{杏}鵦8$テ竵斝奲洵7藀-緹^槳z6猸z嬙殀馰=鎋>榫_R鱎N缹U7阴H礙t欢 ㄅQ槴?(%烦X[鰮|ae儡F骭讑攫謒濄ㄙM*<1V91kl廹ケ*鵒虨b棺n嶅觬悡*晵6+LtM"]f韒悗LG\U?潕楄j穲 R臹B%饨*踭*嘏]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼亍孬盞盬b$~#%鷿蚺 12N$驀桛ay,+9I.&P颀^9k\U さ并]|錵FVZ 亱XR郓娵T蓝ch\E/筴96茩F贱醤孴怿ヴ棭4蓘鏐C騷膠侸)Je;x徒盟篠垠/-坰疋,X祚苽\獿Rv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲襭ゲ*) w蚙j 佢斔裎掟徧O A蹑e悵:6W蟌螜鮗nf3Jo"In斏Z[頨:f貄4珌瓾*讯IV颟U马匱躣 UlSk暼!Q.突蜿sQC(蜱炴盉5)?.鱖U2€0e幏W蟄簮a1*エr4舠妼 8昡乚娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* 赇m]\m]喺豰]匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼噡d22i騁/赨b>t臺>p蜾魱 P骿醆U#SCS娋淶詔粵4皯甀|U糈爩AE玹薷猀疧袗蓕(帥飱緒湞XC陂\d嶤|冁賺T臮"U)乕臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]乚娀 v*霼豍霼孬盬bJ靑]啎孬碍穈K盬b]娀v*霼孬盬b]娀v*霼孬盬b玗V絨W髸?曇9嘴!(溆1W输P袏f煐{o)j堰-Db們鐘钧鸭遡uā1€82跨&繇#潟榗0Γ鹋_0y芋gX4嶕墜Dk@|1V鼋剽瑑藒E5 n麾qW慦~^銄+(鏐G|U(4鴔W线髷^B}v豭+鮱*(h聡棱潯躩'5凇I臹a8莧u蔓R鈈z'cLU羟?-礋-偏gB<KZ1W邕鎳敟蝾4L糲錋姲頣豣_虓Nkd眊e塛幪F孬笎蠕硹&L/+_kn#盢d歜癄- 餕漖^>噅獐v 磈驭欤ddp(狏臰é*楇鶵j杛Y* U蚪稂 槬 ?n,+鈗W簓騭G騬,p#濥0MqW$b?*帞_姢衏,コ帴qW擓c揌觧-Z袓縙*鯷 *谄5袯€* U娀uqC盞盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b,KcC盝湱M艪等咇岾efNI铙o?y瞷F圗哌 K瓬轊鍻2轡1揹>*欃譮潉匲湧,|05挶WlX挮O* 霰lTc8郻栯態鷃b挡A恜煄0啠O嶼樑>蚱恥) -v(铞克$[Ch蕤藿芞疵灂cj怐睜鳪Lc孮吷 酜盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b玕W 瓡C偔=怖T0O蘝.踈Y匟]/ ǔ|轾佸D嗧伐G唌1鋀瀥汵-""箼娗E+L殊J洨S\J組w埔觾%*肐hu艎JE[聒4ǔ 燃廫 刐哣猁9 "◣壴#壭忌u1^^(1} 鵠珂]%~硆r顂]鳐隤I Tp謇鑣_(2専T幵施 鳸孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bZa^槴x_!ㄛ 鹵鴸臺紎\┶剬Uf*茸骿莤 CLU鯊?)4.臓D咥MVqI狏臰XIN蛔B唠簔n錢1*蛲O/K凑"# #q.z祹 +qlC#D侳8珚択]盪鬲襞W 杜]娀v*.玿;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*鈏+韁X #oJ &G檡L>嵒(璻抅fL浖熗z_4Ee吅黉c7!鋽騤尞E辽; 橻奐雰夕,mIA猈l,┚m酼-廊:#-7\ 嫮NL"1N羲r蕼jNX矄7珇]鵨a%觠e€9格铛 T8(犓(鞆D犐記﹨地Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b+珚┖1躠 挡飘€H+柲<塍捎陾謯 e馊@K3?.5{{xBw2荫_0h轵Q攦L賶猑鈯+&$PFLN挋00@*顇R誶% T 撙[v(rA]蛩WJ樗U8^N`橳艿&1#mo秃,l( 靤 p囆轋皜谇厅 S1★?潿uILP7臠8 蚋犠*/SQ\ * *霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*oK踺&=V蝃IED奧锱_~vyyGY{H攬峓锱^q娋淾[+ヒD}taQ姱U 芭T..槴蜄碇Q0bX指?ε9&X枝/炫^榻}盫馱b 髋Z|Uv*霼孬v(p臗盞盬b]\P赆W`K盬b]娀v*霼孬盬b]娀v*霼孬盬PV砈 P7w 瑮y(<鸰螗糂U櫠ˉ2抅v\呪15')%咒萴幥A-+%譐e|h9幑 q"裓X阱lPC樷)罇扰 磓HZqf搷-9窣Zs蚶!u晧殧r窤燍W勺慮B炜淅w0幛槁胀Gl;7(﹃kL[纎v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬*霼腤$玓0蹜営h-CN婅Rdc朏T兽鶟涿s﹪返猶俨?4緆.乽 靵1⒍eFHI.熞j┨樕*?抯 K蛂薐 敦U Uk苳dUj姭腃6偟r8澏V囐,Tc挍(FAG*! Wi擩(n肦 悊 槼欎6碬rWo脭7C锜藷8跭j鎇#W固9AF醇Y慸岒1蘒谓 Hs焽lV片w泉vv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*窨K坈琦€|/}h謘郊冣CC姠4MN]69鄏2詮 獐衞蕂;[k贘H魬C|Uo澘8t/F羏G橝鴎娋Z湇矿{k>PQ蒒*瘾軳纟馆H7U}啅u8幰3#{_宸}霾.>#}]?藳/(讠胶E 伖臲v*霼孬盬b8珋臷1WSS媙pZ Y$y7\mㄉ/梊6糍9Xq*坳1粈道$槅96郲ヘR.╫'b]娀v*霼孬盬b]娀v*霼vjj2Jri傏e$揯 蕤]%菧蒙|s鯀Nx觩RK疄M瀃猨3+rA噬u2 悂*.搴桒衜€1vk糕梂l(]莬B暦縢槾囜‰妟'`7 P捿0播RP赢X(ah鲿掸哯棊W7査Y獻 Z絅L>薜﹂!( ;圕dxe9q姠-伡Y;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]匳功悥遈窖沁/勀R馃<_]-账2G3!0椡呵枻矊椿汌特Kdブ靤2%[旘<哱 %郸+WFw泉1@#T'Z`Uも刳狧懿`獱J甇塒P﹎)SC扷i邜肏A4F\爠U宐'綽N邢<$Km*&W痩聰 G+骳N{8# 軟o筵0﹝\Sル+'B3莿n劼=敂*L偦 Wb]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲呿歖芺擴H臺 蜙I逋D萜靃a娂tGe綫<玨%灆/殲釜E穤赐sz茕~AEo$枯ヽqW﹡^~Dj~he搹鷲鉀}8o孙萞#1B 李)娊R4(U孬盬b]娀v*信mkJ\, 繞j刅鑔n\y 烃{刀t;鋗艝P5熖 f勅<2劁)鼥哬1 N櫁1)xO榺.檥,H" ,JFhゥ 2c$24銠q洫腢敦d‐o儏*覵X愹%彟E+D s9`U9/2v春j丄!iu*輗处8_鸳袍鐦賟漼o:v 1㈡!淤.? g2<ぇ冱3x乄簓O-j賔E|sx橽捠:茢)*粊烙(怋鑳(渼I礣藧霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*<+:遳m*3蟑騄鉙%褂r)A飱枱髮Ii沏V /| } j薉孍eE沚動 v*霼孬墻*痴0ザpr$盳d熔%'光:2j9)%詜贫爾用 f鉪逝u_倘QMk愨qe晠y擉jP%dx媺,墙刜y鸓檲鮋雰壟瀥wび貉樊 q鳗$OL襯*銎7g4sGL-笔^呬O8K咸灆+vX{敿捧籸筦摳6]湐7嶽n|J娽 脥p玌8X蹍qP輕2恶K盬b]娀v*霼k- 淀懙 眸稴) 吀鬄'蜔楤臰迎N']1y72nn>\吅欑梴冈d,\讞\甆L(d`沝 竖7浓暐MN U淑$7J幞qZdJ踃耘Z ZM甁,檞80璯i陶幵'覢螋纷K 焻驺蜂纤h`澨"1鄩z濆;;9盕廀`tpG?娸W,\q€0N.臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼挠v*誵T稵雁俊棤薱*f/?私>K瑰湔巊c焭_:kz?栳,悐卌诅橯楰(劧B濎烨2W,E€'-*寑.K*bR裯g|_鑼 裐d偞Tg夤+T8洃6珰R26珫泍 )曁Z sB8r媩づWZ阺槭L`T錜欎復絉仆-釻&|鷉$爄熺;笋.L律 C裮芘針r"懙甯蔵 ;焊诨 v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盪遭狹o4 Pov*霼孬盪)濫窺n咶a b钝`J暷戢Q-S楰{錮覆v界 媃YR K,k榳(S暼竃熽>o还4qNP梋軁fP歪傑s+}I8餥)団羗fJ巍zclmo!MVHB罟+g娨鮇媀,€ot&冰}鍷揱翤鍠k 凡閃7埶枚;L &N b嗰K盞盬b]娀v*霼孬F槺+累 労筪RW叭夊蛍PZI 膊\ 檭堑1O}OR沞D荷 v^,鼪#n 筜.<)!\ 6祰樬骪応l{ch"淩槩诃0Z\Mq-0[&廉(o7" R$㊣P*2L谩B鄵衋 v B怠 d輸q棾鵦蓯B鹜絟H9貭^昪 浣NZv樴櫔S&鎴$图R霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姾暲]匷8赑篗肌櫺缹癏孂妊%斚絡I豧P壬螫浖=挮垔冺汱s Q檲鴶屚劮Ub~ 虂J匫L%YS|瓵*N(v蘨*崛d*躣d璘Cl6≦\mW刅槏誨l袴A衩聡79Y姸%斵(始绘紽+╥r湿sx】.|$簐购犷sx愼.雙苣尾嚒,搁J 獪臽簶)]乚匽匽娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼j7*鸼瓊脢穵v*赈媕腑粬+kZAHY.蠢`稉:K vyT}9 &V/H敻~@y瀠瓂惧#槡xd p鍣堔y嗩yK<宬傑c鱮=Abk旽竬r趭趥jq糆郑扁]隁S牭Jo傃mV--| ゲC奡$ )I 宝L赝;5I- 1鷽W,豤嘶蔹碑r傒y`.Kzge扮壓蚺傻h隡騦1M7;v*霼耘.臸娀v*,亃庹)R[}ㄅ 鴾 寽<)婢h髆$8﹂^*%謊舔o]垢嶃鮅湪梍6%汗葳筜.搏适晵优j 儴熔W#県婖普损羝灶旱菩阞8o鉀p颅磿扫 890蘀 Gu 7м_靴橸姃<2@7銋愼*yb7硩2趙懩DUP,l10"鎴修I.臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b姯*I雎穎n*H噵~]過C禥J锒l1eW亂啡氟t2汼68鎚Xd辈拰#甽1-Em(I-▅2挃@ 嶒猂 Rい儕沚玒伵Z獷茕猥櫣'柣S#Hm[埀l亰窇cj對QC!製糯棛$W甊`鯫&~gi鷇4v4璑鶏酑奂基儳^CB壨A茊h "倢 >鵈R)p< !频臸娀 v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*臫0穦Us1-\雿庉0[X風皵攳耶膴喽hi礨}△%仛G▂嫫褗籲0q8由LG^婴n!廀qe敿鱗骴 躖,B骛K^$#n驍'琒 p鍚7.h3+鉆:d$Zdms 弴骾峼鈵ME1M,0%里姇ed璦]睝4擬螸+穤'暭oo`.譕7奸zl#岋L草)鞛频霋B6-d#5,晛,\O(l{猱(%廿孬盬雠Z,(%Ibz`冻&3褐*磉"K厳&8髈濎鍛V6;尙梇!j垰鍲Rhr杭 ^(k郚d粈蕢k稒j(r m撣[乕(k4Mp%矔aE船诼歓Ic稬$擀L^ 2濊>]夯擣a9*o0'yR 翤)伺圶z唻`袲#a八@w逼uJ d軕TQL[o$梑]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀q髀-蒦j韁暐妅7魎m河3q魏ンo?/甼u<6 R(3a'毤i4蹐?{0+頇q全抧躪L擟矵.J誦k& 级畅\P銾' 甝矮g CY R鞎歶 ykL塀%n窲PP))畷痎[輈 ;鎏崑鐿 1吡腣1rc騅踭o3i鷩/獿3 p*$娒挼FSLW┊C盫穵v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶酽鬲0跖W|#rw5扤爊r$凳a/焆秵2钹S礈%詜椐锱N@YG{ 旨藾S鲮r6銣=€g抐p 浊禍媒#拐鈊,|k懛yw鎾&戼8-9<谞и8蹚,妶犩ST. i2h踋:`J襭%i8 亾\%绽跺8  寴B攽筵, 版9#壆X/薿3綰朲 w90])祺-'Q嗐霫,嫴4较簩R睝{b7=馎\qbV,W`f霼咋EmI阷[Y+滼觼2qg<筇~l亽TI℅伻q8彩;?zY♀攮r禾箇婺樛4佡庂p'4羉U^D詼窼暕詄d疮+郿WN臶 孶 旲羯 !e呚詀獸W蓘"笩XV!杉2窤搃>]箶罗夬埳€驺砌o)鵪暌﹛槎X ^L庵!4 淅r釒zd茑竊d)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b1*迪!A+$隽h[%逝岗X址遒gHQ祍&W?攚鷠€欇j[鎡2 d駶SM桱慥R7跳IP/3洇曁去\倊雪蒜'LJZ峢r勃鋪怳孎*$扖YR鞓(iN懈曘嘎厬Q庁蹆t8*蠻>秾(#+0`榠驔'HkL菧鮛丝-+@Y#7/'B?谔臹帖 R$Do焞孜毘踜臄爭B箮b卻若取~;v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼 q~眜嶋t从泴娖A.瞴眐呶=22褬逘{L.<dZ逨癌飷%臑@茂o嵮r6釱(K$.$9 q%(Cf鄸=餥I迅菎S諶bJ蕆喽睻t閸帝\﹤覯)Ι 崖暓A搉-pL mr2%; 楨(<舧ra!$dC洒`r瘿逹熤j涿 l鱛蔬1羥岰.~)媧綅葯旑"U<珌*b拓8P庠舖iq亸浬L塳斠-w[偳彣ぴ鍪,<蠃媏-Z焞](y 龊穜陕1飷 YBE<韁.L€栦N+A嵈q[@8)鍔i -4栺;WcJ8) 壽 !+曑bb塼,6€劸V簷鞷G溔穡$剨洵藢/$腋- 囑 i懊躡膮2茊竄IK.趸{z嘸 鋗茤JbZ擎U降煌蔴Rd噤^k/蚘飻QWn橯摨灓见U%課> ¢禦K,臓k K巊j偧Bh<踗-J銎胤萪贷d€KY*K睺梕r4ベ47LT杋麦"8迺y[0j`嫇爝M@眮.#鉣眗"6_衊n K妌0%赎G$瑨`媄庠f堑2瓝刟Z錐N緔^c鎜釺郚 K厯#睡荚稱糰溴d狐撦'Y龁VK)"!L鍶L讳 n篡; V' 踑i 2J阛V朗B-杏,淡Ws 聦漣搊FXi "y%枩憅錦 驥桠妎A+\蓪漏糀s"3 XE2蠷顃%鈻R隃挾窾xZzv猘5纫,怞闁68P<丅錽 *筜 Z諌=颍S$褆5孎8㏑k榞W畒k骭Q cQ粗熭橋€C"<蟥贐覈1鍖!棹R謈笉QLも ?'y陔Rr'旽cb檄D缛靤Q*裆 吪h)慐4暲書U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼甔SM\U爌ゼv*霼孬盬b+y4歗E嫬娀v*霵霷霼甌舏馨襥i挊i4$鄔"菶E當w~O厽涍(麽醘 伡 T糨~駢1%W~g./邇c淫蜢LJ絴q醟郿最5 朓2佦# (-甐譓猸8b〖 v**霼孬盬b8牎d峽鄎%眉洽A*O!]鴵鴈2u耿4_脿湉胧d瓴莡4閿[0嗻郬 P嘏 盋x珘肑2]臜$淠T6r|,25(竔0V囍~*w$"銰d^[[t&矩x\堚 铀^D矓$gol p崵y*8铅9!+l娪D ^!:8b":蕩0擲r"喢&CJ8UaA4嚃U*0闶i6豹-巽p魇蓂'惣客紿擡 . 驐氷辤构禃掚鐢襐艻U\I([x竘h9 蕵q(菳郎胆 跖P&(Si8歜歕粖鈪繵 S 玿∝珌肒KKv罥ラ}l€钉雴泟瓟3倃捎A濝w识忧咣&洀z錵 @蓘1b 蚕O娷HR筦笎幐@o圲&仂*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬*霼膩古\)訿Wcj, 0朒I,+蟐WK10+恷3&K良玟K艠*趤Q釞褲ャ顏{mu"J%M 稇;毪."&%NTq钕tO"]xj>Y*sa嬌辁朢6X€勖& ^L氉K傑7錾€鍳.€0€WE@樣g `7-1犅俆剙a &H韃}聪#旨遜揌~1塽硾蓇5I)t嶸 撨#n$媾烔Y#n嫘嚯^ p% v9Z <``,mI另0V*撟$g4"晬c\ %J乭)b拍aU$柅$O錔o :BOみ忯冕":sH;翦u6 熷蔘{`燅|2陛C:戍箞^ H< aH美阛噥>BN耺蜇炼墟負禟伡cTHH敲n誈%鑢< 6敱j渷P#啼)ち抆a5*佝筡|vIiz歕42U&芽 VC奅+/J洰[﹤曊茠*霼孬珚-廿孬C ‘2+'垿E巧y7鍺傊篖+Z计擼.l{'づ韵l 0P!侣澽8Y屮厊0鸩i蹗=駼+胟€0孍j嵪禮M DB灝 6%<蛹漲v#`+朌9X蟶幅Ux嶿輍FO吽帨塔M柭#,Mk.sl唐l洕 4奨閱軕scm犛h8嶐轄沨=vii河lX,y攃MG(i5碛#n4!巏緓兑2趣佱戔p濯05-‵鋏-淵闑<鏫浙簮 璼壸滰J泺妨m2 ほ'R豥 iW*Z榫u58-iiq朲i疗 ZX娓 S"蒦)旹乐B阴5)4 V搮- €X65l[8鐵LE糲T[臮郌>褎o敭/dR>,悑搹NK<擓iwk9欸R鑐/W裻ceδ涓]a痴"跦峖羴8猠娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b\EqW *霼鬲F*aT疷"紽I 6善Iyw#- gHc^鵻+<座 bW犟跆圢殷輄:9忖€u惕I,l@峙 撂ㄉ+裐A螞J覟焅h剩,W-嘎曖 弗cH0!W喨襐\!)姫n琺Z普葁$甴剻!釓覑|!抜緂汱摐@x2邧?-&6N C蟒檱8=F湉巟R+Jf!+G裯"鯀X霐)狱鉧吧ZeF 汣r撉 F@ 陃纫V鍌暥`絧玚v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bゝ犜夠Py婢燻癇;禱鏔6瓠b恙v 议鉗A杸1啛V9e6宎o鎨ㄇ悷 *7洴?攄c釁h<雧'#LN0宊蘿Q:F跨鬭awT鹤宨|0腰握琸F4厦 噬訵宨贮淘廌_篾1 фNa翔茥仸韵/ G孂R?畹? /媦颮?畹?$xU蒖x标穕这2T秨J锜2T -税珚i碅Jf鍗' l脺ix[硼鉑骂^腸^鳶,坓2菩 $2甐C焨蕡i!7:~犚庪O讜0亵垮井o鞾盒錯藻 41|.ЬTb喥mSov*霼琗穵ZcLUj絅d:E阷40咛 '霘d 霑雛朋菦<ㄚXI G,ず櫯#奱藻d:鵈襀q!1j!葴i癱t6罾吤ME.n8昞6N _O  2TA揦~O-L狤~y0堘 揗鼦禘R冷竅_^谫1抜銝.V<4-慈帑5绅笴28€5罬駦*Smo%lX挵癸bdB媇X潌I伿栟y⒅赊暺躽ecz=澔馟8),#Ux藞笢. 驏瘇a輏V #n(虼d$Z%2 1躪_9骼艩2(^1b輕!il'姽*懈絊61b佶0*+错,!N4352冷(=钬e佁^擓d議冏&=S@幵FMvhf.6硔%阅昮$飱S!~Z搦孰衼Y#m娊庾睨甒k狲b鼰掘|0icb8f逘S}%8崇鎨 `褗纠臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀p 娾]娀v*霼犂歜*輜h0=0+墻S穚V绝U鋜蓚;*扡漀X%Ia綽皷襫`諉dG#'咘抿玁KeJ磿赴9 q%尣 36η5e梚轉眽i葎6d6瀆D:r#P€ 9%v J皮Y墩#l) 嵠(u6舖i 奰`d︻0次awzē伻掆O(c:讟&礪羧q8r珁怫7`H"徭)乯辪紤"(r玴x;岼K擇`冻% I鲳衐芬T j&誧晣\嵉愛啻蹬- kZ猱&譢R擐 係%W )i搎p襥|d礽 #卍拻(2`9P苅dQ椳嵅T銰f[蜈善Y駆d1棲yw芍贾j瞏9伛杮ц馵蓘!5o頁(AEp厂F林 益艙擯SuEio|9Y瓾2X9>氜b聡 _x6yv谶薞揍G"頸1W;b3驡市隯T蔻俁2F孬笄蘘[i窂mB^*(9,|舉CDiE~霼9op$弖8*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姶EqV鶟鶆|梐%讧≒Wx?x鼶7育橚T蜭绥峞4柎艄帲U遱娀 v*禓J:猱嚠*等E鴯*<嚣イh尦'?qW抷據r 1傻協砝琿?5︼`?淆 VS }@aX侂S)^靛徧]7%瑘Y 媏)奬霌Z%憍皑9 i)贰弁C K<脘H癴疤ㄤぜ/蘜E簬i埖*匠(eW欇樽q蛰@9tr獟4W2D⒄菒虂4環(\槡ThW嵘q%糾.羓璪梎4旁聡S$桗a喘,q祃8趇r評繯K璎7厹8n筜)x粯}+O E&7檕 'u裉ycV鍙;虝躅豲苠瑰锾{8K纊剁1r釩音8i膊⑤)蘏帎拳u{I稁P賅 R岻T;di蠤暓|罦 `$嘼v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬OHc瀊搮斍2C荤_袒蟁6_i媌ノ^厣 ∷脳綯R此償 琛Zd扟斒乐J栝-v)僧丌j襞mXLGl j!# ㎎叡BG%{馄1+w8V袶,愐苭6猐L ジ洑倍豣玌q刀渙嵀.6浦輱∝诨$\zdJ┻+,V)t4输1+m R(!脺_Q.銶蹶3a藻矐綽候,i v)v*霼孬盬b]娀i卶bB暾&賿j1hv閷襮N:qA啒渉厐|睺藺PGL,腤ɡ赅d頧蟶45?%劜R撧*璛禍 漥谲唁"K,詯j^u睵%PFVd嵯;忘渔颮2!燁9'y┉軱V车>y'錔婊9c!l劋阆%4噟8桮0[&鵲Lm-鉲h酼盬`K嗀ウ\籦(单l 酻阉佬寭!^移峕咺葞4B顴o磒觩臋辁5由楝e浊,颓噁錩(K2$=騎錑 4.d纑慐b嬾@:sc瘪*rDix4劓胗 道u]l穯鱏傄俫[a\R垎E+U<噹(T*稧憃褰5郙+翕囃 _e.k$l逨*3胇@颸U 瘈l'娍<6銔5w N猢O邈赚 褹W栾梔3Y芹M+*鈏娀q4臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*飽*駉u忯 翋T颃cJ碛z奎^}鉌]扺bZ蘧增炉O-=崨|m鎜6辻俢5鉹蓿 ゑ[)硘8%礇0J閵·奌H霦0也O(~`阇W檈睋€凷?特<擐 [擮寭 疊>/祤%5k]睞[d 'iXaNA溶a博M邧璷=C2讟B髈9i `!玏符Y/箫,瑢k粋|鰂lfU遐晝[\磃69)髫L窱*3兌LI-d頁摆 稬捄榠]L41u0+禢 J1疮F[憗閺岽+傾B敁S(N@!*尙 F( X攎窚/ L犪e^Z v>育r硤+贮┆軧镜迈( 疺屑拮-歵5(\菛0%萈:=芻歙礶}!LW郈盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀i鷄 G万p皽鹒Hv8面;\-.|\舝郳〞'%^檟.lH膃喙atr2v却喽⒋=rǜ89B磓玼羒E-磘胕B螆1匆支L歸M*巡Mt椿 V趇z3钙覬恶P飩覭.鉌8趇t h14阶ZR(J退lmir3ckJ牅6淬崵aO 睼b存缼€录嶣 0淸[喎T跏K0鷩蜱R?A=Fc芍dL€潾槻uRW授潑v*誵Cu臸奭娀uqEj#痿履舧m8谝阘eM癦,k稬m*2适F鳽e"嚉#$3~x捬,斉u34H)飼蔔L<鉥簋牚%r籷Nb悯?9_芴9紼2$碖1If綒vb蛺2q銭 8胰WJ鋈q4枤S2-l0"藆6媂S) (]LP穵臸乗p2h U莑 筂qA^d樬芵&,釳∕2NT"墕.W態~寭}暹'X籇蚵氰虛a牒旍Q%桪; x2[]2+e!2(bPceJu6埉艣盪捵痭Q殜>m螗彆韃觊嚶+@EqW?熩柀睌隊=蟮5鴵N邓壟^鴦ㄨzb棓蜙~^窓碨5*鶝螓P罪Y%ZE馺聲咚 (邰跔Y€姵`)姤~h~e藊F孬髼削隩懴夶x錦bO2兀n ⒖v*$穪`Ab1U岐+姤:彊ll輇欁4孶3V(鐰R1ULU孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬 U孬趴&/\*鳶{掐o逮9矮盬b]姞u郏ic4泠淯)u漞頧7qVan譻姉4炉?##l移-B鮦绋a\*鲩鼤に□h€*W綾渽鼞嘕忯晠IsR豦€◇;)Rk赜U髰緃汳越bD+}h}栒in X鑋J-VA晾e魃僆磸\蜾7|i5?憡u6>運_K%)CBgG([xN璙)k~!I虉 磰]&廨L枌乵 p=N\$卩勪羀j澆a-嶛v薆慯5h 飬]LQM8 ii u嗜J漫 r4Y7A%i$t灩`(o覵'hm6韵^QVd; 噘("€dHB吷?畛J鴈F \狋銘丽'(2勥I罪mfFy 菛"疷騱鎉E-;湢*隹(hk3] 拙cd膡暃Z~`i`f ^檳酙&裫蠰罳狽寘N嵃=2&$-.0R觿奙Zo娀v*霼孬癦 v*霼孬盬b]娀Z鏻!恆v窤縧巽墊擎y这魉DK:d*袨鵣DP2捊+.%{ 縇9bAH蕜. 崋.KQ媃(K :!瑺銌V韾(取憐沇鮽+B葝/剡+ ke2殤. 墘i '#kp v普 腠傄姶(冥倥6擻が -獴J7\ j谗舖疩質fVq添筇埻-R+顾膾邋菆8挗2┄胘3穸AP崻痞 V€羓豛暳pZ笇X柋C+盬`Wb]厠瞛暧U錎*[`Γ*!S[ N鄀R姵>跰X闷O8臻z7F释豦S舑蝨_蟏*韼躪鈙XIVYi鶏狕┛鵆)8U7嬏v.贾TY芔祄"哬|亗)鬙舶葮 羴閻Cx+﹤暎禗劧 ra庐臸娀v*グ1C V€┧祣Y0濝鋪к|2.澌梋"H9鶬aB6@9I鍜 +螣 NL7;&L#隔2a4#5聜泣p4筋j)(儜b磰掍0瞐M)3匾ic>4奿gU韨枟齝桝啎cHGc+b銜i"枦_|i 8[2\Wl*紤%E滝艁+3d乵乭+gn樭\g嵩W, \% KY+Y噬ak熵B鼛鵜*$玵|仕 蜏yN粉 ê鞉};瑠€(齓L滾聁P\B膏b;(觮罈b梑[珚跡盵Z(雮貦┑覂Bp[ .Wj9R1诼紜晵鉑0Io0琡;悀湉L1峉骹蒜P勪Iqg晝6*x雀撊聈J;$/|嵏矚 嵃[巉!^ 4NV簷 Sl`V僚*9 甁覯霊Wb唸聳笇 单I6紼0③-(σP#H1kc嘎 -`Iě 9偓v驨y?禯1綯夯!",葎鵲v$掸褨€鎐冇<诲m槼濖"蚻璟!BrT鏎##r庐庐臷苽釜6玀 峺潡y忔熺5彇m^(4旎zU馹灴1u/4;]JZ"j臱鍘5浍 \穩*鷎3灝≌ㄈ(A臺R亻沿 €qb億U擞璹V馱bX_妤鸞枳(:4L1W-帻魺讑涧(9*鱛蝟蠇o-,朧菙U5攵*剔j鹤{-RH痐qT稯觛繑Cn歭+娋渪鼭阂=V鏵S]鹋WS*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬蜰;q臺 b痑淰斒鮋肱_y猱臸娀v*霼孬TU辙槳B捛稆煽蚄{4{7瑧5b瘶濌呕濕W/.]J躅輛崈}ဠU糢孬盬b]娀X鏇S狾n瞝>鞎襒讟<鹤Rr%;x 葐Zgo/錰1欻碜夐扶fLs<六{┵翷眖3#惈剐娣#愄24R樝l窱W+@2|Ih+ 瞦4雿u飴③韨肇-.6; 娀v*霵]胔ui匳nNy厛"b曡9jDV囵褽鹫 瓳 ゞ<駛903敎aSka`孷g朦曲'Vie绺")櫕O硎 朩b訑妥躯r硤!闅'鏂暽Lz箅樻4?3t*2┝S玙:i迎VJ&SH5(┴0TH鋥藡浩9>m笜3".癊Q6чQ騇*梹瑄爉瞐)蔒v蓜.:嶑E7*S%(R椽慦 丛戱4野飬禙\捯腵N4擝,i\瞩茣A 茣V+TA*cJ噋X:cHSh8舀啶筧q-P!p5捁)亖*拉0[(蒫:竫檘)檆疋`d9怦期陶玪X*螋Y,80yv釓赖9 bf崈勺掺L-2檉騷鬗 袑ǜ3撦t+;篙=U2俓 朠倷Qq婌q臯葬M6+ 猱臵$馄阡qEù郼m"涊N c 5鑑鸐懚硵総皩麿C懚迃御I傏b5o:[H吐C縻mG1bz蠘諸⑷輡r瞈96.v賶鶱F贜b嚪iY蛂$此)W碖)w鹍m3.F豵7乔狈q拉S祳q1k .羖 `馀v(qC娳o妋v谺鄙S 穳=0R[昫 蕵鸩m!wS7)緳逅━鳹竔蛦 +y>踱~q徎-蛶洗,1 t弆碋8C-返TQ八╟d脮獸|LB黋v*霼膚臯攘T硉獐厄蘯ef噍8歜瘝鎨峼釱洤<檳A.但乵h紲戻獐?$跨SJT空墔To笈_A舘Q覀槳礹7電紱髙螈耸慂q€琜騩|8痹橵B: UR,$MU孬4裦宮娍;顛f鯊肱S_/y︺D%lUG_譭枝7,L驮WlUKE裯u媴闯^R纠b#跨⒁c]CSB&a;婟8;x#禥 @(芭U盬LU孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b湞攙泯_釆臹8)隉讑倔臸娀v*霼孬伄*毙S[,陼琊€+S娂筵缶 "郁 #揣∨_kず澝菸艥虸8/薧]怪n絆lU鼢戔蜣 ,9x猬v*霼孬盬b]姼娾獼鋗(9鏥^T鍠&?- z洆0葪旟rY惈 项倘/$/务黔ZfLf琭鉒{Z黆.J隲v9't蒢U叹趺j賴'hQ簅卪)啎琔孬矮盬aWaD!篴WR%r袾/抦镀旸张 *皬覲N狦21闫E喋44Y 酬缞eD*嚖堠])E+AJ亼1Bc鏒咵瑌3羵}g吆瓺羒樿_溕`}膻}虺z欩V熯+.铱3V鏁姍I茤Km驿怶邮"勨跴(~曧0あ镇K筗)pli輗kvv簷 ↘鄅H鹚廨嶁煒S慹s翩Hw8绥=%#-禶 耞ms(*d,f沝乪抹暞"6銌涯詮\6钉@擹6F觤斿傊执m噿喼匝hr踓膴I)嵂颻^%縓6糐o01碘S+嵂絩:ch鈕隭-x歬硲%M-杨2$2\f瓸趯汚\嵉⑧3妰L劋葇匆硐#募iA22\L ;曙[嵃3N-( w熭%>颤渁O熭晵脥;秉ML? `r'?&1Ze>瞅墖K)瞷k6垈Z 恃y穈WS 祳穃U⑧b臅#'% %やJ5颫禙谖DⅢ蝛 ~ N$菠邫J濬贜F/﹡bs'鱴-<仄厏戯傏O6?7橠畘`秲撏-6;cmG'洐 涼噬q3k鎴)熔"釯羖I.GóB蠻旜熔Y C暓 磒ィ奦搳]娀桽"敦盶(道S7Zd愱譴!Zh2蔰7CH裘M駣6肕 斪坝7茮銔撻梠+膤ZW 9橊=3F6‐ 9砿+C暛k杸#4 m蘡Ul背吀荾眆彘&閬.臸娀kz鸼瘽??;ぱ,罻5RA臺#隯逦1富r顊淯攗k噩A鈋jW}郭7%e燴莡?d#7臹虋眬([< 棓€)8:>-^荗q,贷Jw臺鶕谭z趺\]任 *夠t涋G)ヤ*S+娍B/覮勢硓狓猬衽[臱囨晱謙K歶X~p蕖I漍P?QSCS姴+y:魈W+碙Q堒 U鰃澉鋗煐碇骓I70>;b牠+姶蔥ˇ*簺Sv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬趴'W鴅瘏1W+蔱踱馱b]姼锒*佯臶矶*42H@Q娋m}0緭⑸K4o 盬:苇.1笜捘拁gFy_首~`筙-敋慮盬掃抭y}铄(qW"W`1V馱b]娀v*霼孬h銾)綱+搾VMn%霔敳讛r褢6羥蕀*y濬CR3+D凵鵮D8垲似@&!睻eF 蛶AL樰)nR,T阱 沇&&紥莾澧I[bHCds^Y4幑愝p%莬)iF捀a+yZpU躓& 4)u雲T歒2*氛| ú蛇 "U竟袹啶8讴閻醔袑鸥纀獽 `U6敷濅 q=2┪燍—B@VY芔斬~o}睉鹗硩骳Tx訙嬿2片鏚几機却S++壹$燔潂駩%kㄆ笋隘(慿t嵭徔*酖 ~=4川孒#L]蕵]餜\HK6菱囍犯寕yW禯 矂闷g蜮F偍遶[9 P:钏8 赗 鱝鈒B楝 *5~XxP匉渻鯫輶鉕$瞺9\ぃ L砜,茨齼儔N@氎i%嶥}繏靊 q鈑隋泆 4H讐谱猥-:c膹]-J銵姟x j3 墊r籭 4 5哹017$u閸┦涗衩mg8P決E0&MG8I/貅1FZ弢M'8c鬡幐8歂p斶y驪Q硨M'0cW緗陨?熔Y;<]紸m6釡#熖6詒诂线乤PT趿mjV|灼筧 傌.鋀a鍻\ K亨(\`P6纫E[/Lオ章Cu聠壜柋KDb\p簷8aB頒%KNr*P濸Mp13q莂癱礝X魉i葐"墕'!hw肗\1鸌蚋懇挠鍐湣埥>L礹%=rTE鑦~U秶*7*s便dp佗咾呂:E7窊 *霼孬盬b]姾奖W蟔髳繏ku=9?x€烩瘞/,こ惻0 儕t蹌紑襀虵*7 螵-~4IQS嵊{敺崖兢7臺4蜝}Qひ穿?x*瘖綱烤烚c4某1'锱S'"魈稩ol剛;b'?%-紵 \軤(qW璖廚槴c*曳cK忌g跬>x:桞1W鐕鏌棢D葜暕黴UO丝薑7]"绹 裨v臺j~SZ鵑`1W **霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娂[w蹚*鳶{伏^*v*霼孬盬b3J栮e暔|垸稆鸲堏v溊 挧q娋M究烚Ssp泡簱姴#~^遹苪逊 噇U鰃錡渫棖-扞T<崔U闎5 6鬲釆 b]娀v*霼孬盬`*讶儏]JcJ輕诃)SZ鋪U峫泎澍揾;襠!鉙_6沜Z清枱 R姶鎏憺搇]渰宇e.ts赹Q鎜熔[S#3"9U苿歞|曺镒2#慠h馽2Eu脭.d叄|)n%o$nI\0寱mr祏r)n暳j穾H**e€獶q59+U2鴅獶*TJdiZ 倰轋愌l*夜xP╆寈UI=<* 銉乁C*羧+嶄嬾q鹫z^躭D帐%峣絳哬遫|伷ㄛ=j0I唢J漍~rjvi脫=;摃淎S/}J*匌9Y曢?髵髀伃霅養砞篾{滗#+8 2?驧顐0+書@e6>e7,>筜膾粄烶mJ4諻/ +應Eヲ0MQ$kC頄[x 弪}冹bO沨蘐:>>"|u<崸鱆}谼賹鑩鼉糄H>k{E2q2' 狐袙1碿#挠-II.85滻J羁9疂J埄^0:拹輣h^稝G訌O鍶W/無﹃>年掶掓M掏鬣冻谳笼尔餥Y微鷶险 k9攲8b瘲缍{y R2U:E受Z笲CM伵^[齂Nt5F(0w豣腹栧坛1wn臲у镥ff珓  鸆}爹e鵚c錕E+蘐T懜8Rvd R獅鴅﹐樇薵燵5蛙J#|閧9:苍]#} 犽掇c硯  *@臹g渙?w^郻?椫^X禭bE.觸U榖LU糢孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀x伏滹 U穰*/o鵏T糢鳀*霼孬盬b^#B魮剽瘔祶RMJ孱e5.I臩咚&繗o盅dH誋-虁H臺s~\yKB騷毩i,X魬w?~*虵礲 4睇毗釜岘 颈鼘_電稓艙"菭谍x2涀v*霼孬盬b]娀vE]扸!]L 霼硳WS 匿 奦I ?善e6抝^M觧涯盬樳.嶣 ]鼰%肤偷M隙fBe/惭.!V螰菠憵伎P旬=F)7軳^&0鯄>;m2!+gDCl顿.pJ誏*銙 釖U$猯r挅梶乁CZdUh搦0玔|Sh芞參1姰  U帘し+Eq!蹻WQq鱣4璸饱u)*愆S斒!VG匳碻銵B稜(銗 茨z審獵q4=G丵嬫{踑H灆\犇-r慜濼bN 8鉸O窥姈[ty亙 n?线1=唑淄7簽尿哹r珃lD博;頂繵6抅A-韻捕%鹌幽E防ckm疗种 釃墬p厊1釭]/ ^"驻隈z+噳x嫿%鹆k腫0Z-逇鴄捣zk釐纗ckn<1捣p谮臃l嵄%郊1刀1篡1刀稹獪(穟霊) B]匳宝N)v<佰H陊j2/)准酴[B25噬q参键现杂?+%9 2旦:威~VKD n捡狫),礬瑮Y ]'橆リ-菛B唊殇阸稉數闔z6謗暚I雮豿吺噶h.dO 2鹆k腬#\"擀1碘p# m儶pZ碵%m, o枂%⒇-;銳Z 繓E A罆U6聴 Ux艐x釁\鏼盤8@M6rT"皟 淅r 着b艁糌桌9p扑紮録o飫s泪i2T鍳z迊鵼帮挧"8.觸筰j燜敠X a80€錌T &抁n旈夿]俺"咆U孬盬b]娀v*鈎+姷飱: N买F韸;渻鼦}"o疿'钰琱+W€盓N 8電☉娊蚨o:_V@憪X1徔}虽"蠃^誱鞵)V8&b蔷*槴罂焞集l,Z+娋)倔e用刋知b/Ti s峋*^dF雦顷醻 奲@n槴*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姼歜^-96G鴡*鳻亰睡<躽/SMZ誄:mC娊}跨35癫勰~镩姶?3|赁/铭b∥ELU唪9轥杊閵罘╙-夹Fㄝ?*鷁/3?K虴&"囡瓦:繖礽.U鈥碜`寘i^鹻﹎蹟.绒*H齒/麮薒唑1慨*啉嘠?聃7鼘o電根嘠柀夸c\U拁\k鷦瀉盬箷斕* ?^*嬱惻Wb]娀v*霼孬盬b]娀v*霼"%R薐PWdSP 9虪淠捓|射朹J(T見?& ."曕丢;樚測鐨熷霪b  M)5迚uzn9tf< /%lq桒F^$$lMOl糎%违徝墣HXU箠鋗掕h W&葍 瓟囬!P瀑隥! 駟]埲劗g,)3U 普 崶糦;v*挢U张]匷$幕"嘼偞X钝e€*鐯n筎漏'B瑬FS 蘑,佮O邩 橄蓕>岽HI裉 骲蛗悎瓻.臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bU孬矮盪7雼L抅r縒恵er.+曼鶯6岷o晽Y敋y詭_"\ :晽D簳蕥]"媈副+攵,Z)uqWWkv*)h猱 祴'b;V,, 贝7LU躴CaqE访邓瘐忏 觼\ 鎍 6;f倮啗J容h7Qk9 儺J浧"嫹衝頞J洎葞2纱"呷溄*洎虇=逈狔NhV/R郗FH6冱:dhX慜d樗馌汼$+$揿U孬盬b]娀v*霼孬盬b]娀v*霼-僶Ier牞倳"瘑;?(.集}%煩謯;獐$zU檦X\y?PY猁5|1W蘅楟{大]奬鄹f8*fc姲?蘯蚆?6& "|M鶕鶝}鏇21X猧C澲8臟櫯_E﨟>躙┆FV啝}cV鶯B+u 6臩,U孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼鬲譲b湊碁鰿 h欸e蹐痩U馱/Y; 9苦*辜摥囮s罍Uh騐秤阺罍U巧Z9苦*坐/Y9苦*镳^,sU5蚯搖q|湱%_r}囨t絿裳Z膶\繟o娋-熒,>1鴰麿*J只偻qU苦絞€8羫宵蓖qU虽峞裤蝍拟偟燍c淊猬擈缟诖:龜糙蕡矀IS娍D5E U~*霼孬盬b]娀v* 霼孬盬b]+矮盫榃u0*袩>9+TK踱h杏朳襒7,%匝BH2駱%>c鼉緰c"J)L9B笺R鼣造萆&O愃銛%庍yQ癘Q檟蕯*陪a_l竐T "HT偞裆 枑Zゲbl棿4痋癕TV3\癐UTq;洵U怕ㄩ倳鱝罦稖*貗o6崼U WR岗,秐普篴CXU豒孬矑嘾P 鞓U2廓se乚j齬2 $茯裺\槯>U穔綼;fB傶駽H+犈饲5賕E嬙誼€<38uo$]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]\P霷禇%:<醧頃梍/0殍/2碴硦+嚘雈讲册I纄EdR8≤盋珔]\U张]娀v*霷霼孬礚V軱SkH"J6都a碵摆6吜蔼 zb愐荿竔*餚:寪 X\!挦肉i蛰瑷rT銰 *跥腹堖voS;"蒈Da鬭醨q`輹檫杦FD&爘瞈.`訓q^K捦L lpgy璚5rB.Lpn@v捎1玴4雲碋p飬7奭娀v*霼孬盬b]娀v*霼孬盬b]姼猬s无R刁%沍軤m+鉒U饤骁鍈讚镔J枀蒼@l+娂zт擎烃N糉檵[簒獐た0?!47I巤Rk堦澰樑_7筴嫻晱C姤:v=鼈P韧盃*鷵;佑=[V諈Dl7b愠圕 馯W臸姼b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫矾*袬N*KP)P0記釁Q&B祵. 2ヘY-CQ姸u-鈬b]娀v*霼孬盬b]娀v*霼孬盬b8S評臱W鎜-|拽 玏" 馱吝F蛤刁玛D!à猬X9 Qm$qGf#軠U7虔柈记t,m馱卓捒鐷/u$虪嵇馱氦m<1U|U孬嘙馱Wv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬`W`Wb# aWa礿窾k mR=棬64 &襅,齚7'[敄 畘P 襼$燇項寜y菣跨湿恐,糓<)~)2X钓€,狢颚_笣僼/U替,J"紣>$璳Z鴐T50讵:cj鏠MS AJW]\6矮睞[Z+筧V颌嘾U秤$`- 弓鵨乑M8*RO芃卹!ZK瓹3]愳嚦;Y浂光:u3]悺鮛-L卒R漞,\1 *霼孬盬bZn&€b╭ㄛ摯[鶵T)姱%oI[w鬣臯>`9孶畅[*銻欶翉*瓓 qU癄勔G qV啠nz8臵:暩赉p原廔*倏儻1姰芳庘緫錘磁U盬b,]姺亾盪)c-26鄂4~唪胜陁Cg€kp2觢ずI$kQ.綷之)k*妏$-|Y40眓窹v*簶≡臸LU瑨[W 搳)晹SB)+] 5f4| 娂喉L3+d锋j*g繯耳湂歛嗣徤恏轉7d跈*r?&m屣示q抐’銰3?.阹薉\剽eZ~巂氫腬榗L 讲m1m 潑v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姼婌qW梸s~T[y怖碕4`殎古_ y呈>^糼;*A4*堯棐/<蓆桍ㄅYㄌ;b'%lj扤%h嶑W娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* 霼孬盬cJ阠J*霼d|]0倳磳u蓂%B驞泛P "klwP绎湙c91憁婈?悮=驴氟3"9€V4E$C戗\3卆毾N畳?线.哷R玫赏kN懩卙熺銞,j鉑付$哇$2匤dX鈈:鍍 U5簠趭Ld祒a賎歔t(躳*1f愣X[&p|榃V5u0Lǐu全xvk9\+`4韤*N禸瘫Eh栯ㄝ+5竖{Q7屻凸$緛祱F€ 脩材獙臸娀v*霼孬盫3鶃┸i趌砙0F?p臺^~}鶘9帮泱臫胯`-颃釜嚣_緃侩姷+笸qV鍉*傀=琮X邿緂c__\U爝髲_檢讟嗉搻'}J€侎u臯芄H潡≧ U駨婵鏥砳↖ ご腷?夹qV乡櫹Y_跖V庶8?膻釜蜙u無獐r渓拯$雥'*1W意催**霼,[奦港a_橵薜姀蚩7Y>w蟠>嵤弆牶<&堩晽[1粓迿Iq邾0(h鈻蔼9$;(而醄j耘]LU95而舛88襐宝,偫)4%^WsvRW%沦ER6鎝 懢HE葞"渋綧援$291&8 %?(u;濫镐腬橀!涌&g0e氫竅茪L睬虍貰橳Ta醨编!愗y以誛嫆0斵覩庉x犐稧=#)抩硋)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬]*耧拖入6萶m衹f猬凃域桸騯竫v髋Y1c葈淯~*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盫>'玿诖TGUC裇餡臎C蓍俽*H汕%-盷G蜈 鎟-駲0mc奘h毘摉G5ョ>p幢糍fm dW瀔?棸i.M25b,醇h毃KwYH誮蚛 曌饴珦w*佣L*音+玕ēp9^1Wzd氫偖aL*墶9`TL(Bdd翹镾榮,S?+OSZ峼窔虈e}凒9o椠`R熸3Y/P嬱)b[p臶绹b]娀v*?2埤盼狂[~琔絊艶齡v沚鼢谀*0P1W'@麏猸泄k匡嚺]B瀹Z?碘hm躡.Zt>*跸萇虱C宻]F矬臺K猢o槷叺敭M>齒k蝫鉜籿j酴麾4q4 淯 埻1W~兗}淯场^ 蘥}8煣Mk,逯#鴅I犈]娀u1C盞盪琿`X邷!鮩傷9v缈趟>i蛱r椴 豮Yuy隃,ǜ挡鈘,W猈Z延 鄄huqM;+M`Wb],Zk庸獯u檥k蒬'zO鐤m济第z垹}靮o娠.,j>:箝姰?撧\韑?閵箍'鉄U玺b┚冧}+A┌凢[*\U孬盬b8—酔璴X縐乪弸 飼L8Z伋?8燲 6銟:l佹e暅:ee謉狟6鵌p% 乒譲l躾`dZRM2M斺rHu0ボrT蹿)顀.搉榠槀昘幡^H嶰|媊 p A烌~缮S`;懼ZC? ccOl7頛囹4a&瓅2T4耦f篛搈Jj7 `覩箻i^B訅 枰箌b)颓re6濼岸^1茿撪 SH,bQ@0饐栳圖,J: -/蕍)v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bU爇乕庐庐臵銌觡YI韱觠F+M磎#m) [A辤愃Q g龍8蕣盡{搔錊2F@=+o橅最贪e 筝S颍ZFn6鉄珥枌鵺M`褦*Gq錆I~詔蓪{/^屡J裘at雱C萪劼U,爎!0獖瘢|Y`榁镜 4甃H*澫鋜|JΚ飍€蓧n↗w蘨I嬟#雌M~+埴f!畉鑮0vfR嘼]娀v*霼孬<哧7昱_湚楙/黡o讑@怗;t-qW桴窐l$d~琔S麰g腣蠆甅v諈yb橃婆馮]ボw戵屧b▽U髸诳占篵C駍b谋阸W0鶑J蝾-姗'Ζ3啃qW絡髶瀂哋N阡2嵑電_+] .€v6斧4O4X(往姦聘珘鹋]娀v*銑屡i艍C]俉l寽l胓噡qZ紬駩?g1萿3嬋 N厘d:鞈*5甌C當 裷F歺 嫨飴6R>めm+K秦溟|2磹遟d1 w} 6宔Tiw#鰌觝腢b.\罡i癰)暱梘a鰓茩孍2打v1⒛)8\邧诔喧?琪a醘0朘_吣8FJ汧"唆+鶥%Md桗4k_M~釗醤奰枈冾薸糀Y zS$ t1eM .臸娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬Z vv6mZ佔Kg6甞樬礚簶D曑霌[Q{d鸍K埈蝽斂j p駮串锷Zs篢灞葨'獃O胬Z冿L糴f枼l溶-? 樖'^€S鱡* 謡2JBZ>Yh痊n(\继>尠dBP效AC'%.幝'觓鬰颇鄼瘯J2橫嬮渴=4莲@鳪鹛,噀}W3牤取孬盬b]娀v*霼圑io鮞MK楟27肱T牆鄒#旁姴1鶗瘉Av錯蛑垮e蛑稆Y綼}rOU颤套劔伍1W诳髲殱匹狕.]箇臹綧湷讒婚蹊A*鵾V痘 鷊珝ぴ >4臯4 .7u=I盬樁辤礡剆 +*婉Wb]娀u1E-# `iY鶛i阇!鉥 C8<Z嶥絬 z錎:Q0蘻#+醦% #鱠xZ%_裺稨涱菂癰E[hW娔膢瞈- om濠飊遶f0 ?蔩蚽~<,鲜悅+o鴄醡Y yN赜# h聵賧F霞# h聸G鍆%鋭[c;獙x\眳栣v 32T藺p匜鴌闟 *lSN臸奭娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]姾)]乚娀v*諩]奭乚倳豬[ 嘾曉庐*雌ФM6镴Pa釳¨盰6>觳3掃yzI\樠i蛩TZC▂&鎉钏d湛-5 獶_,U媉軎@V5blK嬺籗傹Y衹3C<″涩n@ 3gez'L艭盬b]娀v*霼孬盫y吭o諍95/鳘_忒T裻衷"矎鞪罣訆疥? Y7釜嵇輀?U唪)悍l&贻恾ク订奺宷}鵞 Jf錈徦={]%捍@智*馱諺Qяc娊唑箕q傊钶.5<堩銑絉O-<邅∨^8鴟紗鏙O 揰 U郋檏靟WAy鲧I" \\U鲗R A臰猱臸娀v*銑沧 -坹獶烐ut衊.<囹 c萙寳蘍F+!聹`煐鷼0)惂 ク/转 腷 乍.楉*涓[c&鰹X2 *渝噮竌 IOv4籴|V`u 3偤诏咼汧0 i癱 1α挥Yp. gM酜盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬+盬b]娀+++耙 v*霼孬盬bZ+\)hЬ6鼎Mˇ峑'苽曄鍏iD曪\x悳Gb#8=VJ去糚唇0襥発乕臸娀v*霼圑io鮞MK楟27肱S熕哮镓芿臺ブ咻'鮞獦WbZaQN槴㏎LUBk&魿|馮/鴖Nf'!迾=!D^8佱姱υ臱鐭4仫魶樹PH崹N*6淂>鯤F齲挳遅稇Mq娍E鼑xo4ém膳Y*霼孬盬b\qU 0j袈膭︾@/|嫃(O4渒捴)!-騎1T仑 繄鹋矝銑i躴Zn槮潑]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* 霼豒孬盬b]娀v*霼孬盬b]娀v*霼-Zb{cj剡 籲-\=0獿h1HC玈,f圓,J ]娀v*霼孬<哧7昱_湚楙/黡o讑?棢襁屗娍K篛鮃昱U1Wb]娀C掭-;元姎b+'巵夜a霰V>矿梌]箄傒$Vm霚U炀T祝譼彷d臩s姢辯淎HM)b4遾oP払k讑L}^!諡槴鬧萔Meu\U慴]娀v*霼挠Y*0瞉訿`B娄淀伂喡鈵挛洣)v*霼孬盬b]娀v*霼孬癦 v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬bJ++矮癛楿k皂-,岽跔缺v*霼孬盬bX囨p澶;zmW.]縙*泘_癕z蓮A2獐mj滓O寎扂盪_覸课1W~毜姶5獸姰:虐赉n Z趙翥pX雠U/睨劈聵岿萶,蓍汈2憃伥電紶1R 霧*左σ+(碷B@1=kLU'鵀那 x囩m暤涁XHo|g3ゑ$?!|.帆CzA儕绝%厁.*v*霼孬盬\U皂姾澅WS)月挫R阞]娀v*霼孬盬b]娀vvv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬v*霼孬盬b]姳/堂M"b適W姚實U;[-eY<] A髋Y`mA姺+s虩蛑孬垮ny據Zh~ny宼籰Uq)剌*?$25絆谲V聩獐,&,j膗臹S鵟辦胫蹬_膻Y佳鎥g壴!"b MBK2荞qd夰/橚栢v臱觚糇巇筺lqT绒E襟5役聦鳓孬頞蔩薍|礠旰娾疊 駌臰b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼弝螲沀眥h匥)~*>齄qoX瀏!j31镘猹W\!?y臵?'8鑅u削甥*嵇]s~髪髪谳>M~淯M点鳒U楟X=j~^肘几埅瘆馱远aX麃LUW妳=馰鏮蕔7蛁2軤RF蹳迪7桎g玕U姱筯M+鈗Vg鍙a譂z獐t騁鍉撳8耎嶵罾Wf\G輮穄閵v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]LU孬盬b]娀h;髋[臵+S**霼孬盬Sv*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v*霼孬盬b]娀v* endstream endobj 32 0 obj<> endobj 33 0 obj<> endobj 34 0 obj<> endobj 35 0 obj<> endobj 36 0 obj<> endobj 37 0 obj<> endobj 38 0 obj<> endobj 39 0 obj<> endobj 40 0 obj<> endobj 41 0 obj<> endobj 42 0 obj<> endobj 43 0 obj<> endobj 44 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 45 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 46 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 47 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 48 0 obj<>stream /GS1 gs BT /F8 1 Tf 9 0 0 9 49.6063 758.8912 Tm /Cs6 cs 0.15294 0.15294 0.15294 scn 0 Tc 0 Tw [(risk)-286.8(HPV)-286.5(genomes)-285.1(are)-282.2(commonly)-284.2(integrated)-292.6(into)-280.5(the)-288(host)-280.9(genome)]TJ 0 -1.3858 TD 0.0228 Tc [(in)-519.7(most)-525.6(progressive)-518.7(c)-2.1(ancer)-520.3(c)-2.1(as)]TJ 13.7575 0 TD 0.021 Tc [(es)-5.6(.)-523.2(C)-3.3(onv)-6(e)2.4(r)-5.6(s)0.7(e)-3.9(l)0.1(y,)-529.5(low-)-3(risk)-529.4(HP)-2.8(V)]TJ -13.7575 -1.3921 TD 0 Tc [(genomes)-322.9(are)-326.3(commonly)-328.3(identi)]TJ /F9 1 Tf 12.2898 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(ed)-323.8(extra-chromosomally)-327.9(in)-326.6(benign)]TJ -12.8189 -1.3858 TD [(and)-303.6(low-grade)-301.1(lesions,)-305.9(which)-299.9(are)-301.1(rarely)-306.3(found)-298.8(in)-301.4(tumors)-306.5(\()]TJ 0.85098 0.19216 0.2 scn 23.4079 0 TD (23)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj /F1 1 Tf 13.5 0 0 13.5 49.6063 671.8676 Tm 0.85098 0.19216 0.2 scn [(3)-298.9(Current)-303.5(status)-304.4(of)-300.2(HPV)-301.3(vaccines)]TJ 11.9999 0 0 11.9999 49.6063 646.866 Tm 0.15294 0.15294 0.15294 scn [(3.1)-301.1(Currently)-300.5(available)-306.9(prophylactic)]TJ 0 -1.0394 TD [(HPV)-298.2(vaccines)]TJ /F8 1 Tf 9 0 0 9 63.6094 609.392 Tm (Currently,)Tj /F9 1 Tf 4.5165 0 TD ()Tj /F8 1 Tf 0.5354 0 TD [(ve)-423.6(commercial)-431.9(HPV)-425.1(vaccines)-433.7(targeting)-430.5(high-risk)]TJ -6.6079 -1.3858 TD [(HPV)-362.1(types)-358.9(have)-356.4(been)-356.9(approved)-365.8(for)-356.8(prophylactic)-361.4(use.)-359.1(All)-356.3(licensed)]TJ 0 -1.3921 TD [(vaccines)-351.8(contain)-347.9(L1)-344.3(VLP.)-347.9(One)-351.2(of)-342.9(the)-344.7(primary)-350.3(distinctions)-352.6(among)]TJ 0 -1.3858 TD [(these)-301.7(authorized)-307.2(HPV)-299.1(vaccines)-307.7(is)-295.7(their)-306.5(level)-301.3(of)-298.8(valency.)]TJ 1.5559 -1.3921 TD (Cervarix)Tj /F13 1 Tf 7.4999 0 0 7.4999 94.4504 563.4141 Tm ()Tj /F8 1 Tf 9 0 0 9 104.4283 559.3889 Tm [(was)-481(licensed)-489.4(by)-484.5(the)-483.3(European)-486.4(Medicines)-488.9(Agency)]TJ -6.0913 -1.3858 TD [(\(EMA\))-417.8(in)-414.7(2007)-408.4(and)-417(by)-415.2(the)-414(U.S.)-414.2(Food)-416.7(and)-416.9(Drug)-410.9(Administration)]TJ 0 -1.3921 TD [(\(FDA\))-275.6(in)-269.9(2009.)-272.3(Cervarix)]TJ /F13 1 Tf 7.4999 0 0 7.4999 137.8204 538.4125 Tm ()Tj /F8 1 Tf 9 0 0 9 145.8708 534.3873 Tm [(is)-270.5(ef)58.2(fective)-269.3(in)-276.2(defending)-276.3(against)-268.7(HPV-16)]TJ -10.6961 -1.3858 TD [(and)-366.6(HPV-18,)-362.8(responsible)-367.9(for)-363.1(nearly)-368.6(70%)-364.4(of)-361.7(cervical)-365.6(cancers)-365.7(\()]TJ 0.85098 0.19216 0.2 scn 25.2661 0 TD (24)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj -26.2236 -1.3921 TD (Cervarix)Tj /F13 1 Tf 7.4999 0 0 7.4999 80.4472 513.4109 Tm ()Tj /F8 1 Tf 9 0 0 9 88.4409 509.3857 Tm [(is)-264.2(formulated)-268.3(in)-263.6(a)-262.2(proprietary)-263.5(AS04)-268.1(adjuvant)-264.1(containing)]TJ -4.315 -1.3858 TD [(aluminum)-295.2(hydroxide)-290.5(combined)-293.2(with)-296.1(a)-287.4(Toll-like)-295.7(receptor)-292.5(4)-289.5(\(TLR4\))]TJ 0 -1.3921 TD [(ligand,)-314.4(3-O-desacyl-4)]TJ /F12 1 Tf 8.6236 0 TD ()Tj /F8 1 Tf 0.2142 0 TD [(-monophosphoryl)-314(lipid)-312.8(A)-308.3(\(MPL\))-315.5(\()]TJ 0.85098 0.19216 0.2 scn 13.9969 0 TD (25)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5291 0 TD (26)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-314.6(It)]TJ -25.2787 -1.3858 TD [(is)-402.8(indicated)-409.9(for)-400.9(use)-407.1(in)-402.1(females)-403(aged)-405.2(10)-402.6(through)-409.7(25)-402.6(years)-405.1(for)-400.9(the)]TJ 28.3654 31.8866 TD [(prevention)-469.4(of)-462.5(persistent)-472.2(infection,)-469.1(premalignant)-469.8(cervical)-466.4(lesions,)]TJ 0 -1.3858 TD [(and)-297.3(cervical)-302.7(cancer)-307.6(caused)-300.2(by)-301.8(HPVs)-306.7(in)-295.1(the)-306.9(US.)]TJ 1.5496 -1.3921 TD [(Ga)17.4(rd)21(as)19.9(i)14.3(l)]TJ /F13 1 Tf 7.4999 0 0 7.4999 348.1511 737.9148 Tm ()Tj /F8 1 Tf 9 0 0 9 353.707 733.8896 Tm [(,)-260.7(a)-255.9(q)12.4(u)0(a)18.4(d)0(r)21(i)0(v)18.8(a)15(le)17.2(nt)-246.8(HP)18.1(V)-260.5(v)0(a)25.7(c)0(c)19.4(i)0(n)19.9(e)12.9(,)-260.7(i)0(s)-251.6(t)0(h)20.4(e)]TJ /F9 1 Tf 14.2992 0 TD ()Tj /F8 1 Tf 0.5165 0 TD [(rs)16.2(t)-258.6(c)12.9(om)20.7(me)18.6(rc)24.1(ia)23(ll)21.3(y)]TJ -20.2394 -1.3858 TD [(a)15(v)0(a)19.4(i)14.3(la)19.3(bl)19.3(e)-390.3(H)0(P)18.1(V)-392.8(va)19.4(c)12.8(c)0(i)20.9(n)0(e)-384.7(a)0(p)18.4(p)0(r)21(o)15(ve)17.3(d)-393.4(i)0(n)-383.3(2)12.9(00)19.4(6)-396.6(f)13.8(or)-383.2(pe)16.3(o)15(p)0(l)20.4(e)-396.6(9)-390.3(t)0(h)20.4(r)0(o)19.9(u)0(g)20.5(h)-395(2)12.9(6)]TJ 0 -1.3921 TD [(y)17.1(e)0(a)15.2(r)0(s)-286.2(o)15(f)-301.1(a)0(g)19.4(e)-295.8(fo)22.5(r)-297.4(t)0(h)20.4(e)-302.1(pr)21(e)12.8(v)0(e)23.6(n)0(t)17.8(i)14.3(on)-288.1(of)-292.5(d)16.1(i)0(s)19.3(e)12.9(as)19.9(es)-290.9(c)12.8(a)0(u)18.4(s)0(e)24.1(d)-298.9(by)-289.2(HP)24.4(V)-304.6(i)14.3(nf)19.4(e)12.8(c)0(t)18.8(i)14.3(on)]TJ 0 -1.3858 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3276 0 TD (27)Tj 0.15294 0.15294 0.15294 scn 0.9386 0 TD [(\).)-396.5(As)17.9(i)14.3(d)0(e)-399.4(f)0(r)18.8(o)15(m)-410(H)0(P)18.1(V)0(-)24.2(1)12.9(6)-409.2(a)0(n)20.5(d)-412.3(1)12.9(8)12.9(,)-411.9(G)15.1(a)0(r)19.9(d)0(a)18.4(s)0(i)25.6(l)]TJ /F13 1 Tf 7.4999 0 0 7.4999 463.0109 700.3842 Tm ()Tj /F8 1 Tf 9 0 0 9 472.3085 696.4156 Tm [(al)19.3(so)-395.8(pr)21(ot)20.9(e)12.8(c)0(t)18.8(s)-410.8(a)15(g)0(a)19.4(i)0(n)19.9(s)0(t)]TJ -18.6016 -1.3921 TD [(H)16.7(P)0(V)18.1(-)13.8(6)-232.8(a)15(nd)-217.7(-1)20.4(1)-226.5(i)14.3(nf)19.4(ec)19.4(ti)20.3(o)15(n)0(s)16.8(,)-222.9(wh)17.5(i)14.3(c)0(h)-218.3(c)12.8(au)18.4(se)-215.3(ap)18.4(pr)21(o)15(x)0(i)16.2(m)0(a)20.7(t)0(e)25.1(l)0(y)-218(9)12.9(0)12.9(%)-226.4(of)-216.9(ge)17.3(ni)26.2(ta)20.9(l)]TJ 0 -1.3858 TD 0.037 Tc [(wart)5.1(s.)-551.3(Gardasil)]TJ /F13 1 Tf 7.4999 0 0 7.4999 365.7826 675.3826 Tm 0 Tc ()Tj /F8 1 Tf 9 0 0 9 376.6676 671.4141 Tm 0.0359 Tc [(is)-545(a)-5.8(d)1.6(sorbed)-546.5(on)-550.7(an)-550.7(amorpho)-5.8(u)1.6(s)-551.3(a)0.5(lu)-4.7(minu)-4.7(m)]TJ -7.9748 -1.3921 TD 0 Tc [(h)14.5(y)0(d)20.5(r)0(o)19.9(x)14.5(yp)20.5(ho)23.1(sp)21(ha)16.8(te)-277.3(su)21(lf)24.5(at)20.9(e)-289.5(a)0(d)18.4(j)0(u)20.4(v)0(a)25.7(n)0(t)-278.3(\()]TJ 0.85098 0.19216 0.2 scn 14.3622 0 TD (28)Tj 0.15294 0.15294 0.15294 scn 0.9386 0 TD (\).)Tj -13.7512 -1.3858 TD 0.0104 Tc [(Gardasil)-508.1(9)]TJ /F13 1 Tf 7.4999 0 0 7.4999 358.6393 650.381 Tm 0 Tc ()Tj /F8 1 Tf 9 0 0 9 364.3653 646.4125 Tm 0.0103 Tc [(,)-508.7(l)2(ic)10.3(e)-8.1(n)-3(sed)-509.1(b)0.1(y)-508.1(t)3.6(he)-512.3(FDA)-512.1(i)10.3(n)-517.8(2)10.3(0)-8.1(1)-2(4)10.3(,)-514.7(of)61.9(fe)10.3(r)-9.7(s)-507.6(broader)]TJ -6.6079 -1.3921 TD 0 Tc [(protection)-464.8(by)-459.3(covering)]TJ /F9 1 Tf 9.8835 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(ve)-461.4(additional)-470.6(HPV)-462.9(types)-459.7(\(HPV-31,)-467(33,)]TJ -10.4126 -1.3858 TD [(45,)-247.6(53,)-253.9(and)-253.2(58\))-254.9(that)-254.8(might)-251.2(account)-256.9(for)-256(about)-254.4(20%)-251(of)-254.7(cervical)-252.3(cancer)]TJ 0 -1.3921 TD [(cases)-321.1(\()]TJ 0.85098 0.19216 0.2 scn 2.6646 0 TD (29)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-320.9(Gardasil)-326.1(9)]TJ /F13 1 Tf 7.4999 0 0 7.4999 382.7338 612.907 Tm ()Tj /F8 1 Tf 9 0 0 9 391.2944 608.8818 Tm [(is)-320.9(indicated)-328(for)-325.3(females)-327.4(aged)-323.3(9)-321(through)-327.8(45)]TJ -9.6 -1.3858 TD [(years)-323.2(for)-325.3(the)-319.5(prevention)-330.8(of)-317.7(HPV-associated)-332.2(diseases.)-326(Additionally,)]TJ 0 -1.3921 TD [(Gardasil)-288.3(9)]TJ /F13 1 Tf 7.4999 0 0 7.4999 341.8582 587.9054 Tm ()Tj /F8 1 Tf 9 0 0 9 350.0786 583.8802 Tm [(is)-289.4(indicated)-296.5(in)-288.8(males)-291.1(9)-289.5(through)-290(45)-289.2(years)-291.7(of)-292.5(age)-289(for)-293.8(the)]TJ -5.0205 -1.3858 TD 0.0297 Tc [(prevention)-525.4(of)-529.7(anal,)-527.1(o)0.6(ropharyn)]TJ 13.5685 0 TD 0.0263 Tc [(ge)-4.9(al,)-536.8(h)-3.3(ea)-9.1(d)-530.9(n)-5.9(ec)-4.9(k)-536.7(c)1.4(a)-9.1(n)0.4(c)-5(e)-4.9(rs)-6.6(,)-530.5(a)-2.8(n)-5.9(a)-2.8(l)]TJ -13.5685 -1.3921 TD 0 Tc [(precancerous,)-353.6(dysplastic)-354.6(lesions,)-356.3(and)-347.7(genital)-353.3(warts)-350.5(caused)-356.9(by)-345.9(HR-)]TJ 0 -1.3858 TD [(HPVs)-319.3(\()]TJ 0.85098 0.19216 0.2 scn 3.0488 0 TD (30)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-320.9(Gardasil)-326.1(9)]TJ /F13 1 Tf 7.4999 0 0 7.4999 386.192 550.3747 Tm ()Tj /F8 1 Tf 9 0 0 9 394.696 546.4062 Tm [(is)-320.9(formulated)-325(with)-327.6(amorphous)-321.2(aluminum)]TJ -9.978 -1.3921 TD [(hydroxyphosphate)-302.8(sulfate)-305(\(AAHS\))-302.5(as)-301.4(an)-300.7(adjuvant)-301.9(\()]TJ 0.85098 0.19216 0.2 scn 20.6929 0 TD (31)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj -20.1008 -1.3858 TD [(Recently,)-387.9(two)-379.3(more)-383.6(bivalent)-382.4(HPV)-381(vaccines)-389.6(\(HPV-16)-382.7(and)-379.2(18\))]TJ -1.5496 -1.3921 TD [(have)-230.4(been)-237.2(approved)-239.8(in)-238.4(China)-233.2(for)-237.1(protection)-238(against)-237.2(HPV)-236.1(infection-)]TJ 0 -1.3858 TD [(induced)-246.3(precancerous)-250.4(lesions)-253(or)-244.7(high-grade)-244.2(genital)-252.5(lesions)-246.7(\()]TJ 0.85098 0.19216 0.2 scn 23.7921 0 TD (32)Tj /F12 1 Tf 0.15294 0.15294 0.15294 scn 0.9638 0 TD ()Tj /F8 1 Tf 0.85098 0.19216 0.2 scn 0.5102 0 TD (34)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj -26.2236 -1.3921 TD 0.0124 Tc [(Clinical)-512.4(data)-508.1(revealed)-507(that)-510.8(the)-510.2(2)0.1(-)-5.3(v)4.3(alent)-510.8(H)-2.4(PV)-512.7(vaccine)-510.2(showed)]TJ 0 -1.3858 TD 0 Tc [(favorable)-422.6(immunogenicity,)-425.9(safety,)-424.2(and)-423.3(a)-426(positive)-422.3(seroconvertsion)]TJ ET 0.49804 0.49804 0.49804 scn 49.833 401.726 496.006 27.666 re f 0.63529 0.63529 0.63529 scn 49.606 429.392 496.346 0.22678 re f 545.726 91.956 0.22681 337.436 re f 49.606 91.956 0.22676 337.436 re f 132.831 401.726 m 49.833 401.726 l 49.833 401.953 l 132.831 401.953 l 132.831 401.726 l f* 132.831 401.726 0.28346 27.666 re f 133.115 401.726 82.715 0.22678 re f 215.83 401.726 0.28345 27.666 re f 216.113 401.726 82.772 0.22678 re f 298.885 401.726 0.22678 27.666 re f 299.112 401.726 82.772 0.22678 re f 381.883 401.726 0.22678 27.666 re f 382.11 401.726 81.751 0.22678 re f 463.861 401.726 0.22678 27.666 re f 464.088 401.726 81.751 0.22678 re f 132.831 385.115 m 49.833 385.115 l 49.833 385.342 l 132.831 385.342 l 132.831 385.115 l f* 132.831 385.115 0.28346 16.611 re f 133.115 385.115 82.715 0.22678 re f 215.83 385.115 0.28345 16.611 re f 216.113 385.115 82.772 0.22678 re f 298.885 385.115 0.22678 16.611 re f 299.112 385.115 82.772 0.22678 re f 381.883 385.115 0.22678 16.611 re f 382.11 385.115 81.751 0.22678 re f 463.861 385.115 0.22678 16.611 re f 464.088 385.115 81.751 0.22678 re f 132.831 359.036 m 49.833 359.036 l 49.833 359.263 l 132.831 359.263 l 132.831 359.036 l f* 132.831 359.036 0.28346 26.079 re f 133.115 359.036 82.715 0.22678 re f 215.83 359.036 0.28345 26.079 re f 216.113 359.036 82.772 0.22678 re f 298.885 359.036 0.22678 26.079 re f 299.112 359.036 82.772 0.22678 re f 381.883 359.036 0.22678 26.079 re f 382.11 359.036 81.751 0.22678 re f 463.861 359.036 0.22678 26.079 re f 464.088 359.036 81.751 0.22678 re f 132.831 304.384 m 49.833 304.384 l 49.833 304.668 l 132.831 304.668 l 132.831 304.384 l f* 132.831 304.384 0.28346 54.652 re f 133.115 304.384 82.715 0.28345 re f 215.83 304.384 0.28345 54.652 re f 216.113 304.384 82.772 0.28345 re f 298.885 304.384 0.22678 54.652 re f 299.112 304.384 82.772 0.28345 re f 381.883 304.384 0.22678 54.652 re f 382.11 304.384 81.751 0.28345 re f 463.861 304.384 0.22678 54.652 re f 464.088 304.384 81.751 0.28345 re f 132.831 278.305 m 49.833 278.305 l 49.833 278.532 l 132.831 278.532 l 132.831 278.305 l f* 132.831 278.305 0.28346 26.079 re f 133.115 278.305 82.715 0.22678 re f 215.83 278.305 0.28345 26.079 re f 216.113 278.305 82.772 0.22678 re f 298.885 278.305 0.22678 26.079 re f 299.112 278.305 82.772 0.22678 re f 381.883 278.305 0.22678 26.079 re f 382.11 278.305 81.751 0.22678 re f 463.861 278.305 0.22678 26.079 re f 464.088 278.305 81.751 0.22678 re f 132.831 261.694 m 49.833 261.694 l 49.833 261.978 l 132.831 261.978 l 132.831 261.694 l f* 132.831 261.694 0.28346 16.611 re f 133.115 261.694 82.715 0.28348 re f 215.83 261.694 0.28345 16.611 re f 216.113 261.694 82.772 0.28348 re f 298.885 261.694 0.22678 16.611 re f 299.112 261.694 82.772 0.28348 re f 381.883 261.694 0.22678 16.611 re f 382.11 261.694 81.751 0.28348 re f 463.861 261.694 0.22678 16.611 re f 464.088 261.694 81.751 0.28348 re f 132.831 197.631 m 49.833 197.631 l 49.833 197.858 l 132.831 197.858 l 132.831 197.631 l f* 132.831 197.631 0.28346 64.063 re f 133.115 197.631 82.715 0.22676 re f 215.83 197.631 0.28345 64.063 re f 216.113 197.631 82.772 0.22676 re f 298.885 197.631 0.22678 64.063 re f 299.112 197.631 82.772 0.22676 re f 381.883 197.631 0.22678 64.063 re f 382.11 197.631 81.751 0.22676 re f 463.861 197.631 0.22678 64.063 re f 464.088 197.631 81.751 0.22676 re f 132.831 181.02 m 49.833 181.02 l 49.833 181.247 l 132.831 181.247 l 132.831 181.02 l f* 132.831 181.02 0.28346 16.611 re f 133.115 181.02 82.715 0.22676 re f 215.83 181.02 0.28345 16.611 re f 216.113 181.02 82.772 0.22676 re f 298.885 181.02 0.22678 16.611 re f 299.112 181.02 82.772 0.22676 re f 381.883 181.02 0.22678 16.611 re f 382.11 181.02 81.751 0.22676 re f 463.861 181.02 0.22678 16.611 re f 464.088 181.02 81.751 0.22676 re f 132.831 164.409 m 49.833 164.409 l 49.833 164.636 l 132.831 164.636 l 132.831 164.409 l f* 132.831 164.409 0.28346 16.611 re f 133.115 164.409 82.715 0.22675 re f 215.83 164.409 0.28345 16.611 re f 216.113 164.409 82.772 0.22675 re f 298.885 164.409 0.22678 16.611 re f 299.112 164.409 82.772 0.22675 re f 381.883 164.409 0.22678 16.611 re f 382.11 164.409 81.751 0.22675 re f 463.861 164.409 0.22678 16.611 re f 464.088 164.409 81.751 0.22675 re f 132.831 128.806 m 49.833 128.806 l 49.833 129.033 l 132.831 129.033 l 132.831 128.806 l f* 132.831 128.806 0.28346 35.603 re f 133.115 128.806 82.715 0.22675 re f 215.83 128.806 0.28345 35.603 re f 216.113 128.806 82.772 0.22675 re f 298.885 128.806 0.22678 35.603 re f 299.112 128.806 82.772 0.22675 re f 381.883 128.806 0.22678 35.603 re f 382.11 128.806 81.751 0.22675 re f 463.861 128.806 0.22678 35.603 re f 464.088 128.806 81.751 0.22675 re f 132.831 102.728 m 49.833 102.728 l 49.833 102.954 l 132.831 102.954 l 132.831 102.728 l f* 132.831 102.728 0.28346 26.079 re f 133.115 102.728 82.715 0.22678 re f 215.83 102.728 0.28345 26.079 re f 216.113 102.728 82.772 0.22678 re f 298.885 102.728 0.22678 26.079 re f 299.112 102.728 82.772 0.22678 re f 381.883 102.728 0.22678 26.079 re f 382.11 102.728 81.751 0.22678 re f 463.861 102.728 0.22678 26.079 re f 464.088 102.728 81.751 0.22678 re f 49.833 102.217 496.006 0.51022 re f 1 1 1 scn 540.85 91.956 4.989 10.261 re f 540.85 91.956 15.024 10.261 re f 49.833 91.956 5.0457 10.261 re f 39.855 91.956 15.024 10.261 re f 39.855 101.48 516.019 0.73703 re f BT /F5 1 Tf 6.9999 0 0 6.9999 49.6063 439.6534 Tm 0.49804 0.49804 0.49412 scn [(TABLE)-306.1(1)-794(Summary)-301.7(of)-303.6(marketed)-300.2(prophylactic)-308.8(HPV)-301.2(vaccines.)]TJ /F1 1 Tf 9 0 0 9 75.1748 417.5432 Tm 1 1 1 scn (Valency)Tj -1.285 -1.1087 TD [(\(Brand)-303.8(name\))]TJ 10.7969 1.1087 TD (2vHPV)Tj -0.9323 -1.1087 TD (\(Cervarix)Tj 6.0001 0 0 6.0001 189.0708 410.0598 Tm ()Tj 9 0 0 9 193.9464 407.5653 Tm (\))Tj 5.5181 1.1087 TD (4vHPV)Tj -0.8756 -1.1087 TD (\(Gardasil)Tj 6.0001 0 0 6.0001 271.729 410.0598 Tm ()Tj 9 0 0 9 276.6047 407.5653 Tm (\))Tj 5.5622 1.1087 TD (9vHPV)Tj -1.3291 -1.1087 TD [(\(Gardasil)-307.3(9)]TJ 6.0001 0 0 6.0001 358.7527 410.0598 Tm ()Tj 9 0 0 9 363.6282 407.5653 Tm (\))Tj 5.0709 1.1087 TD (2vHPV)Tj -0.8 -1.1087 TD (\(Cecolin)Tj 6.0001 0 0 6.0001 436.3652 410.0598 Tm ()Tj 9 0 0 9 441.2408 407.5653 Tm (\))Tj 5.5622 1.1087 TD (2vHPV)Tj -1.3354 -1.1087 TD (\(WalrinVax)Tj 6.0001 0 0 6.0001 523.162 410.0598 Tm ()Tj 9 0 0 9 528.0376 407.5653 Tm (\))Tj /F8 1 Tf 6.9999 0 0 6.9999 78.2929 391.181 Tm 0.15294 0.15294 0.15294 scn [(Approval)-9044.5(2009)-9941.2(2006)-9941.2(2014)-9876.4(2019)-9795.4(2022)]TJ -0.8828 -3.0453 TD [(Manufacturer)-4946.9(GlaxoSmithKline)-307(plc)-4143.2(Merck)-305.3(&)-304.4(Co.,)-295.1(Inc)-4792.5(Merck)-305.3(&)-304.4(Co.,)-295.1(Inc)]TJ 46.7806 0.6803 TD [(Xiamen)-298.8(Innovax)]TJ 1.6117 -1.3607 TD [(Co.,)-303.2(Ltd.)]TJ 10.1644 0.6803 TD [(Walvax)-302.7(Co.,)-303.2(Ltd)]TJ -59.2128 -5.0863 TD [(Vaccine)-307.8(antigens)]TJ 0.9557 -1.3607 TD [(\(L1)-299.2(protein\))]TJ 11.0229 1.3607 TD [(HPV-16)-297.5(\(20)]TJ /F14 1 Tf 5.232 0 TD (m)Tj /F8 1 Tf 0.575 0 TD (g\))Tj -5.8071 -1.3607 TD [(HPV-18)-297.5(\(20)]TJ /F14 1 Tf 5.232 0 TD (m)Tj /F8 1 Tf 0.575 0 TD (g\))Tj 4.6489 1.3607 TD [(HPV-6,18)-305.1(\(20)]TJ /F14 1 Tf 5.9286 0 TD (m)Tj /F8 1 Tf 0.575 0 TD [(g)-303.3(each\))]TJ -6.7466 -1.3607 TD [(HPV-11,16)-304(\(40)]TJ /F14 1 Tf 6.4145 0 TD (m)Tj /F8 1 Tf 0.575 0 TD [(g)-295.2(each\))]TJ 6.7466 3.3935 TD [(HPV-6)-306.7(\(30)]TJ /F14 1 Tf 4.7542 0 TD (m)Tj /F8 1 Tf 0.575 0 TD (g\))Tj -5.5641 -1.3526 TD [(HPV-16)-297.5(\(60)]TJ /F14 1 Tf 5.232 0 TD (m)Tj /F8 1 Tf 0.575 0 TD (g\))Tj -7.597 -1.3607 TD [(HPV-11,)-298.2(18)-305.5(\(40)]TJ /F14 1 Tf 6.7061 0 TD (m)Tj /F8 1 Tf 0.575 0 TD [(g)-303.3(each\))]TJ -6.8114 -1.3526 TD [(HPV-31,)-306.3(33,)-298.1(45,)-306.2(52,)-298.1(58)]TJ 2.0815 -1.3607 TD (\(20)Tj /F14 1 Tf 1.6036 0 TD (m)Tj /F8 1 Tf 0.575 0 TD [(g)-295.2(each\))]TJ 8.8442 3.3935 TD [(HPV-16)-297.5(\(40)]TJ /F14 1 Tf 5.232 0 TD (m)Tj /F8 1 Tf 0.575 0 TD (g\))Tj -5.8071 -1.3607 TD [(HPV-18)-297.5(\(20)]TJ /F14 1 Tf 5.232 0 TD (m)Tj /F8 1 Tf 0.575 0 TD (g\))Tj 5.9043 1.3607 TD [(HPV-16)-305.6(\(40)]TJ /F14 1 Tf 5.2401 0 TD (m)Tj /F8 1 Tf 0.5669 0 TD (g\))Tj -5.8071 -1.3607 TD [(HPV-18)-305.6(\(20)]TJ /F14 1 Tf 5.2401 0 TD (m)Tj /F8 1 Tf 0.5669 0 TD (g\))Tj -65.279 -5.0863 TD [(Expression)-306.2(system)]TJ /F11 1 Tf 11.3955 0.6803 TD (Trichoplusiani)Tj /F8 1 Tf 6.0339 0 TD (insect)Tj -3.4178 -1.3526 TD [(cell)-304.1(line)]TJ /F11 1 Tf 8.4717 0.6722 TD [(Saccharomyces)-298.4(cerevisiae)-1987(Saccharomyces)-298.4(cerevisiae)-3801.2(Escherichia)-303.2(coli)-5767.2(Pichia)-295.9(pastoris)]TJ /F8 1 Tf -20.6528 -3.0453 TD [(Adjuvant)-8960.2(AS04)-9501.2(AAHS)-9255.2(AAHS)-6112.7(Aluminum)-303.7(hydroxide)-2912.2(Aluminum)-303.7(Phosphate)]TJ -1.9276 -5.7666 TD [(Other)-304.6(components)]TJ 11.436 1.3607 TD [(Sodium)-305.5(chloride)-306.7(and)]TJ 0.2997 -1.3607 TD [(sodium)-304.2(dihydrogen)]TJ -0.2754 -1.3526 TD [(phosphate)-309.3(dehydrate)]TJ 12.0353 2.7132 TD [(Sodium)-305.5(chloride,)-299.3(L-)]TJ -1.0124 -1.3607 TD [(histidine,)-304.8(polysorbate)-305.3(80,)]TJ 2.1382 -1.3526 TD [(sodium)-304.2(borate)]TJ 10.7314 3.3854 TD [(Sodium)-305.5(chloride,)-299.3(L-)]TJ -1.0124 -1.3526 TD [(histidine,)-304.8(polysorbate)-305.3(80,)]TJ 2.0248 -1.3607 TD [(sodium)-304.2(borate,)]TJ 0.4212 -1.3526 TD [(yeast)-298.9(protein)]TJ 9.3059 5.4264 TD [(Sodium)-305.5(chloride,)-299.3(sodium)]TJ 0.5669 -1.3607 TD [(dihydrogen)-307.8(phosphate)]TJ 0.3807 -1.3526 TD [(dehydrate,)-305(disodium)]TJ 0.0162 -1.3607 TD [(hydrogen)-302.2(phosphate)]TJ 1.1096 -1.3526 TD [(dehydrate,)-305(and)]TJ 0.0567 -1.3607 TD [(polysorbate)-305.3(80)]TJ 11.2254 4.7542 TD [(Sodium)-297.4(chloride,)]TJ 0.6884 -1.3607 TD [(histidine,)-304.8(and)]TJ -0.1944 -1.3526 TD [(polysorbate)-305.3(80)]TJ -59.6096 -4.414 TD [(Volume)-303.9(per)-303.7(dose)-7020(0.5)-298.1(mL)-9040.1(0.5)-298.1(mL)-9040.1(0.5)-298.1(mL)-8967.2(0.5)-298.1(mL)-8894.3(0.5)-306.2(mL)]TJ -1.3688 -2.3649 TD [(Route)-296.5(of)-302.4(administration)-4224.1(Intramuscular)-6197.3(Intramuscular)-6197.3(Intramuscular)-6124.4(Intramuscular)-6051.5(Intramuscular)]TJ 0.5507 -3.7337 TD [(Vaccination)-303.7(schedule)]TJ 14.6756 1.3606 TD [(3)-298.5(doses)]TJ -1.3364 -1.3606 TD [(\(0,)-304.5(1)]TJ /F12 1 Tf 1.8223 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(2,)-299.2(and)-308.1(6)]TJ -2.4054 -1.3526 TD [(months)-303.1(apart\))]TJ 13.2664 2.7132 TD [(3)-298.5(doses)]TJ -1.3364 -1.3606 TD [(\(0,)-304.5(1)]TJ /F12 1 Tf 1.8223 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(2,)-307.3(and)-300(6)]TJ -2.4054 -1.3526 TD [(months)-303.1(apart\))]TJ 13.2664 2.7132 TD [(3)-298.5(doses)]TJ -1.3364 -1.3606 TD [(\(0,)-304.5(1)]TJ /F12 1 Tf 1.8223 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(2,)-307.3(and)-300(6)]TJ -2.4054 -1.3526 TD [(months)-303.1(apart\))]TJ 13.1935 2.7132 TD [(3)-298.5(doses)]TJ -0.8342 -1.3606 TD [(\(0,)-296.4(1,)-307.3(and)-300(6)]TJ -0.575 -1.3526 TD [(months)-303.1(apart\))]TJ 13.1206 2.7132 TD [(3)-306.6(doses)]TJ -0.8342 -1.3606 TD [(\(0,)-304.5(2,)-299.2(and)-300(6)]TJ -0.5669 -1.3526 TD [(months)-303.1(apart\))]TJ -59.885 -3.0534 TD [(Vaccine)-299.7(recipients)-4167.3(Females)-300.1(aged)-307.2(10)]TJ /F12 1 Tf 18.1178 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (25)Tj 4.2763 0.6803 TD [(Female)-299.6(and)-308.1(male)-296.1(aged)]TJ 3.5231 -1.3607 TD (9)Tj /F12 1 Tf 0.4859 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (26)Tj 6.9999 0 0 6.9999 308.9763 118.3181 Tm [(Female)-299.6(and)-308.1(male)-296.1(aged)]TJ 3.5231 -1.3607 TD (9)Tj /F12 1 Tf 0.486 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (45)Tj 7.9695 0.6803 TD [(Females)-300.1(aged)-307.2(9)]TJ /F12 1 Tf 6.131 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(45)-4298.4(Female)-299.6(aged)-299.1(9)]TJ /F12 1 Tf 11.0229 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (30)Tj /F11 1 Tf -1.636 -2.9805 TD (\(Continued\))Tj /F1 1 Tf 0.49804 0.49804 0.49412 scn -66.0808 101.1825 TD [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.5051 0 TD (03)Tj ET endstream endobj 49 0 obj<> endobj 50 0 obj<> endobj 51 0 obj<> endobj 52 0 obj<> endobj 53 0 obj<> endobj 54 0 obj<> endobj 55 0 obj<> endobj 56 0 obj<> endobj 57 0 obj<> endobj 58 0 obj<> endobj 59 0 obj<> endobj 60 0 obj<> endobj 61 0 obj<> endobj 62 0 obj<> endobj 63 0 obj<> endobj 64 0 obj<> endobj 65 0 obj<> endobj 66 0 obj<> endobj 67 0 obj<> endobj 68 0 obj<> endobj 69 0 obj<> endobj 70 0 obj<> endobj 71 0 obj<> endobj 72 0 obj<> endobj 73 0 obj<> endobj 74 0 obj<> endobj 75 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 76 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 77 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 78 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 79 0 obj<>stream /GS1 gs BT /F8 1 Tf 9 0 0 9 49.6063 616.2518 Tm /Cs6 cs 0.15294 0.15294 0.15294 scn 0 Tc 0 Tw [(rate)-370.8(\()]TJ 0.85098 0.19216 0.2 scn 2.2299 0 TD (35)Tj /F12 1 Tf 0.15294 0.15294 0.15294 scn 0.9575 0 TD ()Tj /F8 1 Tf 0.85098 0.19216 0.2 scn 0.5165 0 TD (37)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-365(Both)-370.6(bivalent)-369.8(vaccines)-370.7(contain)-373.1(twice)-366.8(the)-369.9(amount)-371.4(of)]TJ -4.6614 -1.3858 TD [(HPV-16)-486.3(L1)-482.9(protein)-485.9(as)-477.7(the)-483.3(Cervarix)]TJ /F13 1 Tf 7.4999 0 0 7.4999 185.8393 607.7479 Tm ()Tj /F8 1 Tf 9 0 0 9 195.8173 603.7794 Tm [(vaccine)-489(and)-479.9(use)-489(dif)63.1(ferent)]TJ -16.2457 -1.3921 TD 0.0225 Tc [(adjuvants)-526.9(a)-0.3(nd)-528.4(antigen)-520(e)-2.4(xpress)]TJ 13.3669 0 TD 0.0184 Tc [(io)-4.4(n)-530.4(s)-1.9(y)-8.6(s)-1.9(t)-7.2(e)-6.5(ms)-8.2(.)-525.8(A)-529.2(co)-4.4(m)-7.4(p)-3.3(r)-8.2(e)-0.2(h)-4.9(e)-6.5(n)-7.5(s)-1.9(i)-5.1(v)-2.3(e)]TJ -13.3669 -1.3858 TD 0 Tc [(comparison)-306.4(of)-298.8(marketed)-307(HPV)-299.1(vaccines)-307.7(is)-295.7(shown)-303.5(in)]TJ 0.85098 0.19216 0.2 scn 21.0457 0 TD [(Table)-302.7(1)]TJ 0.15294 0.15294 0.15294 scn 2.9984 0 TD (.)Tj -22.4882 -1.3921 TD [(The)-259.5(immunogenicity)-259.7(and)-259.5(ef)]TJ /F9 1 Tf 11.0362 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(cacy)-263.5(of)]TJ /F9 1 Tf 2.9732 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(ve)-259.9(licensed)-256.3(HPV)-261.3(vaccines)]TJ -16.6236 -1.3858 TD [(have)-280.8(been)-287.6(summarized)-288.4(elsewhere)-282.2(\()]TJ 0.85098 0.19216 0.2 scn 13.9717 0 TD (33)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5039 0 TD (38)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.4976 0 TD (39)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-283.1(Brie)]TJ /F9 1 Tf 2.4693 0 TD ()Tj /F8 1 Tf 0.5354 0 TD [(y,)-281.5(all)-285(marketed)]TJ -20.8504 -1.3921 TD 0.0253 Tc [(HPV)-524.9(v)4.6(accines)-524.1(e)0.4(licit)-529.4(p)3.6(otent)-523.1(h)-4.3(umoral)-524.7(im)5.8(mune)-522.5(responses)-524.1(a)-3.8(nd)]TJ 0 -1.3858 TD 0 Tc [(exhibited)-314.4(long-lasting)-305.4(protective)-316.8(ef)]TJ /F9 1 Tf 13.9213 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(cacy)-313.9(after)-306.5(vaccination)-313.8(\()]TJ 0.85098 0.19216 0.2 scn 9.3858 0 TD (34)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5228 0 TD (40)Tj /F12 1 Tf 0.15294 0.15294 0.15294 scn 0.9575 0 TD ()Tj /F8 1 Tf 0.85098 0.19216 0.2 scn -26.274 -1.3921 TD (43)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-396.5(Serum)-393.2(antibody)-393.8(responses)-396.6(are)-395.6(the)-395.1(major)-389.7(indicators)-395(used)-397.3(for)]TJ -0.9575 -1.3858 TD [(evalsuating)-494.2(immunogenicity)-492.8(evoked)-489.2(by)-490.8(HPV)-488.1(vaccines)-490.4(in)-490.3(clinical)]TJ 0 -1.3921 TD [(trials,)-286.9(and)-284.7(comparison)-287.5(of)-286.2(vaccine-induced)-293.2(antibody)-286.7(levels)-283.8(or)-282.4(B-cell)]TJ 0 -1.3858 TD [(response)-11(s)-499(between)-505.2(HPV)-507(vaccines)-503(have)-507.6(been)-501.8(discussed)-514.2(\()]TJ 0.85098 0.19216 0.2 scn 23.7921 0 TD (44)Tj /F12 1 Tf 0.15294 0.15294 0.15294 scn 0.9638 0 TD ()Tj /F8 1 Tf 0.85098 0.19216 0.2 scn 0.5102 0 TD (46)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj -26.2236 -1.3921 TD 0.0156 Tc [(Nevert)-3.7(heless)-4.7(,)-516(d)0.2(e)]TJ /F9 1 Tf 6.9543 0 TD 0 Tc ()Tj /F8 1 Tf 0.548 0 TD 0.0171 Tc [(n)3.8(i)-0.1(tive)-511.8(correlat)4.1(ion)-519.1(b)6.9(etwe)4.8(en)-519.1(h)6.4(u)-4.6(m)3.9(o)0.6(ral)-520.3(i)6.2(mmun)3.8(e)]TJ -7.5024 -1.3858 TD 0 Tc [(responses)-333.6(and)-328.8(ef)]TJ /F9 1 Tf 6.652 0 TD ()Tj /F8 1 Tf 0.5354 0 TD [(cacy)-326.5(of)-324(HPV)-330.6(vaccines)-332.9(has)-324.7(not)-332.6(yet)-323.2(been)-331.7(reported)]TJ -7.1874 -1.3921 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3465 0 TD (47)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-352.4(Prophylactic)-363.5(HPV)-355.8(vaccines)-358.1(based)-358.3(on)-357.4(L1-VLPs)-356(trigger)-357.5(T-cell)]TJ -1.3039 -1.3858 TD [(responses,)-329.8(which)-318.8(showed)-324.3(no)-319.6(correlation)-324(with)-321.3(protection,)-328.7(probably)]TJ 0 -1.3921 TD [(due)-200.7(to)-199.6(the)-206.1(lack)-197(of)-204.3(L1)-199.4(expression)-209(in)-200.6(HPV-infected)-203.5(cells)-206.3(\()]TJ 0.85098 0.19216 0.2 scn 21.5118 0 TD (48)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-201.2(Since)-204.5(the)]TJ -22.4693 -1.3858 TD [(protection)-439.6(ef)]TJ /F9 1 Tf 5.2032 0 TD ()Tj /F8 1 Tf 0.5354 0 TD [(cacy)-433.6(of)-437.3(HPV)-437.7(vaccines)-433.7(are)-439.7(characterized)-437.2(in)-439.9(clinical)]TJ -5.7386 -1.3921 TD [(trials)-265.5(by)-270.3(prevention)-267.8(of)-267.3(cervical)-264.9(cancer)-269.8(and)-265.8(intraepithelial)-274.4(neoplasia,)]TJ 0 -1.3858 TD [(im)-11.5(mu)-9.7(n)-7(e)-510(pro)]TJ /F9 1 Tf 5.2976 0 TD ()Tj /F8 1 Tf 0.5354 0 TD [(le)-8(s)-511.6(oth)-8.7(er)-517.6(t)-6.7(h)0(a)-8.4(n)-511(ser)-15(um)-513.7(n)-7(e)0(u)-8.9(t)0(r)-8(a)0(l)-12.2(i)0(z)-10.6(ing)-517.4(an)-11(ti)-11.2(bo)-7.9(dy)-514.9(tit)-11.6(ers)]TJ -5.8331 -1.3921 TD [(should)-313.4(be)-312.3(clari)]TJ /F9 1 Tf 5.9591 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(ed,)-313.7(such)-317(as)-314(characteristics)-316.3(of)-311.4(Fc-ef)56.9(fector)-312.6(functions,)]TJ -6.4882 -1.3858 TD [(mucosal)-203.3(immunity)-211.3(and)-202.8(T-cell)-200.8(responses)-207.7(against)-205.7(HPV)-204.6(early)-210.4(proteins.)]TJ T* 0.0404 Tc [(For)-534.2(e)-3.4(xample,)-535.3(a)-543.1(compa)5(r)-5(a)5(t)-4.1(ive)-538.9(s)1.2(tu)6.1(dy)-541(between)-539.9(G)5.1(ardasil)]TJ /F13 1 Tf 7.4999 0 0 7.4999 265.6629 345.2598 Tm 0 Tc ()Tj /F8 1 Tf 9 0 0 9 276.4912 341.2913 Tm 0.0354 Tc [(an)-9.4(d)]TJ -25.2094 -1.3921 TD 0 Tc (Cervarix)Tj /F13 1 Tf 7.4999 0 0 7.4999 80.4472 332.7873 Tm ()Tj /F8 1 Tf 9 0 0 9 90.4819 328.7622 Tm [(indicated)-498(that)-494.1(the)-495.9(dif)63.1(ferences)-498.8(in)-490.3(antibody)-494.6(Fc-ef)56.9(fector)]TJ -4.5417 -1.3858 TD 0.02 Tc [(func)-4.9(tions)-523.1(m)0.5(ight)-515.8(c)-4.9(o)3.5(ntribute)-521.5(to)-519.4(post-infe)-4.9(c)1.4(tion)-522.5(prote)-4.9(c)1.4(tion)-522.5(\()]TJ 0.85098 0.19216 0.2 scn 25.2032 0 TD 0.0249 Tc (49)Tj 0.15294 0.15294 0.15294 scn 1.0016 0 TD 0.0224 Tc (\).)Tj -26.2047 -1.3921 TD 0.0314 Tc [(Imm)5.6(u)-2.9(ne)-529(correlat)5.8(e)-535.3(o)2.3(f)-528(p)-2.9(rotect)5.8(ion)-530(b)2.3(y)-531.1(H)-2.3(PV)-531.4(vaccination)-530(needs)]TJ 0 -1.3858 TD 0 Tc [(further)-481.3(elucidation)-485(based)-477.9(on)-483.4(more)-478.1(clinical)-483.4(data)-477.2(with)-485.1(functional)]TJ 0 -1.3921 TD [(characteristic)-409.4(of)-405.8(serum)-402.7(or)-408.4(mucosal)-404.9(antibodies,)-406.4(as)-408.4(well)-403.8(as)-402.1(cellular)]TJ 0 -1.3858 TD [(immune)-305.1(responses)-302.1(\()]TJ 0.85098 0.19216 0.2 scn 8.1638 0 TD (50)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj -7.5654 -1.3921 TD [(Despi)-10.2(te)-504(the)-502.2(high)-506.6(ef)]TJ /F9 1 Tf 8.2079 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(cacy)-509.2(again)-8.7(st)-499.4(HPV)-507(infe)-10.1(ction)-507(and)-505.1(HPV-)]TJ -10.2929 -1.3858 TD [(r)-7.7(e)0(l)-8(a)-10.2(ted)-519.5(d)-9.1(ise)-12(a)-10.2(se,)-520.1(l)-8.3(o)0(w)-517.5(vac)-11.8(ci)-16.9(na)-11(ti)-11.2(on)-514.9(co)-10(v)-8.1(era)-17.6(ge)-518.1(of)-512.9(p)-9.1(r)0(o)-11.6(phy)-15.4(la)-12.2(cti)-17.3(c)-510(H)0(P)-13.4(V)]TJ 0 -1.3921 TD [(vaccines)-496.7(still)-501.5(exists.)-493(Particularly,)-503.7(most)-497.6(low-)-493(and)-498.8(middle-income)]TJ 0 -1.3858 TD [(countries)-228.8(incompletely)-225.9(implement)-231.6(HPV)-223.5(vaccination)-225.7(programs)-225.1(\()]TJ 0.85098 0.19216 0.2 scn 25.2661 0 TD (51)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj -26.2236 -1.3921 TD [(The)-234.3(high)-229.4(cost,)-228.3(limited)-235.1(supply,)-236.6(and)-228(delivery)-234.3(requirements)-239.4(of)-229.5(the)-231.3(cold)]TJ 0 -1.3858 TD 0.0174 Tc [(chai)-6.1(n)-518.8(m)-2.1(ake)-524.1(i)0.2(t)-518.4(u)2(navai)-6.1(l)2.8(ab)-5.4(le)-517.8(to)-522(peop)-4.3(le)-524.1(in)-518.8(these)-517.8(c)-1.2(ountries)-519.4(\()]TJ 0.85098 0.19216 0.2 scn 25.2094 0 TD 0.0186 Tc (52)Tj 0.15294 0.15294 0.15294 scn 0.9953 0 TD 0.0224 Tc (\).)Tj -26.2047 -1.3921 TD 0 Tc [(Additionally,)-371.8(the)-363.6(biosesafety)-371.2(considerations)-369.3(played)-372.2(a)-363(critical)-369(role)-366.1(in)]TJ 0 -1.3858 TD [(t)-6.7(h)0(e)-520.7(s)-7.7(u)-9.1(c)0(c)-12.1(e)0(s)-13.7(s)-7.7(fu)-14.2(l)-512.2(d)-9.1(ev)-14.2(el)-14.3(op)-13.1(m)-6.9(e)0(n)-13.1(t)-510.6(a)-10.2(n)-7(d)-513.1(d)-9.1(ep)-15.2(lo)-12.2(ym)-8.7(e)-12.3(n)-7(t)-510.6(o)0(f)-519.2(H)-8.5(PV)-523.7(va)-12.1(cc)-12.1(i)-10.9(n)-7(es)-13.7(.)]TJ 0 -1.3921 TD [(Based)-331.9(on)-332.2(high)-330.2(quality)-337(data)-332.3(from)-332.2(very)-332.3(large)-330.1(studies,)-336.8(HPV)-336.9(vaccines)]TJ 0 -1.3858 TD [(exhibit)-330.7(favorable)-334.4(safety)-333.6(pro)]TJ /F9 1 Tf 11.0425 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(les)-330.6(\()]TJ 0.85098 0.19216 0.2 scn 1.7071 0 TD (53)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.548 0 TD (54)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-327.2(The)-335.1(implementation)-333.3(of)-330.3(a)]TJ -15.7417 -1.3921 TD 0.0391 Tc [(robust)-534.5(safety)-536(monitoring)-542.3(s)6.2(y)]TJ 12.7244 0 TD 0.0392 Tc [(ste)-4.6(m)-534.6(f)-3.7(o)3.8(r)-541.7(H)5.5(P)-3.5(V)-536.2(vaccines,)-536.5(which)]TJ -12.7244 -1.3858 TD 0 Tc [(consistently)-344.2(updated)-342.9(data)-344.9(and)-341.4(promptly)-343.3(disclosed)]TJ /F9 1 Tf 20.5417 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(ndings,)-348.4(would)]TJ -21.0709 -1.3921 TD [(en)-13.1(ha)-14.7(n)-7(c)0(e)-516(a)-10.2(cc)-12.1(ur)-10.5(a)-10.2(t)0(e)-516.6(u)-9.1(nd)-9.9(er)-13.7(s)-7.7(t)-6.7(an)-11(d)-9.1(i)0(n)-11.6(g)-512.1(an)-11(d)-513.1(c)0(o)-16.3(m)-6.9(pr)-10.5(eh)-10.5(en)-13.1(s)-7.7(i)0(v)-12.7(e)-516.3(aw)-7.3(a)-10.2(r)-7.7(en)-13.1(es)-13.7(s)]TJ 0 -1.3858 TD [(r)-7.7(e)0(g)-14.2(a)0(r)-11.6(d)-9.1(in)-11.6(g)-512.1(H)0(P)-13.4(V)-512.4(va)-12.1(cc)-12.1(in)-11.6(e)-516.3(s)-7.7(af)-9(et)-12.7(y)-8.1(,)-512.7(m)-6.9(i)0(t)-11.2(i)0(g)-12.7(a)0(t)-10.6(e)-516.3(va)-12.1(cc)-12.1(in)-11.6(e)-516.3(h)0(e)-10.5(s)-7.7(it)-11.2(a)-10.2(n)0(c)-13.1(y)0(,)-514.5(a)-10.2(n)-7(d)]TJ 0 -1.3921 TD [(increase)-307.2(vaccine)-300.1(acceptance)-306.6(and)-303.6(coverage)-301.9(rates.)]TJ /F1 1 Tf 11.9999 0 0 11.9999 304.8944 614.0408 Tm [(3.2)-298.5(Prophylactic)-303.9(HPV)-302.9(vaccines)-304.9(in)]TJ 0 -1.0394 TD [(clinical)-303.1(testing)]TJ /F8 1 Tf 9 0 0 9 318.8409 576.5668 Tm [(There)-323.6(are)-326.3(12)-320.7(high-risk)-319.7(HPV)-324.3(types)-321.1(that)-324.1(are)-320(involved)-319.8(in)-320.2(cancer,)]TJ -1.5496 -1.3921 TD [(including)-246.6(types)-245.5(16,)-247.6(18,)-247.6(31,)-247.6(33,)-247.6(35,)-247.6(39,)-247.6(45,)-241.3(51,)-247.6(52,)-247.6(56,)-247.6(58,)-247.6(and)-246.9(59)-245.1(\()]TJ 0.85098 0.19216 0.2 scn 25.2661 0 TD (55)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj -26.2236 -1.3858 TD [(The)-416.9(Gardasil)-420.6(9)]TJ /F13 1 Tf 7.4999 0 0 7.4999 360.8503 555.5338 Tm ()Tj /F8 1 Tf 9 0 0 9 370.2613 551.5652 Tm [(vaccine,)-422.2(which)-419.6(contains)-424.8(the)-420.3(highest)-419.9(number)-418.6(of)]TJ -7.263 -1.3921 TD [(high-risk)-382.7(HPV)-381(serotypes)-384.2(in)-383.2(circulation)-389.1(worldwide,)-385.4(does)-379.5(not)-383(fully)]TJ 0 -1.3858 TD [(cover)-277.5(all)-278.7(high-risk)-281.9(HPV)-273.9(types.)-285.8(To)-271.8(achieve)-284.9(complete)-279.8(protection,)-284.6(the)]TJ 0 -1.3921 TD [(development)-310.4(of)-311.4(prophylactic)-311(HPV)-311.7(vaccines)-314(should)-313.4(further)-311.2(enlarge)]TJ 0 -1.3858 TD [(their)-356.9(protective)-367.2(extent)-364.4(to)-357.1(target)-360.4(more)-364.7(life-threatening)-368(HPV)-362.1(types.)]TJ 0 -1.3921 TD 0.0396 Tc [(The)-539.7(f)-3.3(ollowing)-541.8(se)-4.2(ction)-540.7(w)-1.5(ill)-541.9(s)0.4(um)-5.1(marize)-539.7(the)-539.7(p)-1(r)-5.9(o)4.2(gr)-5.8(ess)-541.3(i)-2.8(n)-540.7(t)1.4(he)]TJ 0 -1.3858 TD 0.044 Tc [(development)-542.2(o)2.3(f)-546.9(p)3.4(rophylactic)-547.9(L)1.8(1-VLP)-5(-)1.1(based)-544.7(H)-2.3(PV)-544(vaccines)]TJ 0 -1.3921 TD 0 Tc [(currently)-299.7(in)-301.4(clinical)-307(trials)-297(\()]TJ 0.85098 0.19216 0.2 scn 10.7906 0 TD [(Table)-302.7(2)]TJ 0.15294 0.15294 0.15294 scn 2.9984 0 TD (\).)Tj -12.2394 -1.3858 TD [(All)-299.6(9-valent)-303.1(HPV)-299.1(vaccines)-301.4(target)-303.7(the)-300.6(same)-301.7(highly)-296.2(carcinogenic)]TJ -1.5496 -1.3921 TD [(H)-8.5(P)-11.2(V)-518.7(t)-13(y)-8.1(p)-15.4(es)-530.2(\()-9.8(H)-8.5(P)-11.2(V)-14.8(-)-11.4(6)0(/)-17.9(1)-12.3(1)-12.3(/)-11.9(16)-18.4(/)-11.9(1)-12.3(8/)-17.9(3)-12.3(1)-12.3(/)-11.9(33)-18.4(/)-11.9(4)-12.3(5/)-17.9(5)-12.3(2)-12.3(/)-11.9(58)-18.4(\))-9.8(.)-525.3(S)-10.7(h)-10.7(a)-10.2(n)-7(g)-14.4(h)-10.7(a)-10.2(i)-521.1(B)-9.1(o)-10.2(v)-8.1(a)-16.5(x)]TJ 0 -1.3858 TD [(Biotechnology)-388.9(Co.,)-385.9(Ltd.)-388(has)-387.7(created)-392(a)-381.9(9-valent)-391.3(HPV)-387.3(vaccine)-388.3(that)]TJ 0 -1.3921 TD [(exhibits)-300.5(high)-305(immunogenicity,)-312.5(good)-302.3(tolerance,)-310(and)-303.6(non-inferiority)]TJ 0 -1.3858 TD [(to)-426.3(Gardasil)-426.9(4)-428.1(i)0(n)-433.6(terms)-425.4(of)-431(both)-428.4(immunogenicity)-436.1(and)-429.5(safety)-428(\()]TJ 0.85098 0.19216 0.2 scn 25.2661 0 TD (56)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj -26.2236 -1.3921 TD [(However,)-361(data)-370.1(regarding)-364.6(other)-362.6(HPV)-368.4(vaccines)-364.4(has)-362.5(not)-364.1(been)-369.5(made)]TJ 0 -1.3858 TD [(public.)-490.8(The)-492.5(11-valent)-498.1(HPV)-494.4(vaccine,)-491.5(developed)-500.5(by)-490.8(the)-489.6(National)]TJ 0 -1.3921 TD [(Vaccine)-275.2(and)-284.7(Serum)-279.8(Institute)-275.7(\(China\),)-280.4(covered)-286.4(two)-272.2(additional)-281.6(HPV)]TJ 0 -1.3858 TD [(types)-289.6(\(HPV-59/68\))-296.6(on)-288.1(top)-290.6(of)-286.2(the)-294.3(commonly)-290.5(used)-290.2(HPV)-292.8(types)-289.6(in)-295.1(9-)]TJ 0 -1.3921 TD [(valent)-487.3(vaccines.)-492.9(The)-486.2(underlying)-497.2(development)-493(strategy)-489.5(might)-484.2(be)]TJ 0 -1.3858 TD [(linked)-220(to)-218.5(the)]TJ /F9 1 Tf 5.1843 0 TD ()Tj /F8 1 Tf 0.5354 0 TD [(ndings)-219.9(that)-223.3(HPV-59)-221.7(and)-221.7(68)-219.9(are)-219.2(potentially)-223.8(associated)]TJ -5.7197 -1.3921 TD 0.0506 Tc [(with)-552.3(genital)-549.8(c)-5.8(ancerogenesis)-549.2(\()]TJ 0.85098 0.19216 0.2 scn 13.6504 0 TD 0.0501 Tc (57)Tj 0.15294 0.15294 0.15294 scn 1.0583 0 TD 0.0507 Tc [(\).)-550.2(SC)-5.1(T1000,)-550.2(developed)-550.6(b)2.7(y)]TJ -14.7087 -1.3858 TD 0 Tc [(Sinocelltech)-399.3(Ltd,)-400.6(is)-402.8(a)-400.8(recombinant)-403.9(14-valent)-403.6(L1-VLP-based)-403(HPV)]TJ 0 -1.3921 TD 0.0162 Tc [(vaccine)-519(d)0.8(esigned)-515.8(t)-3.1(o)-510.6(p)-5.5(revent)-513.3(HP)5(V)-521.4(i)5.3(nfection)-513.7(and)-515.8(H)1.4(PV-related)]TJ 0 -1.3858 TD 0 Tc [(cancers.)-399.6(It)-398.1(covers)]TJ /F9 1 Tf 7.5276 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(ve)-398.4(additional)-401.3(HPV)-399.9(types)-403(\(35,)-402.3(39,)-398.8(51,)-398.8(56,)-398.8(and)]TJ -8.0567 -1.3921 TD 0.0168 Tc [(59\))-522.1(c)4.5(omp)-4.9(a)0.3(red)-521.5(w)0.9(ith)-516.8(G)0.4(arda)-6(sil)-520.6(9)]TJ /F13 1 Tf 7.4999 0 0 7.4999 425.1967 268.044 Tm 0 Tc ()Tj /F8 1 Tf 9 0 0 9 430.9227 264.0189 Tm 0.0184 Tc [(.)-519.5(S)1.4(CT1000)-516.8(is)-512.1(current)5.4(l)-2.5(y)-512.6(b)1.9(eing)]TJ -14.0032 -1.3858 TD 0 Tc [(investigated)-475.4(in)-477.7(a)-476.4(Phase)-474.2(III)-475(study)-481.7(for)-470.2(HPV)-481.8(infection)-479.3(and)-473.6(HPV-)]TJ 0 -1.3921 TD [(related)-293.4(carcinoma)-302(\(NCT06041061\).)-297.4(A)-295.7(15-valent)-296.6(vaccine)-300.1(developed)]TJ 0 -1.3858 TD [(by)-314.4(Chengda)-321.3(Bio)-313.7(targets)-323.9(HPV-68,)-318.7(in)-320.3(addition)-319.8(to)-313(the)-319.5(14)-314.4(HPV)-324.3(types)]TJ T* [(covered)-210.8(by)-213.6(SCT1000,)-216.1(is)-213.8(currently)-217.8(in)-213.2(development)-215.9(for)-218.2(the)-212.4(prevention)]TJ 0 -1.3921 TD [(of)-298.8(HPV-infected)-304.3(diseases.)]TJ /F1 1 Tf 11.9999 0 0 11.9999 304.8944 164.0692 Tm [(3.3)-298.5(Therapeutic)-306.7(HPV)-298.2(vaccines)-304.9(in)]TJ 0 -1.0441 TD [(clinical)-303.1(testing)]TJ /F8 1 Tf 9 0 0 9 318.8409 126.5386 Tm 0.0245 Tc [(P)-5.6(r)4.2(ophylactic)-523.3(HPV)-525.8(v)-2.5(accin)4.9(e)-0.4(s)-524.9(s)-2.1(carce)5.9(l)-2.7(y)-525.4(e)5.9(radicate)-523.3(preexist)5.2(i)1(ng)]TJ -1.5496 -1.3858 TD 0 Tc [(infe)-10.1(cti)-11(on)-508.6(bec)-9.7(ause)-518.1(L1)-508.1(ca)-10(psi)-8.8(d)-506.8(pro)-8.1(tei)-11(ns)-506(ar)-11.6(e)-503.7(n)-7(ot)-508.2(expr)-14.7(ess)-8.7(ed)-506.5(on)-514.9(the)]TJ 0 -1.3921 TD 0.0241 Tc [(surface)-523.7(o)1.3(f)-522.7(i)0.6(n)4.5(f)0.1(ecte)5.5(d)-526.8(basal)-519.6(epithelial)-519.6(cells)-519(\()]TJ 0.85098 0.19216 0.2 scn 18.463 0 TD 0.0186 Tc (58)Tj 0.15294 0.15294 0.15294 scn 1.0016 0 TD 0.0238 Tc [(\).)-526.7(Therefore,)-520.4(the)]TJ -19.4646 -1.3858 TD 0 Tc [(de)-8.9(v)-8.1(e)0(l)-14.3(o)0(p)-13.1(m)-6.9(en)-13.1(t)-510.6(o)-10.2(f)-509(p)-9.1(r)-7.7(o)0(p)-13.1(h)0(y)-12.6(l)-8.3(ac)-10(t)-6.7(i)-10.9(c)-510(H)-8.5(PV)-517.4(v)-8.1(a)-10.2(cc)-12.1(in)-11.6(es)-523.9(is)-516.2(n)-7(o)0(t)-520.8(a)0(n)-521.2(e)0(f)51.9(f)0(e)-17.4(c)0(t)-12.7(i)0(v)-12.7(e)]TJ 0 -1.3921 TD [(treatment)-460.7(approach)-463.9(for)-457.6(people)-464.6(already)-462.9(infected)-460(with)-459.9(HPV)-462.9(\()]TJ 0.85098 0.19216 0.2 scn 25.2661 0 TD (59)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj ET 0.49804 0.49804 0.49804 scn 49.833 722.494 496.006 27.666 re f 0.63529 0.63529 0.63529 scn 545.726 648.907 0.22681 116.617 re f 49.606 648.907 m 49.606 765.524 l 49.833 765.524 l 49.833 648.907 l 49.606 648.907 l f* 49.833 648.907 496.006 0.28345 re f 545.839 750.16 m 49.833 750.16 l 545.839 750.16 l f* 132.831 722.494 m 49.833 722.494 l 49.833 722.778 l 132.831 722.778 l 132.831 722.494 l f* 132.831 722.494 0.28346 27.666 re f 133.115 722.494 82.715 0.28345 re f 215.83 722.494 0.28345 27.666 re f 216.113 722.494 82.772 0.28345 re f 298.885 722.494 0.22678 27.666 re f 299.112 722.494 82.772 0.28345 re f 381.883 722.494 0.22678 27.666 re f 382.11 722.494 81.751 0.28345 re f 463.861 722.494 0.22678 27.666 re f 464.088 722.494 81.751 0.28345 re f 132.831 649.19 0.28346 73.304 re f 215.83 649.19 0.28345 73.304 re f 298.885 649.19 0.22678 73.304 re f 381.883 649.19 0.22678 73.304 re f 463.861 649.19 0.22678 73.304 re f 49.833 749.934 496.006 0.45355 re f /Cs6 cs 1 1 1 scn 49.606 750.387 0.22676 19.502 re f 545.839 750.387 0.28345 19.502 re f /Cs6 cs 1 1 1 scn 49.606 750.387 4.989 19.502 re f 39.628 750.387 14.967 19.502 re f 541.077 750.387 5.0457 19.502 re f 541.077 750.387 15.024 19.502 re f 39.628 750.387 516.472 9.978 re f BT /F5 1 Tf 6.9999 0 0 6.9999 49.6063 760.3652 Tm 0.49804 0.49804 0.49412 scn [(TABLE)-306.1(1)-794(Continued)]TJ /F1 1 Tf 9 0 0 9 75.1748 738.3116 Tm 1 1 1 scn (Valency)Tj -1.285 -1.1087 TD [(\(Brand)-303.8(name\))]TJ 10.7969 1.1087 TD (2vHPV)Tj -0.9323 -1.1087 TD (\(Cervarix)Tj 6.0001 0 0 6.0001 189.0708 730.8282 Tm ()Tj 9 0 0 9 193.9464 728.3337 Tm (\))Tj 5.5181 1.1087 TD (4vHPV)Tj -0.8756 -1.1087 TD (\(Gardasil)Tj 6.0001 0 0 6.0001 271.729 730.8282 Tm ()Tj 9 0 0 9 276.6047 728.3337 Tm (\))Tj 5.5622 1.1087 TD (9vHPV)Tj -1.3291 -1.1087 TD [(\(Gardasil)-307.3(9)]TJ 6.0001 0 0 6.0001 358.7527 730.8282 Tm ()Tj 9 0 0 9 363.6282 728.3337 Tm (\))Tj 5.0709 1.1087 TD (2vHPV)Tj -0.8 -1.1087 TD (\(Cecolin)Tj 6.0001 0 0 6.0001 436.3652 730.8282 Tm ()Tj 9 0 0 9 441.2408 728.3337 Tm (\))Tj 5.5622 1.1087 TD (2vHPV)Tj -1.3354 -1.1087 TD (\(WalrinVax)Tj 6.0001 0 0 6.0001 523.162 730.8282 Tm ()Tj 9 0 0 9 528.0376 728.3337 Tm (\))Tj /F8 1 Tf 6.9999 0 0 6.9999 78.0094 683.5463 Tm 0.15294 0.15294 0.15294 scn (Ef)Tj /F9 1 Tf 0.8585 0 TD ()Tj /F8 1 Tf 0.5264 0 TD [(cacy)-305.9(*)]TJ 7.759 1.3526 TD [(VE)-304.2(against)-303(HPV-16/18)]TJ 0.2025 -1.3526 TD [(incident)-307.7(infection)-304(was)]TJ 2.2597 -1.3607 TD [(66.8%)-300.2(\(40\))]TJ 9.7514 5.4264 TD [(100%)-299.5(ef)]TJ /F9 1 Tf 3.1992 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cacy)-297.8(against)]TJ -3.264 -1.3526 TD [(HPV)-305.5(16/18-related)]TJ -0.6236 -1.3607 TD [(cervical)-303.7(intraepithelial)]TJ 0.0405 -1.3526 TD [(neoplasia)-300.4(and)-300(ef)]TJ /F9 1 Tf 6.536 0 TD ()Tj /F8 1 Tf 0.5264 0 TD (cacy)Tj -7.3054 -1.3607 TD [(against)-303(HPV)-305.5(persistent)]TJ 2.1463 -1.3607 TD [(infection)-304(for)]TJ -0.5831 -1.3526 TD [(78)-200.2(months)-295(\(41\))]TJ 9.8809 8.1396 TD [(At)-298.8(1)-298.5(month)-302.7(post-Dose)-300.3(3,)]TJ 0.3159 -1.3526 TD [(>99%)-302.3(of)-302.4(participants)-306.7(in)]TJ 1.4578 -1.3607 TD [(the)-298(per-protocol)]TJ 0 -1.3526 TD (immunogenicity)Tj -1.8385 -1.3607 TD [(population)-299(seroconverted)]TJ 0.8828 -1.3607 TD [(to)-299.5(each)-297.7(vaccine)-303.8(HPV)]TJ 2.4135 -1.3526 TD [(type)-296.4(\(42\))]TJ 9.4922 6.7871 TD [(Vaccine)-299.7(ef)]TJ /F9 1 Tf 4.1954 0 TD ()Tj /F8 1 Tf 0.5264 0 TD [(cacy)-305.9(was)]TJ -5.5722 -1.3607 TD [(100%)-299.5(against)-303(high-grade)]TJ -0.1215 -1.3526 TD [(genital)-300.4(lesions)-301.8(and)-308.1(97.3%)]TJ 1.6036 -1.3607 TD [(against)-311.1(persistent)]TJ 0.7451 -1.3607 TD [(infection)-304(\(43\))]TJ 11.2416 5.4345 TD [(100%)-307.6(in)-300.5(postive)]TJ -1.5955 -1.3607 TD [(seropositive)-305.7(at)-297.7(Month)-302.5(7)]TJ 0.1944 -1.3526 TD [(in)-300.5(two-)-297.1(and)-308.1(three-dose)]TJ 1.4497 -1.3607 TD [(regimens)-297.2(for)-302.9(all)]TJ -0.1782 -1.3607 TD [(participants)-306.7(\(34\))]TJ 6.5001 0 0 6.5001 49.6063 640.403 Tm [(*,)-302.8(Protection)-302.5(rate)-303.8(for)-301.5(precancerous)-307.9(lesions)-296.5(or)-304.7(high-grade)-302.2(genital)-301.4(lesions)-305.3(caused)-301.1(by)-306.7(HPV)-301(infection.)]TJ /F1 1 Tf 6.9999 0 0 6.9999 49.6063 800.9573 Tm 0.49804 0.49804 0.49412 scn [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.5213 0 TD (04)Tj ET endstream endobj 80 0 obj<> endobj 81 0 obj<> endobj 82 0 obj<> endobj 83 0 obj<> endobj 84 0 obj<> endobj 85 0 obj<> endobj 86 0 obj<> endobj 87 0 obj<> endobj 88 0 obj<> endobj 89 0 obj<> endobj 90 0 obj<> endobj 91 0 obj<> endobj 92 0 obj<> endobj 93 0 obj<> endobj 94 0 obj<> endobj 95 0 obj<> endobj 96 0 obj<> endobj 97 0 obj<> endobj 98 0 obj<> endobj 99 0 obj<> endobj 100 0 obj<> endobj 101 0 obj<> endobj 102 0 obj<> endobj 103 0 obj<> endobj 104 0 obj<> endobj 105 0 obj<> endobj 106 0 obj<> endobj 107 0 obj<> endobj 108 0 obj<> endobj 109 0 obj<> endobj 110 0 obj<> endobj 111 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 112 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 113 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 114 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 115 0 obj<>stream /GS1 gs BT /F8 1 Tf 9 0 0 9 49.6063 333.1842 Tm /Cs6 cs 0.15294 0.15294 0.15294 scn 0 Tc 0 Tw [(Cellular)-208.2(immune)-216.9(responses)-207.7(to)-212.2(HPV)-210.9(antigens)-208.5(play)-212.2(important)-207.6(roles)-209.9(in)]TJ 0 -1.3921 TD 0.0207 Tc [(vi)3.5(ral)-516.7(c)-4.2(l)6.1(e)-4.2(a)4.2(r)0.4(ance)-520.8(and)-517.6(a)-2.1(nti)3.5(c)2.1(ancer)-516.1(i)]TJ 13.9969 0 TD 0.0199 Tc [(mmune)-521.6(responses.)-518(Inef)58.9(fective)]TJ -13.9969 -1.3858 TD 0 Tc [(ce)-12.1(ll)-10.2(ul)-11.1(ar)-515.5(im)-11.5(mu)-9.7(n)-7(e)-510(res)-15(pon)-13.8(s)-7.7(e)0(s)-517.6(t)0(o)-514.5(HPV)-15.6(-16)-514.8(E)-11.2(2)0(,)-512.4(E)0(6)-11(,)-512.7(or)-509.2(E)-11.2(7)-510(pe)-8.9(pt)-9.5(id)-13.7(es)]TJ 0 -1.3921 TD [(involve)-417.8(infection)-416.3(persistence)-421(or)-414.7(disease)-423(progression)-419.8(in)-414.7(low-grade)]TJ 0 -1.3858 TD [(intrae)-10.7(pitheli)-12.2(al)-503.5(lesion)-509.9(\(LSIL\))-506.1(patie)-11.4(nts)-506.4(\()]TJ 0.85098 0.19216 0.2 scn 15.9685 0 TD (60)Tj 0.15294 0.15294 0.15294 scn 0.9638 0 TD [(\).)-503.6(HPV-16)-511.5(E6)-502.3(and)-505.1(E7-)]TJ -16.9323 -1.3858 TD 0.0133 Tc (speci)Tj /F9 1 Tf 2.0409 0 TD 0 Tc ()Tj /F8 1 Tf 0.5417 0 TD 0.0131 Tc [(c)-515.8(cellular)-517.4(i)2.2(mmune)-509.5(responses)-511.1(f)1.7(acilitate)-509.5(t)0.1(he)-509.5(regression)-516.8(of)]TJ -2.5827 -1.3921 TD 0.0182 Tc [(HPV-16-associated)-513.8(lesion)4.9(s)-518.6(\()]TJ 0.85098 0.19216 0.2 scn 12.2142 0 TD 0.0186 Tc (61)Tj 0.15294 0.15294 0.15294 scn 0.9953 0 TD 0.0173 Tc [(\).)-520.6(Similarly,)-520.6(t)4.3(h)0.3(e)-517.9(p)-4.4(ercentages)-519.5(o)0.8(f)]TJ -13.2094 -1.3858 TD 0 Tc (IFN-)Tj /F14 1 Tf 1.9528 0 TD (g)Tj /F8 1 Tf 0.9071 0 TD [(positi)-11.3(ve)-499.2(enzyme-)-13.7(linked)-509.8(immun)-9.3(ospot)-503.7(\(ELISpo)-12.3(t\))-501.5(res)-8.7(ponses)]TJ -2.8598 -1.3921 TD [(to)-401.1(HPV-16)-398.1(E6)-401.5(and)-398.1(E7)-401.5(are)-401.9(signi)]TJ /F9 1 Tf 13.2157 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(cantly)-405.4(increased)-404.5(among)-395.3(women)]TJ -13.7449 -1.3858 TD [(with)-346.5(recently)-351.9(resolved)-352.9(HPV)-349.5(infection)-347(versus)-354.9(those)-343.7(with)-352.8(persistent)]TJ 0 -1.3921 TD [(HPV-16)-303.6(infection)-302.9(in)-301.4(the)-300.6(cervix)-301.4(\()]TJ 0.85098 0.19216 0.2 scn 13.1465 0 TD (62)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj -12.548 -1.3858 TD [(Th)-7.7(era)-11.3(pe)-8.9(ut)-9.5(ic)-508.2(H)-8.5(P)0(V)-511.1(vac)-11.8(ci)-10.6(nes)-512.1(ar)-11.6(e)-503.7(d)-9.1(ev)-7.9(el)-8(oped)-519.6(to)-508.2(st)-8(imu)-14.3(late)-516.2(ce)-12.1(ll-)]TJ -1.5559 -1.3921 TD 0.0307 Tc [(me)5.8(diat)5.1(ed)-526.5(immunit)5.1(y)-531.8(f)6.7(o)1.6(r)-531.3(t)-1.2(he)-523.4(clearan)4.8(c)-0.5(e)-529.7(o)1.6(f)-528.7(i)0.9(nf)6.7(ection)-524.4(\()]TJ 0.85098 0.19216 0.2 scn 23.3827 0 TD 0.0312 Tc (63)Tj 0.15294 0.15294 0.15294 scn 1.0205 0 TD 0 Tc (,)Tj 0.85098 0.19216 0.2 scn 0.7748 0 TD 0.0312 Tc (64)Tj 0.15294 0.15294 0.15294 scn 1.0205 0 TD 0.0287 Tc (\).)Tj -26.1984 -1.3858 TD 0 Tc [(Among)-309.1(HPV)-311.7(early)-304.9(proteins)-310.9(\(E1,)-312.9(E2,)-309.5(E6,)-309.5(and)-309.9(E7\))-304.2(and)-309.9(late)-308.4(proteins)]TJ 0 -1.3921 TD [(\(L1,)-356.5(L2\),)-356.5(HPV)-355.8(E6)-351.1(and)-354(E7)-357.4(proteins)-355(are)-357.8(constitutively)-358(expressed)-359.8(in)]TJ 0 -1.3858 TD [(both)-371.7(premalignant)-381.6(and)-372.9(invasive)-377.6(lesions)-379(and)-372.9(play)-375.9(key)-375.6(roles)-373.7(in)-376.9(the)]TJ 0 -1.3921 TD [(development)-348.2(of)-349.2(malignancy)-347.4(\()]TJ 0.85098 0.19216 0.2 scn 11.9433 0 TD (65)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-346.1(Further,)-349.2(E6)-351.1(and)-347.7(E7)-344.8(can)-344.6(activate)]TJ -12.9008 -1.3858 TD (antigen-speci)Tj /F9 1 Tf 5.2913 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(c)-402.9(CD8)]TJ 6.7499 0 0 5.9992 126.1417 124.6677 Tm (+)Tj 9 0 0 9 133.6818 120.6992 Tm [(or)-402.1(CD4)]TJ 6.7499 0 0 5.9992 161.8582 124.6677 Tm (+)Tj 9 0 0 9 169.3417 120.6992 Tm [(T)-406.5(cells)-401.6(and)]TJ /F9 1 Tf 5.0205 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(nally)-407.3(evoke)-404.4(cellular)]TJ -18.8535 -1.3921 TD [(immune)-506.7(response)-11(s)-499(\()]TJ 0.85098 0.19216 0.2 scn 8.5732 0 TD (66)Tj /F12 1 Tf 0.15294 0.15294 0.15294 scn 0.9575 0 TD ()Tj /F8 1 Tf 0.85098 0.19216 0.2 scn 0.5102 0 TD (68)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-503.6(Therefore)-12.4(,)-500.1(E)0(6)-502.3(and)-498.8(E7)-502.3(pro)-8.1(teins)-504.4(are)]TJ -10.9984 -1.3858 TD 0.0136 Tc [(conside)-5(r)-0.4(ed)-518.4(ideal)-511.2(a)-2.9(ntigens)-516.9(f)2.2(or)-516.9(the)-5(r)-0.4(apeutic)-515.3(H)-1.2(PV)-517.7(vac)-5(c)1.3(in)-6(es.)-511.7(T)-2.3(LR)]TJ 0 -1.3921 TD 0 Tc [(agonists)-471.6(alone)-470.2(or)-471.4(mixed)-472(with)-472.5(other)-469.7(components)-473.8(are)-471.2(commonly)]TJ 0 -1.3858 TD [(tested)-420.1(adjuvants)-416.6(for)-413.5(therapeutic)-423(HPV)-412.5(vaccines)-421.1(\()]TJ 0.85098 0.19216 0.2 scn 19.9685 0 TD (69)Tj /F12 1 Tf 0.15294 0.15294 0.15294 scn 0.9575 0 TD ()Tj /F8 1 Tf 0.85098 0.19216 0.2 scn 0.5102 0 TD (72)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-415.4(Recently)]TJ 5.9717 29.1654 TD 0.0233 Tc [(dev)-3.7(e)-1.6(lo)-5.8(ped)-527.6(n)-2.6(ew)-528(adj)-3.9(u)-4.7(va)-5.8(nts,)-527.2(such)-529.2(as)]TJ /F14 1 Tf 15.6472 0 TD 0 Tc (a)Tj /F8 1 Tf 0.6488 0 TD 0.0245 Tc [(-G)-4.5(alactosylceramid)-3.5(e)-523.3(\()]TJ /F14 1 Tf 9.4866 0 TD 0 Tc (a)Tj /F8 1 Tf 0.6488 0 TD (-)Tj -26.4315 -1.3921 TD [(Ga)-7.8(lC)-7.4(er\))-10.8(,)-512.7(man)-11.6(gan)-12.8(ese)-517.4(\(Mn)-13.7(4)]TJ 6.7499 0 0 5.9992 405.3542 324.6803 Tm (+)Tj 9 0 0 9 409.2661 320.6551 Tm [(\)-)-8.5(dop)-9.6(ed)-512.8(s)-7.7(ili)-11.1(ca)-513.9(na)-11(nopa)-17.7(rt)-8(icl)-12.6(es)-511.3(\(Mn)-13.7(4)]TJ 6.7499 0 0 5.9992 538.866 324.6803 Tm (+)Tj 9 0 0 9 542.7778 320.6551 Tm (-)Tj -26.4315 -1.3858 TD 0.02 Tc [(SNPs\),)-524.2(and)-524.6(v)-0.7(ery)-523.6(s)-0.3(mall-size)]TJ 12.3654 0 TD 0.0221 Tc [(pro)5.6(t)-3.5(eol)7.5(i)-1.4(po)5.6(so)5.6(mes)-514.7(\()-0.3(VSSP\))-516.8(\()]TJ 0.85098 0.19216 0.2 scn 11.3071 0 TD 0.0186 Tc (73)Tj /F12 1 Tf 0.15294 0.15294 0.15294 scn 1.0016 0 TD 0 Tc ()Tj /F8 1 Tf 0.85098 0.19216 0.2 scn 0.5291 0 TD 0.0186 Tc (75)Tj 0.15294 0.15294 0.15294 scn 0.9953 0 TD 0.0224 Tc (\),)Tj -26.1984 -1.3921 TD 0.039 Tc [(might)-540.9(p)-1.6(lay)-542.4(r)-0.2(oles)-541.9(in)-541.3(reinforcing)-536.1(t)0.8(he)-534(ef)]TJ /F9 1 Tf 17.5055 0 TD 0 Tc ()Tj /F8 1 Tf 0.5732 0 TD 0.039 Tc [(cacy)-536.1(of)-539.3(the)-4.8(r)-0.2(apeutic)]TJ -18.0787 -1.3858 TD 0 Tc [(HPV)-299.1(vaccines.)]TJ 1.5496 -1.3858 TD [(Prophylac)-12.4(tic)-502.3(HPV)-500.7(vaccine)-10.3(s)-499(are)-502.7(mainly)-505(protein-b)-9.9(ased)-505.5(VLPs.)]TJ -1.5496 -1.3921 TD [(Therapeutic)-470.1(HPV)-469.2(vaccines)-471.5(are)-471.2(primarily)-476.5(based)-465.3(on)-470.8(nucleic)-475.5(acid,)]TJ 0 -1.3858 TD [(bacterial/viral)-334.8(vector,)-330.7(protein/peptide)-334.3(or)-332.9(whole)-328.3(cells)-332.3(\()]TJ 0.85098 0.19216 0.2 scn 21.5937 0 TD (76)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-333.5(To)-328.5(date,)]TJ -22.5512 -1.3921 TD [(no)-313.3(therapeutic)-322.3(HPV)-318(vaccine)-319(has)-318.4(been)-319.1(licensed.)-321.8(Safety)-324(pro)]TJ /F9 1 Tf 23.4079 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(les)-318(and)]TJ -23.937 -1.3858 TD [(vaccine)-224.5(ef)]TJ /F9 1 Tf 3.8173 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(cacy)-225.7(for)-224.5(therapeutic)-227.8(HPV)-229.8(vaccines)-225.8(tested)-231.2(in)-219.5(clinical)-231.4(trials)]TJ -4.3465 -1.3921 TD 0.0111 Tc [(a)11.1(r)-6.8(e)-505.2(s)-2.9(umm)4.2(a)0.8(rized)-508.3(in)]TJ 0.85098 0.19216 0.2 scn 8.6173 0 TD 0.0096 Tc [(Table)-513(3)]TJ 0.15294 0.15294 0.15294 scn 3.263 0 TD 0.0129 Tc [(.)-512.4(A)-503.2(com)6(p)3.8(le)12.9(t)-6.1(e)-503.4(re)12.9(g)-7.6(r)5.2(essi)12.9(on)-510.7(of)-502.4(le)12.9(s)-7.1(i)2(o)12.9(n)-4.4(s)]TJ -11.8803 -1.3858 TD 0 Tc [(triggered)-379(by)-377.4(therapeutic)-385.2(HPV)-381(vaccines)-383.3(has)-375.1(been)-382.1(reported,)-380(with)-384.3(a)]TJ 0 -1.3921 TD [(regression)-249(rate)-251.1(ranging)-248.1(from)-250.3(17.4%)-246.9(to)-250(89.4%)-246.9(in)-251(female)-250.4(patients)-253.3(\()]TJ 0.85098 0.19216 0.2 scn 25.6063 0 TD (54)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn -26.5638 -1.3858 TD (78)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5291 0 TD (81)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5291 0 TD (82)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5291 0 TD (84)Tj /F12 1 Tf 0.15294 0.15294 0.15294 scn 0.9575 0 TD ()Tj /F8 1 Tf 0.85098 0.19216 0.2 scn 0.5102 0 TD (86)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5291 0 TD (88)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5291 0 TD (89)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-308.3(The)-309.9(clearance)-319.6(of)-305.1(HPV)-311.7(DNA)-314.3(in)-307.7(infected)]TJ -9.8583 -1.3921 TD [(cells)-256.7(is)-264.2(considered)-268.8(a)-262.2(predictor)-262.4(of)-261(vaccine)-268.6(ef)]TJ /F9 1 Tf 16.9575 0 TD ()Tj /F8 1 Tf 0.5354 0 TD [(cacy,)-259.7(as)-263.6(the)-262.8(presence)-263.5(of)]TJ -17.4929 -1.3858 TD [(HPV)-223.5(DNA)-219.8(at)-224.8(the)-225(cervical)-220.8(site)-226.5(is)-220.1(often)-224(associated)-229.6(with)-220.5(histologic)-228.3(and)]TJ 0 -1.3921 TD [(cytological)-332.5(changes)-339.3(in)-332.9(cervical)-334.2(intraepithelial)-337.4(neoplasia)-338(\(CIN\))-338.7(\()]TJ 0.85098 0.19216 0.2 scn 25.6063 0 TD (77)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn -26.5638 -1.3858 TD (79)Tj /F12 1 Tf 0.15294 0.15294 0.15294 scn 0.9575 0 TD ()Tj /F8 1 Tf 0.85098 0.19216 0.2 scn 0.5102 0 TD (81)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5165 0 TD (83)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5228 0 TD (87)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5165 0 TD (90)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (\).)Tj -5.3039 -1.3921 TD 0.011 Tc [(In)-512.6(addition,)-508(v)-3.4(acc)11(i)-5.9(ne)-511.6(antigen-speci)]TJ /F9 1 Tf 14.5197 0 TD 0 Tc ()Tj /F8 1 Tf 0.5417 0 TD 0.0114 Tc [(c)-511.2(T)1.8(-cell)-507.1(r)-2.6(e)11.4(s)-8.6(ponses)-506.5(were)]TJ -16.611 -1.3858 TD 0.0585 Tc [(compr)-5.9(e)2.1(hen)-5.2(s)0.5(ivel)-6.5(y)-554.4(e)-4.2(valuate)-4.2(d)-1(.)-561.3(I)0.9(n)-559.5(a)-562.8(P)-3.1(h)3.7(ase)-564.9(I)-559.7(tr)-5.9(ial,)-561.3(A)-4.1(M)-1.4(V00)-4.2(2)]TJ 0 -1.3921 TD 0.0282 Tc [(vaccination)-526.9(i)-1.6(nduced)-529(E6)-525.9(and/o)5.4(r)-533.8(E7)-532.2(speci)]TJ /F9 1 Tf 18.085 0 TD 0 Tc ()Tj /F8 1 Tf 0.5606 0 TD 0.029 Tc [(c)-525.1(cellular)-526.7(i)-0.8(mmune)]TJ -18.6457 -1.3858 TD 0 Tc [(response)-338.6(in)-332.9(83.3%)-341.4(subjects)-338.8(\()]TJ 0.85098 0.19216 0.2 scn 11.515 0 TD (78)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\).)-339.8(In)-335.4(a)-337.8(Phase)-335.6(II)-341.9(study)-336.8(of,)-339(GX-188E,)]TJ ET 0.49804 0.49804 0.49804 scn 49.833 712.46 470.098 37.644 re f 519.931 750.104 m 545.726 750.104 l 545.726 712.46 l 519.931 712.46 l f* 0.63529 0.63529 0.63529 scn 49.606 750.104 496.346 0.28351 re f 545.726 365.839 0.22681 384.264 re f 49.606 365.839 0.22676 384.264 re f 49.833 365.839 495.893 0.22678 re f 109.871 712.46 m 49.833 712.46 l 49.833 712.686 l 109.871 712.686 l 109.871 712.46 l f* 109.871 712.46 0.22678 37.644 re f 110.098 712.46 72.624 0.22675 re f 182.721 712.46 0.22678 37.644 re f 182.948 712.46 45.808 0.22675 re f 228.756 712.46 0.22678 37.644 re f 228.983 712.46 54.709 0.22675 re f 283.691 712.46 0.28348 37.644 re f 283.975 712.46 59.754 0.22675 re f 343.729 712.46 0.22678 37.644 re f 343.956 712.46 57.657 0.22675 re f 401.612 712.46 0.22678 37.644 re f 401.839 712.46 35.773 0.22675 re f 437.612 712.46 0.22675 37.644 re f 437.839 712.46 82.091 0.22675 re f 519.931 712.46 0.22675 37.644 re f 520.157 712.46 25.568 0.22675 re f 109.871 657.864 m 49.833 657.864 l 49.833 658.091 l 109.871 658.091 l 109.871 657.864 l f* 109.871 657.864 0.22678 54.595 re f 110.098 657.864 72.624 0.22675 re f 182.721 657.864 0.22678 54.595 re f 182.948 657.864 45.808 0.22675 re f 228.756 657.864 0.22678 54.595 re f 228.983 657.864 54.709 0.22675 re f 283.691 657.864 0.28348 54.595 re f 283.975 657.864 59.754 0.22675 re f 343.729 657.864 0.22678 54.595 re f 343.956 657.864 57.657 0.22675 re f 401.612 657.864 0.22678 54.595 re f 401.839 657.864 35.773 0.22675 re f 437.612 657.864 0.22675 54.595 re f 437.839 657.864 82.091 0.22675 re f 519.931 657.864 0.22675 54.595 re f 520.157 657.864 25.568 0.22675 re f 109.871 612.737 m 49.833 612.737 l 49.833 612.964 l 109.871 612.964 l 109.871 612.737 l f* 109.871 612.737 0.22678 45.128 re f 110.098 612.737 72.624 0.22681 re f 182.721 612.737 0.22678 45.128 re f 182.948 612.737 45.808 0.22681 re f 228.756 612.737 0.22678 45.128 re f 228.983 612.737 54.709 0.22681 re f 283.691 612.737 0.28348 45.128 re f 283.975 612.737 59.754 0.22681 re f 343.729 612.737 0.22678 45.128 re f 343.956 612.737 57.657 0.22681 re f 401.612 612.737 0.22678 45.128 re f 401.839 612.737 35.773 0.22681 re f 437.612 612.737 0.22675 45.128 re f 437.839 612.737 82.091 0.22681 re f 519.931 612.737 0.22675 45.128 re f 520.157 612.737 25.568 0.22681 re f 109.871 548.617 m 49.833 548.617 l 49.833 548.901 l 109.871 548.901 l 109.871 548.617 l f* 109.871 548.617 0.22678 64.12 re f 110.098 548.617 72.624 0.28345 re f 182.721 548.617 0.22678 64.12 re f 182.948 548.617 45.808 0.28345 re f 228.756 548.617 0.22678 64.12 re f 228.983 548.617 54.709 0.28345 re f 283.691 548.617 0.28348 64.12 re f 283.975 548.617 59.754 0.28345 re f 343.729 548.617 0.22678 64.12 re f 343.956 548.617 57.657 0.28345 re f 401.612 548.617 0.22678 64.12 re f 401.839 548.617 35.773 0.28345 re f 437.612 548.617 0.22675 64.12 re f 437.839 548.617 82.091 0.28345 re f 519.931 548.617 0.22675 64.12 re f 520.157 548.617 25.568 0.28345 re f 109.871 503.546 m 49.833 503.546 l 49.833 503.773 l 109.871 503.773 l 109.871 503.546 l f* 109.871 503.546 0.22678 45.071 re f 110.098 503.546 72.624 0.22675 re f 182.721 503.546 0.22678 45.071 re f 182.948 503.546 45.808 0.22675 re f 228.756 503.546 0.22678 45.071 re f 228.983 503.546 54.709 0.22675 re f 283.691 503.546 0.28348 45.071 re f 283.975 503.546 59.754 0.22675 re f 343.729 503.546 0.22678 45.071 re f 343.956 503.546 57.657 0.22675 re f 401.612 503.546 0.22678 45.071 re f 401.839 503.546 35.773 0.22675 re f 437.612 503.546 0.22675 45.071 re f 437.839 503.546 82.091 0.22675 re f 519.931 503.546 0.22675 45.071 re f 520.157 503.546 25.568 0.22675 re f 109.871 448.951 m 49.833 448.951 l 49.833 449.178 l 109.871 449.178 l 109.871 448.951 l f* 109.871 448.951 0.22678 54.595 re f 110.098 448.951 72.624 0.22678 re f 182.721 448.951 0.22678 54.595 re f 182.948 448.951 45.808 0.22678 re f 228.756 448.951 0.22678 54.595 re f 228.983 448.951 54.709 0.22678 re f 283.691 448.951 0.28348 54.595 re f 283.975 448.951 59.754 0.22678 re f 343.729 448.951 0.22678 54.595 re f 343.956 448.951 57.657 0.22678 re f 401.612 448.951 0.22678 54.595 re f 401.839 448.951 35.773 0.22678 re f 437.612 448.951 0.22675 54.595 re f 437.839 448.951 82.091 0.22678 re f 519.931 448.951 0.22675 54.595 re f 520.157 448.951 25.568 0.22678 re f 109.871 366.066 0.22678 82.885 re f 182.721 366.066 0.22678 82.885 re f 228.756 366.066 0.22678 82.885 re f 283.691 366.066 0.28348 82.885 re f 343.729 366.066 0.22678 82.885 re f 401.612 366.066 0.22678 82.885 re f 437.612 366.066 0.22675 82.885 re f 519.931 366.066 0.22675 82.885 re f BT /F5 1 Tf 6.9999 0 0 6.9999 49.6063 760.3652 Tm 0.49804 0.49804 0.49412 scn [(TABLE)-306.1(2)-796.8(Summary)-301.7(of)-303.6(prophylactic)-300.7(HPV)-301.2(vaccines)-306.6(in)-302.3(clinical)-297.1(trials.)]TJ /F1 1 Tf 9 0 0 9 58.5638 728.277 Tm 1 1 1 scn [(HPV)-301.3(types)]TJ 7.2945 0.5543 TD (Expression)Tj 0.8126 -1.1087 TD (System)Tj 6.2488 0.5543 TD [(Adjuvant)-1715.2(Sponsor)-1986.7(Indications)]TJ 18.7591 1.1087 TD (Ef)Tj /F10 1 Tf 0.9071 0 TD ()Tj /F1 1 Tf 0.5795 0 TD (cacy)Tj -0.5417 -1.1087 TD (and)Tj -1.4614 -1.1087 TD (outcomes)Tj 6.1732 1.1087 TD (Phase)Tj 4.0567 0.5543 TD (ClinicalTrials.gov)Tj 1.8142 -1.1087 TD (Identi)Tj /F10 1 Tf 2.6142 0 TD ()Tj /F1 1 Tf 0.5795 0 TD (er)Tj 3.9874 0.5543 TD (Ref.)Tj /F8 1 Tf 6.9999 0 0 6.9999 55.2756 692.4471 Tm 0.15294 0.15294 0.15294 scn (HPV-6/11/16/18/)Tj 0.4698 -1.3606 TD (31/33/45/52/58)Tj 1.0772 -1.3526 TD (\(9-valent\))Tj 10.3912 1.3526 TD [(N.)-298.4(A.)-6327.5(N.)-306.5(A.)]TJ 14.4569 2.7132 TD [(Instituto)-301.7(de)]TJ -0.3159 -1.3526 TD (Investigacio)Tj /F15 1 Tf 4.6651 0.0405 TD ()Tj /F8 1 Tf 0.081 -0.0405 TD (n)Tj -3.7985 -1.3606 TD (Hospital)Tj -0.9314 -1.3526 TD (Universitario)Tj 1.2878 -1.3607 TD [(La)-303.6(Paz)]TJ 6.5198 4.7542 TD [(HPV)-297.4(infection;)]TJ 1.8466 -1.3607 TD (HPV-)Tj -0.2916 -1.3526 TD (Related)Tj -0.8423 -1.3607 TD (Carcinoma.)Tj 9.808 2.0329 TD [(N.A.)-5265.3(IV)-5012(NCT05439083)-3870(N.A.)]TJ -44.4237 -5.7585 TD (HPV-6/11/16/18/)Tj 0.4698 -1.3607 TD (31/33/45/52/58)Tj 1.0772 -1.3607 TD (\(9-valent\))Tj 10.3912 1.3607 TD [(N.)-298.4(A.)-6327.5(N.)-306.5(A.)]TJ 13.5822 1.3607 TD [(Shanghai)-297.6(Bovax)]TJ 0.3483 -1.3607 TD (Biotechnology)Tj 1.1258 -1.3607 TD [(Co.,)-295.1(Ltd.)]TJ 6.6899 3.3935 TD [(HPV)-297.4(Infections;)]TJ 2.0653 -1.3526 TD (HPV-)Tj -0.2916 -1.3607 TD (Related)Tj -0.8423 -1.3526 TD (Carcinoma.)Tj 7.6213 4.0658 TD [(Non-inferior)-304.7(to)]TJ 0.5102 -1.3526 TD [(Gardasil)-304.7(4)-298.5(i)0(n)]TJ -0.6722 -1.3607 TD (immunogenicity)Tj 1.2473 -1.3526 TD [(and)-300(safety)]TJ 8.2449 2.0329 TD [(III)-5026.8(NCT04895020)-3983.4(\()]TJ 0.85098 0.19216 0.2 scn 16.1902 0 TD (56)Tj 0.15294 0.15294 0.15294 scn 0.9638 0 TD (\))Tj -68.7211 -6.4388 TD (HPV-6/11/16/18/)Tj 0.4698 -1.3606 TD (31/33/45/52/58)Tj 1.0772 -1.3607 TD (\(9-valent\))Tj 10.3912 1.3607 TD [(N.)-298.4(A.)-6327.5(N.)-306.5(A.)]TJ 13.971 2.0329 TD [(Weill)-302(Medical)]TJ 0.7937 -1.3526 TD [(College)-301.8(of)]TJ 0.5345 -1.3606 TD (Cornell)Tj -0.5912 -1.3526 TD (University)Tj 7.5646 5.4264 TD [(HPV)-305.5(Positive)]TJ -0.2835 -1.3606 TD (Oropharyngeal)Tj 0.0081 -1.3526 TD [(Squamous)-299.3(Cell)]TJ 0.6803 -1.3606 TD (Carcinoma;)Tj -1.0448 -1.3526 TD (HIV-1-infection;)Tj 0.2916 -1.3607 TD [(HPV)-305.5(Infection.)]TJ 10.5613 3.3935 TD [(N.A.)-5281.5(III)-5026.8(NCT04255849)-3870(N.A.)]TJ -44.4237 -5.7666 TD (HPV-6/11/16/18/)Tj 0.3078 -1.3526 TD (31/33/45/52/58/)Tj 2.0815 -1.3607 TD (59/68)Tj -1.0772 -1.3526 TD (\(11-valent\))Tj /F11 1 Tf 7.2082 2.0329 TD (Hansenulapolymorpha)Tj /F8 1 Tf 11.9057 0 TD [(N.)-306.5(A.)]TJ 6.5684 2.0329 TD (National)Tj -0.7613 -1.3526 TD [(Vaccine)-299.7(and)]TJ 1.1987 -1.3607 TD (Serum)Tj -1.8547 -1.3526 TD [(Institute,)-305.4(China)]TJ 8.3259 4.0658 TD [(HPV)-297.4(infection;)]TJ 1.8466 -1.3526 TD (HPV-)Tj -0.2916 -1.3607 TD (Related)Tj -0.8423 -1.3526 TD (Carcinoma.)Tj 9.808 2.0329 TD [(N.A.)-5281.5(III)-5026.8(NCT05262010)-3870(N.A.)]TJ -44.4237 -4.4059 TD (HPV-6/11/16/18/)Tj 0.3078 -1.3607 TD (31/33/35/39/45/)Tj 0.162 -1.3525 TD (51/52/56/58/59)Tj 0.899 -1.3607 TD (\(14-valent,)Tj -1.3688 -1.3607 TD [(named)-303.1(SCT1000\))]TJ 10.8285 2.7213 TD [(Insect)-308.9(cells)]TJ 8.3016 2.0329 TD (Aluminum-)Tj 0.1377 -1.3606 TD (phosphate-)Tj 1.1258 -1.3526 TD (based)Tj -0.6155 -1.3607 TD (adjuvant)Tj 6.5603 2.7132 TD (Sinocelltech)Tj 1.6036 -1.3526 TD (Ltd.)Tj 5.961 2.7132 TD [(HPV)-297.4(infection;)]TJ 1.8466 -1.3606 TD (HPV-)Tj -0.2916 -1.3526 TD (Related)Tj -0.8423 -1.3607 TD (Carcinoma.)Tj 9.808 2.041 TD [(N.A.)-5281.5(III)-5026.8(NCT06041061)-3870(N.A.)]TJ -44.4237 -7.1272 TD (HPV-6/11/16/18/)Tj 0.3078 -1.3526 TD (31/33/35/39/45/)Tj 0 -1.3607 TD (51/52/56/58/59/)Tj 2.7213 -1.3526 TD (68)Tj -1.717 -1.3607 TD (\(15-valent\))Tj /F11 1 Tf 8.658 2.7132 TD [(Escherichia)-303.2(coli)]TJ /F8 1 Tf 10.456 0 TD [(N.)-306.5(A.)]TJ 5.0782 4.7542 TD [(Liaoning)-303(Cheng)]TJ 2.6403 -1.3607 TD (Da)Tj -2.2759 -1.3607 TD (Biotechnology)Tj 1.1258 -1.3526 TD [(Co.,)-295.1(Ltd;)]TJ -1.1501 -1.3607 TD [(Beijing)-301.6(Health)]TJ 1.6036 -1.3526 TD (Guard)Tj -1.5793 -1.3606 TD (Biotechnology)Tj 2.0977 -1.3526 TD (Inc.)Tj 5.9367 6.779 TD [(HPV)-297.4(infection;)]TJ 1.8466 -1.3526 TD (HPV-)Tj -0.2916 -1.3607 TD (Related)Tj -0.8423 -1.3526 TD (Carcinoma.)Tj 9.808 2.0329 TD (N.A.)Tj 6.9999 0 0 6.9999 413.4046 409.9464 Tm (IND)Tj -0.9638 -1.3607 TD (Approval)Tj 10.1563 0.6803 TD [(/)-6627.1(N.A.)]TJ 6.5001 0 0 6.5001 49.6063 357.3354 Tm [(N.A.,)-301(not)-305.4(available.)]TJ /F1 1 Tf 6.9999 0 0 6.9999 49.6063 800.9573 Tm 0.49804 0.49804 0.49412 scn [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.5051 0 TD (05)Tj ET endstream endobj 116 0 obj<> endobj 117 0 obj<> endobj 118 0 obj<> endobj 119 0 obj<> endobj 120 0 obj<> endobj 121 0 obj<> endobj 122 0 obj<> endobj 123 0 obj<> endobj 124 0 obj<> endobj 125 0 obj<> endobj 126 0 obj<> endobj 127 0 obj<> endobj 128 0 obj<> endobj 129 0 obj<> endobj 130 0 obj<> endobj 131 0 obj<> endobj 132 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 133 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 134 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 135 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 136 0 obj<>stream /Cs6 cs 0.49804 0.49804 0.49804 scn /GS1 gs 49.833 712.46 353.537 37.644 re f 403.37 750.104 m 452.693 750.104 l 452.693 712.46 l 403.37 712.46 l f* 452.693 712.46 46.998 37.644 re f 499.691 750.104 m 545.726 750.104 l 545.726 712.46 l 499.691 712.46 l f* 0.63529 0.63529 0.63529 scn 49.606 750.104 496.346 0.28351 re f 545.726 83.452 0.22681 666.652 re f 49.606 83.452 0.22676 666.652 re f 49.833 83.452 495.893 0.22675 re f 100.517 712.46 m 49.833 712.46 l 49.833 712.686 l 100.516 712.686 l 100.516 712.46 l f* 100.517 712.46 0.22676 37.644 re f 100.743 712.46 55.786 0.22675 re f 156.529 712.46 0.22678 37.644 re f 156.756 712.46 45.808 0.22675 re f 202.564 712.46 0.22678 37.644 re f 248.315 712.46 m 202.79 712.46 l 202.79 712.686 l 248.315 712.686 l 248.315 712.46 l f* 248.315 712.46 0.22676 37.644 re f 248.542 712.46 54.822 0.22675 re f 303.364 712.46 0.22675 37.644 re f 303.59 712.46 99.78 0.22675 re f 403.37 712.46 0.22678 37.644 re f 403.597 712.46 49.096 0.22675 re f 452.693 712.46 0.28345 37.644 re f 452.976 712.46 46.715 0.22675 re f 499.691 712.46 0.28345 37.644 re f 499.975 712.46 45.751 0.22675 re f 100.517 657.864 m 49.833 657.864 l 49.833 658.091 l 100.516 658.091 l 100.516 657.864 l f* 100.517 657.864 0.22676 54.595 re f 100.743 657.864 55.786 0.22675 re f 156.529 657.864 0.22678 54.595 re f 156.756 657.864 45.808 0.22675 re f 202.564 657.864 0.22678 54.595 re f 248.315 657.864 m 202.79 657.864 l 202.79 658.091 l 248.315 658.091 l 248.315 657.864 l f* 248.315 657.864 0.22676 54.595 re f 248.542 657.864 54.822 0.22675 re f 303.364 657.864 0.22675 54.595 re f 303.59 657.864 99.78 0.22675 re f 403.37 657.864 0.22678 54.595 re f 403.597 657.864 49.096 0.22675 re f 452.693 657.864 0.28345 54.595 re f 452.976 657.864 46.715 0.22675 re f 499.691 657.864 0.28345 54.595 re f 499.975 657.864 45.751 0.22675 re f 100.517 612.737 m 49.833 612.737 l 49.833 612.964 l 100.516 612.964 l 100.516 612.737 l f* 100.517 612.737 0.22676 45.128 re f 100.743 612.737 55.786 0.22681 re f 156.529 612.737 0.22678 45.128 re f 156.756 612.737 45.808 0.22681 re f 202.564 612.737 0.22678 45.128 re f 248.315 612.737 m 202.79 612.737 l 202.79 612.964 l 248.315 612.964 l 248.315 612.737 l f* 248.315 612.737 0.22676 45.128 re f 248.542 612.737 54.822 0.22681 re f 303.364 612.737 0.22675 45.128 re f 303.59 612.737 99.78 0.22681 re f 403.37 612.737 0.22678 45.128 re f 403.597 612.737 49.096 0.22681 re f 452.693 612.737 0.28345 45.128 re f 452.976 612.737 46.715 0.22681 re f 499.691 612.737 0.28345 45.128 re f 499.975 612.737 45.751 0.22681 re f 100.517 577.134 m 49.833 577.134 l 49.833 577.417 l 100.516 577.417 l 100.516 577.134 l f* 100.517 577.134 0.22676 35.603 re f 100.743 577.134 55.786 0.28345 re f 156.529 577.134 0.22678 35.603 re f 156.756 577.134 45.808 0.28345 re f 202.564 577.134 0.22678 35.603 re f 248.315 577.134 m 202.79 577.134 l 202.79 577.417 l 248.315 577.417 l 248.315 577.134 l f* 248.315 577.134 0.22676 35.603 re f 248.542 577.134 54.822 0.28345 re f 303.364 577.134 0.22675 35.603 re f 303.59 577.134 99.78 0.28345 re f 403.37 577.134 0.22678 35.603 re f 403.597 577.134 49.096 0.28345 re f 452.693 577.134 0.28345 35.603 re f 452.976 577.134 46.715 0.28345 re f 499.691 577.134 0.28345 35.603 re f 499.975 577.134 45.751 0.28345 re f 100.517 532.063 m 49.833 532.063 l 49.833 532.29 l 100.516 532.29 l 100.516 532.063 l f* 100.517 532.063 0.22676 45.071 re f 100.743 532.063 55.786 0.22681 re f 156.529 532.063 0.22678 45.071 re f 156.756 532.063 45.808 0.22681 re f 202.564 532.063 0.22678 45.071 re f 248.315 532.063 m 202.79 532.063 l 202.79 532.29 l 248.315 532.29 l 248.315 532.063 l f* 248.315 532.063 0.22676 45.071 re f 248.542 532.063 54.822 0.22681 re f 303.364 532.063 0.22675 45.071 re f 303.59 532.063 99.78 0.22681 re f 403.37 532.063 0.22678 45.071 re f 403.597 532.063 49.096 0.22681 re f 452.693 532.063 0.28345 45.071 re f 452.976 532.063 46.715 0.22681 re f 499.691 532.063 0.28345 45.071 re f 499.975 532.063 45.751 0.22681 re f 100.517 505.927 m 49.833 505.927 l 49.833 506.211 l 100.516 506.211 l 100.516 505.927 l f* 100.517 505.927 0.22676 26.135 re f 100.743 505.927 55.786 0.28345 re f 156.529 505.927 0.22678 26.135 re f 156.756 505.927 45.808 0.28345 re f 202.564 505.927 0.22678 26.135 re f 248.315 505.927 m 202.79 505.927 l 202.79 506.211 l 248.315 506.211 l 248.315 505.927 l f* 248.315 505.927 0.22676 26.135 re f 248.542 505.927 54.822 0.28345 re f 303.364 505.927 0.22675 26.135 re f 303.59 505.927 99.78 0.28345 re f 403.37 505.927 0.22678 26.135 re f 403.597 505.927 49.096 0.28345 re f 452.693 505.927 0.28345 26.135 re f 452.976 505.927 46.715 0.28345 re f 499.691 505.927 0.28345 26.135 re f 499.975 505.927 45.751 0.28345 re f 100.517 470.324 m 49.833 470.324 l 49.833 470.608 l 100.516 470.608 l 100.516 470.324 l f* 100.517 470.324 m 100.517 505.927 l 100.743 505.927 l 100.743 470.324 l 100.517 470.324 l f* 100.743 470.324 55.786 0.28345 re f 156.529 470.324 m 156.529 505.927 l 156.756 505.927 l 156.756 470.324 l 156.529 470.324 l f* 156.756 470.324 45.808 0.28345 re f 202.564 470.324 m 202.564 505.927 l 202.79 505.927 l 202.79 470.324 l 202.564 470.324 l f* 248.315 470.324 m 202.79 470.324 l 202.79 470.608 l 248.315 470.608 l 248.315 470.324 l f* 248.315 470.324 m 248.315 505.927 l 248.542 505.927 l 248.542 470.324 l 248.315 470.324 l f* 248.542 470.324 54.822 0.28345 re f 303.364 470.324 m 303.364 505.927 l 303.59 505.927 l 303.59 470.324 l 303.364 470.324 l f* 303.59 470.324 99.78 0.28345 re f 403.37 470.324 m 403.37 505.927 l 403.597 505.927 l 403.597 470.324 l 403.37 470.324 l f* 403.597 470.324 49.096 0.28345 re f 452.693 470.324 m 452.693 505.927 l 452.976 505.927 l 452.976 470.324 l 452.693 470.324 l f* 452.976 470.324 46.715 0.28345 re f 499.691 470.324 m 499.691 505.927 l 499.975 505.927 l 499.975 470.324 l 499.691 470.324 l f* 499.975 470.324 45.751 0.28345 re f 100.517 425.253 m 49.833 425.253 l 49.833 425.48 l 100.516 425.48 l 100.516 425.253 l f* 100.517 425.253 0.22676 45.071 re f 100.743 425.253 55.786 0.22678 re f 156.529 425.253 0.22678 45.071 re f 156.756 425.253 45.808 0.22678 re f 202.564 425.253 0.22678 45.071 re f 248.315 425.253 m 202.79 425.253 l 202.79 425.48 l 248.315 425.48 l 248.315 425.253 l f* 248.315 425.253 0.22676 45.071 re f 248.542 425.253 54.822 0.22678 re f 303.364 425.253 0.22675 45.071 re f 303.59 425.253 99.78 0.22678 re f 403.37 425.253 0.22678 45.071 re f 403.597 425.253 49.096 0.22678 re f 452.693 425.253 0.28345 45.071 re f 452.976 425.253 46.715 0.22678 re f 499.691 425.253 0.28345 45.071 re f 499.975 425.253 45.751 0.22678 re f 100.517 361.134 m 49.833 361.134 l 49.833 361.417 l 100.516 361.417 l 100.516 361.134 l f* 100.517 361.134 0.22676 64.12 re f 100.743 361.134 55.786 0.28345 re f 156.529 361.134 0.22678 64.12 re f 156.756 361.134 45.808 0.28345 re f 202.564 361.134 0.22678 64.12 re f 248.315 361.134 m 202.79 361.134 l 202.79 361.417 l 248.315 361.417 l 248.315 361.134 l f* 248.315 361.134 0.22676 64.12 re f 248.542 361.134 54.822 0.28345 re f 303.364 361.134 0.22675 64.12 re f 303.59 361.134 99.78 0.28345 re f 403.37 361.134 0.22678 64.12 re f 403.597 361.134 49.096 0.28345 re f 452.693 361.134 0.28345 64.12 re f 452.976 361.134 46.715 0.28345 re f 499.691 361.134 0.28345 64.12 re f 499.975 361.134 45.751 0.28345 re f 100.517 316.063 m 49.833 316.063 l 49.833 316.29 l 100.516 316.29 l 100.516 316.063 l f* 100.517 316.063 0.22676 45.071 re f 100.743 316.063 55.786 0.22675 re f 156.529 316.063 0.22678 45.071 re f 156.756 316.063 45.808 0.22675 re f 202.564 316.063 0.22678 45.071 re f 248.315 316.063 m 202.79 316.063 l 202.79 316.29 l 248.315 316.29 l 248.315 316.063 l f* 248.315 316.063 0.22676 45.071 re f 248.542 316.063 54.822 0.22675 re f 303.364 316.063 0.22675 45.071 re f 303.59 316.063 99.78 0.22675 re f 403.37 316.063 0.22678 45.071 re f 403.597 316.063 49.096 0.22675 re f 452.693 316.063 0.28345 45.071 re f 452.976 316.063 46.715 0.22675 re f 499.691 316.063 0.28345 45.071 re f 499.975 316.063 45.751 0.22675 re f 100.517 280.46 m 49.833 280.46 l 49.833 280.687 l 100.516 280.687 l 100.516 280.46 l f* 100.517 280.46 0.22676 35.603 re f 100.743 280.46 55.786 0.22675 re f 156.529 280.46 0.22678 35.603 re f 156.756 280.46 45.808 0.22675 re f 202.564 280.46 0.22678 35.603 re f 248.315 280.46 m 202.79 280.46 l 202.79 280.687 l 248.315 280.687 l 248.315 280.46 l f* 248.315 280.46 0.22676 35.603 re f 248.542 280.46 54.822 0.22675 re f 303.364 280.46 0.22675 35.603 re f 303.59 280.46 99.78 0.22675 re f 403.37 280.46 0.22678 35.603 re f 403.597 280.46 49.096 0.22675 re f 452.693 280.46 0.28345 35.603 re f 452.976 280.46 46.715 0.22675 re f 499.691 280.46 0.28345 35.603 re f 499.975 280.46 45.751 0.22675 re f 100.517 254.324 m 49.833 254.324 l 49.833 254.608 l 100.516 254.608 l 100.516 254.324 l f* 100.517 254.324 0.22676 26.135 re f 100.743 254.324 55.786 0.28346 re f 156.529 254.324 0.22678 26.135 re f 156.756 254.324 45.808 0.28346 re f 202.564 254.324 0.22678 26.135 re f 248.315 254.324 m 202.79 254.324 l 202.79 254.608 l 248.315 254.608 l 248.315 254.324 l f* 248.315 254.324 0.22676 26.135 re f 248.542 254.324 54.822 0.28346 re f 303.364 254.324 0.22675 26.135 re f 303.59 254.324 99.78 0.28346 re f 403.37 254.324 0.22678 26.135 re f 403.597 254.324 49.096 0.28346 re f 452.693 254.324 0.28345 26.135 re f 452.976 254.324 46.715 0.28346 re f 499.691 254.324 0.28345 26.135 re f 499.975 254.324 45.751 0.28346 re f 100.517 209.254 m 49.833 209.254 l 49.833 209.48 l 100.516 209.48 l 100.516 209.254 l f* 100.517 209.254 0.22676 45.071 re f 100.743 209.254 55.786 0.22676 re f 156.529 209.254 0.22678 45.071 re f 156.756 209.254 45.808 0.22676 re f 202.564 209.254 0.22678 45.071 re f 248.315 209.254 m 202.79 209.254 l 202.79 209.48 l 248.315 209.48 l 248.315 209.254 l f* 248.315 209.254 0.22676 45.071 re f 248.542 209.254 54.822 0.22676 re f 303.364 209.254 0.22675 45.071 re f 303.59 209.254 99.78 0.22676 re f 403.37 209.254 0.22678 45.071 re f 403.597 209.254 49.096 0.22676 re f 452.693 209.254 0.28345 45.071 re f 452.976 209.254 46.715 0.22676 re f 499.691 209.254 0.28345 45.071 re f 499.975 209.254 45.751 0.22676 re f 100.517 183.118 m 49.833 183.118 l 49.833 183.402 l 100.516 183.402 l 100.516 183.118 l f* 100.517 183.118 0.22676 26.135 re f 100.743 183.118 55.786 0.28346 re f 156.529 183.118 0.22678 26.135 re f 156.756 183.118 45.808 0.28346 re f 202.564 183.118 0.22678 26.135 re f 248.315 183.118 m 202.79 183.118 l 202.79 183.402 l 248.315 183.402 l 248.315 183.118 l f* 248.315 183.118 0.22676 26.135 re f 248.542 183.118 54.822 0.28346 re f 303.364 183.118 0.22675 26.135 re f 303.59 183.118 99.78 0.28346 re f 403.37 183.118 0.22678 26.135 re f 403.597 183.118 49.096 0.28346 re f 452.693 183.118 0.28345 26.135 re f 452.976 183.118 46.715 0.28346 re f 499.691 183.118 0.28345 26.135 re f 499.975 183.118 45.751 0.28346 re f 100.517 128.523 m 49.833 128.523 l 49.833 128.806 l 100.516 128.806 l 100.516 128.523 l f* 100.517 128.523 0.22676 54.595 re f 100.743 128.523 55.786 0.28348 re f 156.529 128.523 0.22678 54.595 re f 156.756 128.523 45.808 0.28348 re f 202.564 128.523 0.22678 54.595 re f 248.315 128.523 m 202.79 128.523 l 202.79 128.806 l 248.315 128.806 l 248.315 128.523 l f* 248.315 128.523 0.22676 54.595 re f 248.542 128.523 54.822 0.28348 re f 303.364 128.523 0.22675 54.595 re f 303.59 128.523 99.78 0.28348 re f 403.37 128.523 0.22678 54.595 re f 403.597 128.523 49.096 0.28348 re f 452.693 128.523 0.28345 54.595 re f 452.976 128.523 46.715 0.28348 re f 499.691 128.523 0.28345 54.595 re f 499.975 128.523 45.751 0.28348 re f 100.517 83.679 0.22676 44.844 re f 156.529 83.679 0.22678 44.844 re f 202.564 83.679 0.22678 44.844 re f 248.315 83.679 0.22676 44.844 re f 303.364 83.679 0.22675 44.844 re f 403.37 83.679 0.22678 44.844 re f 452.693 83.679 0.28345 44.844 re f 499.691 83.679 0.28345 44.844 re f BT /F5 1 Tf 6.9999 0 0 6.9999 49.6063 760.3652 Tm 0.49804 0.49804 0.49412 scn 0 Tc 0 Tw [(TABLE)-306.1(3)-796.8(Summary)-301.7(of)-303.6(therapeutic)-302.7(HPV)-301.2(vaccines)-298.5(evalsuated)-303.4(as)-301.7(monotherapy)-302.4(in)-302.3(clinical)-305.2(trials.)]TJ /F1 1 Tf 9 0 0 9 62.8724 738.255 Tm 1 1 1 scn (Name)Tj 0.8945 -1.1087 TD (of)Tj -1.3354 -1.1087 TD (Vaccine)Tj 5.8583 1.1087 TD [(Sponsor)-1772.6(Adjuvant)-1097.9(Antigens)-1097.4(Indications)-3697.8(Outcomes)]TJ 33.3606 0.5543 TD (Vaccine)Tj 0.4724 -1.1087 TD (Types)Tj 5.3291 0.5543 TD [(Phase)-2928.1(Ref.)]TJ /F8 1 Tf 6.9999 0 0 6.9999 59.5275 687.6849 Tm 0.15294 0.15294 0.15294 scn (pNGVL4a-)Tj 0.6074 -1.3526 TD (CRT/E7)Tj 6.1715 3.3854 TD [(Sidney)-301.3(Kimmel)]TJ -0.0405 -1.3526 TD (Comprehensive)Tj 0.2187 -1.3606 TD [(Cancer)-304.4(Center)]TJ 2.5431 -1.3526 TD (at)Tj -2.6241 -1.3607 TD [(Johns)-301.4(Hopkins)]TJ 9.2006 2.7132 TD [(N.)-306.5(A.)-4950.7(E7)]TJ 13.1773 1.3606 TD (HPV-16)Tj 0.1053 -1.3606 TD (Positive)Tj -0.0972 -1.3526 TD [(CIN)-304.9(2/3)]TJ 9.7433 2.0329 TD (Well-tolerated.)Tj -2.2516 -1.3526 TD [(Robust)-302(immune)-308(response.)]TJ 14.8295 0.6722 TD [(DNA)-5636.4(I)-5652.3(\()]TJ 0.85098 0.19216 0.2 scn 14.1249 0 TD (77)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -66.2833 -7.1191 TD (AMV002)Tj 7.9776 2.0329 TD (Jingang)Tj -0.3483 -1.3526 TD (Medicine)Tj -0.2916 -1.3607 TD (\(Australia\))Tj 0.6641 -1.3526 TD [(Pty)-297.9(Ltd)]TJ 7.6942 2.0329 TD [(N.)-306.5(A.)-4173.2(E6,)-304.2(E7)]TJ 13.6551 1.3607 TD (HPV-)Tj -0.8261 -1.3607 TD (associated)Tj 0.4697 -1.3607 TD (OPSCC)Tj 9.6623 3.3935 TD [(Well)-302.8(tolerated.)]TJ -1.5145 -1.3526 TD [(E6/E7)-301.2(Speci)]TJ /F9 1 Tf 4.7866 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(c)-296.7(cellular)]TJ -7.1677 -1.3607 TD [(responses)-306(were)-305.7(elicited)-302.5(in)-300.5(10)-305.5(of)]TJ 2.4216 -1.3526 TD [(12)-297.4(\(83.3%\))-302.6(subjects)]TJ 13.4851 2.0329 TD [(DNA)-5636.4(I)-5652.3(\()]TJ 0.85098 0.19216 0.2 scn 14.1249 0 TD (78)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -66.4696 -5.7666 TD (INO-3112)Tj 8.3826 0.6803 TD (Inovio)Tj -1.9681 -1.3526 TD (Pharmaceuticals)Tj 9.4679 0.6722 TD [(N.)-306.5(A.)-4173.2(E6,)-304.2(E7)-2822.3(Cervical)-298.6(cancer)]TJ 20.8634 1.3606 TD [(Antibody)-306(responses)-306(were)]TJ 0.6155 -1.3606 TD [(detected)-304.3(in)-308.6(up)-296.4(to)-299.5(60%)]TJ 2.2111 -1.3526 TD [(of)-302.4(patients.)]TJ 11.8166 1.3526 TD [(DNA)-5474.4(II)-5481.2(\()]TJ 0.85098 0.19216 0.2 scn 14.1249 0 TD (79)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -66.1375 -5.7585 TD (VB10.16)Tj 7.7833 1.3526 TD (Nykode)Tj -1.0205 -1.3526 TD (Therapeutics)Tj 2.0005 -1.3606 TD (AS)Tj 6.7871 1.3606 TD [(N.)-306.5(A.)-4173.2(E6,)-304.2(E7)-4393.5(CIN2/3)]TJ 20.6042 2.0329 TD [(Eliciting)-303.3(CD8)]TJ 5.2498 0 0 4.6661 354.6707 569.7637 Tm (+)Tj 6.9999 0 0 6.9999 359.7731 566.6456 Tm [(T)-301.2(cells)-296.4(and)]TJ -6.6332 -1.3606 TD [(robust)-301(immune)-299.9(responses)-306(to)]TJ 0.486 -1.3526 TD [(regress)-307.4(the)-298(lesion)-301.3(size)-301.5(and)]TJ 0.1134 -1.3607 TD [(grade)-299.6(in)-300.5(CIN2/3)-304.6(patients.)]TJ 14.7242 2.041 TD [(DNA)-5474.4(II)-5481.2(\()]TJ 0.85098 0.19216 0.2 scn 14.1249 0 TD (80)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -66.2833 -5.0863 TD [(GX-188E)-3899.2(Genexine)-4325.1(N.)-306.5(A.)-4173.2(E6,)-304.2(E7)-4393.5(CIN2/3)]TJ 35.7091 0.6722 TD [(Signicant)-301.9(HPV)-305.5(clearance)-308.1(and)]TJ 0.5507 -1.3526 TD [(histopathologic)-299.9(regression.)]TJ 14.9429 0.6803 TD [(DNA)-5474.4(II)-5481.2(\()]TJ 0.85098 0.19216 0.2 scn 14.1249 0 TD (81)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -66.5911 -4.414 TD (VGX-3100)Tj 8.5041 0.6803 TD (Inovio)Tj -1.9681 -1.3526 TD (Pharmaceuticals)Tj 9.4679 0.6722 TD [(N.)-306.5(A.)-4173.2(E6,)-304.2(E7)-5033.4(CIN)]TJ 19.5189 1.3607 TD [(Showed)-297.8(ef)]TJ /F9 1 Tf 4.1225 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cacy)-297.8(against)-303(CIN2/3)]TJ -4.0253 -1.3607 TD [(associated)-309(with)-303.4(HPV-16)-297.5(and)]TJ 3.9929 -1.3526 TD (HPV-18.)Tj 11.3631 1.3526 TD [(DNA)-5223.4(IIb)-5232.3(\()]TJ 0.85098 0.19216 0.2 scn 14.1249 0 TD (82)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -66.0403 -5.7585 TD [(ISA)-301.9(201)]TJ 8.5041 0.6803 TD (ISA)Tj -2.5188 -1.3607 TD (Pharmaceuticals)Tj 9.4679 0.6803 TD [(N.)-306.5(A.)-4950.7(E6)]TJ 12.1406 2.0329 TD [(HPV)-297.4(positive)]TJ 0.5264 -1.3526 TD [(Tumors)-308.7(or)]TJ 0.1134 -1.3607 TD (Malignant)Tj 0.575 -1.3607 TD (Lesions)Tj 9.6056 3.3935 TD [(Well)-302.8(tolerated.)]TJ -2.535 -1.3526 TD [(Robust)-302(HPV-16-speci)]TJ /F9 1 Tf 8.7633 0 TD ()Tj /F8 1 Tf 0.5345 0 TD 0.2967 Tc [(cT)296.7(-)]TJ -6.7223 -1.3607 TD 0 Tc [(cell)-304.1(immunity.)]TJ 12.0839 1.3607 TD [(Peptide)-5216.6(I)-5652.3(\()]TJ 0.85098 0.19216 0.2 scn 14.546 0 TD (83)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -65.9998 -7.7995 TD (PepCan)Tj 6.5846 2.0329 TD [(University)-302.6(of)]TJ 0.0486 -1.3607 TD [(Arkansas)-310(for)]TJ 0.98 -1.3526 TD (Medical)Tj -0.0567 -1.3607 TD (Sciences)Tj 7.2568 3.3935 TD (Candida)Tj 0.8585 -1.3526 TD (skin)Tj -1.4821 -1.3607 TD [(test)-300.6(reagent)]TJ 8.3421 1.3607 TD [(E6)-5179.1(CIN2/3)]TJ 12.9181 3.3935 TD [(Regression)-311.5(rate:)-295.9(50%)-300.6(\(50)-302.6(and)]TJ 4.2115 -1.3607 TD (100)Tj /F14 1 Tf 1.7413 0 TD (m)Tj /F8 1 Tf 0.5669 0 TD (g\).)Tj -6.941 -1.3607 TD [(A)-301.1(trend)-303(of)-302.4(lower)-295.7(doses)-306.3(\(50)-302.7(and)]TJ 0.7046 -1.3526 TD (100)Tj /F14 1 Tf 1.4335 0 TD (m)Tj /F8 1 Tf 0.575 0 TD [(g\))-300.5(being)-303.4(more)-305.4(ef)67.2(fective)]TJ -1.798 -1.3607 TD [(than)-302.9(the)-298(higher)-299.1(doses)-306.3(\(250)]TJ 2.9724 -1.3526 TD [(and)-300(500)]TJ /F14 1 Tf 3.2316 0 TD (m)Tj /F8 1 Tf 0.575 0 TD (g\).)Tj 7.7752 3.3935 TD [(Peptide)-5216.6(I)-5652.3(\()]TJ 0.85098 0.19216 0.2 scn 14.546 0 TD (84)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -65.5625 -7.1272 TD (MVA)Tj -1.0124 -1.3526 TD [(E2)-303.5(vaccine)]TJ 8.0505 2.7132 TD (National)Tj -0.8909 -1.3607 TD (Autonomous)Tj 0.5426 -1.3526 TD (University)Tj 0.0567 -1.3607 TD [(of)-302.4(Me)]TJ /F15 1 Tf 2.3568 0.0405 TD ()Tj /F8 1 Tf 0.0405 -0.0405 TD (xico)Tj 5.8314 2.041 TD [(N.)-306.5(A.)-4950.7(E2)-3753.7(HPV)-305.5(infection)]TJ 19.5756 2.0329 TD [(Histology)-303(complete)-304.3(elimination)]TJ 0.2754 -1.3607 TD [(of)-302.4(lesions:)-302.4(89.3%)-300.2(\(female\))-304.3(and)]TJ 3.4097 -1.3526 TD [(100%)-299.5(\(male\).)]TJ -2.8023 -1.3607 TD [(HPV)-297.4(DNA)-299.1(clearance:)-308.8(83%.)]TJ 13.7442 2.041 TD [(Viral)-300.3(vector)-3999.1(III)-5318.3(\()]TJ 0.85098 0.19216 0.2 scn 15.4289 0 TD (85)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -67.1499 -5.7666 TD (ADXS11)Tj /F12 1 Tf 3.4907 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(001)-2418.2(Advaxis.)-305.6(Inc)-3699.1(N.)-306.5(A.)-4950.7(E7)]TJ 25.4232 0.6803 TD (Recurrent)Tj -0.98 -1.3606 TD [(cervical)-303.7(cancer)]TJ 8.7552 2.0329 TD [(12-month)-302.7(survival:)-307.6(30.9%.)]TJ 0 -1.3526 TD [(18-month)-302.7(survival:)-307.6(23.6%.)]TJ 2.7213 -1.3607 TD [(ORR:)-301.5(17.4%.)]TJ 10.8447 1.3607 TD [(Viral)-300.3(vector)-4169.2(II)-5481.2(\()]TJ 0.85098 0.19216 0.2 scn 15.4289 0 TD (54)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -67.2066 -3.7337 TD (Tipapkinogen)Tj 0.8585 -1.3526 TD (Sovacivec)Tj 8.3826 1.3526 TD (Taiho)Tj -1.6603 -1.3526 TD [(Oncology,)-301.7(Inc)]TJ 9.0386 0.6803 TD [(N.)-306.5(A.)-4319(E6,E7)-4551.9(CIN2/3)]TJ 24.3136 0.6722 TD (CR:24%)Tj 0.0486 -1.3526 TD (PR:12%)Tj 9.8405 0.6803 TD [(Viral)-300.3(vector)-4169.2(II)-5481.2(\()]TJ 0.85098 0.19216 0.2 scn 15.4289 0 TD (86)Tj 6.9999 0 0 6.9999 526.1668 265.2094 Tm 0.15294 0.15294 0.15294 scn (\))Tj -66.178 -5.0863 TD (Vvax001)Tj 7.3054 2.0329 TD (University)Tj 0.4859 -1.3607 TD (Medical)Tj 0.243 -1.3526 TD (Center)Tj -0.818 -1.3607 TD (Groningen)Tj 8.3745 2.041 TD [(N.)-306.5(A.)-4173.2(E7,)-304.2(E6)]TJ 13.1854 0.6722 TD [(CIN)-304.9(2/3)]TJ -1.5388 -1.3526 TD [(Cervical)-298.6(Cancer)]TJ 8.3664 2.7132 TD [(Well)-302.8(tolerated;)-308.5(Elicited)-302.3(CD4)]TJ 5.2498 0 0 4.6661 391.7479 246.9543 Tm (+)Tj 6.9999 0 0 6.9999 315.6661 234.3118 Tm [(and)-308.1(CD8)]TJ 5.2498 0 0 4.6661 341.3479 237.4299 Tm (+)Tj 6.9999 0 0 6.9999 346.4503 234.3118 Tm [(T)-301.2(cell)-296(responses)]TJ -3.1911 -1.3526 TD [(against)-303(E6)-303.5(and)-300(E7)-303.5(in)]TJ 1.1015 -1.3607 TD [(all)-302.2(participants.)]TJ 11.3793 2.041 TD [(Viral)-300.3(vector)-4331.1(I)-5652.3(\()]TJ 0.85098 0.19216 0.2 scn 15.4289 0 TD (87)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -66.3157 -5.0863 TD [(BLS-M07)-3542.7(BioLeaders)-4129.4(N.)-298.4(A)-5063.4(E)0(7)-5179.1(CIN2/3)-3657.7(CIN)-296.8(3)-306.6(cured)-299.1(in)-300.5(75%)-300.6(patients.)]TJ 50.5791 0.6803 TD (Bacterial)Tj 0.5021 -1.3606 TD (vector)Tj 7.2325 0.6803 TD [(I/IIa)-4940(\()]TJ 0.85098 0.19216 0.2 scn 7.0462 0 TD (88)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -67.0608 -5.7666 TD (IGMKK16E7)Tj 7.9291 0.6803 TD (GLOVACC)Tj 0.9314 -1.3607 TD [(Co)-301.9(Ltd)]TJ 7.7266 0.6803 TD [(N.)-298.4(A)-5063.4(E)0(7)-5179.1(CIN2/3)]TJ 21.1468 2.7132 TD [(31.7%)-300.2(CR)-301.2(in)-300.5(high-dose)]TJ 2.7213 -1.3526 TD (recipients)Tj -2.8347 -1.3607 TD (E7)Tj /F12 1 Tf 1.0448 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (speci)Tj /F9 1 Tf 1.9762 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(c)-296.7(interferon-)]TJ /F14 1 Tf 5.0701 0 TD (g)Tj /F8 1 Tf -10.4722 -1.3607 TD [(producing)-307(cells)-296.4(increased)-307.6(with)]TJ -0.0648 -1.3526 TD [(level)-299.6(of)-302.4(response)-305.5(\(SD,)-299.2(PR,)-306.9(CR\))]TJ 15.1049 3.3935 TD (Bacterial)Tj 0.5021 -1.3607 TD (vector)Tj 7.4512 0.6803 TD [(I/II)-5158.3(\()]TJ 0.85098 0.19216 0.2 scn 6.8276 0 TD (89)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -66.2347 -5.7666 TD (NZ8123-)Tj 0.1377 -1.3526 TD (HPV16-)Tj 0.3564 -1.3607 TD (optiE6)Tj 5.9772 3.3935 TD [(Department)-312.2(of)]TJ 0.4131 -1.3607 TD (Parasitology,)Tj 1.0772 -1.3526 TD (Pasteur)Tj -1.7251 -1.3607 TD [(Institute)-304.7(of)-302.4(Iran)]TJ 9.5651 2.041 TD [(N.A.)-5103.3(E6)]TJ 13.5013 0.6722 TD (HPV-)Tj -1.2068 -1.3526 TD [(16)-297.4(infection)]TJ 10.5127 2.0329 TD [(Well)-302.8(tolerated.)]TJ -2.0653 -1.3526 TD [(Long-term)-306.2(and)-300(favorable)]TJ 1.2635 -1.3607 TD [(immune)-299.9(responses)]TJ 11.7518 2.0329 TD (Recombinant)Tj 1.223 -1.3526 TD (protein)Tj 8.1639 0.6803 TD 5.6523 Tc (I\()Tj 0.85098 0.19216 0.2 scn 6.3335 0 TD 0 Tc (90)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj 6.5001 0 0 6.5001 49.6063 74.948 Tm [(CIN,)-304.2(Cervical)-301.4(Intraepithelial)-303(Neoplasia;)-307.1(OPSCC,)-303.1(Oropharyngeal)-308.2(Squamous)-299.6(Cell)-303.2(Carcinoma.)-304.2(CR,)-299.9(Complete)-305.7(Response;)-303.2(PR,)-306.7(Partial)-301(Response;)-303.2(SD,)-303.2(Stable)-304.6(D)]TJ 61.5724 0 TD (isease.)Tj /F1 1 Tf 6.9999 0 0 6.9999 49.6063 800.9573 Tm 0.49804 0.49804 0.49412 scn [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.5213 0 TD (06)Tj ET endstream endobj 137 0 obj<> endobj 138 0 obj<> endobj 139 0 obj<> endobj 140 0 obj<> endobj 141 0 obj<> endobj 142 0 obj<> endobj 143 0 obj<> endobj 144 0 obj<> endobj 145 0 obj<> endobj 146 0 obj<> endobj 147 0 obj<> endobj 148 0 obj<> endobj 149 0 obj<> endobj 150 0 obj<> endobj 151 0 obj<> endobj 152 0 obj<> endobj 153 0 obj<> endobj 154 0 obj<> endobj 155 0 obj<> endobj 156 0 obj<> endobj 157 0 obj<> endobj 158 0 obj<> endobj 159 0 obj<> endobj 160 0 obj<> endobj 161 0 obj<> endobj 162 0 obj<> endobj 163 0 obj<> endobj 164 0 obj<> endobj 165 0 obj<> endobj 166 0 obj<> endobj 167 0 obj<> endobj 168 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 169 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 170 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 171 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 172 0 obj<>stream /GS1 gs BT /F8 1 Tf 9 0 0 9 49.6063 758.8912 Tm /Cs6 cs 0.15294 0.15294 0.15294 scn 0 Tc 0 Tw [(67.3%)-328.8(of)-330.3(patients)-335.1(showed)-330.6(histopathologic)-338.2(regression)-330.9(\(> endobj 174 0 obj<> endobj 175 0 obj<> endobj 176 0 obj<> endobj 177 0 obj<> endobj 178 0 obj<> endobj 179 0 obj<> endobj 180 0 obj<> endobj 181 0 obj<> endobj 182 0 obj<> endobj 183 0 obj<> endobj 184 0 obj<> endobj 185 0 obj<> endobj 186 0 obj<> endobj 187 0 obj<> endobj 188 0 obj<> endobj 189 0 obj<> endobj 190 0 obj<> endobj 191 0 obj<> endobj 192 0 obj<> endobj 193 0 obj<> endobj 194 0 obj<> endobj 195 0 obj<> endobj 196 0 obj<> endobj 197 0 obj<> endobj 198 0 obj<> endobj 199 0 obj<> endobj 200 0 obj<> endobj 201 0 obj<> endobj 202 0 obj<> endobj 203 0 obj<> endobj 204 0 obj<> endobj 205 0 obj<> endobj 206 0 obj<> endobj 207 0 obj<> endobj 208 0 obj<> endobj 209 0 obj<> endobj 210 0 obj<> endobj 211 0 obj<> endobj 212 0 obj<> endobj 213 0 obj<> endobj 214 0 obj<> endobj 215 0 obj<> endobj 216 0 obj<> endobj 217 0 obj<> endobj 218 0 obj<> endobj 219 0 obj<> endobj 220 0 obj<> endobj 221 0 obj<> endobj 222 0 obj<> endobj 223 0 obj<> endobj 224 0 obj<> endobj 225 0 obj<> endobj 226 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 227 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 228 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 229 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 230 0 obj<>stream /GS1 gs BT /F8 1 Tf 9 0 0 9 49.6063 459.9495 Tm /Cs6 cs 0.15294 0.15294 0.15294 scn 0 Tc 0 Tw [(candidate)-264.3(for)-256(vaccine)-262.3(antigens)-258.9(in)-257.3(immunotherapy)-260.8(of)-261(pre-cancerous)]TJ 0 -1.3858 TD [(cervical)-447.5(lesions)-442(\()]TJ 0.85098 0.19216 0.2 scn 6.948 0 TD (109)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD [(\).)-446.9(E1)-439.3(is)-446.9(continuously)-446.8(expressed)-448(in)-446.2(the)-445.5(basal)]TJ -8.3843 -1.3921 TD [(epithelial)-320.2(cells)-326(after)-319.1(HPV)-324.3(infection)-321.8(and)-322.5(plays)-320.6(an)-319.6(important)-321(role)-322(in)]TJ 0 -1.3858 TD [(v)-8.1(i)-10.9(r)-14(u)-9.1(s)-517.9(r)-14(ep)-15.2(l)-14.6(i)-10.9(ca)-16.3(t)-13(i)-10.9(on)-527.5(\()]TJ 0.85098 0.19216 0.2 scn 7.7669 0 TD 0.0123 Tc [(11)12.3(0)]TJ 0.15294 0.15294 0.15294 scn 1.4677 0 TD 0.0111 Tc [(\).)-507.9(E1)-505.2(is)-513.1(c)11.1(r)-8.9(ucial)-507.4(f)11.1(or)-513.1(c)11.1(a)-5.2(rc)11.1(i)-5.8(n)-2.2(ogenesis)-513.1(\()]TJ 0.85098 0.19216 0.2 scn 15.515 0 TD 0 Tc [(11)-18.4(1)]TJ 0.15294 0.15294 0.15294 scn 1.4677 0 TD 0.0098 Tc (\).)Tj -26.2173 -1.3921 TD 0 Tc [(However,)-474.4(E1)-477.1(might)-471.6(not)-477.5(be)-476.1(an)-470.8(ideal)-479.2(target)-473.7(for)-476.5(vaccine)-476.4(antigens)]TJ 0 -1.3858 TD 0.0397 Tc [(due)-539.6(to)-537.5(its)-541.2(u)-0.9(b)4.3(i)-2.7(quitinati)3.6(o)-2(n)-540.6(a)-2(nd)-536.4(ra)]TJ 14.9669 0 TD 0.0401 Tc [(pid)-536(d)-0.5(egra)4.7(datio)4.7(n)-540.2(attributes)]TJ -14.9669 -1.3921 TD 0 Tc (\()Tj 0.85098 0.19216 0.2 scn 0.3465 0 TD (112)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5165 0 TD (113)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD (\).)Tj -2.1795 -1.3858 TD [(The)-360.2(minor)-363.9(capsid)-368(protein)-366.3(L2)-363.2(is)-358.7(a)-363(promising)-368.2(candidate)-365.1(for)-363.1(an)]TJ -1.5559 -1.3921 TD [(HPV)-387.3(vaccine)-382(since)-390.4(the)-382.5(linear)-383.9(neutralizing)-387.7(epitopes)-387(on)-382.6(the)-388.8(L2)-382.1(N-)]TJ 0 -1.3858 TD [(terminus)-225.7(are)-225.5(well)-227.5(conserved)-231.7(across)-225.8(several)-224.1(HPV)-229.8(genotypes)-226.5(\()]TJ 0.85098 0.19216 0.2 scn 23.6913 0 TD (114)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD [(\).)-226.4(In)]TJ -25.1276 -1.3921 TD [(mouse)-228.9(models,)-233.4(HPV-16)-228(L2)-224.6(antigen-induced)-238.1(neutralizing)-230.2(antibodies)]TJ 0 -1.3858 TD 0.0114 Tc [(protect)4.7(ed)-514.3(against)-511.8(i)0.5(n)4.4(f)0(ectious)-512.8(HPV-16)11.4(/)-6.5(4)-0.9(5)-511.2(c)-0.9(hallenges)-512.8(\()]TJ 0.85098 0.19216 0.2 scn 22.5323 0 TD 0.0123 Tc (115)Tj 0.15294 0.15294 0.15294 scn 1.4677 0 TD 0 Tc (,)Tj 0.85098 0.19216 0.2 scn 0.7433 0 TD 0.0123 Tc [(11)12.3(6)]TJ 0.15294 0.15294 0.15294 scn 1.4677 0 TD 0.0098 Tc (\).)Tj -26.211 -1.3921 TD 0 Tc [(Howe)-9.2(ver,)-509.3(L2)-501.8(m)-6.9(ight)-508.8(be)-501.3(le)-8(ss)-500.3(immu)-8.6(n)-7(ogenic)-508.2(s)-7.7(ince)-508.7(it)-502.6(is)-509.9(unable)-510.8(to)]TJ 0 -1.3858 TD 0.0695 Tc [(fo)-3.7(rm)-567.3(VL)-4.2(Ps)-574.4(\()]TJ 0.85098 0.19216 0.2 scn 6.2362 0 TD 0.0753 Tc [(11)6.3(7)]TJ 0.15294 0.15294 0.15294 scn 1.6504 0 TD 0.07 Tc [(\).)-568.7(There)-5.3(f)1.9(ore,)-568.7(strategie)-5.3(s)-567.6(to)-570.2(en)-6.3(hance)-572.3(t)0.3(he)]TJ -7.8866 -1.3921 TD 0 Tc [(immunogenicity)-410.9(of)-412.1(L2)-407.3(protein)-410.4(have)-406.8(become)-410.8(attractive)-406.8(\()]TJ 0.85098 0.19216 0.2 scn 23.0677 0 TD (114)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.6299 0 TD (118)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD (,)Tj 0.85098 0.19216 0.2 scn -26.5701 -1.3858 TD (119)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD [(\).)-251.6(Notably,)-249.5(peptide)-258.6(antigens)-252.6(\()]TJ 0.85098 0.19216 0.2 scn 11.5906 0 TD (120)Tj 0.15294 0.15294 0.15294 scn 1.4425 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.4661 0 TD (121)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD [(\))-249.1(and)-253.2(HSP70-based)-254.6(fusion)]TJ -16.3717 -1.3921 TD [(proteins)-399.1(are)-395.6(widely)-392.2(tested)-394.9(in)-395.8(both)-390.6(preclinical)-399.1(and)-398.1(clinical)-395.2(studies)]TJ 0 -1.3858 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3465 0 TD (122)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5165 0 TD (123)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD (\).)Tj /F1 1 Tf 11.9999 0 0 11.9999 49.6063 209.9339 Tm [(4.2)-299(Adjuvant)-305.9(optimization)]TJ /F8 1 Tf 9 0 0 9 63.6094 184.989 Tm 0.0107 Tc (Cervarix)Tj /F13 1 Tf 7.4999 0 0 7.4999 95.1874 188.9575 Tm 0 Tc ()Tj /F8 1 Tf 9 0 0 9 105.5055 184.989 Tm 0.0107 Tc [(and)-508.7(G)0.6(ardasil)]TJ /F13 1 Tf 7.4999 0 0 7.4999 154.7149 188.9575 Tm 0 Tc ()Tj /F8 1 Tf 9 0 0 9 165.033 184.989 Tm 0.0111 Tc [(we)11.1(r)-8.9(e)-511.5(formulated)-508.3(with)-509.9(A)11.1(S)-5.5(04)-511.5(and)]TJ -12.8252 -1.3921 TD 0.0224 Tc [(amorphous)-520.7(a)-0.4(lumi)5.2(num)-519.9(h)-0.9(ydroxyphos)]TJ 15.5717 0 TD 0.0215 Tc [(phate)-520(s)-5.1(ulfa)5(te,)-522.7(r)-5(esp)-6.5(e)2.9(ctivel)-5.7(y)]TJ -15.5717 -1.3858 TD 0 Tc (\()Tj 0.85098 0.19216 0.2 scn 0.378 0 TD 0.0312 Tc (124)Tj 0.15294 0.15294 0.15294 scn 1.5307 0 TD 0 Tc (,)Tj 0.85098 0.19216 0.2 scn 0.7811 0 TD 0.0312 Tc (125)Tj 0.15294 0.15294 0.15294 scn 1.5307 0 TD 0.0314 Tc [(\).)-531.7(A)-6(l)4.2(um-based)-532.1(adjuvants)-530.6(c)-6.1(ould)-532.1(induce)-529(Th2-)-5.1(biased)]TJ -4.2205 -1.3921 TD 0.0331 Tc [(imm)-5.3(u)-1.2(ne)-539.9(resp)-7.5(on)-5.4(ses)-535.2(\()]TJ 0.85098 0.19216 0.2 scn 9.1843 0 TD 0.0375 Tc [(12)6.3(6)]TJ 0.15294 0.15294 0.15294 scn 1.5433 0 TD 0.0362 Tc [(\).)-533.2(The)-530.5(i)0.1(mm)4.1(unos)3.3(ti)6.4(mulant)-531.1(MPL,)-533.2(on)4(e)]TJ -10.7276 -1.3858 TD 0.0319 Tc [(compon)6(ent)-529.1(o)2.8(f)-527.5(t)0(he)-528.5(AS0)7(4)-528.5(adjuvant)6.3(,)-531.2(a)2.8(ctivates)-530.1(in)6(nat)6.3(e)-528.5(im)6.1(mun)6(e)]TJ 0 -1.3921 TD 0.0119 Tc [(responses)-512.3(t)-1.1(hrough)-509.1(Toll-like)-510.7(r)4.2(eceptor)-512.3(4)-510.7(\(TLR4\))-514.4(and)-507.5(i)1(nduces)-512.3(a)]TJ 0 -1.3858 TD 0.0096 Tc [(mixe)9.6(d)-515.8(T)0(h1)9.6(/)-8.3(T)0(h2)-506.7(immune)-506.7(response)-513(\()]TJ 0.85098 0.19216 0.2 scn 15.5213 0 TD 0 Tc [(12)-18.4(7)]TJ 0.15294 0.15294 0.15294 scn 1.4614 0 TD 0.0159 Tc [(\))6.1(.)-503.1(P)4.7(a)15.9(rt)9.2(i)5(c)15.9(ip)6.8(a)5.7(n)8.9(ts)-502(r)8.2(e)15.9(ce)15.9(iv)7.8(ed)]TJ -16.9827 -1.3921 TD 0 Tc (Cervarix)Tj /F13 1 Tf 7.4999 0 0 7.4999 80.4472 101.4803 Tm ()Tj /F8 1 Tf 9 0 0 9 89.0645 97.4551 Tm [(displayed)-336.9(stronger)-338.2(humoral)-334(and)-335.1(CD4)]TJ 6.7499 0 0 5.9992 225.6377 101.4803 Tm (+)Tj 9 0 0 9 232.4976 97.4551 Tm [(T)-330.9(cell)-337.3(responses)]TJ -20.3213 -1.3858 TD [(against)-262.4(HPV-16)-265.8(and)-259.5(18)-257.7(than)-261.4(patients)-265.8(received)-267.8(Gardasil)]TJ /F13 1 Tf 7.4999 0 0 7.4999 247.4645 88.9512 Tm ()Tj /F8 1 Tf 9 0 0 9 255.4582 84.9827 Tm (\()Tj 0.85098 0.19216 0.2 scn 0.3402 0 TD (125)Tj 0.15294 0.15294 0.15294 scn 1.4425 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.4787 0 TD (128)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD (,)Tj 0.85098 0.19216 0.2 scn -26.5701 -1.3921 TD (129)Tj 0.15294 0.15294 0.15294 scn 1.4425 0 TD [(\).)-503.6(Meanwh)-9(ile,)-506.4(distincti)-12.8(ve)-505.5(immune)-506.7(pro)]TJ /F9 1 Tf 16.0882 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(les)-507(induc)-10.7(ed)-500.2(by)-503.4(HPV)]TJ 10.3055 76.2709 TD [(vaccines)-339.2(formulated)-343.9(with)-340.2(an)-344.8(Alum-based)-343.1(adjuvant,)-342.2(or)-339.1(AS04,)-339.8(have)]TJ 0 -1.3858 TD [(been)-300.2(reported)-301.9(\()]TJ 0.85098 0.19216 0.2 scn 6.2236 0 TD (129)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5165 0 TD (130)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD (\).)Tj -8.063 -1.3921 TD [(Adjuvants)-424.9(may)-415.8(af)60.3(fect)-420.7(the)-414(strength)-425.9(and)-417(durability)-418.7(of)-418.4(antigen-)]TJ -1.5496 -1.3858 TD (speci)Tj /F9 1 Tf 1.978 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(c)-308.4(immune)-311.4(responses.)-310.9(Exploratory)-314.3(studies)-309.1(of)-311.4(novel)-304.3(adjuvants)]TJ -2.5071 -1.3921 TD [(used)-220.9(alone)-224.5(or)-219.5(in)-219.5(combination)-222.3(have)-224.1(highlighted)-226.3(their)-218.3(potential)-226.3(use)-224.4(in)]TJ 0 -1.3858 TD [(HPV)-469.2(vaccines)-477.8(\()]TJ 0.85098 0.19216 0.2 scn 6.6142 0 TD [(Table)-472.7(4)]TJ 0.15294 0.15294 0.15294 scn 3.1685 0 TD [(\).)-472.1(Bacterial-derived)-483.6(components,)-476.3(such)-474.5(as)]TJ -9.7827 -1.3921 TD 0.0308 Tc [(Beclin-1)-529.6(\()]TJ 0.85098 0.19216 0.2 scn 4.4472 0 TD 0.0312 Tc (105)Tj 0.15294 0.15294 0.15294 scn 1.5307 0 TD 0.0297 Tc [(\),)-533.4(AS04)-530.7(\()-5.3(N)0.2(LX)-5.6(+Alu)-4.6(m\))-534.4(\()]TJ 0.85098 0.19216 0.2 scn 10.5764 0 TD 0.0312 Tc (25)Tj 0.15294 0.15294 0.15294 scn 1.0205 0 TD 0.0316 Tc [(\),)-531.5(CI)5.5(A06B)-531.9(\(nontoxic)]TJ -17.5748 -1.3858 TD 0 Tc [(derivative)-493.2(of)-494(lipopolysaccharide)-499(\(CIA05\))-497.3(+)-492.6(Alum\))-493.5(\()]TJ 0.85098 0.19216 0.2 scn 21.915 0 TD (100)Tj 0.15294 0.15294 0.15294 scn 1.4425 0 TD [(\),)-491(rough)]TJ -23.3575 -1.3921 TD [(LPS)-240.6(\(R-LPS\))-243.2(\()]TJ 0.85098 0.19216 0.2 scn 5.6 0 TD (98)Tj 0.15294 0.15294 0.15294 scn 0.9638 0 TD [(\),)-239(and)-240.6(bacterial)-246.3(enzymatic)-244.3(combinatorial)-247.7(chemistry)]TJ -6.5638 -1.3858 TD [(\(BECC\)-derived)-408.8(TLR4)-414(agonists/Alum)-412.9(\()]TJ 0.85098 0.19216 0.2 scn 16.0819 0 TD (70)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD [(\),)-409.1(are)-408.2(widely)-411.1(utilized)-413.5(in)]TJ -17.0394 -1.3921 TD [(exploratory)-302.8(studies.)]TJ 1.5496 -1.3858 TD -0.0168 Tc [(I)-16.8(n)-490.8(addition)-16.8(,)-492.4(n)1.4(ovel)-510.1(molecules)-509.5(w)5.1(it)]TJ 13.3417 0 TD [(h)-506.3(d)-0.7(istinc)-4(tive)-507.9(contr)-16.8(i)15.1(butions)-503.2(t)-16.8(o)]TJ -14.8913 -1.3921 TD -0.0216 Tc [(i)5.3(m)-3.3(munogenicity)-470.7(are)-474.9(b)-0.3(eing)-470.7(evalsu)-5.5(a)5.9(ted)-478(i)-1(n)-469.6(p)-5.5(reclini)5.3(c)-2.5(al)-470.8(studies)-470.2(of)-473.9(HPV)]TJ 0 -1.3858 TD 0 Tc [(v)-8.1(a)0(c)-16.3(c)-12.3(in)-17.9(es)-13.7(,)-544.2(s)-7.7(u)-9.1(c)-12.3(h)-539.9(a)-10.2(s)-536.8(C)-11.7(p)-9.1(G)-539.2(o)-10.2(l)-8.3(ig)-19(od)-13.1(e)-12.3(o)-10.2(xy)-18.9(n)-7(u)-9.1(c)-12.3(l)-8.3(eo)-16.3(t)-6.7(i)-10.9(d)-9.1(e)-541.5(\()-9.8(C)0(p)-14.5(G)-10.1(\))-545.2(\()]TJ 0.85098 0.19216 0.2 scn 23.0173 0 TD (71)Tj 0.15294 0.15294 0.15294 scn 0.9701 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.7622 0 TD [(10)-18.4(4)]TJ 0.15294 0.15294 0.15294 scn 1.4614 0 TD 0.0098 Tc (\),)Tj -26.211 -1.3921 TD -0.0213 Tc [(po)6.3(lyinosini)5.6(c)-2.2(-polycytidylic)-298.2(acid)-301.3(\(Po)6.3(l)-4.4(y)-300.3(I)3(:C\))-301.9(\()]TJ 0.85098 0.19216 0.2 scn 16.2646 0 TD -0.0192 Tc [(10)6.3(4)]TJ 0.15294 0.15294 0.15294 scn 1.3732 0 TD -0.0217 Tc (\),)Tj /F14 1 Tf 0.8189 0 TD 0 Tc (a)Tj /F8 1 Tf 0.6047 0 TD -0.0216 Tc [(-)4.8(G)-0.2(alactosylceramide)]TJ -19.0614 -1.3858 TD 0 Tc (\()Tj /F14 1 Tf 0.3213 0 TD (a)Tj /F8 1 Tf 0.5984 0 TD -0.0201 Tc [(-GalCe)5.3(r\))-288.1(\()]TJ 0.85098 0.19216 0.2 scn 3.9685 0 TD -0.0255 Tc (73)Tj 0.15294 0.15294 0.15294 scn 0.9134 0 TD -0.0227 Tc [(\),)-289.7(very)-289.1(s)-5.2(m)1.9(all)-295.5(s)1.1(ize)-293.3(p)-0.3(rot)-4.2(e)2.8(olipos)-5.2(om)-4.4(es)-294.9(\(VSSP\))-290.7(\()]TJ 0.85098 0.19216 0.2 scn 16.5732 0 TD -0.0255 Tc (75)Tj 0.15294 0.15294 0.15294 scn 0.9134 0 TD -0.0223 Tc [(\),)-289.3(poly)-295(di)]TJ -23.2882 -1.3921 TD 0 Tc [(\(ca)11.8(rboxyl)14(atoeth)12.4(ylphe)14.4(noxy\))-512(phos)12.6(phazene)-508.8(\(PC)11.4(EP\))-517.2(\()]TJ 0.85098 0.19216 0.2 scn 20.7307 0 TD (99)Tj 0.15294 0.15294 0.15294 scn 0.9512 0 TD [(\),)-516.2(c-di-A)14.6(MP)]TJ -21.6819 -1.3858 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3213 0 TD -0.0255 Tc [(10)-6.3(1)]TJ 0.15294 0.15294 0.15294 scn 1.3669 0 TD -0.0216 Tc [(\),)-465(S-540956)-462.3(\(a)-466.5(Cp)-5.5(G)-460.1(O)-0.7(ligonucleoti)5.3(de\))-466(\()]TJ 0.85098 0.19216 0.2 scn 15.5843 0 TD -0.0192 Tc (72)Tj 0.15294 0.15294 0.15294 scn 0.9134 0 TD -0.0217 Tc [(\),)-465.1(th)5.4(e)-468.7(m)2.9(etal)-464.6(ions)-470.3(like)]TJ -18.1858 -1.3921 TD -0.0183 Tc [(ma)-18.3(n)8.5(g)-18.3(a)7.4(n)-18.3(e)6.4(s)-18.3(e)-498.1(\()-18.3(M)6.6(n)-18.3(4)]TJ 6.7499 0 0 5.9992 367.9369 537.9023 Tm 0 Tc (+)Tj 9 0 0 9 371.6786 533.8771 Tm [(\))15.4(-)13.8(do)24.7(p)16.1(e)12.8(d)-494.2(s)0(i)25.6(l)0(i)25(c)12.9(a)-495.3(n)0(a)26.8(n)0(o)26.8(p)16.1(ar)26.2(ti)26.6(c)12.8(l)0(e)23.5(s)-492.7(\()15.4(M)0(n)27.6(4)]TJ 6.7499 0 0 5.9992 496.5731 537.9023 Tm (+)Tj 9 0 0 9 500.3148 533.8771 Tm [(-)13.8(S)0(N)22.8(P)14(s\))-483.6(\()]TJ 0.85098 0.19216 0.2 scn 3.5906 0 TD -0.0129 Tc (74)Tj 0.15294 0.15294 0.15294 scn 0.9323 0 TD -0.0154 Tc (\),)Tj -26.2362 -1.3858 TD 0 Tc [(plan)-9.5(t)-523.2(e)0(x)-10.5(tract)-12.1(s)-524.2(lik)-8.9(e)-528.9(Bai)-534.2(Hua)-531.8(She)-531.4(She)-531.4(Cao)-529.8(\(BH)-8.5(SS)-8.9(C\))-531.7(\()]TJ 0.85098 0.19216 0.2 scn 22.7465 0 TD (102)Tj 0.15294 0.15294 0.15294 scn 1.4425 0 TD [(\),)-528.8(and)]TJ -24.189 -1.3921 TD [(mR)-10.2(NA)-10.2(-e)-11.1(n)-7(c)0(o)-10(d)0(e)-8.9(d)-538.3(ST)-7.8(I)-7.2(N)0(G)]TJ 6.7499 0 0 5.9992 395.0361 512.9007 Tm [(V1)-16.7(55)-16.3(M)]TJ 9 0 0 9 420.4345 508.8755 Tm (\()Tj 0.85098 0.19216 0.2 scn 0.3465 0 TD [(10)-12.1(6)]TJ 0.15294 0.15294 0.15294 scn 1.4551 0 TD [(\),)-541.4(Ca)-9.4(n)-7(did)-16.5(a)-533.1(s)-7.7(kin)-543.1(t)-6.7(est)-543.2(rea)-17.6(ge)-7.9(n)-7(t)]TJ -14.6394 -1.3858 TD -0.0202 Tc [(\(E)6.4(xtract)-297.7(o)7.4(f)-302.4(C)5.9(a)1.1(ndida)-295(a)1(lb)7.4(icans\))-294.5(\()]TJ 0.85098 0.19216 0.2 scn 11.8551 0 TD -0.0192 Tc [(10)6.3(3)]TJ 0.15294 0.15294 0.15294 scn 1.3732 0 TD -0.0217 Tc (\).)Tj -11.6787 -1.3921 TD 0.0198 Tc [(A)-5(l)5.2(thoug)5.4(h)-520.1(many)-523.8(novel)-517.6(a)3.3(djuvan)]TJ 13.3795 0 TD 0.0184 Tc [(ts)-518.4(have)-523.1(de)-6.5(monstrated)-519.9(their)]TJ -14.9291 -1.3858 TD 0.0275 Tc [(uniqu)-6.8(e)-532.9(ef)]TJ /F9 1 Tf 4.1827 0 TD 0 Tc ()Tj /F8 1 Tf 0.5606 0 TD 0.0311 Tc [(c)6.2(a)-4.3(c)6.2(y)-531.4(in)-530.3(m)5.3(o)2(dulat)5.5(i)1.3(ng)-531.4(im)5.3(mune)-529.3(re)6.2(sponses)-524.6(i)1.3(n)-530.3(m)-1(ouse)]TJ -4.7433 -1.3921 TD 0 Tc [(models,)-340.4(only)-336(a)-337.8(few)-342(have)-337.5(been)-344.3(licensed)-338.2(for)-344.2(use)-337.8(in)-339.1(humans)-341.4(to)-338.2(date,)]TJ 0 -1.3858 TD [(primarily)-432.4(due)-440(to)-432.6(safety)-440.6(concerns.)-438.1(Therefore,)-436.9(novel)-436.6(HPV)-437.7(vaccine)]TJ 0 -1.3921 TD 0.5811 Tc [(a)539.4(d)540.5(j)541.3(u)540.5(v)535.2(a)539.4(n)542.6(t)536.6(sr)535.7(e)543.6(q)536.8(u)540.5(i)538.7(r)541.9(e)-4.5(f)538.2(u)540.5(r)535.7(t)542.9(h)538.9(e)537.3(rs)535.6(a)539.4(f)538.2(e)543.6(t)536.6(ya)539.4(n)536.3(d)-1.3(e)537.3(f)]TJ /F9 1 Tf 18.0095 0 TD 0 Tc ()Tj /F8 1 Tf 0.5669 0 TD 0.0427 Tc [(cacy)-538.7(validati)6.6(on)-543.9(in)]TJ -18.5764 -1.3858 TD 0 Tc [(clinical)-300.7(trials.)]TJ /F1 1 Tf 11.9999 0 0 11.9999 304.8944 371.3952 Tm [(4.3)-299(Combination)-305.3(with)-302.8(immune)-302.4(checkpoint)]TJ 0 -1.0441 TD [(blockade)-304.7(therapy)]TJ /F8 1 Tf 9 0 0 9 318.8409 333.9212 Tm [(HPVs)-369.7(employ)-370(multiple)-367.6(strategies)-367.4(to)-363.3(evade)-367.2(the)-369.9(host)]TJ /F12 1 Tf 20.9197 0 TD ()Tj /F8 1 Tf 0.2205 0 TD [(s)-366.7(immune)]TJ -22.6898 -1.3921 TD 0.0356 Tc [(res)-3.6(p)-5(on)-2.9(se,)-540.1(i)-0.5(n)-2.9(c)-1.9(l)-4.2(u)1.3(d)-5(i)-0.5(n)-2.9(g)-539.5(in)-2.9(t)-2.6(e)-1.9(rf)-7.3(eren)-2.9(ce)-537.4(w)-5.5(i)-0.5(t)-2.6(h)-535.8(an)-2.9(t)-2.6(i)-0.5(g)-4(e)-1.9(n)-538.4(p)-5(res)-3.5(e)-1.9(n)-2.9(t)-2.6(at)-2.6(ion)-2.9(,)]TJ 0 -1.3858 TD 0.0168 Tc [(downregulation)-519.4(of)-517.4(antigen)-519.4(p)1.4(ro)-6(duction,)-521.1(i)-0.4(nhibitio)-6(n)-513.1(o)0.3(f)-517.4(a)-6(ntiviral)]TJ 0 -1.3921 TD 0 Tc [(mol)-12.8(ec)-12.1(ul)-11.1(es,)-520.1(s)-7.7(u)0(p)-12(p)0(r)-10.5(ess)-15(io)-8.5(n)-511(o)0(f)-519.2(t)0(y)-8.5(p)0(e)-512.8(1)-510(T)-513.6(h)0(e)-10.5(l)0(p)-11.1(e)0(r)-517.6(\(Th)-17.5(1\))-513.4(ce)-12.1(ll)-514.2(im)-11.5(m)-6.9(u)0(n)-9.9(e)]TJ 0 -1.3858 TD [(responses,)-468.4(and)-461(promotion)-469.5(of)-462.5(regulatory)-466.4(T)-463.2(cell)-463.3(\(Treg\))-466.7(responses)]TJ 0 -1.3921 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3402 0 TD (84)Tj 0.15294 0.15294 0.15294 scn 0.9575 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.4724 0 TD (131)Tj 0.15294 0.15294 0.15294 scn 1.4425 0 TD [(\).)-257.9(Therapeutic)-255.9(HPV)-261.3(vaccine-evoked)-258.8(antigen-speci)]TJ /F9 1 Tf 19.7984 0 TD ()Tj /F8 1 Tf 0.5354 0 TD [(c)-251.7(T)-255.3(cells)]TJ -23.5465 -1.3858 TD [(are)-269.6(the)-269.1(key)-274.8(to)-268.9(tumor)-273.6(cell)-274.3(elimination)-271.4(and)-272.1(rely)-275.8(primarily)-275(on)-269.2(the)-269.1(loss)]TJ 0 -1.3921 TD [(of)-254.7(inhibitory)-263.3(signals)-255.1(in)-263.6(the)-256.5(tumor)-261(microenvironment)-263.9(\(TME\).)-260.2(Thus,)]TJ 0 -1.3858 TD 0.0286 Tc [(the)-525.5(c)-2.6(ombination)-526.5(of)-530.8(therapeutic)-525.5(H)1.2(PV)-527.9(vaccines)-527.1(and)-528.6(i)-1.2(mmune)]TJ 0 -1.3921 TD 0.0829 Tc [(checkpoint)-578.9(i)-3.6(nhibitors)-579.9(m)0.4(ay)-580.4(sh)]TJ 14.6835 0 TD 0.0824 Tc [(ow)-582.3(syne)-5.5(rgistic)-585.1(e)0.8(f)64.7(f)-4.6(ects)-580.4(i)-4.1(n)]TJ -14.6835 -1.3858 TD 0 Tc [(tumor)-298.8(regression.)]TJ 1.5496 -1.3921 TD [(Preclinical)-489.4(studies)-479.2(have)-482.4(demonstrated)-490.2(that)-475.2(therapeutic)-486(HPV)]TJ -1.5496 -1.3858 TD [(vaccines,)-486.6(such)-487.1(as)-490.3(adenovirus)-489.2(delivery)-492.6(vectors)-487.1(carrying)-487.8(modi)]TJ /F9 1 Tf 25.3165 0 TD ()Tj /F8 1 Tf 0.5291 0 TD (ed)Tj -25.8457 -1.3921 TD [(HPV-16)-284.7(E6)-281.8(and)-291(E7)-281.8(genes,)-289.3(HPV-16)-284.7(E7)-288.1(long)-285.6(peptide)-290.1(with)-283.5(DCs,)-288.1(and)]TJ 0 -1.3858 TD 0.0483 Tc [(the)-543.6(L)-0.2(m-)5.4(LLO)-548.1(f)5.4(u)-4.9(sed-E)5.6(6)-549.9(vaccine)-543.6(\()0.7(Lm-LLO-)5.4(E)-0.7(6\),)-546.3(s)2.9(igni)]TJ /F9 1 Tf 23.5654 0 TD 0 Tc ()Tj /F8 1 Tf 0.5732 0 TD 0.0488 Tc [(cant)4.3(ly)]TJ -24.1386 -1.3921 TD 0 Tc [(promoted)-506.9(tumor)-500.4(regressi)-11.3(on)-502.3(and)-498.8(surviva)-11.4(l)-499.6(rate)-503(in)-502.9(tumor-bear)-10.5(ing)]TJ 0 -1.3858 TD [(m)-6.9(o)0(u)-13.1(s)-7.7(e)-516.3(m)-6.9(o)-10.2(d)0(e)-15.2(l)0(s)-519.9(w)-9.6(he)-10.5(n)-517.3(u)-9.1(s)-7.7(e)0(d)-525.4(w)0(i)-14.2(t)-6.7(h)-514.7(a)-514.2(p)-9.1(r)-7.7(og)-12.1(r)-7.7(a)-10.2(m)-6.9(m)-6.9(e)0(d)-525.4(d)-9.1(ea)-16.3(t)-6.7(h)0(-)-15.8(l)0(i)-12.8(g)-8.1(an)-17.3(d)-513.1(1)]TJ 0 -1.3921 TD [(\(P)-14.7(D)-8(-)0(L)-15.8(1)0(\))-519.7(i)-10.9(n)-7(h)-10.7(ib)-14.8(it)-17.5(or)-521.8(\()]TJ 0.85098 0.19216 0.2 scn 8.3528 0 TD [(13)-12.1(2)]TJ /F12 1 Tf 0.15294 0.15294 0.15294 scn 1.4614 0 TD ()Tj /F8 1 Tf 0.85098 0.19216 0.2 scn 0.5165 0 TD [(13)-12.1(4)]TJ 0.15294 0.15294 0.15294 scn 1.4614 0 TD [(\).)-522.5(T)-9.6(h)0(e)-520.7(c)-12.3(li)-12.8(n)-7(i)-10.9(ca)-16.3(l)-512.2(t)-6.7(r)-14(i)0(a)-14.8(l)-8.3(s)-511.6(o)-10.2(f)-515.3(t)-6.7(h)-10.7(e)0(r)-13.7(a)-10.2(p)-9.1(e)0(u)-15.2(t)-6.7(i)-10.9(c)]TJ -11.7921 -1.3858 TD 0.0155 Tc [(HP)4.3(V)-515.8(v)1.1(acci)4.6(nes)-515(c)3.2(ombi)4.6(ned)-516.5(w)5.9(ith)-518.1(I)2(CB)-516.5(therapeu)6.4(ti)4.6(c)-513.4(m)-4(o)5.3(d)0.1(alities)-515(a)-1(re)]TJ 0 -1.3921 TD 0 Tc [(mainly)-498.7(in)-496.6(Phase)-505.7(I/II.)-495.6(Preliminary)-504.3(data)-502.4(show)-498.1(good)-497.6(ef)]TJ /F9 1 Tf 22.526 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(cacy)-502.9(and)]TJ -23.0551 -1.3858 TD [(safety,)-291.9(and)-291(further)-292.3(veri)]TJ /F9 1 Tf 9.1465 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(cation)-290.4(in)-295.1(later)-290.8(clinical)-288.1(trials)-290.7(is)-295.7(needed.)-291.6(The)]TJ -9.6756 -1.3921 TD [(current)-302.2(status)-300(of)-305.1(combination)-297.9(trials)-303.3(is)-302(listed)-300.6(in)]TJ 0.85098 0.19216 0.2 scn 18.9984 0 TD [(Table)-302.7(5)]TJ 0.15294 0.15294 0.15294 scn 2.9984 0 TD (.)Tj ET 0.49804 0.49804 0.49804 scn 49.833 702.538 240.605 47.622 re f 0.63529 0.63529 0.63529 scn 290.438 484.101 0.28348 281.424 re f 49.606 484.101 0.22676 281.424 re f 49.833 484.101 240.605 0.28348 re f 290.438 750.16 m 49.833 750.16 l 290.438 750.16 l f* 106.356 702.538 m 49.833 702.538 l 49.833 702.765 l 106.356 702.765 l 106.356 702.538 l f* 106.356 702.538 0.22678 47.622 re f 106.583 702.538 44.844 0.22681 re f 151.427 702.538 0.22678 47.622 re f 151.654 702.538 88.781 0.22681 re f 240.435 702.538 0.28348 47.622 re f 240.718 702.538 49.72 0.22681 re f 106.356 666.935 m 49.833 666.935 l 49.833 667.162 l 106.356 667.162 l 106.356 666.935 l f* 106.356 666.935 0.22678 35.603 re f 106.583 666.935 44.844 0.22675 re f 151.427 666.935 0.22678 35.603 re f 151.654 666.935 88.781 0.22675 re f 240.435 666.935 0.28348 35.603 re f 240.718 666.935 49.72 0.22675 re f 106.356 621.808 m 49.833 621.808 l 49.833 622.091 l 106.356 622.091 l 106.356 621.808 l f* 106.356 621.808 m 106.356 666.935 l 106.583 666.935 l 106.583 621.808 l 106.356 621.808 l f* 106.583 621.808 44.844 0.28345 re f 151.427 621.808 m 151.427 666.935 l 151.654 666.935 l 151.654 621.808 l 151.427 621.808 l f* 151.654 621.808 88.781 0.28345 re f 240.435 621.808 m 240.435 666.935 l 240.718 666.935 l 240.718 621.808 l 240.435 621.808 l f* 240.718 621.808 49.72 0.28345 re f 106.356 529.228 m 49.833 529.228 l 49.833 529.455 l 106.356 529.455 l 106.356 529.228 l f* 106.356 529.228 0.22678 92.579 re f 106.583 529.228 44.844 0.22675 re f 151.427 529.228 0.22678 92.579 re f 151.654 529.228 88.781 0.22675 re f 240.435 529.228 0.28348 92.579 re f 240.718 529.228 49.72 0.22675 re f 106.356 484.384 0.22678 44.844 re f 151.427 484.384 0.22678 44.844 re f 240.435 484.384 0.28348 44.844 re f 49.833 749.934 240.605 0.45355 re f /Cs6 cs 1 1 1 scn 49.606 750.387 0.22676 19.502 re f 290.438 750.387 0.22678 19.502 re f /Cs6 cs 1 1 1 scn 49.606 750.387 4.989 19.502 re f 39.628 750.387 14.967 19.502 re f 285.676 750.387 4.989 19.502 re f 285.676 750.387 15.024 19.502 re f 39.628 750.387 261.071 9.978 re f BT /F5 1 Tf 6.9999 0 0 6.9999 49.6063 760.3652 Tm 0.49804 0.49804 0.49412 scn [(TABLE)-306.1(4)-795.3(Continued)]TJ /F1 1 Tf 9 0 0 9 59.9811 723.3447 Tm 1 1 1 scn (Adjuvant)Tj 5.8646 0.5543 TD (Vaccine)Tj 0.4661 -1.115 TD (Types)Tj 4.3906 2.2236 TD (Pro)Tj /F10 1 Tf 1.5937 0 TD ()Tj /F1 1 Tf 0.5858 0 TD [(les)-290.6(of)-287.6(Immune)]TJ -2.1795 -1.1087 TD [(Responses)-209.7(with)-206.7(the)]TJ 2.4693 -1.115 TD (Addition)Tj -0.7055 -1.1087 TD [(of)-300.2(Adjuvant)]TJ 9.474 1.6693 TD (Ref.)Tj /F8 1 Tf 6.9999 0 0 6.9999 66.5574 682.5259 Tm 0.15294 0.15294 0.15294 scn [(Beclin-1)-4541(DNA)]TJ 13.6713 1.3607 TD [(Increased)-307.5(production)-303.2(of)]TJ -0.5912 -1.3607 TD (IFN-)Tj /F14 1 Tf 1.9519 0 TD (g)Tj /F8 1 Tf 0.7046 0 TD [(and)-300(highly)-306.3(inhibited)]TJ -1.0772 -1.3607 TD [(tumor)-304.4(progression.)]TJ 12.7075 1.3607 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3483 0 TD (105)Tj 0.15294 0.15294 0.15294 scn 1.4335 0 TD (\))Tj -30.6795 -5.7666 TD (MPL+)Tj /F14 1 Tf 2.5512 0 TD (a)Tj /F8 1 Tf 0.6236 0 TD [(-GalCer)-3010.9(DNA)]TJ 12.4646 2.041 TD [(Increased)-307.5(lymphocyte)]TJ -0.98 -1.3607 TD [(proliferation,)-308.9(CTL)-296.7(activity,)]TJ 0.5912 -1.3607 TD [(cytokine)-303.2(responses,)-306.6(and)]TJ 1.3283 -1.3526 TD [(tumor)-304.4(remission.)]TJ 12.5618 2.0329 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3402 0 TD (73)Tj 0.15294 0.15294 0.15294 scn 0.9557 0 TD (\))Tj -30.5256 -9.152 TD (mRNA-encoded)Tj 0.7046 -1.3607 TD (STING)Tj 5.2498 0 0 4.6661 80.2204 571.6912 Tm (V155M)Tj 6.9999 0 0 6.9999 118.9984 573.3353 Tm (mRNA)Tj 5.7585 5.4264 TD [(Enhanced)-304.3(antigen-speci)]TJ /F9 1 Tf 9.557 0 TD ()Tj /F8 1 Tf 0.5345 0 TD (c)Tj -8.6742 -1.3606 TD [(T)-301.2(cell)-304.1(responses)-306(by)]TJ -0.3645 -1.3526 TD [(activating)-300.2(type)-304.5(I)-298.7(IFN)]TJ -0.8585 -1.3607 TD [(responses)-306(via)-302.9(the)-298(nuclear)]TJ 0.4778 -1.3526 TD [(factor)-298(kB)-304.9(\(NF-kB\))-306.1(and)]TJ -0.3807 -1.3607 TD [(IFN-stimulated)-301.9(response)]TJ -0.2268 -1.3526 TD [(element)-305.4(\(ISRE\))-301.4(pathways;)]TJ 2.2192 -1.3607 TD [(reduced)-310.7(HPV)]TJ 5.2498 0 0 4.6661 213.7889 547.9369 Tm (+)Tj 6.9999 0 0 6.9999 175.5779 535.2944 Tm [(tumor)-304.4(growth.)]TJ 11.7923 5.4345 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3483 0 TD (106)Tj 0.15294 0.15294 0.15294 scn 1.4335 0 TD (\))Tj -29.2946 -9.8404 TD (Chitosan)Tj 7.9857 0.6803 TD (DNA)Tj -0.3888 -1.3526 TD (vaccine)Tj 6.2525 2.7132 TD [(Strong)-307(induction)-303.1(of)-302.4(E7-)]TJ -0.8585 -1.3606 TD (speci)Tj /F9 1 Tf 1.9843 0 TD ()Tj /F8 1 Tf 0.5264 0 TD [(c)-304.8(CD8)]TJ 5.2498 0 0 4.6661 192.1322 512.3337 Tm (+)Tj 6.9999 0 0 6.9999 197.2346 509.2157 Tm [(T)-301.2(cells,)-305.2(IFN-)]TJ /F14 1 Tf 5.0782 0 TD (g)Tj /F8 1 Tf -10.5775 -1.3526 TD [(responses,)-306.6(and)-300(therapeutic)]TJ 1.9438 -1.3607 TD [(antitumor)-303.2(ef)59.1(fects)]TJ 12.254 2.0329 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3483 0 TD (107)Tj 0.15294 0.15294 0.15294 scn 1.4335 0 TD (\))Tj /F1 1 Tf 0.49804 0.49804 0.49412 scn -31.5704 42.3585 TD [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.5213 0 TD (08)Tj ET endstream endobj 231 0 obj<> endobj 232 0 obj<> endobj 233 0 obj<> endobj 234 0 obj<> endobj 235 0 obj<> endobj 236 0 obj<> endobj 237 0 obj<> endobj 238 0 obj<> endobj 239 0 obj<> endobj 240 0 obj<> endobj 241 0 obj<> endobj 242 0 obj<> endobj 243 0 obj<> endobj 244 0 obj<> endobj 245 0 obj<> endobj 246 0 obj<> endobj 247 0 obj<> endobj 248 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 249 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 250 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 251 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 252 0 obj<>stream /GS1 gs BT /F1 1 Tf 11.9999 0 0 11.9999 49.6063 328.252 Tm /Cs6 cs 0.15294 0.15294 0.15294 scn 0 Tc 0 Tw [(4.4)-299.5(HPV)-302.9(L1)-300.2(VLP)-301.4(vaccine)-303(as)]TJ 0 -1.0394 TD [(adjuvant)-307(therapy)]TJ /F8 1 Tf 9 0 0 9 63.6094 290.7779 Tm [(L1)-268.7(VL)18.6(Ps)18.9(-)13.8(b)0(a)23.6(s)0(e)17.8(d)-286.3(H)16.7(P)0(V)-278(v)0(a)25.7(c)0(c)19.4(i)0(n)19.9(e)12.9(s)-284.8(h)0(a)23.1(v)0(e)-272.5(b)0(e)21.5(e)0(n)-277.6(a)15(pp)19.5(ro)19.9(ve)23.6(d)-286.3(p)0(r)21(i)14.3(ma)20.7(ri)19.3(ly)-268.4(fo)16.2(r)]TJ -1.5559 -1.3921 TD [(th)20.4(e)-295.8(p)0(r)21(e)0(v)17.3(e)12.9(nt)24.1(io)16.7(n)-296.8(o)0(f)-286.2(c)0(e)19.4(r)0(v)22(i)0(c)20.9(a)0(l)-289.4(c)12.9(an)20.5(c)12.8(e)0(r)-290.9(i)0(n)-288.8(p)0(o)24.7(p)0(u)19.5(l)0(a)19.3(t)0(i)20.3(o)15(ns)-291.8(w)15.6(i)0(t)20.3(h)0(o)23.1(u)0(t)-293(p)0(r)21(e)12.8(e)12.8(x)0(i)16.2(s)0(t)23.5(i)14.3(ng)]TJ 0 -1.3858 TD [(HP)24.4(V)-260.5(i)14.3(nf)19.4(ec)19.4(ti)20.3(o)15(n)0(.)-248.9(S)14.5(tu)15.7(d)16.1(i)0(e)20.9(s)-259.6(h)14.5(a)0(v)19.4(e)-258(su)21(gg)21.5(e)12.9(s)0(t)17.2(e)12.9(d)-254.8(a)0(n)-244(i)0(n)19.9(d)0(i)17.8(s)0(p)21(e)12.8(ns)23.1(ab)17.3(le)-241.1(ro)19.9(le)-247.4(o)15(f)-257(HP)18.1(V)]TJ 0 -1.3921 TD [(L1)-426.2(VL)18.6(P)-433.3(v)0(a)19.4(c)12.8(ci)20.9(ne)18.4(s)-436(a)0(s)-427.3(a)0(d)18.4(j)0(u)20.4(v)0(a)25.7(n)0(t)-429.4(t)0(h)20.4(e)12.9(ra)19.9(py)-426.7(af)22.5(te)18.8(r)-436(s)0(u)21(r)0(g)22(i)0(c)20.9(a)0(l)-428(t)0(r)23.5(e)12.8(at)20.9(me)18.6(nt)-423.1(fo)16.2(r)]TJ 0 -1.3858 TD 0.0173 Tc [(pati)6.4(ent)4.3(s)-525.8(suf)62.6(f)5.9(ering)-526.3(f)-0.4(rom)-525(H)2.5(PV-rel)]TJ 13.9906 0 TD 0.0164 Tc [(ated)-528.2(clinical)-527.3(diseases)-526.7(such)-529.8(as)]TJ -13.9906 -1.3921 TD 0.0136 Tc [(recurrent)-522.2(respir)5.9(atory)-523.7(p)-1.8(apill)5.3(o)-2.9(matosis)-523.2(\()3.8(RRP\))-519(\()]TJ 0.85098 0.19216 0.2 scn 19.263 0 TD 0.0123 Tc (140)Tj 0.15294 0.15294 0.15294 scn 1.474 0 TD 0.0132 Tc [(\))-525.7(a)3(nd)-525.1(cervical)]TJ -20.737 -1.3858 TD 0.0167 Tc [(intraepi)5.8(thelial)-527(n)3.4(eoplasia)-529(\(C)5(IN)6.1(\))-528.5(\()]TJ 0.85098 0.19216 0.2 scn 14.085 0 TD 0.0186 Tc [(14)6.3(1)]TJ 0.15294 0.15294 0.15294 scn 1.4866 0 TD 0.0163 Tc [(\).)-521.6(The)-525.2(d)-5.4(a)6.1(t)-3(a)-523.1(r)-4(eported)-522(t)-3(ha)6.1(t)]TJ -15.5717 -1.3921 TD 0 Tc [(su)14.7(rg)15.7(ic)14.6(al)-490.9(in)13.6(te)12.5(rv)15.7(en)12.1(ti)20.3(on)-489.7(an)14.2(d)-500.5(H)0(P)18.1(V)-499.9(va)13.1(cc)13.1(in)19.9(at)14.6(ion)-481.7(com)20.9(bin)22.3(at)14.6(ion)-481.7(th)14.1(er)11.5(ap)12.1(y)]TJ 0 -1.3858 TD [(ca)15.2(n)-498.4(e)0(f)70.8(f)0(e)14.1(c)0(t)12.5(i)0(v)12.5(e)0(l)17.2(y)-499.5(re)11.5(du)13.2(ce)-490.8(th)14.1(e)-497.4(r)0(e)11.5(c)0(u)16.3(rre)16.4(nc)12.1(e)-497.4(a)0(n)14.2(d)-500.5(se)11.5(ve)17.3(ri)13(ty)-493.5(of)-487.7(re)11.5(sp)14.7(ir)13(ato)17(ry)]TJ 0 -1.3921 TD [(papillom)15.2(atosis)-500.5(\()]TJ 0.85098 0.19216 0.2 scn 6.6016 0 TD (142)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD [(\).)-503.6(Likewis)11.2(e,)-506.2(anothe)12.1(r)-511.6(study)-500.5(has)-507.4(repo)11(rted)-508.2(that)]TJ -8.0378 -1.3858 TD 0.0159 Tc [(HPV)-528(v)1.5(accination)-526.6(signi)]TJ /F9 1 Tf 9.8205 0 TD 0 Tc ()Tj /F8 1 Tf 0.548 0 TD 0.0151 Tc [(cantly)-528.5(pr)-5.2(olongs)-528(the)-526.4(i)-2.1(nterv)-5.6(a)-1.4(ls)-521.7(between)]TJ -10.3685 -1.3921 TD 0 Tc [(su)21(rg)22(ic)20.9(al)-390.2(pr)21(oc)21.5(ed)16.3(ur)21(e)12.8(s)-404.5(a)15(n)0(d)-394.1(r)0(e)17.8(d)0(u)19.5(c)12.9(e)12.9(s)-404.5(th)20.4(e)-402.9(n)0(u)21.6(m)0(b)20.7(e)12.8(r)-404.5(o)0(f)-393.2(p)0(r)21(o)15(ce)19.4(du)19.5(re)24.1(s)-404.5(i)0(n)-395.8(t)0(h)26.7(e)]TJ 0 -1.3858 TD [(ma)20.7(jo)25.6(ri)19.3(ty)-462(of)-462.5(RR)18.6(P)-471.1(p)0(a)18.4(t)0(i)20.3(e)12.8(nt)24.1(s)-473.8(\()]TJ 0.85098 0.19216 0.2 scn 11.1496 0 TD -0.0129 Tc [(14)-12.9(3)]TJ 0.15294 0.15294 0.15294 scn 1.4047 0 TD 0 Tc [(\).)-465.8(M)15.7(o)0(s)19.9(t)-472.8(CI)18.9(N)14.6(s)-473.8(ar)19.9(e)-472.2(c)0(a)15.2(u)16.1(se)17.8(d)-475.3(b)15(y)-474.3(H)0(P)18.1(V)]TJ -12.5543 -1.3921 TD [(in)19.9(f)13.8(e)0(c)19.4(t)0(i)20.3(o)15(n)-347.2(\()]TJ 0.85098 0.19216 0.2 scn 4.1197 0 TD -0.0129 Tc [(14)-12.9(4)]TJ 0.15294 0.15294 0.15294 scn 1.4047 0 TD 0 Tc [(\))-343.6(a)0(n)20.5(d)-343(mi)20(gh)18.9(t)-340.5(p)0(r)21(o)0(g)19.4(r)0(e)24.1(s)0(s)-336.6(t)0(o)-331.9(c)0(e)19.4(r)0(v)22(i)0(c)20.9(a)0(l)-333.5(c)0(a)21.5(n)0(c)18.4(e)12.8(r)-347.8(\()]TJ 0.85098 0.19216 0.2 scn 16.4346 0 TD -0.0129 Tc (145)Tj 0.15294 0.15294 0.15294 scn 1.4047 0 TD -0.0145 Tc [(\).)-363.4(CI)-14.5(N)-347.2(1)]TJ -23.3638 -1.3858 TD 0 Tc [(ra)19.9(re)24.1(ly)-274.7(pr)21(og)19.4(re)24.1(ss)22.5(es)-278.3(to)-268.9(ma)20.7(li)18.7(gn)22.6(an)20.5(c)12.8(y)-285.3(wi)23.6(th)-275.7(a)-281.1(h)0(i)22.5(g)0(h)-277.1(p)0(o)24.7(t)0(e)18.8(n)0(t)24.1(i)0(a)23(l)-285.4(fo)22.5(r)-284.8(r)0(e)17.8(g)0(r)22(e)12.8(ss)22.5(io)16.7(n.)]TJ 0 -1.3921 TD [(In)23.6(st)17.2(e)12.9(a)0(d)18.4(,)-481.2(CI)18.9(N)-483(2)-484.8(an)20.5(d)-487.9(3)12.9(,)-487.5(a)0(s)-471.4(t)0(h)20.4(e)-484.8(hi)22.5(gh)18.9(-)13.8(g)0(r)22(a)0(d)18.4(e)-484.8(le)23.5(si)19.3(on)20.5(s,)-476.3(b)15(e)0(c)19.4(o)0(m)20.7(e)-484.8(hi)22.5(gh)18.9(ly)]TJ 0 -1.3858 TD [(c)12.9(a)0(n)20.5(c)0(e)19.4(r)0(o)19.9(u)0(s)-356.9(w)0(i)17.3(t)0(h)-357.5(a)-369.3(lo)19.3(w)15.6(e)0(r)-360.2(p)0(o)18.4(t)0(e)18.8(n)0(t)24.1(i)14.3(al)-365(f)13.8(o)0(r)-358(r)0(e)17.8(g)0(r)22(e)12.9(ss)16.2(i)14.3(o)0(n)-363.7(\()]TJ 0.85098 0.19216 0.2 scn 19.6787 0 TD [(14)19.4(6)]TJ 0.15294 0.15294 0.15294 scn 1.4047 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5921 0 TD -0.0129 Tc (147)Tj 0.15294 0.15294 0.15294 scn 1.4047 0 TD 0 Tc [(\))15.4(.)-374.1(St)20.4(ud)19.5(i)14.3(e)0(s)]TJ -23.0803 -1.3921 TD [(ha)23.1(ve)-228.4(re)24.1(po)18.4(rt)23.5(e)12.9(d)-235.9(th)20.4(at)-224.8(va)19.4(c)12.8(c)12.9(in)19.9(at)20.9(io)23(n)-240.1(w)15.6(it)20.3(h)-237.5(t)0(h)26.7(e)-239.1(q)12.4(u)0(a)18.4(d)0(r)21(i)14.3(va)19.4(le)23.5(nt)-227.9(HP)24.4(V)-235.3(v)0(a)19.4(c)12.8(ci)20.9(ne)-227.2(in)]TJ 28.3654 28.0252 TD 0.0181 Tc [(patients)-531.3(after)-531.3(l)3.5(oop)-532.8(electrosurg)]TJ 13.1906 0 TD 0.0178 Tc [(ical)-532.2(excision)-531(pro)-5(c)5.5(edure)-530(\()-4.6(LEEP\))]TJ -13.1906 -1.3858 TD 0 Tc [(tr)23.5(e)12.8(a)0(t)20.9(m)0(e)18.6(n)0(t)-423.1(s)0(i)25.6(g)0(n)16.3(i)]TJ /F9 1 Tf 6.0661 0 TD ()Tj /F8 1 Tf 0.5228 0 TD [(c)12.8(a)0(n)20.5(t)0(l)22.9(y)-436.5(pr)21(e)12.8(v)0(e)17.3(n)0(t)24.1(s)-436(th)20.4(e)-434.4(r)0(e)24.1(c)0(u)16.3(r)0(r)22.5(e)12.8(nc)18.4(e)-434.4(o)0(f)-424.7(C)13.5(IN)20(2)]TJ /F12 1 Tf 16.1386 0 TD ()Tj /F8 1 Tf 0.5039 0 TD 0.4344 Tc [(3r)434.4(e)458.5(l)434.4(a)453.7(t)434.4(e)459.5(d)]TJ -23.2315 -1.3921 TD 0 Tc [(to)-281.5(va)25.7(cc)19.4(in)19.9(e)-289.5(H)0(P)18.1(V)-292(ty)23(pe)16.3(s)-291.1(c)12.8(om)20.7(pa)18.4(re)24.1(d)-292.6(w)0(i)17.3(t)0(h)-282(n)0(o)20.5(n)0(-)25.7(H)0(P)18.1(V)0(-)24.2(v)0(a)19.4(c)12.9(ci)20.9(na)20.5(te)18.8(d)-292.6(p)0(a)18.4(t)0(i)26.6(e)0(n)18.4(t)0(s)]TJ 0 -1.3858 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3276 0 TD [(14)19.4(8)]TJ 0.15294 0.15294 0.15294 scn 1.4047 0 TD [(\).)-283.1(Th)23.7(es)17.8(e)-289.5(d)0(a)18.4(t)0(a)-275.2(d)0(e)16.3(m)0(o)27(n)0(s)16.8(t)0(r)23.5(a)0(t)20.9(e)-289.5(th)20.4(at)-281.5(HP)24.4(V)-292(v)0(a)19.4(c)12.9(c)12.8(i)0(n)19.9(a)0(t)20.9(i)0(o)23(n)-290.5(pl)20.4(ay)19.4(s)-291.1(a)-287.4(cr)17.8(i)14.3(t)0(i)20.3(c)0(a)21.5(l)]TJ -1.7323 -1.3921 TD [(ro)26.2(le)-234.8(as)-232.1(ad)18.4(ju)20.4(va)25.7(nt)-234.2(th)20.4(er)17.8(a)14.9(p)0(y)-237.7(i)14.3(n)-246.4(H)0(P)18.1(V)0(-)24.2(r)0(e)17.8(l)0(a)25.6(t)0(e)18.8(d)-242.2(di)17.8(so)26.2(rd)21(er)17.8(s)-247(o)15(th)20.4(e)12.8(r)-247(th)20.4(a)14.9(n)-246.4(ca)21.5(nc)18.4(e)12.8(r)0(.)]TJ /F1 1 Tf 11.9999 0 0 11.9999 304.8944 239.7543 Tm [(4.5)-299(Exploration)-303.1(in)-301.9(formulation)-306.2(strategy,)]TJ 0 -1.0441 TD [(dosing)-299.5(regimens,)-303.1(and)-301.9(expansion)-309.7(of)]TJ 0 -1.0394 TD [(vaccine)-303(recipients)]TJ 10.5001 0 0 10.5001 304.8944 190.2047 Tm [(4.5.1)-295.5(Alternative)-307.9(strategies)-301.3(for)-303.2(HPV)]TJ 0 -1.1392 TD [(vaccine)-298.9(formulation)]TJ /F8 1 Tf 9 0 0 9 318.8409 165.7134 Tm [(Hi)18.4(gh)-251.9(co)21.5(st)17.2(,)-267(c)12.9(ol)25.6(d)-267.4(c)0(h)21(a)0(i)16.7(n)-265.3(st)23.5(or)19.9(a)15(g)0(e)-259.9(a)15(nd)-255.5(de)16.3(li)25(ve)17.3(ry)22(,)-260.7(a)0(n)20.5(d)-267.4(re)17.8(q)12.4(u)0(i)24.1(r)0(e)17.8(m)0(e)18.6(n)0(t)24.1(s)-265.9(fo)22.5(r)]TJ -1.5496 -1.3858 TD [(tr)23.5(a)14.9(i)0(n)19.9(e)0(d)-393.1(v)0(a)19.4(c)12.9(c)12.8(i)0(n)19.9(a)0(t)20.9(o)0(r)19.9(s)-398.2(li)18.7(mi)26.3(t)-403.5(v)0(a)19.4(c)12.9(c)12.9(i)0(n)19.9(a)0(t)20.9(i)0(o)23(n)-403.9(c)12.8(o)0(v)19.4(e)12.8(ra)19.9(ge)23.6(,)-405.6(w)15.6(hi)22.5(ch)-394.7(pr)21(o)15(m)0(p)21.8(t)0(s)-392.3(t)0(h)20.4(e)]TJ 0 -1.3921 TD 0.0345 Tc [(dev)-5.1(e)3.2(lopment)-545.4(o)-0.9(f)-543.8(n)-4(ano-)-550.1(o)5.4(r)-546.4(micr)]TJ 14.0535 0 TD 0.035 Tc [(o-)4.7(p)-5.6(a)-0.4(rticulate)-544.3(v)1.7(accines)-545.9(\()]TJ 0.85098 0.19216 0.2 scn 10.589 0 TD 0.0375 Tc [(14)6.3(9)]TJ 0.15294 0.15294 0.15294 scn 1.5433 0 TD 0.035 Tc (\).)Tj -26.1858 -1.3858 TD 0 Tc [(N)14.6(a)0(n)20.5(o)0(t)20.9(e)12.8(ch)21(no)20.5(lo)19.3(gy)-337.5(h)14.5(a)0(s)-339.2(b)0(e)21.5(e)12.9(n)-353.5(e)12.9(xt)20.4(e)12.9(n)0(s)23.1(i)0(v)18.8(e)12.8(ly)-337.7(us)21(ed)-342.7(i)14.3(n)-347.2(va)19.4(cc)19.4(i)14.3(n)0(e)-340.6(d)0(e)22.6(v)0(e)17.3(l)0(o)25.6(p)0(m)21.8(e)0(n)18.4(t)]TJ 0 -1.3921 TD [(v)17.1(i)0(a)-222.7(t)0(h)20.4(e)-232.8(ut)22(il)18.7(i)14.3(t)0(y)-222.7(o)0(f)-223.2(a)0(d)18.4(v)0(a)19.4(n)0(c)24.7(e)0(d)-223(n)0(a)20.5(n)0(o)20.5(-)13.8(ba)17.3(se)24.1(d)-235.9(p)0(a)24.7(r)0(t)17.2(i)14.3(cl)17.2(e)12.9(s)-234.4(o)15(r)-234.4(ma)20.7(te)18.8(ri)25.6(al)19.3(s)-234.4(d)0(e)22.6(s)0(i)19.3(g)0(n)22.6(e)12.8(d)]TJ 0 -1.3858 TD [(f)13.8(o)0(r)-345.4(a)0(n)20.5(t)0(i)20.3(g)0(e)23.6(n)-359.8(de)22.6(li)25(ve)17.3(ry)-343.4(or)-345.4(as)-345.5(ad)18.4(ju)20.4(va)25.7(nt)17.8(s)-354.1(t)0(o)-344.5(e)0(n)18.4(h)14.5(an)20.5(ce)-346(im)20(mu)21.8(ne)-346.9(re)17.8(sp)21(o)15(n)0(s)16.8(e)12.8(s)]TJ 0 -1.3921 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3339 0 TD (150)Tj 0.15294 0.15294 0.15294 scn 1.4236 0 TD [(\).)-497.3(Ar)11.6(chae)17.3(oso)16(mes)-493(are)-490.1(com)14.6(mon)13.6(ly)-495.1(use)15(d)-506.8(i)0(n)-496.6(can)14.5(ce)13.1(r)-505.3(v)0(a)13.1(cci)14.8(nes)-493.2(as)]TJ -1.7575 -1.3858 TD [(d)16.1(e)0(l)17.2(i)14.3(ve)17.3(ry)-286.7(to)20.9(ol)19.3(s.)-287.3(HP)18.1(V)-298.3(D)0(N)19.2(A)-302(va)25.7(cc)19.4(in)19.9(e)12.9(s)-303.7(c)12.9(o)0(n)20.5(t)0(a)20.9(i)0(n)19.9(i)14.3(ng)-292.3(th)20.4(e)-302.1(t)0(r)23.5(u)0(n)21.6(c)12.9(at)20.9(ed)-292.3(L1)21(,)-298.5(E)0(6)20.5(,)]TJ ET 0.49804 0.49804 0.49804 scn 49.833 732.416 435.855 17.688 re f 485.688 750.104 m 545.726 750.104 l 545.726 732.416 l 485.688 732.416 l f* 0.63529 0.63529 0.63529 scn 49.606 750.104 496.346 0.28351 re f 545.726 371.622 0.22681 378.482 re f 49.606 371.622 0.22676 378.482 re f 49.833 371.622 495.893 0.28348 re f 92.013 732.416 m 49.833 732.416 l 49.833 732.699 l 92.013 732.699 l 92.013 732.416 l f* 92.013 732.416 0.22678 17.688 re f 92.239 732.416 63.496 0.28351 re f 155.735 732.416 0.28346 17.688 re f 156.019 732.416 55.276 0.28351 re f 211.294 732.416 0.28345 17.688 re f 271.332 732.416 m 211.578 732.416 l 211.578 732.699 l 271.332 732.699 l 271.332 732.416 l f* 271.332 732.416 0.22678 17.688 re f 271.559 732.416 90.198 0.28351 re f 361.757 732.416 0.22678 17.688 re f 361.984 732.416 123.704 0.28351 re f 485.688 732.416 0.28345 17.688 re f 485.972 732.416 59.754 0.28351 re f 92.013 687.345 m 49.833 687.345 l 49.833 687.572 l 92.013 687.572 l 92.013 687.345 l f* 92.013 687.345 0.22678 45.071 re f 92.239 687.345 63.496 0.22681 re f 155.735 687.345 0.28346 45.071 re f 156.019 687.345 55.276 0.22681 re f 211.294 687.345 0.28345 45.071 re f 271.332 687.345 m 211.578 687.345 l 211.578 687.572 l 271.332 687.572 l 271.332 687.345 l f* 271.332 687.345 0.22678 45.071 re f 271.559 687.345 90.198 0.22681 re f 361.757 687.345 0.22678 45.071 re f 361.984 687.345 123.704 0.22681 re f 485.688 687.345 0.28345 45.071 re f 485.972 687.345 59.754 0.22681 re f 92.013 623.225 m 49.833 623.225 l 49.833 623.509 l 92.013 623.509 l 92.013 623.225 l f* 92.013 623.225 0.22678 64.12 re f 92.239 623.225 63.496 0.28345 re f 155.735 623.225 0.28346 64.12 re f 156.019 623.225 55.276 0.28345 re f 211.294 623.225 0.28345 64.12 re f 271.332 623.225 m 211.578 623.225 l 211.578 623.509 l 271.332 623.509 l 271.332 623.225 l f* 271.332 623.225 0.22678 64.12 re f 271.559 623.225 90.198 0.28345 re f 361.757 623.225 0.22678 64.12 re f 361.984 623.225 123.704 0.28345 re f 485.688 623.225 0.28345 64.12 re f 485.972 623.225 59.754 0.28345 re f 92.013 587.622 m 49.833 587.622 l 49.833 587.905 l 92.013 587.905 l 92.013 587.622 l f* 92.013 587.622 0.22678 35.603 re f 92.239 587.622 63.496 0.28345 re f 155.735 587.622 0.28346 35.603 re f 156.019 587.622 55.276 0.28345 re f 211.294 587.622 0.28345 35.603 re f 271.332 587.622 m 211.578 587.622 l 211.578 587.905 l 271.332 587.905 l 271.332 587.622 l f* 271.332 587.622 0.22678 35.603 re f 271.559 587.622 90.198 0.28345 re f 361.757 587.622 0.22678 35.603 re f 361.984 587.622 123.704 0.28345 re f 485.688 587.622 0.28345 35.603 re f 485.972 587.622 59.754 0.28345 re f 92.013 533.027 m 49.833 533.027 l 49.833 533.31 l 92.013 533.31 l 92.013 533.027 l f* 92.013 533.027 m 92.013 587.622 l 92.239 587.622 l 92.239 533.027 l 92.013 533.027 l f* 92.239 533.027 63.496 0.28345 re f 155.735 533.027 m 155.735 587.622 l 156.019 587.622 l 156.019 533.027 l 155.735 533.027 l f* 156.019 533.027 55.276 0.28345 re f 211.294 533.027 m 211.294 587.622 l 211.578 587.622 l 211.578 533.027 l 211.294 533.027 l f* 271.332 533.027 m 211.578 533.027 l 211.578 533.31 l 271.332 533.31 l 271.332 533.027 l f* 271.332 533.027 m 271.332 587.622 l 271.559 587.622 l 271.559 533.027 l 271.332 533.027 l f* 271.559 533.027 90.198 0.28345 re f 361.757 533.027 m 361.757 587.622 l 361.984 587.622 l 361.984 533.027 l 361.757 533.027 l f* 361.984 533.027 123.704 0.28345 re f 485.688 533.027 m 485.688 587.622 l 485.971 587.622 l 485.971 533.027 l 485.688 533.027 l f* 485.972 533.027 59.754 0.28345 re f 92.013 449.915 m 49.833 449.915 l 49.833 450.198 l 92.013 450.198 l 92.013 449.915 l f* 92.013 449.915 0.22678 83.112 re f 92.239 449.915 63.496 0.28348 re f 155.735 449.915 0.28346 83.112 re f 156.019 449.915 55.276 0.28348 re f 211.294 449.915 0.28345 83.112 re f 271.332 449.915 m 211.578 449.915 l 211.578 450.198 l 271.332 450.198 l 271.332 449.915 l f* 271.332 449.915 0.22678 83.112 re f 271.559 449.915 90.198 0.28348 re f 361.757 449.915 0.22678 83.112 re f 361.984 449.915 123.704 0.28348 re f 485.688 449.915 0.28345 83.112 re f 485.972 449.915 59.754 0.28348 re f 92.013 423.836 m 49.833 423.836 l 49.833 424.063 l 92.013 424.063 l 92.013 423.836 l f* 92.013 423.836 0.22678 26.079 re f 92.239 423.836 63.496 0.22678 re f 155.735 423.836 0.28346 26.079 re f 156.019 423.836 55.276 0.22678 re f 211.294 423.836 0.28345 26.079 re f 271.332 423.836 m 211.578 423.836 l 211.578 424.063 l 271.332 424.063 l 271.332 423.836 l f* 271.332 423.836 0.22678 26.079 re f 271.559 423.836 90.198 0.22678 re f 361.757 423.836 0.22678 26.079 re f 361.984 423.836 123.704 0.22678 re f 485.688 423.836 0.28345 26.079 re f 485.972 423.836 59.754 0.22678 re f 92.013 397.757 m 49.833 397.757 l 49.833 397.984 l 92.013 397.984 l 92.013 397.757 l f* 92.013 397.757 0.22678 26.079 re f 92.239 397.757 63.496 0.22678 re f 155.735 397.757 0.28346 26.079 re f 156.019 397.757 55.276 0.22678 re f 211.294 397.757 0.28345 26.079 re f 271.332 397.757 m 211.578 397.757 l 211.578 397.984 l 271.332 397.984 l 271.332 397.757 l f* 271.332 397.757 0.22678 26.079 re f 271.559 397.757 90.198 0.22678 re f 361.757 397.757 0.22678 26.079 re f 361.984 397.757 123.704 0.22678 re f 485.688 397.757 0.28345 26.079 re f 485.972 397.757 59.754 0.22678 re f 92.013 371.905 0.22678 25.852 re f 155.735 371.905 0.28346 25.852 re f 211.294 371.905 0.28345 25.852 re f 271.332 371.905 0.22678 25.852 re f 361.757 371.905 0.22678 25.852 re f 485.688 371.905 0.28345 25.852 re f BT /F5 1 Tf 6.9999 0 0 6.9999 49.6063 760.3652 Tm 0.49804 0.49804 0.49412 scn [(TABLE)-306.1(5)-798.7(Clinical)-300.2(trials)-304.7(of)-303.6(therapeutic)-294.6(HPV)-301.2(vaccines)-306.6(in)-302.3(combination)-301.5(with)-297.8(ICB)-306.9(therapy.)]TJ /F1 1 Tf 9 0 0 9 54.6519 738.255 Tm 1 1 1 scn [(Vaccine)-1100.8(Combination)-1746.1(Sponsor)-2358.4(Phase)-301.3(\(N\))-2913.7(Safety)-305.5(Pro)]TJ /F10 1 Tf 30.5386 0 TD ()Tj /F1 1 Tf 0.5858 0 TD [(les)-6841.8(Ef)]TJ /F10 1 Tf 9.0079 0 TD ()Tj /F1 1 Tf 0.5858 0 TD [(cacy)-7535.8(Ref.)]TJ /F8 1 Tf 6.9999 0 0 6.9999 57.9401 707.6975 Tm 0.15294 0.15294 0.15294 scn [(GX-188E)-2554.7(Pembrolizumab)-2446.8(Genexine,)-308.7(Inc.)]TJ 25.8848 0.6803 TD (II)Tj -0.494 -1.3607 TD (\(36\))Tj 7.2811 2.7132 TD [(AEs:)-299.1(44%;)-301.3(Grade)-308.8(3)]TJ /F12 1 Tf 7.5889 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (4)Tj -6.2768 -1.3526 TD [(TRAE:)-309.9(11%.)]TJ -0.4293 -1.3607 TD [(No)-299.9(treatment-)]TJ -0.0081 -1.3526 TD [(related)-307.9(deaths.)]TJ 16.012 3.3854 TD [(ORR:)-301.5(42%.)]TJ 0.3483 -1.3526 TD [(CR:)-301.9(15%.)]TJ 0.0486 -1.3607 TD [(PR:)-298.8(27%.)]TJ 13.8819 1.3607 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3483 0 TD (135)Tj 0.15294 0.15294 0.15294 scn 1.4335 0 TD (\))Tj -65.8864 -7.7995 TD [(ISA)-301.9(101)-3730.3(Nivolumab)]TJ 16.9677 0.6803 TD (ISA)Tj -2.5188 -1.3607 TD (Pharmaceuticals)Tj 11.193 1.3607 TD (II)Tj -0.494 -1.3607 TD (\(24\))Tj 7.1434 4.0739 TD [(Grades)-309.2(3)]TJ /F12 1 Tf 3.596 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(4)-298.5(toxicity:)-306.8(2)]TJ -4.4464 -1.3607 TD [(patients;)-300.9(Asymptomatic)]TJ -0.5588 -1.3526 TD [(grade)-299.6(3)-306.6(transaminase)-305.4(level)]TJ 1.385 -1.3607 TD [(elevation:)-300.3(1)-306.6(patient;)]TJ -0.9962 -1.3607 TD [(Grade)-300.7(4)-298.5(lipase)-304.3(elevation:)]TJ 3.0453 -1.3526 TD [(1)-298.5(patient.)]TJ 13.153 6.1068 TD [(mPFS:)-303.4(2.66)-296.9(months.)]TJ 0.1701 -1.3607 TD [(mOS:)-298.1(15.3)-305(months.)]TJ -0.2592 -1.3526 TD [(2-year)-302.5(OS)-299.5(rate:)-304(33%.)]TJ -2.4945 -1.3607 TD [(objective)-304.9(response:)-298.1(38%)-300.6(\(without)]TJ 2.0572 -1.3526 TD [(progression)-305.8(at)-297.7(3)-298.5(years\))]TJ 16.6518 2.7132 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3483 0 TD (136)Tj 0.15294 0.15294 0.15294 scn 1.4335 0 TD (\))Tj -65.8945 -7.1191 TD [(TG4001)-3921.7(Avelumab)-4408(Transgene)]TJ 25.0668 0.6722 TD (Ib/II)Tj 0.0891 -1.3526 TD (\(34\))Tj 10.4884 0.6803 TD [(N.)-298.4(A.)]TJ 13.8414 1.3526 TD [(ORR:)-301.5(23.5%.)]TJ 0.5831 -1.3526 TD [(CR:)-302(2.9%.)]TJ -0.1863 -1.3607 TD [(PR:)-298.8(20.6%.)]TJ 14.2302 1.3607 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3483 0 TD (137)Tj 0.15294 0.15294 0.15294 scn 1.4335 0 TD (\))Tj -65.765 -5.7666 TD (PRGN-)Tj 0.5345 -1.3606 TD (2009)Tj 7.1353 0.6803 TD (M7824)Tj 8.1882 1.3607 TD (National)Tj 0.324 -1.3607 TD (Cancer)Tj -1.6198 -1.3606 TD [(Institute)-304.7(\(NCI\))]TJ 10.6261 2.041 TD (I/II)Tj 0.081 -1.3606 TD (\(6\))Tj 7.6537 2.041 TD [(Grade)-308.8(1)]TJ /F12 1 Tf 3.2316 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (2)Tj /F9 1 Tf 0.7775 0 TD ()Tj /F8 1 Tf 0.5345 0 TD (u-like)Tj -6.2363 -1.3607 TD [(syndrome;)-310.2(Injection)-304.4(site)]TJ -0.6641 -1.3606 TD [(reactions,)-304.6(fatigue,)-305.3(and)-300(rash.)]TJ 17.5022 4.0739 TD [(SD:)-302(2/3)-299.4(patients.)]TJ -4.0982 -1.3526 TD [(Increased)-307.5(T)-301.2(cells)-304.5(were)-297.6(detected)-304.3(in)-300.5(all)]TJ 0.2511 -1.3607 TD [(patients,)-309(with)-295.3(3/6)-299.4(\(50%\))-303.1(developing)]TJ 1.0205 -1.3606 TD [(HPV-16)-297.5(T)-301.2(cells)-304.5(and)-300(5/6)-299.4(\(83%\))]TJ 0.6074 -1.3525 TD [(developing)-301.9(HPV-18)-305.6(T)-293.1(cells.)]TJ 17.6237 2.7132 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3483 0 TD (138)Tj 0.15294 0.15294 0.15294 scn 1.4335 0 TD (\))Tj -66.2671 -9.8323 TD [(PDS)-306.3(0101)]TJ 8.172 0.6722 TD (M9241)Tj -0.899 -1.3526 TD [(and)-300(M7824)]TJ 9.9457 2.0329 TD (PDS)Tj -1.9843 -1.3526 TD (Biotechnology)Tj 0.3888 -1.3606 TD (Corporation)Tj 10.3993 2.0329 TD (II)Tj -0.494 -1.3526 TD (\(14\))Tj 6.3416 0.6803 TD [(Manageable)-309.4(safety)-299.5(pro)]TJ /F9 1 Tf 9.0386 0 TD ()Tj /F8 1 Tf 0.5345 0 TD (le.)Tj 3.1101 4.7461 TD [(Evidence)-306.8(of)-294.3(notable)-301.8(clinical)-304.4(activity)-306.2(for)]TJ -0.2754 -1.3606 TD [(patients)-308.3(with)-303.4(both)-297.1(checkpoint)-306.6(na飗e)-301.6(and)]TJ 2.0491 -1.3526 TD [(refractory)-299.7(HPV-16+)-308.6(advanced)]TJ 3.3773 -1.3607 TD (malignancies.)Tj -1.1096 -1.3526 TD [(ORR:)-301.5(10/14)-297.1(\(71%\).)]TJ -0.0486 -1.3607 TD [(CR:)-301.9(1\(anal)-299.2(cancer\).)]TJ -3.4178 -1.3526 TD [(PR:)-298.8(9)-298.5(\()0(3)-303.8(cervical,)-304.4(2)-298.5(vulvar/vaginal,)-311.8(2)]TJ 2.6322 -1.3607 TD [(anal,)-303.8(2)-298.5(oropharyngeal\).)]TJ 16.7247 4.7542 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3483 0 TD (139)Tj 0.15294 0.15294 0.15294 scn 1.4335 0 TD (\))Tj -66.5263 -7.8076 TD [(MG1-E6E7)-2562.7(Atezolizumab)]TJ 16.2712 0.6803 TD (Turnstone)Tj -0.9881 -1.3526 TD [(Biologics,)-297.4(Corp)]TJ 11.1606 1.3526 TD (I)Tj -0.656 -1.3526 TD (\(75\))Tj 10.4884 0.6722 TD [(N.)-298.4(A.)-13155.1(N.)-298.4(A.)-9138(NCT03618953)]TJ -35.7415 -3.7256 TD [(ISA101b)-3410.8(Cemiplimab)]TJ 17.073 0.6803 TD (ISA)Tj -2.5188 -1.3607 TD (Pharmaceuticals)Tj 11.193 1.3607 TD (II)Tj 6.9999 0 0 6.9999 234.0283 403.8235 Tm (\(194\))Tj 10.7233 0.6803 TD [(N.)-298.4(A.)-13155.1(N.)-298.4(A.)-9138(NCT03669718)]TJ -36.0654 -3.7256 TD [(INO-3112)-3022(Durvalumab)]TJ 14.9996 0.6722 TD [(M.D.)-306.9(Anderson)]TJ 0.2268 -1.3526 TD [(Cancer)-304.4(Center)]TJ 10.8447 1.3526 TD (II)Tj -0.494 -1.3526 TD (\(77\))Tj 10.4884 0.6803 TD [(N.)-298.4(A.)-13155.1(N.)-298.4(A.)-9138(NCT03439085)]TJ 6.5001 0 0 6.5001 49.6063 363.1181 Tm [(AE,)-268.6(Adverse)-272.4(Event;)-267.8(TRAE,)-270.4(Adverse)-272.4(Event;)-267.8(ORR,)-265.8(Objective)-272.4(Response)-277(Rate;)-263.2(CR,)-273.8(Complete)-270.8(Response;)-268.3(PR,)-271.8(Partial)-266.2(Response;)-277(SD,)-268.3(Stable)-261(Disease;)-276(OS,)-267(Overall)-269.4(S)]TJ 62.0092 0 TD [(urvival;)-273.7(DCR,)-268.7(Disease)-267.2(Control)-271(Rate;)]TJ -62.0092 -1.3083 TD [(N.A.,)-301(not)-305.4(available.)]TJ /F1 1 Tf 6.9999 0 0 6.9999 49.6063 800.9573 Tm 0.49804 0.49804 0.49412 scn [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.5213 0 TD (09)Tj ET endstream endobj 253 0 obj<> endobj 254 0 obj<> endobj 255 0 obj<> endobj 256 0 obj<> endobj 257 0 obj<> endobj 258 0 obj<> endobj 259 0 obj<> endobj 260 0 obj<> endobj 261 0 obj<> endobj 262 0 obj<> endobj 263 0 obj<> endobj 264 0 obj<> endobj 265 0 obj<> endobj 266 0 obj<> endobj 267 0 obj<> endobj 268 0 obj<> endobj 269 0 obj<> endobj 270 0 obj<> endobj 271 0 obj<> endobj 272 0 obj<> endobj 273 0 obj<> endobj 274 0 obj<> endobj 275 0 obj<> endobj 276 0 obj<> endobj 277 0 obj<> endobj 278 0 obj<> endobj 279 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 280 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 281 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 282 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 283 0 obj<>stream /GS1 gs BT /F8 1 Tf 9 0 0 9 49.6063 758.8912 Tm /Cs6 cs 0.15294 0.15294 0.15294 scn 0 Tc 0 Tw [(an)14.2(d)-494.2(E)0(7)-489.7(g)0(e)17.3(n)0(e)12.1(s)-499(in)-484(co)15.2(mb)14.4(in)13.6(at)14.6(io)16.7(n)-498.4(w)0(i)17.3(t)0(h)-489.8(a)0(r)19.9(c)0(h)14.7(a)0(e)15.2(o)0(s)13.6(o)0(m)14.4(e)0(s)-486.1(i)0(n)13.6(d)0(u)13.2(c)0(e)-490.8(s)0(t)17.2(r)0(o)13.6(n)0(g)]TJ 0 -1.3858 TD [(c)12.9(y)0(t)16.7(o)15(ly)21.4(ti)20.3(c)-459.6(i)0(m)20(m)0(u)21.8(n)0(e)-454(r)0(e)24.1(s)0(p)21(o)0(n)20.5(s)0(e)17.8(s)-461.2(to)-451.5(e)12.9(l)0(i)18.7(m)0(i)20(n)0(a)26.8(t)0(e)-453.6(t)0(u)22(m)0(o)20.7(r)-461.2(ce)19.4(ll)21.3(s)-461.2(\()]TJ 0.85098 0.19216 0.2 scn 22.4252 0 TD -0.0129 Tc (151)Tj 0.15294 0.15294 0.15294 scn 1.4047 0 TD 0 Tc [(\).)-453.2(G)15.1(o)0(l)19.3(d)]TJ -23.8299 -1.3921 TD [(na)20.5(no)20.5(pa)24.7(rt)17.2(i)14.3(c)0(l)17.2(e)12.9(s)-417.1(c)12.9(an)-407.8(al)19.3(so)-402.1(be)-406.8(po)24.7(te)18.8(nt)24.1(ia)16.7(ll)21.3(y)-411.3(u)0(s)21(e)0(d)-412(i)14.3(n)-416.5(t)0(h)20.4(e)-415.5(HP)18.1(V)-411.7(v)0(a)19.4(c)0(c)19.4(i)0(n)19.9(e)-415.5(to)]TJ 0 -1.3858 TD [(st)23.5(re)17.8(ng)22.6(th)20.4(e)12.9(n)-214.9(c)12.9(y)0(t)23(o)0(t)20.9(o)15(xi)16.2(c)-207.6(i)0(m)20(m)0(u)21.8(n)0(e)-202(r)0(e)24.1(s)0(p)21(o)0(n)20.5(s)0(e)17.8(s)-209.2(by)-201(i)14.3(n)0(c)18.4(r)0(e)24.1(a)0(s)19.9(i)0(n)19.9(g)-209.7(ox)23.1(id)17.8(a)15(t)0(i)20.3(v)0(e)-203.2(s)0(t)23.5(r)0(e)17.8(s)0(s)]TJ 0 -1.3921 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3339 0 TD -0.0129 Tc (152)Tj 0.15294 0.15294 0.15294 scn 1.4047 0 TD 0 Tc [(\).)-201.2(C)13.5(h)0(i)22.5(t)0(o)20.9(s)0(a)19.9(n)-214.9(i)14.3(s)-215.5(a)15(l)0(s)21.9(o)-211.8(us)21(ed)-204.2(as)-200.6(a)-211.8(n)0(a)20.5(n)0(o)20.5(p)0(a)24.7(r)0(t)17.2(i)14.3(cl)17.2(e)-207.6(a)0(d)18.4(j)0(u)20.4(v)0(a)19.4(n)0(t)-196.4(d)0(u)19.5(e)-213.9(to)-199.6(it)20.3(s)-209.2(n)0(o)20.5(n)0(-)]TJ -1.7386 -1.3858 TD [(to)20.9(x)14.5(i)0(c)20.9(,)-418.2(h)14.5(i)0(g)18.8(h)14.5(ly)-400.7(bi)23(oc)21.5(om)20.7(pa)18.4(ti)20.3(b)15(l)0(e)17.2(,)-411.9(lo)25.6(w)-412.8(s)0(u)21(s)0(c)17.8(e)12.8(pt)22(ib)23(il)18.7(i)14.3(t)0(y)16.7(,)-411.9(a)15(n)0(d)-406.7(b)15(io)23(de)16.3(gr)22(ad)24.7(at)20.9(io)23(n)]TJ 0 -1.3921 TD [(pr)21(op)18.4(e)12.9(r)0(t)23.5(i)0(e)20.9(s)-303.7(\()]TJ 0.85098 0.19216 0.2 scn 4.5669 0 TD -0.0129 Tc (153)Tj 0.15294 0.15294 0.15294 scn 1.3984 0 TD 0 Tc [(\).)-295.7(C)13.5(h)0(i)22.5(t)0(o)20.9(s)0(a)19.9(n)0(-)19.4(b)15(as)19.9(e)12.9(d)-305.2(DN)25.5(A)-302(v)0(a)19.4(c)12.8(ci)20.9(ne)18.4(s)-297.4(e)0(x)21(p)0(r)21(e)0(s)17.8(s)0(i)19.3(n)0(g)-286(H)0(P)18.1(V)0(-)24.2(1)12.9(6)]TJ -5.9654 -1.3858 TD [(E7)-489.7(si)13(gn)16.3(i)]TJ /F9 1 Tf 3.3827 0 TD ()Tj /F8 1 Tf 0.5228 0 TD [(ca)15.2(ntl)22.1(y)-499.5(p)0(r)14.7(o)0(m)14.4(o)0(t)14.6(e)-497.4(T)-501(c)0(e)13.1(l)0(l)15(-)0(m)13.2(e)0(d)16.3(iat)16.3(ed)-487.6(im)13.7(mun)14.7(e)-497.4(r)0(e)17.8(spo)17.1(ns)16.8(e)-497.4(and)]TJ -3.9055 -1.3921 TD [(an)20.5(ti)20.3(bo)17.3(dy)-477.1(pr)14.7(od)18.4(uc)22.6(ti)20.3(on)-483.4(ag)19.4(ai)23(ns)16.8(t)-491.7(H)0(P)18.1(V)0(-)24.2(i)0(n)19.9(d)0(u)13.2(c)12.8(ed)-481.3(tu)15.7(mo)20.7(rs)-481.4(\()]TJ 0.85098 0.19216 0.2 scn 21.6189 0 TD -0.0129 Tc (154)Tj 0.15294 0.15294 0.15294 scn 1.4047 0 TD 0 Tc [(\).)-478.4(He)16.9(nc)18.4(e)12.8(,)]TJ -23.0236 -1.3858 TD [(t)-6.7(h)0(e)-527(n)0(a)-11(n)0(o)-11(tec)-12.4(hn)-11.5(ol)-12.2(ogy)-13.9(-c)-11.1(rea)-11.3(t)-6.7(e)0(d)-525.4(H)-8.5(PV)-530(vac)-11.8(ci)-10.6(n)-7(e)-522.6(wo)-7.2(u)-9.1(l)0(d)-521.3(p)-9.1(r)-7.7(ovi)-10.3(d)-9.1(e)-522.6(mo)-10.8(re)]TJ 0 -1.3921 TD [(op)18.4(ti)14(on)14.2(s)-492.7(f)0(o)16.2(r)-492.7(th)14.1(e)-497.4(t)0(r)17.2(e)0(a)15.2(t)0(m)17.9(e)0(n)18.4(t)-498(of)-487.7(HP)18.1(V-)17.9(re)11.5(la)19.3(te)18.8(d)-500.5(d)0(i)17.8(s)0(e)17.8(a)0(s)13.6(e)0(s)17.8(.)-493.8(Add)19.9(it)14(io)16.7(na)20.5(ll)15(y,)]TJ 0 -1.3858 TD [(HP)24.4(V)-386.5(p)0(r)21(o)15(te)18.8(in)-370.6(an)20.5(ti)20.3(ge)23.6(ns)-373.7(c)12.9(a)0(n)-370(b)0(e)-375.3(f)13.8(or)19.9(mu)21.8(la)19.3(te)25.1(d)-380.8(i)0(n)19.9(t)0(o)-369.7(g)0(l)21.4(a)0(s)19.9(s)0(y)-368.5(m)0(i)20(c)12.8(ro)19.9(sp)21(he)21(re)17.8(s)]TJ 0 -1.3921 TD [(us)-10.5(ing)-523.7(spr)-11.8(ay-)-10.8(dri)-8.7(ed)-525.4(tech)-10.6(n)-7(ique)-13.7(s)-517.9(and)-524(t)-6.7(hen)-521.4(co)-10(ate)-10.3(d)-519.4(b)0(y)-522.3(ato)-8.2(mic)-521.4(l)-8.3(aye)-11.8(r)]TJ 0 -1.3858 TD [(de)22.6(po)18.4(si)19.3(ti)26.6(on)-294.4(\(A)22.1(LD)19.1(\))-305.8(w)15.6(it)20.3(h)-306.8(n)0(a)26.8(n)0(o)20.5(m)0(e)18.6(t)0(e)25.1(r)0(-)18.8(t)0(h)20.4(i)14.3(n)-309.4(p)16.1(ro)19.9(te)18.8(c)12.9(t)0(i)20.3(v)0(e)-291.3(l)0(a)19.3(y)0(e)23.6(r)0(s)-292.5(o)0(f)-292.5(a)0(l)19.3(u)0(m)21.8(i)0(n)19.9(a)]TJ 0 -1.3921 TD [(to)-501.9(impro)11.9(ve)-505.5(their)-501.8(ther)13(mostab)11.1(ility)-498.3(\()]TJ 0.85098 0.19216 0.2 scn 14.3748 0 TD (155)Tj 0.15294 0.15294 0.15294 scn 1.4299 0 TD [(\).)-503.6(Given)-495.7(the)-502.2(advant)11.6(age)-503.2(of)]TJ -15.8047 -1.3858 TD [(na)20.5(no)20.5(te)25.1(ch)21(no)20.5(lo)19.3(gy)-425.7(ut)22(il)18.7(i)14.3(z)0(a)21.5(t)0(i)20.3(o)0(n)-426.7(i)0(n)-433.6(H)16.7(PV)-429.2(va)19.4(c)12.8(c)0(i)20.9(n)0(e)-428.8(f)0(o)16.2(r)0(m)23.2(u)0(l)20.4(a)15(ti)20.3(on)20.5(,)-437.1(i)0(t)-433.3(w)15.6(ou)18.4(ld)]TJ 0 -1.3921 TD [(pr)21(ov)19.4(i)14.3(d)0(e)-456.1(m)0(o)20.7(r)0(e)-454.6(o)15(pt)22(io)23(ns)-455.6(fo)22.5(r)-467.5(p)0(a)24.7(t)0(i)20.3(e)0(n)18.4(t)0(s)-449(i)0(n)-458.8(p)16.1(re)17.8(ve)23.6(nt)17.8(i)14.3(o)0(n)-458.2(o)15(r)-467.5(t)0(r)23.5(e)12.9(at)20.9(me)18.6(nt)-454.6(o)15(f)]TJ 0 -1.3858 TD [(HP)24.4(V-)17.9(re)24.1(la)19.3(te)18.8(d)-317.8(d)0(i)17.8(s)0(e)24.1(a)0(s)19.9(e)0(s)17.8(.)-317.4(Ho)19.1(we)22.1(ve)23.6(r,)-312.5(th)20.4(e)-321(c)0(u)16.3(r)0(r)22.5(e)12.9(nt)-309.7(na)20.5(no)20.5(pa)18.4(rt)23.5(ic)20.9(le)-310.4(ag)19.4(e)12.9(n)0(t)17.8(s)-316.3(fo)16.2(r)]TJ 0 -1.3921 TD [(th)20.4(e)-314.7(H)0(P)24.4(V)-317.2(va)25.7(cc)19.4(in)19.9(e)-314.7(a)15(re)-303.5(st)17.2(i)14.3(l)0(l)-300(f)0(a)16.2(r)-310(aw)17.9(a)15(y)-316.8(f)13.8(o)0(r)-301.3(h)0(u)17.9(m)0(a)20.7(n)-315.7(u)16.1(s)0(e)17.8(,)-311.1(wi)17.3(th)-300.9(un)21.6(c)12.8(e)0(r)17.8(t)0(a)20.9(i)14.3(nt)17.8(y)]TJ 0 -1.3858 TD [(c)12.9(o)0(n)20.5(c)0(e)19.4(r)0(n)23.1(i)0(n)19.9(g)0(.)-369.7(F)0(u)19.5(r)0(t)23.5(h)0(e)21(r)-379.3(st)23.5(ud)19.5(ie)20.9(s)-379.3(r)0(e)24.1(g)0(a)19.4(r)0(d)21(i)0(n)19.9(g)-379.8(th)20.4(e)-377.7(s)0(a)19.9(f)13.8(e)12.8(t)0(y)16.7(,)-374.1(st)17.2(a)15(b)0(i)16.7(l)0(i)25(t)0(y)23(,)-380.4(po)18.4(te)25.1(nc)18.4(y,)]TJ 0 -1.3921 TD [(an)20.5(d)-286.3(r)0(a)19.9(p)0(i)17.8(d)-286.3(pr)21(od)18.4(uc)22.6(ti)20.3(on)-275.5(of)-279.9(HP)18.1(V)-285.7(a)0(r)19.9(e)-289.5(re)17.8(q)12.4(u)0(i)24.1(r)0(e)17.8(d)-286.3(to)-281.5(b)15(e)-289.5(ex)21(pl)20.4(or)19.9(e)12.9(d)0(.)]TJ 1.5559 -1.3858 TD -0.0211 Tc [(Oral)-413.6(admi)5.8(nistration)-412.4(of)-416.7(the)-411.4(H)1.9(PV)-413.9(vacci)5.8(ne)-411.4(is)-413(easy,)-414.1(w)0.8(ith)-409.8(f)-1(avorable)]TJ -1.5559 -1.3921 TD 0 Tc [(sa)26.2(fe)20.4(ty)-487.2(pr)27.3(o)]TJ /F9 1 Tf 4.0567 0 TD ()Tj /F8 1 Tf 0.5165 0 TD [(le)23.5(s)-499(a)0(n)20.5(d)-494.2(po)18.4(te)25.1(nt)24.1(i)14.3(a)0(l)-484.6(l)0(o)19.3(n)0(g)28.9(-)0(l)24.5(a)0(s)19.9(t)0(i)26.6(n)0(g)-487.6(p)0(r)21(o)15(te)25.1(ct)18.8(i)14.3(v)0(e)-486.6(e)12.8(f)70.5(f)13.8(e)12.8(c)12.9(ts)-486.8(in)-490.3(th)26.7(e)]TJ -4.5732 -1.3858 TD -0.0213 Tc [(intestine)-499.8(\()]TJ 0.85098 0.19216 0.2 scn 4.0315 0 TD -0.0192 Tc [(15)6.3(6)]TJ 0.15294 0.15294 0.15294 scn 1.3732 0 TD -0.0213 Tc [(\).)-502.5(Oral)-502(vaccination)-500.8(c)-2.2(o)6.3(u)-5.2(ld)-496.6(di)]TJ 11.3953 0 TD -0.0201 Tc [(m)4.5(i)0.5(n)4.4(i)0.5(sh)-497(vaccin)4.4(e)-498.6(h)0.7(esit)4.7(ancy)]TJ -16.8 -1.3921 TD -0.0203 Tc [(and)-363.3(boost)-360.8(v)3.1(accine)-360.2(co)7.3(vera)7.3(ge)-360.2(\()]TJ 0.85098 0.19216 0.2 scn 11.3449 0 TD -0.0255 Tc [(15)-6.3(7)]TJ 0.15294 0.15294 0.15294 scn 1.3732 0 TD -0.0218 Tc [(\).)-358.1(A)-367.9(c)3.6(linical)-363.9(s)2(tudy)-363.8(has)-363.3(r)-4.3(eported)-358.5(t)-3.3(hat)]TJ -12.7181 -1.3858 TD -0.0216 Tc [(an)-387.7(oral)-388.9(th)5.5(erapeuti)5.3(c)-393(v)1.8(accine)-393(has)-388.3(d)0.8(em)]TJ 14.3307 0 TD [(onstrated)-389.8(s)-4.1(af)4.8(ety)-388.8(a)-0.3(nd)-389.8(potency)-388.8(t)3.2(o)]TJ -14.3307 -1.3921 TD [(induce)-342.5(persistent)-336.8(immunity)-338.3(\()]TJ 0.85098 0.19216 0.2 scn 11.3071 0 TD -0.0255 Tc (90)Tj 0.15294 0.15294 0.15294 scn 0.9134 0 TD -0.0217 Tc [(\).)-339.1(The)-336.4(c)-2.6(ombinational)-332.3(ap)-5.6(plicati)5.2(o)-0.4(n)-343.7(o)5.9(f)-341.7(a)]TJ -12.2205 -1.3858 TD -0.0209 Tc [(nanotechno)6.7(lo)6.7(gy-b)6.7(ased)-219(DNA)-215.8(v)2.5(acci)6(ne)-215.9(and)-219(a)-220.1(VLP)-221.1(v)2.5(accine)-222.2(could)-219(p)1.5(otently)]TJ 0 -1.3921 TD 0 Tc [(st)17.2(im)20(ul)14.1(at)14.6(e)-503.7(b)0(o)17.3(t)0(h)-496.1(h)0(u)17.9(m)0(o)20.7(r)0(a)13.6(l)-505.9(an)20.5(d)-506.8(c)0(e)19.4(l)0(l)15(u)0(l)20.4(a)0(r)-496.6(i)0(m)13.7(m)0(u)15.5(n)0(i)19.9(t)0(y)16.7(,)-506.4(wh)17.5(ic)14.6(h)-502.1(h)0(a)16.8(s)-505.3(be)21.5(en)]TJ 0 -1.3858 TD -0.0215 Tc [(investigated)-301.5(for)-300(H)1.5(IV)-300.9(inf)4.9(e)-2.3(ction)-299.4(\()]TJ 0.85098 0.19216 0.2 scn 12.1449 0 TD -0.0192 Tc [(15)6.3(8)]TJ 0.15294 0.15294 0.15294 scn 1.3732 0 TD -0.0218 Tc [(\).)-301.4(Oral)]TJ /F9 1 Tf 2.8221 0 TD 0 Tc ()Tj /F8 1 Tf 0.5102 0 TD -0.0223 Tc [(lms)-300.8(h)-1.5(av)-5.2(e)-299.2(b)-1(een)-306.5(e)3.1(xtensively)]TJ -16.8504 -1.3921 TD -0.0212 Tc [(used)-219.3(in)-217.2(formulati)5.7(o)0.1(ns)-217.8(for)-217.8(t)3.6(he)-222.5(admini)5.7(stra)6.4(tion)-217.2(of)-221.5(many)-224.6(drugs)-224.1(\()]TJ 0.85098 0.19216 0.2 scn 22.5701 0 TD -0.0255 Tc [(15)-6.3(9)]TJ 0.15294 0.15294 0.15294 scn 1.3669 0 TD -0.0154 Tc [(\).)-213.1(F)7(i)5.2(l)7.8(m)9.2(-)]TJ -23.937 -1.3858 TD -0.0215 Tc [(based)-207(HPV)-212.7(v)1.9(accines)-205.5(w)0.4(ould)-207(be)-210.2(attracti)5.4(ve)-210.2(a)6(s)-211.8(a)-208.1(n)-3.3(ovel)-212.4(typ)-5.4(e)-203.9(of)-209.2(HPV)-212.7(v)1.9(accine)]TJ 0 -1.3921 TD 0.0105 Tc [(t)3.8(o)-535.2(t)3.8(r)2.8(eat)-531.6(H)2(PV-relat)3.8(ed)-527.8(carcin)3.5(ogen)3.5(esis.)-527.4(F)1.4(ilm)-531.8(m)-2.7(a)10.5(t)-6.4(erials)-532.6(m)3.6(a)0.3(ke)-531(th)10.5(e)]TJ 0 -1.3858 TD 0 Tc [(ad)24.7(mi)20(ni)19.9(st)23.5(ra)26.2(ti)20.3(o)15(n)-498.4(of)-487.7(th)20.4(e)-497.4(H)0(P)18.1(V)-499.8(v)17.1(a)0(c)21.5(c)0(i)20.9(n)0(e)-485.5(e)0(a)21.5(s)0(y)-488.2(a)0(n)20.5(d)-500.5(re)24.1(du)19.5(c)12.9(e)-497.4(th)20.4(e)-497.4(r)0(i)19.3(s)0(k)-488.7(o)15(f)]TJ T* -0.0212 Tc [(ch)5.9(oking)-344.3(o)0.1(r)-343.8(s)2.6(uf)61.9(focati)5.7(on)-349.5(i)5.7(n)-349.5(ped)-5.1(i)5.7(atric,)-344.9(geri)5.7(atric,)-344.9(and)-345.3(p)1.2(sychiatri)5.7(c)-348.5(patients)]TJ 0 -1.3921 TD 0 Tc (\()Tj 0.85098 0.19216 0.2 scn 0.3213 0 TD -0.0192 Tc [(16)6.3(0)]TJ 0.15294 0.15294 0.15294 scn 1.3732 0 TD -0.0215 Tc [(\).)-238.1(The)]TJ /F9 1 Tf 2.4882 0 TD 0 Tc ()Tj /F8 1 Tf 0.5102 0 TD -0.0215 Tc [(lm)-236.3(dosage)-235.4(forms)-237(i)-0.9(ncorporated)-238.5(w)0.4(ith)-240.1(D)2(NA-)-234.4(a)-0.3(nd)-238.5(VLP)5.1(-)-1.4(based)]TJ -4.6929 -1.3858 TD -0.0222 Tc [(vaccines)-458.2(of)60.9(fer)-458.2(a)-460.8(promisi)4.7(n)-4(g)-458.7(a)5.4(p)-6.1(p)0.2(r)]TJ 12.7055 0 TD -0.0218 Tc [(oach)-460.9(f)-1.7(o)5.8(r)-457.8(future)-456.2(HPV)-458.7(d)0.6(evelopment.)]TJ -12.7055 -1.3921 TD -0.0214 Tc [(While)-449.5(i)-0.8(ntramuscular)-444.8(injection)-450.5(o)-0.1(f)-448.5(H)1.6(PV)-445.7(vaccines)-444.8(has)-451.1(s)2.4(hown)-444.2(clinical)]TJ 0 -1.3858 TD -0.0209 Tc [(ef)68.5(fec)4.5(t)-2.4(iven)3.6(ess,)-262.7(t)3.9(h)-0.1(e)-260(e)4.5(f)]TJ /F9 1 Tf 7.1055 0 TD 0 Tc ()Tj /F8 1 Tf 0.5102 0 TD -0.0202 Tc [(c)5.2(a)1.1(cy)-255.1(of)-258.3(orally)-261.4(adm)4.4(i)0.4(ni)6.7(st)4.6(ered)-256.1(HPV)-255.5(v)-3.1(a)7.4(cci)6.7(nes)-254.6(r)3.6(em)4.4(ains)]TJ -7.6157 -1.3921 TD 0.0312 Tc [(un)5.3(ce)-6.3(rtain.)-550.8(Additional)-550.3(research)-552.8(is)-556(needed)-557.5(to)-552.3(investigate)-554.4(t)-0.7(he)]TJ 0 -1.3858 TD 0.0109 Tc [(bioavailability,)-533.3(i)0(mmune)-530.6(r)-3.1(e)10.9(s)-9.1(ponse,)-533.3(and)-527.4(s)-3.1(afety)-532.7(a)0.7(spec)10.9(t)-8.1(s)-532.2(of)-529.6(orally)]TJ 0 -1.3921 TD -0.0215 Tc [(admi)5.4(nistered)-301.5(HPV)-300.9(v)1.9(accines)-300(i)-0.9(n)-299.4(p)0.9(recl)]TJ 13.8583 0 TD -0.021 Tc [(i)5.9(n)-2.8(ical)-300.1(studies)-293.2(and)-301(c)4.4(linical)-300.1(t)3.8(ri)5.9(als.)]TJ /F1 1 Tf 10.5001 0 0 10.5001 304.8944 757.7573 Tm 0 Tc [(4.5.2)-298.8(Dosing)-305.3(regimens)]TJ /F8 1 Tf 9 0 0 9 318.8409 745.2849 Tm [(For)-411.3(novel)-411.4(HPV)-412.5(vaccines,)-417.3(reducing)-410.5(the)-414(vaccination)-414.6(frequency)]TJ -1.5496 -1.3921 TD [(would)-506.2(be)-507.6(a)-507.9(wise)-506.6(st)-8(rategy)-9.1(.)-506.4(T)0(o)-504.9(ach)-8.1(ieve)-509.8(this)-10.7(,)-500.1(part)-8.5(ici)-8.9(pants)-513.2(will)-509.4(be)]TJ 0 -1.3858 TD [(admini)-10.9(ste)-7.8(red)-507.9(high)-9(er)-505(conc)-10.4(entr)-8.5(ations)-512.5(of)-506.6(HPV)-507(anti)-9.6(gens)-10(.)-500.1(A)-503.6(rece)-13.2(nt)]TJ 0 -1.3921 TD 0.0101 Tc [(study)-508.3(d)-5.3(e)-2.2(monstrated)-509.3(the)-512.5(e)-2.2(f)]TJ /F9 1 Tf 11.3134 0 TD 0 Tc ()Tj /F8 1 Tf 0.5417 0 TD 0.0106 Tc [(cac)10.6(y)-520.1(of)-511(a)-509.9(s)2.9(ingle)-512(d)1.5(ose)-512(o)0.4(f)-511(t)3.9(he)-512(HPV)]TJ -11.8551 -1.3858 TD 0 Tc [(va)-12.1(cc)-12.1(in)-11.6(e)-516.3(i)0(n)-521.8(y)0(o)-12.1(u)0(n)-9.9(g)-518.4(wo)-7.2(m)-6.9(e)0(n)-523.3(i)0(n)-521.8(A)0(f)-11(r)-7.7(ic)-10.6(a)-514.2(\()]TJ 0.85098 0.19216 0.2 scn 15.9937 0 TD [(16)-12.1(1)]TJ 0.15294 0.15294 0.15294 scn 1.4551 0 TD [(\))-9.8(.)-512.7(An)-12.9(ot)-10.6(he)-16.8(r)-511.6(r)-7.7(ep)-15.2(or)-11.6(t)-510.6(h)0(a)-14.7(s)]TJ -17.4488 -1.3858 TD 0.0725 Tc [(sh)5.1(own)-570.8(o)-0.7(ne)-576.1(dose)-569.8(of)-568.8(quadrivalent)-570.4(HPV)-572.2(v)1.4(acci)4.9(natio)5.6(n)-577.1(h)5.1(a)-0.7(d)]TJ 0 -1.3921 TD 0.0136 Tc [(com)-5.9(p)4.5(arable)-515.3(ef)58.9(fe)-5(ctive)-5(n)0.3(ess)-516.9(a)-2.9(s)-510.6(t)0.6(wo)-513.2(or)-510.6(three)-515.3(d)-1.8(ose)-5(s)-510.6(in)-516.3(pre)-5(v)-0.8(enting)]TJ 0 -1.3858 TD 0 Tc [(cervical)-422.3(intraepithelial)-425.6(neoplasia)-426.1(\()]TJ 0.85098 0.19216 0.2 scn 13.9087 0 TD (162)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD [(\).)-428(More)-417.7(studies)-428.8(to)-420(compare)]TJ -15.3449 -1.3921 TD [(the)-199.8(ef)]TJ /F9 1 Tf 2.0976 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(cacy)-206.8(among)-200(the)-206.1(one-dose,)-208.8(two-dose,)-205.7(and)-202.8(three-dose)-207.5(regimens)]TJ -2.6268 -1.3858 TD [(ar)-11.6(e)-516.3(p)0(r)-10.5(e)0(s)-13.7(e)-12.3(n)-7(t)-6.7(ed)-519.1(in)]TJ 0.85098 0.19216 0.2 scn 7.4961 0 TD 0.0119 Tc [(Ta)11.9(bl)11.9(e)-506.4(6)]TJ 0.15294 0.15294 0.15294 scn 3.2441 0 TD 0 Tc [(.)-512.7(T)-9.6(hi)-15.3(s)-511.6(i)0(n)-17.9(f)0(o)-9(r)-7.7(m)-6.9(a)-10.2(t)-6.7(i)0(o)-14.8(n)-511(i)-10.9(n)-7(di)-13.7(ca)-10(t)-6.7(e)-12.3(d)-513.1(t)-6.7(ha)-14.7(t)-510.6(t)-6.7(h)-10.7(e)]TJ -10.7402 -1.3921 TD [(potency)-437.5(induced)-441.6(by)-440.4(one)-439.1(dose)-442.5(vaccination)-439.8(was)-443.2(almost)-440.5(similar)-440.4(to)]TJ 0 -1.3858 TD 0.0475 Tc [(that)-545(of)-543.4(two)-548.6(o)-0.5(r)-546(t)3(hree)-544.4(doses)-546(i)-1.2(n)-545.4(p)0.6(reventi)5.1(n)-3.6(g)-546.5(H)1.2(PV)-546.8(i)5.1(n)-3.6(fection.)]TJ 0 -1.3921 TD 0 Tc [(Additionally,)-378(self-boosting)-374(vaccination)-376.8(for)-375.7(HPV)-374.7(could)-376.7(reduce)-377.9(the)]TJ 0 -1.3858 TD [(dosing)-374.3(frequency)-382.9(and)-379.2(improve)-373.9(its)-377.9(lasting)-380.1(ef)58.2(fectiveness)-379.6(by)-377.4(loading)]TJ 0 -1.3921 TD [(HPV)-229.8(antigens)-240(into)-236.4(microparticles.)-236.4(This)-234.1(could)-238.1(be)-236.8(released)-237.4(over)-233.6(time,)]TJ 0 -1.3858 TD [(continuously)-302(boosting)-304.1(its)-296(immune)-305.1(response)-307.1(\()]TJ 0.85098 0.19216 0.2 scn 18.2236 0 TD (167)Tj 0.15294 0.15294 0.15294 scn 1.4425 0 TD (,)Tj 0.85098 0.19216 0.2 scn 0.5165 0 TD (168)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD (\).)Tj -20.0693 -1.3921 TD [(Th)17.4(e)-434.4(c)12.9(ur)21(re)24.1(nt)-423.1(HP)18.1(V)-430.6(d)0(o)24.7(s)0(e)-423.1(s)0(c)17.8(h)14.5(ed)16.3(ul)26.7(e)-434.4(r)0(e)17.8(c)12.9(om)20.7(me)24.9(nd)15.3(e)12.8(d)-431.2(by)-421.5(th)20.4(e)-434.4(W)0(H)20.9(O)]TJ -1.5496 -1.3858 TD [(S)14.5(t)0(r)23.5(a)0(t)20.9(e)0(g)17.3(i)14.3(c)-283.2(A)13(dv)20.5(is)19.3(o)15(r)0(y)-274.1(G)15.1(ro)19.9(up)-270.2(of)-267.3(Ex)15.8(p)16.1(e)0(r)17.8(t)0(s)-266.3(o)0(n)-269.2(I)0(m)17.4(m)0(u)21.8(n)0(i)19.9(z)12.9(at)20.9(io)23(n)-284.2(\()15.4(SA)21.1(GE)16.5(\))-280.6(i)14.3(s)-278.5(a)0(s)]TJ 0 -1.3921 TD [(f)13.8(o)0(l)19.3(l)16.9(ow)17.9(s:)-293.6(1\))-299.3(On)20.2(e)-308.4(o)0(r)-295.1(t)0(w)21.5(o)0(-)22.5(d)0(o)18.4(s)0(e)-297.2(s)0(c)24.1(h)0(e)21(d)0(u)19.5(l)0(e)-297.8(f)13.8(or)-301.3(th)20.4(e)-302.1(p)0(r)14.7(i)14.3(ma)20.7(ry)-299.3(ta)20.9(rg)22(e)12.8(t)-309(o)15(f)-313.7(gi)25.1(rl)21.9(s)]TJ 0 -1.3858 TD -0.0162 Tc [(ag)-16.2(ed)-226.9(9)]TJ /F12 1 Tf 2.4756 0 TD 0 Tc ()Tj /F8 1 Tf 0.5039 0 TD [(1)12.9(4)-213.9(ye)23.6(ar)19.9(s;)-199.1(2\))-204.8(On)20.2(e)-213.9(o)15(r)-215.5(t)0(w)21.5(o)0(-)22.5(d)0(o)18.4(s)0(e)-202.7(s)0(c)24.1(h)0(e)21(d)0(u)19.5(l)0(e)-203.3(f)13.8(or)-200.6(yo)19.4(un)21.6(g)-216(w)15.6(om)20.7(en)-202(ag)19.4(e)12.8(d)]TJ -2.9795 -1.3921 TD -0.0129 Tc (15)Tj /F12 1 Tf 0.9323 0 TD 0 Tc ()Tj /F8 1 Tf 0.4976 0 TD [(20)-251.4(ye)17.3(a)15(r)0(s)22.5(;)-267(3)12.9(\))-261.7(Tw)24.9(o)-262.2(d)0(o)18.4(s)0(e)24.1(s)-259.6(wi)17.3(th)-250.5(a)-262.2(6)12.9(-)13.8(m)0(o)20.7(n)0(t)17.8(h)-256.4(in)19.9(te)18.8(rv)22(a)14.9(l)-266.5(f)13.8(o)0(r)-250.9(w)0(o)24.3(m)0(e)18.6(n)-259(ol)19.3(de)22.6(r)]TJ -1.4299 -1.3858 TD 0.0263 Tc [(than)-541.4(2)-4.9(1)-540.4(ye)-4.9(ars)-542(\()]TJ 0.85098 0.19216 0.2 scn 7.1055 0 TD 0.0249 Tc [(16)-6.3(9)]TJ 0.15294 0.15294 0.15294 scn 1.5181 0 TD 0.0279 Tc [(\).)-541.5(Som)-4.2(e)-538.8(expert)-4(s)-534.1(s)-4.9(uggest)-539.4(that)-539.4(single-dose)]TJ -8.6236 -1.3921 TD 0 Tc [(va)19.4(cc)13.1(in)13.6(ati)16.3(on)-489.7(is)-491(le)17.2(ss)-494(ex)14.7(pe)16.3(nsi)18.6(ve,)-482.8(sup)18.2(po)12.1(rt)17.2(s)-499(m)0(o)14.4(r)0(e)-492.4(c)0(o)15.2(mpl)19.8(ian)22.3(ce)13.1(,)-500.1(a)0(n)14.2(d)-500.5(is)]TJ 0 -1.3858 TD [(th)26.7(er)17.8(e)12.9(f)0(o)22.5(r)0(e)-391.6(l)0(o)19.3(g)0(i)25.1(s)0(t)17.2(i)14.3(c)12.8(a)0(l)19.3(l)0(y)-388.1(e)0(a)21.5(s)0(i)19.3(e)12.9(r)-404.5(c)12.9(om)20.7(pa)18.4(re)24.1(d)-399.7(w)0(i)17.3(t)0(h)-389(m)0(u)21.8(l)0(t)22.9(i)0(p)17.8(l)16.9(e)-402.9(d)0(o)18.4(s)0(e)24.1(s)0(,)-394.4(m)0(a)27(k)0(i)18.3(n)0(g)]TJ 0 -1.3921 TD [(i)14.3(t)-201.9(mo)20.7(re)-190.1(f)13.8(e)12.8(as)19.9(ib)23(le)-190.7(to)-187(va)19.4(c)12.9(c)0(i)20.9(n)0(a)20.5(t)0(e)-189.1(m)0(o)20.7(r)0(e)-190.1(w)0(o)24.3(m)0(e)18.6(n)-202.3(i)14.3(n)-202.3(lo)19.3(w)15.6(-)-200.3(an)20.5(d)-198.1(m)0(i)20(d)0(d)19.5(l)0(e)23.5(-)0(i)21.9(n)0(c)18.4(o)0(m)20.7(e)]TJ 0 -1.3858 TD [(c)12.8(o)15(un)15.3(tr)23.5(ie)20.9(s)-316.3(\()]TJ 0.85098 0.19216 0.2 scn 4.2394 0 TD [(17)19.4(0)]TJ 0.15294 0.15294 0.15294 scn 1.4047 0 TD [(\).)-308.3(S)14.5(i)0(m)20(i)0(l)18.7(a)15(rl)21.9(y,)-306.7(th)20.4(e)-308.4(J)0(o)15.7(i)14.3(nt)-303.5(Co)22.1(mm)17.7(i)14.3(t)0(t)18.2(e)12.8(e)-314.7(o)15(n)-315.7(V)0(a)19(c)12.9(ci)20.9(na)20.5(ti)20.3(on)-300.7(an)20.5(d)]TJ -5.6441 -1.3921 TD [(Im)23.7(mu)21.8(ni)19.9(z)12.8(a)0(t)20.9(i)0(o)23(n)-303.1(\(J)16.2(C)13.5(V)0(I)22.1(\))-305.8(st)23.5(at)20.9(em)18.6(e)12.9(n)0(t)-297.1(a)15(ls)21.9(o)-306.3(c)12.9(on)20.5(si)19.3(de)22.6(rs)-292.5(th)20.4(e)-302.1(p)0(o)18.4(t)0(e)25.1(n)0(t)17.8(i)14.3(al)-295.7(c)12.8(h)0(a)16.8(n)0(g)22.6(e)]TJ 0 -1.3858 TD 0.0258 Tc [(to)-532.5(a)-538.8(o)-3.3(ne-dose)-534.6(s)-0.8(c)-5.4(h)2.5(edule)-534.6(f)-4.5(or)-542.5(the)-540.9(r)-0.8(outine)-534.6(HPV)-537(i)2.3(mm)-6.3(un)-6.4(ization)]TJ 0 -1.3921 TD -0.018 Tc [(pr)-18(og)-18(r)4(a)-18(m)-299.7(\()]TJ 0.85098 0.19216 0.2 scn 4.0126 0 TD -0.0129 Tc (171)Tj 0.15294 0.15294 0.15294 scn 1.4047 0 TD -0.0154 Tc (\).)Tj /F1 1 Tf 10.5001 0 0 10.5001 304.8944 371.1118 Tm 0 Tc [(4.5.3)-298.8(Expansion)-307.1(of)-300.2(vaccine)-304.3(recipients)]TJ /F8 1 Tf 9 0 0 9 318.8409 358.6393 Tm [(In)-266.2(2018,)-259.7(the)-256.5(FDA)-262.4(approved)-265(the)-262.8(expanded)-262.8(use)-262.2(of)-261(Gardasil)-263.1(9)]TJ /F13 1 Tf 7.4999 0 0 7.4999 530.7589 362.6078 Tm ()Tj /F8 1 Tf 9 0 0 9 538.7526 358.6393 Tm (to)Tj -25.9843 -1.3921 TD [(include)-245.5(individuals)-252.5(27)-251.4(through)-245.9(45)-245.1(years)-247.6(old)-248.1(\()]TJ 0.85098 0.19216 0.2 scn 17.8268 0 TD (172)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD [(\).)-251.6(According)-247.4(to)-250(the)]TJ -19.263 -1.3858 TD [(WHO)-449.5(guidelines,)-463.6(HPV)-450.3(vaccination)-458.7(is)-459.5(usually)-451.4(recommended)-459.1(for)]TJ 0 -1.3921 TD [(boys)-237.8(and)-246.9(girls)-237.8(aged)-247.7(11)-238.8(to)-243.7(12,)-241.3(but)-240.2(can)-243.8(be)-243.1(given)-241.8(as)-244.7(early)-241.9(as)-244.7(age)-244.9(9)-239.1(years)]TJ 0 -1.3858 TD [(for)-501.7(the)]TJ /F9 1 Tf 3.4079 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(rst)-507(dose)-505.5(before)-505.1(sexual)-511.9(contact)-506.4(and)-505.1(exposure)-507.6(to)-501.9(HPV.)]TJ -3.937 -1.3921 TD [(Children)-310.8(between)-309.9(the)-306.9(ages)-309.2(of)-305.1(11)-308.1(to)-306.7(12)-308.1(years)-310.6(are)-307.4(suggested)-314.2(to)-306.7(get)-310.6(2)]TJ 0 -1.3858 TD [(doses)-204.5(of)-198(the)-206.1(HPV)-204.6(vaccine)-205.6(6)-201.3(t)0(o)-205.9(1)0(2)-201(months)-206.7(apart.)-203.9(For)-203.4(teens)-203.5(and)-202.8(young)]TJ T* [(adults)-397.5(at)-394.9(ages)-403.7(15)-396.3(through)-397.1(26,)-398.8(they)-396.9(need)-399.9(three)-402.5(doses)-399.8(of)-399.5(the)-395.1(HPV)]TJ 0 -1.3921 TD [(vacc)-11.6(ine)-11.3(.)-500.1(E)0(a)-8.9(r)0(l)-9.6(y)-505.8(pre)-10.2(ven)-8.6(tio)-8.9(n)-504.7(w)0(i)-7.9(t)0(h)-508.7(the)-508.5(HPV)-513.3(vac)-11.8(cin)-11.3(e)-503.7(i)0(s)-509.8(a)-507.9(safe)-514(and)]TJ 0 -1.3858 TD 0.0332 Tc [(ef)59.6(f)-3.4(e)-4.3(ct)-5(ive)-539.8(w)-1.6(ay)-535.6(to)-537.7(re)-4.3(du)-7.4(ce)-539.8(HP)-3.2(V)-535.9(i)-2.9(n)-5.3(f)2.9(e)-4.3(c)-4.3(t)1.3(ion)-534.5(\()]TJ 0.85098 0.19216 0.2 scn 18.4945 0 TD 0.0312 Tc [(17)-6.3(3)]TJ 0.15294 0.15294 0.15294 scn 1.537 0 TD 0.0413 Tc [(\).)-528.1(S)5.4(t)9.4(u)7(d)0.7(i)11.5(e)3.8(s)-527(h)5.4(a)5.9(v)1.7(e)]TJ ET 0.49804 0.49804 0.49804 scn 49.833 186.406 495.893 17.688 re f 0.63529 0.63529 0.63529 scn 49.606 204.094 496.346 0.22678 re f 545.726 81.978 0.22681 122.117 re f 49.606 81.978 0.22676 122.117 re f 49.833 81.978 495.893 0.28348 re f 95.471 186.406 m 49.833 186.406 l 49.833 186.633 l 95.471 186.633 l 95.471 186.406 l f* 95.471 186.406 0.22676 17.688 re f 95.698 186.406 59.698 0.22676 re f 155.395 186.406 0.28346 17.688 re f 201.827 186.406 m 155.679 186.406 l 155.679 186.633 l 201.827 186.633 l 201.827 186.406 l f* 201.827 186.406 0.22676 17.688 re f 254.324 186.406 m 202.053 186.406 l 202.053 186.633 l 254.324 186.633 l 254.324 186.406 l f* 254.324 186.406 0.22678 17.688 re f 254.551 186.406 235.105 0.22676 re f 489.657 186.406 0.22678 17.688 re f 489.883 186.406 55.842 0.22676 re f 95.471 160.271 m 49.833 160.271 l 49.833 160.554 l 95.471 160.554 l 95.471 160.271 l f* 95.471 160.271 0.22676 26.135 re f 95.698 160.271 59.698 0.28348 re f 155.395 160.271 0.28346 26.135 re f 201.827 160.271 m 155.679 160.271 l 155.679 160.554 l 201.827 160.554 l 201.827 160.271 l f* 201.827 160.271 0.22676 26.135 re f 254.324 160.271 m 202.053 160.271 l 202.053 160.554 l 254.324 160.554 l 254.324 160.271 l f* 254.324 160.271 0.22678 26.135 re f 254.551 160.271 235.105 0.28348 re f 489.657 160.271 0.22678 26.135 re f 489.883 160.271 55.842 0.28348 re f 95.471 134.192 m 49.833 134.192 l 49.833 134.419 l 95.471 134.419 l 95.471 134.192 l f* 95.471 134.192 0.22676 26.079 re f 95.698 134.192 59.698 0.22675 re f 155.395 134.192 0.28346 26.079 re f 201.827 134.192 m 155.679 134.192 l 155.679 134.419 l 201.827 134.419 l 201.827 134.192 l f* 201.827 134.192 0.22676 26.079 re f 254.324 134.192 m 202.053 134.192 l 202.053 134.419 l 254.324 134.419 l 254.324 134.192 l f* 254.324 134.192 0.22678 26.079 re f 254.551 134.192 235.105 0.22675 re f 489.657 134.192 0.22678 26.079 re f 489.883 134.192 55.842 0.22675 re f 95.471 108.113 m 49.833 108.113 l 49.833 108.34 l 95.471 108.34 l 95.471 108.113 l f* 95.471 108.113 0.22676 26.079 re f 95.698 108.113 59.698 0.22675 re f 155.395 108.113 0.28346 26.079 re f 201.827 108.113 m 155.679 108.113 l 155.679 108.34 l 201.827 108.34 l 201.827 108.113 l f* 201.827 108.113 0.22676 26.079 re f 254.324 108.113 m 202.053 108.113 l 202.053 108.34 l 254.324 108.34 l 254.324 108.113 l f* 254.324 108.113 0.22678 26.079 re f 254.551 108.113 235.105 0.22675 re f 489.657 108.113 0.22678 26.079 re f 489.883 108.113 55.842 0.22675 re f 95.471 82.261 0.22676 25.852 re f 155.395 82.261 0.28346 25.852 re f 201.827 82.261 0.22676 25.852 re f 254.324 82.261 0.22678 25.852 re f 489.657 82.261 0.22678 25.852 re f BT /F5 1 Tf 6.9999 0 0 6.9999 49.6063 214.2992 Tm 0.49804 0.49804 0.49412 scn 0 Tc [(TABLE)-306.1(6)-800.1(A)-296.4(summary)-301.4(of)-303.6(one-dose)-306.4(regimen)-294.8(for)-307.4(HPV)-301.2(vaccines.)]TJ /F1 1 Tf 9 0 0 9 54.6519 192.2456 Tm 1 1 1 scn [(locations)-1189.2(Participants)-1191(Vaccines)-1101(Follow-up)-11215.6(Outcomes)-11212.5(References)]TJ /F8 1 Tf 6.9999 0 0 6.9999 59.7543 171.1559 Tm 0.15294 0.15294 0.15294 scn (Tanzania)Tj 6.1553 0.6803 TD [(Schoolgirls)-296.1(aged)]TJ 1.1015 -1.3607 TD (9)Tj /F12 1 Tf 0.4778 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(14)-297.4(years)]TJ 6.8762 1.3607 TD (Cervarix/)Tj -0.2106 -1.3607 TD (Gardasil-9)Tj 7.9209 0.6803 TD [(1)-306.6(year)]TJ 8.091 0.6803 TD [(HPV)-305.5(16)-297.4(IgG)-307.1(positive:)-298.1(99%)-300.6(\(one)-305.8(dose\))-303(vs)-303.8(100%)-299.5(\(two)-300(doses\))-303.5(vs)-295.7(100%)]TJ 11.1039 -1.3607 TD [(\(three)-308.9(doses\))]TJ 22.3455 0.6803 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3483 0 TD (163)Tj 0.15294 0.15294 0.15294 scn 1.4335 0 TD (\))Tj -65.2547 -3.7337 TD (USA)Tj 5.4345 0.6803 TD [(Females)-308.2(aged)-299.1(9)]TJ 0.8666 -1.3526 TD [(to)-299.5(26)-297.4(years)]TJ 8.1234 0.6722 TD [(Gardasil)-4168(1)-306.6(year)]TJ 13.3069 0.6803 TD [(Hazard)-305.7(ratio)-299.5(for)-302.9(histologically)-303.9(con)]TJ /F9 1 Tf 13.8576 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(rmed)-301.6(preinvasive)-300.8(cervical)-303.7(disease:)-309.5(0.64)-296.9(\(one)]TJ -7.759 -1.3526 TD [(dose\))-303(vs)-295.7(0.72)-305(\(two)-300(doses\))-303.5(vs)-303.8(0.66)-296.9(\(three)-300.8(doses\))]TJ 29.1083 0.6722 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3483 0 TD (164)Tj 0.15294 0.15294 0.15294 scn 1.4335 0 TD (\))Tj -65.36 -3.7256 TD (India)Tj 5.6856 0.6803 TD [(Girls)-297.5(aged)-299.1(10)]TJ /F12 1 Tf 5.3373 0 TD ()Tj /F8 1 Tf -4.0658 -1.3607 TD [(18)-297.4(years)]TJ 7.5727 0.6803 TD [(Gardasil)-3989.8(9)-298.5(years)]TJ 13.4608 0.6803 TD [(Vaccine)-307.8(ef)]TJ /F9 1 Tf 4.1954 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cacy)-297.8(against)-303(HPV)-305.5(16/18)-297.1(infection:)-304.7(95.4%)-308.3(\(one)-297.7(dose\))-303(vs)-303.8(93.1%)-300.2(\(two)]TJ 5.1915 -1.3607 TD [(doses\))-303.5(vs)-303.8(93.3%)-300.2(\(three)-308.9(doses\))]TJ 25.6661 0.6803 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3483 0 TD (165)Tj 0.15294 0.15294 0.15294 scn 1.4335 0 TD (\))Tj -65.441 -3.0534 TD (Costa)Tj 0.2673 -1.3526 TD (Rica)Tj 5.1025 1.3526 TD [(Women)-302.4(aged)-307.2(18)]TJ 1.1177 -1.3526 TD [(to)-299.5(25)-297.4(years)]TJ 8.0829 0.6803 TD [(Cervarix)-3356.1(11.3)-305(years)]TJ 14.1411 0.6722 TD [(Vaccine)-307.8(ef)]TJ /F9 1 Tf 4.1954 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cacy)-297.8(against)-303(HPV16)-303.2(or)-302.3(18)-297.4(infection:)-304.7(82.1%)-308.3(\(one)-297.7(dose\))-303(vs)-303.8(83.8%)]TJ 3.4907 -1.3526 TD [(\(two)-308.1(doses\))-303.5(vs)-295.7(80.2%)-300.2(\(three)-308.9(doses\))]TJ 26.7271 0.6803 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3483 0 TD (166)Tj 0.15294 0.15294 0.15294 scn 1.4335 0 TD (\))Tj /F1 1 Tf 0.49804 0.49804 0.49412 scn -67.6035 101.1582 TD [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.4647 0 TD (10)Tj ET endstream endobj 284 0 obj<> endobj 285 0 obj<> endobj 286 0 obj<> endobj 287 0 obj<> endobj 288 0 obj<> endobj 289 0 obj<> endobj 290 0 obj<> endobj 291 0 obj<> endobj 292 0 obj<> endobj 293 0 obj<> endobj 294 0 obj<> endobj 295 0 obj<> endobj 296 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 297 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 298 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 299 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 300 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 301 0 obj<>stream /GS1 gs BT /F8 1 Tf 9 0 0 9 49.6063 758.8912 Tm /Cs6 cs 0.15294 0.15294 0.15294 scn 0 Tc 0 Tw [(demonstrated)-225.6(that)-223.3(adolescents)-223.6(who)-225.8(initiated)-223.2(the)-218.7(HPV)-223.5(vaccine)-224.5(series)]TJ 0 -1.3858 TD [(at)-300.4(age)-301.6(9)-302.1(o)0(r)-301.4(1)0(0)-295.5(were)-306.5(22)-301.8(times)-296.4(more)-308(likely)-302.2(to)-294.1(complete)-305(the)-300.6(two-dose)]TJ 0 -1.3921 TD [(series)-342(by)-339.6(age)-345.7(15)-339.6(than)-337(those)-343.7(who)-339.2(started)-343.8(the)-338.4(series)-342(at)-344.5(age)-339.4(11)-339.6(or)-339.1(12)]TJ 0 -1.3858 TD (\()Tj 0.85098 0.19216 0.2 scn 0.3465 0 TD (174)Tj 0.15294 0.15294 0.15294 scn 1.4362 0 TD [(\).)-459.5(To)-460.8(date,)-462.9(the)-458.1(safety)-465.8(and)-461(ef)]TJ /F9 1 Tf 12.0567 0 TD ()Tj /F8 1 Tf 0.5354 0 TD [(cacy)-458.8(of)-462.5(the)-458.1(HPV)-462.9(vaccine,)-466.3(for)]TJ -14.3748 -1.3921 TD [(example,)-267.7(Gardasil)]TJ /F13 1 Tf 7.4999 0 0 7.4999 113.9527 712.9132 Tm ()Tj /F8 1 Tf 9 0 0 9 119.5653 708.8881 Tm [(,)-267(i)0(n)-269.9(children)-267.3(below)-271.2(9)-264.3(years)-266.5(of)-267.3(age)-270.1(have)-261.9(not)-269.6(been)]TJ -7.7732 -1.3858 TD [(established.)-272.3(Thus,)-266.4(whether)-271.6(HPV)-267.6(vaccination)-269.8(programs)-269.2(are)-269.6(adopted)]TJ 0 -1.3921 TD [(for)-463.9(children)-468.9(below)-466.4(9)-459.6(years)-468.1(old)-462.3(requires)-471(further)-468.7(investigation.)-465.6(A)]TJ 0 -1.3858 TD 0.0226 Tc [(qua)6.1(l)1.7(ity)-521(i)5.4(mprovement)-519.5(initiative)-525.2(perf)4.9(ormed)-522(i)-0.9(n)-519.9(t)3.3(he)-525.2(N)5.7(a)-0.2(ti)5.4(onw)6.7(i)-0.9(de)]TJ 0 -1.3921 TD 0.012 Tc (Children)Tj /F12 1 Tf 3.6346 0 TD 0 Tc ()Tj /F8 1 Tf 0.2268 0 TD 0.0123 Tc [(s)-511.9(H)-2.5(ospital)-512.5(s)4.6(yst)5.6(e)0(m)-511.1(u)-3.1(tilizin)5.3(g)-512.4(ele)12.3(c)-6.1(tronic)-510.3(medical)-506.2(r)-1.7(ecord)]TJ -3.8614 -1.3858 TD 0 Tc [(alerts)-361.5(has)-356.2(shown)-360.2(rapid)-355.7(uptake)-358.5(of)-361.7(the)-357.3(HPV)-355.8(vaccine)-363.1(before)-360.2(age)-358.3(11,)]TJ 0 -1.3921 TD [(suggesting)-425.9(a)-426(willingness)-425.3(by)-427.8(parents)-426.1(and)-423.3(providers)-429.2(to)-420(initiate)-428.3(the)]TJ 0 -1.3858 TD [(vaccine)-337.9(earlier)-340.2(than)-330.7(previously)-343.5(recommended)-339.4(\()]TJ 0.85098 0.19216 0.2 scn 19.137 0 TD (175)Tj 0.15294 0.15294 0.15294 scn 1.4425 0 TD [(\).)-333.5(On)-332.6(the)-338.4(other)]TJ -20.5795 -1.3921 TD 0.0309 Tc [(ha)-4.5(nd)-3.4(,)-532.2(p)2.9(a)-4.5(r)-1.9(ents)-531.1(h)-5(a)1.8(ve)-535.8(wo)-4.5(rri)-5.2(e)-0.3(d)-532.6(t)-1(ha)-4.5(t)-530.1(e)-6.6(arly)-531.6(HPV)-531.9(v)-2.4(ac)-6.6(cina)-4.5(tion)-536.8(in)]TJ 0 -1.3858 TD 0 Tc [(adolescents)-305.5(would)-304.6(increase)-313.5(sexual)-304(behavior,)-303.4(thereby)-307.5(increasing)-308.3(the)]TJ 0 -1.3921 TD 0.0091 Tc [(risks)-508.8(o)9.1(f)-516.4(H)0.6(P)9.1(V)-514.6(infe)9.1(ct)-3.9(i)9.1(o)-5.7(n.)-509.9(How)9.1(e)-6.6(ve)9.1(r)-4.6(,)-509.9(a)-511.4(s)1.4(tudy)-509.3(re)9.1(p)-6.1(o)-1.1(rted)-504(t)-3.9(h)9.1(a)-5.6(t)-507.8(HP)9.1(V)]TJ 0 -1.3858 TD 0 Tc [(vaccination)-345.3(has)-343.6(not)-338.9(increased)-347.9(sexual)-341.8(activity)-344.8(or)-339.1(accelerated)-347(sexual)]TJ 0 -1.3921 TD [(debut)-343.6(in)-345.5(a)-344.1(college-aged)-343.6(cohort)-347.6(of)-342.9(men)-341.2(and)-347.7(women)-342.2(\()]TJ 0.85098 0.19216 0.2 scn 21.4425 0 TD (176)Tj 0.15294 0.15294 0.15294 scn 1.4425 0 TD [(\).)-339.8(Experts)]TJ -22.885 -1.3858 TD [(bel)-11.9(ieve)-509.8(t)-6.7(h)0(a)-8.4(t)-504.3(ear)-11.3(ly)-507.7(HPV)-513.3(vacc)-11.6(ina)-9.2(tio)-8.9(n)-504.7(aga)-9.7(ins)-12.9(t)-504.3(HPV)-513.3(can)-514.7(not)-509(only)]TJ 0 -1.3921 TD [(increase)-307.2(completion)-301.9(rates)-302.8(but)-296.9(also)-307.3(reduce)-302.3(cancer)-301.3(mortality.)]TJ 1.5559 -1.3858 TD 0.0123 Tc [(HPV)-443.5(v)4.2(accin)5.3(a)-4.2(t)5.6(i)1.4(on)-435.7(has)-436.3(b)2.1(een)-442(expanded)-437.8(to)-438.9(young)-436.8(m)-0.9(ales)-442.6(sin)5.3(c)0(e)]TJ -1.5559 -1.3921 TD 0.0129 Tc [(2009)-358.5(in)-359.5(the)-364.8(U)-1.4(nit)6.2(e)0.6(d)-367.9(S)2.2(tates)-360.1(\()]TJ 0.85098 0.19216 0.2 scn 11.452 0 TD 0 Tc [(17)-18.4(7)]TJ 0.15294 0.15294 0.15294 scn 1.4677 0 TD 0.0114 Tc [(\),)-369(and)-369.4(g)3.3(ender-ne)11.4(u)-10.1(t)-1.6(ral)-368.5(\()1.6(G)-5(N)0.8(\))-363.7(H)-3.4(PV)]TJ -12.9197 -1.3858 TD 0.0125 Tc [(vaccin)5.5(a)-4(t)5.8(i)1.6(on)-202.4(has)-203(b)-4(e)12.5(e)-5.9(n)-208.7(a)2.3(dopte)12.5(d)-210.6(in)-202.4(33)-201.4(out)-202(o)2.3(f)-206.7(1)12.5(0)-5.9(7)-207.7(c)12.5(o)-10.1(untries)-203(a)-4(s)-203(o)2.3(f)-200.4(2019,)]TJ 0 -1.3921 TD 0.0117 Tc [(with)-395.9(4%)-391.1(of)-396.5(m)4.8(a)-4.8(les)-392.8(w)2.1(orldwide)-391.2(get)-391.8(v)-2.7(accinate)11.7(d)-400.3(\()]TJ 0.85098 0.19216 0.2 scn 19.1496 0 TD 0.0123 Tc [(17)12.3(8)]TJ 0.15294 0.15294 0.15294 scn 1.4677 0 TD 0.0139 Tc [(\).)-391.7(D)5.9(a)3.7(ta)-393.2(fro)3.7(m)-389.8(a)]TJ -20.6173 -1.3858 TD 0.0124 Tc [(community)-323.3(randomized)-324.3(clin)5.4(ic)12.4(a)-10.2(l)]TJ 13.5307 0 TD 0.0121 Tc [(trial)-323.7(\()2.3(NCT000)12.1(5)-6.3(34638)12.1(\))-337.5(i)1.2(ndicated)]TJ -13.5307 -1.3921 TD 0.0111 Tc [(the)-461.1(a)0.9(dvanta)-5.4(ge)-461.1(of)-460.1(GN)-459.3(over)-456.4(girls-o)-5.4(n)4.1(ly)-456.9(\(G)-5.3(O\))-458.5(va)-5.4(cc)11.1(i)-12.1(n)4.1(a)-5.4(t)4.4(io)-5.4(n)-455.8(a)0.9(gainst)]TJ 0 -1.3858 TD [(HP)-6.3(V)-318.6(i)0.3(nfection)-323.4(\()]TJ 0.85098 0.19216 0.2 scn 6.6835 0 TD 0.0123 Tc (179)Tj 0.15294 0.15294 0.15294 scn 1.474 0 TD 0.0114 Tc [(\).)-324.9(Vaccination)-323.2(in)-323.2(both)-320.6(g)-3(en)4.4(ders)-323.8(might)-316.5(h)0.7(elp)-319(t)-1.6(o)]TJ -8.1575 -1.3921 TD 0.0605 Tc [(build)-547.1(r)2.5(esilient)-544.6(cervica)6.2(l)-552.5(c)4.1(ancer)-545.6(p)1(reventio)6.2(n)-551.3(\()]TJ 0.85098 0.19216 0.2 scn 20.5732 0 TD 0.0564 Tc [(18)-6.3(0)]TJ 0.15294 0.15294 0.15294 scn 1.6126 0 TD 0.0597 Tc [(\).)-553.8(Despite)]TJ -22.1858 -1.3858 TD 0.0317 Tc [(prelim)-6.7(ina)-3.7(r)-1.2(y)-518.2(s)-1.1(c)-5.8(i)1.9(ent)-6.5(i)]TJ /F9 1 Tf 8.3528 0 TD 0 Tc ()Tj /F8 1 Tf 0.5606 0 TD 0.0337 Tc [(c)-526.7(e)2.5(vidences)-522(a)4.6(n)1.5(d)-523.5(p)-0.6(o)4.6(t)1.8(ential)-516.3(publ)6.5(i)-2.4(c)-520.4(h)4.1(ea)4.6(lth)]TJ -8.9134 -1.3921 TD 0.0123 Tc (bene)Tj /F9 1 Tf 1.9213 0 TD 0 Tc ()Tj /F8 1 Tf 0.5417 0 TD 0.0125 Tc [(ts)4.8(,)-475(m)-0.7(ore)-472.3(i)1.6(ssues)-473.9(shoul)4.2(d)-475.4(take)-472.3(in)]TJ 13.0646 0 TD 0.012 Tc [(to)-470.7(consideration)-473.8(r)-2(egarding)]TJ -15.5276 -1.3858 TD 0.0117 Tc [(the)-221.1(d)2.6(eploymen)4.7(t)-221.7(o)1.5(f)-226.4(H)3.2(PV)-223.6(vaccin)4.7(a)-4.8(t)5(i)-5.5(on)-222.1(program)-222(i)0.8(n)-222.1(t)-1.3(he)-221.1(future.)-217.5(D)-2.6(ue)-221.1(to)]TJ 0 -1.3921 TD [(lim)4.8(i)0.8(ted)-306.1(v)3.6(accine)-303(supply,)-305.7(t)-1.3(he)-303(WHO)-301.3(r)-2.3(ecomm)4.8(ended)-306.1(t)-1.3(o)-300.9(p)-3.7(ostpon)4.7(e)-309.3(t)5(he)]TJ 0 -1.3858 TD 0.0194 Tc [(GN)-507.7(vacc)-5.5(ination)-510.5(p)-2.3(olicy)-505.3(i)-4.1(n)-504.2(2)-5.5(019)-509.5(\()]TJ 0.85098 0.19216 0.2 scn 14.5323 0 TD 0.0249 Tc [(18)6.3(1)]TJ 0.15294 0.15294 0.15294 scn 1.4992 0 TD 0.0191 Tc [(\).)-512.5(Factors)-511.4(a)2.6(f)64.4(f)-4.9(ecting)-505.6(H)-2(PV)]TJ -16.0315 -1.3921 TD 0.0222 Tc [(vaccinati)5(o)-0.6(n)-514(i)5(n)-514(m)2.7(ales)-508.3(have)-506.7(been)-514(reviewed)-509.8(by)-508.8(several)-508.9(r)1.9(eports,)]TJ 0 -1.3858 TD 0.0193 Tc [(in)-6.6(cluding)-505.4(l)-1.6(imited)-512.7(economic)-509.6(r)-1(esources,)-512.3(a)2.8(s)-511.2(w)3.4(e)-5.6(l)-1.6(l)-505.5(a)-3.5(s)-504.9(e)-5.6(thical)-511.8(an)-6.6(d)]TJ T* 0.0119 Tc [(l)3.6(e)-0.4(gal)-298.7(c)-0.4(onsiderations)-298.1(\()]TJ 0.85098 0.19216 0.2 scn 8.7685 0 TD 0.0123 Tc (177)Tj 0.15294 0.15294 0.15294 scn 1.474 0 TD 0 Tc (,)Tj 0.85098 0.19216 0.2 scn 0.5291 0 TD 0.0123 Tc (182)Tj 0.15294 0.15294 0.15294 scn 1.4677 0 TD 0 Tc (,)Tj 0.85098 0.19216 0.2 scn 0.5354 0 TD [(18)-18.4(3)]TJ 0.15294 0.15294 0.15294 scn 1.4677 0 TD 0.0098 Tc (\).)Tj /F1 1 Tf 13.5 0 0 13.5 49.6063 295.3701 Tm 0.85098 0.19216 0.2 scn 0 Tc [(5)-298.9(Future)-305.4(perspective)]TJ /F8 1 Tf 9 0 0 9 63.6094 270.3685 Tm 0.15294 0.15294 0.15294 scn [(Prophylactic)-350.9(HPV)-349.5(vaccines)-351.8(have)-350.1(shown)-347.6(ef)]TJ /F9 1 Tf 17.1906 0 TD ()Tj /F8 1 Tf 0.5354 0 TD [(cacy)-345.4(in)-351.8(preventing)]TJ -19.2819 -1.3858 TD [(HPV)-229.8(transmission)-232.7(and)-228(infection,)-229.8(controlling)-229(the)-225(incidence)-232.9(of)-223.2(HPV-)]TJ 0 -1.3921 TD 0.0469 Tc [(rela)5.2(ted)-548.1(c)3.1(ancers)-546.6(and)-548.1(g)1(enital)-540.9(wa)]TJ 14.3307 0 TD 0.0463 Tc [(rts,)-548.3(and)-548.7(i)-2.4(mprovin)-4.8(g)-541.4(clinical)]TJ -14.3307 -1.3858 TD 0 Tc [(manifestations.)-342.3(Correlates)-334.1(of)-336.6(protection)-332.5(need)-336.9(to)-331.9(be)-331.2(better)-339.3(de)]TJ /F9 1 Tf 24.5606 0 TD ()Tj /F8 1 Tf 0.5291 0 TD (ned,)Tj -25.0898 -1.3858 TD [(such)-291.8(as)-282.5(the)-288(magnitude)-294.6(of)-286.2(humoral)-289.9(and)-284.7(cellular)-290.7(immune)-292.5(responses,)]TJ 0 -1.3921 TD (speci)Tj /F9 1 Tf 1.978 0 TD ()Tj /F8 1 Tf 0.5354 0 TD [(c)-384(antibody)-393.8(characteristics,)-400.7(adjuvants,)-393.9(and)-391.8(age)-389.8(of)-386.9(recipients.)]TJ -2.5134 -1.3858 TD [(This)-278.2(information)-281.7(might)-282.6(guide)-282.7(the)-275.4(development)-285.2(and)-278.4(deployment)-285.4(of)]TJ 0 -1.3921 TD [(HPV)-475.5(vaccines)-477.8(for)-470.2(protection)-477.4(against)-476.6(HPV)-475.5(infection.)-475.4(Enhancing)]TJ 0 -1.3858 TD [(vaccine)-356.8(ef)]TJ /F9 1 Tf 3.9433 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(cacy)-351.7(through)-353(diverse)-357.9(L1)-350.6(antigens,)-349.6(potent)-354.4(adjuvants)-353.6(for)]TJ -4.4724 -1.3921 TD [(cellular)-290.7(immunity,)-289.4(and)-284.7(therapeutic)-297.1(HPV)-286.5(vaccines)-288.8(targeting)-291.9(E6)-281.8(and)]TJ 28.3654 66.778 TD [(E7)-363.7(proteins,)-363.8(particularly)-373.1(in)-364.3(conjunction)-365.7(with)-365.4(immune)-368.1(checkpoint)]TJ 0 -1.3858 TD [(blockade,)-411.4(may)-409.5(pave)-411.5(the)-407.7(way)-412.2(for)-413.5(eradicating)-414.2(HPV)-406.2(infections)-417.6(and)]TJ 0 -1.3921 TD [(associated)-273.7(cancers.)-273.6(As)-271.8(an)-269.2(attractive)-274.5(research)-276.2(area,)-276(therapeutic)-271.9(HPV)]TJ 0 -1.3858 TD [(vaccines)-383.3(in)-383.3(clinical)-388.9(trials)-385.2(have)-381.6(shown)-385.4(promising)-387.1(results)-386.9(in)-383.2(safety,)]TJ 0 -1.3921 TD [(HPV)-267.6(DNA)-270.2(clearance,)-271.6(tumor)-273.6(regression,)-276.7(and)-265.8(antigen-speci)]TJ /F9 1 Tf 23.263 0 TD ()Tj /F8 1 Tf 0.5354 0 TD [(c)-270.6(T-cell)]TJ -23.7984 -1.3858 TD 0.0149 Tc [(resp)-6.8(on)-4.7(ses)-5.4(.)-510.4(The)-514(i)-2.3(nvestigation)-515(is)-509.3(const)-4.4(a)4.7(n)-4.7(t)1.9(ly)-516.1(progressing)-516.1(toward)]TJ 0 -1.3921 TD 0 Tc [(enl)-8.7(arg)-13.4(ing)-511.1(t)-6.7(h)0(e)-508.1(p)0(r)-10.5(ote)-10.3(cti)-11(ve)-505.5(br)-11.6(ead)-12.8(th)-508.7(of)-506.6(p)-9.1(rop)-8.1(hyl)-8.2(ac)-10(t)-6.7(i)0(c)-508.2(vac)-11.8(cin)-11.3(es,)-513.8(wi)-7.9(th)]TJ 0 -1.3858 TD 0.0285 Tc [(most)-526.2(already)-527.7(i)-1.3(n)-526.6(t)2.9(he)-531.9(late)-525.6(stages)-527.2(o)5.7(f)-530.9(cli)5(n)-3.7(ical)-527.8(tri)5(a)-0.6(ls.)-528.3(P)4.7(romising)]TJ 0 -1.3921 TD 0 Tc (preclinical)Tj /F9 1 Tf 4.4976 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(ndings)-371.1(support)-368.2(novel)-367.3(antigenic)-369(targets)-368(and)-366.6(adjuvants)]TJ -5.0268 -1.3858 TD [(for)-344.2(vaccine)-350.5(design.)-353.7(However,)-348.4(con)]TJ /F9 1 Tf 13.5433 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(rming)-349.2(these)]TJ /F9 1 Tf 5.1654 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(ndings)-352.2(in)-345.4(clinical)]TJ -19.7669 -1.3921 TD [(trials)-315.9(is)-314.6(necessary.)-320.9(Moreover,)-319.9(recent)-316.6(progress)-322.4(in)-314(the)-319.5(exploration)-317.5(of)]TJ 0 -1.3858 TD [(vaccine)-382(formulation,)-384.5(immunization)-386.2(schedules,)-388.1(and)-385.4(age)-383.5(expansion)]TJ 0 -1.3921 TD [(may)-277.2(help)-286.1(reduce)-289.7(HPV)-280.2(transmission)-289.4(and)-284.7(infection)-284(due)-282.6(to)-281.5(increased)]TJ 0 -1.3858 TD [(vaccine)-300.1(coverage.)]TJ /F1 1 Tf 13.5 0 0 13.5 304.8944 558.8787 Tm 0.85098 0.19216 0.2 scn [(Author)-302.2(contributions)]TJ /F8 1 Tf 9 0 0 9 318.8409 533.8771 Tm 0.15294 0.15294 0.15294 scn 0.0428 Tc [(LX)-5.1(:)-539.2(W)2.9(riting)]TJ /F12 1 Tf 6.0535 0 TD 0 Tc ()Tj /F8 1 Tf 1.0961 0 TD 0.0453 Tc [(r)6.1(e)1.5(vie)7.8(w)-537.5(&)-538(e)1.5(di)9.2(ting)5.7(,)-536.7(S)3.1(up)4.7(er)6.1(vis)6.2(i)2.9(o)3.6(n)0.5(,)-536.7(F)4.7(un)6.8(di)9.2(ng)]TJ -8.6992 -1.3858 TD 0 Tc [(acquisition,)-426.1(Conceptualization.)-426(RW:)-423.6(Writing)]TJ /F12 1 Tf 18.7339 0 TD ()Tj /F8 1 Tf 0.926 0 TD [(review)-426.3(&)-419.6(editing,)]TJ -19.6598 -1.3921 TD (Writing)Tj /F12 1 Tf 3.4142 0 TD ()Tj /F8 1 Tf 0.7748 0 TD [(original)-268.6(draft.)-268(HH:)-265.1(Writing)]TJ /F12 1 Tf 11.1622 0 TD ()Tj /F8 1 Tf 0.7748 0 TD [(original)-268.5(draft.)-268(CY:)-264.8(Writing)]TJ /F12 1 Tf -16.126 -1.3858 TD ()Tj /F8 1 Tf 0.8945 0 TD [(original)-388.2(draft.)-387.7(XL:)-388.7(Writing)]TJ /F12 1 Tf 11.3008 0 TD ()Tj /F8 1 Tf 0.9008 0 TD [(review)-388.5(&)-381.8(editing.)-395.1(YW:)-387.4(Writing)]TJ /F12 1 Tf 13.178 0 TD ()Tj /F8 1 Tf -26.274 -1.3921 TD [(review)-300.3(&)-299.9(editing.)]TJ /F1 1 Tf 13.5 0 0 13.5 304.8944 446.3999 Tm 0.85098 0.19216 0.2 scn (Funding)Tj /F8 1 Tf 9 0 0 9 318.8409 421.3984 Tm 0.15294 0.15294 0.15294 scn [(The)-435.8(author\(s\))-440.9(declare)]TJ /F9 1 Tf 9.3984 0 TD ()Tj /F8 1 Tf 0.5291 0 TD [(nancial)-437.7(support)-437.5(was)-437(received)-437.9(for)-438.7(the)]TJ -11.4772 -1.3921 TD [(research,)-335.4(authorship,)-334.8(and/or)-333.3(publication)-338.1(of)-330.3(this)-332(article.)-335.4(This)-334.9(study)]TJ 0 -1.3858 TD [(received)-280.4(funding)-289.4(from)-281.8(the)-281.7(Achievement)-282(Transformation)-287.1(Project)-282.9(of)]TJ 0 -1.3921 TD 0.0278 Tc [(Ad)-6.5(mi)-8.3(nis)-5.1(t)-4.1(rat)-4.1(i)-2(v)-5.5(e)-532.6(Comm)-4.3(is)-5.1(sion)-533.6(of)]TJ 14.2173 0 TD 0.0291 Tc [(Zh)-6.8(onggu)-5.2(a)0(ncun)-532.3(Science)-531.3(P)-1(ark)]TJ -14.2173 -1.3858 TD 0 Tc [(\(201905180-15\).)-313.9(The)-309.9(funder)-321.2(was)-311(not)-313.7(involved)-313.5(in)-314(the)-313.2(study)-311.6(design,)]TJ 0 -1.3921 TD [(collection,)-258.5(analysis,)-261.5(interpretation)-270.2(of)-254.7(data,)-265.5(the)-256.5(writing)-262.4(of)-261(this)-256.4(article)]TJ 0 -1.3858 TD [(or)-295.1(the)-300.6(decision)-307.2(to)-300.4(submit)-303.4(it)-301(for)-300.1(publication.)]TJ /F1 1 Tf 13.5 0 0 13.5 304.8944 308.9196 Tm 0.85098 0.19216 0.2 scn (Con)Tj /F10 1 Tf 1.9234 0 TD ()Tj /F1 1 Tf 0.5963 0 TD [(ict)-302.2(of)-300.2(interest)]TJ /F8 1 Tf 9 0 0 9 318.8409 283.9181 Tm 0.15294 0.15294 0.15294 scn [(All)-305.9(authors)-301.7(were)-300.2(employed)-303.2(by)-301.8(Sinocelltech)-304.8(Ltd.)]TJ /F1 1 Tf 13.5 0 0 13.5 304.8944 246.3874 Tm 0.85098 0.19216 0.2 scn (Publisher)Tj /F2 1 Tf 4.2583 0 TD ()Tj /F1 1 Tf 0.2184 0 TD [(s)-300.5(note)]TJ /F8 1 Tf 9 0 0 9 318.8409 221.3858 Tm 0.15294 0.15294 0.15294 scn [(All)-211.4(claims)-213.7(expressed)-215(in)-213.2(this)-206(article)-213.2(are)-212.9(solely)-212.4(those)-211.4(of)-210.6(the)-206.1(authors)]TJ -1.5496 -1.3858 TD 0.0497 Tc [(and)-545.3(d)-3.5(o)-546.4(n)-1.4(ot)-549.1(necessarily)-544.3(represent)-549.1(t)5.2(hose)-554.8(of)-547.5(their)-550.1(a)1.7(f)]TJ /F9 1 Tf 23.7669 0 TD 0 Tc ()Tj /F8 1 Tf 0.5858 0 TD 0.049 Tc (liated)Tj -24.3528 -1.3921 TD 0.0168 Tc [(o)6.6(r)-3.5(ganizations,)-521.1(or)-513.7(those)-518.4(o)0.3(f)-517.4(t)3.8(he)-518.4(publisher,)-521.1(t)3.8(he)-518.4(editors)-513.7(a)0.3(nd)-515.2(the)]TJ 0 -1.3858 TD 0 Tc [(reviewers.)-424.9(Any)-430.5(product)-423.3(that)-424.8(may)-428.4(be)-425.7(evalsuated)-426.6(in)-427.3(this)-426.4(article,)-429.9(or)]TJ 0 -1.3921 TD [(claim)-313.2(that)-311.5(may)-315(be)-312.3(made)-315.8(by)-314.4(its)-314.9(manufacturer,)-321(is)-314.6(not)-313.7(guaranteed)-319.7(or)]TJ 0 -1.3858 TD [(endorsed)-302.3(by)-301.8(the)-300.6(publisher.)]TJ /F1 1 Tf 13.5 0 0 13.5 49.6063 107.8866 Tm 0.85098 0.19216 0.2 scn (References)Tj /F8 1 Tf 6.9999 0 0 6.9999 56.126 82.885 Tm 0.13725 0.12157 0.12549 scn [(1.)-501.7(Mayeaux)-485.4(EJ.)-493.6(Reducing)-490.9(the)-484.2(economic)-488.3(burden)-492.1(of)-488.7(HPV-related)-494.3(diseases.)]TJ /F11 1 Tf 31.2708 0 TD 0.4898 Tc [(JA)489.8(m)]TJ -32.2022 -1.142 TD 0 Tc [(Osteopath)-301.4(Assoc)]TJ /F8 1 Tf 6.4469 0 TD [(.)-300.3(\(2008\))-305.7(108:2)]TJ /F12 1 Tf 5.556 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(7.)-299.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.8023 0 TD (10.7556/jaoa.2008.20005)Tj 0.13725 0.12157 0.12549 scn 22.0782 1.142 TD [(2.)-501.7(Araldi)-397.8(RP,)-395.9(Sant)]TJ /F12 1 Tf 7.6618 0 TD ()Tj /F8 1 Tf 0.2187 0 TD [(Ana)-392.2(TA,)-400.5(Mo)]TJ /F15 1 Tf 5.2806 0.0405 TD ()Tj /F8 1 Tf 0.081 -0.0405 TD [(dolo)-400.6(DG,)-394.1(de)-400.4(Melo)-395(TC,)-399.1(Spadacci-Morena)-399.4(DD,)-397.4(de)]TJ -14.1654 -1.142 TD [(Cassia)-341.1(Stocco)-346.1(R,)-342.4(et)-334.9(al.)-350.4(The)-342.3(human)-342(papillomavirus)-349.3(\(HPV\)-related)-342.9(cancer)-350.1(biology:)-338.7(An)]TJ /F1 1 Tf 0.49804 0.49804 0.49412 scn -36.4704 103.7256 TD [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.3918 0 TD (11)Tj ET endstream endobj 302 0 obj<> endobj 303 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 304 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 305 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 306 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 307 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 308 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 309 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 310 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 311 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 312 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 313 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 314 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 315 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 316 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 317 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 318 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 319 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 320 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 321 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 322 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 323 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 324 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 325 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 326 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 327 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 328 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 329 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 330 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 331 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 332 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 333 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 334 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 335 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 336 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 337 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 338 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 339 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 340 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 341 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 342 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 343 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 344 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 345 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 346 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 347 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 348 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 349 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 350 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 351 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 352 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 353 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 354 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 355 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 356 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 357 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 358 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 359 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 360 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 361 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 362 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 363 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 364 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 365 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 366 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 367 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 368 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 369 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 370 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 371 0 obj<>stream /GS1 gs BT /F8 1 Tf 6.9999 0 0 6.9999 49.6063 760.3652 Tm /Cs6 cs 0.13725 0.12157 0.12549 scn 0.0938 Tc 0 Tw [(ov)-7(erview.)]TJ /F11 1 Tf 5.2239 0 TD 0.0936 Tc [(Bio)-5.3(M)-3.3(ed)-597(Ph)-3.8(ar)-4(maco)-5.3(the)-5.4(r)]TJ /F8 1 Tf 10.9905 0 TD 0.0961 Tc [(.)-593(\()1.7(2018\))-589.5(106:15)8.2(37)]TJ /F12 1 Tf 9.0062 0 TD 0 Tc ()Tj /F8 1 Tf 0.6074 0 TD 0.0954 Tc [(56.)-593.7(doi:)]TJ 0.15294 0.15294 0.15294 scn 4.5355 0 TD 0.0963 Tc [(1)8.4(0)0.3(.1016/)]TJ -30.3637 -1.142 TD 0 Tc (j.biopha.2018.06.149)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(3.)-501.7(Bray)-336.7(F,)-331.1(Ferlay)-341.2(J,)-342.8(Soerjomataram)-340(I,)-331.8(Siegel)-340(RL,)-337.9(Torre)-341.9(LA,)-337.7(Jemal)-338.6(A.)-334.2(Global)-335.6(cancer)]TJ -0.9314 -1.142 TD [(statistics)-387.1(2018:)-376.8(GLOBOCAN)-384.7(estimates)-384.8(of)-375.3(incidence)-385.2(and)-381(mortality)-389(worldwide)-384(for)-375.8(36)]TJ T* [(cancers)-229(in)-219.5(185)-223.4(countries.)]TJ /F11 1 Tf 9.9943 0 TD [(CA)-225.5(Cancer)-225.8(J)-222.5(Clin)]TJ /F8 1 Tf 6.7142 0 TD [(.)-219.4(\(2018\))-224.7(68:394)]TJ /F12 1 Tf 5.88 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(424.)-224(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.6041 0 TD (10.3322/caac.21492)Tj 0.13725 0.12157 0.12549 scn -25.7714 -1.5712 TD [(4.)-501.7(Arbyn)-211.9(M,)-217.2(Weiderpass)-222.5(E,)-216.2(Bruni)-210.4(L,)-214.8(de)-222.2(Sanjose)]TJ /F15 1 Tf 18.6604 0.0405 TD ()Tj /F8 1 Tf 0.2592 -0.0405 TD [(S,)-213(Saraiya)-216.7(M,)-217.2(Ferlay)-219.7(J,)-213.2(et)-213.4(al.)-212.7(Estimates)]TJ -19.851 -1.142 TD [(of)-221.4(incidence)-231.3(and)-219(mortality)-227(of)-221.4(cervical)-222.7(cancer)-228.6(in)-219.5(2018:)-222.9(a)-227.1(worldwide)-222(analysis.)]TJ /F11 1 Tf 29.7319 0 TD [(Lancet)-219.9(Glob)]TJ -29.7319 -1.142 TD (Health)Tj /F8 1 Tf 2.6808 0 TD [(.)-300.3(\(2020\))-297.6(8:e191)]TJ /F12 1 Tf 5.9691 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(203.)-305(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.758 0 TD (10.1016/S2214)Tj /F12 1 Tf 5.8071 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (109X\(19\)30482)Tj /F12 1 Tf 6.1229 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (6)Tj 0.13725 0.12157 0.12549 scn -24.9372 -1.5712 TD [(5.)-501.7(De)-288.6(Martel)-294.2(C,)-300.4(Georges)-297.2(D,)-292.2(Bray)-296.2(F,)-290.6(Ferlay)-300.7(J,)-294.2(Clif)63.9(ford)-293.1(GM.)-302.9(Global)-287(burden)-297.7(of)-294.3(cancer)]TJ -0.9314 -1.1501 TD [(attributable)-285.8(to)-275.2(infections)-288.3(in)-276.2(2018:)-287.7(a)-275.7(worldwide)-286.8(incidence)-279.9(analysis.)]TJ /F11 1 Tf 26.5004 0 TD [(Lancet)-276.6(Glob)-283.3(Health)]TJ /F8 1 Tf 7.7266 0 TD (.)Tj -34.2269 -1.142 TD [(\(2020\))-305.7(8:e180)]TJ /F12 1 Tf 5.4588 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(e90.)-303.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.6932 0 TD (10.1016/S2214)Tj /F12 1 Tf 5.799 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (109X\(19\)30488)Tj /F12 1 Tf 6.131 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (7)Tj 0.13725 0.12157 0.12549 scn -21.6814 -1.5712 TD [(6.)-501.7(WHO.)-400.8(Human)-404.6(papillomavirus)-414.1(and)-405.3(cancer)-406.7(\(2024\).)-403.5(Available)-403.3(online)-407.7(at:)]TJ 0.85098 0.19216 0.2 scn 30.6228 0 TD (https://)Tj -31.5542 -1.142 TD 0.0144 Tc [(ww)-5.1(w.w)-5.1(h)2.8(o.int)-7.6(/)4.3(new)-5.1(s)-2.3(-room)-7.8(/)4.3(fact)-7.6(-sh)-5.3(eets/det)-7.6(a)14.4(i)-9.4(l)]TJ 17.7695 0 TD 0.017 Tc [(/h)5.4(uman)7.3(-papillo)6.8(ma-v)5.3(irus-and-)6.5(c)-4.4(an)7.3(ce)3.7(r#:~)5.9(:)]TJ -17.7695 -1.142 TD 0.0638 Tc [(te)-6.1(x)5.4(t)-6.8(=G)-5.7(l)6(oba)6.8(lly%2C%20it%20)-7.9(is%20est)-6.8(im)]TJ 17.9477 0 TD 0.064 Tc [(ated)-7.2(%20that,and%20social%20an)5.7(d)-7.2(%)]TJ -17.9477 -1.142 TD 0 Tc (20economic%20determinants)Tj 0.13725 0.12157 0.12549 scn 12.1163 0 TD [(\(Accessed)-302.1(May)-301.5(14)-297.4(2024\).)]TJ -11.1849 -1.5712 TD [(7.)-501.7(Beavis)-308.7(AL,)-313.4(Meek)-312.9(K,)-314.7(Moran)-310.2(MB,)-306.4(Fleszar)-318.8(L,)-312(Adler)-314.3(S,)-310.2(Rositch)-309.4(AF.)-316.4(Exploring)-313(HPV)]TJ -0.9314 -1.142 TD 0.0233 Tc [(vac)-6.2(c)1.9(in)5.5(e)-524.5(h)-4.5(esitan)5.5(t)-525.1(p)0.7(arents)]TJ /F12 1 Tf 10.6018 0 TD 0 Tc ()Tj /F8 1 Tf 0.7613 0 TD 0.0226 Tc [(perspec)-6.9(tives)-528.6(o)4.3(n)-529.8(d)0(ecision-making)-523.7(a)-2.1(nd)-526.5(motivator)5.9(s)-528.6(for)]TJ -11.3631 -1.142 TD 0 Tc (vaccination.)Tj /F11 1 Tf 5.0944 0 TD [(Vaccine)-300.7(X)]TJ /F8 1 Tf 4.0334 0 TD [(.)-300.3(\(2022\))-305.7(12:100231.)-300(doi:)]TJ 0.15294 0.15294 0.15294 scn 9.8 0 TD (10.1016/j.jvacx.2022.100231)Tj 0.13725 0.12157 0.12549 scn -17.9963 -1.5712 TD [(8.)-501.7(Adjei)-304.9(Boakye)-308.1(E,)-305.3(Nair)-305.8(M,)-306.3(Abouelella)-301.5(DK,)-306.5(Joseph)-311.3(CL,)-304(Gerend)-307.1(MA,)-307.7(Subramaniam)]TJ -0.9314 -1.142 TD [(DS,)-310.2(et)-302.5(al.)-309.9(Trends)-307.3(in)-308.6(reasons)-310.4(for)-311(human)-309.6(papillomavirus)-308.8(vaccine)-311.9(hesitancy:)-309.2(2010)]TJ /F12 1 Tf 31.7972 0 TD ()Tj /F8 1 Tf 0.5103 0 TD (2020.)Tj /F11 1 Tf -32.3074 -1.1501 TD (Pediatrics)Tj /F8 1 Tf 3.8552 0 TD [(.)-300.3(\(2023\))-305.7(151:e2022060410.)-299.5(doi:)]TJ 0.15294 0.15294 0.15294 scn 12.6023 0 TD (10.1542/peds.2022)Tj /F12 1 Tf 7.3783 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (060410)Tj 0.13725 0.12157 0.12549 scn -23.4146 -1.5712 TD [(9.)-501.7(De)-215.7(Villiers)-216.7(EM,)-222.1(Fauquet)-217.2(C,)-219.4(Broker)-224.1(TR,)-214.4(Bernard)-225.3(HU,)-220.6(Zur)-215.8(Hausen)-226(H.)-212.6(Classi)]TJ /F9 1 Tf 30.5175 0 TD ()Tj /F8 1 Tf 0.5345 0 TD (cation)Tj -31.9835 -1.142 TD [(of)-302.4(papillomaviruses.)]TJ /F11 1 Tf 8.3502 0 TD (Virology)Tj /F8 1 Tf 3.3368 0 TD [(.)-300.3(\(2004\))-297.6(324:17)]TJ /F12 1 Tf 6.0339 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(27.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2802 0 TD (10.1016/j.virol.2004.03.033)Tj 0.13725 0.12157 0.12549 scn -20.5799 -1.5712 TD [(10.)-500.6(Bernard)-265.8(HU,)-269.2(Burk)-263.2(RD,)-269.4(Chen)-269.6(Z,)-266.2(Van)-268.8(Doorslaer)-263.4(K,)-266.1(Zur)-272.4(Hausen)-266.5(H,)-261.2(de)-270.8(Villiers)-265.3(E-)]TJ -0.9314 -1.142 TD [(MJV.)-283.5(Classi)]TJ /F9 1 Tf 4.738 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cation)-281.6(of)-278.1(papillomaviruses)-290.1(\(PVs\))-282.8(based)-281.9(on)-279.2(189)-280(PV)-279.9(types)-280.7(and)-283.8(proposal)-286.9(of)]TJ -5.2725 -1.142 TD [(taxonomic)-307.7(amendments.)]TJ /F11 1 Tf 10.2211 0 TD (Virology)Tj /F8 1 Tf 3.3368 0 TD [(.)-300.3(\(2010\))-305.7(401:70)]TJ /F12 1 Tf 6.042 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(9.)-299.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.7942 0 TD (10.1016/j.virol.2010.02.002)Tj 0.13725 0.12157 0.12549 scn -21.9729 -1.5712 TD [(11.)-500.6(Doorbar)-275(J,)-269.9(Egawa)-271.9(N,)-274.1(Grif)]TJ /F9 1 Tf 11.7923 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(n)-268.9(H)0(,)-277.4(Kranjec)-271.2(C,)-276.1(Murakami)-274.9(I.)-275.1(Human)-275(papillomavirus)]TJ -13.2583 -1.142 TD [(molecular)-222.4(biology)-216.5(and)-210.9(disease)-219.7(association.)]TJ /F11 1 Tf 16.8543 0 TD [(Rev)-219.2(Med)-214.3(Virol)]TJ /F8 1 Tf 5.6451 0 TD [(.)-211.3(\(2015\))-216.6(25:2)]TJ /F12 1 Tf 4.9081 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(23.)-217.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.1101 0 TD (10.1002/)Tj -31.0278 -1.142 TD (rmv.1822)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(12)-13.9(.)-510.9(G)-12.8(al)-17.6(l)-17.3(o)-10.2(wa)-19.9(y)-513.9(D)-16.1(A)-9.5(,)-519(L)-11.6(a)0(i)-23.8(m)0(i)-13.3(n)-17.8(s)-518.8(L)-11.6(A)-9.5(.)-519(H)-9.4(u)-14.5(ma)-14.5(n)-528.1(p)0(a)-14.9(p)-14.5(il)-16.5(l)-9.2(o)-10.2(m)-14.1(a)0(v)-20.2(i)0(r)-23.9(u)0(s)-15(e)-13.3(s:)-535.7(sh)-20.2(ar)-17(e)-13.3(d)-516.7(a)-16.6(n)-9.7(d)-516.7(d)-14.5(is)-15.8(t)-13.9(i)0(n)-17(c)-13.2(t)]TJ -0.9314 -1.142 TD 0.0323 Tc [(pathw)4.7(a)-0.5(ys)-535.1(fo)5.9(r)-535.1(p)1.6(atho)5.9(genesis.)]TJ /F11 1 Tf 12.5618 0 TD 0.0319 Tc [(Curr)-527.4(Opin)-538.6(Virol)]TJ /F8 1 Tf 7.3459 0 TD 0.0314 Tc [(.)-536.2(\()1.8(2015\))-532.7(14:87)]TJ /F12 1 Tf 6.3983 0 TD 0 Tc ()Tj /F8 1 Tf 0.5426 0 TD 0.0317 Tc [(92.)-527.8(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.9605 0 TD 0.0312 Tc [(10.)6.2(1)-8.1(016/)]TJ 6.9999 0 0 6.9999 49.6063 482.3999 Tm 0 Tc (j.coviro.2015.09.001)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD 0.0277 Tc [(1)4.6(3)4.6(.)-499.4(Wi)4.2(lli)4.2(a)3.1(mson)-524.7(AL.)-523.7(R)1.9(ec)6.3(ent)-520.7(d)-3(ev)7.9(elopm)5.5(e)-1.8(nt)5.7(s)-523.5(i)-3.9(n)-524.7(h)-0.1(u)5.1(m)-2.6(an)-524.7(p)5.1(a)-5(p)5.1(i)4.2(llom)5.5(avi)4.2(r)-5.2(u)5.1(s)-523.5(\(HPV)3.9(\))]TJ -0.9314 -1.1501 TD 0 Tc (vaccinology.)Tj /F11 1 Tf 5.2158 0 TD (Viruses)Tj /F8 1 Tf 2.8995 0 TD [(.)-300.3(\(2023\))-297.6(15:1440.)-302.3(doi:)]TJ 0.15294 0.15294 0.15294 scn 8.8362 0 TD (10.3390/v15071440)Tj 0.13725 0.12157 0.12549 scn -16.0201 -1.5712 TD [(14.)-500.6(Wheeler)-275.6(CM,)-265.8(Hunt)-274.4(WC,)-271.9(Cuzick)-272.1(J,)-269.9(Langsfeld)-282.2(E,)-264.8(Pearse)-275.8(A,)-269.4(Montoya)-272.8(GD,)-272.6(et)-270.1(al.)-277.5(A)]TJ -0.9314 -1.142 TD [(population-based)-348.4(study)-338.7(of)-342.9(human)-342(papillomavirus)-349.3(genotype)-341.5(prevalsence)-342.1(in)-341(the)-338.5(United)]TJ T* [(Stat)-13.7(es:)-508.5(bas)-11.1(eline)-514.4(meas)-12(ures)-514.7(prior)-510.9(to)-510.1(mass)-517.6(human)-512.1(pap)-13.3(illom)-9.5(avi)-11.3(rus)-509.5(vacci)-13.5(nation)-18.9(.)]TJ /F11 1 Tf 32.4532 0 TD [(Int)-510.5(J)]TJ -32.4532 -1.142 TD (Cancer)Tj /F8 1 Tf 2.778 0 TD [(.)-300.3(\(2013\))-305.7(132:198)]TJ /F12 1 Tf 6.5198 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(207.)-305(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.758 0 TD (10.1002/ijc.27608)Tj 0.13725 0.12157 0.12549 scn -12.6346 -1.5712 TD [(15.)-500.6(Liu)-462.7(F,)-468.8(Chang)-470.9(L,)-465.9(Bai)-469.4(T,)-472(Liu)-462.7(X,)-473.4(Hu)-461.3(J.)-472.4(Association)-471.6(of)-464.4(human)-471.6(papillomavirus)]TJ -0.9314 -1.142 TD [(genotype)-333.4(distribution)-336.7(and)-332.4(cervical)-336.1(cytology:)-335.8(a)-332.4(cross-sectional)-339.9(study.)]TJ /F11 1 Tf 27.7233 0 TD [(Epidemiol)-338.7(Infect)]TJ /F8 1 Tf 6.4955 0 TD (.)Tj -34.2188 -1.142 TD [(\(2021\))-305.7(149:e95.)-300.5(doi:)]TJ 0.15294 0.15294 0.15294 scn 8.253 0 TD (10.1017/S0950268821000741)Tj 0.13725 0.12157 0.12549 scn -7.3216 -1.5712 TD [(16.)-500.6(Kirnbauer)-386.6(R,)-382.9(Booy)-380.7(F,)-387.8(Cheng)-386.6(N,)-379.4(Lowy)-385.3(D,)-389.4(Schiller)-381.9(J.)-383.3(Papillomavirus)-388.3(L1)-383.1(major)]TJ -0.9314 -1.142 TD [(capsid)-414.9(protein)-409.6(self-assembles)-419.8(into)-413.7(virus-like)-411.9(particles)-412.9(that)-412.3(are)-410.9(highly)-411.6(immunogenic.)]TJ /F11 1 Tf T* [(Proc)-298.2(Natl)-305.9(Acad)-296.4(Sci)-306.3(U.S.A)]TJ /F8 1 Tf 10.0834 0 TD [(.)-300.3(\(1992\))-305.7(89:12180)]TJ /F12 1 Tf 6.9977 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(4.)-299.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.8023 0 TD (10.1073/pnas.89.24.12180)Tj 0.13725 0.12157 0.12549 scn -19.4622 -1.5712 TD [(17.)-500.6(Graham)-290.9(SV.)-293.6(Human)-291.2(papillomavirus:)-293.3(gene)-291(expression,)-299(regulation)-293.2(and)-291.9(prospects)]TJ -0.9314 -1.1501 TD [(for)-254.3(novel)-256.7(diagnostic)-267(methods)-256.4(and)-259.5(antiviral)-254.7(therapies.)]TJ /F11 1 Tf 21.2683 0 TD [(Future)-256.6(Microbiol)]TJ /F8 1 Tf 6.7142 0 TD [(.)-259.9(\(2010\))-257.1(5:1493)]TJ /F12 1 Tf 5.9529 0 TD ()Tj /F8 1 Tf -33.9354 -1.142 TD [(506.)-305(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.758 0 TD (10.2217/fmb.10.107)Tj 0.13725 0.12157 0.12549 scn -2.8266 -1.5712 TD [(18.)-500.6(Pappa)-285.9(KI,)-281.4(Kontostathi)-284.2(G,)-288.9(Lygirou)-278.3(V,)-291.8(Zoidakis)-286.5(J,)-278(Anagnou)-284.7(NP.)-287.1(Novel)-285.5(structural)]TJ -0.9314 -1.142 TD [(approache)-14(s)-502.6(concerning)-511.9(HPV)-499.9(prote)-11.9(ins:)-504.1(Insight)-507.4(into)-502.8(targeted)-510.7(therapies)-512.6(for)-505.3(cervical)]TJ T* (cancer.)Tj /F11 1 Tf 3.1101 0 TD [(Oncol)-306.1(Rep)]TJ /F8 1 Tf 4.082 0 TD [(.)-300.3(\(2018\))-305.7(39:1547)]TJ /F12 1 Tf 6.5198 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(54.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2721 0 TD (10.3892/or.2018.6257)Tj 0.13725 0.12157 0.12549 scn -16.5627 -1.5712 TD [(19.)-500.6(Li)-205.2(Z,)-209.5(Yan)-203.1(X,)-206.1(Yu)-207.6(H,)-204.5(Wang)-212.1(D,)-203.1(Song)-211.7(S,)-204.9(Li)-205.2(Y,)-209.9(et)-205.3(al.)-204.6(The)-212.7(C-terminal)-208.4(arm)-209.3(of)-205.2(the)-200.8(human)]TJ -0.9314 -1.142 TD [(pap)-13.3(ill)-9.4(o)-10.2(mav)-10.1(iru)-14.2(s)-510.7(majo)-9.6(r)-510.7(c)0(a)-13.6(psi)-14.2(d)-508.6(prot)-14.9(ein)-516.2(is)-509.9(im)-13.3(mun)-14.1(oge)-11(nic)-516.2(an)-10.1(d)-508.6(inv)-12.6(olv)-15(ed)-505.7(in)-519.2(vir)-11.4(us-h)-12.8(o)-10.2(s)0(t)]TJ T* (interaction.)Tj /F11 1 Tf 4.8595 0 TD (Structure)Tj /F8 1 Tf 3.6284 0 TD [(.)-300.3(\(2016\))-305.7(24:874)]TJ /F12 1 Tf 6.0339 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(85.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1016/j.str.2016.04.008)Tj 0.13725 0.12157 0.12549 scn -17.3807 -1.5712 TD [(20.)-500.6(Wang)-276.9(JW,)-273.8(Roden)-276.2(RB.)-269.7(L2,)-278.5(the)-273.7(minor)-276.8(capsid)-277.3(protein)-271.9(of)-278.1(papillomavirus.)]TJ /F11 1 Tf 29.9587 0 TD (Virology)Tj /F8 1 Tf 3.3368 0 TD (.)Tj -34.2269 -1.142 TD [(\(2013\))-305.7(445:175)]TJ /F12 1 Tf 6.0015 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(86.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2721 0 TD (10.1016/j.virol.2013.04.017)Tj 0.13725 0.12157 0.12549 scn -8.8524 -1.5712 TD [(21.)-500.6(Yim)-295.4(EK,)-303.4(Park)-302.4(JS.)-304.1(The)-301.8(role)-308.5(of)-294.3(HPV)-305.5(E6)-303.5(and)-300(E7)-303.5(oncoproteins)-307.9(in)-300.5(HPV-associated)]TJ -0.9314 -1.142 TD 0.0452 Tc [(cervi)5.5(cal)-547.1(c)7.7(arci)5.5(noge)7.7(ne)7.6(si)5.5(s.)]TJ /F11 1 Tf 11.0796 0 TD 0.0418 Tc [(Ca)-3.7(nc)-4.4(er)-541.8(R)-5(e)-0.6(s)-548.5(T)3.1(r)-7.3(e)-0.6(a)-3.7(t)]TJ /F8 1 Tf 7.9372 0 TD 0.0474 Tc [(.)-544.5(\()9.7(20)8.1(05)8.1(\))-541(3)0(7)8.1(:)6.2(31)8.1(9)]TJ /F12 1 Tf 7.0867 0 TD 0 Tc ()Tj /F8 1 Tf 0.5507 0 TD 0.0463 Tc [(24)7(.)-545.6(d)7.5(oi:)]TJ 0.15294 0.15294 0.15294 scn 4.0658 0 TD 0.0399 Tc [(1)-7.5(0)0.6(.4)-7.5(14)-7.5(3/)]TJ -30.72 -1.1501 TD 0 Tc (crt.2005.37.6.319)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(22.)-500.6(Silva)-216.6(L,)-214.8(Teles)-215.9(AM,)-218.6(Santos)-214.7(JM,)-219.2(Souza)-218.4(de)-214.1(Andrade)-216.4(M,)-217.2(Medeiros)-219.4(R,)-212.8(Faustino-Rocha)]TJ -0.9314 -1.142 TD [(AI,)-292.8(et)-286.3(al.)-293.7(Malignancy)-290(associated)-300.9(with)-287.2(low-risk)-289.5(HPV6)-296.3(and)-291.9(HPV11:)-287.7(a)-291.9(systematic)-291.2(review)]TJ T* [(and)-291.9(implications)-285.9(for)-294.8(cancer)-285.3(prevention.)]TJ /F11 1 Tf 16.1497 0 TD [(Cancers)-289.7(\(Basel\))]TJ /F8 1 Tf 6.0905 0 TD [(.)-292.2(\(2023\))-289.5(15:4068.)-286.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 8.7876 0 TD (10.3390/)Tj -31.0278 -1.142 TD (cancers15164068)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD 0.0647 Tc [(23.)-494.8(Rusa)7.7(n)-560.6(M)-6(,)-559.6(L)4.5(i)-566.2(Y)1.3(Y)9.4(,)-567.7(H)6.7(a)-0.4(mmer)7.5(m)2(an)-560.6(PS)6.3(.)-559.6(G)-4.8(eno)5.9(m)2(ic)-564.1(l)6.9(a)-0.4(ndscape)-556(o)-2.2(f)-559.5(h)-3.6(uman)]TJ -0.9314 -1.142 TD 0 Tc (papillomavirus)Tj /F12 1 Tf 5.961 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(associated)-309(cancers.)]TJ /F11 1 Tf 7.8157 0 TD [(Clin)-311.2(Cancer)-314.9(Res)]TJ /F8 1 Tf 6.3902 0 TD [(.)-316.5(\(2015\))-305.7(21:2009)]TJ /F12 1 Tf 6.536 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(19.)-314.3(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.3044 0 TD (10.1158/)Tj -31.0278 -1.142 TD (1078)Tj /F12 1 Tf 1.9195 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (0432.CCR-14)Tj /F12 1 Tf 5.3697 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (1101)Tj 0.13725 0.12157 0.12549 scn -7.3783 -1.5712 TD [(24.)-500.6(Ahmed)-387.1(HG,)-387.4(Bensumaidea)-387.8(SH,)-392.5(Alshammari)-391.6(FD,)-387.7(Alenazi)-386.6(FSH,)-390.9(ALmutlaq)-389.4(BA,)]TJ -0.9314 -1.142 TD [(Alturkstani)-262.6(MZ,)-264(et)-262(al.)-253.2(Prevalsence)-267.7(of)-261.9(human)-261(papillomavirus)-260.2(subtypes)-265.5(16)-256.9(and)-267.6(18)-256.9(among)]TJ T* [(Yemeni)-453.2(patients)-454.1(with)-449.2(cervical)-457.6(cancer.)]TJ /F11 1 Tf 16.0768 0 TD [(Asian)-450.5(Pac)-446.8(J)-449.3(Cancer)-452.6(Prev)]TJ /F8 1 Tf 10.3426 0 TD [(.)-446.1(\(2017\))-451.4(18:1543)]TJ /F12 1 Tf 6.8114 0 TD ()Tj /F8 1 Tf 0.5103 0 TD (8.)Tj -33.741 -1.142 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.22034/APJCP.2017.18.6.1543)Tj 0.13725 0.12157 0.12549 scn -0.8666 -1.5793 TD [(25.)-500.6(Didierlaurent)-209.6(AM,)-210.5(Morel)-209.2(S,)-204.9(Lockman)-210.3(L,)-206.7(Giannini)-210.1(SL,)-208.5(Bisteau)-211.9(M,)-201(Carlsen)-211.7(H,)-204.5(et)-213.4(al.)]TJ -0.9314 -1.142 TD [(AS04,)-268.9(an)-261.2(aluminum)-270.2(salt-and)-269.6(TLR4)-264.7(agonist-based)-273.2(adjuvant)-268.8(system,)-265.2(induces)-275.6(a)-259.5(transient)]TJ T* [(localized)-244.5(innate)-232.5(immune)-243.2(response)-240.7(leading)-244.3(to)-234.7(enhanced)-239.8(adaptive)-246.1(immunity.)]TJ /F11 1 Tf 30.0073 0 TD [(J)-238.7(Immunol)]TJ /F8 1 Tf 4.2116 0 TD (.)Tj -34.2188 -1.142 TD [(\(2009\))-305.7(183:6186)]TJ /F12 1 Tf 6.4793 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(97.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2721 0 TD (10.4049/jimmunol.0901474)Tj 0.13725 0.12157 0.12549 scn -9.3302 -1.5712 TD [(26.)-500.6(Monie)-273.3(A,)-277.5(Hung)-280.4(CF,)-274.5(Roden)-276.2(R,)-277.6(Wu)-277.6(TC.)-277.6(Cervarix)]TJ /F16 1 Tf 6.5001 0 0 6.5001 202.3936 105.9023 Tm ()Tj /F8 1 Tf 6.9999 0 0 6.9999 208.7433 104.3716 Tm [(:)-276(a)-275.7(vaccine)-279.5(for)-270.5(the)-281.8(prevention)]TJ -22.7343 -1.142 TD [(of)-432(HPV)-435.1(16,)-427.7(18-associated)-438.7(cervical)-433.3(cancer.)]TJ /F11 1 Tf 17.7371 0 TD (Biologics)Tj /F8 1 Tf 3.4178 0 TD [(.)-429.9(\(2008\))-435.2(2:107)]TJ /F12 1 Tf 5.8233 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(13.)-427.7(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.5393 0 TD (10.2147/)Tj -31.0278 -1.142 TD (btt.s12160259)Tj 0.13725 0.12157 0.12549 scn 37.3937 95.999 TD [(27.)-500.6(Siddiqui)-270(MAA,)-260.6(Perry)-257.7(CM.)-265.8(Human)-258.8(papillomavirus)-268.3(quadrivalent)-265.8(\(types)-261.7(6,)-258.7(11,)-265.7(16,)]TJ -0.9233 -1.142 TD 0.0159 Tc [(18\))-523.9(re)-5.5(c)-5.5(o)-2.4(m)-6.3(b)-2.4(ina)-8.8(n)-1.9(t)-516.3(v)-3.9(a)]TJ 8.6175 0 TD 0.0216 Tc [(cci)6.2(ne)-510(\(Gardasi)6.2(l)]TJ /F13 1 Tf 5.5001 0 0 5.5001 410.8534 754.866 Tm 0 Tc ()Tj /F8 1 Tf 6.9999 0 0 6.9999 415.1054 752.3715 Tm 0.0215 Tc (\).)Tj /F11 1 Tf 1.1177 0 TD 0.0222 Tc [(Dr)5.5(ugs)]TJ /F8 1 Tf 2.4378 0 TD 0.0231 Tc [(.)-520.2(\()9.7(20)8(06)8(\))-516.7(6)8.1(6:)6.2(1)8(2)-0.1(6)8.1(3)]TJ /F12 1 Tf 7.2163 0 TD 0 Tc ()Tj /F8 1 Tf 0.5264 0 TD 0.0207 Tc [(71)5.6(.)-514.5(d)-1.9(oi)5.3(:)]TJ 0.15294 0.15294 0.15294 scn 3.8471 0 TD 0.0232 Tc [(1)8.2(0)0(.)6.3(2)8.1(16)8.2(5/)]TJ -30.8901 -1.142 TD 0 Tc (00003495)Tj /F12 1 Tf 3.8309 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (200666090)Tj /F12 1 Tf 4.3087 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (00008)Tj 0.13725 0.12157 0.12549 scn -8.2368 -1.5712 TD [(28.)-508.6(Mc)-11.1(Co)-10.3(rmac)-12(k)-507.2(PL.)-511.3(Qu)-12.6(adri)-14.6(val)-13.2(ent)-506.6(hu)-10(man)-518.3(pap)-13.3(ill)-9.4(omav)-12.2(iru)-14.2(s)-502.6(\()0(t)-11(ypes)-517.9(6,)-509.8(11,)-516.7(16,)-508.6(18\))]TJ -0.9233 -1.142 TD 0.0405 Tc [(r)7.6(e)-5.2(comb)6(inant)-540.3(v)4.5(accin)6.5(e)-539.7(\(Gardasil)]TJ /F13 1 Tf 5.5001 0 0 5.5001 401.9526 727.8801 Tm 0 Tc ()Tj /F8 1 Tf 6.9999 0 0 6.9999 406.3747 725.3857 Tm 0.0393 Tc [(\):)-544.5(a)-536.1(r)-1.7(e)-6.4(v)3.3(iew)-539.1(o)-3.3(f)-536.3(i)-8.5(ts)-536.2(use)-540.9(i)-0.4(n)-545.5(t)1.1(he)-540.9(prev)-4.8(ention)-537.4(of)]TJ -14.4974 -1.142 TD 0 Tc [(premalignant)-355.8(anogenital)-369.3(lesions,)-359.1(cervical)-360.4(and)-356.7(anal)-359.8(cancers,)-367.4(and)-356.7(genital)-357(warts.)]TJ /F11 1 Tf 31.8782 0 TD (Drugs)Tj /F8 1 Tf 2.3407 0 TD (.)Tj -34.2188 -1.142 TD [(\(2014\))-297.6(74:1253)]TJ /F12 1 Tf 5.9934 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(83.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1007/s40265-014-0255-z)Tj 0.13725 0.12157 0.12549 scn -8.8605 -1.5712 TD [(29.)-500.6(Signorelli)-266.5(C,)-259.9(Odone)-264.6(A,)-269.4(Ciorba)-255.5(V,)-267.5(Cella)-258.8(P,)-264.8(Audisio)-266.4(R,)-261.4(Lombardi)-263.4(A,)-261.3(et)-262(al.)-269.4(Human)]TJ -0.9233 -1.1501 TD [(papillomavirus)-478.9(9-valent)-488.7(vaccine)-482(for)-481(cancer)-479.6(prevention:)-485.6(a)-478.2(systematic)-485.6(review)-486.7(of)-480.6(the)]TJ 0 -1.142 TD 0.0668 Tc [(availabl)-7.2(e)-562(e)-3.2(vidence.)]TJ /F11 1 Tf 9.4436 0 TD 0.066 Tc [(Epidemio)-8.6(l)-561.6(I)-6(nfect)]TJ /F8 1 Tf 7.7266 0 TD 0.0636 Tc [(.)-568.8(\()-6.5(20)-8.1(17)-8.1(\))-565.3(1)-8.1(45:)-10(196)-8.1(2)]TJ /F12 1 Tf 8.5284 0 TD 0 Tc ()Tj /F8 1 Tf 0.575 0 TD 0.0693 Tc [(82)5.7(.)-563.1(d)-2(oi)5.3(:)]TJ 0.15294 0.15294 0.15294 scn 4.2763 0 TD 0.0644 Tc [(1)-7.3(0)0.8(.1)-7.3(017)-7.3(/)]TJ -30.5499 -1.142 TD 0 Tc (S0950268817000747)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(30.)-500.6(Linton)-265(D,)-259.8(Taylor)-260.4(S.)-261.6(The)-253.2(human)-269.1(papillomavirus)-260.2(vaccine)-263.3(expanded)-268.4(to)-259(middle)-259.2(age)]TJ -0.9233 -1.142 TD (adults.)Tj /F11 1 Tf 2.9076 0 TD [(J)-303.5(Nurse)-304.2(Pract)]TJ /F8 1 Tf 5.3211 0 TD [(.)-300.3(\(2019\))-305.7(15:530)]TJ /F12 1 Tf 6.042 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(1.)-299.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.7942 0 TD (10.1016/j.nurpra.2019.04.006)Tj 0.13725 0.12157 0.12549 scn -16.6518 -1.5712 TD [(31.)-500.6(Soliman)-222.8(M,)-225.3(Oredein)-226.7(O,)-217.4(Dass)-228(CR.)-221(Update)-218.5(on)-222.5(safety)-226.6(and)-219(ef)]TJ /F9 1 Tf 24.2488 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cacy)-216.8(of)-221.4(HPV)-224.5(vaccines:)]TJ -25.7066 -1.142 TD 0.0581 Tc [(focus)-566(o)-0.7(n)-559.1(g)-2.2(a)-7(r)0.9(d)-5(a)1.1(s)-7.2(i)2.2(l.)]TJ /F11 1 Tf 9.0791 0 TD 0.6198 Tc [(I)564(n)559.6(tJM)555.3(o)561.4(lC)564.5(e)553.2(l)559.1(lM)563.4(e)561.3(d)]TJ /F8 1 Tf 9.4031 0 TD 0.0555 Tc [(.)-568.8(\()-6.5(20)-8.1(21)-8.1(\))-565.3(1)0(0)-8.1(:)-1.9(1)-8.1(0)-0.1(1)]TJ /F12 1 Tf 7.3378 0 TD 0 Tc ()Tj /F8 1 Tf 0.5669 0 TD 0.0629 Tc [(3.)-553.3(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.677 0 TD 0.0637 Tc [(10)8.2(.)6.3(2)0(20)8.2(88)8.2(/)]TJ -30.064 -1.142 TD 0 Tc (IJMCM.BUMS.10.2.101)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(32.)-500.6(Tang)-428.4(X,)-424.8(Jones)-432.6(TE,)-428.3(Jiang)-428(W,)-425.8(Austin)-428(M,)-427.8(He)-419.5(Y,)-428.6(Li)-423.9(L,)-425.4(et)-432.1(al.)-423.3(Extended)-434.3(Human)]TJ -0.9233 -1.142 TD [(Papillomavirus)-339.7(genotype)-341.5(distribution)-344.8(in)-341(cervical)-344.2(intraepithelial)-342.2(neoplasia)-349(and)-340.5(cancer:)]TJ T* [(analysis)-209.7(of)-213.3(40,352)-213.7(cases)-214.1(from)-219.8(a)-210.9(large)-213.2(academic)-222.3(gynecologic)-210.9(center)-217.8(in)-211.4(China.)]TJ /F11 1 Tf 29.6995 0 TD [(J)-214.4(Med)-214.3(Virol)]TJ /F8 1 Tf 4.5193 0 TD (.)Tj -34.2188 -1.1501 TD [(\(2023\))-297.6(95:e28302.)-306.3(doi:)]TJ 0.15294 0.15294 0.15294 scn 9.2087 0 TD (10.1002/jmv.28302)Tj 0.13725 0.12157 0.12549 scn -8.2854 -1.5712 TD [(33.)-500.6(Li)-334.8(M,)-330.6(Zhao)-336.4(C,)-332.8(Zhao)-336.4(Y,)-331.4(Wei)-332.2(L.)-336.3(Immunogenicity,)-337.1(ef)]TJ /F9 1 Tf 22.305 0 TD ()Tj /F8 1 Tf 0.5265 0 TD [(cacy,)-339(and)-332.4(safety)-331.9(of)-334.8(human)]TJ -23.7548 -1.142 TD 0.0221 Tc [(p)7.6(a)-2.6(pil)4.8(l)-3.3(omavirus)-521(vaccine)-7.4(:)-521.2(d)-0.5(a)5.6(t)0.1(a)-520.9(f)-2.8(rom)-518.5(C)-2.2(hina)5.5(.)]TJ /F11 1 Tf 18.8143 0 TD 0.0211 Tc [(Fro)-4.9(n)1.4(t)-519.2(I)-2.3(mmu)-6.7(nol)]TJ /F8 1 Tf 6.6413 0 TD 0.0231 Tc [(.)-520.2(\()1.6(202)8.1(3)0(\))-524.8(1)-0.1(4)8(:)-1.9(1112)8.1(750.)]TJ -25.4556 -1.142 TD 0 Tc (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.3389/)Tj /F9 1 Tf 3.4178 0 TD ()Tj /F8 1 Tf 0.5264 0 TD (mmu.2023.1112750)Tj 0.13725 0.12157 0.12549 scn -4.819 -1.5712 TD [(34.)-500.6(Li)-213.3(J,)-221.3(Shi)-215.1(LW,)-210.6(Li)-213.3(K,)-217.5(Huang)-216(LR,)-216.4(Li)-213.3(JB,)-213.4(Dong)-218(YL,)-213.5(et)-213.4(al.)-220.8(Comparison)-213.4(of)-213.3(the)-217(safety)-218.5(and)]TJ -0.9233 -1.142 TD [(persistence)-245.7(of)-245.7(immunogenicity)-255.6(of)-245.7(bivalent)-245.8(HPV16/18)-246.2(vaccine)-247.1(in)-243.8(healthy)-249.9(9)]TJ /F12 1 Tf 29.3108 0 TD ()Tj /F8 1 Tf 0.5103 0 TD (14-year-old)Tj -29.821 -1.142 TD [(and)-494.4(18)]TJ /F12 1 Tf 2.9481 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(26-year-old)-499.7(Chinese)-493.1(females:)-497.4(A)-495.5(randomized,)-495.4(double-blind,)-498.7(non-inferiority)]TJ -3.4583 -1.142 TD [(clinical)-296.3(trial.)]TJ /F11 1 Tf 5.2644 0 TD (Vaccine)Tj /F8 1 Tf 3.102 0 TD [(.)-300.3(\(2023\))-305.7(41:7212)]TJ /F12 1 Tf 6.5198 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(19.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.1016/j.vaccine.2023.10.041)Tj 0.13725 0.12157 0.12549 scn -17.7452 -1.5712 TD [(35.)-500.6(Hu)-477.5(YM,)-466.9(Guo)-475(M,)-468.3(Li)-472.5(CG,)-467.1(Chu)-471.7(K,)-476.7(He)-468.1(WG,)-471(Zhang)-477.2(J,)-472.4(et)-472.6(al.)-471.9(Immunogenicity)]TJ -0.9233 -1.142 TD [(noninferiority)-436(study)-427.8(of)-432(2)-436.2(doses)-427.8(and)-437.7(3)-428.1(doses)-435.9(of)-432(an)-431.3(Escherichia)-432.2(coli-produced)-437.5(HPV)]TJ T* [(bivalent)-237.7(vaccine)-247.1(in)-243.8(girls)-247.8(vs.)-247.8(3)-241.8(doses)-241.5(in)-243.8(young)-244.4(women.)]TJ /F11 1 Tf 21.1711 0 TD [(Sci)-241.5(China)-247.8(Life)-243(Sci)]TJ /F8 1 Tf 6.8357 0 TD [(.)-243.6(\(2020\))-240.9(63:582)]TJ /F12 1 Tf 5.9205 0 TD ()Tj /F8 1 Tf -33.9273 -1.142 TD [(91.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.1007/s11427)Tj /F12 1 Tf 6.1796 0 TD ()Tj /F8 1 Tf 0.5103 0 TD (019-9547)Tj /F12 1 Tf 3.7094 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (7)Tj 0.13725 0.12157 0.12549 scn -13.2583 -1.5793 TD [(36.)-500.6(Chen)-261.5(Q,)-257.9(Zhao)-255.4(H,)-261.2(Yao)-260.3(X,)-254.7(Lin)-263.5(Z,)-258.1(Li)-253.8(J,)-261.8(Lin)-255.5(B,)-260(et)-262(al.)-253.2(Comparing)-263(immunogenicity)-263.7(of)]TJ -0.9233 -1.142 TD [(the)-395.1(Escherichia)-399.8(coli-produced)-405.1(bivalent)-399.7(human)-398.7(papillomavirus)-397.9(vaccine)-401(in)-397.7(females)-399.5(of)]TJ T* [(dif)66.7(ferent)-302.3(ages.)]TJ /F11 1 Tf 5.8395 0 TD (Vaccine)Tj /F8 1 Tf 3.102 0 TD [(.)-300.3(\(2020\))-297.6(38:6096)]TJ /F12 1 Tf 6.5117 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(102.)-305(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.758 0 TD (10.1016/j.vaccine.2020.07.030)Tj 0.13725 0.12157 0.12549 scn -18.7981 -1.5712 TD [(37.)-500.6(Qiao)-412.8(YL,)-399.7(Wu)-407.2(T,)-407.2(Li)-407.7(RC,)-407.2(Hu)-412.7(YM,)-402.1(Wei)-405.1(LH,)-410.5(Li)-407.7(CG,)-402.3(et)-407.8(al.)-407.1(Ef)]TJ /F9 1 Tf 26.2331 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cacy,)-403.8(safety,)-413.6(and)]TJ -27.6909 -1.142 TD [(im)-13.3(mu)-12.5(n)-9.7(o)0(g)-13.9(e)0(n)-14.9(i)0(c)-12.4(i)0(t)-13(y)-513.9(o)-10.2(f)-510.8(an)-520.4(E)-13(s)0(c)-13.7(h)0(e)-16.8(ric)-21(hi)-10.8(a)-518.7(col)-16.5(i-)-17.7(pr)-15(odu)-23.2(ce)-10.3(d)-516.7(b)0(i)-9.4(v)-11.7(al)-17.6(en)-14.9(t)-507.9(h)-11.6(um)-12.5(an)-520.4(pa)-14.9(pi)-13.7(l)-9.2(l)-9.2(o)0(m)-16.3(a)0(v)-12.1(i)0(r)-15.8(u)0(s)]TJ T* [(vaccine:)-336.9(an)-342.2(interim)-341.4(analysis)-339.3(of)-334.8(a)-340.5(randomized)-340.9(clinical)-344.9(trial.)]TJ /F11 1 Tf 23.941 0 TD [(J)-335.9(Natl)-338.3(Cancer)-347.3(Inst)]TJ /F8 1 Tf 7.3378 0 TD [(.)-332.7(\(2020\))]TJ -31.2789 -1.142 TD (112:145)Tj /F12 1 Tf 3.0939 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(53.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.1093/jnci/djz074)Tj 0.13725 0.12157 0.12549 scn -5.9529 -1.5712 TD [(38.)-500.6(Guo)-272.5(J,)-269.9(Guo)-272.5(S,)-269.7(Dong)-274.7(S.)-269.7(Ef)]TJ /F9 1 Tf 11.6951 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cacy,)-266.1(immunogenicity)-279.8(and)-275.7(safety)-267.1(of)-278.1(HPV)-265(vaccination)]TJ -13.153 -1.142 TD [(in)-511.1(Ch)-11.7(ine)-14.1(se)-515.9(po)-16.7(pu)-12.9(la)-9.5(ti)-13(on:)-514.7(a)-510.6(m)0(e)-11.2(t)0(a)-14.2(-)0(a)-10.8(n)-9.7(al)-9.5(ys)-12.2(is.)]TJ /F11 1 Tf 17.3564 0 TD [(Fr)-15(ont)-521.3(Pu)-10.4(bl)-10.9(ic)-513.2(Hea)-13.1(l)-12.1(t)0(h)]TJ /F8 1 Tf 8.4069 0 TD [(.)-510.9(\()0(2)-12.2(0)0(2)-13.9(3)0(\))-514.4(1)0(1)-13.9(:11)-14.6(287)-12.8(17)-13.9(.)]TJ -25.7633 -1.142 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.3389/fpubh.2023.1128717)Tj 0.13725 0.12157 0.12549 scn -0.8747 -1.5712 TD [(39.)-500.6(Turner)-323.5(TB,)-310.2(Huh)-319.1(WK.)-310.5(HPV)-321.7(vaccines:)-313.1(translating)-320.1(immunogenicity)-320.3(into)-316.5(ef)]TJ /F9 1 Tf 31.0359 0 TD ()Tj /F8 1 Tf 6.9999 0 0 6.9999 532.2896 396.3968 Tm (cacy.)Tj /F11 1 Tf -32.4856 -1.142 TD [(Hum)-297.8(Vaccin)-298.8(Immunother)]TJ /F8 1 Tf 10.3588 0 TD [(.)-300.3(\(2016\))-297.6(12:1403)]TJ /F12 1 Tf 6.5117 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(5.)-307.3(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.8023 0 TD (10.1080/21645515.2015.1103936)Tj 0.13725 0.12157 0.12549 scn -19.2597 -1.5712 TD [(40.)-500.6(Hu)-453.2(S,)-447.9(Xu)-446.7(X,)-449.1(Zhu)-453.7(F,)-444.5(Hong)-446.2(Y,)-452.9(Hu)-445.1(Y,)-452.9(Zhang)-444.8(X,)-449.1(et)-448.3(al.)-455.7(Ef)]TJ /F9 1 Tf 25.3989 0 TD ()Tj /F8 1 Tf 0.5346 0 TD [(cacy)-451.7(of)-448.2(the)-443.7(AS04-)]TJ -26.8567 -1.1501 TD [(ad)-14.9(j)-17.3(u)0(v)-18.2(a)0(n)-18.2(t)-13.9(e)-13.3(d)-516.7(H)-9.4(P)-13(V)-15.7(-)-10.5(16)-22(/)-10.1(1)0(8)-532.3(v)0(a)-20.2(c)0(c)-18.4(i)-15.4(n)-9.7(e)-515.4(i)-15.4(n)-520(y)-11.8(o)-10.2(u)-14.5(n)-9.7(g)-522(C)0(h)-19.8(i)0(n)-17(e)-13.3(se)-532.1(w)-11.4(o)-10.3(me)-19.3(n)-520(w)-11.4(i)-15.4(t)0(h)-527.7(o)-10.2(n)-9.7(c)-13.3(o)-10.2(g)-11.7(e)-13.3(n)-9.7(ic)-530.8(H)-9.4(P)-13(V)]TJ 0 -1.142 TD [(infection)-336.4(at)-338.2(baseline:)]TJ /F11 1 Tf 8.6823 0 TD (post-hoc)Tj /F8 1 Tf 3.6041 0 TD [(analysis)-347.4(of)-334.8(a)-332.4(randomized)-349(controlled)-338.9(trial.)]TJ /F11 1 Tf 17.0568 0 TD [(Hum)-338.3(Vaccin)]TJ -29.3432 -1.142 TD (Immunother)Tj /F8 1 Tf 4.9972 0 TD [(.)-300.3(\(2021\))-297.6(17:955)]TJ /F12 1 Tf 6.0338 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(64.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1080/21645515.2020.1829411)Tj 0.13725 0.12157 0.12549 scn -13.8981 -1.5712 TD [(41.)-500.6(Zhao)-231.1(C,)-227.5(Zhao)-231.1(Y,)-226.1(Li)-229.5(J,)-229.4(Li)-229.5(M,)-225.3(Su)-226.9(Y,)-234.2(Mi)-223.8(X,)-230.4(et)-229.6(al.)-228.9(The)-228.9(eight-year)-231.9(long-term)-230.8(follow-up)]TJ -0.9233 -1.142 TD [(on)-441.2(the)-443.7(ef)59.1(fectiveness)-453.6(of)-448.2(the)-443.7(quadrivalent)-452.1(human)-447.3(papillomavirus)-446.5(vaccine)-449.6(in)-446.3(Chinese)]TJ T* [(women)-220.8(20)]TJ /F12 1 Tf 4.1225 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(45)-224.5(years)-228.8(of)-221.4(age.)]TJ /F11 1 Tf 6.2201 0 TD [(Hum)-224.9(Vaccin)-217.9(Immunother)]TJ /F8 1 Tf 10.2049 0 TD [(.)-219.4(\(2022\))-224.7(18:2052700.)-226(doi:)]TJ 0.15294 0.15294 0.15294 scn 9.9619 0 TD (10.1080/)Tj -31.0197 -1.142 TD (21645515.2022.2052700)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(42.)-500.6(Lv)-250.2(H,)-236.9(Wang)-252.6(S,)-245.4(Liang)-243.3(Z,)-241.9(Yu)-248.1(W,)-247.6(Yan)-243.6(C,)-243.7(Chen)-245.3(Y,)-242.3(et)-245.8(al.)-245.1(Immunogenicity)-247.3(and)-251.4(safety)]TJ -0.9233 -1.142 TD [(of)-261.9(the)-265.6(9-valent)-261.9(human)-269.1(papillomavirus)-268.3(vaccine)-271.4(in)-268.1(Chinese)-266.3(females)-261.8(9)]TJ /F12 1 Tf 26.8648 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(45)-265(years)-261.2(of)-270(age:)-260.9(A)]TJ -27.3751 -1.142 TD 0.0858 Tc [(p)6.5(h)1.3(a)4.5(s)-3.8(e)-575.4(3)-585.3(op)6.5(en-l)3.7(abe)7.8(l)-579.4(st)7.1(udy)9.3(.)]TJ /F11 1 Tf 13.4851 0 TD 0.0791 Tc [(Va)-6.9(c)-7.6(c)0.6(i)-7.3(n)-5.4(e)]TJ /F8 1 Tf 3.6851 0 TD 0.0798 Tc [(.)-585(\()-6.5(20)-8.1(22)-8.1(\))-581.5(4)-8.1(0:)-10(326)-8.1(3)]TJ /F12 1 Tf 8.2449 0 TD 0 Tc ()Tj /F8 1 Tf 0.5993 0 TD 0.0804 Tc [(71.)-592.5(doi)-7.9(:)]TJ 0.15294 0.15294 0.15294 scn 4.4221 0 TD 0.0879 Tc [(10)8.1(.)6.2(1)0(0)8.1(1)0(6)8(/)]TJ -30.4365 -1.1501 TD 0 Tc (j.vaccine.2022.02.061)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(43.)-500.6(Zhao)-255.4(FH,)-251.5(Wu)-253.3(T,)-253.3(Hu)-258.9(YM,)-248.2(Wei)-259.3(LH,)-248.6(Li)-253.8(MQ,)-255.7(Huang)-256.4(WJ,)-249.5(et)-253.9(al.)-253.2(Ef)]TJ /F9 1 Tf 26.5409 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cacy,)-249.9(safety,)-259.7(and)]TJ -27.9987 -1.142 TD [(immunogenicity)-312.2(of)-318.6(an)-309.8(Escherichia)-318.8(coli-produced)-316(Human)-315.5(Papillomavirus)-315.4(\(16)-318.8(and)-308.1(18\))]TJ T* [(L1)-528.9(v)-11.7(i)-15.4(ru)-23.1(s-)-19(l)-9.2(i)-15.4(k)-13.1(e)-13.3(-)-10.5(p)0(a)-23(r)0(t)-22.4(i)0(c)-20.5(l)-9.2(e)-523.5(v)-11.7(a)-16.6(c)0(c)-18.4(i)-15.4(n)-9.7(e)-13.3(:)-519(e)-13.2(n)-9.7(d)-14.5(-)-10.5(o)-10.2(f)-16.8(-)-10.5(st)-22.4(ud)-21(y)-522(a)-16.6(n)-9.7(a)0(l)-17.6(y)-11.7(s)-16.7(i)0(s)-534.2(o)-10.3(f)-518.9(a)-526.8(p)-14.5(h)-11.6(as)-17(e)-523.5(3)-15.1(,)-519(d)-14.5(o)-10.2(u)-14.5(b)-10.2(l)-9.2(e)-13.3(-)-10.5(b)-10.2(l)-9.2(i)-15.4(n)-9.7(d)-14.5(,)]TJ T* [(ran)-10.6(do)-16.7(mi)-13.3(sed)-12.1(,)-510.9(c)-13.3(ont)-9.6(ro)-18.8(ll)-10.3(ed)-513.8(tr)-14.3(ial)-16.8(.)]TJ /F11 1 Tf 12.5132 0 TD [(Lan)-12.2(ce)-15.6(t)-507.9(I)0(n)-10.7(f)-13.5(ect)-515.5(Di)-13(s)]TJ /F8 1 Tf 7.2244 0 TD [(.)-510.9(\()0(2)-12.2(0)0(2)-13.9(2)0(\))-514.4(2)0(2)-13.9(:17)-14.6(56)]TJ /F12 1 Tf 7.0058 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(68)-13.9(.)-510.9(d)0(o)-16.7(i)0(:)]TJ 0.15294 0.15294 0.15294 scn 3.7256 0 TD [(10)-13.9(.1)-15.7(016)-12.8(/)]TJ -30.9792 -1.142 TD (S1473)Tj /F12 1 Tf 2.3811 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (3099\(22\)00435)Tj /F12 1 Tf 5.961 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (2)Tj 0.13725 0.12157 0.12549 scn -8.4393 -1.5712 TD 0.0476 Tc [(44.)-503.8(Prabhu)-550.1(P)-5.9(R)5.6(,)-552.4(C)-1(arter)-552.2(J)-3(J,)-552.4(Galloway)-547.3(D)-0.9(A.)-544.3(B)-551.9(c)2(e)-6.1(l)6(l)-552.8(r)-1.5(esponses)-552.2(upon)-545.3(h)-4.5(uman)]TJ -0.9233 -1.142 TD 0 Tc [(papill)-14.6(omavi)-11.4(rus)-509.5(\(HPV)-11.1(\))-507.4(infec)-11.7(tion)-510.9(and)-510.6(vacc)-14.4(ination)-18.1(.)]TJ /F11 1 Tf 21.0901 0 TD [(Vacci)-11.8(nes)-506.6(\(B)-10.2(asel\))]TJ /F8 1 Tf 6.6575 0 TD [(.)-502.8(\(20)-11.1(22\))-505.1(10:)-14.6(837.)]TJ -27.7476 -1.142 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.3390/vaccines10060837)Tj 0.13725 0.12157 0.12549 scn -0.8747 -1.5712 TD [(45.)-500.6(Steele)-437.2(J,)-431.9(Mann)-438.9(C,)-438.1(Rookes)-429.6(S,)-439.8(Rollason)-431.7(T,)-439.6(Murphy)-431.5(D,)-438(Freeth)-431.5(M,)-435.9(et)-432.1(al.)-439.5(T-cell)]TJ -0.9233 -1.142 TD [(responses)-378.8(to)-380.5(human)-382.5(papillomavirus)-381.7(type)-377.4(16)-378.4(among)-386.4(women)-374.7(with)-384.4(dif)66.7(ferent)-383.3(grades)-381.1(of)]TJ T* [(cervical)-303.7(neoplasia.)]TJ /F11 1 Tf 7.5646 0 TD [(Br)-303.2(J)-295.4(Cancer)]TJ /F8 1 Tf 4.6327 0 TD [(.)-300.3(\(2005\))-297.6(93:248)]TJ /F12 1 Tf 6.0339 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(59.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2802 0 TD (10.1038/sj.bjc.6602679)Tj 0.13725 0.12157 0.12549 scn -21.0982 -1.5793 TD [(46.)-500.6(Mariz)-278.4(FC,)-266.4(Bender)-278.2(N,)-274.1(Anantharaman)-274.8(D,)-276(Basu)-266.6(P,)-272.9(Bhatla)-278.6(N,)-266(Pillai)-273.1(MR,)-275.4(et)-270.1(al.)-277.5(Peak)]TJ -0.9233 -1.142 TD [(neutralizing)-321.4(and)-324.3(cross-neutralizing)-332.5(antibody)-321.1(levels)-324.4(to)-323.8(human)-317.7(papillomavirus)-333.1(types)-321.2(6/)]TJ T* [(16)-22(/)-10.1(1)0(8)-22(/)-10.1(3)-15(1)0(/)-25.1(3)0(3)-22(/)-10.1(4)-15(5)0(/)-17(5)-15(2)-15(/)-10.1(58)-532.2(i)-15.4(n)-9.7(d)-14.5(u)0(c)-19.7(e)-13.3(d)-524.8(b)-10.2(y)-522(b)-10.2(i)-15.4(v)-11.8(al)-17.6(e)-13.3(n)-9.7(t)-524.1(a)-16.5(n)-9.7(d)-524.8(qu)-22.9(ad)-23(ri)-23.9(v)-11.7(a)0(l)-25.7(e)-13.3(n)-9.7(t)-524.1(H)-9.4(P)-13(V)-517.9(v)-11.8(a)-16.6(c)-13.2(c)-13.3(i)0(n)-17(e)-13.3(s)-16.7(.)]TJ /F11 1 Tf 32.8501 0 TD 0.0157 Tc [(NP)15.7(J)]TJ -32.8501 -1.142 TD 0 Tc (Vaccines)Tj /F8 1 Tf 3.434 0 TD [(.)-300.3(\(2020\))-305.7(5:14.)-297.6(doi:)]TJ 0.15294 0.15294 0.15294 scn 7.3945 0 TD (10.1038/s41541-020-0165-x)Tj 0.13725 0.12157 0.12549 scn -9.9052 -1.5712 TD [(47.)-500.6(Joura)-278.7(EA,)-274.3(Kjaer)-272.5(SK,)-276(Wheeler)-275.6(CM,)-273.9(Sigurdsson)-273.8(K,)-274.2(Iversen)-274.8(O-E,)-273.3(Hernandez-Avila)]TJ -0.9233 -1.142 TD [(M,)-492.6(et)-488.8(al.)-496.2(HPV)-491.8(antibody)-499.3(levels)-494.5(and)-494.4(clinical)-490.7(ef)]TJ /F9 1 Tf 19.3407 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cacy)-492.2(following)-492.7(administration)-498.5(of)-496.8(a)]TJ -19.8753 -1.142 TD [(prophylactic)-452.6(quadrivalent)-460.2(HPV)-459.4(vaccine.)]TJ /F11 1 Tf 17.0001 0 TD (Vaccine)Tj /F8 1 Tf 3.102 0 TD [(.)-454.2(\(2008\))-459.5(26:6844)]TJ /F12 1 Tf 6.8276 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(51.)-452(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.5798 0 TD (10.1016/)Tj -31.0197 -1.142 TD (j.vaccine.2008.09.073)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(48.)-500.6(Meyer)-393(SI,)-398.4(Fuglsang)-396.4(K,)-395.7(Blaakaer)-393.7(J.)-391.4(Cell-mediated)-400.7(immune)-389(response:)-403.4(a)-389.1(clinical)]TJ -0.9233 -1.142 TD [(review)-308.5(of)-302.4(the)-306.1(therapeutic)-318.9(potential)-303(of)-310.5(human)-309.6(papillomavirus)-316.9(vaccination.)]TJ /F11 1 Tf 29.7967 0 TD [(Acta)-308.1(Obstet)]TJ -29.7967 -1.142 TD [(Gynecol)-295.9(Scand)]TJ /F8 1 Tf 5.7747 0 TD [(.)-300.3(\(2014\))-305.7(93:1209)]TJ /F12 1 Tf 6.5198 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(18.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.1111/aogs.12480)Tj /F1 1 Tf 0.49804 0.49804 0.49412 scn -52.5472 101.6522 TD [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.4323 0 TD (12)Tj ET endstream endobj 372 0 obj<> endobj 373 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 374 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 375 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 376 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 377 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 378 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 379 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 380 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 381 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 382 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 383 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 384 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 385 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 386 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 387 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 388 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 389 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 390 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 391 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 392 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 393 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 394 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 395 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 396 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 397 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 398 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 399 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 400 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 401 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 402 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 403 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 404 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 405 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 406 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 407 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 408 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 409 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 410 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 411 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 412 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 413 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 414 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 415 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 416 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 417 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 418 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 419 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 420 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 421 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 422 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 423 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 424 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 425 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 426 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 427 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 428 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 429 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 430 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 431 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 432 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 433 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 434 0 obj<>stream /GS1 gs BT /F8 1 Tf 6.9999 0 0 6.9999 56.126 760.3652 Tm /Cs6 cs 0.13725 0.12157 0.12549 scn 0 Tc 0 Tw [(49.)-500.6(Roy)-226(V,)-235.1(Jung)-232.4(W,)-231.4(Linde)-234.7(C,)-235.6(Coates)-232.7(E,)-232.4(Ledgerwood)-233(J,)-229.4(Costner)-234.4(P,)-232.4(et)-229.6(al.)-237(Dif)65.1(ferences)-242.5(in)]TJ -0.9314 -1.142 TD 0.0174 Tc (HPV-speci)Tj /F9 1 Tf 4.5031 0 TD 0 Tc ()Tj /F8 1 Tf 0.5507 0 TD 0.017 Tc [(c)-474.1(a)0.4(ntibody)-472.6(F)-5.6(c-ef)56.9(fector)-477.5(functions)-477.5(f)0.2(ollow)5.6(i)1.6(ng)-480.7(G)4.2(a)0.5(rdasil)]TJ /F13 1 Tf 5.5001 0 0 5.5001 239.8676 754.866 Tm 0 Tc ()Tj /F8 1 Tf 6.9999 0 0 6.9999 247.4645 752.3715 Tm 0.0168 Tc [(and)-475.6(C)0.6(ervari)-6.7(x)]TJ /F13 1 Tf 5.5001 0 0 5.5001 286.5826 754.866 Tm 0 Tc ()Tj /F8 1 Tf 6.9999 0 0 6.9999 49.6063 744.3778 Tm (vaccination.)Tj /F11 1 Tf 5.0944 0 TD [(NPJ)-301.8(Vaccines)]TJ /F8 1 Tf 5.2968 0 TD [(.)-300.3(\(2023\))-305.7(8:39.)-297.6(doi:)]TJ 0.15294 0.15294 0.15294 scn 7.4026 0 TD (10.1038/s41541)Tj /F12 1 Tf 6.1715 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (023-00628)Tj /F12 1 Tf 4.1873 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (8)Tj 0.13725 0.12157 0.12549 scn -28.2417 -1.5712 TD [(50.)-508.6(Pl)-14.1(otk)-13(in)-519.2(SA.)-514.1(Co)-10.3(rre)-14.2(l)-9.2(ate)-11.3(s)-510.7(o)-10.2(f)-502.7(p)0(r)-15(ote)-13.1(ct)-10.9(io)-9.4(n)-511.9(ind)-15.4(uc)-11.6(ed)-513.8(by)-516.1(vacc)-14.4(in)-17(ati)-13.4(on)-11.9(.)]TJ /F11 1 Tf 28.185 0 TD [(Cl)-10.7(in)-519.2(Va)-11.3(ccin)-20.3(e)]TJ -29.1164 -1.142 TD (Immunol)Tj /F8 1 Tf 3.6689 0 TD [(.)-300.3(\(2010\))-297.6(17:1055)]TJ /F12 1 Tf 6.5117 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(65.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1128/CVI.00131)Tj /F12 1 Tf 7.7185 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (10)Tj 0.13725 0.12157 0.12549 scn -21.2683 -1.5712 TD [(51.)-500.6(Ebrahimi)-226.5(N,)-225.5(Youse)]TJ /F9 1 Tf 9.233 0 TD ()Tj /F8 1 Tf 0.7532 0 TD [(Z,)-225.7(Khosravi)-226.7(G,)-224.1(Malayeri)-226.8(FE,)-222.7(Golabi)-228.4(M,)-225.3(Askarzadeh)-231(M,)-217.2(et)-229.6(al.)]TJ -10.9176 -1.142 TD [(Human)-275(papillomavirus)-276.4(vaccination)-275.4(in)-268.1(low-and)-276.6(middle-income)-272.9(countries:)-278.3(progression,)]TJ T* [(barriers,)-463(and)-462(future)-462.2(prospective.)]TJ /F11 1 Tf 13.8009 0 TD [(Front)-463.5(Immunol)]TJ /F8 1 Tf 6.3173 0 TD [(.)-454.2(\(2023\))-467.6(14:1150238.)-460.9(doi:)]TJ 0.15294 0.15294 0.15294 scn 10.9095 0 TD (10.3389/)Tj /F9 1 Tf -31.0278 -1.1501 TD ()Tj /F8 1 Tf 0.5345 0 TD (mmu.2023.1150238)Tj 0.13725 0.12157 0.12549 scn 0.3969 -1.5712 TD [(52.)-516.7(Mad)-12.7(ri)-15.8(d-M)-14.7(ar)-17(ina)-519.5(V,)-518.6(To)-11.8(rre)-14.2(s-)-10.9(P)-13(ove)-11(da)-517.1(K,)-517.2(L)-11.6(o)]TJ /F15 1 Tf 18.7738 0.0486 TD ()Tj /F8 1 Tf 0.0891 -0.0486 TD [(pe)-11.6(z-)-15.6(To)-11.8(led)-12.7(o)-512.4(G)0(,)-515.7(G)0(a)-13.2(r)0(c)]TJ /F17 1 Tf 8.4636 0 TD ()Tj /F15 1 Tf 0.2916 0.0486 TD ()Tj /F8 1 Tf -0.0243 -0.0486 TD [(a-)-10.8(Car)-17.1(ran)-18.7(ca)]TJ /F15 1 Tf 4.4383 0.0486 TD ()Tj /F8 1 Tf 0.5669 -0.0486 TD (A.)Tj -33.5304 -1.142 TD [(Advantages)-434(and)-429.6(disadvantages)-430.9(of)-423.9(current)-430.1(prophylactic)-436.4(vaccines)-425.8(against)-432.6(HPV.)]TJ /F11 1 Tf 32.5342 0 TD (Arch)Tj -32.5342 -1.142 TD [(Med)-303.4(Res)]TJ /F8 1 Tf 3.3935 0 TD [(.)-300.3(\(2009\))-305.7(40:471)]TJ /F12 1 Tf 6.042 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(7.)-299.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.7942 0 TD (10.1016/j.arcmed.2009.08.005)Tj 0.13725 0.12157 0.12549 scn -11.8085 -1.5712 TD [(53.)-500.6(Nicol)-232.4(AF,)-235.4(Andrade)-232.6(C,)-235.6(Russomano)-240(FB,)-234.1(Rodrigues)-236.2(LLS,)-236.3(Oliveira)-233.9(N,)-233.6(Provance)-242.3(D)-89(Jr.)]TJ -0.9314 -1.142 TD [(HPV)-208.3(vaccines:)-215.9(a)-210.9(controversial)-206(issue?)]TJ /F11 1 Tf 14.5055 0 TD [(Braz)-216.2(J)-206.3(Med)-206.2(Biol)-208.6(Res)]TJ /F8 1 Tf 7.6375 0 TD [(.)-203.2(\(2016\))-216.6(49:e5060.)-210.3(doi:)]TJ 0.15294 0.15294 0.15294 scn 8.8847 0 TD (10.1590/)Tj -31.0278 -1.142 TD (1414)Tj /F12 1 Tf 1.9195 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (431X20155060)Tj 0.13725 0.12157 0.12549 scn -1.4983 -1.5712 TD [(54.)-500.6(WHO.)-238.9(Safety)-244.1(of)-245.7(HPV)-240.7(vaccines)-247.6(\(2017\).)-241.6(Available)-241.3(online)-245.8(at:)]TJ 0.85098 0.19216 0.2 scn 25.0182 0 TD (https://www.who.int/)Tj -25.9496 -1.142 TD [(g)-11.7(r)0(o)-18.8(u)-14.5(p)-14.5(s)0(/)-18.6(g)-11.8(l)-9.2(o)-10.2(b)-10.2(a)-16.5(l)-9.2(-)-10.5(ad)-23(v)-11.7(i)0(s)-23.9(o)-10.2(ry)-20.3(-)-10.5(c)-13.3(o)-10.2(m)0(m)-20.1(i)-15.4(tt)-19.6(e)-13.3(e)0(-)-15.6(o)-18.3(n)-9.7(-)-10.5(v)-11.7(a)0(c)-21.7(c)-13.3(in)-17(e)-13.3(-)-10.5(sa)-25.1(fe)-21.9(t)-13.9(y)0(/)-21.8(t)0(o)-16(p)-14.5(ic)-20.5(s)-16.7(/)-10.1(h)-11.6(u)0(m)-20.6(a)0(n)-18.2(-)-18.6(pa)-14.9(p)-14.5(i)-15.4(l)-9.2(l)-9.2(o)-10.2(m)-14.1(a)0(v)-20.2(i)0(r)-23.9(u)0(s)-23.1(-)]TJ T* (vaccines/safety)Tj 0.13725 0.12157 0.12549 scn 6.2039 0 TD [(\(Accessed)-310.1(May)-301.5(17)-297.4(2024\).)]TJ -5.2725 -1.5712 TD [(55.)-500.6(National)-300.2(Cancer)-296.3(Institute.)-305.4(HPV)-297.4(and)-308.1(cancer)-301.5(\(2023\).)-298.2(Available)-298(online)-302.5(at:)]TJ 0.85098 0.19216 0.2 scn 30.6228 0 TD (https://)Tj -31.5542 -1.142 TD 0.027 Tc [(www.c)5.6(a)-5.7(nc)5.6(er.)-6.1(g)7.1(ov/a)-5.8(bout-c)5.6(a)-5.7(nc)5.6(er/causes-pre)5.6(v)-0.9(en)]TJ 19.0006 0 TD 0.0263 Tc [(tion/risk/inf)-6.7(e)4.9(ctious)-6.6(-age)5(n)-7.7(t)4.3(s/hpv-and-)]TJ -19.0006 -1.1501 TD 0 Tc (cancer)Tj 0.13725 0.12157 0.12549 scn 2.8914 0 TD [(\(Accessed)-310.1(December)-304.6(5)-298.5(2023\).)]TJ -1.96 -1.5712 TD [(56.)-500.6(Shu)-238.5(Y,)-234.2(Yu)-240(Y,)-242.3(Ji)-236(Y,)-242.3(Zhang)-242.4(L,)-239.1(Li)-237.6(Y,)-234.2(Qin)-241.8(H,)-236.9(et)-237.7(al.)-245.1(Immunogenicity)-239.3(and)-243.3(safety)-242.8(of)-237.6(two)]TJ -0.9314 -1.142 TD [(novel)-337.7(human)-342(papillomavirus)-349.3(4-and)-341.8(9-valent)-342.9(vaccines)-336.7(in)-341(Chinese)-347.3(women)-342.3(aged)-339.6(20)]TJ /F12 1 Tf 32.9716 0 TD ()Tj /F8 1 Tf 0.5103 0 TD (45)Tj -33.4818 -1.142 TD [(years:)-415.8(a)-413.4(randomized,)-422.6(blinded,)-411.6(controlled)-419.9(with)-416.8(Gardasil)-410(\(type)-415.1(6/11/16/18\),)-425.1(phase)-412.9(III)]TJ T* 0.0654 Tc [(non-)6.3(i)-6.7(n)-1(feriority)-561.9(c)-4.5(l)7.6(i)-6.7(nical)-567.4(t)2.9(ri)-6.7(al.)]TJ /F11 1 Tf 14.2059 0 TD 0.0708 Tc [(Va)9.1(cc)8.4(i)8.7(n)2.5(e)]TJ /F8 1 Tf 3.5636 0 TD 0.0638 Tc [(.)-568.6(\()1.8(20)-7.9(22\))-565.1(4)-7.9(0)0.2(:6947)]TJ /F12 1 Tf 7.9614 0 TD 0 Tc ()Tj /F8 1 Tf 0.575 0 TD 0.0641 Tc [(55.)-568.3(doi:)]TJ 0.15294 0.15294 0.15294 scn 4.2601 0 TD 0.0639 Tc [(10.1)-7.8(016/)]TJ -30.5661 -1.142 TD 0 Tc (j.vaccine.2022.10.022)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD 0.0236 Tc [(57.)-503.5(Faridi)-526.3(R,)-519.7(Z)-7(a)7(h)-4.2(r)-1.2(a)-527.5(A)6(,)-527.8(K)1.2(h)-4.2(a)-1(n)-520.7(K)-6.9(,)-519.7(I)0.2(dre)-5.9(e)2.2(s)-527.6(M)1.5(.)-527.8(O)1.3(ncoge)-5.9(n)-2.3(ic)-524.2(potential)-528.2(o)-2.8(f)-519.6(H)-2(um)-6.7(a)7.1(n)]TJ -0.9314 -1.142 TD 0 Tc [(Papillomavirus)-469.3(\(HPV\))-469.9(and)-470.1(its)-467.1(relation)-469.4(with)-465.4(cervical)-473.8(cancer.)]TJ /F11 1 Tf 25.5447 0 TD [(Virol)-471.4(J)]TJ /F8 1 Tf 2.7861 0 TD [(.)-470.4(\(2011\))-467.6(8:269.)]TJ -28.3308 -1.142 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1186/1743)Tj /F12 1 Tf 5.3373 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (422X-8)Tj /F12 1 Tf 2.9157 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (269)Tj 0.13725 0.12157 0.12549 scn -10.1401 -1.5712 TD [(58.)-500.6(Wang)-357.9(R,)-358.6(Pan)-355.2(W,)-361(Jin)-359.2(L,)-360.6(Huang)-361.7(W,)-352.9(Li)-359.1(Y,)-355.7(Wu)-358.6(D,)-357(et)-359.2(al.)-358.5(Human)-364.1(papillomavirus)]TJ -0.9314 -1.142 TD [(vaccine)-214.7(against)-222(cervical)-214.6(cancer:)-213.1(Opportunity)-222.4(and)-210.9(challenge.)]TJ /F11 1 Tf 23.5442 0 TD [(Cancer)-209.7(Lett)]TJ /F8 1 Tf 4.5274 0 TD [(.)-211.3(\(2020\))-216.6(471:88)]TJ /F12 1 Tf 5.8638 0 TD ()Tj /F8 1 Tf -33.9354 -1.1501 TD [(102.)-305(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.758 0 TD (10.1016/j.canlet.2019.11.039)Tj 0.13725 0.12157 0.12549 scn -2.8266 -1.5712 TD [(59.)-500.6(Khallouf)-305(H,)-309.8(Grabowska)-302.6(AK,)-308(Riemer)-309.1(AB.)-301.9(Therapeutic)-314.7(vaccine)-311.9(strategies)-301.9(against)]TJ -0.9314 -1.142 TD 0.0608 Tc [(human)-556.4(p)-2.3(apil)-5.1(lo)-6.1(m)6.2(a)-4.3(virus)-4.5(.)]TJ /F11 1 Tf 11.3712 0 TD 0.0614 Tc [(Vacc)7.1(in)-6.9(es)-561.3(\(Basel\))]TJ /F8 1 Tf 7.6051 0 TD 0.0636 Tc [(.)-560.7(\()1.6(20)8.1(14\))-557.2(2:)6.2(422)]TJ /F12 1 Tf 6.8195 0 TD 0 Tc ()Tj /F8 1 Tf 0.5669 0 TD 0.0636 Tc [(62.)-560.7(d)8.6(o)-3.3(i)7.7(:)]TJ 0.15294 0.15294 0.15294 scn 4.2277 0 TD [(10.)6.2(3390)8.1(/)]TJ -30.5904 -1.142 TD 0 Tc (vaccines2020422)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD 0.5522 Tc [(6)529.1(0)529.1(.)25.1(W)524(o)525.8(oY)529.3(L)524.4(,)0.8(v)532.4(a)527.6(nd)521.5(e)530.8(n)-0.2(H)526.6(e)522.7(n)526.3(d)529.6(eM)530.1(,S)526.2(t)522.1(e)530.8(r)527.4(l)518.7(i)528.7(n)526.3(g)5.9(J)525.9(C)519.8(,)0.8(C)527.9(o)525.8(l)526.8(e)530.8(m)521.9(a)527.5(nN)529.9(,C)527.9(r)519.3(a)527.5(w)532.7(f)519.2(o)533.9(r)519.3(dR)526.4(A)526.5(F)529.6(,)]TJ -0.9314 -1.142 TD 0 Tc [(Kwappenberg)-421.8(KMC,)-417.9(et)-415.9(al.)-415.2(A)-414.5(prospective)-420.8(study)-411.6(on)-416.9(the)-419.4(natural)-413(course)-416.7(of)-415.8(low-grade)]TJ T* [(squamous)-306.1(intraepithelial)-309.8(lesions)-309.8(and)-308.1(the)-306.1(presence)-305.1(of)-310.5(HPV16)-303.2(E2-,)-306.5(E6-)-305.9(and)-308.1(E7-speci)]TJ /F9 1 Tf 33.4899 0 TD ()Tj /F8 1 Tf 0.5345 0 TD (c)Tj -34.0245 -1.142 TD [(T-cell)-299.9(responses.)]TJ /F11 1 Tf 6.9734 0 TD [(Int)-300(J)-303.5(Cancer)]TJ /F8 1 Tf 6.9999 0 0 6.9999 132.4346 423.3826 Tm [(.)-300.3(\(2010\))-305.7(126:133)]TJ /F12 1 Tf 6.5198 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(41.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1002/ijc.24804)Tj 0.13725 0.12157 0.12549 scn -21.2116 -1.5712 TD [(61.)-500.6(Sarkar)-227.2(AK,)-218.9(Tortolero-Luna)-229.8(G,)-224.1(Follen)-220.1(M,)-225.3(Sastry)-223.1(KJ.)-227.6(Inverse)-226.2(correlation)-226.1(of)-221.4(cellular)]TJ -0.9314 -1.142 TD [(immune)-316.1(responses)-322.2(speci)]TJ /F9 1 Tf 9.8242 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(c)-312.9(t)0(o)-307.6(synthetic)-322(peptides)-310.5(from)-317(the)-314.2(E6)-311.6(and)-316.2(E7)-311.6(oncoproteins)-324.1(of)]TJ -10.3588 -1.142 TD [(HPV-16)-257(with)-254.8(recurrence)-254(of)-253.8(cervical)-255.1(intraepithelial)-261.2(neoplasia)-259.9(in)-251.9(a)-251.4(cross-sectional)-258.9(study.)]TJ /F11 1 Tf T* [(Gynecol)-304(Oncol)]TJ /F8 1 Tf 5.7342 0 TD [(.)-300.3(\(2005\))-305.7(99:S251)]TJ /F12 1 Tf 6.5117 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(S61.)-299.8(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.7418 0 TD (10.1016/j.ygyno.2005.07.099)Tj 0.13725 0.12157 0.12549 scn -15.5665 -1.5712 TD [(62.)-500.6(Farhat)-470.5(S,)-480.3(Nakagawa)-473.2(M,)-476.4(Moscicki)-475.9(A-B.)-474.4(Cell-mediated)-481.7(immune)-478.1(responses)-476(to)]TJ -0.9314 -1.1501 TD [(human)-479.7(papillomavirus)-478.9(16)-467.5(E6)-473.6(and)-478.2(E7)-473.6(antigens)-479.6(as)-470.6(measured)-476(by)-475.6(interferon)-475.8(gamma)]TJ 0 -1.142 TD 0.0547 Tc [(enzyme-linke)-7.1(d)-551.1(i)-1.2(mmunos)5.6(p)-0.3(ot)-550.4(in)-554.4(women)-554.4(w)2.8(ith)-556.3(c)1(lea)5.8(r)-2.5(ed)-551.1(or)-553.2(pers)5.6(istent)-558.5(human)]TJ T* 0.011 Tc [(p)-3.5(a)11(p)-3.9(i)-4.4(lloma)11(v)-9.2(i)11(r)-12.9(u)11(s)-522.4(i)11(n)-6(f)11(e)-10.9(c)-2.3(t)11(i)-10.1(on.)]TJ /F11 1 Tf 10.9743 0 TD 0 Tc [(I)-15.3(n)-11.6(t)-516(J)-522.2(G)-11.4(y)0(n)-20.1(e)-10(c)-13.8(o)-9.8(l)-522.3(C)0(a)-19.9(n)-11.6(ce)-23.7(r)]TJ /F8 1 Tf 9.0953 0 TD [(.)-519(\()-13.4(20)-22(09)-22(\))-515.5(1)-15(9:)-23.8(50)-13.9(8)]TJ /F12 1 Tf 6.5927 0 TD ()Tj /F8 1 Tf 0.5183 0 TD 0.0126 Tc [(12)12.6(.)-513.4(d)-1.9(oi)12.6(:)]TJ 0.15294 0.15294 0.15294 scn 3.7742 0 TD 0 Tc [(10)-22(.1)-15.7(1)-15(1)0(1)-22(/)]TJ -30.9549 -1.142 TD (IGC.0b013e3181a388c4)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(63.)-500.6(Kamolratanakul)-280.5(S,)-285.9(Pitisuttithum)-283.4(P.)-281(Human)-275(papillomavirus)-292.6(vaccine)-279.5(ef)]TJ /F9 1 Tf 29.4727 0 TD ()Tj /F8 1 Tf 0.5264 0 TD [(cacy)-281.6(and)]TJ -30.9306 -1.142 TD 0.0456 Tc [(ef)69.3(fe)8(cti)5.9(v)1.5(eness)-546.1(a)]TJ 6.4793 0 TD 0.0432 Tc [(gainst)-545.7(cancer.)]TJ /F11 1 Tf 6.8276 0 TD 0.0409 Tc [(Va)-4.6(c)-5.3(c)2.8(i)-5(n)-3.1(es)-549.4(\(Ba)-4.6(s)1.3(e)-9.5(l)4.5(\))]TJ /F8 1 Tf 7.3135 0 TD 0.0399 Tc [(.)-543.9(\()-5.9(20)-7.5(21)-7.5(\))-548.5(9)0.6(:1)-7.5(41)-7.5(3.)-552(doi)-7.9(:)]TJ 0.15294 0.15294 0.15294 scn 10.0996 0 TD [(1)-7.5(0)0.6(.3)-7.5(39)-7.5(0/)]TJ -30.72 -1.142 TD 0 Tc (vaccines9121413)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD 0.014 Tc [(6)14(4)-8(.)-496.9(V)-1.7(e)14(r)-7.8(ma)14(e)-7.7(l)4.8(en)-506(K.)-513.1(V)14(a)-10.2(cci)14(ne)-509.5(str)14(a)-3(tegie)14(s)-518.1(to)-506.5(im)14(p)-6.6(r)14(o)-12.9(v)2.3(e)-509.5(a)14(nti-ca)14(ncer)-512.9(ce)14(l)-8.4(l)4.8(ula)14(r)-521.4(im)14(m)-6.1(u)-0.5(ne)]TJ -0.9314 -1.142 TD 0 Tc (responses.)Tj /F11 1 Tf 4.3735 0 TD [(Front)-301.5(Immunol)]TJ /F8 1 Tf 6.1553 0 TD [(.)-300.3(\(2019\))-297.6(10:8.)-305.7(doi:)]TJ 0.15294 0.15294 0.15294 scn 7.3945 0 TD (10.3389/)Tj /F9 1 Tf 3.4178 0 TD ()Tj /F8 1 Tf 0.5345 0 TD (mmu.2019.00008)Tj 0.13725 0.12157 0.12549 scn -20.9444 -1.5712 TD [(65.)-500.6(Chabeda)-415(A,)-423.3(Yanez)-416(RJR,)-426.9(Lamprecht)-417.2(R,)-423.4(Meyers)-417.7(AE,)-420.1(Rybicki)-420.9(EP,)-423.6(Hitzeroth)-417.3(II.)]TJ -0.9314 -1.142 TD [(Therapeutic)-217.5(vaccines)-215.2(for)-213.8(high-risk)-220(HPV-associated)-220.1(diseases.)]TJ /F11 1 Tf 23.9248 0 TD [(Papillomavirus)-214.5(Res)]TJ /F8 1 Tf 7.4836 0 TD [(.)-211.3(\(2018\))]TJ -31.4084 -1.1501 TD (5:46)Tj /F12 1 Tf 1.6603 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(58.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2721 0 TD (10.1016/j.pvr.2017.12.006)Tj 0.13725 0.12157 0.12549 scn -4.5112 -1.5712 TD [(66.)-500.6(Yang)-255.4(A,)-261.3(Jeang)-255.8(J,)-261.8(Cheng)-257.1(K,)-258(Cheng)-257.1(T,)-253.3(Yang)-263.5(B,)-251.9(Wu)-261.4(T-C,)-255.7(et)-262(al.)-253.2(Current)-263(state)-260.5(in)-251.9(the)]TJ -0.9314 -1.142 TD [(development)-486.1(of)-488.7(candidate)-484.1(therapeutic)-489(HPV)-483.7(vaccines.)]TJ /F11 1 Tf 22.7424 0 TD [(Expert)-485.3(Rev)-486.4(Vaccines)]TJ /F8 1 Tf 8.3907 0 TD [(.)-486.6(\(2016\))]TJ -31.1331 -1.142 TD (15:989)Tj /F12 1 Tf 2.616 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(1007.)-303.9(doi:)]TJ 0.15294 0.15294 0.15294 scn 4.2358 0 TD (10.1586/14760584.2016.1157477)Tj 0.13725 0.12157 0.12549 scn -6.4307 -1.5712 TD [(67.)-500.6(Castro-Eguiluz)-273.5(D,)-267.9(Barquet-Mu駉z)-277.3(SA,)-271.2(Arteaga-Go)]TJ /F15 1 Tf 21.981 0.0405 TD ()Tj /F8 1 Tf 0.081 -0.0405 TD [(mez)-275.5(AC,)-269.4(Salcedo)-273.2(Herna)]TJ /F15 1 Tf 9.5003 0.0405 TD ()Tj /F8 1 Tf 0.0486 -0.0405 TD (ndez)Tj -32.5423 -1.142 TD 0.0191 Tc [(RA)-6.6(,)-516.1(R)-6.7(odr)]TJ /F17 1 Tf 4.1792 0 TD 0 Tc ()Tj /F15 1 Tf 0.2916 0.0405 TD ()Tj /F8 1 Tf -0.0081 -0.0405 TD 0.0206 Tc [(gu)6.1(ez-Trejo)-524.2(A)3(,)-522.7(G)-0.3(allard)6.1(o-Rinco)]TJ /F15 1 Tf 12.8209 0.0405 TD 0 Tc ()Tj /F8 1 Tf 0.1053 -0.0405 TD 0.0205 Tc [(n)-523.8(D)4.4(,)-522.8(e)-0.9(t)-519.8(a)3.9(l.)-522.8(Therapeut)6.6(i)-3(c)-519.2(u)-2.1(se)-519.2(of)-514.6(human)]TJ -17.3888 -1.142 TD 0.0192 Tc [(p)4.7(a)-5.5(p)4.7(i)-4.3(llom)5.1(a)2.6(vi)3.8(ru)4.7(s)-515.8(v)-0.6(acc)5.9(i)-4.3(ne)5.9(s)-515.8(i)-4.3(n)-517(c)5.9(ervi)3.8(cal)-516.4(l)1.9(esi)3.8(o)0.9(ns.)]TJ /F11 1 Tf 19.3083 0 TD 0.0142 Tc [(Rev)-520.7(I)-9.2(nv)-10.5(est)-518(C)-8.7(li)-7.4(n)]TJ /F8 1 Tf 6.6899 0 TD 0.0154 Tc [(.)-519.8(\()-6.1(202)-7.7(0\))-516.3(7)-7.7(2)0.4(:2)-7.7(39)]TJ /F12 1 Tf 6.698 0 TD 0 Tc ()Tj /F8 1 Tf 0.5345 0 TD 0.0151 Tc (49.)Tj -33.2307 -1.142 TD 0 Tc (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.24875/RIC.20000059)Tj 0.13725 0.12157 0.12549 scn -0.8666 -1.5712 TD [(68)-13.9(.)-510.9(K)-14.3(im)-531.6(D,)-535.2(Ga)-21.3(mb)-16.3(h)-11.6(i)0(r)-23.9(a)-518.7(R)-9.6(,)-519(K)-14.3(a)0(r)-17(a)-16.6(n)-9.7(a)0(m)-532.8(B)0(,)-527.3(M)-14(o)-10.2(n)-9.7(ie)-530.8(A)-9.5(,)-519(H)-9.4(u)-14.5(n)-9.7(g)-522(C-)-18.6(F)-14.5(,)-519(R)-9.6(o)-10.2(d)-14.5(e)0(n)-525.2(R)-9.6(,)-527.1(e)0(t)-529.3(a)0(l)-17.6(.)]TJ -0.9314 -1.142 TD [(Generation)-334.1(and)-340.5(characterization)-339.7(of)-334.8(a)-332.4(preventive)-336(and)-332.4(therapeutic)-343.2(HPV)-329.8(DNA)-331.5(vaccine.)]TJ /F11 1 Tf T* (Vaccine)Tj /F8 1 Tf 3.102 0 TD [(.)-300.3(\(2008\))-305.7(26:351)]TJ /F12 1 Tf 6.042 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(60.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.1016/j.vaccine.2007.11.019)Tj 0.13725 0.12157 0.12549 scn -11.9948 -1.5712 TD [(69.)-500.6(Bonam)-447.7(SR,)-441.3(Partidos)-449.1(CD,)-446.1(Halmuthur)-444.6(SKM,)-452(Muller)-449.4(S.)-439.8(An)-448.5(overview)-444(of)-448.2(novel)]TJ -0.9314 -1.1501 TD [(adj)-16(uva)-10.5(nts)-518.1(des)-12.1(ign)-12.6(ed)-513.8(for)-513.4(imp)-11.7(ro)-10.7(vin)-12.6(g)-505.8(vacc)-14.4(ine)-516.2(ef)]TJ /F9 1 Tf 18.9196 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cac)-10.7(y.)]TJ /F11 1 Tf 2.4702 0 TD [(Tren)-20.3(ds)-511.5(Pha)-12.2(rma)-10.2(col)-513.6(Sc)-9.3(i)]TJ /F8 1 Tf 9.1682 0 TD [(.)-502.8(\()0(2)-12.2(017)-12.8(\))]TJ -31.0926 -1.142 TD (38:771)Tj /F12 1 Tf 2.616 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(93.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2721 0 TD (10.1016/j.tips.2017.06.002)Tj 0.13725 0.12157 0.12549 scn -5.4669 -1.5712 TD [(70.)-508.6(Zac)-11.9(ha)-12(ria)-510.3(A,)-512.4(Ha)-9.8(rber)-16.4(ts)-508.4(E,)-507.8(Va)-16.1(lenc)-13.1(ia)-509.8(SM,)-518.6(Myer)-15.2(s)-502.6(B)0(,)-511.1(S)-9.8(ande)-13.6(rs)-511.2(C,)-511(Ja)-10.4(in)-511.1(A,)-512.4(et)-513.1(al.)]TJ -0.9314 -1.142 TD [(Optimization)-401.5(of)-399.6(RG1-VLP)-404.3(vaccine)-401(performance)-406.3(in)-397.7(mice)-404.3(with)-392.5(novel)-402.5(TLR4)-402.4(agonists.)]TJ /F11 1 Tf T* (Vaccine)Tj /F8 1 Tf 3.102 0 TD [(.)-300.3(\(2021\))-305.7(39:292)]TJ /F12 1 Tf 6.042 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(302.)-296.9(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.758 0 TD (10.1016/j.vaccine.2020.11.066)Tj 0.13725 0.12157 0.12549 scn -12.4808 -1.5712 TD [(71.)-516.7(Ma)-14.4(yn)-13.4(ard)-525.6(SK,)-527(Mar)-14.9(sh)-12.1(al)-17.6(l)-511.3(J)0(D)-10(,)-510.9(Ma)-14.4(cG)-9.9(il)-16.5(l)-511.3(R)-9.6(S,)-512.7(Yu)-523.4(L,)-514.5(Ca)-16.6(nn)-521.6(JA)-11.5(,)-510.9(C)0(h)-11.7(e)0(n)-14.9(g)-513.9(LI)-10.7(,)-510.9(e)0(t)-521.2(a)0(l)-9.5(.)]TJ -0.9314 -1.142 TD [(Vaccination)-506.2(with)-497.8(synthetic)-500.2(long)-502.6(peptide)-504.4(formulated)-496.2(with)-505.9(CpG)-497.2(in)-494.9(an)-504.2(oil-in-water)]TJ T* [(emulsion)-224.7(induces)-218.9(robust)-228.1(E7-speci)]TJ /F9 1 Tf 13.2907 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(c)-215.7(CD8)-225.6(T)-220.2(cell)-215(responses)-225(and)-219(TC-1)-221.5(tumor)-223.4(eradication.)]TJ /F11 1 Tf -13.8252 -1.142 TD [(BMC)-301.1(Cancer)]TJ /F8 1 Tf 5.151 0 TD [(.)-300.3(\(2019\))-305.7(19:1)]TJ /F12 1 Tf 5.0863 0 TD ()Tj /F8 1 Tf 6.9999 0 0 6.9999 124.8378 94.3937 Tm [(12.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.1186/s12885-019-5725-y)Tj 0.13725 0.12157 0.12549 scn 23.3741 95.1405 TD [(72.)-500.6(Nakagawa)-303.1(T,)-293.8(Tanino)-298.1(T,)-293.8(Onishi)-301.8(M,)-290.1(Tofukuji)-306(S,)-294(Kanazawa)-301.3(T,)-293.8(Ishioka)-293.3(Y,)-299(et)-294.4(al.)-293.7(S-)]TJ -0.9233 -1.142 TD 0.0234 Tc [(5)8.4(40956,)-519.9(a)-519.6(C)-0.9(pG)-524(oligon)5.6(ucleotide)-516.3(a)-1.2(nn)5.6(e)-6.1(a)6.9(led)-525.7(t)1.4(o)-521.4(a)-519.6(compl)6.1(e)2.1(me)-6(n)5.6(t)1.4(ary)-522.9(s)6.7(trand)-517.6(w)3.9(ith)-522.8(a)-1.2(n)]TJ T* 0.0154 Tc [(amph)-4.3(iph)-4.3(i)0(lic)-524.3(c)2.1(h)-4.3(a)-1.2(in)-520.8(unit,)-519.8(a)-1.1(c)-6(t)1.5(s)-519.6(a)-1.2(s)-519.6(a)-519.5(potent)-524.9(cance)-6(r)-519.6(vac)-5.9(c)2.1(i)-8.1(n)5.7(e)-524.3(a)-1.2(djuv)-4.4(ant)-516.8(b)-2.9(y)-514.7(t)-6.6(arge)-5.9(ting)]TJ T* 0.0583 Tc [(dr)-7(ai)-5.7(ni)-5.7(ng)-560.9(l)-7.6(y)-2(mph)-568.9(n)0(odes.)]TJ /F11 1 Tf 11.3469 0 TD 0.0605 Tc [(Fro)-6(n)0.3(t)-560.8(I)4.7(mmuno)-6(l)]TJ /F8 1 Tf 7.1434 0 TD 0.0636 Tc [(.)-552.6(\()1.6(202)8.1(1\))-557.2(12)8.1(:8)8.1(030)8.1(9)-0.1(0.)-552.6(doi:)]TJ 0.15294 0.15294 0.15294 scn 12.1082 0 TD 0.0565 Tc [(10)-7.1(.3)-7.2(3)-7.1(8)1(9)-7.2(/)]TJ /F9 1 Tf -30.5985 -1.142 TD 0 Tc ()Tj /F8 1 Tf 0.5264 0 TD (mmu.2021.803090)Tj 0.13725 0.12157 0.12549 scn 0.3969 -1.5712 TD [(73.)-508.6(Gable)-13.5(h)-505.7(F)0(,)-509.3(Saei)-14.6(di)-507.8(M,)-508.8(Hemat)-10.6(i)-501.3(S)-9.9(,)-502.8(Hamd)-14.2(i)-501.3(K)0(,)-509.1(Sole)-10.2(iman)-15.3(jahi)-506.3(H)-9.4(,)-502.8(Gorji)-517.9(A,)-504.3(et)-505(al)-9.5(.)]TJ -0.9233 -1.142 TD 0.0161 Tc [(C)16.1(o)-10.4(mbination)-512(o)-2.2(f)-519(t)2.2(he)-515.5(t)-5.9(o)5.9(ll)-511.4(lik)-5.1(e)-515.5(rece)-5.3(ptor)-510.8(agon)6.4(ist)-516.1(a)-0.5(nd)]TJ /F14 1 Tf 22.5156 0 TD 0 Tc (a)Tj /F8 1 Tf 0.6398 0 TD 0.0158 Tc [(-Galactosylceramide)-515.8(a)-0.8(s)-519.2(a)-0.8(n)]TJ -23.1554 -1.1501 TD 0 Tc (ef)Tj /F9 1 Tf 0.6398 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cient)-486.7(adjuvant)-495.6(for)-489.1(cancer)-487.7(vaccine.)]TJ /F11 1 Tf 14.7566 0 TD [(J)-489.8(BioMed)-491.8(Sci)]TJ /F8 1 Tf 5.475 0 TD [(.)-486.6(\(2016\))-491.9(23:1)]TJ /F12 1 Tf 5.4507 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(11.)-492.4(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.6527 0 TD (10.1186/)Tj -31.0197 -1.142 TD (s12929)Tj /F12 1 Tf 2.7537 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (016-0238)Tj /F12 1 Tf 3.7094 0 TD ()Tj /F8 1 Tf 0.5103 0 TD (3)Tj 0.13725 0.12157 0.12549 scn -6.5603 -1.5712 TD [(74.)-500.6(Chandra)-239.7(J,)-229.4(Teoh)-231.1(SM,)-235.2(Kuo)-233.5(P,)-232.4(Tolley)-233.4(L,)-231(Bashaw)-235(AA,)-238.4(Tuong)-234.2(ZK,)-231.9(et)-229.6(al.)-237(Manganese-)]TJ -0.9233 -1.142 TD 0.0562 Tc [(do)5.5(p)-6.9(e)2.4(d)-557.7(s)-1(ilica-b)5.5(a)-0.8(sed)-557.7(n)-2.1(anoparticles)-559.8(promote)-556.4(t)1.8(he)-556.4(ef)]TJ /F9 1 Tf 22.8558 0 TD 0 Tc ()Tj /F8 1 Tf 0.5912 0 TD 0.0535 Tc [(cacy)-557.6(o)-5.3(f)-562.6(ant)-9(i)-2.4(ge)-8.4(n-)-5.6(spe)-8.4(c)-0.2(i)]TJ /F9 1 Tf 9.9862 0 TD 0 Tc ()Tj /F8 1 Tf 0.5831 0 TD (c)Tj -34.0164 -1.142 TD (immunotherapy.)Tj /F11 1 Tf 6.9977 0 TD [(J)-295.4(Immunol)]TJ /F8 1 Tf 4.2763 0 TD [(.)-300.4(\(2021\))-305.7(206:987)]TJ /F12 1 Tf 6.5198 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(98.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.4049/jimmunol.2000355)Tj 0.13725 0.12157 0.12549 scn -20.6528 -1.5712 TD [(75.)-500.6(Granadillo)-260.5(M,)-257.7(Batte)-252.1(A,)-261.3(Alfonso)-252.5(AB,)-261.5(Blanco)-253.5(A,)-253.2(Urquiza)-262.9(D,)-251.7(Varas)-260.4(L,)-255.3(et)-253.9(al.)-253.2(Impact)]TJ -0.9233 -1.142 TD [(on)-279.2(antitumor)-278.9(response)-289.3(using)-286.8(a)-275.7(new)-285.5(adjuvant)-285(preparation)-287.7(as)-276.2(a)-283.8(component)-287.3(of)-278.1(a)-283.8(human)]TJ T* [(papillomavirus)-454.6(type)-450.3(16)-451.3(therapeutic)-456.6(vaccine)-457.7(candidate.)]TJ /F11 1 Tf 22.8233 0 TD (Vaccine)Tj /F8 1 Tf 3.1101 0 TD [(.)-446.1(\(2019\))-459.5(37:3957)]TJ /F12 1 Tf 6.8195 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (60.)Tj -33.2631 -1.142 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1016/j.vaccine.2019.05.060)Tj 0.13725 0.12157 0.12549 scn -0.8747 -1.5712 TD [(76.)-500.6(Mo)-226.8(Y,)-226.1(Ma)-225(J,)-221.3(Zhang)-226.2(H,)-228.8(Shen)-222.7(J,)-221.3(Chen)-229.1(J,)-221.3(Hong)-227.5(J,)-229.4(et)-221.5(al.)-220.8(Prophylactic)-232.4(and)-227.1(therapeutic)]TJ -0.9233 -1.142 TD [(HPV)-354.1(vaccines:)-369.8(current)-357.2(scenario)-362.9(and)-364.8(perspectives.)]TJ /F11 1 Tf 20.4746 0 TD [(Front)-358.2(Cell)-356.7(Infect)-361.5(Microbiol)]TJ /F8 1 Tf 10.7799 0 TD [(.)-357(\(2022\))]TJ -31.2545 -1.1501 TD [(12:909223.)-300(doi:)]TJ 0.15294 0.15294 0.15294 scn 6.3659 0 TD (10.3389/fcimb.2022.909223)Tj 0.13725 0.12157 0.12549 scn -5.4426 -1.5712 TD [(77.)-500.6(Alvarez)-252.2(RD,)-245.2(Huh)-246.2(WK,)-253.8(Bae)-248.6(S,)-245.4(Lamb)-247(LS,)-249(Conner)-246(MG,)-246.2(Boyer)-254.6(J,)-245.6(et)-245.8(al.)-245.1(A)-252.5(pilot)-249.5(study)]TJ -0.9233 -1.142 TD [(of)-440.1(pNGVL4a-CRT/E7\(detox\))-459.7(for)-440.6(the)-451.8(treatment)-449.2(of)-440.1(patients)-454.1(with)-441.1(HPV16)-449(+)-448.5(cervical)]TJ T* [(intraepithelial)-228.8(neoplasia)-219.4(2/3)-226.5(\(CIN2/3\).)]TJ /F11 1 Tf 15.3641 0 TD [(Gynecol)-231.1(Oncol)]TJ /F8 1 Tf 5.6613 0 TD [(.)-227.5(\(2016\))-224.7(140:245)]TJ /F12 1 Tf 6.3659 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(52.)-217.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.1182 0 TD (10.1016/)Tj -31.0197 -1.142 TD (j.ygyno.2015.11.026)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(78.)-500.6(Chandra)-255.9(J,)-261.8(Woo)-251.2(W,)-255.7(Finlayson)-259.7(N,)-249.8(Liu)-260.3(H,)-253.1(McGrath)-252.8(M,)-257.7(Ladwa)-257.1(R,)-253.3(et)-253.9(al.)-253.2(A)-252.5(phase)-259(1,)]TJ -0.9233 -1.142 TD [(single)-408.1(centre,)-412.8(open)-412.3(label,)-407.4(escalating)-419.7(dose)-411.1(study)-411.6(to)-404.8(assess)-412.4(the)-411.3(safety,)-413.6(tolerability)-414.8(and)]TJ T* 0.0219 Tc [(i)6.5(m)-8.4(munogenicity)-524.4(of)-529.4(a)-521.1(t)-0.1(he)-7.6(r)5.2(a)-2.8(pe)-7.5(utic)-517.8(h)-5.9(u)-0.7(man)-522.4(p)-0.7(apillomav)-6.1(i)6.5(rus)-529.3(\()0.4(HP)-7.3(V\))-517.9(DNA)-522.2(v)-6.1(a)5.3(c)-7.5(cine)]TJ T* 0 Tc [(\(A)-14.8(MV)-21.7(00)-13.9(2)-15(\))-515.5(fo)-18.9(r)-518.8(H)-9.4(PV)-20.7(-)-10.5(a)0(s)-17(s)0(o)-18.8(c)0(i)-20.5(a)0(t)-14.2(e)-13.3(d)-516.7(h)-11.6(ea)-13.6(d)-516.7(a)-16.6(n)-9.7(d)-516.7(n)-9.7(e)0(c)-18.4(k)-515.3(c)-13.2(a)0(n)-18.2(c)-13.3(er)-524(\()-13.4(H)-9.4(NC)-14.3(\))-13.4(.)]TJ /F11 1 Tf 27.3751 0 TD [(Ca)-11.8(n)-11.7(c)-13.8(e)-10(r)-510.7(I)-15.3(m)0(m)-17.4(u)-11.6(no)-13.4(l)]TJ -27.3751 -1.142 TD (Immunother)Tj /F8 1 Tf 4.9972 0 TD [(.)-300.3(\(2021\))-297.6(70:743)]TJ /F12 1 Tf 6.0338 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(53.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1007/s00262)Tj /F12 1 Tf 6.1796 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (020-02720)Tj /F12 1 Tf 4.1873 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (7)Tj 0.13725 0.12157 0.12549 scn -25.2855 -1.5712 TD [(79.)-500.6(Hasan)-271.5(Y,)-266.6(Furtado)-271.1(L,)-271.5(Tergas)-262.8(A,)-269.4(Lee)-273.1(N,)-266(Brooks)-269.6(R,)-269.5(McCall)-264.7(A,)-269.4(et)-270.1(al.)-261.3(A)-268.7(phase)-275.2(1)-266.1(trial)]TJ -0.9233 -1.142 TD [(assessing)-303.5(the)-298(safety)-307.6(and)-300(tolerability)-309.5(of)-302.4(a)-300(therapeutic)-310.8(DNA)-299.1(vaccination)-307.8(against)-303(HPV16)]TJ 0 -1.1501 TD [(and)-381(HPV18)-376.1(E6/E7)-382.2(oncogenes)-383.6(after)-384.9(chemoradiation)-386(for)-375.8(cervical)-384.7(cancer.)]TJ /F11 1 Tf 29.5537 0 TD [(Int)-381(J)-376.4(Radiat)]TJ -29.5537 -1.142 TD [(Oncol)-298(Biol)-305.7(Phys)]TJ /F8 1 Tf 6.293 0 TD [(.)-300.3(\(2020\))-305.7(107:487)]TJ /F12 1 Tf 6.5198 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(98.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.1016/j.ijrobp.2020.02.031)Tj 0.13725 0.12157 0.12549 scn -15.6718 -1.5712 TD [(80.)-500.6(Hillemanns)-342(P,)-337.7(Denecke)-335.1(A,)-334.2(Woelber)-336(L,)-336.3(B鰄mer)-341.5(G,)-337.5(Jentschke)-333.7(M,)-338.7(Schjetne)-337.1(KW,)]TJ -0.9233 -1.142 TD [(et)-221.5(al.)-228.9(A)-228.2(therapeutic)-229.8(antigen-presenting)-235.8(cell-targeting)-226.9(DNA)-226.2(vaccine)-230.9(VB10.16)-230.7(in)-219.5(HPV16-)]TJ T* [(positive)-362.2(high-grade)-368.6(cervical)-368.5(intraepithelial)-374.6(neoplasia:)-373.9(results)-368.1(from)-365.6(a)-364.8(phase)-364.3(I/IIa)-372.1(trial.)]TJ /F11 1 Tf T* [(Clin)-295(Cancer)-306.8(Res)]TJ /F8 1 Tf 6.3659 0 TD [(.)-300.3(\(2022\))-305.7(28:4885)]TJ /F12 1 Tf 6.5198 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(92.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.1158/1078)Tj /F12 1 Tf 5.3373 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (0432.ccr-22)Tj /F12 1 Tf 4.6489 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (1927)Tj 0.13725 0.12157 0.12549 scn -26.7514 -1.5712 TD [(81.)-500.6(Choi)-450.4(YJ,)-454.9(Hur)-445.6(SY,)-454.6(Kim)-448.8(T-J,)-452(Hong)-454.3(SR,)-449.5(Lee)-451.2(JK,)-454.3(Cho)-451.2(C-H,)-449.9(et)-448.3(al.)-447.6(A)-455(Phase)-451.9(II,)]TJ -0.9233 -1.142 TD [(Prospective,)-395.7(randomized,)-406.4(multicenter,)-407.1(open-label)-400.2(study)-395.4(of)-399.6(GX-188E,)-401(an)-398.9(HPV)-402.7(DNA)]TJ T* [(vaccine,)-482.7(in)-478.7(patients)-486.5(with)-473.5(cervical)-490(intraepithelial)-479.9(neoplasia)-486.7(3A)-478.1(phase)-485.8(II)-476(study)-484.5(of)-480.6(a)]TJ T* [(th)-17.4(e)-13.3(r)0(a)-17(p)-14.5(eu)-19.7(ti)-21.1(c)-515.4(H)-17.5(PV)-530.9(DN)-14.2(A)-519.8(v)-11.7(a)-16.6(c)0(c)-18.4(i)0(n)-17(e)-523.5(in)-535.4(CI)-15.3(N)-524.5(3)0(.)]TJ /F11 1 Tf 18.7171 0 TD [(C)-14.8(l)-12.1(in)-527.3(Ca)-19.9(n)-11.6(c)0(e)-23.7(r)-518.8(Re)-16.3(s)]TJ /F8 1 Tf 6.9248 0 TD [(.)-519(\()-13.4(20)-22(20)-13.9(\))-523.6(2)0(6)-22(:)0(1)-15.7(6)-15.1(16)]TJ /F12 1 Tf 7.0786 0 TD ()Tj /F8 1 Tf 0.5183 0 TD [(23)-22(.)]TJ -33.2388 -1.1501 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1158/1078)Tj /F12 1 Tf 5.3292 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (0432.CCR-19)Tj /F12 1 Tf 6.9999 0 0 6.9999 395.9999 413.348 Tm ()Tj /F8 1 Tf 0.5103 0 TD (1513)Tj 0.13725 0.12157 0.12549 scn -12.6023 -1.5712 TD [(82.)-500.6(Trimble)-299.1(CL,)-287.8(Morrow)-289.9(MP,)-295(Kraynyak)-296.9(KA,)-291.8(Shen)-287.5(X,)-295.2(Dallas)-294.9(M,)-290.1(Yan)-292.2(J,)-286.1(et)-294.4(al.)-293.7(Safety,)]TJ -0.9233 -1.142 TD (ef)Tj /F9 1 Tf 0.6398 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cacy,)-476.7(and)-478.2(immunogenicity)-490.4(of)-472.5(VGX-3100,)-483.6(a)-478.2(therapeutic)-480.9(synthetic)-484(DNA)-477.3(vaccine)]TJ -1.1744 -1.142 TD 0.0311 Tc [(ta)6.4(rge)-6.4(t)1(i)7.6(n)-2.9(g)-531.4(h)3.3(uman)-529.4(papil)5.7(l)-2.4(oma)6.4(v)-4.9(ir)6.3(us)-536.3(1)8(6)-534.7(and)-534.2(1)-0.1(8)-526.6(E)1.9(6)-534.7(a)6.4(nd)-526.1(E)-6.2(7)-526.6(proteins)-528.2(for)-536.3(cervical)]TJ T* 0 Tc [(intraepithelial)-455.6(neoplasia)-462.3(2/3:)-453.9(a)-453.9(randomised,)-458.4(double-blind,)-466.3(placebo-controlled)-461.1(phase)]TJ T* [(2b)-292.6(trial.)]TJ /F11 1 Tf 3.4097 0 TD (Lancet)Tj /F8 1 Tf 2.6241 0 TD [(.)-300.3(\(2015\))-305.7(386:2078)]TJ /F12 1 Tf 6.9977 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(88.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.1016/S0140)Tj /F12 1 Tf 5.8071 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (6736\(15\)00239)Tj /F12 1 Tf 5.961 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (1)Tj 0.13725 0.12157 0.12549 scn -28.679 -1.5712 TD [(83.)-500.6(LARVOL.)-389(ISA201/ISA)-383.8(Pharma-LARVOL)-382.2(DELTA)-384(\(2022\).)-379.2(Available)-387.1(online)-383.4(at:)]TJ 0.85098 0.19216 0.2 scn -0.9233 -1.142 TD 0.073 Tc [(h)4.7(ttp)-6.3(s:/)6.2(/)-1.9(del)7.1(t)-5.7(a.l)7.1(a)-0.2(rvo)6.1(l)-1(.com/pro)]TJ 12.9667 0 TD 0.0718 Tc [(duc)-6.2(ts/?Produc)-6.2(tId=e78d6)-8(e)1.9(97-ee7)-8(5)]TJ /F12 1 Tf 15.5017 0 TD 0 Tc ()Tj /F8 1 Tf 0.5831 0 TD 0.0721 Tc (4a91)Tj /F12 1 Tf 2.1625 0 TD 0 Tc ()Tj /F8 1 Tf 0.5831 0 TD 0.0714 Tc (84dd-)Tj -31.7972 -1.142 TD 0.0554 Tc [(03489e467f9e&)-6(P)1.9(rod)-7.7(u)0.4(ctName)-6.4(=ISA201&Inst)]TJ 19.4865 0 TD 0.0561 Tc [(itut)-6.4(ions=+ISA+P)-5.5(h)4(arma&Index=0)]TJ 0.13725 0.12157 0.12549 scn -19.4865 -1.142 TD 0 Tc [(\(Accessed)-302(December)-304.6(7)-298.5(2023\).)]TJ 0.9233 -1.5712 TD [(84.)-500.6(Hatano)-246.5(T,)-253.3(Sano)-248.9(D,)-243.6(Takahashi)-249.4(H,)-245(Oridate)-250.3(N.)-249.8(Pathogenic)-250.3(role)-243.7(of)-245.7(immune)-251.3(evasion)]TJ -0.9233 -1.142 TD [(and)-372.9(integration)-381.4(of)-375.3(human)-374.4(papillomavirus)-389.8(in)-373.4(oropharyngeal)-379.5(cancer.)]TJ /F11 1 Tf 27.8772 0 TD (Microorganisms)Tj /F8 1 Tf 6.3416 0 TD (.)Tj -34.2188 -1.1501 TD [(\(2021\))-297.6(9:891.)-304.6(doi:)]TJ 0.15294 0.15294 0.15294 scn 7.354 0 TD (10.3390/microorganisms9050891)Tj 0.13725 0.12157 0.12549 scn -6.4307 -1.5712 TD [(85.)-500.6(Rosales)-400(R,)-399.1(Lo)]TJ /F15 1 Tf 7.2001 0.0486 TD ()Tj /F8 1 Tf 0.0891 -0.0486 TD [(pez-Contreras)-400.2(M,)-395.4(Rosales)-400(C,)-405.7(Magallanes-Molina)-397.4(J-R,)-403.4(Gonzalez-)]TJ -8.2125 -1.142 TD 0.039 Tc [(V)7.1(e)1.4(rgar)6.1(a)-536.4(R)-3(,)-536.7(A)5.2(rr)6.1(oyo-C)6.6(a)-1.8(zar)6.1(e)1.5(z)-541.2(J)4.6(M,)-536.7(et)-533.7(al)5.5(.)-536.7(R)-3(egres)6.1(s)-2(ion)-537.7(o)4.5(f)-536.6(h)3.1(uman)-529.6(papil)5.5(l)-2.6(oma)6.2(v)-5.1(i)7.4(r)-2(us)]TJ T* 0 Tc [(intraepithelial)-390.8(lesions)-398.9(is)-388.4(induced)-395(by)-394.6(MVA)-395.7(E2)-392.6(therapeutic)-391.8(vaccine.)]TJ /F11 1 Tf 27.5209 0 TD [(Hum)-386.9(Gene)-399.4(Ther)]TJ /F8 1 Tf 6.698 0 TD (.)Tj -34.2188 -1.142 TD [(\(2014\))-297.6(25:1035)]TJ /F12 1 Tf 5.9934 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(49.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1089/hum.2014.024)Tj 0.13725 0.12157 0.12549 scn -8.8605 -1.5712 TD [(86.)-500.6(Harper)-330.1(DM,)-330.5(Nieminen)-323.8(P,)-329.6(Donders)-332.2(G,)-321.3(Einstein)-333.9(MH,)-323.8(Garcia)-334.3(F,)-323(Huh)-327.2(WK,)-326.7(et)-326.8(al.)]TJ -0.9233 -1.142 TD [(The)-245.1(ef)]TJ /F9 1 Tf 2.454 0 TD ()Tj /F8 1 Tf 0.5264 0 TD [(cacy)-257.3(and)-251.4(safety)-250.9(of)-245.7(Tipapkinogen)-251.2(Sovacivec)-253.1(therapeutic)-254.1(HPV)-256.9(vaccine)-247.1(in)-251.9(cervical)]TJ -2.9805 -1.142 TD [(intraepithelial)-277.4(neoplasia)-284.2(grades)-275.8(2)-282.3(and)-275.7(3:)-274.9(Randomized)-285.3(controlled)-282.2(phase)-275.2(II)-273.5(trial)-282.2(with)-279.1(2.5)]TJ T* [(years)-277.4(of)-221.4(follow-up.)]TJ /F11 1 Tf 7.6942 0 TD [(Gynecol)-287.8(Oncol)]TJ /F8 1 Tf 5.718 0 TD [(.)-284.1(\(2019\))-281.4(153:521)]TJ /F12 1 Tf 6.4793 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(9.)-283(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.7618 0 TD (10.1016/j.ygyno.2019.03.250)Tj 0.13725 0.12157 0.12549 scn -22.2402 -1.5712 TD [(87.)-500.6(Komdeur)-267.9(FL,)-261.8(Singh)-269(A,)-261.3(van)-264.8(de)-262.7(Wall)-257.5(S,)-261.6(Meulenberg)-271.8(JJM,)-261.6(Boerma)-265.4(A,)-261.3(Hoogeboom)]TJ -0.9233 -1.142 TD [(BN,)-314.7(et)-310.6(al.)-318(First-in-human)-327.6(phase)-315.7(I)-314.9(clinical)-320.6(trial)-314.6(of)-318.6(an)-309.8(SFV-based)-324.4(RNA)-316.9(replicon)-321(cancer)]TJ 0 -1.1501 TD [(vaccine)-498.2(against)-497.4(HPV-induced)-500.4(cancers.)]TJ /F11 1 Tf 16.4736 0 TD [(Mol)-499.5(Ther)]TJ /F8 1 Tf 3.9443 0 TD [(.)-494.7(\(2021\))-500(29:611)]TJ /F12 1 Tf 6.4226 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(25.)-500.5(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.6689 0 TD (10.1016/)Tj -31.0197 -1.142 TD (j.ymthe.2020.11.002)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(88.)-500.6(Park)-261.9(Y-C,)-252.8(Ouh)-259.1(Y-T,)-262.4(Sung)-256.5(M-H,)-261.4(Park)-253.8(H-G,)-260.2(Kim)-262.5(T-J,)-257.6(Cho)-256.8(C-H,)-255.5(et)-262(al.)-253.2(A)-260.6(phase)-259(1/)]TJ -0.9233 -1.142 TD [(2a,)-259.1(dose-escalation,)-273.6(safety)-267.1(and)-259.5(preliminary)-266.7(ef)]TJ /F9 1 Tf 17.8505 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cacy)-265.4(study)-265.8(of)-261.9(oral)-263.3(therapeutic)-270.3(vaccine)-263.3(in)]TJ -18.385 -1.142 TD [(subjects)-399.3(with)-408.7(cervical)-400.9(intraepithelial)-415.1(neoplasia)-405.7(3.)]TJ /F11 1 Tf 20.3207 0 TD [(J)-400.7(Gynecol)-401.2(Oncol)]TJ /F8 1 Tf 6.5522 0 TD [(.)-405.6(\(2019\))-402.8(30\(6\):e88.)]TJ -26.8729 -1.142 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.3802/jgo.2019.30.e88)Tj 0.13725 0.12157 0.12549 scn -0.8747 -1.5712 TD [(89.)-500.6(Kawana)-255.3(K,)-249.9(Kobayashi)-253(O,)-249.8(Ikeda)-251(Y,)-250.4(Yahata)-252(H,)-245(Iwata)-251.9(T,)-253.3(Satoh)-248.5(T,)-253.3(et)-245.8(al.)-253.2(Phase)-249.4(I)-250.1(and)]TJ -0.9233 -1.142 TD 0.0315 Tc [(II)-526.4(ra)-9.3(n)5.6(d)-7.3(o)5.1(m)-6.9(ize)-6.1(d)-533.8(clinic)-6.1(al)-528.4(tri)-8.2(a)-1.3(l)-528.4(o)-3(f)-536(a)-1.2(n)-529(o)-3(ral)-528.4(t)-6.7(he)-6(rapeu)-7.3(t)1.4(ic)-532.5(vacc)-6.1(ine)-532.5(t)1.4(argeti)-8.2(n)5.6(g)-539.1(hu)-7.3(man)]TJ T* 0 Tc [(pa)-14.9(pi)-21.8(l)-9.2(l)-9.2(o)0(m)-16.3(a)0(v)-12.1(i)-15.4(ru)-15(s)-518.8(f)0(o)-18.9(r)-518.8(tr)-14.3(e)-13.3(a)0(t)-14.2(m)-14.1(en)-14.9(t)-516(o)-10.3(f)-518.9(c)-13.3(er)-13.7(v)-11.8(i)0(c)-20.5(a)0(l)-527.9(i)0(n)-17(t)0(r)-14.3(a)0(e)-21.7(p)0(i)-21.8(t)0(h)-17.4(e)0(l)-14.3(i)0(a)-15.7(l)-519.4(n)-9.7(e)-13.3(op)-16.7(l)-9.2(a)0(s)-17(i)0(a)-526(2)-517.2(an)-18.2(d)-516.7(3)-15.1(.)]TJ /F11 1 Tf 32.4451 0 TD [(JN)-19.6(CI)]TJ -32.4451 -1.142 TD [(Cancer)-298.7(Spectr)]TJ /F8 1 Tf 5.4507 0 TD [(.)-300.3(\(2023\))-305.7(7:pkad101.)-306.7(doi:)]TJ 0.15294 0.15294 0.15294 scn 9.8485 0 TD (10.1093/jncics/pkad101)Tj 0.13725 0.12157 0.12549 scn -14.376 -1.8628 TD [(90.)-500.6(Taghinezhad-S)-447.9(S,)-447.9(Mohseni)-447.4(AH,)-440.8(Keyvani)-449.2(H,)-439.4(Razavi)-447.6(MR.)-445.5(Phase)-443.8(1)-444.3(safety)-445.3(and)]TJ -0.9233 -1.142 TD 0.0468 Tc [(i)7.1(m)-7.8(munoge)-6.9(nicit)-7.6(y)-540(t)-7.6(r)5.8(ial)-545.5(o)-3.9(f)-545(r)-2.3(ecombinant)-542.1(l)]TJ 18.0449 0 TD 0.0512 Tc [(ac)5.6(t)4.9(o)0.5(c)5.5(o)8.6(cc)5.5(u)4.3(s)-540.5(lac)5.6(t)4.9(i)3.4(s)-540.5(ex)9(p)4.3(r)2.1(es)10.2(si)3.4(ng)-543.7(h)7.2(u)4.3(m)4.7(a)2.3(n)]TJ -18.0449 -1.142 TD 0 Tc [(papillomavirus)-357.4(type)-353.1(16)-354.1(E6)-360.2(oncoprotein)-356(vaccine.)]TJ /F11 1 Tf 19.8105 0 TD [(Mol)-353.7(Ther)-357.2(Methods)-358.9(Clin)-359.8(Dev)]TJ /F8 1 Tf 11.4522 0 TD [(.)-348.9(\(2019\))]TJ -31.2627 -1.142 TD (15:40)Tj /F12 1 Tf 2.1301 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(51.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1016/j.omtm.2019.08.005)Tj /F1 1 Tf 0.49804 0.49804 0.49412 scn -42.3909 100.656 TD [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.4323 0 TD (13)Tj ET endstream endobj 435 0 obj<>stream H塨d`ad`dd攑貅r鲵講L)1LM375O660蒊龕f!#V伙楙蟇#G vb`bd摊_ーd``"S驌R+婯Rs<髵髬 驄KRSsr23J俁婼嬍@偂z羫 @y% .┡z 破:f&z %〦 `゜厒约斕紅= 罝怌榯哮>Ql)击臇Iぞ縝O▽畫h(f?4≥S陊 籟K婳玕!;@€皊O< endstream endobj 436 0 obj<> endobj 437 0 obj<> endobj 438 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 439 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 440 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 441 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 442 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 443 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 444 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 445 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 446 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 447 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 448 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 449 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 450 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 451 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 452 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 453 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 454 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 455 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 456 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 457 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 458 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 459 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 460 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 461 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 462 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 463 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 464 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 465 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 466 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 467 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 468 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 469 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 470 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 471 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 472 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 473 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 474 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 475 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 476 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 477 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 478 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 479 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 480 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 481 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 482 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 483 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 484 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 485 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 486 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 487 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 488 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 489 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 490 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 491 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 492 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 493 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 494 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 495 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 496 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 497 0 obj<>stream /GS1 gs BT /F8 1 Tf 6.9999 0 0 6.9999 56.126 760.3652 Tm /Cs6 cs 0.13725 0.12157 0.12549 scn 0 Tc 0 Tw [(91.)-500.6(Schiller)-495.3(JT,)-506.3(M黮ler)-498(M.)-500.7(Next)-496.7(generation)-503.1(prophylactic)-501.1(human)-504(papillomavirus)]TJ -0.9314 -1.142 TD (vaccines.)Tj /F11 1 Tf 3.8309 0 TD [(Lancet)-300.9(Oncol)]TJ /F8 1 Tf 5.2401 0 TD [(.)-300.3(\(2015\))-297.6(16:e217)]TJ /F12 1 Tf 6.455 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(e25.)-295.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.6932 0 TD (10.1016/s1470)Tj /F12 1 Tf 5.6937 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (2045\(14\)71179)Tj /F12 1 Tf 5.961 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (9)Tj 0.13725 0.12157 0.12549 scn -31.4732 -1.5712 TD [(92.)-500.6(Shirbaghaee)-268.4(Z,)-274.3(Bolhassani)-268.6(A,)-269.4(Mirsha)]TJ /F9 1 Tf 16.4007 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(ey)-268(A,)-269.4(Motevalsli)-267.4(F,)-266.3(Zohrei)-276.1(N.)-266(A)-268.7(live)-268.2(vector)]TJ -17.8667 -1.142 TD [(expressing)-259.3(HPV16)-254.6(L1)-261.6(generates)-254.7(an)-261.2(adjuvant-induced)-261.2(antibody)-256.3(response)]TJ /F11 1 Tf 28.9301 0 TD (in-vivo)Tj /F8 1 Tf 2.7537 0 TD (.)Tj /F11 1 Tf 0.4697 0 TD [(Iran)-259.2(J)]TJ -32.1536 -1.142 TD [(Cancer)-298.7(Prev)]TJ /F8 1 Tf 4.8352 0 TD [(.)-300.3(\(2015\))-297.6(8\(6\):e3991.)-309.9(doi:)]TJ 0.15294 0.15294 0.15294 scn 9.9376 0 TD (10.17795/ijcp-3991)Tj 0.13725 0.12157 0.12549 scn -13.8414 -1.5712 TD [(93.)-500.6(Chan)-208.1(PK,)-206.3(Liu)-211.7(SJ,)-206.9(Cheung)-214.9(JL,)-208.7(Cheung)-214.9(T,)-204.7(Yeo)-208.4(W,)-215.2(Chong)-205.5(P,)-208.1(et)-213.4(al.)-204.6(T-cell)-210.8(response)-216.4(to)]TJ -0.9314 -1.142 TD [(human)-471.6(papillomavirus)-470.8(type)-466.5(52)-459.4(L1,)-464.7(E6,)-466.1(and)-470.1(E7)-465.5(peptides)-472.5(in)-462.5(women)-463.8(with)-465.4(transient)]TJ T* [(infection,)-377.6(cervical)-376.6(intraepithelial)-382.7(neoplasia,)-382(and)-372.9(invasive)-377.8(cancer.)]TJ /F11 1 Tf 26.4032 0 TD [(J)-376.4(Med)-368.2(Virol)]TJ /F8 1 Tf 4.8433 0 TD [(.)-373.2(\(2011\))]TJ -31.2465 -1.1501 TD (83:1023)Tj /F12 1 Tf 3.0939 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(30.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2802 0 TD (10.1002/jmv.21889)Tj 0.13725 0.12157 0.12549 scn -5.9529 -1.5712 TD [(94.)-500.6(謍lschl鋑er)-338.5(P,)-337.7(Osen)-345.5(W,)-336.7(Dell)-339.3(K,)-339(Faath)-340.5(S,)-342.6(Garcea)-340.2(RL,)-337.8(Jochmus)-341.7(I,)-339.9(et)-334.9(al.)-342.3(Human)]TJ -0.9314 -1.142 TD [(papillomavirus)-252.1(type)-247.8(16)-248.8(L1)-245.4(capsomeres)-250.6(induce)-250.9(L1-speci)]TJ /F9 1 Tf 21.7381 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(c)-240(cytotoxic)-249.5(T)-252.6(lymphocytes)-245.7(and)]TJ -22.2726 -1.142 TD 0.0225 Tc [(tumor)-520.6(r)-2.3(egression)-513.7(i)-1(n)-521.8(C)-1.8(57)7.5(BL/6)-519(mice.)]TJ /F11 1 Tf 16.2388 0 TD 0.5465 Tc [(JV)524.1(i)524.9(r)529.8(o)520.5(l)]TJ /F8 1 Tf 2.9724 0 TD 0.0231 Tc [(.)-520.2(\()1.6(2003)8.1(\))-524.8(7)0(7)8.1(:)-1.9(4635)]TJ /F12 1 Tf 7.2568 0 TD 0 Tc ()Tj /F8 1 Tf 0.5345 0 TD 0.0225 Tc [(45.)-520.8(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.8714 0 TD 0.0234 Tc [(10)8.4(.1128)8.4(/)]TJ -30.8739 -1.142 TD 0 Tc (jvi.77.8.4635)Tj /F12 1 Tf 4.981 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (4645.2003)Tj 0.13725 0.12157 0.12549 scn -4.5598 -1.5712 TD 0.4945 Tc [(9)494.5(5)494.5(.)-6.1(B)478.2(h)466.7(a)477.9(t)472.5(tK)472.1(H)468.9(,)-0.2(N)472.2(e)473.1(l)477.2(l)469.1(e)473.1(r)0(M)472.4(A)476.9(,S)468.5(r)477.8(i)471(h)474.8(a)469.8(r)469.7(i)1.3(S)476.6(,)-0.2(C)470.2(r)477.8(o)468.1(o)476.2(k)473.3(s)0(P)473.4(,)-0.2(L)474.8(e)473.1(k)473.3(i)471(e)473.1(f)534.4(f)469.6(r)477.8(eL)474.8(,A)476.9(f)469.6(t)472.5(a)478(b)-1.7(B)470.1(T)476.8(,e)473.1(ta)469.9(l)477.2(.)]TJ -0.9314 -1.142 TD 0.023 Tc (Pro)Tj /F9 1 Tf 1.4902 0 TD 0 Tc ()Tj /F8 1 Tf 0.5507 0 TD 0.0249 Tc [(lin)7.1(g)-432.3(H)7.4(P)3.8(V-1)9.9(6)]TJ /F12 1 Tf 5.4912 0 TD 0 Tc ()Tj /F8 1 Tf 0.5345 0 TD 0.0223 Tc (speci)Tj /F9 1 Tf 2.0896 0 TD 0 Tc ()Tj /F8 1 Tf 0.5507 0 TD 0.0222 Tc [(c)-428.4(T)-432.9(cell)-432.4(r)5.5(esponses)-431.8(re)-7.3(veals)-431.8(b)3.9(road)-429.7(anti)6.8(g)-5.7(e)0.8(n)-433(r)5.5(eactivities)-431.8(i)-1.3(n)]TJ -10.7071 -1.142 TD 0.0216 Tc [(oroph)-6.2(a)5(ryngeal)-230.5(c)0.2(ancer)-238(patients.)]TJ /F11 1 Tf 13.0315 0 TD 0.2549 Tc [(JE)231.9(x)228.9(p)5(M)230.9(e)236.8(d)]TJ /F8 1 Tf 4.2035 0 TD 0.0228 Tc [(.)-228.9(\()1.3(202)7.8(0\))-233.5(217)7.8(\()-6.8(1)7.8(0\):e202)7.8(00389)7.8(.)-237(d)0.2(oi:)]TJ 0.15294 0.15294 0.15294 scn 13.6389 0 TD 0.0231 Tc [(10.)6.2(1084/)]TJ -30.8739 -1.142 TD [(jem.)6.1(2020)8(0389)]TJ 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD 0 Tc [(96.)-500.6(Boilesen)-282.3(DR,)-285.6(Nielsen)-286.1(KN,)-280.3(Holst)-286.2(PJ.)-283(Novel)-277.4(antigenic)-289.1(targets)-280.9(of)-286.2(HPV)-281.2(therapeutic)]TJ -0.9314 -1.142 TD (vaccines.)Tj /F11 1 Tf 3.8309 0 TD [(Vaccines)-307.9(\(Basel\))]TJ /F8 1 Tf 6.4226 0 TD [(.)-300.3(\(2021\))-305.7(9:1262.)-303.4(doi:)]TJ 0.15294 0.15294 0.15294 scn 8.3583 0 TD (10.3390/vaccines9111262)Tj 0.13725 0.12157 0.12549 scn -17.6804 -1.5712 TD [(97.)-500.6(Carre駉)-293.8(JM,)-300.1(Alshammary)-298.9(H,)-293.6(Tcheou)-299.4(J,)-294.2(Singh)-293.3(G,)-297(Raskin)-299.8(AJ,)-295.7(Kawabata)-294.4(H,)-301.7(et)-294.4(al.)]TJ -0.9314 -1.1501 TD [(Activity)-396.4(of)-399.6(convalescent)-402(and)-405.3(vaccine)-401(serum)-399.2(against)-400.2(SARS-CoV-2)-400.6(Omicron.)]TJ /F11 1 Tf 31.4408 0 TD (Nature)Tj /F8 1 Tf 2.778 0 TD (.)Tj -34.2188 -1.142 TD [(\(2022\))-305.7(602:682)]TJ /F12 1 Tf 6.0015 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(8.)-299.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.7942 0 TD (10.1038/s41586)Tj /F12 1 Tf 6.1796 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (022-04399)Tj /F12 1 Tf 4.1873 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (5)Tj 0.13725 0.12157 0.12549 scn -19.7619 -1.5712 TD [(98.)-500.6(Kianmehr)-330.4(Z,)-322.9(Soleimanjahi)-329.4(H,)-334.1(Ardestani)-328.8(SK,)-324.6(Fotouhi)-333.5(F,)-323(Abdoli)-328.4(A.)-326.1(In)]TJ /F9 1 Tf 29.5456 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(uence)-331.4(of)]TJ -31.0116 -1.142 TD [(Brucella)-262.9(abortus)-252.7(lipopolysaccharide)-267.3(as)-251.9(an)-261.2(adjuvant)-260.7(on)-254.9(the)-257.5(immunogenicity)-263.7(of)-253.8(HPV-16)]TJ T* [(L1VLP)-399.2(vaccine)-409.1(in)-397.7(mice.)]TJ /F11 1 Tf 10.2778 0 TD [(Med)-400.6(Microbiol)-403.7(Immunol)]TJ /F8 1 Tf 10.0429 0 TD [(.)-405.6(\(2015\))-394.7(204:205)]TJ /F12 1 Tf 6.7142 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(13.)-403.4(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.4826 0 TD (10.1007/)Tj -31.0278 -1.142 TD (s00430-014-0356-z)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(99.)-500.6(Valencia)-417.5(SM,)-421.4(Zacharia)-428.9(A,)-415.2(Marin)-420.6(A,)-423.3(Matthews)-419.1(RL,)-418.8(Wu)-423.4(C-K,)-414.3(Myers)-420.7(B,)-422(et)-424(al.)]TJ -0.9314 -1.142 TD [(Improvement)-389.9(of)-391.5(RG1-VLP)-388.1(vaccine)-392.9(performance)-390.1(in)-389.6(BALB/c)-393.1(mice)-388.1(by)-386.5(substitution)-391.9(of)]TJ T* [(alhydrogel)-319.2(with)-311.5(the)-314.2(next)-314(generation)-316.8(polyphosphazene)-320.8(adjuvant)-317.4(PCEP.)]TJ /F11 1 Tf 28.6385 0 TD [(Hum)-314(Vaccines)]TJ -28.6385 -1.142 TD (Immunother)Tj /F8 1 Tf 4.9972 0 TD [(.)-300.3(\(2021\))-305.7(17:2748)]TJ /F12 1 Tf 6.5198 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(61.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1080/21645515.2021.1875763)Tj 0.13725 0.12157 0.12549 scn -14.376 -1.5712 TD [(100.)-499.4(Han)-286.8(JE,)-291.1(Wui)-293(SR,)-295.6(Park)-286.2(SA,)-295.5(Lee)-289.3(NG,)-295(Kim)-286.8(KS,)-292.2(Cho)-289.2(YJ,)-292.9(et)-286.3(al.)-293.7(Comparison)-294.4(of)-286.2(the)]TJ -0.9314 -1.1501 TD [(immune)-364.7(responses)-362.6(to)-356.2(the)-362.8(CIA06-adjuvanted)-362.1(human)-358.2(papillomavirus)-365.5(L1)-358.8(VLP)-364.4(vaccine)]TJ 0 -1.142 TD [(with)-473.5(those)-470.7(against)-465(the)-476.1(licensed)-469.8(HPV)-467.5(vaccine)-473.9(Cervarix)]TJ /F16 1 Tf 6.5001 0 0 6.5001 209.1968 478.8849 Tm ()Tj /F8 1 Tf 6.9999 0 0 6.9999 218.8913 477.3542 Tm [(in)-470.6(mice.)]TJ /F11 1 Tf 3.8633 0 TD (Vaccine)Tj /F8 1 Tf 3.102 0 TD [(.)-470.4(\(2012\))]TJ -31.1493 -1.142 TD (30:4127)Tj /F12 1 Tf 3.0939 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(34.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2802 0 TD (10.1016/j.vaccine.2012.04.079)Tj 0.13725 0.12157 0.12549 scn -5.9529 -1.5712 TD [(101.)-499.4(Ebensen)-215.6(T,)-220.9(Delandre)-222.8(S,)-213(Prochnow)-217.8(B,)-219.5(Guzma)]TJ /F15 1 Tf 19.7295 0.0405 TD ()Tj /F8 1 Tf 0.0567 -0.0405 TD [(n)-212.2(CA,)-220.9(Schulze)-222.7(K.)-217.5(The)-212.7(combination)]TJ -20.7176 -1.142 TD 0.0148 Tc [(vac)-6.6(c)1.5(ine)-508.7(a)-1.8(djuv)-5.1(a)14.8(n)-11.5(t)-517.4(s)-1.9(ystem)-517.7(a)-1.8(lum/c-d)-7.8(i)-0.6(-AMP)-516.6(re)]TJ 18.8953 0 TD 0.0159 Tc [(sults)-511(i)0.5(n)-512.2(q)-0.5(uantitative)-507.6(a)-0.7(nd)-517(qual)6.7(itative)]TJ -18.8953 -1.142 TD 0 Tc [(enhanced)-369.4(immune)-372.8(responses)-370.7(post)-371.2(immunization.)]TJ /F11 1 Tf 20.4422 0 TD [(Front)-374.4(Cell)-364.8(Infect)-369.6(Microbiol)]TJ /F8 1 Tf 10.8123 0 TD [(.)-365.1(\(2019\))]TJ -31.2545 -1.142 TD [(9:31.)-305.7(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.9767 0 TD (10.3389/fcimb.2019.00031)Tj 0.13725 0.12157 0.12549 scn -3.0453 -1.5712 TD [(102.)-499.4(Song)-446.6(Y-C,)-447.2(Huang)-450.8(H-C,)-441.8(Chang)-454.7(CY-Y,)-445.9(Lee)-443.1(H-J,)-451.8(Liu)-446.5(C-T,)-450.1(Lo)-443.1(H-Y,)-448.5(et)-448.3(al.)-447.6(A)]TJ -0.9314 -1.142 TD [(potential)-359.7(herbal)-361.1(adjuvant)-357.9(combined)-360(with)-360.1(a)-356.7(peptide-based)-359.4(vaccine)-360.5(acts)-360(against)-359.7(HPV-)]TJ T* [(related)-445.6(tumors)-442.5(through)-446.8(enhancing)-443.2(ef)59.1(fector)-440.5(and)-445.8(memory)-444.7(T-cell)-445.7(immune)-445.7(responses.)]TJ /F11 1 Tf T* [(Front)-301.5(Immunol)]TJ /F8 1 Tf 6.1553 0 TD [(.)-300.3(\(2020\))-297.6(11:62.)-304.6(doi:)]TJ 0.15294 0.15294 0.15294 scn 7.8724 0 TD (10.3389/)Tj /F9 1 Tf 3.4178 0 TD ()Tj /F8 1 Tf 0.5345 0 TD (mmu.2020.00062)Tj 0.13725 0.12157 0.12549 scn -17.0487 -1.5712 TD [(103.)-499.4(Wang)-438.9(X,)-449.1(Che)-438(Y,)-444.8(Chen)-439.7(B,)-446.3(Zhang)-436.7(Y,)-444.8(Nakagawa)-440.8(M,)-444(Wang)-447(X.)-441(evalsuation)-446.8(of)]TJ -0.9314 -1.1501 TD [(immune)-218.9(responses)-225(induced)-224.9(by)-224.5(a)-219(novel)-216.2(human)-228.6(papillomavirus)-219.7(type)-223.5(16)-216.4(E7)-222.5(peptide-based)]TJ 0 -1.142 TD 0.0221 Tc [(vacci)6.7(ne)-517.6(with)-516(C)5.9(a)-2.5(ndida)-520.9(s)5.4(kin)-514.1(t)0.1(est)-518.2(r)5.4(eagent)-518.2(as)-521(an)-522.2(ad)7.6(juvant)-518.2(i)6.7(n)-522.2(C5)7.1(7BL/6)-519.4(m)-0.1(ice)8.8(.)]TJ /F11 1 Tf 33.2307 0 TD 0.0216 Tc (Int)Tj -33.2307 -1.142 TD 0 Tc (Immunopharmacol)Tj /F8 1 Tf 7.6213 0 TD [(.)-308.4(\(2018\))-297.6(56:249)]TJ /F12 1 Tf 6.042 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(60.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2802 0 TD (10.1016/j.intimp.2018.01.037)Tj 0.13725 0.12157 0.12549 scn -16.5222 -1.5712 TD [(104.)-499.4(Liu)-454.6(C,)-454.3(Chu)-455.5(X,)-457.2(Sun)-455.3(P,)-451.1(Feng)-462.4(X,)-457.2(Huang)-450.8(W,)-458.2(Liu)-454.6(H,)-455.6(et)-456.4(al.)-455.7(Synergy)-457.4(ef)67.2(fects)-462.6(of)]TJ -0.9314 -1.142 TD [(Polyinosinic-polycytidylic)-421.9(acid,)-416.8(CpG)-416.2(oligodeoxynucleotide,)-422.8(and)-421.5(cationic)-415.5(peptides)-415.8(to)]TJ T* [(adjuvant)-220.2(HPV)-224.5(E7)-222.5(epitope)-224.7(vaccine)-222.8(through)-220(preventive)-230.7(and)-219(therapeutic)-229.8(immunization)-219.1(in)]TJ T* 0.0376 Tc [(a)-537.8(T)3.7(C)5.2(-)2.8(1)-536.3(g)1.6(rafted)-535.8(m)7.3(o)-5(u)6.9(s)-3.4(e)-534.5(m)7.3(od)6.9(el.)]TJ /F11 1 Tf 14.1654 0 TD 0.0367 Tc [(Hum)-534.9(V)6.2(acci)7(n)-533.8(I)-2.9(mmunoth)4.1(er)]TJ /F8 1 Tf 11.5089 0 TD 0.0393 Tc [(.)-528.3(\()1.6(20)8.1(18)8.1(\))-532.9(14:)6.2(93)8.1(1)]TJ /F12 1 Tf 6.9734 0 TD 0 Tc ()Tj /F8 1 Tf 0.5426 0 TD 0.0393 Tc [(40)8.1(.)]TJ -33.1902 -1.142 TD 0 Tc (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1080/21645515.2017.1420446)Tj 0.13725 0.12157 0.12549 scn -0.8666 -1.5712 TD [(105.)-499.4(Naziri)-213(H,)-204.5(Tahamtan)-214(A,)-212.7(Dadmanesh)-210.3(M,)-209.1(Barati)-216.9(M,)-209.1(Ghorban)-209.5(K.)-209.4(Antitumor)-215.2(ef)67.2(fects)]TJ -0.9314 -1.142 TD [(of)-383.4(HPV)-386.5(DNA)-388.2(vaccine)-384.8(adjuvanted)-393.8(with)-384.4(beclin-1)-388.2(as)-381.5(an)-382.7(autophagy)-388.8(inducer)-389(in)-389.6(a)-381(mice)]TJ 0 -1.1501 TD (model.)Tj /F11 1 Tf 3.021 0 TD [(Iran)-299.7(BioMed)-305.5(J)]TJ /F8 1 Tf 5.7099 0 TD [(.)-300.3(\(2019\))-305.7(23:388.)-303.4(doi:)]TJ 0.15294 0.15294 0.15294 scn 8.3583 0 TD (10.29252/ibj.23.6.388)Tj 0.13725 0.12157 0.12549 scn -16.1578 -1.5712 TD [(106.)-499.4(Tse)-460.7(S-W,)-454.2(McKinney)-466(K,)-452.4(Walker)-461.5(W,)-458.2(Nguyen)-464.1(M,)-460.2(Iacovelli)-454.3(J,)-464.3(Small)-455.8(C,)-454.3(et)-464.5(al.)]TJ -0.9314 -1.142 TD [(mRNA-encoded,)-390.6(constitutively)-385.3(active)-383.8(STINGV155M)-387.9(is)-380.3(a)-381(potent)-383.4(genetic)-382.1(adjuvant)-390.3(of)]TJ T* (antigen-speci)Tj /F9 1 Tf 5.2887 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(c)-418.2(CD8+)-414.9(T)-414.6(cell)-409.3(response.)]TJ /F11 1 Tf 10.5775 0 TD [(Mol)-418.5(Ther)]TJ /F8 1 Tf 3.8633 0 TD [(.)-413.7(\(2021\))-419(29:2227)]TJ /F12 1 Tf 6.7466 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(38.)-411.5(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.5069 0 TD (10.1016/)Tj -31.0278 -1.142 TD (j.ymthe.2021.03.002)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(107.)-499.4(Tahamtan)-335.5(A,)-334.2(Ghaemi)-326.8(A,)-334.2(Gorji)-331.6(A,)-334.2(Kalhor)-337.8(HR,)-327.5(Sajadian)-335.2(A,)-334.2(Tabarraei)-334.1(A,)-334.2(et)-334.9(al.)]TJ -0.9314 -1.142 TD [(Antitumor)-271.9(ef)59.1(fect)-267.8(of)-270(therapeutic)-278.4(HPV)-265(DNA)-274.8(vaccines)-271.9(with)-271(chitosan-based)-278.3(nanodelivery)]TJ T* (systems.)Tj /F11 1 Tf 3.6041 0 TD [(J)-295.4(BioMed)-305.5(Sci)]TJ /F8 1 Tf 5.0944 0 TD [(.)-300.3(\(2014\))-305.7(21:69.)-304.6(doi:)]TJ 0.15294 0.15294 0.15294 scn 7.8805 0 TD (10.1186/s12929)Tj /F12 1 Tf 6.1796 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (014-0069-z178)Tj 0.13725 0.12157 0.12549 scn -22.3374 -1.5712 TD [(108.)-499.4(Bi)-323.3(Z,)-322.9(Hong)-324.7(W,)-328.6(Que)-325.5(H,)-317.9(He)-330.5(C,)-324.7(Ren)-324.2(W,)-320.5(Yang)-328.3(J,)-318.5(et)-326.8(al.)-326.1(Inactivated)-324.2(SARS-CoV-2)]TJ -0.9314 -1.142 TD [(induces)-340.4(acute)-330.7(respiratory)-340.5(distress)-334.3(syndrome)-341.9(in)-332.9(human)-333.9(ACE2-transgenic)-339(mice.)]TJ /F11 1 Tf 32.0321 0 TD (Signal)Tj -32.0321 -1.142 TD [(Transduct)-298.9(Target)-308.2(Ther)]TJ /F8 1 Tf 9.0467 0 TD [(.)-300.3(\(2021\))-305.7(6:439.)-304.6(doi:)]TJ 0.15294 0.15294 0.15294 scn 7.8805 0 TD (10.1038/s41392)Tj /F12 1 Tf 6.1715 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (021-00851)Tj /F12 1 Tf 4.1953 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (6)Tj 0.13725 0.12157 0.12549 scn -27.3832 -1.5712 TD [(109.)-499.4(Dillon)-450.5(S,)-447.9(Sasagawa)-448.1(T,)-455.8(Crawford)-451.2(A,)-447.6(Prestidge)-452.5(J,)-448.1(Inder)-450.2(MK,)-450.2(Jerram)-451.8(J,)-456.2(et)-448.3(al.)]TJ -0.9314 -1.142 TD [(Resolution)-454.9(of)-456.3(cervical)-457.6(dysplasia)-455.9(is)-453.2(associated)-454.8(with)-457.3(T-cell)-453.8(proliferative)-459(responses)-451.7(to)]TJ 0 -1.1501 TD [(hu)-10(man)-510.2(pap)-13.3(ill)-9.4(oma)-16.6(vir)-11.4(us)-509.1(ty)-9.4(pe)-505.7(16)-516.1(E2.)]TJ /F11 1 Tf 15.3317 0 TD [(J)-506(Gen)-510.9(Vi)-11.6(rol)]TJ /F8 1 Tf 4.9567 0 TD [(.)-510.9(\(20)-11.1(07\))-513.2(88:)-14.6(803)]TJ /F12 1 Tf 6.4874 0 TD ()Tj /F8 1 Tf 0.5183 0 TD [(13.)-516.8(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.7094 0 TD [(10.1)-13.5(099/)]TJ -31.0035 -1.142 TD (vir.0.82678)Tj /F12 1 Tf 4.3978 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (0)Tj 0.13725 0.12157 0.12549 scn -3.9767 -1.5712 TD [(110.)-499.4(Bergvall)-469.2(M,)-468.3(Melendy)-466.5(T,)-463.9(Archambault)-470.2(J.)-472.4(The)-463.8(E1)-465.5(proteins.)]TJ /F11 1 Tf 26.8891 0 TD (Virology)Tj /F8 1 Tf 3.3287 0 TD [(.)-470.4(\(2013\))]TJ -31.1493 -1.142 TD (445:35)Tj /F12 1 Tf 2.616 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(56.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2721 0 TD (10.1016/j.virol.2013.07.020)Tj 0.13725 0.12157 0.12549 scn -5.4669 -1.5712 TD [(111.)-499.4(Mirabello)-276.8(L,)-279.6(Schif)54.6(fman)-275.9(M,)-282(Ghosh)-273.7(A,)-277.5(Rodriguez)-281.3(AC,)-285.6(Vasiljevic)-282.2(N,)-274.1(Wentzensen)]TJ -0.9314 -1.142 TD [(N,)-322.7(et)-318.7(al.)-318(Elevated)-324.2(methylation)-317.9(of)-318.6(HPV16)-319.4(DNA)-323.4(is)-315.5(associated)-325.2(with)-319.6(the)-322.3(development)-324.2(of)]TJ T* 0.0143 Tc [(high)-515.7(g)-5.5(r)14.3(a)-10.8(d)-0.2(e)-517.3(cervical)-513.2(i)-1.1(ntraepithelia)14.3(l)-521.7(neoplasia)14.3(.)]TJ /F11 1 Tf 19.6566 0 TD 0 Tc [(In)-26.9(t)-524.1(J)-530.3(C)-14.8(a)-13.1(n)-11.6(c)-13.8(e)-18.1(r)]TJ /F8 1 Tf 5.4264 0 TD 0.015 Tc [(.)-512.1(\()1.6(2013)15(\))-523.7(132:)15(1)-8.8(412)]TJ /F12 1 Tf 7.6294 0 TD 0 Tc ()Tj /F8 1 Tf 0.5264 0 TD 0.015 Tc [(22)15(.)]TJ -33.2388 -1.142 TD 0 Tc (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1002/ijc.27750)Tj 0.13725 0.12157 0.12549 scn -0.8666 -1.5712 TD [(112.)-499.4(Malcles)-318.9(M-H,)-318.1(Cueille)-317.8(N,)-314.6(Mechali)-320.1(F,)-314.9(Coux)-318.2(O,)-314.6(Bonne-Andrea)-328.4(C.)-316.6(Regulation)-318.6(of)]TJ -0.9314 -1.142 TD [(bovine)-313.6(papillomavirus)-316.9(replicative)-315.1(helicase)-311.7(E1)-311.6(by)-313.6(the)-314.2(ubiquitin-proteasome)-316.1(pathway.)]TJ /F11 1 Tf 6.9999 0 0 6.9999 288.5102 97.3984 Tm (J)Tj -34.1297 -1.142 TD (Virol)Tj /F8 1 Tf 2.0086 0 TD [(.)-300.3(\(2002\))-305.7(76:11350)]TJ /F12 1 Tf 6.9977 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(8.)-299.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.8023 0 TD (10.1128/jvi.76.22.11350)Tj /F12 1 Tf 9.3545 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (11358.2002)Tj 0.13725 0.12157 0.12549 scn 15.2102 95.8532 TD 0.0483 Tc [(11)9(3.)-495(M)10(ech)4.3(a)7.5(l)6.7(i)-542.1(F)1.4(,)-535.5(H)6.5(su)-533.2(C-)5.4(Y)9.2(,)-543.6(C)7.8(a)7.4(st)10.1(ro)-537(A)6.4(,)-535.5(L)4.3(o)5.7(rc)10.7(a)-543.3(T)6.3(,)-535.5(B)-0.4(o)5.7(n)6.2(n)6.2(e)2.6(-)5.4(A)6.4(nd)9.5(re)10.8(a)-543.3(C)7.8(.)-535.5(B)-0.4(o)5.7(v)4.1(i)8.6(n)-1.9(e)]TJ -0.9233 -1.142 TD 0 Tc [(papillomavirus)-333.1(replicative)-339.4(helicase)-336(E1)-335.9(is)-331.7(a)-332.4(target)-337.1(of)-334.8(the)-330.4(ubiquitin)-336.2(ligase)-342(APC.)]TJ /F11 1 Tf 31.5623 0 TD [(J)-335.9(Virol)]TJ /F8 1 Tf 2.6565 0 TD (.)Tj -34.2188 -1.142 TD [(\(2004\))-297.6(78:2615)]TJ /F12 1 Tf 5.9934 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(9.)-299.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.8023 0 TD (10.1128/jvi.78.5.2615)Tj /F12 1 Tf 8.3907 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (2619.2004)Tj 0.13725 0.12157 0.12549 scn -17.2835 -1.5712 TD [(114.)-499.4(Diamos)-259.2(AG,)-249.8(Larioses)-257.3(D,)-251.7(Brown)-258.9(L,)-247.2(Kilbourne)-259.4(J,)-253.7(Kim)-254.4(HS,)-254.9(Saxena)-254(D,)-251.7(et)-253.9(al.)-253.2(Vaccine)]TJ -0.9233 -1.142 TD [(synergy)-261.7(with)-262.9(virus-like)-266.1(particle)-258.5(and)-267.6(immune)-259.4(complex)-270.8(platforms)-258.3(for)-262.4(delivery)-267.8(of)-261.9(human)]TJ T* 0.0832 Tc [(pa)-6.2(p)-4.2(i)-5.1(llo)-8(mavi)-5.1(r)-6.4(u)-4.2(s)-581.4(L)-9.4(2)-587.9(a)1.8(n)-7.5(t)4.5(i)-5.1(g)-1.4(en)-7.5(.)]TJ /F11 1 Tf 13.9548 0 TD 0.086 Tc [(Vac)7.4(c)-0.6(ine)]TJ /F8 1 Tf 3.7013 0 TD 0.0881 Tc [(.)-584.8(\()1.8(20)8.3(19\))-581.3(37)8.3(:13)8.3(7)]TJ /F12 1 Tf 7.7185 0 TD 0 Tc ()Tj /F8 1 Tf 0.5993 0 TD 0.0868 Tc [(44)7(.)-586.1(d)-0.6(oi:)]TJ 0.15294 0.15294 0.15294 scn 4.4464 0 TD 0.0882 Tc [(10)8.4(.10)8.4(1)0.2(6/)]TJ -30.4203 -1.142 TD 0 Tc (j.vaccine.2018.11.021)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(115.)-499.4(Gambhira)-462.3(R,)-463.9(Karanam)-460.9(B,)-462.5(Jagu)-466(S,)-456(Roberts)-463.2(JN,)-462.3(Buck)-462.3(CB,)-462.5(Bossis)-456.4(I,)-461.4(et)-456.4(al.)-463.8(A)]TJ -0.9233 -1.1501 TD [(protective)-249.6(and)-259.5(broadly)-251.2(cross-neutralizing)-259.6(epitope)-257.1(of)-245.7(human)-261(papillomavirus)-252.1(L2.)]TJ /F11 1 Tf 31.6433 0 TD [(J)-254.9(Virol)]TJ /F8 1 Tf 2.5755 0 TD (.)Tj -34.2188 -1.142 TD [(\(2007\))-297.6(81:13927)]TJ /F12 1 Tf 6.4712 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(31.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1128/JVI.00936)Tj /F12 1 Tf 7.3864 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (07)Tj 0.13725 0.12157 0.12549 scn -17.235 -1.5712 TD [(116.)-499.4(Alphs)-418(HH,)-416.4(Gambhira)-413.7(R,)-415.3(Karanam)-420.4(B,)-413.9(Roberts)-414.6(JN,)-413.7(Jagu)-417.4(S,)-407.4(Schiller)-422.4(JT,)-409.2(et)-415.9(al.)]TJ -0.9233 -1.142 TD [(Pr)-21.6(o)-10.2(t)0(e)-19(c)-13.3(t)-13.9(i)0(o)-17.5(n)-528.1(ag)-20.2(ai)-23.8(n)-9.7(s)0(t)-532.7(h)-11.6(e)-13.3(t)-13.9(er)-21.8(o)-10.2(l)-9.2(o)-10.3(g)-11.7(o)-10.2(u)-14.5(s)-518.8(h)-11.6(u)-14.5(m)-14.1(an)-528.5(p)-14.5(a)0(p)-23(i)-15.4(l)-9.2(l)-9.2(o)-10.2(m)-14.1(a)0(v)-20.2(i)-15.4(ru)-23.1(s)-518.8(c)-13.2(h)-11.7(a)0(l)-25.7(l)-9.2(e)-13.3(n)-9.7(g)-11.7(e)-523.5(b)-10.2(y)-522(a)-518.7(s)-16.7(y)-11.8(n)-9.7(t)-13.9(h)-11.7(et)-19(i)-15.4(c)]TJ T* [(lipopeptide)-367.5(vaccine)-376.7(containing)-376.8(a)-364.8(broadly)-372.7(cross-neutralizing)-381.1(epitope)-370.5(of)-367.2(L2.)]TJ /F11 1 Tf 30.5823 0 TD [(Proc)-363(Natl)]TJ -30.5823 -1.142 TD [(Acad)-296.4(Sci)-298.2(U.S.A)]TJ /F8 1 Tf 5.9934 0 TD [(.)-300.4(\(2008\))-297.6(105:5850)]TJ /F12 1 Tf 6.9977 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(5.)-299.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.7942 0 TD (10.1073/pnas.0800868105)Tj 0.13725 0.12157 0.12549 scn -15.3722 -1.5712 TD [(117.)-499.4(Pogoda)-222.2(CS,)-213.1(Roden)-219.5(RB,)-213(Garcea)-218.8(RL.)-216.4(Immunizing)-214.4(against)-222.1(anogenital)-215.4(cancer:)-213(HPV)]TJ -0.9233 -1.142 TD (vaccines.)Tj /F11 1 Tf 3.8309 0 TD [(PloS)-299.7(Pathog)]TJ /F8 1 Tf 4.7542 0 TD [(.)-300.3(\(2016\))-305.7(12:e1005587.)-304.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 10.6908 0 TD (10.1371/journal.ppat.1005587)Tj 0.13725 0.12157 0.12549 scn -18.3526 -1.5712 TD [(118.)-499.4(Seitz)-227.6(H,)-228.8(Ribeiro-M黮ler)-234.9(L,)-222.9(Canali)-229.5(E,)-224.3(Bolchi)-230(A,)-228.9(Tommasino)-222.1(M,)-233.4(Ottonello)-225.4(S,)-229.2(et)-221.5(al.)]TJ -0.9233 -1.142 TD [(Robust)-204.9(in)]TJ /F11 1 Tf 4.0172 0 TD (vitro)Tj /F8 1 Tf 2.0491 0 TD [(and)-210.9(in)]TJ /F11 1 Tf 2.7213 0 TD (vivo)Tj /F8 1 Tf 1.8223 0 TD [(neutralization)-212.6(against)-214(multiple)-209.4(high-risk)-211.9(HPV)-208.3(types)-207.8(induced)]TJ -10.6099 -1.142 TD [(by)-337.9(a)-348.6(thermostable)-346(thioredoxin-L2)-348.2(vaccine.)]TJ /F11 1 Tf 17.5022 0 TD [(Cancer)-347.3(Prev)-341.6(Res)-347.5(\(Phila\))]TJ /F8 1 Tf 9.6056 0 TD [(.)-340.8(\(2015\))-346.1(8:932)]TJ /F12 1 Tf 5.6451 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (41.)Tj -33.2631 -1.1501 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1158/1940)Tj /F12 1 Tf 5.3292 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (6207.CAPR-15)Tj /F12 1 Tf 5.9691 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (0164)Tj 0.13725 0.12157 0.12549 scn -13.1935 -1.5712 TD [(119.)-499.4(Khanal)-207.6(S,)-196.8(Ferraris)-207.4(ED,)-200(Zahin)-205.5(M,)-201(Joh)-202.1(J,)-205.1(Ghim)-199.8(S-j,)-200.3(Jenson)-207.5(AB.)-204.8(Targeting)-199.7(synthetic)]TJ -0.9233 -1.142 TD [(H)-9.4(u)-14.5(m)-14.1(a)0(n)-536.5(P)-13(ap)-23(i)-15.4(l)-9.2(l)-17.3(o)-10.2(m)-14.1(a)0(v)-20.2(i)-15.4(r)-16.7(u)0(s)-533.4(\()-13.4(H)-17.5(P)-13(V\))-539.4(L)-11.6(2)-525.3(di)-21.8(s)-16.7(u)0(l)]TJ /F9 1 Tf 17.1378 0 TD ()Tj /F8 1 Tf 0.5426 0 TD 0.0132 Tc [(de-induced)-511.6(N-ter)13.2(m)-9.5(inus)-513.7(conforma)13.2(t)-9.1(i)-2.2(onal)]TJ -17.6804 -1.142 TD 0.0139 Tc [(epi)13.9(t)-7.2(opes)-513(for)-513(p)-0.6(an-HP)-7.2(V)-512.1(vaccine)-517.7(d)-0.6(eve)-7.5(l)4.7(op)13.9(m)-6.7(e)-7.5(nt.)]TJ /F11 1 Tf 19.7214 0 TD 0.0152 Tc [(Exp)-510.1(M)-0.7(o)5.4(l)-515.2(Patho)5.4(l)]TJ /F8 1 Tf 6.8357 0 TD [(.)-511.8(\()-6.2(2)15.3(0)-6.7(15\))-508.3(99:330)]TJ /F12 1 Tf 6.6413 0 TD 0 Tc ()Tj /F8 1 Tf 0.5264 0 TD 0.0151 Tc (4.)Tj -33.7248 -1.142 TD 0 Tc (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1016/j.yexmp.2015.06.021)Tj 0.13725 0.12157 0.12549 scn -0.8747 -1.5712 TD [(120.)-499.4(Bendz)-245.4(H,)-245(Ruhland)-239.8(SC,)-245.5(Pandya)-236.1(MJ,)-243.5(Hainzl)-243.7(O,)-241.7(Riegelsberger)-244(S,)-245.4(Bra點hle)-241.1(C,)-243.7(et)-237.7(al.)]TJ -0.9233 -1.142 TD [(Human)-283.1(heat)-282.1(shock)-283.7(protein)-288.1(70)-281.2(enhances)-290.5(tumor)-280.1(antigen)-292.8(presentation)-285.4(through)-284.8(complex)]TJ T* [(formation)-342.3(and)-340.5(intracellular)-344.2(antigen)-341.4(delivery)-348.8(without)-342.1(innate)-337.8(immune)-348.5(signaling.)]TJ /F11 1 Tf 32.2345 0 TD [(J)-335.9(Biol)]TJ -32.2345 -1.142 TD (Chem)Tj /F8 1 Tf 2.3083 0 TD [(.)-300.3(\(2007\))-305.7(282:31688)]TJ /F12 1 Tf 7.4755 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(702.)-305(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.758 0 TD (10.1074/jbc.M704129200)Tj 0.13725 0.12157 0.12549 scn -13.1287 -1.5712 TD [(121.)-499.4(Zong)-273(J,)-269.9(Wang)-260.7(C,)-268(Liu)-268.4(B,)-268.1(Liu)-268.4(M,)-265.8(Cao)-269.8(Y,)-266.6(Sun)-269(X,)-262.8(et)-270.1(al.)-269.4(Human)-266.9(hsp70)-267.4(and)-267.6(HPV16)]TJ -0.9233 -1.142 TD [(oE7)-321.8(fusion)-326.4(protein)-328.6(vaccine)-328.1(induces)-324.2(an)-326(ef)59.1(fective)-332.5(antitumor)-327.5(ef)]TJ /F9 1 Tf 24.3784 0 TD ()Tj /F8 1 Tf 0.5345 0 TD (cacy.)Tj /F11 1 Tf 2.2678 0 TD [(Oncol)-330.4(Rep)]TJ /F8 1 Tf 4.1063 0 TD [(.)-324.6(\(2013\))]TJ -31.287 -1.142 TD (30:407)Tj /F12 1 Tf 2.6079 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(12.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2802 0 TD (10.3892/or.2013.2445)Tj 0.13725 0.12157 0.12549 scn -5.475 -1.5793 TD [(122.)-499.4(Maecker)-335.1(HT,)-327.5(Ghanekar)-329.2(SA,)-319.8(Suni)-333(MA,)-323.9(He)-330.5(X-S,)-323.6(Picker)-327.8(LJ,)-330.2(Maino)-325.1(VC.)-324.2(Factors)]TJ -0.9233 -1.142 TD [(af)63.9(fecting)-515.2(the)-500.4(ef)]TJ /F9 1 Tf 6.2606 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(ciency)-505.9(of)-504.9(CD8+)-504(T)-503.7(cell)-506.5(cross-)-11.1(primi)-11.3(ng)-499.4(with)-505.9(exogen)-11.5(ous)-503.1(antig)-10.6(ens.)]TJ /F11 1 Tf 27.3265 0 TD (J)Tj -34.1216 -1.142 TD (Immunol)Tj /F8 1 Tf 6.9999 0 0 6.9999 330.5196 469.3605 Tm [(.)-300.3(\(2001\))-305.7(166:7268)]TJ /F12 1 Tf 6.9977 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(75.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.4049/jimmunol.166.12.7268)Tj 0.13725 0.12157 0.12549 scn -13.5256 -1.5712 TD [(123.)-499.4(Neefjes)-477.3(J,)-472.4(Ovaa)-464.1(H.)-471.8(A)-471.2(peptide)]TJ /F12 1 Tf 14.6351 0 TD ()Tj /F8 1 Tf 0.2187 0 TD [(s)-470.2(perspective)-480.5(on)-465.5(antigen)-471(presentation)-479.7(to)-469.6(the)]TJ -15.7771 -1.142 TD [(immune)-299.9(system.)]TJ /F11 1 Tf 6.9005 0 TD [(Nat)-301.9(Chem)-297(Biol)]TJ /F8 1 Tf 5.9529 0 TD [(.)-300.4(\(2013\))-305.7(9:769)]TJ /F12 1 Tf 5.556 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(75.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1038/nchembio.1391)Tj 0.13725 0.12157 0.12549 scn -21.2764 -1.5712 TD [(124.)-499.4(Haghshenas)-458(MR,)-445.5(Mousavi)-447.5(T,)-447.7(Kheradmand)-457.9(M,)-443.9(Afshari)-451.5(M,)-452.1(Moosazadeh)-452.9(M.)]TJ -0.9233 -1.142 TD (Ef)Tj /F9 1 Tf 0.8018 0 TD ()Tj /F8 1 Tf 0.5426 0 TD [(ca)-13.6(cy)-519.1(o)-10.2(f)-518.9(hu)-10(m)-14.1(a)0(n)-520.4(p)0(a)-14.9(p)-14.5(ill)-17.5(o)-10.2(m)0(a)-14.5(v)-11.7(ir)-15.8(us)-517.2(l)-9.2(1)-517.2(pr)-15(o)-10.2(t)0(e)-10.9(i)0(n)-527.3(v)0(a)-12.1(c)-13.3(ci)-12.4(n)-9.7(e)0(s)-524(\()0(c)-18.5(e)0(r)-13.7(v)-11.7(ari)-16.2(x)-520.1(a)0(n)-18.2(d)-516.7(ga)-12.1(rd)-15(as)-17(il)-16.4(\))-515.5(i)0(n)]TJ -1.3445 -1.142 TD [(reducing)-506.1(the)-508.5(risk)-507.3(of)-504.9(cervical)-506.2(intrae)-12.6(pithelial)-507.8(neoplasi)-16.5(a:)-503.2(a)-502.5(meta-analysis.)]TJ /F11 1 Tf 30.1936 0 TD [(Int)-510.5(J)-497.9(Prev)]TJ -30.1936 -1.142 TD (Med)Tj /F8 1 Tf 1.7656 0 TD [(.)-300.3(\(2017\))-305.7(8\(1\):44.)-298.9(doi:)]TJ 0.15294 0.15294 0.15294 scn 8.5689 0 TD (10.4103/ijpvm.IJPVM_413_16)Tj 0.13725 0.12157 0.12549 scn -9.4112 -1.5712 TD [(125.)-499.4(Chen)-472.1(J,)-464.3(Ni)-467(G,)-467.1(Liu)-470.8(XS.)-467(Papillomavirus)-469.3(virus)-471.9(like)-464(particle-based)-478(therapeutic)]TJ -0.9233 -1.142 TD [(va)-20.2(cc)-18.4(in)-17(e)-523.5(a)0(g)-20.2(a)0(i)-23.8(n)-9.7(st)-532.7(hu)-18.1(ma)-22.6(n)-520(p)0(a)-14.9(p)-14.5(il)-24.6(l)-9.2(o)-10.3(ma)-14.5(v)-11.8(i)-15.4(ru)-15(s)-526.9(i)0(n)-17(f)0(e)-21.9(c)-13.3(ti)-13.1(o)-10.2(n)-520(r)-16.7(e)0(l)-14.3(a)-16.6(te)-19(d)-516.7(d)-14.5(is)-23.9(ea)-13.6(s)-16.7(e)0(s)-21.8(:)-519(im)-21.4(mu)-20.6(n)-9.7(o)-10.2(l)-9.2(o)-10.3(g)-11.7(i)0(c)-20.5(a)0(l)]TJ T* 0.0244 Tc [(problem)-5.9(s)-526.8(a)-0.3(nd)-524.7(f)-8.6(u)1.8(tu)-6.3(re)-523.4(d)-6.3(i)0.9(rect)-5.7(ions.)]TJ /F11 1 Tf 14.6189 0 TD 0.0273 Tc [(Cel)7.1(l)-527.4(Imm)6.5(unol)]TJ /F8 1 Tf 5.9772 0 TD 0.0235 Tc [(.)-527.9(\()2(20)-7.8(11\))-532.5(269)-7.8(:5)]TJ /F12 1 Tf 6.3092 0 TD 0 Tc ()Tj /F8 1 Tf 0.5345 0 TD 0.0313 Tc [(9.)-520.1(d)8.7(o)4.8(i)7.8(:)]TJ 0.15294 0.15294 0.15294 scn 3.4016 0 TD 0.0235 Tc [(10)-7.7(.10)-7.8(1)0.4(6/)]TJ -30.8415 -1.1501 TD 0 Tc (j.cellimm.2011.03.003)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(126.)-499.4(Simon)-221.4(P,)-224.3(Buxant)-218.7(F,)-217.7(Hallez)-216.7(S,)-221.1(Burny)-223(A,)-220.8(Fayt)-218.7(I,)-218.4(Anaf)-214.6(V,)-218.9(et)-221.5(al.)-220.8(Cervical)-217.6(response)-224.5(to)]TJ -0.9233 -1.142 TD [(vaccination)-259.2(against)-262.5(HPV16)-254.6(E7)-263(in)-260(case)-254.1(of)-261.9(severe)-263.1(dysplasia.)]TJ /F11 1 Tf 23.2121 0 TD [(Eur)-253.9(J)-263(Obstet)-253.9(Gynecol)-263.5(Reprod)]TJ -23.2121 -1.142 TD (Biol)Tj /F8 1 Tf 1.5469 0 TD [(.)-300.3(\(2003\))-305.7(109:219)]TJ /F12 1 Tf 6.5198 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(23.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2721 0 TD (10.1016/s0301)Tj /F12 1 Tf 5.7018 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (2115\(03\)00093)Tj /F12 1 Tf 5.961 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (9)Tj 0.13725 0.12157 0.12549 scn -23.609 -1.5712 TD 0.023 Tc [(127.)-496(Schwar)6.3(z)-524.8(T)5.3(F,)-520.3(Leo)-521.8(O)0.7(.)-520.3(I)7.7(mmune)-516.7(respons)6.3(e)-524.8(to)-513.7(huma)6.4(n)-521.3(p)0.4(apil)5.7(lomavir)6.3(u)0.4(s)-520.1(a)-1.7(fter)]TJ -0.9233 -1.142 TD 0 Tc [(prophylactic)-306.8(vaccination)-307.8(with)-303.4(AS04-adjuvanted)-316.1(HPV-16/18)-305.3(vaccine:)-304.5(Improving)-313.9(upon)]TJ T* (nature.)Tj /F11 1 Tf 3.102 0 TD [(Gynecol)-295.9(Oncol)]TJ /F8 1 Tf 5.7342 0 TD [(.)-300.3(\(2008\))-305.7(110:S1)]TJ /F12 1 Tf 6.0258 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(S10.)-299.8(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.7499 0 TD (10.1016/j.ygyno.2008.05.036)Tj 0.13725 0.12157 0.12549 scn -18.1987 -1.5712 TD [(128.)-499.4(Einstein)-374.4(MH,)-372.4(Baron)-377.4(M,)-371.1(Levin)-369.6(MJ,)-373(Chatterjee)-372.7(A,)-374.7(Edwards)-370.8(RP,)-371.6(Zepp)-380.8(F,)-371.6(et)-367.3(al.)]TJ -0.9233 -1.142 TD [(Comparison)-367.3(of)-375.3(the)-370.9(immunogenicity)-377(and)-372.9(safety)-372.4(of)-367.2(Cervarix)]TJ /F16 1 Tf 6.5001 0 0 6.5001 473.8959 308.863 Tm ()Tj /F8 1 Tf 6.9999 0 0 6.9999 482.8534 307.3889 Tm [(and)-372.9(Gardasil)]TJ /F13 1 Tf 5.5001 0 0 5.5001 519.3069 309.8834 Tm ()Tj /F8 1 Tf 6.9999 0 0 6.9999 526.0534 307.3889 Tm (human)Tj -31.5947 -1.142 TD [(papillomavirus)-365.5(\(HPV\))-372.7(cervical)-368.5(cancer)-366.2(vaccines)-369.1(in)-365.3(healthy)-371.4(women)-366.6(aged)-363.9(18)]TJ /F12 1 Tf 30.3393 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(45)-370.3(years.)]TJ /F11 1 Tf -30.8496 -1.142 TD [(Hum)-297.8(Vaccin)]TJ /F8 1 Tf 5.0539 0 TD [(.)-300.3(\(2009\))-305.7(5:705)]TJ /F12 1 Tf 5.5641 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(19.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.4161/hv.5.10.9518)Tj 0.13725 0.12157 0.12549 scn -13.477 -1.5712 TD [(129.)-499.4(Herrin)-356.5(DM,)-346.7(Coates)-346(EE,)-350.8(Costner)-347.8(PJ,)-355.9(Kemp)-347.9(TJ,)-344.4(Nason)-350.9(MC,)-346.8(Saharia)-354.3(KK,)-345.2(et)-351.1(al.)]TJ -0.9233 -1.1501 TD [(Comparison)-213.4(of)-205.2(adaptive)-213.7(and)-210.9(innate)-216.3(immune)-210.8(responses)-216.9(induced)-216.8(by)-208.3(licensed)-210.6(vaccines)-215.2(for)]TJ 0 -1.142 TD [(human)-390.6(papillomavirus.)]TJ /F11 1 Tf 9.7999 0 TD [(Hum)-395(Vaccin)-396(Immunother)]TJ /F8 1 Tf 10.5451 0 TD [(.)-397.5(\(2014\))-394.7(10:3446)]TJ /F12 1 Tf 6.7061 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(54.)-387.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.4583 0 TD (10.4161/)Tj -31.0197 -1.142 TD (hv.34408)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(130.)-499.4(Einstein)-212.4(MH,)-210.4(Levin)-215.7(MJ,)-211.1(Chatterjee)-210.7(A,)-212.7(Chakhtoura)-206(N,)-209.3(Takacs)-215.4(P,)-208.1(Catteau)-210.2(G,)-216(et)-205.3(al.)]TJ -0.9233 -1.142 TD 0.0555 Tc [(C)6.9(o)4.8(mpa)6.6(r)-1.7(at)9.2(ive)-549(h)3.4(umo)4.8(r)-1.7(a)6.6(l)-553(an)5.3(d)-550.3(cel)5.8(lul)5.8(a)6.5(r)-552.4(i)-0.4(mmu)8.6(no)4.8(geni)7.7(city)-547.5(an)5.3(d)-550.3(s)-1.7(a)6.5(f)-1.8(et)9.2(y)-555.6(o)4.8(f)-552.5(h)3.3(um)9(an)]TJ T* 0 Tc [(papillomavirus)-373.6(\(HPV\)-16/18)-372.5(AS04-adjuvanted)-372.8(vaccine)-376.7(and)-364.8(HPV-6/11/16/18)-378.7(vaccine)]TJ T* [(in)-430.1(healthy)-444.3(women)-431.4(aged)-444.9(18)]TJ /F12 1 Tf 11.2092 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(45)-435.1(years:)-440.1(Follow-up)-444.6(through)-430.6(Month)-440.2(48)-435.1(in)-438.2(a)-437.7(Phase)-443.8(III)]TJ -11.7194 -1.142 TD 0.0141 Tc [(r)14.1(a)-11(ndomized)-510.7(study.)]TJ /F11 1 Tf 8.415 0 TD 0.0139 Tc [(Hu)-5.8(m)-509.1(V)-0.4(acci)-7.7(n)-508(I)-1.4(mmu)-5.8(nother)]TJ /F8 1 Tf 11.0472 0 TD 0 Tc [(.)-535.2(\()-13.4(20)-22(1)-15(4)-15(\))-531.7(10)-22(:)-16.9(3)-15.1(4)-15.1(5)-15(5)]TJ /F12 1 Tf 7.1353 0 TD ()Tj /F8 1 Tf 0.5264 0 TD 0.0139 Tc [(65.)-513.2(d)-0.6(oi:)]TJ 0.15294 0.15294 0.15294 scn 3.7985 0 TD 0.0154 Tc [(10.41)15.4(6)-6.6(1/)]TJ -30.9225 -1.142 TD 0 Tc (hv.36117)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(131.)-499.4(Zhou)-212.9(C,)-211.3(Tuong)-209.9(ZK,)-207.7(Frazer)-212.5(IH.)-203.6(Papillomavirus)-218.2(immune)-210.8(evasion)-207(strategies)-212.8(target)]TJ -0.9233 -1.142 TD [(the)-241.3(infected)-247.8(cell)-247.4(and)-251.4(the)-249.4(local)-244.7(immune)-251.3(system.)]TJ /F11 1 Tf 18.6199 0 TD [(Front)-244.8(Oncol)]TJ /F8 1 Tf 4.738 0 TD [(.)-251.7(\(2019\))-249(9:682.)-247.9(doi:)]TJ 0.15294 0.15294 0.15294 scn 7.6618 0 TD (10.3389/)Tj -31.0197 -1.1501 TD (fonc.2019.00682)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(132.)-499.4(Liu)-397.9(Z,)-403.9(Zhou)-391.1(H,)-398.9(Wang)-398.4(W,)-401.5(Fu)-393.6(Y-X,)-401.5(Zhu)-397(M.)-395.4(A)-398.3(novel)-394.4(dendritic)-402.1(cell)-401.3(targeting)]TJ -0.9233 -1.142 TD [(HPV16)-327.5(E7)-327.8(synthetic)-330.1(vaccine)-336.2(in)-324.8(combination)-333.3(with)-335.8(PD-L1)-325.5(blockade)-335.4(elicits)-331.9(therapeutic)]TJ T* [(antitumor)-513.8(immunity)-505.8(in)-511.1(mice.)]TJ /F11 1 Tf 12.9586 0 TD [(Onco)-10.5(immunolo)-13.1(gy)]TJ /F8 1 Tf 7.0139 0 TD [(.)-502.8(\(20)-11.1(16\))-505.1(5:e1147641)-12.9(.)-502.8(doi:)]TJ 0.15294 0.15294 0.15294 scn 11.0391 0 TD [(10.108)-11.2(0/)]TJ -31.0116 -1.142 TD (2162402X.2016.1147641)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(133.)-499.4(Lin)-206.9(PL,)-211.7(Cheng)-208.5(YM,)-207.7(Wu)-204.8(DW,)-207(Huang)-207.9(YJ,)-211.9(Lin)-206.9(HC,)-204.5(Chen)-204.8(CY,)-210(et)-205.3(al.)-204.6(A)-212(combination)]TJ -0.9233 -1.142 TD [(of)-245.7(anti-PD-L1)-245.8(mA)-250.4(b)-253.2(plus)-249.3(Lm-LLO-E6)-250.1(vaccine)-247.1(ef)]TJ /F9 1 Tf 19.2192 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(ciently)-248.5(suppresses)-250.7(tumor)-247.7(growth)-253.8(and)]TJ -19.7538 -1.142 TD [(metastasis)-477.6(in)-470.6(HPV-infected)-482.8(cancers.)]TJ /F11 1 Tf 15.4774 0 TD [(Cancer)-476.9(Med)]TJ /F8 1 Tf 5.0215 0 TD [(.)-478.5(\(2017\))-475.7(6:2052)]TJ /F12 1 Tf 6.3902 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(62.)-468.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.6203 0 TD (10.1002/)Tj -31.0197 -1.142 TD (cam4.1143)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(134.)-499.4(Rice)-278.3(AE,)-274.3(Latchman)-269.4(Y,)-274.7(Balint)-275.5(JP,)-266.8(Lee)-273(JH,)-279.4(Gabitzsch)-269.6(ES,)-274.7(Jones)-270.6(FR.)-276(An)-270.4(HPV-E6/)]TJ -0.9233 -1.142 TD [(E7)-327.8(immunotherapy)-346.6(plus)-338.4(PD-1)-330.1(checkpoint)-339(inhibition)-337.6(results)-343.8(in)-332.9(tumor)-336.8(regression)-342.8(and)]TJ /F1 1 Tf 0.49804 0.49804 0.49412 scn -36.4704 101.6522 TD [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.4485 0 TD (14)Tj ET endstream endobj 498 0 obj<> endobj 499 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 500 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 501 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 502 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 503 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 504 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 505 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 506 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 507 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 508 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 509 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 510 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 511 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 512 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 513 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 514 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 515 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 516 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 517 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 518 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 519 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 520 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 521 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 522 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 523 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 524 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 525 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 526 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 527 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 528 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 529 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 530 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 531 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 532 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 533 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 534 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 535 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 536 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 537 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 538 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 539 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 540 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 541 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 542 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 543 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 544 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 545 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 546 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 547 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 548 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 549 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 550 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 551 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 552 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 553 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 554 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 555 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 556 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 557 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 558 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 559 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 560 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 561 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 562 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 563 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 564 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 565 0 obj<>stream /GS1 gs BT /F8 1 Tf 6.9999 0 0 6.9999 49.6063 760.3652 Tm /Cs6 cs 0.13725 0.12157 0.12549 scn 0 Tc 0 Tw [(reduction)-405(in)-405.8(PD-L1)-398.4(expression.)]TJ /F11 1 Tf 13.3474 0 TD [(Cancer)-404(Gene)-399.4(Ther)]TJ /F8 1 Tf 7.4431 0 TD [(.)-405.6(\(2015\))-402.8(22:454)]TJ /F12 1 Tf 6.2444 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(62.)-403.4(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.4826 0 TD (10.1038/)Tj -31.0278 -1.142 TD (cgt.2015.40)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD 0.0395 Tc [(135.)-495.7(Youn)-537.2(JW,)-544.3(H)5.8(u)-7.4(r)-536(S-Y,)-544.3(Woo)-537.7(J)5.1(W)-4.9(,)-536.2(Kim)-541.5(Y)0.4(-M,)-536.2(L)-4.5(im)-533.5(M)-6.9(C)7.1(,)-544.3(P)2.2(ark)-540.6(S)5.4(Y,)-544.3(et)-541.3(al)6(.)]TJ -0.9314 -1.142 TD 0 Tc [(Pembrolizumab)-422(plus)-411.3(GX-188E)-416.5(therapeutic)-424.2(DNA)-412.5(vaccine)-417.2(in)-413.9(patients)-413.6(with)-416.8(HPV-16-)]TJ T* [(positive)-289.3(or)-294.2(HPV-18-positive)-289.5(advanced)-296.6(cervical)-295.6(cancer:)-294(interim)-292.8(results)-287.2(of)-294.3(a)-283.8(single-arm,)]TJ T* [(phase)-299.5(2)-306.6(trial.)]TJ /F11 1 Tf 5.4831 0 TD [(Lancet)-300.9(Oncol)]TJ /F8 1 Tf 5.2401 0 TD [(.)-300.3(\(2020\))-297.6(21:1653)]TJ /F12 1 Tf 6.5117 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(60.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1016/s1470)Tj /F12 1 Tf 5.7018 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (2045\(20\)30486)Tj /F12 1 Tf 5.9529 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (1)Tj 0.13725 0.12157 0.12549 scn -32.7691 -1.5712 TD [(136.)-499.4(De)-410.1(Sousa)-416.2(LG,)-413.9(Rajapakshe)-421.3(K,)-411.9(Canales)-422.2(JR,)-409.2(Chin)-417.5(RL,)-418.8(Feng)-413.8(L,)-409.2(Wang)-422.7(Q,)-411.8(et)-415.9(al.)]TJ -0.9314 -1.142 TD [(ISA101)-403.8(and)-405.3(nivolumab)-403.4(for)-400.1(HPV-16+)-405.8(cancer:)-407.4(updated)-401.6(clinical)-409.7(ef)]TJ /F9 1 Tf 26.5166 0 TD ()Tj /F8 1 Tf 0.5264 0 TD [(cacy)-403.1(and)-405.3(immune)]TJ -27.043 -1.1501 TD [(correlates)-447.4(of)-448.2(response.)]TJ /F11 1 Tf 9.6704 0 TD [(J)-441.2(Immunother)-446.8(Cancer)]TJ /F8 1 Tf 8.9819 0 TD [(.)-446.1(\(2022\))-443.3(10:e004232.)-451(doi:)]TJ 0.15294 0.15294 0.15294 scn 10.788 0 TD (10.1136/jitc-)Tj -29.4403 -1.142 TD (2021)Tj /F12 1 Tf 1.9195 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (004232)Tj 0.13725 0.12157 0.12549 scn -1.4983 -1.5712 TD [(137.)-499.4(Le)-308.4(Tourneau)-307.7(C,)-308.5(Cassier)-305.8(P,)-305.3(Rolland)-305.9(F,)-306.8(Salas)-311.8(S,)-302.1(Limacher)-315.1(JM,)-308.3(Capitain)-304.6(O,)-306.5(et)-310.6(al.)]TJ -0.9314 -1.142 TD [(TG4)-13.2(001)-506.8(\(Ti)-14.1(pap)-13.3(kinog)-11.7(ene)-514.1(so)-10.7(vaciv)-12(ec)-10.3(\))-507.4(and)-510.6(av)-12.1(elum)-10.6(ab)-512.8(for)-505.3(re)-13.7(cur)-12.1(rent)-13.1(/met)-10.8(asta)-15.1(tic)-512.2(\(R/M)-14.7(\))]TJ T* [(human)-487.8(papilloma)-476.7(virus)-488.1(\(HPV\)-16+)-489.3(cancers:)-480.8(clinical)-482.6(ef)]TJ /F9 1 Tf 22.9367 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(cacy)-484.1(and)-478.2(immunogenicity.)]TJ /F11 1 Tf -23.4713 -1.142 TD [(BMJ)-298.2(Specialist)-310.1(J)]TJ /F8 1 Tf 6.2849 0 TD [(.)-300.3(\(2020\))-305.7(8:A841.)-306(doi:)]TJ 0.15294 0.15294 0.15294 scn 8.5689 0 TD (10.1136/jitc-2020-SITC2020.0793)Tj 0.13725 0.12157 0.12549 scn -13.9224 -1.5712 TD [(138.)-499.4(Floudas)-274.5(C,)-276.1(Strauss)-274.9(J,)-269.9(Allen)-277.7(C,)-268(Donahue)-278.5(R,)-269.5(Jochems)-275.6(C,)-276.1(Steinberg)-276.1(S,)-269.7(et)-278.2(al.)-269.4(Initial)]TJ -0.9314 -1.142 TD [(safety)-210.4(results)-206.2(and)-202.8(immune)-210.8(responses)-208.8(induced)-208.7(by)-200.2(a)-210.9(novel)-200(human)-212.4(papillomavirus)-203.5(\(HPV\)-)]TJ T* (speci)Tj /F9 1 Tf 1.9843 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(c)-507.3(gorilla)-510.1(ade)-12(noviru)-13.6(s)-502.6(immun)-11.3(otherap)-15.8(y)-497.7(vacc)-14.4(ine,)-508.8(PRGN-)-11.7(2009,)-506.4(in)-511.1(patient)-16.3(s)-502.6(with)]TJ -2.5188 -1.142 TD 0.0449 Tc [(advanced)-536.6(HPV)4.9(-)2(associ)5.2(ated)-544.7(cancers.)]TJ /F11 1 Tf 16.2712 0 TD 0.0443 Tc [(BMJ)-542.7(S)0.2(pecia)6.9(l)-0.2(ist)-544.6(J)-0.1(ournals)]TJ /F8 1 Tf 10.6504 0 TD 0.0474 Tc [(.)-536.4(\()1.6(20)8.1(21)8.1(\))-541(9)0(:)6.2(A)-2.6(5)8.1(1)0(3)8.1(.)]TJ -26.9215 -1.1501 TD 0 Tc (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1136/jitc-2021-SITC2021.483)Tj 0.13725 0.12157 0.12549 scn -0.8666 -1.5712 TD [(139.)-499.4(Strauss)-258.7(J,)-261.8(Floudas)-258.3(CS,)-261.7(Sater)-256.5(HA,)-262.6(Manu)-257.4(M,)-257.7(Lamping)-255.8(E,)-264.8(Francis)-256.7(DC,)-259.8(et)-253.9(al.)-261.3(Phase)]TJ -0.9314 -1.142 TD [(II)-411.2(evalsuation)-406.5(of)-407.7(the)-411.3(triple)-406.9(combination)-414.2(of)-407.7(PDS0101,)-407.7(M9241,)-415.1(and)-405.3(bintrafusp)-412.3(alfa)-407.3(in)]TJ T* [(patients)-219.2(with)-222.4(HPV)-224.5(16)-216.4(positive)-224.5(Malignancies.)]TJ /F11 1 Tf 17.7857 0 TD [(J)-214.4(Clin)-222.1(Oncol)]TJ /F8 1 Tf 4.7299 0 TD [(.)-219.4(\(2021\))-216.6(39:2501.)-221.3(doi:)]TJ 0.15294 0.15294 0.15294 scn 8.5122 0 TD (10.1200/)Tj -31.0278 -1.142 TD (JCO.2021.39.15_suppl.2501)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(140.)-499.4(Dion)-464.6(GR,)-460.5(Teng)-457.5(S,)-464.1(Boyd)-457.9(LR,)-467.4(Northam)-461.8(A,)-463.8(Mason-Apps)-465.1(C,)-454.3(Vieira)-465.5(D,)-462.3(et)-464.5(al.)]TJ -0.9314 -1.142 TD [(Adjuvant)-383.3(human)-390.6(papillomavirus)-381.7(vaccination)-388.8(for)-383.9(secondary)-390(prevention:)-388.4(a)-381(systematic)]TJ T* 0.0247 Tc [(review)5.2(.)]TJ /F11 1 Tf 3.4907 0 TD 0.025 Tc [(JA)8.8(MA)-517.7(Otol)4.8(ary)8.4(n)-2.8(gol)-513.5(H)2.7(ead)-519.8(N)1.2(eck)-519.4(S)-2.9(u)5.3(r)0.2(g)]TJ /F8 1 Tf 15.688 0 TD 0.0233 Tc [(.)-520(\()1.8(2017\))-524.6(143:6)8.3(1)0.2(4)]TJ /F12 1 Tf 7.273 0 TD 0 Tc ()Tj /F8 1 Tf 0.5345 0 TD 0.0236 Tc [(22.)-519.7(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.8795 0 TD 0.0234 Tc (10.1001/)Tj -30.8658 -1.142 TD 0 Tc (jamaoto.2016.4736)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(141.)-499.4(Di)-250.2(Donato)-246.9(V,)-243.2(Caruso)-252.9(G,)-248.4(Petrillo)-246.6(M,)-249.6(Kontopantelis)-248.7(E,)-248.6(Palaia)-249.3(I,)-250.8(Perniola)-249.9(G,)-240.3(et)-253.9(al.)]TJ -0.9314 -1.142 TD [(A)-9.5(d)0(j)-15.6(u)0(v)-18.2(a)0(n)-10.1(t)-516(H)-9.4(P)0(V)-522.8(v)0(a)-12.1(c)-13.3(ci)-12.4(n)-9.7(a)0(t)-14.2(i)0(o)-17.5(n)-511.9(to)-526.3(pr)-15(ev)-16.9(en)-14.9(t)-516(r)0(e)-13.7(c)0(u)-19.7(rre)-22.3(n)-9.7(t)-507.9(c)-13.3(e)0(r)-13.7(v)-11.8(ic)-12.4(al)-519.8(d)-14.5(y)0(s)-12.2(p)0(l)-15.6(a)0(s)-17(i)0(a)-517.9(a)0(f)-17.1(t)-13.9(er)-515.9(su)-23.1(rg)-12.2(ic)-12.4(al)]TJ T* 0.0551 Tc [(treatm)-7.6(ent:)-553(a)-560.8(m)0.5(et)-7.4(a-analy)-5.2(s)-2.1(is.)]TJ /F11 1 Tf 13.2664 0 TD [(Va)-6.5(ccin)-5(e)-3.4(s)-551.3(\()-0.6(B)-4.5(a)1.6(sel)-5.5(\))]TJ /F8 1 Tf 7.516 0 TD 0.0559 Tc [(.)-560.3(\()2(2021\))-556.8(9:410.)-560.3(doi:)]TJ 0.15294 0.15294 0.15294 scn 9.8485 0 TD 0.0557 Tc (10.3390/)Tj -30.6309 -1.1501 TD 0 Tc (vaccines9050410)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(142.)-499.4(M)26.5(a)32(t)26.6(s)31.9(u)26(z)27.2(a)23.9(k)27.4(i)-331.2(H)31.1(,)-332.7(M)26.5(a)32(k)27.3(i)25.1(y)28.7(a)32(m)26.4(a)-332.4(K)26.2(,)-332.7(H)31.1(a)23.9(s)31.9(e)27.2(g)28.7(a)23.9(w)29.1(a)-332.4(H)31.1(,)-332.7(A)22.9(s)31.9(a)23.9(i)-331.2(R)30.9(,)-332.7(M)26.5(o)30.3(r)23.8(i)33.2(t)26.6(a)-332.4(M)26.5(,)-332.7(O)26.3(s)31.9(h)28.9(i)25.1(m)26.4(a)-332.4(T)30.9(.)-332.7(H)23(u)34(m)26.4(a)23.9(n)]TJ -0.9314 -1.142 TD -0.031 Tc [(p)-5(a)1(p)-5(i)-5.9(llo)-8.8(ma)-7.1(vi)-5.9(ru)-5(s)-306.8(v)-2.3(acci)-5.9(na)-7.1(ti)-5.9(on)-308(as)-306.8(a)-7.1(n)-299.9(a)-7.1(d)-5(ju)-5(van)-8.3(t)-304(t)-4.4(h)-2.1(era)-7.1(p)3.1(y)-310(f)0.8(o)-8.8(r)-298.7(r)-7.2(ecu)-5(rren)-8.3(t)-304(res)-7.2(p)-5(ir)-7.2(at)-4.4(or)-7.2(y)-301.9(p)-5.1(ap)-5(i)-5.9(llo)-8.8(ma)-7.1(t)-4.4(o)-0.7(si)-5.9(s:)]TJ T* [(ad)-5.1(d)-5.1(i)-6(ti)-6(on)-8.4(al)-299.4(ca)-7.2(se)-303.5(s)-7.3(e)-3.9(ri)-6(es.)]TJ /F11 1 Tf 8.3745 0 TD 0.2711 Tc [(JV)297.3(o)301.7(i)298.1(c)297.8(e)]TJ /F8 1 Tf 2.616 0 TD -0.0335 Tc [(.)-309.5(\()1.7(2)-8.1(0)-8(21)-8.1(\))-306(3)-8.1(8:)-9.9(20)-8.1(4)]TJ /F12 1 Tf 5.6694 0 TD 0 Tc ()Tj /F8 1 Tf 0.4778 0 TD -0.0262 Tc [(9.)-294.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.6241 0 TD [(10.)5.6(10)7.4(16/j)5.2(.)-2.5(j)5.2(v)2.6(oice.)5.6(202)7.4(1.)5.6(07.)5.6(01)7.5(9)]TJ 0.13725 0.12157 0.12549 scn -18.8305 -1.5712 TD 0 Tc [(143.)-499.4(Hoc)]TJ /F15 1 Tf 3.8228 0.0405 TD ()Tj /F8 1 Tf 0.0081 -0.0405 TD (evar-Boltez)Tj /F15 1 Tf 4.4869 0.0405 TD ()Tj /F8 1 Tf 0.0162 -0.0405 TD [(ar)-349.1(I,)-348(Matic)]TJ /F15 1 Tf 4.3411 0.0405 TD ()Tj /F8 1 Tf 0.0081 -0.0405 TD (ic)Tj /F15 1 Tf 0.6641 0.0405 TD ()Tj /F8 1 Tf 0.3564 -0.0405 TD [(M,)-354.9(S)]TJ /F15 1 Tf 1.879 0.2511 TD ()Tj /F8 1 Tf 0.0486 -0.2511 TD [(ereg-Bahar)-345.7(M,)-354.9(Gale)-343.4(N,)-355.1(Poljak)-346.8(M,)-346.8(Kocjan)-348.7(B,)]TJ -16.5627 -1.142 TD [(et)-432.1(al.)-423.3(Human)-437(papilloma)-428.1(virus)-431.4(vaccination)-437.4(in)-430.1(patients)-429.8(with)-424.9(an)-431.3(aggressive)-435.3(course)-432.9(of)]TJ T* [(recurrent)-314.3(respiratory)-308.1(papillomatosis.)]TJ /F11 1 Tf 14.9753 0 TD [(Eur)-310.5(Arch)-306.1(Otorhinolaryngol)]TJ /F8 1 Tf 10.7718 0 TD [(.)-308.4(\(2014\))-305.7(271:3255)]TJ /F12 1 Tf 7.0057 0 TD ()Tj /F8 1 Tf 0.5103 0 TD (62.)Tj -33.2631 -1.142 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1007/s00405-014-3143-y)Tj 0.13725 0.12157 0.12549 scn -0.8666 -1.5712 TD [(144.)-499.4(Schif)62.7(fman)-284(MH,)-275.2(Bauer)-279.9(HM,)-275.2(Hoover)-282.2(RN,)-275.6(Glass)-282.5(AG,)-274.1(Cadell)-281.5(DM,)-281.9(Rush)-271.2(BB,)-284.5(et)-278.2(al.)]TJ -0.9314 -1.142 TD [(Epidemiologic)-445.8(evidence)-444.7(showing)-443.3(that)-436.6(human)-439.2(papillomavirus)-446.5(infection)-449.8(causes)-439.3(most)]TJ T* [(cervical)-360.4(intraepithelial)-358.4(neoplasia.)]TJ /F11 1 Tf 13.5903 0 TD [(J)-352.1(Natl)-362.6(Cancer)-355.4(Inst)]TJ /F8 1 Tf 7.3864 0 TD [(.)-357(\(1993\))-354.3(85:958)]TJ /F12 1 Tf 6.1472 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(64.)-362.9(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.3935 0 TD (10.1093/)Tj -31.0278 -1.1501 TD (jnci/85.12.958)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(145.)-499.4(Yang)-223(X,)-222.3(Cheng)-224.7(Y,)-226.1(Li)-221.4(C.)-227.5(The)-228.9(role)-219.4(of)-221.4(TLRs)-225.8(in)-227.6(cervical)-222.7(cancer)-228.6(with)-222.4(HPV)-232.6(infection:)]TJ -0.9314 -1.142 TD 0.5916 Tc [(ar)550.6(e)546(v)547.5(i)543.8(e)545.9(w)547.8(.)]TJ /F11 1 Tf 4.6975 0 TD 0.0451 Tc [(Signal)-542(Transduct)-543.8(T)-1.7(arget)-543.8(T)6.4(her)]TJ /F8 1 Tf 6.9999 0 0 6.9999 177.6755 383.3574 Tm 0.047 Tc [(.)-536.8(\()1.2(201)7.7(7\))-541.4(2\(1)7.7(\))1.2(:e1)7.7(705)7.7(5.)-544.9(doi)7.3(:)]TJ 0.15294 0.15294 0.15294 scn 12.416 0 TD 0.0477 Tc [(10)8.4(.10)8.4(38/)]TJ -30.7119 -1.142 TD 0 Tc (sigtrans.2017.55)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(146.)-499.4(Bansal)-279.5(N,)-274.1(Wright)-275.7(JD,)-278(Cohen)-271.7(CJ,)-278.1(Herzog)-277.1(TJ.)-279.6(Natural)-279.8(history)-274.4(of)-278.1(established)-272.8(low)]TJ -0.9314 -1.142 TD [(grade)-299.6(cervical)-303.7(intraepithelial)-309.8(\(CIN)-302.1(1\))-303.8(lesions.)]TJ /F11 1 Tf 18.385 0 TD [(Anticancer)-304.3(Res)]TJ /F8 1 Tf 5.9124 0 TD [(.)-300.3(\(2008\))-305.7(28:1763)]TJ /F12 1 Tf 6.5198 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (6.)Tj -30.396 -1.5712 TD [(147.)-499.4(Chan)-467.3(J,)-464.3(Monk)-460.2(B,)-462.5(Brewer)-468.3(C,)-462.4(Keefe)-467.8(K,)-468.6(Osann)-463.8(K,)-460.5(McMeekin)-470.6(S,)-464.1(et)-464.5(al.)-463.8(HPV)]TJ -0.9314 -1.142 TD 0.0396 Tc [(in)5.6(fectio)5.1(n)-537.1(a)-1.2(n)5.6(d)-541.9(n)5.6(u)0.8(mb)5.1(e)-6(r)-535.9(o)5.1(f)-536(l)6.1(i)-0.1(fetime)-532.5(sex)5.5(u)0.8(al)-536.5(pa)6.8(rtner)6.7(s)-535.9(are)-532.5(s)-1.4(tr)6.7(on)5.6(g)-539.1(p)0.8(r)6.7(e)-6.1(d)8.9(i)-0.1(ctor)6.7(s)-535.9(f)-1.5(o)5.1(r)]TJ /F12 1 Tf T* 0 Tc ()Tj /F8 1 Tf 0.2187 0 TD (natural)Tj /F12 1 Tf 2.8509 0 TD ()Tj /F8 1 Tf 0.2187 0 TD [(regression)-496.7(of)-480.6(CIN)-491.2(2)-484.8(and)-486.3(3.)]TJ /F11 1 Tf 12.1649 0 TD [(Br)-489.5(J)-481.7(Cancer)]TJ /F8 1 Tf 5.0053 0 TD [(.)-486.6(\(2003\))-483.8(89:1062)]TJ /F12 1 Tf 6.8843 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(6.)-485.5(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.1749 0 TD (10.1038/)Tj -31.0278 -1.142 TD (sj.bjc.6601196)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(148.)-499.4(Kang)-319.7(W,)-328.6(Choi)-320.8(H,)-326(Kim)-319.2(S.)-326.4(Is)-323.5(vaccination)-324(with)-327.7(quadrivalent)-330.6(HPV)-321.7(vaccine)-328.1(after)]TJ -0.9314 -1.142 TD 0.0291 Tc [(LEEP)-526.6(ef)60.9(fective)-526.8(i)5.6(n)-531.4(p)-1.6(revent)7.1(ing)-533.4(r)4.3(ecurrenc)]TJ 17.405 0 TD 0.0258 Tc [(e)-530.1(i)-5.8(n)-526.6(p)-4.9(a)-7(t)-4.3(ie)-3.7(nt)-4.3(s)-533.5(w)-1.8(i)-5.8(t)3.8(h)-536.6(h)-2(ig)-10.3(h-gra)-7(d)-4.9(e)-530.1(c)-3.6(e)-3.7(r)1(vi)-5.8(c)-3.7(a)1.1(l)]TJ -17.405 -1.1501 TD 0 Tc [(intraepithelial)-455.6(neoplasia)-446.1(\(CIN2)]TJ /F12 1 Tf 12.7237 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (3\).)Tj /F11 1 Tf 1.4902 0 TD [(Gynecol)-449.8(Oncol)]TJ /F8 1 Tf 5.8881 0 TD [(.)-446.1(\(2013\))-451.4(130:264)]TJ /F12 1 Tf 6.8114 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(8.)-445(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.0939 0 TD (10.1016/)Tj -31.0278 -1.142 TD (j.ygyno.2013.04.050)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(149.)-499.4(Uddin)-256.7(MN,)-255.7(Kouzi)-262.2(SA,)-255(Hussain)-261(MD.)-249.5(Strategies)-262.7(for)-254.3(developing)-261.4(oral)-255.1(vaccines)-263.8(for)]TJ -0.9314 -1.142 TD [(human)-398.7(papillomavirus)-406(\(HPV\))-397(induced)-403.1(cancer)-398.6(using)-400.2(nanoparticle)-402.1(mediated)-399.1(delivery)]TJ T* (system.)Tj /F11 1 Tf 3.2397 0 TD [(J)-295.4(Pharm)-308.8(Pharm)-300.7(Sci)]TJ /F8 1 Tf 7.7104 0 TD [(.)-300.3(\(2015\))-305.7(18:220)]TJ /F12 1 Tf 6.0339 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(34.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.18433/J3RS3V)Tj 0.13725 0.12157 0.12549 scn -19.8429 -1.5712 TD [(150.)-499.4(Kim)-416.4(MG,)-408.2(Park)-415.8(JY,)-414.4(Shon)-414.1(Y,)-412.4(Kim)-416.4(G,)-410.4(Shim)-415.5(G,)-410.4(Oh)-414.6(YK.)-410.5(Nanotechnology)-416.9(and)]TJ -0.9314 -1.142 TD 0.0539 Tc [(vacci)6.1(n)-4.4(e)-550.6(d)-1.1(evelo)-4.9(p)-1.1(m)7.4(e)0.2(nt.)]TJ /F11 1 Tf 10.4398 0 TD 0.0491 Tc [(As)-6.7(i)-4.9(a)-4.5(n)-553.8(J)-562.2(Ph)-7.8(arm)-562.9(S)-3.1(c)-5.2(i)]TJ /F8 1 Tf 8.7957 0 TD 0.0559 Tc [(.)-552.2(\()2(2)8.5(014)8.5(\))-556.8(9)8.5(:22)8.5(7)]TJ /F12 1 Tf 6.698 0 TD 0 Tc ()Tj /F8 1 Tf 0.5669 0 TD 0.0491 Tc [(35)-6.4(.)-559(d)-5.9(oi)-6.8(:)]TJ 0.15294 0.15294 0.15294 scn 4.1468 0 TD 0.0555 Tc [(10.)6.2(1016)8.1(/)]TJ -30.6471 -1.142 TD 0 Tc (j.ajps.2014.06.002)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(151.)-499.4(Karimi)-432.6(H,)-431.3(Soleimanjahi)-442.7(H,)-431.3(Abdoli)-433.6(A,)-431.4(Banijamali)-438.7(RS.)-433.2(Combination)-433.4(therapy)]TJ -0.9314 -1.142 TD [(using)-278.7(human)-269.1(papillomavirus)-284.5(L1/E6/E7)-273.2(genes)-275.3(and)-275.7(archaeosome:)-274.7(A)-276.8(nanovaccine)-277.3(confer)]TJ T* 0.032 Tc [(immuneadj)6.6(u)1.3(va)7.3(nting)-522.4(e)-5.6(f)63.8(f)7.1(ects)-527.3(to)]TJ /F9 1 Tf 13.7118 0 TD 0 Tc ()Tj /F8 1 Tf 0.5588 0 TD 0.0309 Tc [(g)-5.1(h)3.1(t)-525.6(c)-6.7(ervical)-529(c)1.4(anc)-6.6(e)1.4(r.)]TJ /F11 1 Tf 9.2654 0 TD 0.0276 Tc [(Sci)-536.6(R)-3(ep)]TJ /F8 1 Tf 3.2801 0 TD 0.0314 Tc [(.)-536.2(\()1.8(202)8.3(0)0.2(\))-532.7(10:57)8.2(87.)]TJ -26.8162 -1.142 TD 0 Tc (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1038/s41598)Tj /F12 1 Tf 6.1796 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (020-62448)Tj /F12 1 Tf 4.1873 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (3)Tj 0.13725 0.12157 0.12549 scn -12.254 -1.5712 TD [(152.)-499.4(Rupar)-355.5(MJ,)-364.9(Golusinski)-360.6(P,)-353.9(Golusinski)-360.6(W,)-361(Masternak)-365.4(M.)-354.9(Radiotherapy.)-359.8(human)]TJ -0.9314 -1.1501 TD [(pap)-13.3(ill)-9.4(oma)-16.6(vir)-11.4(us)-509.1(an)-10.1(d)-508.6(the)-508.5(us)-15(e)-507.3(o)0(f)-504.9(n)-9.7(an)-10.1(opart)-15.2(ic)-12.4(les)-508.9(fo)-10.8(r)-510.7(imm)-11.2(uno)-10.3(th)-9.3(erap)-12.5(y)-505.8(i)0(n)-511.1(H)-9.4(PV-r)-15.4(ela)-14.7(ted)]TJ 0 -1.142 TD 0.0212 Tc [(cancer:)-522.1(a)-521.8(rev)-6.7(i)5.8(ew)-6.4(.)]TJ /F11 1 Tf 7.9371 0 TD 0.0221 Tc [(Rep)-519.4(P)-0.9(r)5.4(a)0.9(ct)-518.2(Oncol)-516.4(R)-0.4(adiother)]TJ /F8 1 Tf 11.7923 0 TD 0.0231 Tc [(.)-520.2(\()1.6(2)8.1(019\))-516.7(24:)6.2(544)]TJ /F12 1 Tf 6.7466 0 TD 0 Tc ()Tj /F8 1 Tf 0.5345 0 TD 0.0237 Tc [(50.)-511.5(doi)8.3(:)]TJ 0.15294 0.15294 0.15294 scn 3.8633 0 TD 0.0234 Tc [(10.1)8.4(0)0.2(16/)]TJ -30.8739 -1.142 TD 0 Tc (j.rpor.2019.08.006)Tj 0.13725 0.12157 0.12549 scn 0.9314 -1.5712 TD [(153.)-499.4(Idrees)-470.4(H,)-463.7(Zaidi)-465.1(SZJ,)-472.4(Sabir)-465.6(A,)-463.8(Khan)-473.5(RU,)-463.8(Zhang)-469.1(X,)-465.3(Hassan)-466.3(S.)-472.2(A)-463.1(review)-470.5(of)]TJ -0.9314 -1.142 TD [(biodegradabl)-13.5(e)-499.2(natural)-502.1(polymer-b)-13.4(ased)-498.4(nanopar)-13.1(ticles)-502.8(for)-505.3(drug)-503(delivery)-502.7(applications.)]TJ /F11 1 Tf T* [(Nanomaterials)-308.5(\(Basel\))]TJ /F8 1 Tf 8.8443 0 TD [(.)-300.3(\(2020\))-297.6(10:1970.)-302.3(doi:)]TJ 0.15294 0.15294 0.15294 scn 8.8362 0 TD (10.3390/nano10101970)Tj 0.13725 0.12157 0.12549 scn -16.749 -1.5712 TD [(154.)-499.4(Gohar)-505.3(A,)-504.3(Ali)-503.8(AA,)-505.7(Elkhati)-11.9(b)-496.2(WF,)-505.1(El-S)-10.2(ayyad)-508.6(GS,)-501.2(Elfadil)-507.7(D,)-502.8(Nored)-12.3(din)-501.3(AM.)]TJ -0.9314 -1.142 TD [(Combination)-441.5(therapy)-438.5(between)-441.5(prophylactic)-436.4(and)-445.8(therapeutic)-440.4(human)-439.2(papillomavirus)]TJ T* [(\(HPV\))-291.7(vaccines)-296.2(with)-295.3(special)-293.3(emphasis)-297.1(on)-287.3(implementation)-296.8(of)-294.3(nanotechnology.)]TJ /F11 1 Tf 31.6109 0 TD (Microb)Tj -31.6109 -1.142 TD (Pathog)Tj /F8 1 Tf 2.7375 0 TD [(.)-300.3(\(2022\))-305.7(171:105747.)-298.9(doi:)]TJ 0.15294 0.15294 0.15294 scn 10.2778 0 TD (10.1016/j.micpath.2022.105747)Tj 0.13725 0.12157 0.12549 scn 24.3784 94.282 TD [(155.)-499.4(Witeof)-227.4(AE,)-225.8(Meinerz)-225.2(NM,)-231.4(Walker)-226.6(KD,)-225.5(Funke)-219.2(HH,)-230.1(Garcea)-226.9(RL,)-224.5(Randolph)-225.8(TW.)-224.8(A)]TJ -0.9233 -1.142 TD [(single)-383.8(dose,)-387.5(thermostable,)-387.1(trivalent)-387.6(human)-382.5(papillomavirus)-389.8(vaccine)-384.8(formulated)-390.9(using)]TJ T* 0.0554 Tc [(a)6.5(t)1(o)4.7(m)0.8(ic)-557.2(l)5.7(a)-1.6(yer)-552.5(d)0.4(epo)4.7(s)-1.8(itio)4.7(n.)]TJ /F11 1 Tf 11.9057 0 TD 0.6032 Tc [(JP)547.8(h)546.3(a)549.6(r)554.1(m)-8.8(S)551(c)548.9(i)]TJ /F8 1 Tf 5.7018 0 TD 0.0556 Tc [(.)-552.5(\()1.7(202)8.2(3\))-557.1(11)8.2(2:22)8.2(23)]TJ /F12 1 Tf 8.3097 0 TD 0 Tc ()Tj /F8 1 Tf 0.5669 0 TD 0.0474 Tc [(29)-8.1(.)-560.7(d)-7.7(o)-11.4(i)-0.4(:)]TJ 0.15294 0.15294 0.15294 scn 4.1549 0 TD 0.0559 Tc [(10.1)8.5(0)0.4(16/)]TJ -30.639 -1.142 TD 0 Tc (j.xphs.2023.02.007)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(156.)-499.4(Wahid)-296.9(R,)-301.9(Cannon)-291(MJ,)-300.1(Chow)-292.6(M.)-298.2(Virus-speci)]TJ /F9 1 Tf 20.1263 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(c)-296.7(CD4+)-293.5(and)-291.9(CD8+)-301.6(cytotoxic)-290(T-)]TJ -21.5842 -1.142 TD [(cell)-296(responses)-306(and)-308.1(long-term)-303.7(T-cell)-299.9(memory)-307(in)-300.5(individuals)-307.6(vaccinated)-308.3(against)-303(polio.)]TJ /F11 1 Tf 34.1216 0 TD (J)Tj -34.1216 -1.142 TD (Virol)Tj /F8 1 Tf 2.0086 0 TD [(.)-300.3(\(2005\))-297.6(79:5988)]TJ /F12 1 Tf 6.5117 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(95.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2802 0 TD (10.1128/JVI.79.10.5988)Tj /F12 1 Tf 9.2573 0 TD ()Tj /F8 1 Tf 0.5103 0 TD (5995.2005)Tj 0.13725 0.12157 0.12549 scn -21.1549 -1.5712 TD [(15)-13.9(7.)-517.9(Pu)-11.4(g)-11.7(l)-9.2(ie)-12.4(se)-13.7(-)-10.5(G)0(a)-13.2(r)0(c)-13.7(i)0(a)-526(M)0(,)-516.9(H)-9.4(ey)-16.9(er)-13.7(da)-14.9(hl)-523(LW)-15.6(,)-510.9(M)0(w)-17.4(a)0(m)-14.5(b)0(a)-520.9(C)0(,)-519.1(N)-14.2(kwe)-21.7(mu)-522.7(S,)-520.8(Ch)-11.7(il)-16.4(en)-14.9(gi)-521.2(R)-9.6(,)]TJ -0.9233 -1.1501 TD [(Dem)-11.1(o)-10.2(lis)-519.1(R)-9.6(,)-510.9(et)-513.1(al)-17.6(.)-510.9(Fac)-12(to)-16(rs)-519.3(in)]TJ /F9 1 Tf 12.1487 0 TD ()Tj /F8 1 Tf 6.9999 0 0 6.9999 393.6755 690.3495 Tm [(ue)-11.6(n)-9.7(c)0(i)-12.4(n)0(g)-515.6(v)0(a)-12.1(c)0(c)-10.3(i)0(n)-17(e)-507.3(ac)-13.6(ce)-10.3(pt)-12.2(an)-18.2(ce)-512.5(an)-10.1(d)-516.7(hes)-17.3(it)-13(an)-10.1(cy)-519.1(in)-511.1(th)-17.4(re)-13.7(e)]TJ -12.6832 -1.142 TD [(informal)-424.6(settlements)-423.2(in)-422(Lusaka,)-430(Zambia.)]TJ /F11 1 Tf 17.1216 0 TD (Vaccine)Tj /F8 1 Tf 3.102 0 TD [(.)-421.8(\(2018\))-427.1(36:5617)]TJ /F12 1 Tf 6.7628 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(24.)-427.7(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.5231 0 TD (10.1016/)Tj -31.0197 -1.142 TD (j.vaccine.2018.07.042)Tj 0.13725 0.12157 0.12549 scn 0.9233 -1.5712 TD [(158.)-499.4(Uddin)-386.2(MN,)-385.3(Henry)-384.8(B,)-381.5(Carter)-384.9(KD,)-379.4(Roni)-385.2(MA,)-380.6(Kouzi)-383.7(SS.)-384.9(A)-382.1(novel)-386.3(formulation)]TJ -0.9233 -1.142 TD [(strategy)-308.8(to)-299.5(deliver)-312.7(combined)-311.4(DNA)-307.2(and)-300(VLP)-307.7(based)-314.3(HPV)-305.5(vaccine.)]TJ /F11 1 Tf 26.4923 0 TD [(J)-303.5(Pharm)-308.8(Pharm)-308.8(Sci)]TJ /F8 1 Tf 7.7266 0 TD (.)Tj -34.2188 -1.142 TD [(\(2019\))-297.6(22:536)]TJ /F12 1 Tf 5.5155 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(47.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2802 0 TD (10.18433/jpps30768)Tj 0.13725 0.12157 0.12549 scn -8.3826 -1.5712 TD [(159.)-499.4(He)-273.8(M,)-273.9(Zhu)-275.5(L,)-271.5(Yang)-271.6(N,)-274.1(Li)-270(H,)-277.4(Yang)-271.6(Q.)-274.1(Recent)-275.6(advances)-274.4(of)-270(oral)]TJ /F9 1 Tf 27.0997 0 TD ()Tj /F8 1 Tf 0.5265 0 TD [(lm)-274.4(as)-268.1(platform)]TJ -28.5494 -1.142 TD [(for)-278.6(drug)-276.2(delivery.)]TJ /F11 1 Tf 7.2163 0 TD [(Int)-283.8(J)-279.2(Pharm)]TJ /F8 1 Tf 4.738 0 TD [(.)-284.1(\(2021\))-281.4(604:120759.)-282.7(doi:)]TJ 0.15294 0.15294 0.15294 scn 10.1887 0 TD (10.1016/j.ijpharm.2021.120759)Tj 0.13725 0.12157 0.12549 scn -21.2197 -1.5712 TD [(160.)-499.4(Jacob)-408.7(S,)-399.3(Nair)-403(AB,)-407.2(Boddu)-402.3(SH,)-400.6(Gorain)-405.4(B,)-405.8(Sreeharsha)-410.1(N,)-395.6(Shah)-406.1(J.)-407.6(An)-400(updated)]TJ -0.9233 -1.142 TD [(ove)-11(rv)-12.2(ie)-12.4(w)-513.6(o)0(f)-513(t)0(h)-9.3(e)-515.4(em)-11.2(er)-13.7(gi)-10.9(ng)-515.6(ro)-10.7(l)-9.2(e)-507.3(o)-10.2(f)-510.8(pat)-12.6(ch)-519(an)-10.1(d)]TJ /F9 1 Tf 19.5837 0 TD ()Tj /F8 1 Tf 0.5345 0 TD [(l)-9.2(m-b)-10.6(as)-17(ed)-513.8(b)-10.2(u)0(c)-11.6(cal)-516.8(de)-11.6(l)-9.2(i)0(v)-10.9(e)0(r)-13.7(y)-505.8(sy)-12.2(st)-14.3(em)-11.2(s.)]TJ /F11 1 Tf -20.1182 -1.142 TD (Pharmaceutics)Tj /F8 1 Tf 5.7666 0 TD [(.)-300.3(\(2021\))-305.7(13:1206.)-302.3(doi:)]TJ 0.15294 0.15294 0.15294 scn 8.8361 0 TD (10.3390/pharmaceutics13081206)Tj 0.13725 0.12157 0.12549 scn -13.6794 -1.5712 TD [(161.)-499.4(Barnabas)-289.5(RV,)-285.2(Brown)-291.2(ER,)-282.6(Onono)-289.1(MA,)-283.4(Bukusi)-293.1(EA,)-282.4(Njoroge)-288.1(B,)-284.3(Winer)-293.9(RL,)-281.2(et)-286.3(al.)]TJ -0.9233 -1.1501 TD (Ef)Tj /F9 1 Tf 0.8018 0 TD ()Tj /F8 1 Tf 0.5426 0 TD [(ca)-13.6(cy)-519.1(o)-10.2(f)-518.9(si)-15.8(ng)-13.4(l)-9.2(e)0(-)-15.6(dos)-17.2(e)-515.4(h)-11.6(um)-12.5(an)-528.5(pa)-14.9(pi)-13.7(l)-9.2(l)-9.2(o)0(m)-16.3(a)0(v)-12.1(i)0(r)-15.8(u)0(s)-525.3(v)0(a)-12.1(c)-13.3(ci)-12.4(n)-9.7(a)0(t)-14.2(i)0(o)-17.5(n)-511.9(am)-14.5(o)-10.2(n)-9.7(g)-513.9(y)0(o)-13.9(u)0(n)-16.2(g)-513.9(A)-9.5(f)0(r)-17.2(i)0(c)-12.4(a)0(n)]TJ -1.3445 -1.142 TD (women.)Tj /F11 1 Tf 3.4664 0 TD [(NEJM)-301.6(Evid)]TJ /F8 1 Tf 4.495 0 TD [(.)-300.3(\(2022\))-305.7(1:EVIDoa2100056.)-298(doi:)]TJ 0.15294 0.15294 0.15294 scn 13.0558 0 TD (10.1056/EVIDoa2100056)Tj 0.13725 0.12157 0.12549 scn -20.0939 -1.5712 TD [(162.)-499.4(Brotherton)-221.7(JM,)-211.1(Budd)-213.9(A,)-212.7(Rompotis)-218.2(C,)-211.3(Bartlett)-210.8(N,)-217.4(Malloy)-208.6(MJ,)-219.2(Andersen)-216.9(RL,)-208.3(et)-213.4(al.)]TJ -0.9233 -1.142 TD [(Is)-315.4(one)-324.8(dose)-322(of)-326.7(human)-325.8(papillomavirus)-325(vaccine)-328.1(as)-316.7(ef)59.1(fective)-324.3(as)-324.8(three?:)-326.1(a)-324.3(national)-320(cohort)]TJ T* (analysis.)Tj /F11 1 Tf 3.6284 0 TD [(Papillomavirus)-311.7(Res)]TJ /F8 1 Tf 7.5727 0 TD [(.)-300.3(\(2019\))-305.7(8:100177.)-301.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 9.314 0 TD (10.1016/j.pvr.2019.100177)Tj 0.13725 0.12157 0.12549 scn -19.5918 -1.5712 TD [(163.)-499.4(Watson-Jones)-238.7(D,)-235.5(Changalucha)-228.8(J,)-237.5(Whitworth)-230.2(H,)-228.8(Pinto)-232.4(L,)-231(Mutani)-238(P,)-232.4(Indangasi)-231.6(J,)]TJ -0.9233 -1.142 TD [(et)-221.5(al.)-228.9(Immunogenicity)-231.1(and)-227.1(safety)-234.7(of)-229.5(one-dose)-228.1(human)-228.6(papillomavirus)-227.8(vaccine)-230.9(compared)]TJ T* [(with)-295.3(two)-294.7(or)-302.3(three)-295.5(doses)-298.2(in)-300.5(Tanzanian)-303.5(girls)-296.4(\(DoRIS\):)-307.3(an)-293.6(open-label,)-303.7(randomised,)-304.5(non-)]TJ T* [(inferiority)-390(trial.)]TJ /F11 1 Tf 6.6251 0 TD [(Lancet)-381.8(Glob)-388.6(Health)]TJ /F8 1 Tf 7.9371 0 TD [(.)-381.3(\(2022\))-394.7(10:e1473)]TJ /F12 1 Tf 7.1029 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(e84.)-384.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.8633 0 TD (10.1016/S2214)Tj /F12 1 Tf 5.8071 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (109X)Tj -32.356 -1.142 TD (\(22\)00309)Tj /F12 1 Tf 4.0415 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (6)Tj 0.13725 0.12157 0.12549 scn -3.6284 -1.5712 TD [(164.)-499.4(Rodriguez)-297.5(AM,)-299.6(Zeybek)-294.8(B,)-292.4(Vaughn)-290.6(M,)-298.2(Westra)-291.5(J,)-294.2(Kaul)-297.6(S,)-285.9(Montealegre)-303.9(JR,)-287.7(et)-294.4(al.)]TJ -0.9233 -1.1501 TD [(Comparison)-205.3(of)-205.2(the)-208.9(long-term)-206.5(impact)-209.3(and)-210.9(clinical)-207.3(outcomes)-211.6(of)-148.5(fewer)-209.1(doses)-209.1(and)-202.9(standard)]TJ 0 -1.142 TD [(doses)-265.8(of)-261.9(human)-261(papillomavirus)-276.4(vaccine)-263.3(in)-268.1(the)-265.6(United)-261.1(States:)-271.1(a)-259.5(database)-272.2(study.)]TJ /F11 1 Tf 31.4408 0 TD (Cancer)Tj /F8 1 Tf 2.778 0 TD (.)Tj -34.2188 -1.142 TD [(\(2020\))-297.6(126:1656)]TJ /F12 1 Tf 6.4712 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(67.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2801 0 TD (10.1002/cncr.32700)Tj 0.13725 0.12157 0.12549 scn -9.3383 -1.5712 TD [(165.)-499.4(Basu)-218(P,)-216.2(Malvi)-212.7(SG,)-217.8(Joshi)-217.9(S,)-213(Bhatla)-221.9(N,)-209.3(Muwonge)-222.8(R,)-212.8(Lucas)-218.5(E,)-216.2(et)-213.4(al.)-212.7(Vaccine)-218.7(ef)]TJ /F9 1 Tf 31.2545 0 TD ()Tj /F8 1 Tf 0.5345 0 TD (cacy)Tj -32.7124 -1.142 TD [(against)-294.9(persistent)-306(human)-301.5(papillomavirus)-300.7(\(HPV\))-299.9(16/18)-305.2(infection)-295.9(at)-297.7(10)-305.5(years)-293.6(after)-303.9(one,)]TJ T* [(two,)-408.8(and)-421.5(three)-417(doses)-411.6(of)-415.8(quadrivalent)-419.7(HPV)-418.9(vaccine)-417.2(in)-422(girls)-409.8(in)-422(India:)-412.4(a)-413.4(multicentre,)]TJ T* [(prospective,)-300(cohort)-302.8(study.)]TJ /F11 1 Tf 10.6585 0 TD [(Lancet)-300.9(Oncol)]TJ /F8 1 Tf 5.2401 0 TD [(.)-300.3(\(2021\))-305.7(22:1518)]TJ /F12 1 Tf 6.5198 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(29.)-306.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2802 0 TD (10.1016/S1470)Tj /F12 1 Tf 5.799 0 TD ()Tj /F8 1 Tf 0.5103 0 TD (2045)Tj -32.518 -1.142 TD (\(21\)00453)Tj /F12 1 Tf 4.0415 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (8)Tj 0.13725 0.12157 0.12549 scn -3.6284 -1.5712 TD [(166.)-499.4(Kreimer)-403.4(AR,)-392.4(Sampson)-399.6(JN,)-397.6(Porras)-397.7(C,)-397.6(Schiller)-398.1(JT,)-393(Kemp)-396.5(T,)-399.1(Herrero)-395.9(R,)-399.1(et)-391.6(al.)]TJ -0.9233 -1.142 TD [(evalsuation)-292.9(of)-294.3(durability)-300.2(of)-294.3(a)-300(single)-294.7(dose)-297.7(of)-294.3(the)-298(bivalent)-294.4(HPV)-297.4(vaccine:)-304.5(the)-289.9(CVT)-300.8(trial.)]TJ /F11 1 Tf 34.1216 0 TD (J)Tj -34.1216 -1.142 TD [(Natl)-297.8(Cancer)-298.7(Inst)]TJ /F8 1 Tf 6.6089 0 TD [(.)-300.4(\(2020\))-297.6(112:1038)]TJ /F12 1 Tf 6.9896 0 TD ()Tj /F8 1 Tf 0.5183 0 TD [(46.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2721 0 TD (10.1093/jnci/djaa011)Tj 0.13725 0.12157 0.12549 scn -16.4655 -1.5712 TD [(167.)-499.4(Di)-282.6(J,)-278(Wang)-276.9(J,)-278(Wang)-276.9(S,)-277.8(Ma)-273.6(M,)-282(Zhang)-274.8(H,)-277.4(Liu)-276.5(N,)-274.1(et)-278.2(al.)-277.5(Self-boosting)-279.3(vaccination)]TJ -0.9233 -1.1501 TD [(ba)-18.7(se)-21.8(d)-516.7(o)-10.2(n)-520(p)-14.5(ul)-15.6(s)-16.7(a)0(t)-14.2(i)-15.4(l)-9.2(e)-515.4(a)-16.6(n)-9.7(ti)-21.1(ge)-16.9(n)-520(r)0(e)-21.8(l)-9.2(e)-13.3(a)0(s)-17(e)-523.5(fr)-17.2(o)-10.2(m)-524.4(c)-13.3(o)-10.2(re)]TJ /F12 1 Tf 19.3245 0 TD ()Tj /F8 1 Tf 0.5264 0 TD [(sh)-20.2(el)-22.4(l)-519.4(m)0(i)-13.3(c)-13.3(r)0(o)-18.8(p)-14.5(ar)-17(t)-13.9(i)0(c)-20.5(l)-9.2(e)-13.3(s)0(.)]TJ /F11 1 Tf 8.9333 0 TD [(S)-11.7(m)-12.7(al)-17.1(l)]TJ /F8 1 Tf 2.2597 0 TD [(.)-519(\()-13.4(20)-22(23)-13.9(\))]TJ -31.044 -1.142 TD [(19:2207892.)-298.9(doi:)]TJ 0.15294 0.15294 0.15294 scn 6.8438 0 TD (10.1002/smll.202207892)Tj 0.13725 0.12157 0.12549 scn -5.9205 -1.5712 TD [(168.)-499.4(Arinaminpathy)-459.1(N,)-452.3(Lavine)-450.9(JS,)-449.9(Grenfell)-449.2(BT.)-447.8(Self-boosting)-457.4(vaccines)-450.1(and)-445.8(their)]TJ -0.9233 -1.142 TD [(imp)-11.7(l)-9.2(ica)-12.8(ti)-13.1(ons)-514.5(fo)-10.8(r)-510.7(her)-17.3(d)-508.6(i)0(m)-13.3(m)0(u)-12.5(nit)-14.7(y.)]TJ /F11 1 Tf 14.2545 0 TD [(Pro)-17.2(c)-507.8(N)0(a)-12.7(t)0(l)-511.9(A)0(c)-13.8(a)0(d)-509.4(S)-11.8(ci)-513.2(U.)-13.5(S.)-9.5(A)]TJ /F8 1 Tf 10.9986 0 TD [(.)-510.9(\()0(2)-12.2(012)-12.8(\))-515.5(109)-12.8(:20)-14.6(15)-13.9(4)]TJ /F12 1 Tf 7.9614 0 TD ()Tj /F8 1 Tf 0.5183 0 TD (9.)Tj -33.7329 -1.142 TD (doi:)Tj 6.9999 0 0 6.9999 317.4802 345.3731 Tm 0.15294 0.15294 0.15294 scn (10.1073/pnas.1209683109)Tj 0.13725 0.12157 0.12549 scn -0.8747 -1.5712 TD [(169.)-499.4(World)-289.4(Health)-284.5(Organization.)-293.7(One-dose)-288.8(Human)-291.2(Papillomavirus)-283(\(HPV\))-291.8(vaccine)]TJ -0.9233 -1.142 TD [(of)62.1(fers)-274(solid)-268.5(protection)-276.9(against)-270.6(cervical)-279.4(cancer)-277.2(\(2022\).)-273.9(Available)-273.7(online)-270.1(at:)]TJ 0.85098 0.19216 0.2 scn 29.3027 0 TD (https://www.)Tj -29.3027 -1.142 TD 0.0291 Tc [(who)-5.4(.)-4(in)-4.9(t/)-5.3(ne)-8.5(ws)-3.8(/)-5.3(i)-2.5(tem)-9.3(/)2.8(11)]TJ /F12 1 Tf 9.3707 0 TD 0 Tc ()Tj /F8 1 Tf 0.5426 0 TD 0.0318 Tc [(04-2022-one)-5.7(-)5.1(dose-hum)-6.6(an)5.9(-papi)]TJ 13.3393 0 TD 0.0315 Tc [(llom)-6.9(a)6.8(virus-\(hp)-7.3(v)3.6(\)-vac)-6.1(c)2.1(ine-)]TJ -23.2526 -1.142 TD 0 Tc [(of)62.1(fers-solid-protection-against-cervical-cancer)]TJ 0.13725 0.12157 0.12549 scn 18.6685 0 TD [(\(Accessed)-310.2(December)-304.6(5,)-299.2(2023\).)]TJ -17.7452 -1.5712 TD [(170.)-499.4(Prem)-348.7(K,)-339(Choi)-337(YH,)-348.9(Be)]TJ /F15 1 Tf 11.0715 0.0405 TD ()Tj /F8 1 Tf 0.0405 -0.0405 TD [(nard)-341(E)]TJ /F15 1 Tf 2.6565 0.2349 TD ()Tj /F8 1 Tf 0.1134 -0.2349 TD [(,)-340.8(Burger)-340.3(EA,)-339.1(Hadley)-350.1(L,)-336.3(Laprise)-347.7(J-F,)-343.6(et)-334.9(al.)-342.3(Global)]TJ -14.8052 -1.142 TD [(impact)-500.8(and)-502.5(cost-ef)59.3(fectiv)-11.4(eness)-498.9(of)-504.9(one-dose)-503.5(versus)-510.7(two-dose)-505.8(human)-504(papillomavirus)]TJ 0 -1.1501 TD [(vaccination)-405(schedules:)-407.2(a)-405.3(comparative)-415.5(modelling)-407.1(analysis.)]TJ /F11 1 Tf 23.7224 0 TD [(BMC)-406.4(Med)]TJ /F8 1 Tf 4.252 0 TD [(.)-405.6(\(2023\))-402.8(21:313.)]TJ -27.9744 -1.142 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1186/s12916)Tj /F12 1 Tf 6.1715 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (023-02988)Tj /F12 1 Tf 4.1954 0 TD ()Tj /F8 1 Tf 0.5103 0 TD (3)Tj 0.13725 0.12157 0.12549 scn -12.2621 -1.5712 TD 0.0636 Tc [(17)8.1(1.)-495.9(H)5.6(i)7.7(s)-560.5(M)9.1(aj)5.8(es)6.4(t)9.2(y)]TJ /F12 1 Tf 8.0424 0 TD 0 Tc ()Tj /F8 1 Tf 0.2835 0 TD 0.0589 Tc [(s)-557.1(G)-2.5(overnme)5.2(n)-7.5(t.)-565.4(Joint)-562.4(C)2.2(o)-8(m)4.3(mittee)-561.8(on)-558.3(V)-5.4(a)1.8(ccina)-6.2(t)4.5(i)-5.1(o)0.1(n)-558.3(a)1.8(nd)]TJ -9.2492 -1.142 TD 0.0203 Tc [(I)5(m)6.2(muni)4.9(sat)6.4(i)-3.2(on)-515.9(\()6.9(J)-6(C)4.1(V)4.6(I\))-511.4(st)6.4(atem)6.2(ent)-520(o)2(n)-515.9(a)-514.6(one-d)5.8(o)2(se)-511.3(sched)5.8(u)-2.3(le)-519.4(for)-514.7(t)-1.7(h)8.6(e)-519.4(routi)4.9(n)2.5(e)-519.4(H)2.8(PV)]TJ T* 0.0428 Tc [(immuni)-5(sa)-6.1(ti)-5(on)-542(progr)-6.3(a)2(mme)-537.4(\(202)]TJ 14.2545 0 TD 0.0421 Tc [(2\).)-549.8(A)0.2(vai)-5.7(l)0.5(ab)-8.6(le)-546.2(onli)-5.7(ne)-546.2(at:)]TJ 0.85098 0.19216 0.2 scn 11.2983 0 TD 0.0438 Tc [(ht)5.6(tps:/)-6.8(/)1.3(www.gov.uk/)]TJ -25.5528 -1.142 TD 0.0251 Tc [(governmen)7.3(t)-5(/publicat)-5(i)1.6(ons/)6.9(s)-7.8(i)1.6(ngle-d)-5.6(o)6.8(s)0.3(e-)6.5(of-h)]TJ 17.7857 0 TD 0.0255 Tc [(pv)5.6(-vac)4.1(cine)4.1(-jc)4.2(v)-2.5(i-c)4.1(o)-0.9(nc)]TJ 8.7309 0 TD 0.025 Tc [(lud)-5.7(i)1.5(ng)5.1(-advice/jcvi-)]TJ -26.5166 -1.142 TD 0.0184 Tc [(sta)-6.3(t)4.5(ement-on-a-one-dos)-6.4(e)5.1(-)-0.2(s)-6.4(c)5.2(hedule-for-t)]TJ 16.7004 0 TD [(h)6.9(e)-2.9(-routine-h)6.9(pv-immunis)-6.3(ation-programme)]TJ 0.13725 0.12157 0.12549 scn -16.7004 -1.142 TD 0 Tc [(\(Accessed)-302(December)-304.6(5,)-299.2(2023\).)]TJ 0.9233 -1.5712 TD [(172.)-499.4(U.S.)-359.4(FOOD)-358.8(&)-361.1(DRUG.)-355.1(FDA)-356.1(approves)-365.4(expanded)-357.5(use)-360.4(of)-359.1(Gardasil)-353.3(9)-363.3(t)0(o)-356.2(include)]TJ -0.9233 -1.142 TD [(individuals)-331.9(27)-321.7(through)-333.4(45)-329.8(years)-326(old)-333.6(\(2018\).)-330.6(Available)-330.4(online)-326.8(at:)]TJ 0.85098 0.19216 0.2 scn 26.0954 0 TD (https://www.fda.gov/)Tj -26.0954 -1.142 TD 0.0167 Tc [(n)7(e)-4.7(w)5.3(s)-8.1(-)6.2(e)-4.7(vents/press-ann)7(o)-1.6(u)-5.9(n)7(cem)-5.5(e)3.4(nts/fd)-5.9(a-)6.2(ap)-5.9(pr)]TJ 18.3364 0 TD 0.0205 Tc [(ove)7.2(s)3.8(-e)7.2(xp)6(an)10.8(de)7.2(d-)10(us)3.8(e)7.2(-)1.9(g)8.8(a)-4.2(r)3.8(d)6(a)3.9(s)3.8(i)5.1(l)3.2(-9)5.5(-i)5.1(nc)7.2(l)3.2(u)6(de)7.2(-)]TJ -18.3364 -1.1501 TD 0 Tc (individuals-27-through-45-years-old)Tj 0.13725 0.12157 0.12549 scn 14.9024 0 TD [(\(Accessed)-302(December)-304.6(5,)-299.2(2023\).)]TJ -13.9791 -1.5712 TD [(173.)-499.4(Eskandari)-213.4(N,)-201.2(Youse)]TJ /F9 1 Tf 9.9295 0 TD ()Tj /F8 1 Tf 0.7289 0 TD [(Z,)-201.4(Aria)-203.9(H,)-204.5(Bastan)-211.3(R.)-196.6(An)-205.6(update)-208.9(on)-198.2(human)-204.3(papilloma)-209.5(virus)]TJ -11.5818 -1.142 TD [(\(H)-14.7(P)-13(V)0(\))-531.3(v)-11.7(ac)-21.7(c)-13.3(i)0(n)-17(e)-13.3(s:)-527.6(h)-11.6(i)0(s)-23.9(t)0(o)-16(r)0(y)-20.3(,)-527.1(ty)-17.5(pe)-19.7(s,)-535.7(pr)-15(o)-10.3(t)-13.9(e)-13.3(c)0(t)-19(i)0(o)-17.5(n)-9.7(,)-527.1(a)0(n)-18.2(d)-516.7(e)-13.3(f)]TJ /F9 1 Tf 21.5113 0 TD ()Tj /F8 1 Tf 0.5345 0 TD 0.0133 Tc [(ca)13.3(c)-8.4(y)1.6(.)]TJ /F11 1 Tf 2.5107 0 TD [(Fr)13.2(ont)-502.8(I)-2.1(mm)13.2(unol)]TJ /F8 1 Tf 6.4874 0 TD 0 Tc [(.)-519(\()-13.4(20)-22(21)-13.9(\))]TJ -31.044 -1.142 TD [(12:805695.)-300(doi:)]TJ 0.15294 0.15294 0.15294 scn 6.3659 0 TD (10.3389/)Tj /F9 1 Tf 3.4178 0 TD ()Tj /F8 1 Tf 0.5345 0 TD (mmu.2021.805695)Tj 0.13725 0.12157 0.12549 scn -9.395 -1.5712 TD [(174.)-499.4(Sauver)-358(JLS,)-364.3(Rutten)-350.3(LJF,)-360.9(Ebbert)-352.7(JO,)-357.1(Jacobson)-356.3(DJ,)-359(McGree)-358.7(ME,)-359.8(Jacobson)-356.3(RM.)]TJ -0.9233 -1.142 TD [(Younger)-398.9(age)-397.9(at)-394.9(initiation)-394.8(of)-399.6(the)-395.1(human)-398.7(papillomavirus)-406(\(HPV\))-397(vaccination)-405(series)-399.7(is)]TJ T* [(associated)-487.2(with)-481.6(higher)-485.3(rates)-490.1(of)-480.6(on-time)-484(completion.)]TJ /F11 1 Tf 22.3374 0 TD [(Prev)-487.4(Med)]TJ /F8 1 Tf 4.0091 0 TD [(.)-486.6(\(2016\))-483.8(89:327)]TJ /F12 1 Tf 6.4064 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (33.)Tj -33.2631 -1.142 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1016/j.ypmed.2016.02.039)Tj 0.13725 0.12157 0.12549 scn -0.8747 -1.5712 TD [(175.)-499.4(Goleman)-329(MJ,)-316.3(Dolce)-321.3(M,)-322.5(Morack)-326.9(J.)-318.5(Quality)-322.3(improvement)-325.2(initiative)-326.9(to)-315.7(improve)]TJ -0.9233 -1.142 TD [(human)-212.4(papillomavirus)-227.8(vaccine)-214.7(initiation)-224.7(at)-216.7(9)-217.5(years)-220.7(of)-213.3(age.)]TJ /F11 1 Tf 22.9448 0 TD [(Acad)-215.4(Pediatr)]TJ /F8 1 Tf 5.1106 0 TD [(.)-219.4(\(2018\))-216.6(18:769)]TJ /F12 1 Tf 5.8719 0 TD ()Tj /F8 1 Tf -33.9273 -1.142 TD [(75.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.1016/j.acap.2018.05.005)Tj /F1 1 Tf 0.49804 0.49804 0.49412 scn -39.7424 100.081 TD [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.4323 0 TD (15)Tj ET endstream endobj 566 0 obj<> endobj 567 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 568 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 569 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 570 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 571 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 572 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 573 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 574 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 575 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 576 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 577 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 578 0 obj<>/Border[0 0 0]/Type/Annot>> endobj 579 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 580 0 obj<>stream /GS1 gs BT /F8 1 Tf 6.9999 0 0 6.9999 56.126 760.3652 Tm /Cs6 cs 0.13725 0.12157 0.12549 scn 0 Tc 0 Tw [(176.)-499.4(B)48.5(r)48.1(o)54.5(u)50.3(w)45.3(e)51.5(r)-178.6(A)47.2(F)50.3(,)-178.9(D)48.7(e)51.5(l)47.5(i)49.4(n)47(g)53(e)51.5(r)-178.6(R)47.1(L)45.1(,)-178.9(E)51.8(i)49.4(s)48.1(e)51.5(n)47(b)54.5(e)43.4(r)56.2(g)-181.8(M)50.8(C)48.6(,)-178.9(C)48.6(a)48.2(m)50.7(p)50.3(r)48.1(e)51.5(d)50.3(o)46.4(n)-179.8(L)53.2(P)43.7(,)-178.9(W)52.8(a)48.2(l)47.5(l)55.6(i)49.4(n)47(e)-183.3(H)55.4(M)42.7(,)-178.9(C)48.6(a)56.3(r)48.1(e)51.5(y)-181.8(T)47.1(E)51.8(,)-178.9(e)43.4(t)-175.8(a)48.2(l)47.5(.)]TJ -0.9314 -1.142 TD -0.045 Tc [(HP)6.8(V)-303.7(v)-0.1(a)11.3(c)-1.6(c)6.5(i)4.4(na)11.3(ti)4.4(o)9.5(n)-305.8(h)8.2(a)3.2(s)-304.6(n)2(o)9.5(t)-309.9(i)4.4(n)10.1(cr)11.2(eas)11.2(e)-1.6(d)-302.5(s)3.1(e)6.5(x)1.8(u)5.3(a)3.2(l)-305.2(a)11.3(ct)5.9(i)4.4(v)8(i)4.4(t)]TJ 17.6561 0 TD -0.0509 Tc [(y)-313.7(o)3.6(r)-310.5(a)-2.7(cc)-7.5(elerated)-308.4(sexual)-311.1(deb)-4.5(u)-0.6(t)-307.7(i)-1.5(n)-311.7(a)-310.4(co)-4.5(lleg)-6(e-)-4.7(ag)-6(ed)]TJ -17.6561 -1.142 TD -0.0488 Tc [(cohort)-240.8(of)-243.8(men)-252.9(a)7.5(nd)-249.6(women.)]TJ /F11 1 Tf 10.0753 0 TD -0.0449 Tc [(BM)12.1(C)-246(P)5(u)8.3(b)4.8(li)6.4(c)-236.8(H)-2.4(e)9.9(a)6.7(lt)6(h)]TJ /F8 1 Tf 6.941 0 TD -0.0494 Tc [(.)-244.5(\()2(2019\))-249(19:821.)-244.5(doi:)]TJ 0.15294 0.15294 0.15294 scn 7.2406 0 TD -0.0498 Tc (10.1186/s12889)Tj /F12 1 Tf 5.475 0 TD 0 Tc ()Tj /F8 1 Tf 0.4617 0 TD -0.0493 Tc (019-7134)Tj /F12 1 Tf 3.3125 0 TD 0 Tc ()Tj /F8 1 Tf 0.4536 0 TD (1)Tj 0.13725 0.12157 0.12549 scn -33.0283 -1.5712 TD [(177.)-499.4(Logel)-307.2(M,)-306.3(Laurie)-314.9(C,)-308.5(El-Zein)-312.3(M,)-306.3(Guichon)-306.4(J,)-310.4(Franco)-315.9(EL.)-308.9(A)-309.2(review)-308.6(of)-302.4(ethical)-311.9(and)]TJ -0.9314 -1.142 TD [(legal)-351.5(aspects)-347.8(of)-351(gender-neutral)-353.7(human)-350.1(papillomavirus)-349.3(vaccination.)]TJ /F11 1 Tf 27.3589 0 TD [(Cancer)-347.3(Epidemiol)]TJ -27.3589 -1.142 TD [(Biomarkers)-307(Prev)]TJ /F8 1 Tf 6.5603 0 TD [(.)-300.3(\(2022\))-305.7(31:919)]TJ /F12 1 Tf 6.0339 0 TD ()Tj /F8 1 Tf 0.5183 0 TD [(31.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.272 0 TD (10.1158/1055)Tj /F12 1 Tf 5.3373 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (9965.EPI-21)Tj /F12 1 Tf 4.9 0 TD ()Tj /F8 1 Tf 0.5102 0 TD (1256)Tj 0.13725 0.12157 0.12549 scn -26.7109 -1.5712 TD [(178.)-499.4(Bruni)-250.9(L,)-255.3(Saura-La)]TJ /F15 1 Tf 9.1763 0.0405 TD ()Tj /F8 1 Tf 0.0486 -0.0405 TD [(zaro)-251.1(A,)-253.2(Montoliu)-251.2(A,)-253.2(Brotons)-255.8(M,)-249.6(Alemany)-254.3(L,)-247.2(Diallo)-254.9(MS,)-251.4(et)-253.9(al.)]TJ -10.1563 -1.142 TD [(H)-9.4(P)-13(V)-517.9(v)-11.8(ac)-13.6(c)-13.3(i)0(n)-17(a)-16.6(ti)-13(o)-10.2(n)-520(in)-25.1(tr)-14.3(o)-10.2(d)-14.5(uc)-19.7(ti)-13(o)-10.2(n)-520(w)-11.4(o)-10.2(rl)-17.7(d)-14.5(w)0(i)-18.7(d)0(e)-530(a)0(n)-18.2(d)-516.7(W)-12(H)-9.4(O)-516.4(a)0(n)-26.3(d)-516.7(UN)-22.3(IC)-15.3(E)-13(F)-516.7(e)-13.3(s)0(t)-14.3(i)-15.4(ma)-14.5(t)-13.9(e)0(s)-524(o)-10.2(f)]TJ 0 -1.1501 TD [(na)-10.1(ti)-13(on)-11.9(al)-511.7(H)-9.4(P)0(V)-514.7(imm)-11.2(un)-16.2(iz)-12.4(ati)-13.4(on)-514(cov)-19.1(era)-14.1(ge)-511(20)-13.9(10)]TJ /F12 1 Tf 18.5389 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(20)-13.9(19.)]TJ /F11 1 Tf 2.6646 0 TD [(Pr)-15.4(ev)-512.5(Me)-9.7(d)]TJ /F8 1 Tf 4.0577 0 TD [(.)-510.9(\()0(2)-12.2(0)0(2)-13.9(1)0(\))-514.4(144)-12.8(:1)-15.7(063)-12.8(99.)]TJ -25.7714 -1.142 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.1016/j.ypmed.2020.106399)Tj 0.13725 0.12157 0.12549 scn -0.8666 -1.5712 TD [(17)-13.9(9)-15(.)-502.8(L)-11.6(e)-13.3(h)-11.6(t)0(i)-13(n)-9.7(e)-13.3(n)-520(M,)-525(S)-9.8()-10.2(d)-14.5(e)0(r)-13.7(l)-9.2(u)-14.5(n)-9.7(d-)-16.9(S)-9.8(t)-13.9(ra)-17(n)-9.7(d)-516.7(A)-9.5(,)-519(V)-15.7()0(n)-18.2(s)0(k)-21.7()-518.7(S)-9.8(,)-519(L)-11.6(u)0(o)-16.7(s)0(t)-14.3(a)-16.6(ri)-15.8(n)-9.7(e)-13.3(n)-520(T)-9.6(,)-519(E)0(r)-13.5(i)-15.4(ks)-13.6(s)-16.7(o)0(n)-522.1(T)-9.6(,)]TJ -0.9314 -1.142 TD [(Natunen)-367.4(K,)-371.4(et)-367.3(al.)-366.6(Impact)-371.1(of)-359.1(gender-neutral)-378(or)-367.1(girls-only)-364.1(vaccination)-372.6(against)-367.8(human)]TJ T* (papillomavirus)Tj /F12 1 Tf 5.961 0 TD ()Tj /F8 1 Tf 0.9152 0 TD [(Results)-401.6(of)-391.5(a)-397.2(community-randomized)-411.8(clinical)-393.5(trial)-403.7(\(I\).)]TJ /F11 1 Tf 22.2969 0 TD [(Int)-397.2(J)-392.6(Cancer)]TJ /F8 1 Tf 5.0458 0 TD (.)Tj -34.2188 -1.142 TD [(\(2018\))-305.7(142:949)]TJ /F12 1 Tf 6.0015 0 TD ()Tj /F8 1 Tf 0.5102 0 TD [(58.)-298.1(doi:)]TJ 0.15294 0.15294 0.15294 scn 3.2721 0 TD (10.1002/ijc.31119)Tj 0.13725 0.12157 0.12549 scn 27.6099 16.1416 TD [(180.)-499.4(Man)-275.2(I,)-275.1(Georges)-272.9(D,)-276(Sankaranarayanan)-279.8(R,)-277.6(Basu)-266.6(P,)-281(Baussano)-271.3(I.)-275.1(Building)-277(resilient)]TJ -0.9233 -1.142 TD [(cervical)-319.9(cancer)-317.7(prevention)-322.9(through)-317.2(gender-neutral)-321.3(HPV)-321.7(vaccination.)]TJ /F11 1 Tf 28.0716 0 TD (Elife)Tj /F8 1 Tf 1.7332 0 TD [(.)-316.5(\(2023\))-321.9(12:)]TJ -29.8048 -1.142 TD [(e85735.)-299.8(doi:)]TJ 0.15294 0.15294 0.15294 scn 5.1268 0 TD (10.7554/eLife.85735)Tj 0.13725 0.12157 0.12549 scn -4.2034 -1.5712 TD [(181)-12.8(.)-502.8(WHO)-11.4(.)-502.8(Wee)-14.2(kly)-511.9(ep)-11.6(ide)-10.8(miolo)-10.6(gi)-10.9(cal)-508.8(re)-13.7(cord)-14.2(:)-502.8(M)0(e)-11.1(eti)-10.1(ng)-507.5(of)-513(the)-508.5(Stra)-16.5(tegi)-13.8(c)-507.3(Adv)-11.6(iso)-9.9(ry)]TJ -0.9233 -1.142 TD 0.0881 Tc [(Grou)-7.4(p)-590.6(o)5(f)-592.8(E)2.2(xpe)-6.1(r)6.6(t)-6.8(s)-584.6(on)-585.8(Im)-7(munizat)-6.8(i)-0.2(on,)-592.9(O)1(ct)-6.8(ober)-592.7(2019:)-592.9(conclusion)5.5(s)-592.7(a)-1.4(nd)]TJ T* 0.0157 Tc [(r)15.7(e)-14.2(commendations)-511.2(\(2019\))-5.8(.)-511.4(A)-1.9(vailable)-515.9(on)6(line)-515.9(at:)]TJ 0.85098 0.19216 0.2 scn 20.3693 0 TD 0.0168 Tc [(https://)6.7(rel)7.6(i)1.4(efw)5.4(e)3.5(b.int/)6.7(repo)6.6(rt/wo)6.6(r)0.1(ld/)]TJ -20.3693 -1.142 TD 0.0149 Tc [(week)-6.3(l)5.7(y)-4.9(-e)-6.5(pidemiol)5.7(ogic)-6.5(al)5.7(-record-)]TJ 13.072 0 TD 0.0146 Tc [(wer-22-n)4.9(o)-3.7(ve)-6.8(mbe)-6.8(r)-2.1(-2019-vol)5.4(-)-4(94-no-47)]TJ /F12 1 Tf 15.4774 0 TD 0 Tc ()Tj /F8 1 Tf 0.5264 0 TD 0.0153 Tc (541-560-enfr)Tj 0.13725 0.12157 0.12549 scn -29.0759 -1.1501 TD 0 Tc [(\(Accessed)-302(March)-299(13,)-306.2(2024\).)]TJ 0.9233 -1.5712 TD [(18)-13.9(2.)-517.9(Sh)-13.4(in)-519.2(H)-9.4(,)-510.9(J)-10.1(eon)-527.3(S,)-520.8(Ch)-11.7(o)-512.4(I)0(,)-518.1(P)-13(ark)-524.2(H)-9.4(.)-510.9(Fa)-14.9(ct)-10.9(o)-10.2(r)0(s)-519.3(a)0(f)47.7(f)0(e)-13.8(c)0(t)-10.9(i)0(n)-17(g)-513.9(hu)-10(m)-14.1(a)0(n)-520.3(p)0(a)-14.9(p)0(i)-13.7(l)0(l)-10.2(o)0(m)-16.3(a)0(v)-12.1(i)0(r)-15.8(u)0(s)]TJ -0.9233 -1.142 TD [(vaccination)-340.2(in)-341(men:)-345.6(systematic)-339.8(review.)]TJ /F11 1 Tf 16.012 0 TD [(JMIR)-341.1(Public)-340.2(Health)-338.9(Surveill)]TJ /F8 1 Tf 11.193 0 TD [(.)-340.8(\(2022\))-346.1(8:e34070.)]TJ -27.205 -1.142 TD (doi:)Tj 0.15294 0.15294 0.15294 scn 1.798 0 TD (10.2196/34070)Tj 0.13725 0.12157 0.12549 scn -0.8747 -1.5712 TD 0.0225 Tc [(183.)-496.5(Gezimu)-526.6(W,)-520.8(Bekele)-517.2(F,)-520.8(Bekan)4.7(a)-528.6(T)4.8(,)-520.8(Demeke)-525.3(A)4.9(.)-520.8(Males)]TJ /F12 1 Tf 25.1316 0 TD 0 Tc ()Tj /F8 1 Tf 0.7694 0 TD 0.0207 Tc [(Acce)-8.7(ss)-522.4(to)-524.1(human)]TJ -26.8243 -1.142 TD 0 Tc [(papillomavirus)-373.6(vaccination)-380.7(in)-373.4(resource-limited)-382.8(settings.)]TJ /F11 1 Tf 22.9691 0 TD [(Immunotargets)-380.6(Ther)]TJ /F8 1 Tf 8.2692 0 TD [(.)-373.2(\(2024\))]TJ -31.2383 -1.142 TD (13:95)Tj /F12 1 Tf 2.1301 0 TD ()Tj /F8 1 Tf 0.5103 0 TD [(8.)-299.2(doi:)]TJ 0.15294 0.15294 0.15294 scn 2.8023 0 TD (10.2147/ITT.S451659)Tj /F1 1 Tf 0.49804 0.49804 0.49412 scn -41.913 21.9406 TD [(Wang)-305.1(et)-300.8(al.)]TJ 57.1394 0 TD (10.3389/fimmu.2024.1362770)Tj -57.1394 -109.3302 TD [(Frontiers)-304.6(in)]TJ 0.85098 0.19216 0.2 scn 5.5074 0 TD (Immunology)Tj 58.8564 0 TD (frontiersin.org)Tj 0.15294 0.15294 0.15294 scn -29.4485 0 TD (16)Tj ET endstream endobj 581 0 obj<> endobj 582 0 obj<> endobj 583 0 obj<> endobj 584 0 obj<> endobj 585 0 obj<> endobj 586 0 obj<>stream H塨d`ab`dd攑貅魐糁vL)1LM375O662蒊恌!#鯷焀Y縂O忐~G垇墤1縹憗亖4RpL蒓JU,.I-V鹛K/*/J,IM裇p躺Q蔐()VJ-N-* 嗞)鋾(袱)涬樿)鴹d)€ R驲2笠0 瑢孡〦|唧*/2㎏~M電 ─紥鑢供叕'g熭vI闠钠D9犚?D}<\謦n撾a洺t-揨z涑&-X/礶泞=箦鴡L鷳=Vtv綺?€8O9N梫 endstream endobj 587 0 obj<> endobj 588 0 obj<>stream H塨d`ab`dd攑貅 鹦vL)1LM375O6蠳K蒊e!#州鴖嵯诛辄叱102r鹱鰱鎒9B( F: 襀1%?)U!覆$5稾3/9卡 ($5EO1'G!(3=¥X!(8胆 $T怶⑧抁`ll甤f`ⅶ郷拺Z*V(H蚄商K酌p0信韺 藹_101t3搀齒ωRv飰OJ}绒躨-m硸砦蘿髺释熅` 閉k 蒓n氁=}覕墦樢?瓄z訉嗁+齵S踓+摬C闼# 9Z粟姴①篌X/廾孥苕"W`)幌-{舅帮閗墦萘钲*Wv萳癈殎J~|do濸覾跿.9<{j畉RkjMjNp\elKGsI[~睺U {葤 KZ 栦,e鲀xe7鰅擔種狲捅燀韘赏煹p*閡* 嫒 椿% d7@€G昙& endstream endobj 589 0 obj<>stream H塗=o 唚~艒2`籗%嫛"yh誌wg>bリ纐_蛐絬"{觕劻慹滮釆#拔-*諰:€Lp课m+鋀*螒W_稣萇度嶧貪胨wJ鬕8!Eˊ)8yx揍CO2c贵综`oq k讵V<+@k⒐琢黨魑鉱篋策(懜#繍讂1 s襓v/rG炧C灈徃 0 endstream endobj 590 0 obj<> endobj 591 0 obj<> endobj 592 0 obj<> endobj 593 0 obj<>stream H塨d`ab`dd攑貅魐粼vL) I1N4M371蠳K蒊e!#州齂頶雡C铴傒?矂X9肒2轀 !攽s~AeQfzF墏F拨倯亖匓RW~眰SifYj^z俢NXM盉QjqjQYj喺@慧榿頲`b(b枣鹮麌0逊歭=枯Eg玄徉s笤董滋\"7s駵y骻釘咠 珲螢0BW縯W_W煷{gGwOGkO搕ccgg絴}g}[CKCsScs-GsmGE塗枉S伫~<达蜔輑=鮹Mr綅-&碞鞓陨9qR麂蘧钷逓瀆 輂蝽]眄蓓业5浇镇諁kеNm樫4彛in誖_/ t鮞旰呼;忢o?栚靯⒙ endstream endobj 594 0 obj<>stream H塗=o 唚~吳:5b鑅'e鑷歬wRc怌嘃]惘縁麠瀨榒翡棸睧膏 T 污碐遮貲%彳犽匋膛%嚀j愶鞇=Mp8餃pFJ衻粥p蝤j鉀d妣掔-"5V鄍壠"篎閘4 5艳埶h瘑怒篝/Q佲穁dn(/斉頹焓渽猪珳"?(哫鏂#~k6 endstream endobj 595 0 obj<> endobj 596 0 obj<> endobj 597 0 obj<>stream H塗攜PY;Hw艩  。閔IA&r恔 3丂 @(7 葰襋9%僜!(*:3:畎斥;褮仝胡鬓鏦觖緕熐BLM婨蜻絯梼wbNP谾壴萃=A窗粒y,z97~鶡]? /痋I鮗"&,枹喱繷$9.|迚妜 魻R%IS Y姮8$袸- BdI* Dd,,;: 2@篔+Q: \\7塡A猟I 忝朢!IO敟'9| 1E寘槶@重 ^鈉兡 傑B怗A綜0J慖枌U蠚d3針l67321y度nQ芒铅桅Z铀Z侖 ?b枠k肶x6>羄水c蠙E歖0{筙案v耋%罧铺冁涉覭c枎s鴾 媓嬶杫-k[址躪y躜鐤迻M焁|r蚃`昤u曫$7栛绤+釽 Xs赬踙m迵rr敎绁甛2{gU4炩衋t釆u殘 瑡)$槍)謈阘5yV屛b鑳鯼=&x壵L爊豗繡_a愢1瑣)9 梸5oFよ屄黯*羲鵒 a胹@8鱲`铋_b鐒T氶璲廴(嵀8颁湾掩77( V聵u瀮秙so鹜:*輙睩X黺d7(槒7馉{>Q} &O顧驖L1舳隁歂睴7瀗#燏Mx竘坶~&鯞S囝'阴`鵳贶霤~К?寒爱鑺晔—氪 裓\_鳂鞠雄y┚駘5鄹d椇鰠刧$F'SAC蝾Q騀鼯!酒x椮34{〆xj榸鍈;pl/{J~<cpa鱹0p^$鸷\遼?℅?t吇H-隗p繭 \犦€}筚紿 輑甍M*乜 6?環.%Zphs 爺暳.}Z愺/[ 賭箸麗I|攕塶y攢刞@ &@蝸\B┨耸Ш詥$R⑷埵遄Γ7涱?!飬&1髆c爳9o0 1`臘嘵纵IMUf&險楃7!斂廌痓P6oA@噋 ◇8` 劺閟赟嘢垪-畞:ltQG@乜8 .*瘇H覎xXvq [塤<>v(4r推2~巍E@@堄*聐0珌=/绡 遹辷 壩L戵C<歴艳謥駉y觾Q頽b/**8$$,尛⑼鸷 '臌蠧s埑峗漝焜祽趝蜋>邿%WP扁S硅7-琨弃S紈IDiTe:z黡Kw砭鬝p邜x.撘Ti礆ruYQ懚鑠癖拞"vq}_!y6MG躷鶜 v碈咑巔5[攴泾瀹L衬Y@骄5賤铍髐曞竹e雅 呾Q ∮ 樝虂%魕&韧)+玩墬額Y浄| 0o=襯級u5麴8t椟"耯塙奣嚥郯机蕷)恈炐毬5pkU夣 '3埍醼#蘛鴝猴躻GJ%eK3 刭9/H罫蜡3 蘜/铎捣戢k貚'谮萭~S廃襎bh4iSP員朅鵹u>"G._缱{侴^_关A=I|鉓n嵽膁疿富6萟縡z肟洑幷5S邽1!\9瀱禠瀐锸1 x楍 R埧稡 鏫**?GV溙s彍窈a1礰N媹T2Evt梏]*綔鸹S驈N濤@ 磰 璯h%C缏nF撄厅瓴鉠狵cP}皐co:賢o7{頤躧"校8m1q/藽q#b臉売檖锨繀嫱f(悋嗏鬮茘媋SqP9懼歸簨鉴鬊~棥ˉ泑鄂;#I~LI啘*(./-$晢躾~睐馵紀t股q馬%迼&#z 0巋Y咳`蠹讇锂*瑧u瘀`沑m 導e螀鍆6 恘婪UkjN弋稃6恆蛠眴KA'臱:fL笰沉;饪4W PWV臭51昫\柁鬌匲+A1躂馞Q筡"H4 0= 3佑2 2谩矉r壡"^諨不塶掇7曏譫藩闡{稃9u掙群擷菧H1%(uJ示(暈J唴i囫犐%恢|鍪趺蔏嫪鋘捖潬E[Q3捡ぎ帪<穖僿t )鄣_贜@奢.b椝Krk) t昌 譎E剣剐X;赤Gp黮; 8c`霞櫿犾V^鄗濘靻薸t[?;湁黙兖骦";v簙お浻薅)F蕚嘕A鞩8窦┌@觚d}'囡ㄗ夨#:檨%蹊C蛂枮譛yF(?タHf踖Ov漑鍸! 恡|攽蹿獱4?.g2-撳V墺9瞈擈膃 O倵遐J 6872m3J 7(2玠昚鍣芚QsEu粠矅傶s>鴕湜俛mY镭T麣o!%[懎TT,9K诜皠H蛢/灉r匵妟 p9~渹涋俉& ~€,P奢hg('琙m#5sl 嗙硩瘠8'l=Rd`q紃 b g2厵墒4 鱾~n伩絮IhN澨+U=3NB*7峷劐綟Qp!>;QuCΥ4煛艫繋癠Mム*V洎颉p_C/餖郍y苽L,S *oQ^逌j氂Q 鹋湠Q0 綟Q恸挫皽玺)"糭?f例7鑫濥\?N贉 ㈧微 |駐 鲟^,&杧z 紜児(0銨t(kbO -荗7憙譳锢(踠餦0<1SK1N无幘坣,9C凤 窞官_W繞Z悅'5愍#E) N幻6 哿鏶狧L攱a,▊1]7蔔wN盝i>架 VㄑVj闞'=]償6zK螈s渴艎素 鳁Ud藃薝递擬^鯊鸥U"_^? o乪d炰沺檢兦A胟q约5攠#3(蟐尣m葒%^甚j9殯忊髸{攭娯渹鞪躳-`!肞躖r敬M鳜 瀞,#`喗倭L@嵀肁K桁9逃(}9q鎬蒘qb Y猱a齨R莏R╔靆"蹷柛6s鎡蜇2u匯仜&R撎" B橙62L.Rc誸~KAv闀v矯搈!馷Y划壯嫡U鰆1胐埯x糂h趫隆3n倹馮撫. 铂)=渽鹔 [跨9鉔n3 邞IZ;dD%ㄝ臷鷓艽$,`/卓犩20扴Qr即禾闊軇s┛72指`覼z箾元5 \様j枆i塆宼膳蟵傏H8p&$鄗 F駽I榾/ Z劓9受 z欃飝=谧5r:彁p 蝸+){哞]<緋[懥缺樹<)y5躅1i&"1齌雯+)肀C嚉甥-軼签伌鼋鷠懫櫨l..摆黳ょto]5=#潐l紣9&K*L&陬Ja)h垃 /澡儃qhF刈耨)铂$.倴勝\mGぼMU,i2"欶視緹"#o%孽$bv璟胞请yL娐U閕萺*WU+赍あ畢籃C?A 2矿Qg頢荮{緇X骏啈疾M豑Re縵い澨"r8e*m灬矒l8\ㄚ娗)%羓!OV 翔"聫+rZ€+蟄3 w寴攄j鑫u喬觇籕#a汜鉉o[.洯碜帡張.斆侫N_t0&52%*60骣揪ぞ糞G屪E%,* 蟿v觏廅皊Mz騺/噲螖嫕IP曌5_籶/#7符罪=灓)馉#y35C錈嗼sZ.#傒8aS虄缺=Or[4嘢┆(<烤4W{PSgwW脀Ww﹗龊z醉飚;再vwU 埁,P鲤 $剱劶 7$)$芗剟 +V*k分av簘熘nwfm縯.;砡p鲝圭;琰具II:倁T 俖彏fkl8唟Ag-眣"阅g绂/t珄咙 : 嗒luyW﨓騊j辰淔鞉嚲S鑤薭谥-n7w閕Y%状譼赶寒鯍'荜莦:|.笇匊鈞毾蒰#響碓瑡杜y.r c5Q3"尧f_"&Y=Y縇肨館肵I?鍡媇b蚋.ETダ擹}絾 +齧n嚡卹;C^/株nw壬硡: W項)JiEq鯻T溨yW 蹯衷莛惍獰6:[ 厒矺绂墼e'J+虪2K搗?5\s{钜% 扫禝架&n拡堲I M-鎑傔\5b洊7爉R橍硙 甼尵;,傞嗲迱n*橦]B 鱋肬餡=?12.棣Q东棵KE"uyp鏜噶J脽卺废靨g'馡贰 骴Un]怶潥H饌/纨廹)~\困五dXi-kRQ朿橹tr↓蝤e2炞軋&釖J{洁%N劝),%咍a坝韶>"\<帠n謪+氢瑹z畓;彲5B烅S)传刘幩醰rN洺フ5x轧识姚"S壀X|虼:嫨y8湪衤h! (b3 椆夯7熲吆諍ri∑赻S勾挹p蚿絃YT`岮)'7睘cO跬幬T捍*"sU丂[G离⑼線臛>C鶤U埦e9;#.遺京5捑kg褭<+}犟'c沣t租^黚煿!L髦wHK壴祆-麕]橁盱崉╲w匘j山6幍9I.戈帗排橛9 毸9豆0(蒄6虳YX塊鉒庽 {螕 队黺 4睬襀: 岾e5bi,觐閾wU岹@ 莗)萕彖2(兺t勦 @"~"蹭BR#K篸=饺E<$7>|楫$傁疿邑)せ鋤峍%諚1瓩1 Y椔隓絪S]澇弳九镔荙漘櫤 #_u狉4D#egA跣乸dt$铻鱜a犁Rp誨3諺(%"筡榕,-E恒u9&旞]S 汱,V€謽2Y%L畽k瞇]MN禡}3i鰨,,V梐m⑾@>.#,gI$ 兖?帏#q岧>O€o拨vWV氲rJΙTV时哨鼇睟K UV孆 *瞭yFL#LSb lr,碘孺 =闌琯敎欤=()5fQ'惻,O亐誧i螐嚿賞氝譀7 .e期QO偗厂蕤旉UUTu漒P` OqZ焎@i躧嗵Ki$汱 "巰O詠Hhx尲邼{(纩c<轰孩'餡鵁顴觐F髅K+磷 唑玦}倌悌誊詍'總k犩铺: wEW銖羒Uz蒇冰1-Bb13唈室qv;槚G2憜~+譾肬O犸埀蒧鹚鮆S綂Jx鯸 g6+疫|紻 砷x]磿g>3D躱4〧涄3持鮂S揮K隱j[RM黌膼泩>郬劳詗p€ewxoP蕵 r叨{餲'sw>WK昏xHGD暎扔g/鯎7"-埿柡U9Sl詣鄁h/B鶽Ym;捅Nkk py;; ;9Yb*骟!挓杙齧Cs)$2!-磬瀧ewk5}5yD~〥敄;}瘞4 娸-ラ涪$濴|19磄€ v]""}o+J隓~r7尞芇MJ粟h楮x澏`馥8m0I餱.▕彬<1n鏟熏惠铌埥7碜pI摖萬洚餝1晼R衬妟8 螝\)傋伈3歜27葵o4$淋;Jm甹4J-諙跇y/+洔1驦/籙p'桁瑁:B.?&嘭vD雥絓]C耯54谜玸渎颦%+?,xV鼲}辟q脕龡鵵 i* 鉿X;;曒]=岜00M!vE4$1尚磞檼K=涆t7Q粫踆m砞J级y/驋%at虐BHD紾/  A鸳炵y_x咩;聵u-' >9}0`c >X衎6#vK炈淥昇cO毺zM^]j镼墏锱邉_q@\竇槇B7)蒶鮻阳葕 [t譕隼.覆 瓼 ,4=J耬埱O笷I褓*4埱-玴, 趩nv航!沬聞抐熊>冑P/?+色r>u佀枮|;猭fZ筮-墓掙娨SZ&嬃i愴沔Y蝃]7:Z漑宙€/3`9吕!瀀*=R眈d殏媌堵v免佭t来鄏:骴4橓e翥群憟 -笢mns螴fY])M揜>fw8I囃需ぴ^W舳:_碢b;*HヒrUF94F%n K|?VH鴻腘YI脞`悚 endstream endobj 598 0 obj<>stream H塡TiXSW続铄"攝57$0.槀XvYT2%$悇 蘉X$私 [Bt 塄c礿珟Ok雮 冈:訖Qg灀翡擒牽嫦鵴倔搠}匡{/聍C8螌Yk又,L+Z[S+秔8肳氶p3'Mh鷀難I0牔3壄!嚕=-帉寣饾婨iEQ瓼H驖睯宫睵))嬕适D9ヅ%J(GTV.竽筨裧靸r:]嫝c"#cE呭E㈣亘堌鴛(KY"?紦K蕥J藡 d2+Y鋸D# G帧H?操Y腾E鼞Hd+覍貞!4N缇_ O&@(e4綁c4, ;Q4#H魐抯蜍甥赣箙羇廉`蛿桽譓5嘗Q鳴4詻芣翡0= N;arO沦喀闒讕狜萚> 攢鹂噐E@鋂M躂韮▍3阛^,缥w(y 龡€峬@ >"<拦0焷(馷辖渔Q鼟刽丅5 )沉赪攮n抻,憯瀚q頑p4隥P儽麍緸S.!YzP'祰$识飵 ├T5&+ye:x匐蕪7d闔J巶=鞮a(:;禚秌5鄱. 闢R敎0榿}鮨/q#沉 锨刕誝粶岟苃t哾j槐G?X漌劮蝊角凋\#疴嫅 筐撙渶0'N侻'輓趂7 P.墒厏蚂菽歆籩s肳d,权閐]mr弬e膾莒U萠0VD&K硫]*丄∷d>唑嶉"&[讚 €5p\髅,0%$蘧优 {2骧b\X=?塋騀h擋轰鱩)聾入僕 遾L!| C凄yb>J返Zpk鸻S効Hd瞏\ 嬷auks讽k x淏'BY糈D2+& n>0艉璒质*V頡( Y.U+5秌叺m臀东GA:5鲶*絀貜 乴[8+P啚d屾c侴豀G讲U卅6J孁鼺婧砭渚<枮拸樘5裠妛洲>u80i昭巊1}=7陽 鸛掯 [#o>搪 z1Z cw魂+瑽k晀w藶~#忶嘱镭秃l裉rW-WM.糢浩譿#\銧羢@谪徑7厤紽'韗<遒餂笛Gx铀惯舀M%誦tC}&S肦€X 筝柽Η弖[X#澟7,1(臷 岂厥躤H趬5辭毒;_沨衹0苈nzc柏煉C`+ 0 堞MI颳70銮銫鱸 龕!儇O癖ZY支c∕c=6曇-諒,*炛遇囦;蝵螸彶(蛄歒罔~k;黷镌禾}j H炮B轹蟍<籷罢跖3ь覩躶y鯭嬮 缇qW矹猂釆蔙}禶麨桍Z徂靓锰塓w4佡2菩N4a Z瓷L蓏R_伜3盢仔A滊矽}朞N 矿6獼棱RG禮款З騳d.藤斗愜[ó6鴤_藕Kc龇3gH髊7}o蠄 淋A2W釃0鹛}5b*<淲籔邜乮v瓟便7 痨 涕xj4锑\阌镚 廁骗d搶冥o匜^匣i蝔}]i煲稺*扯n驠靥譵+鵿籸咂F噯敢5撈L叜鐥@7蟿 ^'曷该篰u\猖欖8觟縩f;戞 `顐I 攤皻=撀繢窪H`鷜葋$宊 `" 锡/€屣繤%翦鷠胩z鞷2;&2|鴘tc6X/X`癍*唇鉆K 橊樛譧Xh猝=来礫pK涊鵶钉+瑬蟉8鲹.⒁)4兪呈7犏鸨钧7z濠捗J70y(呸嚋甍doxM磑;o鲰碪o顉A鰞(4v'q{6鮨9颛珡U6喹xH-#泤dl覣两驰梔J蠖I呎%l +涞(鹗捋與€鴋鍟呉C杵/w湼瓶q頍湯S栣λτ$e&+ev 噤賟忒?[,霿∽驈Kr鳬7/嚋聎麟CY邽`O Q殄$DWipSf蒘m0m:抧狵葦 4]!呚 &榖cl 仳⒄沴I兜XHIO杁[,賈,啥l0x臽0譮蓜J牬6凬f2筨n:觛3镞=s铢撅滐'j6鶽`-)C,K X顂畧珱靟w[侹尛?ㄥ4氻€4噙Pj獐bjb乹希曏…諸e(墭X詄劢秖:W乶監un丈"丁\脫mS靋a揆鹚 >&:H锛O欮s汞贝页枍﹋迍駖v声Y,樆棷猃搋9她U%{>鋚.沨搇y薏rN謲i璲q&;&湺縄昲o1*P輓2[蟁A3薐&痥:v/^7唘a淏鐶3銞1v籩憺&T酎霼4濸隌獷]S.H虸蒒+/*恍矘█櫟BNG-kl殳q整x諡_棗矎e烧+3UGs(5Z O=2蛎Y麶oFgyg橵S员Vǘ衋慧46^ 徔煒 癵骒祽q蟊c坉 Rh=i/F鬴V陈dRBKM潻 砢bJ^絽倡"p福雪3长塓窌H攚然yx 嫩衕:《B痉﹦L* 麶 7y菫崰u7;q舆=咛Я琖鍠沩|喀L6梪JI眘@唃# 餺讝蠪礆$讼 o篼\=D?@\襝9eW伷t墇7Dj<聇;氩瘊L.*y漋奛劸閭粲 H股/鮂膃'h=S(J赏⑨;溯7}鉷扔巶圤!養Je折,=韼n儞*嘭俱ヅ0鵳I沃熏舓钩缻+G/1E&1貃0妜o鍜尘M錂b誺龑Q.W+餘.5*@螏尧橒噦M竣 .桦w厙寡啷瘪F栰bwcg匎t嫫 -fh↖幛Sl&R蜀! 4(z/~9倊<;簔诼 帍綞樫Y櫬B愐8w賬蕁l嘜}h族o8|3灤紣鸔j徭w9'嫝嫂惠|虓Gs>o? 縬貉陂墍嫶:\f'埫炕KdV MM屍x盼j >鎁*dS砛dUvj¬K蕰%68餁鉤:|7>頔k韘輍涂,O劺#S美雖Bf碤そ烷vq簩b(>"仁厃G%{鋥8eKe值61愵欽[(蚸(/俌佩噿9焺嬫斳l秩1(;雦峹Mzz灳€<蜩S5诖鹋h扇;0/q;9Fm貊珟q皸 峔鷶泄t\囇jl3篘贑藲櫍脚閤Uj*疶6銡鑹纮埏亜愄や衢岜懃~柙晟 QP,鈹d梷虓{;乂1E聤zP鮒k"挵衘咳-跽鍵x~K撠{D€2豑@)渣$D坬謄9俾+茀8gX5k磊k禲p?q寫彟:粢pYd<%鋋9盻n鶤鑪ta液!蓅.揰蠗堓2_71@熉+8矛曭臞犝幅(x 擁k€h_Qfl&醦 P哠*m!芷赮芬弮焈剄gc1挌熊畤誧臤阰悜袝嫇牜]СA碁:M褗趍]淣E(719=+垾'鬎 zk9堚閕1赱€'V}[% ju厦98熞野€舿礳蝢兕騲A纠A欓4y侘|譯4#璫 勁鈌犝Q! 濩G稀?濩櫎傑#" rJ蹝锨;蔨|d|"w漂_齱膝+ 猦韍掽紑J膸T醋Y僔)侚医亿傥hcH傶z崲J搙I镄钲腸痭X膰KS觓粍桴Ev歏ST !&0a詹+M眢五蝢r璆o\炗襉蚌m1A揷蔚>E.E闃拽€搄蘮⒌o$e6鴒 陀獸珯仺AE籗[悅]穃7I鬸X瑜化V( MH.]q檄麓i癝Ja/I]糉€_釻攩誱 襃袇斡E<湨 6屟E((`CbC,佨]o鵃`)鑊,僘Yが+; 掁?珈鴂砏\踫肙q胶揫Q衿糇y栅Ex晸煛m魏∨裯⒔h゜6猇T匀j赝箌eY儴瀖鱰;﨣q倥碪唓|渮v!^:谧魸q&6絇7Q積j覎殪(跒峨'miOロ9嚍梓敮伭 9q$ 宑蓡d31,97巨肯<<&Y塉8*冤勏z瞎<?馔茊 腜s厮D$Eb濪稛荦蝌*覨q麨舣+藝淡~稦盾-^]4/#p8'裸 J&>7癯bv ->P蜃鏰虁千捗€魎z※5兡JG6?7|2帽Q啦^ )3萈: 。Ll#躮e瓲ヱtV棵 裨嵑.匾頣wK/╪v蕁挡㈱玦門ョu2M9贾>=`袍WT;戏峞櫔負煈N缫阌Y憯Q催(<>墢JJY叼* 癬4俗鲅' 颾鏒DW袓=5 彀!贀贩7绉=鷭漋囹睰,\泱螩6弶5歷-葉9_Uw塏r鯘ぎE$伞夷D呜燌f軣D#okj凲=V.&那惽湴|b> 麍Isd琴d蘧眫g>$";&O~3Ю膄y琭x蚐聃蔷蔷]鼇9j匓G嵷峈俢CYB0芾 忇褲噞麷;_根抰j罀嬇a驜縶"q碮P歽電BV=克o嬎3墤a頼幟7#踹~転鍏斶"伵h蠧虭蕯嫊%盍R-&Or`2鹻ZSX玓o泒N曇鵗V2昈幤0#) 嚡嘇<撌`蕱)旿徨d炀N 赃+迨[鰈壗先=萴熡€ M蚸8j纅r j檝^燻' |軀妫銍綻5V稔夯膊鮿?赴嶇熟t)`K€这磻蠴砂摬Lx軶醬錣诼緃k踝\6,繺倀swH 聇U韯余P鐪5算贆 葧y橀O膏逊咠B诈簡/趨噧CT2県尌G"c儞v茗銡v(覃V爍 ;}┷>a籤WTG欫服5 c />'y endstream endobj 599 0 obj<> endobj 600 0 obj<> endobj 601 0 obj<> endobj 602 0 obj<>stream H墊慜kA瞥羦=HEa蹝:勤lc拪bc!BlH鄂燯7硴d`w6丠Oz眻厾噦< =聚闻●9 篁伎飨3R鑄8$I拻_絬3[奺臀猲f襥淛釦堷Q煽pf喝停訯y耮g筗噑鏑醼霮9дui结9|-&q祴A絸J*9蜄aS4決鍽粠溭0)$.艈峳  UL壸掌鍌-0,5簩b鯻Ja羽N2徦y嫅%&:喔 跠篅弃-=w(tl奞蕻S棈xTr\強%纽墙I./goR7E奭т:丣励e- U堐!f|馁 %)鼀牮4鍧蘶漁従靯5蜚醏E+洆#讼潢煮{/原 X跒驽埤蕊矧犥锝o熅髊7牋赖亅癧鄹胫\?=t+6_ <谱:蘳 譅]誣+<莽故<蒰"\48,伮|:鮓€f搛[ endstream endobj 603 0 obj<> endobj 604 0 obj<>stream H塨d`ab`ddu貅rrv詖L)1N0IM35IH恌!#鲔貅鯻瞻~w.佚惝#cL~AeQfzF墏F拨偂4摉 乙L+8︿'*W棨+x%%枻﹁)8驿(€)V(J-N-* :<.f`bX巳县坯擋G麖jQ镞n瑵lm沯7W.贅:fr猡€啘2绋傪F,=柶拖\^肌阬逓i;g=Y别聹嫿fg,.橻蛋y俾e 隀讃L+滑,'i銛妝邓泈g~Q鈝陲wⅤQ錟%MU=絬K/n\荻ⅠpI&樉m申吽缥9V耽iY犰B帴売l'Er瘕喧!穑I7腼/@分莠綳}辫C顠)荮箺MH胧針椭筏se[譵蜑V7玶A若毓搒f驸▓J襳旿灄考SnE琰3w-簯澖}貅|?.滧!=牶1X纬ae2閑+W焟恛<\5枫"銎檏RwI痏7}"鵠kg.2cRvW押聶 [獁/菘|蛑蒶9寿Zr 猤s蕴j^盩陣堥鲒祠唫钴蓅敕鞉悵 2 endstream endobj 605 0 obj<> endobj 606 0 obj<> endobj 607 0 obj<>stream H塨d`ab`dd攑貅rrw詖L) 1礖14稨苍60蒊恊!#鯳蝼穇縿Y揩忐綢垇厬慘惺+1勾$59?74/永乩9繝(3=A#YS列乙B兹览R!㏑! $礖!XO)1;>爡韺 虒孡M|抠*垰鼥gmlmmo杗l8蒋Н靪-筑撖緣矣У5N摕灾字.照菡%晴ST醴'kSHSKk6y诊灛=]=輗'鬙铐殛陸{4iB{痶匎)鍩~e椹洼 撲 朽e endstream endobj 608 0 obj<>stream H塗惢n 唚灺悌:Ru媂RU市嫐宇pRて yMO阚#a 烜緍#&<95ll.8{諅6Q祐1d喦}M 4:!遰qM济镼葸67 _!{氠tV91n1~醾敔$dd獬Yd妣掔="5V氰鄍嵠"篎閘4 5瑶椛~繚(~疎鎺庲BY飒苙蘗h菥)B<狨僢坋n9鈁€k endstream endobj 609 0 obj<> endobj 610 0 obj<> endobj 611 0 obj<>stream H塨d`ab`dd攑貅rv髦vL)I07O66L62蒊恌!#著籓啣蜱U?jJ10乼2蝩/,蔐(Q蠬諸0200 I % !  矽墆櫓: 声y艡%檡 鵬`E幑〦櫳墆 ┕@F嶣p~rfjIgP[IiI*Hc@Feqfr1逥 77)嵢耶9农e櫓E:@掯t驲B€ZP靤虸M.)k蒀根y櫳 畒闄y┅E 鵈%橜O}6問牥1厤ofrQ~@Qj1L] ╪TPp躺Q*V殥ZT枤嘆0搧墤慽忒鬫?礑U貇淈>鵞稃I诌煎l+粬V倘屮菟軽熦&W|>{聞崎互}妘踳斤gX7癵w6档说捶w宕s窙9被╮3鄂升瑰.鱗泫靮f虥穅z巷l演潙瑻s砹獅仾O靍_7"j<@€Z炾 endstream endobj 612 0 obj<> endobj 613 0 obj<> endobj 614 0 obj<> endobj 615 0 obj<> endobj 616 0 obj<> endobj 617 0 obj<> endobj 618 0 obj<> endobj 619 0 obj<> endobj 620 0 obj<> endobj 621 0 obj<> endobj 622 0 obj<> endobj 623 0 obj<> endobj 624 0 obj<> endobj 625 0 obj<> endobj 626 0 obj<> endobj 627 0 obj<> endobj 628 0 obj<> endobj 629 0 obj<> endobj 630 0 obj<> endobj 631 0 obj<> endobj 632 0 obj<> endobj 633 0 obj<> endobj 634 0 obj<> endobj 635 0 obj<> endobj 636 0 obj<> endobj 637 0 obj<> endobj 638 0 obj<> endobj 639 0 obj<> endobj 640 0 obj<> endobj 641 0 obj<> endobj 642 0 obj<> endobj 643 0 obj<> endobj 644 0 obj<> endobj 645 0 obj<> endobj 646 0 obj<> endobj 647 0 obj<> endobj 648 0 obj<> endobj 649 0 obj<> endobj 650 0 obj<> endobj 651 0 obj<> endobj 652 0 obj<> endobj 653 0 obj<> endobj 654 0 obj<> endobj 655 0 obj<> endobj 656 0 obj<> endobj 657 0 obj<> endobj 658 0 obj<> endobj 659 0 obj<> endobj 660 0 obj<> endobj 661 0 obj<> endobj 662 0 obj<> endobj 663 0 obj<> endobj 664 0 obj<> endobj 665 0 obj<> endobj 666 0 obj<> endobj 667 0 obj<> endobj 668 0 obj<> endobj 669 0 obj<> endobj 670 0 obj<> endobj 671 0 obj<> endobj 672 0 obj<> endobj 673 0 obj<> endobj 674 0 obj<> endobj 675 0 obj<> endobj 676 0 obj<> endobj 677 0 obj<> endobj 678 0 obj<> endobj 679 0 obj<> endobj 680 0 obj<> endobj 681 0 obj<> endobj 682 0 obj<> endobj 683 0 obj<> endobj 684 0 obj<> endobj 685 0 obj<> endobj 686 0 obj<> endobj 687 0 obj<> endobj 688 0 obj<> endobj 689 0 obj<> endobj 690 0 obj<> endobj 691 0 obj<> endobj 692 0 obj<> endobj 693 0 obj<> endobj 694 0 obj<> endobj 695 0 obj<> endobj 696 0 obj<> endobj 697 0 obj<> endobj 698 0 obj<> endobj 699 0 obj<> endobj 700 0 obj<> endobj 701 0 obj<> endobj 702 0 obj<> endobj 703 0 obj<> endobj 704 0 obj<> endobj 705 0 obj<> endobj 706 0 obj<> endobj 707 0 obj<> endobj 708 0 obj<> endobj 709 0 obj<> endobj 710 0 obj<> endobj 711 0 obj<> endobj 712 0 obj<> endobj 713 0 obj<> endobj 714 0 obj<> endobj 715 0 obj<> endobj 716 0 obj<> endobj 717 0 obj<> endobj 718 0 obj<> endobj 719 0 obj<> endobj 720 0 obj<> endobj 721 0 obj<> endobj 722 0 obj<> endobj 723 0 obj<> endobj 724 0 obj<> endobj 725 0 obj<> endobj 726 0 obj<> endobj 727 0 obj<> endobj 728 0 obj<> endobj 729 0 obj<> endobj 730 0 obj<> endobj 731 0 obj<> endobj 732 0 obj<> endobj 733 0 obj<> endobj 734 0 obj<> endobj 735 0 obj<> endobj 736 0 obj<> endobj 737 0 obj<> endobj 738 0 obj<> endobj 739 0 obj<> endobj 740 0 obj<> endobj 741 0 obj<> endobj 742 0 obj<> endobj 743 0 obj<> endobj 744 0 obj<> endobj 745 0 obj<> endobj 746 0 obj<> endobj 747 0 obj<> endobj 748 0 obj<> endobj 749 0 obj<> endobj 750 0 obj<> endobj 751 0 obj<> endobj 752 0 obj<> endobj 753 0 obj<> endobj 754 0 obj<> endobj 755 0 obj<> endobj 756 0 obj<> endobj 757 0 obj<> endobj 758 0 obj<> endobj 759 0 obj<> endobj 760 0 obj<> endobj 761 0 obj<> endobj 762 0 obj<> endobj 763 0 obj<> endobj 764 0 obj<> endobj 765 0 obj<> endobj 766 0 obj<> endobj 767 0 obj<> endobj 768 0 obj<> endobj 769 0 obj<> endobj 770 0 obj<> endobj 771 0 obj<> endobj 772 0 obj<> endobj 773 0 obj<> endobj 774 0 obj<> endobj 775 0 obj<> endobj 776 0 obj<> endobj 777 0 obj<> endobj 778 0 obj<> endobj 779 0 obj<> endobj 780 0 obj<> endobj 781 0 obj<> endobj 782 0 obj<> endobj 783 0 obj<> endobj 784 0 obj<> endobj 785 0 obj<> endobj 786 0 obj<> endobj 787 0 obj<> endobj 788 0 obj<> endobj 789 0 obj<> endobj 790 0 obj<> endobj 791 0 obj<> endobj 792 0 obj<> endobj 793 0 obj<> endobj 794 0 obj<> endobj 795 0 obj<> endobj 796 0 obj<> endobj 797 0 obj<> endobj 798 0 obj<> endobj 799 0 obj<> endobj 800 0 obj<> endobj 801 0 obj<> endobj 802 0 obj<> endobj 803 0 obj<> endobj 804 0 obj<> endobj 805 0 obj<> endobj 806 0 obj<> endobj 807 0 obj<> endobj 808 0 obj<> endobj 809 0 obj<> endobj 810 0 obj<> endobj 811 0 obj<> endobj 812 0 obj<> endobj 813 0 obj<> endobj 814 0 obj<> endobj 815 0 obj<> endobj 816 0 obj<> endobj 817 0 obj<> endobj 818 0 obj<> endobj 819 0 obj<> endobj 820 0 obj<> endobj 821 0 obj<> endobj 822 0 obj<> endobj 823 0 obj<> endobj 824 0 obj<> endobj 825 0 obj<> endobj 826 0 obj<> endobj 827 0 obj<> endobj 828 0 obj<> endobj 829 0 obj<> endobj 830 0 obj<> endobj 831 0 obj<> endobj 832 0 obj<> endobj 833 0 obj<> endobj 834 0 obj<> endobj 835 0 obj<> endobj 836 0 obj<> endobj 837 0 obj<> endobj 838 0 obj<> endobj 839 0 obj<> endobj 840 0 obj<> endobj 841 0 obj<>stream Acrobat Distiller 7.0 (Windows) 2024-06-24T09:00:01+08:00 2024-06-24T09:00:01+08:00 Arbortext Advanced Print Publisher 10.0.1306/W Unicode application/pdf uuid:486586ee-12fe-488e-8b79-a67c828153e5 uuid:04548e90-2301-46b2-85b7-e83e6c539b03 endstream endobj 842 0 obj<> endobj xref 0 843 0000000000 65535 f 0000267967 00000 n 0000268340 00000 n 0000268448 00000 n 0000268555 00000 n 0000268660 00000 n 0000268766 00000 n 0000268874 00000 n 0000268980 00000 n 0000269087 00000 n 0000269194 00000 n 0000269302 00000 n 0000269411 00000 n 0000269520 00000 n 0000269631 00000 n 0000269742 00000 n 0000269852 00000 n 0000269963 00000 n 0000270073 00000 n 0000270184 00000 n 0000270293 00000 n 0000270403 00000 n 0000270512 00000 n 0000270623 00000 n 0000270734 00000 n 0000270844 00000 n 0000270954 00000 n 0000271108 00000 n 0000271266 00000 n 0000271405 00000 n 0000271632 00000 n 0000288026 00000 n 0000547032 00000 n 0000547935 00000 n 0000548046 00000 n 0000548157 00000 n 0000548268 00000 n 0000548379 00000 n 0000548489 00000 n 0000548600 00000 n 0000548711 00000 n 0000548822 00000 n 0000548933 00000 n 0000549043 00000 n 0000549152 00000 n 0000549306 00000 n 0000549464 00000 n 0000549603 00000 n 0000549800 00000 n 0000571490 00000 n 0000572014 00000 n 0000572123 00000 n 0000572232 00000 n 0000572340 00000 n 0000572451 00000 n 0000572562 00000 n 0000572671 00000 n 0000572781 00000 n 0000572892 00000 n 0000573001 00000 n 0000573112 00000 n 0000573223 00000 n 0000573331 00000 n 0000573441 00000 n 0000573552 00000 n 0000573662 00000 n 0000573772 00000 n 0000573883 00000 n 0000573994 00000 n 0000574105 00000 n 0000574214 00000 n 0000574322 00000 n 0000574432 00000 n 0000574543 00000 n 0000574653 00000 n 0000574761 00000 n 0000574915 00000 n 0000575073 00000 n 0000575212 00000 n 0000575385 00000 n 0000597258 00000 n 0000598274 00000 n 0000598385 00000 n 0000598496 00000 n 0000598607 00000 n 0000598717 00000 n 0000598828 00000 n 0000598939 00000 n 0000599050 00000 n 0000599161 00000 n 0000599269 00000 n 0000599377 00000 n 0000599488 00000 n 0000599598 00000 n 0000599709 00000 n 0000599817 00000 n 0000599928 00000 n 0000600039 00000 n 0000600150 00000 n 0000600261 00000 n 0000600371 00000 n 0000600482 00000 n 0000600594 00000 n 0000600706 00000 n 0000600818 00000 n 0000600930 00000 n 0000601042 00000 n 0000601153 00000 n 0000601264 00000 n 0000601376 00000 n 0000601486 00000 n 0000601598 00000 n 0000601753 00000 n 0000601912 00000 n 0000602052 00000 n 0000602262 00000 n 0000623121 00000 n 0000624748 00000 n 0000624860 00000 n 0000624972 00000 n 0000625084 00000 n 0000625196 00000 n 0000625308 00000 n 0000625420 00000 n 0000625532 00000 n 0000625644 00000 n 0000625756 00000 n 0000625868 00000 n 0000625980 00000 n 0000626092 00000 n 0000626204 00000 n 0000626314 00000 n 0000626426 00000 n 0000626581 00000 n 0000626740 00000 n 0000626880 00000 n 0000627066 00000 n 0000650067 00000 n 0000651076 00000 n 0000651187 00000 n 0000651297 00000 n 0000651409 00000 n 0000651519 00000 n 0000651630 00000 n 0000651742 00000 n 0000651853 00000 n 0000651964 00000 n 0000652076 00000 n 0000652188 00000 n 0000652300 00000 n 0000652411 00000 n 0000652521 00000 n 0000652635 00000 n 0000652746 00000 n 0000652857 00000 n 0000652968 00000 n 0000653078 00000 n 0000653190 00000 n 0000653302 00000 n 0000653414 00000 n 0000653528 00000 n 0000653642 00000 n 0000653754 00000 n 0000653866 00000 n 0000653980 00000 n 0000654094 00000 n 0000654206 00000 n 0000654320 00000 n 0000654431 00000 n 0000654586 00000 n 0000654745 00000 n 0000654885 00000 n 0000655083 00000 n 0000677454 00000 n 0000678297 00000 n 0000678411 00000 n 0000678525 00000 n 0000678639 00000 n 0000678750 00000 n 0000678862 00000 n 0000678976 00000 n 0000679090 00000 n 0000679204 00000 n 0000679316 00000 n 0000679430 00000 n 0000679544 00000 n 0000679656 00000 n 0000679769 00000 n 0000679883 00000 n 0000679994 00000 n 0000680106 00000 n 0000680217 00000 n 0000680328 00000 n 0000680442 00000 n 0000680555 00000 n 0000680666 00000 n 0000680778 00000 n 0000680886 00000 n 0000681000 00000 n 0000681114 00000 n 0000681224 00000 n 0000681337 00000 n 0000681449 00000 n 0000681563 00000 n 0000681675 00000 n 0000681787 00000 n 0000681898 00000 n 0000682012 00000 n 0000682126 00000 n 0000682237 00000 n 0000682348 00000 n 0000682460 00000 n 0000682574 00000 n 0000682686 00000 n 0000682796 00000 n 0000682910 00000 n 0000683024 00000 n 0000683136 00000 n 0000683248 00000 n 0000683362 00000 n 0000683476 00000 n 0000683590 00000 n 0000683697 00000 n 0000683811 00000 n 0000683923 00000 n 0000684037 00000 n 0000684151 00000 n 0000684306 00000 n 0000684465 00000 n 0000684605 00000 n 0000684803 00000 n 0000709832 00000 n 0000710696 00000 n 0000710810 00000 n 0000710923 00000 n 0000711036 00000 n 0000711150 00000 n 0000711262 00000 n 0000711375 00000 n 0000711487 00000 n 0000711599 00000 n 0000711713 00000 n 0000711827 00000 n 0000711939 00000 n 0000712051 00000 n 0000712165 00000 n 0000712279 00000 n 0000712393 00000 n 0000712507 00000 n 0000712662 00000 n 0000712821 00000 n 0000712961 00000 n 0000713135 00000 n 0000735679 00000 n 0000736343 00000 n 0000736457 00000 n 0000736568 00000 n 0000736681 00000 n 0000736795 00000 n 0000736909 00000 n 0000737020 00000 n 0000737133 00000 n 0000737242 00000 n 0000737355 00000 n 0000737469 00000 n 0000737581 00000 n 0000737695 00000 n 0000737808 00000 n 0000737918 00000 n 0000738031 00000 n 0000738145 00000 n 0000738259 00000 n 0000738372 00000 n 0000738485 00000 n 0000738599 00000 n 0000738713 00000 n 0000738827 00000 n 0000738941 00000 n 0000739055 00000 n 0000739167 00000 n 0000739322 00000 n 0000739481 00000 n 0000739621 00000 n 0000739795 00000 n 0000767905 00000 n 0000768273 00000 n 0000768384 00000 n 0000768498 00000 n 0000768612 00000 n 0000768726 00000 n 0000768839 00000 n 0000768953 00000 n 0000769066 00000 n 0000769179 00000 n 0000769293 00000 n 0000769407 00000 n 0000769521 00000 n 0000769673 00000 n 0000769828 00000 n 0000769987 00000 n 0000770127 00000 n 0000770337 00000 n 0000787716 00000 n 0000788428 00000 n 0000788587 00000 n 0000788745 00000 n 0000788894 00000 n 0000789068 00000 n 0000789239 00000 n 0000789529 00000 n 0000789818 00000 n 0000790107 00000 n 0000790394 00000 n 0000790552 00000 n 0000790713 00000 n 0000790868 00000 n 0000791026 00000 n 0000791173 00000 n 0000791318 00000 n 0000791477 00000 n 0000791635 00000 n 0000791782 00000 n 0000791930 00000 n 0000792086 00000 n 0000792241 00000 n 0000792386 00000 n 0000792537 00000 n 0000792693 00000 n 0000792851 00000 n 0000793007 00000 n 0000793160 00000 n 0000793314 00000 n 0000793466 00000 n 0000793638 00000 n 0000793809 00000 n 0000793967 00000 n 0000794122 00000 n 0000794272 00000 n 0000794420 00000 n 0000794595 00000 n 0000794768 00000 n 0000794924 00000 n 0000795079 00000 n 0000795235 00000 n 0000795394 00000 n 0000795551 00000 n 0000795708 00000 n 0000795855 00000 n 0000796011 00000 n 0000796170 00000 n 0000796338 00000 n 0000796498 00000 n 0000796648 00000 n 0000796804 00000 n 0000796964 00000 n 0000797124 00000 n 0000797284 00000 n 0000797443 00000 n 0000797603 00000 n 0000797762 00000 n 0000797936 00000 n 0000798108 00000 n 0000798262 00000 n 0000798415 00000 n 0000798571 00000 n 0000798731 00000 n 0000798891 00000 n 0000799037 00000 n 0000799192 00000 n 0000799351 00000 n 0000799491 00000 n 0000799689 00000 n 0000837135 00000 n 0000837791 00000 n 0000837958 00000 n 0000838115 00000 n 0000838272 00000 n 0000838428 00000 n 0000838587 00000 n 0000838749 00000 n 0000838904 00000 n 0000839132 00000 n 0000839360 00000 n 0000839587 00000 n 0000839793 00000 n 0000839998 00000 n 0000840202 00000 n 0000840362 00000 n 0000840521 00000 n 0000840685 00000 n 0000840842 00000 n 0000840996 00000 n 0000841148 00000 n 0000841296 00000 n 0000841453 00000 n 0000841612 00000 n 0000841770 00000 n 0000841924 00000 n 0000842075 00000 n 0000842230 00000 n 0000842384 00000 n 0000842543 00000 n 0000842692 00000 n 0000842852 00000 n 0000843008 00000 n 0000843167 00000 n 0000843321 00000 n 0000843474 00000 n 0000843630 00000 n 0000843797 00000 n 0000843965 00000 n 0000844120 00000 n 0000844279 00000 n 0000844435 00000 n 0000844593 00000 n 0000844750 00000 n 0000844919 00000 n 0000845075 00000 n 0000845245 00000 n 0000845415 00000 n 0000845589 00000 n 0000845857 00000 n 0000846125 00000 n 0000846285 00000 n 0000846436 00000 n 0000846594 00000 n 0000846751 00000 n 0000846906 00000 n 0000847057 00000 n 0000847210 00000 n 0000847364 00000 n 0000847519 00000 n 0000847678 00000 n 0000847818 00000 n 0000848028 00000 n 0000885581 00000 n 0000885901 00000 n 0000886101 00000 n 0000886741 00000 n 0000886914 00000 n 0000887063 00000 n 0000887210 00000 n 0000887377 00000 n 0000887544 00000 n 0000887692 00000 n 0000887841 00000 n 0000887995 00000 n 0000888164 00000 n 0000888320 00000 n 0000888475 00000 n 0000888635 00000 n 0000888794 00000 n 0000888948 00000 n 0000889102 00000 n 0000889261 00000 n 0000889420 00000 n 0000889572 00000 n 0000889730 00000 n 0000889887 00000 n 0000890050 00000 n 0000890218 00000 n 0000890376 00000 n 0000890532 00000 n 0000890689 00000 n 0000890836 00000 n 0000891005 00000 n 0000891171 00000 n 0000891331 00000 n 0000891491 00000 n 0000891647 00000 n 0000891801 00000 n 0000891958 00000 n 0000892129 00000 n 0000892286 00000 n 0000892439 00000 n 0000892590 00000 n 0000892749 00000 n 0000892900 00000 n 0000893056 00000 n 0000893216 00000 n 0000893376 00000 n 0000893550 00000 n 0000893708 00000 n 0000893859 00000 n 0000894006 00000 n 0000894153 00000 n 0000894300 00000 n 0000894447 00000 n 0000894601 00000 n 0000894755 00000 n 0000894915 00000 n 0000895075 00000 n 0000895223 00000 n 0000895371 00000 n 0000895526 00000 n 0000895685 00000 n 0000895825 00000 n 0000896023 00000 n 0000932403 00000 n 0000933099 00000 n 0000933249 00000 n 0000933397 00000 n 0000933570 00000 n 0000933731 00000 n 0000933889 00000 n 0000934051 00000 n 0000934211 00000 n 0000934375 00000 n 0000934538 00000 n 0000934694 00000 n 0000934848 00000 n 0000935002 00000 n 0000935153 00000 n 0000935312 00000 n 0000935467 00000 n 0000935620 00000 n 0000935771 00000 n 0000935923 00000 n 0000936075 00000 n 0000936228 00000 n 0000936379 00000 n 0000936537 00000 n 0000936694 00000 n 0000936840 00000 n 0000936995 00000 n 0000937148 00000 n 0000937315 00000 n 0000937471 00000 n 0000937626 00000 n 0000937777 00000 n 0000937936 00000 n 0000938091 00000 n 0000938246 00000 n 0000938415 00000 n 0000938575 00000 n 0000938735 00000 n 0000938883 00000 n 0000939041 00000 n 0000939201 00000 n 0000939353 00000 n 0000939509 00000 n 0000939683 00000 n 0000939857 00000 n 0000940006 00000 n 0000940180 00000 n 0000940353 00000 n 0000940504 00000 n 0000940655 00000 n 0000940807 00000 n 0000941062 00000 n 0000941316 00000 n 0000941571 00000 n 0000941736 00000 n 0000942023 00000 n 0000942309 00000 n 0000942595 00000 n 0000942842 00000 n 0000943088 00000 n 0000943335 00000 n 0000943491 00000 n 0000943648 00000 n 0000943804 00000 n 0000943959 00000 n 0000944118 00000 n 0000944258 00000 n 0000944432 00000 n 0000980793 00000 n 0000981065 00000 n 0000981231 00000 n 0000981403 00000 n 0000981560 00000 n 0000981707 00000 n 0000981855 00000 n 0000982087 00000 n 0000982319 00000 n 0000982462 00000 n 0000982612 00000 n 0000982767 00000 n 0000982926 00000 n 0000983066 00000 n 0000983229 00000 n 0000991268 00000 n 0000991844 00000 n 0000992613 00000 n 0000992796 00000 n 0000993024 00000 n 0000993201 00000 n 0000993601 00000 n 0000993804 00000 n 0000994346 00000 n 0000994640 00000 n 0000994708 00000 n 0000994885 00000 n 0000995086 00000 n 0000995557 00000 n 0000995850 00000 n 0000996273 00000 n 0000996613 00000 n 0001003799 00000 n 0001009082 00000 n 0001009244 00000 n 0001009433 00000 n 0001009632 00000 n 0001010219 00000 n 0001010419 00000 n 0001011089 00000 n 0001011258 00000 n 0001011467 00000 n 0001011830 00000 n 0001012122 00000 n 0001012192 00000 n 0001012394 00000 n 0001012955 00000 n 0001013120 00000 n 0001013286 00000 n 0001013345 00000 n 0001014603 00000 n 0001015799 00000 n 0001017029 00000 n 0001017606 00000 n 0001017657 00000 n 0001017708 00000 n 0001017757 00000 n 0001017806 00000 n 0001017855 00000 n 0001017904 00000 n 0001017953 00000 n 0001018003 00000 n 0001018053 00000 n 0001018103 00000 n 0001018153 00000 n 0001018204 00000 n 0001018255 00000 n 0001018306 00000 n 0001018357 00000 n 0001018408 00000 n 0001018459 00000 n 0001018510 00000 n 0001018561 00000 n 0001018612 00000 n 0001018663 00000 n 0001018714 00000 n 0001018765 00000 n 0001018816 00000 n 0001018867 00000 n 0001018918 00000 n 0001018969 00000 n 0001019020 00000 n 0001019071 00000 n 0001019122 00000 n 0001019173 00000 n 0001019224 00000 n 0001019275 00000 n 0001019326 00000 n 0001019377 00000 n 0001019428 00000 n 0001019479 00000 n 0001019530 00000 n 0001019581 00000 n 0001019632 00000 n 0001019683 00000 n 0001019734 00000 n 0001019785 00000 n 0001019836 00000 n 0001019887 00000 n 0001019938 00000 n 0001019989 00000 n 0001020040 00000 n 0001020091 00000 n 0001020142 00000 n 0001020193 00000 n 0001020244 00000 n 0001020295 00000 n 0001020346 00000 n 0001020397 00000 n 0001020448 00000 n 0001020499 00000 n 0001020550 00000 n 0001020601 00000 n 0001020652 00000 n 0001020703 00000 n 0001020754 00000 n 0001020805 00000 n 0001020856 00000 n 0001020907 00000 n 0001020958 00000 n 0001021009 00000 n 0001021060 00000 n 0001021111 00000 n 0001021162 00000 n 0001021213 00000 n 0001021264 00000 n 0001021315 00000 n 0001021366 00000 n 0001021417 00000 n 0001021468 00000 n 0001021519 00000 n 0001021570 00000 n 0001021621 00000 n 0001021672 00000 n 0001021722 00000 n 0001021772 00000 n 0001021823 00000 n 0001021874 00000 n 0001021925 00000 n 0001021976 00000 n 0001022027 00000 n 0001022078 00000 n 0001022129 00000 n 0001022180 00000 n 0001022231 00000 n 0001022282 00000 n 0001022333 00000 n 0001022384 00000 n 0001022435 00000 n 0001022486 00000 n 0001022537 00000 n 0001022588 00000 n 0001022639 00000 n 0001022690 00000 n 0001022741 00000 n 0001022792 00000 n 0001022843 00000 n 0001022894 00000 n 0001022945 00000 n 0001022996 00000 n 0001023047 00000 n 0001023098 00000 n 0001023149 00000 n 0001023200 00000 n 0001023251 00000 n 0001023302 00000 n 0001023353 00000 n 0001023404 00000 n 0001023455 00000 n 0001023506 00000 n 0001023557 00000 n 0001023608 00000 n 0001023659 00000 n 0001023710 00000 n 0001023761 00000 n 0001023812 00000 n 0001023863 00000 n 0001023914 00000 n 0001023965 00000 n 0001024016 00000 n 0001024067 00000 n 0001024118 00000 n 0001024169 00000 n 0001024220 00000 n 0001024271 00000 n 0001024322 00000 n 0001024373 00000 n 0001024424 00000 n 0001024475 00000 n 0001024526 00000 n 0001024577 00000 n 0001024628 00000 n 0001024679 00000 n 0001024730 00000 n 0001024781 00000 n 0001024832 00000 n 0001024883 00000 n 0001024934 00000 n 0001024985 00000 n 0001025036 00000 n 0001025087 00000 n 0001025138 00000 n 0001025189 00000 n 0001025240 00000 n 0001025291 00000 n 0001025342 00000 n 0001025393 00000 n 0001025444 00000 n 0001025495 00000 n 0001025546 00000 n 0001025597 00000 n 0001025648 00000 n 0001025699 00000 n 0001025750 00000 n 0001025801 00000 n 0001025852 00000 n 0001025903 00000 n 0001025954 00000 n 0001026005 00000 n 0001026056 00000 n 0001026107 00000 n 0001026158 00000 n 0001026209 00000 n 0001026260 00000 n 0001026311 00000 n 0001026362 00000 n 0001026413 00000 n 0001026464 00000 n 0001026515 00000 n 0001026566 00000 n 0001026617 00000 n 0001026668 00000 n 0001026719 00000 n 0001026770 00000 n 0001026821 00000 n 0001026872 00000 n 0001026923 00000 n 0001026974 00000 n 0001027025 00000 n 0001027076 00000 n 0001027127 00000 n 0001027178 00000 n 0001027229 00000 n 0001027280 00000 n 0001027331 00000 n 0001027382 00000 n 0001027433 00000 n 0001027484 00000 n 0001027535 00000 n 0001027586 00000 n 0001027637 00000 n 0001027688 00000 n 0001027739 00000 n 0001027790 00000 n 0001027841 00000 n 0001027892 00000 n 0001027943 00000 n 0001027994 00000 n 0001028045 00000 n 0001028096 00000 n 0001028147 00000 n 0001028198 00000 n 0001028249 00000 n 0001028300 00000 n 0001028351 00000 n 0001028402 00000 n 0001028453 00000 n 0001028504 00000 n 0001028555 00000 n 0001028606 00000 n 0001028657 00000 n 0001028694 00000 n 0001028719 00000 n 0001028782 00000 n 0001028919 00000 n 0001029028 00000 n 0001032516 00000 n trailer <> startxref 116 %%EOF %BeginExifToolUpdate 1470 0 obj << /Type /Metadata /Subtype /XML /Length 4834 >> stream Rui Wang Hongpeng Huang Chulin Yu Xuefeng Li Yang Wang Liangzhi Xie Wang R, Huang H, Yu C, Li X, Wang Y and Xie L (2024) Current status and future directions for the development of human papillomavirus vaccines. Front. Immunol. 15:1362770 Copyright 漏 2024 Wang, Huang, Yu, Li, Wang and Xie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. human papillomavirus vaccine prophylactic therapeutic antigens adjuvants formulation strategy Current status and future directions for the development of human papillomavirus vaccines human papillomavirus vaccine, prophylactic, therapeutic, antigens, adjuvants, formulation strategy True https://www.frontiersin.org/legal/copyright-statement endstream endobj 842 0 obj << /Keywords (human papillomavirus vaccine, prophylactic, therapeutic, antigens, adjuvants, formulation strategy) >> endobj 844 0 obj << /PageMode /UseOutlines /Names 847 0 R /Outlines 1444 0 R /Pages 838 0 R /OpenAction [ null /Fit ] /Threads 845 0 R /Type /Catalog /PageLabels 836 0 R /Metadata 1470 0 R >> endobj xref 0 1 0000000841 65535 f 841 2 0000000000 00001 f 0001054596 00000 n 844 1 0001054735 00000 n 1470 1 0001049667 00000 n trailer << /Size 1471 /Prev 116 /Root 844 0 R /ID [ <58EC4C73563EFA479E438A8963BD223B> ] /Info 842 0 R >> %EndExifToolUpdate 1049645 startxref 1054940 %%EOF